
<html lang="en"     class="pb-page"  data-request-id="8f746c5f-12ef-4eab-ae6c-ce1bbd2beca8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b00147;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-6;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Nitro-Group-Containing Drugs" /></meta><meta name="dc.Creator" content="Kunal  Nepali" /></meta><meta name="dc.Creator" content="Hsueh-Yun  Lee" /></meta><meta name="dc.Creator" content="Jing-Ping  Liou" /></meta><meta name="dc.Description" content="The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often c..." /></meta><meta name="Description" content="The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often c..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 8, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00147" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00147" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00147" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00147" /></link>
        
    
    

<title>Nitro-Group-Containing Drugs | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00147" /></meta><meta property="og:title" content="Nitro-Group-Containing Drugs" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0054.jpeg" /></meta><meta property="og:description" content="The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often categorized as a structural alert or a toxicophore, and evidence related to drugs containing nitro groups is rather contradictory. In general, drugs containing nitro groups have been extensively associated with mutagenicity and genotoxicity. In this context, efforts toward the structure–mutagenicity or structure–genotoxicity relationships have been undertaken. The current Perspective covers various aspects of agents that contain nitro groups, their bioreductive activation mechanisms, their toxicities, and approaches to combat their toxicity issues. In addition, recent advances in the field of anticancer, antitubercular and antiparasitic agents containing nitro groups, along with a patent survey on hypoxia-activated prodrugs containing nitro groups, are also covered." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00147"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00147">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-8/abseba.2021.7.issue-8/20210809/abseba.2021.7.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-15/accacs.2021.11.issue-15/20210806/accacs.2021.11.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-31/acsodf.2021.6.issue-31/20210810/acsodf.2021.6.issue-31.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-31/ascecg.2021.9.issue-31/20210809/ascecg.2021.9.issue-31.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-31/ancham.2021.93.issue-31/20210810/ancham.2021.93.issue-31.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-31/bichaw.2021.60.issue-31/20210810/bichaw.2021.60.issue-31.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-8/bomaf6.2021.22.issue-8/20210809/bomaf6.2021.22.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-29/cgeabj.2021.99.issue-29/20210809-01/cgeabj.2021.99.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-15/cmatex.2021.33.issue-15/20210810/cmatex.2021.33.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-15/enfuem.2021.35.issue-15/20210805/enfuem.2021.35.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-8/estlcu.2021.8.issue-8/20210810/estlcu.2021.8.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-8/jceda8.2021.98.issue-8/20210810/jceda8.2021.98.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-8/jctcce.2021.17.issue-8/20210810/jctcce.2021.17.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-15/joceah.2021.86.issue-15/20210806/joceah.2021.86.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-30/jpcafh.2021.125.issue-30/20210805/jpcafh.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-30/jpcbfk.2021.125.issue-30/20210805/jpcbfk.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-30/jpccck.2021.125.issue-30/20210805/jpccck.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-30/jpclcd.2021.12.issue-30/20210805/jpclcd.2021.12.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-8/jprobs.2021.20.issue-8/20210806/jprobs.2021.20.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-31/langd5.2021.37.issue-31/20210810/langd5.2021.37.issue-31.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-15/mamobx.2021.54.issue-15/20210810/mamobx.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-15/orlef7.2021.23.issue-15/20210806/orlef7.2021.23.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-15/orgnd7.2021.40.issue-15/20210809/orgnd7.2021.40.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00147&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00147&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00147&amp;href=/doi/10.1021/acs.jmedchem.8b00147" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2851-2893</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b01105" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Nitro-Group-Containing Drugs</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Kunal Nepali</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kunal Nepali</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kunal++Nepali">Kunal Nepali</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hsueh-Yun Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hsueh-Yun Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hsueh-Yun++Lee">Hsueh-Yun Lee</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jing-Ping Liou</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jing-Ping Liou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan.</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3258425e72465f471c5756471c4645"><span class="__cf_email__" data-cfemail="bbd1cbd7fbcfd6ce95dedfce95cfcc">[email protected]</span></a>. Phone: +886-2-2736-1661, extension 6130.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jing-Ping++Liou">Jing-Ping Liou</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3775-6405" title="Orcid link">http://orcid.org/0000-0002-3775-6405</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00147&amp;href=/doi/10.1021%2Facs.jmedchem.8b00147" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2851–2893</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 8, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 January 2018</li><li><span class="item_label"><b>Published</b> online</span>8 October 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 March 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00147" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00147</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2851%26pageCount%3D43%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKunal%2BNepali%252C%2BHsueh-Yun%2BLee%252C%2BJing-Ping%2BLiou%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D6%26contentID%3Dacs.jmedchem.8b00147%26title%3DNitro-Group-Containing%2BDrugs%26numPages%3D43%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2893%26publicationDate%3DMarch%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00147"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">10968</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">121</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00147" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Nitro-Group-Containing Drugs&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kunal&quot;,&quot;last_name&quot;:&quot;Nepali&quot;},{&quot;first_name&quot;:&quot;Hsueh-Yun&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Jing-Ping&quot;,&quot;last_name&quot;:&quot;Liou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;2851-2893&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00147&quot;},&quot;abstract&quot;:&quot;The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often categorized as a structural alert or a toxicophore, and evidence related to drugs containing nitro groups is rather contradictory. In general, drugs containing nitro groups have been extensively associated with mutagenicity and genotoxicity. In this context, efforts toward the structure–mutagenicity or structure–genotoxicity relationships have been undertaken. The current Perspective covers various aspects of agents that contain nitro groups, their bioreductive activation mechanisms, their toxicities, and approaches to combat their toxicity issues. In addition, recent advances in the field of anticancer, antitubercular and antiparasitic agents containing nitro groups, along with a patent survey on hypoxia-activated prodrugs containing nitro groups, are also covered.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00147&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00147" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00147&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00147" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00147&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00147" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00147&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00147&amp;href=/doi/10.1021/acs.jmedchem.8b00147" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00147" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00147" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (13 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00147%26sid%3Dliteratum%253Aachs%26pmid%3D30295477%26genre%3Darticle%26aulast%3DNepali%26date%3D2019%26atitle%3DNitro-Group-Containing%2BDrugs%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D6%26spage%3D2851%26epage%3D2893%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/jmcmar.2019.62.issue-6/20190328/jmcmar.2019.62.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0054.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0054.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often categorized as a structural alert or a toxicophore, and evidence related to drugs containing nitro groups is rather contradictory. In general, drugs containing nitro groups have been extensively associated with mutagenicity and genotoxicity. In this context, efforts toward the structure–mutagenicity or structure–genotoxicity relationships have been undertaken. The current Perspective covers various aspects of agents that contain nitro groups, their bioreductive activation mechanisms, their toxicities, and approaches to combat their toxicity issues. In addition, recent advances in the field of anticancer, antitubercular and antiparasitic agents containing nitro groups, along with a patent survey on hypoxia-activated prodrugs containing nitro groups, are also covered.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82620" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82620" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. It possesses a strong electron attracting ability that creates localized electron-deficient sites within molecules and interacts with biological nucleophiles present in living systems, such as proteins, amino acids, nucleic acids, and enzymes. The interaction can occur by nucleophilic addition and electron transfer involving oxidation and reduction, or also simply by molecular complexation, to induce desired or undesired biological changes.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Owing to this, numerous medicinal chemistry campaigns have been initiated to investigate compounds containing nitro groups. As such, drugs containing nitro groups have a long history of use as antineoplastic,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> antibiotic,<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> and antiparasitic agents,<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> as well as tranquilizers, fungicides, insecticides, and herbicides.<a onclick="showRef(event, 'ref2 ref10'); return false;" href="javascript:void(0);" class="ref ref2 ref10">(2,10)</a> Moreover, nitro groups can undergo reduction and may serve as prodrugs due to their bioactivation by enzymatic reduction, generating reactive species and ultimately inducing biological effects. It is well established that some nitroaromatic or nitroheteroaromatic compounds can induce therapeutic effects via redox cycling of single electron reduction by different flavoenzymes or from the alkylation of DNA and/or other cellular nucleophiles by the products of their bioreductive activation process.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Recent publications indicate that the majority of efforts of medicinal chemists in the past decade have been directed toward the exploration of compounds containing nitro groups as anticancer agents, antitubercular agents, and antiparasitic agents. These compounds induce their cell-killing effects by diverse mechanisms, such as topoisomerase inhibition,<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12−15)</a> histone deacetylase inhibition,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> DNA alkylation,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> or tubulin polymerization inhibition,<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> and have significantly demonstrated hypoxia-induced effects that are attributed to their bioreductive activation potential.<a onclick="showRef(event, 'ref18 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref18 ref21 ref22 ref23 ref24">(18,21−24)</a> The antitubercular potential of some successful clinical or preclinical drugs also relies on their bioactivation, and many drugs are undergoing detailed preclinical investigations or are being examined in clinical trials.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Nitroimidazole is one such versatile heterocyclic moiety that has been widely employed to exert diverse biological effects and has often been explored as a bioreductive arm.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26−28)</a> This is clearly evidenced by the number of clinically approved nitroimidazole-containing compounds, mostly for infectious diseases, and the large repository of such compounds endowed with exciting and optimistic preclinical potential.<a onclick="showRef(event, 'ref29 ref30 ref31 ref33 ref34 ref35 ref36 ref37 ref38 ref40'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref33 ref34 ref35 ref36 ref37 ref38 ref40">(29−39)</a> Not only the research literature but also the patent literature emphasizes the effects of compounds that contain nitro groups and are mediated through bioreduction.<a onclick="showRef(event, 'ref41 ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref53'); return false;" href="javascript:void(0);" class="ref ref41 ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref53">(40−52)</a></div><div class="NLM_p">Despite these wide applications, it has also been well evidenced that drugs containing nitro groups can induce severe toxicity, and this is indubitably the reason in many cases for their being avoided. Concomitantly, selective toxicity with nitroaromatic and heteroaromatic compounds also forms the basis of chemotherapy that results in the poisoning of bacteria, parasites, or tumor cells without harming the host organism or normal cells.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> For this reason, medicinal chemists have been constantly striving and making great efforts to explore the bioactive potential of nitroaromatic and heteroaromatic compounds in diverse applications, from the treatment of parasitic infections to cancer and in many enzyme expression-dependent diseases. Overall, the issues related to such agents are indeed contradictory, as the nitro group is considered as both a pharmacophore, or an integral part of the pharmacophore, and a toxicophore or a structural alert.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(53)</a></div><div class="NLM_p last">In this Perspective, we focus on various aspects of agents containing nitro groups and discuss their toxicity issues and their role as prodrugs. This compilation emphasizes the bioreductive mechanisms leading to activation of nitro compounds, FDA-approved drugs containing nitro groups, their toxicities, and a clinical update, along with a section regarding recent developments in the field of anticancer, antitubercular, and antiparasitic agents that contain nitro groups. A library of agents containing nitro groups that have demonstrated their bioactive potential as anticancer, antitubercular, or antiparasitic potential in preclinical and preliminary screening assays is presented to create awareness about those structures rather than merely to treat them as missed opportunities. This Perspective also covers a recent patent survey and includes a discussion of the approaches used to combat the toxicity and selective targeting by nitro compounds.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Drugs Containing Nitro Groups: Current Scenario, Toxicity Issues, and Bioreductive Therapy</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Toxicity has always been an issue with drugs, especially those containing nitro groups, and carcinogenicity, hepatotoxicity, mutagenicity, and bone marrow suppression have been the major adverse effects encountered with such agents.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(54)</a> Owing to this, these agents are often considered by researchers as structural alerts, which blocks exploration of their therapeutic utility.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(55)</a></div><div class="NLM_p">Nitro compounds require enzymatic reduction to induce the therapeutic and cytotoxic effects, and this reduction is usually mediated by nitroreductases using flavin mononucleotide (FMN) or flavin adenine dinucleotide (FAD) as prosthetic groups and nicotinamide adenine dinucleotide (NADH) or nicotinamide adenine dinucleotide phosphate (NADPH) as reducing agents.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(54)</a> A generalized sequence for the bioreductive pathway involves the formation of a nitroso derivative, a nitro radical anion, a nitroxyl radical, hydroxylamine, and a primary amine. The complete pathway is shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. Toxicity issues associated with nitro compounds have been attributed to each of these intermediates, but hydroxylamine derivatives are particularly responsible for methemoglobinemia, whereas the cumulative effects of the nitro radical anion, nitroso derivatives, or esterified hydroxylamine (e.g., sulfate derivatives) are held responsible for the mutagenic and carcinogenic activities. Superoxide anions, hydrogen peroxide, and hydroxyl radicals formed during the redox cycling of the nitro radical anion may also lead to carcinogenicity.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(54)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mutagenic pathway of nitroarenes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Currently, drugs containing nitro groups are being investigated in detail as a part of a drug repurposing program for previously failed drugs and currently used clinical candidates, along with simultaneous efforts to develop new chemical classes. It is highly probable that we will find new treatments based on existing therapeutic drugs or previously failed clinical candidates, as the toxicity data in humans are already available.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(56)</a> As a part of a drug repurposing program to address the urgent need for the development of cost-effective drugs for visceral leishmaniasis, the antitubercular drug delamanid (OPC- 67683, <b>13</b>) was investigated and found to be a potent inhibitor of <i>Leishmania donovani</i>, both in vitro and in vivo. The study revealed that delamanid at 30 mg/kg induced a sterile cure in the mouse model of visceral leishmaniasis. Further exploration of the mechanistic insights revealed the rapid metabolism of delamanid by parasites via an enzyme that is distinct from the nitroreductase activating fexinidazole (<b>9</b>). Overall, the results of the study found that delamanid presents enough promise to be repurposed as an oral therapy for VL.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(57)</a> Furthermore, structural engineering investigations on delamanid have led to the identification of DNDI-0690 and DNDI-2908 as promising agents that are endowed with significant potential for the treatment of VL. A recent study indicated that DNDI-0690 shows promising in vivo efficacy, better solubility, and reduced cardiotoxicity. The toxicity evaluation study further found that DNDI-0690 is a promising preclinical candidate for the treatment of VL.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(58)</a> DNDI-VL-2098 is another delamanid analog that was identified as a VL preclinical candidate. DNDI-VL-2098 was found to possess potent submicromolar in vitro activity in a macrophage amastigote model against various <i>L. donovani</i> strains and demonstrated substantial in vivo activity in a HU3/BALB/c mouse model.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(59,60)</a> Identification of novel bromo- and extra-terminal domain (BET) inhibitors by the drug repurposing of nitroxoline is also a motivating example.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(61)</a> Other investigations on drugs that contain nitro groups involve the bioisosteric replacement of the nitro group in an attempt to solve the toxicity issues. However, this approach has yielded contradictory results, in terms of enhancing the bioactivity and attenuating the toxicity. The investigation of flutamide exemplifies a case where the strategy of bioisosteric replacement of the nitro group with a cyano group was attempted, anticipating a decreased cytotoxic potential of the drug while preserving its antiandrogen activity. The replacement was anticipated to attenuate the reduction of the nitroaromatic group, simultaneously enabling the retention of a strong electron withdrawing group. The results were quite optimistic, as the cyano analog displayed equivalent anti-androgen activity in M12 AR cells to that of flutamide.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(62)</a> However, a recent study on niclosamide (an FDA-approved anthelmintic agent) did not yield favorable results, in which the nitro group was replaced with groups such as acetyl, benzoyl, methyl sulfone, or amide. The replacements led to significant declines in activity, as evidenced in the Wnt-3-A-stimulated TOP flash assay.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(63)</a> Furthermore, this strategy has been extensively attempted at the preclinical level by researchers; often, the analogs lacking the nitro group, the des nitro analogs (anticancer, antitubercular, and antiparasitic agents), were found to have a diminished activity potential. This is discussed in <a class="ref internalNav" href="#sec4" aria-label="sections 4">sections 4</a> and <a class="ref internalNav" href="#sec5" aria-label="5">5</a>. Thus, it can be concluded that the results of bioisosteric replacement studies of the nitro group have demonstrated fluctuating outcomes in the context of the modulation of activity and toxicity. In summary, reinvestigations of some approved drugs using structure–activity relationship studies, redesigning the dosage regimens, and evaluating the drug in a combination therapy may prove to be beneficial. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> present several representative examples of such drugs containing nitro groups and their clinical updates. The structures covered represent the drugs containing nitro groups that either have been employed as leads for the design of new therapeutics or have been evaluated with respect to different indications, combinations, dosage regimens, or formulations. Notably, even some of the withdrawn drugs have been the subject of renewed clinical interest (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00147/suppl_file/jm8b00147_si_001.pdf" class="ext-link">Table 1S, Supporting Information</a>), which may revive their utility.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Drugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Drugs Containing Nitro Groups and Their Associated Clinical Updates</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">drug name</th><th class="colsep0 rowsep0" align="center">disease/use/indication</th><th class="colsep0 rowsep0" align="center">toxicities/drug effects</th><th class="colsep0 rowsep0" align="center">year</th><th class="colsep0 rowsep0" align="center">clinical studies</th><th class="colsep0 rowsep0" align="center">updates and other relevant information</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Azomycin (<b>1</b>)</td><td class="colsep0 rowsep0" align="left">Antimicrobial antibiotic produced by a strain of Nocardia mesenterica</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1950</td><td class="colsep0 rowsep0" align="left">Cervical cancer, renal cancer (NCT00588276)</td><td class="colsep0 rowsep0" align="left">Has been employed as a lead for the design of nitroimidazole-based drugs.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(72)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Nifurtimox(<b>2</b>)</td><td class="colsep0 rowsep0" align="left">Chagas disease</td><td class="colsep0 rowsep0" align="left">Neurological</td><td class="colsep0 rowsep0" align="left">1965</td><td class="colsep0 rowsep0" align="left">Refractory or relapsed neuroblastoma or medulloblastoma (NCT00601003)</td><td class="colsep0 rowsep0" align="left">Is the only available drug in use for the treatment of Chagas disease other than benznidazole.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref75 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref77">(73−76)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Human African trypanosomiasis (NCT01685827)</td><td class="colsep0 rowsep0" align="left">Is a component of nifurtimox–eflornithine combination therapy for human African trypanosomiasis (HAT).</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Benznidazole (<b>3</b>)</td><td class="colsep0 rowsep0" align="left">Chagas disease</td><td class="colsep0 rowsep0" align="left">Hepatotoxicity, peripheral neuropathy, and angioedema</td><td class="colsep0 rowsep0" align="left">1971</td><td class="colsep0 rowsep0" align="left">Dosage regimens and chronic Chagas disease (NCT0238635, NCT0012391, NCT01549236)</td><td class="colsep0 rowsep0" align="left">Accelerated approval was granted for benznidazole for the treatment of Chagas disease in children 2–12 years of age by the FDA (August 29, 2017).</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref75 ref76 ref77 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref77 ref78 ref79">(73−78)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Metronidazole (<b>4</b>)</td><td class="colsep0 rowsep0" align="left">Antibiotic and antiprotozoal</td><td class="colsep0 rowsep0" align="left">Anticipated to be a human carcinogen</td><td class="colsep0 rowsep0" align="left">1960</td><td class="colsep0 rowsep0" align="left">Safety and tolerability studies (NCT02392026)</td><td class="colsep0 rowsep0" align="left">PYLERA, a triple-combination single-capsule product comprising tetracycline, metronidazole, and bismuth, is being developed by Aptalis as a first-line therapy for the eradication of <i>Helicobacter pylori</i> infection.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref4 ref31 ref74 ref75 ref76 ref80'); return false;" href="javascript:void(0);" class="ref ref4 ref31 ref74 ref75 ref76 ref80">(4,31,73−75,79)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>Clostridium difficile</i> diarrhea (NCT02200328)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Bacterial vaginosis (NCT03099408)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Secnidazole (<b>5</b>)</td><td class="colsep0 rowsep0" align="left">Antiprotozoal agent</td><td class="colsep0 rowsep0" align="left">Vulvo-vaginal candidiasis</td><td class="colsep0 rowsep0" align="left">1960–1970</td><td class="colsep0 rowsep0" align="left">Vaginal discharge (NCT02111629)</td><td class="colsep0 rowsep0" align="left">Phase III evaluation of OSTERVA (an oral taste-masked formulation of secnidazole developed by Ethypharm) for bacterial vaginosis is ongoing in the U.S.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref5 ref74 ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref5 ref74 ref75 ref76">(5,73−75)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Bacterial vaginosis (NCT02452866, (NCT02418845)</td><td class="colsep0 rowsep0" align="left">A single-dose oral granule formulation of secnidazole (SOLOSEC) is being developed by Lupin for bacterial vaginosis. The agent obtained approval in the U.S. for this indication.</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tinidazole (<b>6</b>)</td><td class="colsep0 rowsep0" align="left">Antiparasitic</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1972</td><td class="colsep0 rowsep0" align="left">Bacterial vaginosis (NCT0033463, NCT00229216, NCT00324142)</td><td class="colsep0 rowsep0" align="left">Tinidazole (TINDAMAX) received U.S. FDA approval on May 24, 2007, as announced by Mission Pharmacal for the treatment of bacterial vaginosis.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref75 ref76 ref82'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref82">(73−75,80)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Giardiasis (NCT02942485)</td><td class="colsep0 rowsep0" align="left">Already marketed in the U.S. for the treatment of trichomoniasis. This approval was attributed to the results of a randomized, placebo-controlled, double-blind, multicenter phase III trial.</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Crossover bioequivalence study (NCT01591889)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ornidazole (<b>7</b>)</td><td class="colsep0 rowsep0" align="left">Antiprotozoal</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1977</td><td class="colsep0 rowsep0" align="left">Elective colorectal surgery (NCT02618720)</td><td class="colsep0 rowsep0" align="left">Levornidazole (a levo-isomer of ornidazole) for anaerobic bacterial infections has been developed by Nanjing Sanhome Pharmaceutical.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref75 ref76 ref83'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref83">(73−75,81)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Misonidazole (<b>8</b>)</td><td class="colsep0 rowsep0" align="left">Radiosensitizer</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1974</td><td class="colsep0 rowsep0" align="left">Colorectal cancer (NCT00574353)</td><td class="colsep0 rowsep0" align="left">Under investigation in clinical trial NCT00038038 (Assessment of Head and Neck Tumor Hypoxia Using <sup>18</sup>F-Fluoromisonidazole).</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76">(73−75)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Induces sensitization in normally resistant hypoxic tumor cells</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Prostate adenocarcinoma (NCT01898065)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Malignant glioma (NCT01868906)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Adult glioblastoma (NCT00902577)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Fexinidazole (<b>9</b>)</td><td class="colsep0 rowsep0" align="left">HAT, VL, and Chagas disease</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1970–1980</td><td class="colsep0 rowsep0" align="left">Visceral leishmaniasis (NCT01980199)</td><td class="colsep0 rowsep0" align="left">As a part of drugs for neglected diseases initiative (DNDi, Switzerland), sulfone derivative of fexinidazole is being developed for the treatment of visceral leishmaniasis.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref75 ref76 ref84'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref84">(73−75,82)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">African trypanosomiasis (NCT03025789, NCT02169557, NCT02184689, NCT01685827, NCT02571062)</td><td class="colsep0 rowsep0" align="left">Fexinidazole sulfone, an active metabolite of fexinidazole, has shown promise to decrease the time required to attain effective blood levels of the drug.</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Chagas disease (NCT02498782)</td><td class="colsep0 rowsep0" align="left">Being evaluated by Sanofi for the oral therapy of trypanosomiasis (DNDi; Switzerland).</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pimonidazole (<b>10</b>)</td><td class="colsep0 rowsep0" align="left">Radiation sensitizer</td><td class="colsep0 rowsep0" align="left">Transient central nervous system syndrome</td><td class="colsep0 rowsep0" align="left">1970–1980</td><td class="colsep0 rowsep0" align="left">Refractory pulmonary tuberculosis (NCT00374517)</td><td class="colsep0 rowsep0" align="left">Under investigation for the diagnostic of prostate cancer and head and neck cancer.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref75 ref76 ref85'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref85">(73−75,83)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Tongue cancer (NCT03181035)</td><td class="colsep0 rowsep0" align="left">Has been categorized as an oxygen-mimetic radiosensitizer.</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Prostate cancer (NCT02095249)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Melanoma (NCT01992042)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Megazol (<b>11</b>)</td><td class="colsep0 rowsep0" align="left">Used to treat protozoan infections</td><td class="colsep0 rowsep0" align="left">Mutagenic and genotoxic</td><td class="colsep0 rowsep0" align="left">1960–1970</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">More effective than benznidazole therapy for Chagas disease.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref74 ref86 ref87">(73,84,85)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mutagenicity and genotoxicity have hindered its clinical applicability.</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Venetoclax (<b>12</b>)</td><td class="colsep0 rowsep0" align="left">Used for the treatment of chronic lymphocytic leukemia (CLL)</td><td class="colsep0 rowsep0" align="left">Tumor lysis syndrome</td><td class="colsep0 rowsep0" align="left">U.S. FDA granted breakthrough therapy designation to venetoclax for CLL in 2015</td><td class="colsep0 rowsep0" align="left">Follicular lymphoma, Non-Hodgkin’s lymphoma, lollicular non-Hodgkin’s lymphoma (NCT03113422)</td><td class="colsep0 rowsep0" align="left">Being evaluated in a phase III combination study with rituximab (phase III) in patients of relapsed/refractory chronic lymphocytic leukemia.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref75 ref76 ref88'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref88">(73−75,86)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Relapsed or refractory malignancies (NCT03236857, NCT02966756, NCT02756897, NCT02980731)</td><td class="colsep0 rowsep0" align="left">Roche is conducting CLL clinical trials, and recent results revealed that the tested combination prolonged the progression-free survival in comparison to the combination of bendamustine with rituximab.</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Delamanid (OPC- 67683, <b>13</b>)</td><td class="colsep0 rowsep0" align="left">A mycolic acid biosynthesis inhibitor endowed with highly potent activity against TB, including MDR-TB</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Approved for medical use in 2014 in Europe, Japan, and South Korea</td><td class="colsep0 rowsep0" align="left">Safety, tolerability, and efficacy studies (NCT02573350)</td><td class="colsep0 rowsep0" align="left">In combination studies with standard drugs ethambutol, isoniazid, pyrazinamide, rifampicin, aminoglycoside antibiotics, and quinolones (phase II clinical trials), it was observed that the healing rates (measured as sputum culture conversion) were substantially better in patients who additionally took delamanid.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref75 ref76 ref89'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref89">(73−75,87)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Multidrug-resistant tuberculosis (NCT01424670)</td><td class="colsep0 rowsep0" align="left">Commercialization rights were acquired by Mylan, which was granted an exclusive license by Otsuka on August 24, 2017, for prioritizing access to delamanid (Deltyb) in South Africa and India.</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Pulmonary tuberculosis (NCT00401271)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Multidrug-resistant refractive tuberculosis (NCT01131351).</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Niclosamide (<b>14</b>)</td><td class="colsep0 rowsep0" align="left">Used for the treatment of tapeworm infections</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1982</td><td class="colsep0 rowsep0" align="left">Metastatic prostate cancer (NCT02532114)</td><td class="colsep0 rowsep0" align="left">Reported to suppress the Wnt/β-catenin pathways and the mTOR/STAT3 pathway.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref64 ref74 ref75 ref76 ref90'); return false;" href="javascript:void(0);" class="ref ref64 ref74 ref75 ref76 ref90">(63,73−75,88)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">In rheumatoid arthritis (NCT03160001)</td><td class="colsep0 rowsep0" align="left">Preclinical trials attempting to replace the nitro group of niclosamide have yielded analogs with mixed results.</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Resectable colon cancer (NCT02687009)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Entacapone (<b>15</b>)</td><td class="colsep0 rowsep0" align="left">Used for the treatment of Parkinson’s disease</td><td class="colsep0 rowsep0" align="left">Orthostatic hypotension, severe rhabdomyolysis</td><td class="colsep0 rowsep0" align="left">1999</td><td class="colsep0 rowsep0" align="left">Parkinson’s disease (NCT00373087, NCT00391898, NCT00237263)</td><td class="colsep0 rowsep0" align="left">Approval from the European Commission for the marketing of entacapone was received by Orion Pharma and Novartis in Europe.</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74 ref75 ref76 ref91'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref91">(73−75,89)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">A COMT inhibitor</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Chizophrenia (NCT00192855)</td><td class="colsep0 rowsep0" align="left">Entacapone has been launched by Novartis in the U.S. (Novartis, Oct 1999), Canada (Novartis, Oct 2001), and Russia (IMS, Feb 2009).</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Methamphetamine abuse (NCT02058966)</td><td class="colsep0 rowsep0" align="left">It was launched by Orion Pharma in Russia in Feb 2009.</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_p">The risk of mutagenicity is one of the prime reasons why nitroarenes are less preferred in the area of drug design. The nitro group and its location on aromatic rings influence the DNA binding and mutagenic profile of an aromatic compound. It has widely been suggested that nitro reduction plays a critical role in mutagenesis, as major DNA adducts formed with nitroaromatics have been isolated and characterized. However, there is a difference in their rates of formation and in the sites at which they may be preferentially introduced. There is a characteristic signature of mutagenic specificity associated with each mutagen, and thus they exert differential mutagenic effects.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(64)</a> At the same time, not every drug containing a nitro group is mutagenic, and the antitubercular drug discovery field exemplifies this. Delamanid (<b>13</b>), BTZ043 (<b>18</b>), and pretomanid (PA-824, <b>24</b>) represent antitubercular drugs in clinical development that have not been found to be mutagenic.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(65)</a> Numerous studies are being conducted to solve the mutagenicity issue of drugs containing nitro groups. An interesting study aimed at mitigating the mutagenicity of nitro compounds was conducted by Landge et al.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(66)</a> The investigation led to the identification of benzothiazole-based compounds containing nitro groups that were nonmutagenic and demonstrated improved safety profiles. Electronic factors and the appropriate positioning of substituents in the vicinity of the nitro group (stereoelectronic factors) were found to be critical in modulating the mutagenic profile of the compounds.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(66)</a> Recently, structure–genotoxicity relationship studies were carried out by Shamovsky et al. for aromatic amines. The investigation was based on a clear understanding that activation of ArNH<sub>2</sub> generally is initiated with N-hydroxylation by P450 enzymes (CYP1A2). The same pathway is followed by nitroarenes after undergoing nitroreduction by a bacterial nitroreductase to hydroxylamines. Further, the generation of nitrenium ions by the heterolytic dissociation of hydroxylamines and their esters is catalyzed by protonation under acidic conditions. It was concluded that structural alterations in ArNH<sub>2</sub> moieties enabling the disruption of the geometric compatibility with CYP1A2 either hinder the proton abstraction or strongly destabilize the nitrenium ion, thus preventing genotoxicity. The authors continued their investigations on the mechanistic aspects of N-hydroxylation by P450 enzymes leading to mutagenicity and deduced logical strategies to avoid genotoxicity issues by hindering N-hydroxylation.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(67)</a> It is well-known that hydroxylamino, nitro, and nitroso groups are able to generate amine groups by metabolic conversion. Moreover, the formation of <i>N</i>-hydroxylamines by microsomal and cytosolic enzyme-catalyzed reduction is also responsible for the initial activation of nitroaromatic hydrocarbons. In this context, microsomal nitroreduction also appears to depend on the cytochrome P-450 complex.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(68)</a> Thus, the results of these structure–genotoxicity studies can be of utility for the class of compounds containing nitro groups, which are essentially masked amines. Seger et al. also explored the CYP-mediated N-hydroxylation of primary and secondary amines and deduced that the hydrogen abstraction mechanism is preferred over a direct oxygen transfer mechanism. Their results could be quite useful in predicting those compounds that are likely to be N-hydroxylated by CYPs.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(69)</a> Another study was recently conducted by Boechat et al. to evaluate a series of nitroimidazoles for genotoxicity (the comet assay) and mutagenicity (the Salmonella/microsome assay). The results of this study indicated that the placement of a nitro group at C-4 and a −CH<sub>3</sub> group at C-2 in nitroimidazoles diminished the genotoxic effects.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(70)</a> In view of these optimistic results, several programs to establish the structure–genotoxicity and mutagenicity relationship for drugs containing nitro groups must be conducted.</div><div class="NLM_p">Overall, the toxicities associated with drugs containing nitro groups have been extensively reported, but several other chemotherapeutics also have similar issues. Several drugs that do not contain nitro groups have been withdrawn due to these issues.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(71)</a> The evidence clearly indicates the association of toxicity issues with most chemotherapeutics, but it is also clearly evident that toxicity issues are far more intensified in the case of drugs containing nitro groups. In fact, the understanding of drugs containing nitro groups is somewhat better and more clarified, as the reasons for the toxicities attributed to their uncontrolled bioactivation are well-known. Thus, the available information could be employed as a tool with which to solve the issues of associated mutagenicity and genotoxicity.</div><div class="NLM_p">The term “bioreductive therapy” depends on enzyme-mediated reduction, which converts a nontoxic prodrug into a relatively cytotoxic reduced drug. This therapy can be utilized for attaining tumor tissue selectivity via the assistance of endogenous reductases that either are inhibited by oxygen or have the ability to metabolize the prodrug to a metabolite, a transient intermediate that can be back-scavenged by oxygen. This phenomenon laid the foundation for the design of selective cancer chemotherapeutic agents, particularly those directed toward solid tumors, which have a diminished oxygen supply, with compounds capable of undergoing anaerobic reduction to a cytotoxin anticipated to exert higher cell killing effects toward hypoxic tumor cells in comparison to oxygenated normal tissues.<a onclick="showRef(event, 'ref92 ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref92 ref93 ref94 ref95">(90−93)</a> In this view, the design of hypoxia-activated drugs or prodrugs appears to be an immediate need, and drugs containing nitro groups are the class most sought after, having been well explored mechanistically.</div><div class="NLM_p">Nitroaryl/heteroaryl-based compounds have demonstrated an immense potential, both as bioreductive components incorporated in the chemical architecture of the bioactive molecules and as triggers capable of inducing fragmentation. Numerous examples, such as PR-104A (<b>16</b>),<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(94)</a> TH4000 (<b>17</b>),<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(95)</a> BTZ-403 (<b>18</b>),<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(96,97)</a> pretomanid (<b>24</b>),<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(98)</a> SN-38 (<b>27</b>),<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(99)</a> CB-1954 (<b>25</b>),<a onclick="showRef(event, 'ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref102 ref103">(100,101)</a> and TH-302 (<b>26</b>),<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(102)</a> stand out as comprehensively explored bioreductive agents, while the concept has been expanded and applied to other established chemotherapeutic agents, such as paclitaxel prodrug (<b>19</b>),<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(103)</a> nitrochlormethylbenzinidazoles (nitroCBI, <b>20</b>),<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(104)</a> nitrobenzylphosphoramide mustards (<b>21</b>),<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(105)</a> CH-01 (<b>23</b>),<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(106)</a> KS-119 (<b>28</b>),<a onclick="showRef(event, 'ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref109 ref110">(107,108)</a> and O6-benzylguanine prodrugs (<b>22</b>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> with results indicating optimistic outcomes. These agents have demonstrated a promising preclinical potential and are undergoing clinical trials for diverse tumor types. <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> shows the structures, and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>–<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a><named-content content-type="anchor" rid="fig5" type="simple"></named-content><named-content content-type="anchor" rid="fig6" type="simple"></named-content><named-content content-type="anchor" rid="fig7" type="simple"></named-content><named-content content-type="anchor" rid="fig8" type="simple"></named-content><named-content content-type="anchor" rid="fig9" type="simple"></named-content><named-content content-type="anchor" rid="fig10" type="simple"></named-content><named-content content-type="anchor" rid="fig11" type="simple"></named-content><named-content content-type="anchor" rid="fig12" type="simple"></named-content><named-content content-type="anchor" rid="fig13" type="simple"></named-content><named-content content-type="anchor" rid="fig14" type="simple"></named-content><named-content content-type="anchor" rid="fig15" type="simple"></named-content><named-content content-type="anchor" rid="fig16" type="simple"></named-content>represent the bioreductive metabolic pathway of these agents. <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> presents a brief overview of some selected nitroaryl/heteroaryl-based bioreductive agents that are being examined at the clinical stage or are undergoing preclinical evaluation. In view of the aforementioned evidence, the nitroaryl- and nitroheteroaryl-based compounds appear to be logical and probable candidates for use in the development of bioreductive prodrugs. Thus, O’Connor et al., while working on bioreductive prodrugs of (1-methyl-2-nitro-1<i>H</i>-imidazol-5-yl)methanol, proposed various strategies for attaching the bioreductive nitro group to a range of functionalities by methods such as alkylation of nitrobenzyl halides, esterification of nitroaroyl halides, reductive amination with nitrobenzldehydes, and carbonate/carbamate formation of nitrobenzyl carbonobromidates using alcohols and amines. Their attempts clarified many aspects of the design of molecularly targeted hypoxia-activated prodrugs, as the study revealed that the point of attachment of the bioreductive group is crucial for attaining the required difference in activity under aerobic and anaerobic conditions. The authors also emphasized the desired inactivity of the unreduced form in comparison to the active compounds generated after fragmentation.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(109)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Agents containing nitro groups with bioreductive potential.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Bioreductive activation of PR104.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Bioreductive activation of TH-4000.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Bioreductive activation of BTZ-043.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Bioreductive activation of paclitaxel prodrug.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Bioreductive activation of nitroCBI as hypoxia activated prodrug.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Bioreductive activation of nitrobenzylphosphoramide mustards.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Bioreductive activation of 4-nitrobenzyloxycarbonyl derivatives of O6-benzylguanine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Bioreductive activation of protected chk1 inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Bioreductive activation of PA-824.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Bioreductive activation of CB-1954.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Bioreductive activation of TH-302.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Bioreductive activation of SN-38 prodrug activated via enzymatic metabolism under hypoxic conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Bioreductive activation of KS119 prodrug activated via enzymatic metabolism under hypoxic conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Nitro-Group-Containing Agents with Bioreductive Potential and Their Clinical/Preclinical Update</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">clinical/preclinical update</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PR-104 (<b>16</b>)</td><td class="colsep0 rowsep0" align="left">Solid tumors (phase 1, NCT00616213, NCT00349167, NCT00459836, NCT01358227).</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tarloxotinib (TH-4000, <b>17</b>)</td><td class="colsep0 rowsep0" align="left">Improves selectivity and reduces some of the toxicities observed with existing EGFR TKIs.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(95)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BTZ043 (<b>18</b>)</td><td class="colsep0 rowsep0" align="left">Has been employed as a lead molecule for several preclinical investigations.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(96,97)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">Paclitaxel prodrug (<b>19</b>)</td><td class="colsep0 rowsep0" align="left">1. The prodrug releases paclitaxel after reduction and subsequent 1,6-elimination or 1,8-elimination.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2. The prodrug exhibits stability in buffer.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3. Prodrug exhibited diminished cytotoxic profile in aerobic cytotoxicity assays.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(103)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">Nitrochloromethylbenzindolines (NitroCBI, <b>20</b>)</td><td class="colsep0 rowsep0" align="left">1. Efficiently and selectively metabolized to the aminoCBI.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2. Displayed selective cytotoxicity under hypoxic conditions in several cell lines.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3. Hypoxic cytotoxicity ratios of 275 and 330 in Skov3 and HT29 human tumor cell lines.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4. Demonstrates activity against hypoxic tumor cells in a human tumor xenograft in vivo.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(104)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">Nitrobenzylphosphoramide mustards (<b>21</b>)</td><td class="colsep0 rowsep0" align="left">1. The prodrugs exhibit low IC<sub>50</sub> and the high selectivity toward <i>E</i>. <i>coli</i> nitroreductase-expressing cells.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2. Prodrugs exhibit low cytotoxicity before reduction and release the phosphoramide mustard upon bioreduction.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3. Also exhibits good bystander effects in NTR-expressing cells.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(105)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">4-Nitrobenzyloxycarbonyl derivatives of O6-benzylguanine (<b>22</b>)</td><td class="colsep0 rowsep0" align="left">1. Induced preferential release of the AGT inhibitor O6-BG under hypoxia.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2. The prodrug demonstrated significant enhancement on laromustine cytotoxicity under hypoxic conditions with little or negligible effects under aerobic conditions.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">CH-01 (<b>23</b>)</td><td class="colsep0 rowsep0" align="left">1. Selectively inhibits Chk1/Aurora A in hypoxic conditions.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2. Induces substantial loss of viability in the cancer cell lines tested.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3. Demonstrates the potential for the bioreductive release of cancer chemotherapeutics.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(106)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">Pretomanid (<b>24</b>)</td><td class="colsep0 rowsep0" align="left">1. Safety and tolerability studies (phase1, NCT03202693, completed).</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2. Bioavailability and pharmacokinetics study (phase1, NCT01828827, completed).</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3. Pulmonary tuberculosis (phase 2, NCT00567840, completed).</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4. Drug resistant pulmonary tuberculosis (phase 3, NCT02333799 NCT00567840, recruiting).</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">(5-[Aziridin-1-yl]-2,4-dinitrobenzamide (Prolarix, CB-1954, <b>25</b>)</td><td class="colsep0 rowsep0" align="left">1. In rat Walker 256 carcinoma cells, CB-1954 undergoes reduction by NAD(P)H: quinone oxidoreductase (NQO1) to the cytotoxic derivative 5-(aziridin-1-yl)-4-hydroxylamino-2 nitrobenzamide, a bifunctional alkylating agent.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(100)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2. Maximum tolerable dose is 24 mg/m<sup>2</sup> by iv administration and 37.5 mg/m<sup>2</sup> by ip route. <a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(101)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">Evofosfamide (TH-302, <b>26</b>)</td><td class="colsep0 rowsep0" align="left">1. Neuroendocrine pancreatic tumors (phase 2, NCT02402062, recruiting).</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2. Advanced solid tumors (phase 1, NCT02020226, active, not recruiting). Metastatic soft tissue sarcoma (phase 3, NCT01440088, completed). Advanced leukemias (phase 1, NCT01149915, completed).</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3. Non-small-cell lung cancer (phase 1, phase 2, NCT00743379, completed).</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">SN-38 prodrug (<b>27</b>)</td><td class="colsep0 rowsep0" align="left">1. Demonstrated significant hypoxia-selective antitumor effects, endowed with a 10-fold higher toxicity than evofosfamide.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2. Less toxic than SN-38 under normoxic conditions.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(99)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">KS119 (<b>28</b>)</td><td class="colsep0 rowsep0" align="left">1. KS119 is endowed with substantial potential as a hypoxia-selective tumor-cell cytotoxin and is unlikely to induce toxicity to well oxygenated normal tissues.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2. KS119 in combination with radiations decreased viability of cells in EMT6 tumors in comparison to KS119 or irradiation alone.<a onclick="showRef(event, 'ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref109 ref110">(107,108)</a></td></tr></tbody></table></div></div><div class="NLM_p">The structures of some other nitro-group-containing bioreductive compounds other than the agents presented in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>–<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> are shown in <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>. Among them, NCLQ-1/2 (<b>72</b>, <b>73</b>) represents the DNA-targeted bioreductive prodrug for cancer therapy,<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(110)</a> BCCA621C (<b>75</b>)<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(111)</a> is a DNA-dependent protein kinase (DNA-PK) inhibitor, and nimorazole (<b>76</b>) is a nitroimidazole being investigated for effects in locally advanced head and neck cancer (NCT02976051). FSL-61 (<b>74</b>) is a hypoxia-selective POR-activated fluorogenic probe for one-electron reductases. It is employed to activate bioreductive prodrugs for targeting tumor hypoxia.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(112)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Bioreductive agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">3.  Recent Advances of Anticancer Drugs Containing Nitro Groups</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This section presents the diverse chemical architectures possessing nitro groups, which induce the cell-killing effects that are primarily attributed to their bioreductive metabolism. Some selected exciting studies are covered that highlight the current focus of extracting the value of the nitro group based on its reduction potential.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.1.  Anticancer Prodrugs Containing Nitro Groups (Hypoxia-Activated Prodrugs and Others)</h3><div class="NLM_p">The duocarmycins represent a small group of extremely cytotoxic natural products that alkylate adenine in the minor groove of DNA. Over the years, duocarmycin analogs have displayed positive antitumor activity in preclinical and clinical studies. With this background, Tercel et al. designed several nitro analogs of the duocarmycins and evaluated them for hypoxia-selective anticancer potential. Compound <b>77</b> at 42 μmol/kg in combination with a single dose of γ irradiation eliminated detectable clonogens in some SiHa cervical carcinoma xenografts. Compound <b>77</b> also induced the regression of all treated A2780 ovarian tumor xenografts in combination with a well-tolerated multidose schedule of gemcitabine (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(113)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Duan et al. designed a series of achiral hypoxia-activated prodrugs bearing a 2-nitroimidazole moiety as the hypoxic trigger and an isophosphoramide mustard as the released toxin (a DNA cross-linking toxin of the prodrug, ifosfamide). Among the prodrugs synthesized, compound <b>78</b> was identified as a promising antitumor agent possessing substantial hypoxia-dependent cytotoxicity and microsomal stability in addition to a striking efficacy in vivo in an MIA PaCa-2 pancreatic cancer orthotopic xenograft model (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(114)</a></div><div class="NLM_p">Naimi et al. designed a series of nitric oxide donor 3′-<i>O</i>-nitro derivatives of 2′-deoxyuridine, 2′-deoxycytidine, and 5′-<i>O</i>-nitro-2′-deoxyuridine. Biological evaluation indicated that upon incubation in the presence of <span class="smallcaps smallerCapital">l</span>-cysteine or serum, the designed compounds (<b>79</b>–<b>81</b>) released a greater percentage of NO in comparison to isosorbide dinitrate, and their cytotoxicity against a variety of cancer cell lines was comparable to that of 5-iodo-2′-deoxyuridine but weaker than that of 5-fluoro-2′-deoxyuridine (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(115)</a></div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In view of evidence that nitrochloromethylbenzindolines (nitroCBIs) as prodrugs are capable of undergoing hypoxia-selective metabolism forming potent DNA minor groove alkylating agents exerting antitumor effects, Tercel et al. reported a series of analogs with an extra electron-withdrawing substituent that serves to elevate the one-electron reduction potential of the nitroCBI. The most potent compound (<b>82</b>) was endowed with promising biological attributes, including (1) hypoxic cytotoxicity ratios of 275 and 330 in Skov3 and HT29 human tumor cell lines, respectively, (2) capability of being efficiently and selectively metabolized to the desired aminoCBI, (3) selective cytotoxic effects under hypoxia toward the panel of cell lines tested, and (4) showing in vivo potential against hypoxic tumor cells in a human tumor xenograft (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>).<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(104)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ikeda et al. proposed the development of novel hypoxia-activated prodrugs of well-explored anticancer agents. This process involved the addition of a 2-nitroimidazole moiety to two standard anticancer drugs, doxorubicin and gemcitabine (<b>83</b> and <b>84</b>). An interesting finding was the formation of a six-membered cyclic structure from the prodrug that enabled the release of the active drug under hypoxia. Various favorable trends were observed in the study, including (1) selective activation under hypoxic conditions, (2) a significant reduction of adverse effects associated with these anticancer drugs in the normoxic region and improvement of the survival rate of mice as indicated by the results of in vivo studies, and (3) localization of the prodrugs at the hypoxic region compared to conventional anticancer drugs, which localize only in the normoxic region, as revealed by immunofluorescence analysis (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Checkpoint kinase 1 (Chk1) is a promising cancer therapeutic target that is associated with high levels of hypoxia-induced replication stress. Coupled with the fact that hypoxic cells also exhibit similar levels of sensitivity to inhibition of the Aurora A kinase, this evidence motivated the authors to design a bioreductive Chk1/Aurora A inhibitor, CH-01 (<b>27</b>). The biological evaluation results of CH-01 showed the dual inhibitor-induced selective inhibition of Chk1/Aurora A in hypoxic conditions and a significant loss of viability in the cancer cell lines. In view of these optimistic results, compound <b>27</b> appears to be a promising bioreductive chemotherapeutic agent, as it targets the therapy-resistant tumor fraction while shielding the normal tissue from therapy-induced genomic instability (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(106)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Zhu et al. synthesized 4-nitrobenzyloxycarbonyl prodrugs of O6-benzylguanine (O6-BG), which is known to be an effective known inhibitor of O6-alkylguanine-DNA alkyltransferase (AGT). Among the synthesized compounds, compound <b>85</b> and its monomethyl (<b>86</b>) and gem-dimethyl analogs (<b>87</b>) were evaluated for bioreductive activation by reductase enzymes under oxygen deficiency. The compound <b>87</b> released O6-BG in the highest yield by the reduction of the nitro group trigger. In addition, it also induced significant enhancement of laromustine cytotoxicity under oxygen-deficient conditions in comparison to normoxic conditions, indicating the selective release of the AGT inhibitor O6-BG under hypoxia (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Colon et al. conducted a comparative analysis of 3-nitro-10-methylbenzothiazolo[3,2-<i>a</i>]quinolinium chloride (NBQ-91) and 10-methylbenzothiazolo[3,2-<i>a</i>]quinolinium chloride (BQ-106) to ascertain the importance of the nitro functionality to the DNA binding ability under hypoxic conditions. The results of the dialysis experiments revealed that NBQ-91 (<b>88</b>) binds DNA under N<sub>2</sub>-saturated conditions with increasing concentrations of reducing agent due to the reduction of nitro functionality. The same was not observed with the compound lacking the nitro group. NBQ-91 exhibited covalent binding to DNA in the presence of hypoxanthine and xanthine oxidase under N<sub>2</sub>-saturated conditions, clearly showing that the presence of a nitro group is required for the activity (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(116)</a></div><div class="NLM_p">Rami et al. designed and synthesized nitroimidazole-based inhibitors as radio- and chemosensitizing agents targeting the tumor-associated carbonic anhydrase (CA) isoforms. The designed compounds exhibited in vitro efficacy toward the inhibition of extracellular tumor acidification in colorectal HT-29 and cervical HeLa carcinoma cell lines overexpressing CA IX. In both tumor types, a substantial decrease in hypoxia-induced tumor acidosis was also observed. Together with doxorubicin, compound <b>89</b> was endowed with sensitization potential toward radiotherapy and chemotherapy in vivo. (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Karwa et al. employed an extremely interesting and practical approach to the design of phototherapeutic agents based on the incorporation of an S-N moiety in previously discovered phosensitizer structures. The authors synthesized novel photolabile sulfenamides and conducted cell viability studies of the compounds. The compounds were evaluated for free radical generation and cell killing effects toward a panel of cancer cell lines (U937, HTC11, KB, and HT29). Photoexcitation of the copious synthetic free radicals was confirmed by electron spin resonance spectroscopy. Sulfenamides <b>90</b> and <b>91</b> demonstrated striking effects against all of the cell lines. The results of this study further confirmed the role of nitrogen-centered radicals inducing cell death (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(117)</a></div><div class="NLM_p">In view of the clinical acceptance of 2-nitroimidazole-based molecules as hypoxic tumor radiodiagnostics, novel 6-O-glucoazomycin bioreductive agents were designed with 2-nitroimidazole (bioreductive arm, <b>92</b>–<b>94</b>) as putative substrates of glucose transport proteins (GLUTs) capable of inducing hypoxia-selective radiosensitization. The results of these in vitro experiments clearly indicate the potential of these glucoazomycins as radiosensitizers with the ability to competitively inhibit glucose uptake. Among them, <b>94</b> induced moderate hypoxiaselective radiosensitization of MOO6X, EMT-6, and HeLa cancer cells (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(118)</a></div><div class="NLM_p">The potential of nitroimidazoles as radiosensitizers with which to increase the radiation response has been well explored. In this view, nitroimidazole alkylsulfonamides as hypoxic cell radiosensitizers were synthesized by Bonnet et al. The 2-nitroimidazole sulfonamide-based synthetic compounds (<b>95</b>–<b>97</b>) exhibited significant 6- to 64-fold increases in hypoxia-selective cytotoxicity. The results of the study were quite optimistic, as all of the analogs at nontoxic concentrations were able to sensitize anoxic HCT-116 human colorectal cells to radiation. The study also strengthened the optimistic future prospects of a “mixed mechanism” of radiosensitization and hypoxia-selective cytotoxicity (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(119)</a></div><div class="NLM_p">Cheng et al. incorporated the hypoxia-activated nitroimidazole moiety into a quinazoline scaffold for the design of EGFR inhibitors. Among the synthetic novel 6-(nitroimidazole-1<i>H</i>-alkyloxyl)-4-anilinoquinazoline derivatives, compound <b>98</b>, with an IC<sub>50</sub> of 0.47 nM, was found to be the most potent, with substantial inhibitory effects against EGFR kinase and potent cell-killing effects against HT-29 cells under hypoxia with IC<sub>50</sub> values of 1.62 μM. Compound <b>98</b> underwent reductive activation under hypoxia, as indicated by the mimic reductive activation study and could emerge as a potential cancer therapeutic agent (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(120)</a></div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Zhu et al. designed 2-(4-nitrophenyl)propan-2-yl 6-((3-((dimethylamino)methyl)benzyl)oxy)-9H-purin-2-yl) carbamate (<b>99</b>), a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyl-transferase, employing an α,α-dimethyl-4-nitrobenzyloxycarbonyl moiety. The designed prodrug demonstrated hypoxia-selective conversion by EMT6 cells to the active drug. In addition, the prodrug was able to cause hypoxic sensitization of DU145 cells containing AGT to the cytotoxic actions of laromustine and was also endowed with improved solubility (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Atwell et al. designed and synthesized a series of 2,4-dinitrobenzamide mustards (<b>100</b>–<b>102</b>) as potential prodrugs for GDEPT. The results showed cytotoxic activation toward the four genetic backgrounds: human WiDr colon carcinoma, Skov3 ovarian carcinoma, EMT6 mouse mammary carcinoma, and V79 Chinese hamster fibroblasts. It was observed that analogs exhibited higher potencies and NTR selectivities than dichloromustards (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(121)</a></div><div class="NLM_p">In view of the role of hypoxia-inducible factors (HIFs) as heterodimeric transcription factors of cancer in tumorigenesis, a detailed investigation was performed to explore the prerequisite structural features. This was accomplished by the design of small molecules intended to inhibit HIF-2α–ARNT heterodimerization by binding to an internal cavity of the HIF-2α PAS-B domain. The overall structures of the compounds synthesized for the SAR study involved two aromatic/heterocyclic rings connected by short linkers. The results indicated that the NO<sub>2</sub>-substituted benzoxadiazole was mandatory for high affinity and potency, and compound <b>103</b>, a potently disrupting disubstituted analog, exhibited significant ability to interrupt HIF-2α–ARNT heterodimerization using the AlphaScreen, with an IC<sub>50</sub> of 0.1 μM (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(122)</a></div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ambrosio et al. designed and synthesized a series of 2-substituted-5-nitrobenzenesulfonamides as bioreducible inhibitors targeting the hypoxia-overexpressed tumor-associated isozymes, CA IX/XII. The designed compounds (<b>104</b>) were found to be potent inhibitors of the tumor-associated CA IX and XII (<i>K</i><sub>i</sub> of 7.4–653 nM against CA IX and 5.8–175 nM against CA XII). Some compounds even displayed excellent selectivity ratios toward the inhibition of the tumor-associated isozymes over the cytosolic isozymes (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(123)</a></div><div class="NLM_p">Jiang et al. reported nitrobenzylphosphoramide mustards with a strategically incorporated nitro group <i>para</i> to the benzylic carbon to facilitate reductive activation. The compounds were found to be good substrates of <i>E. coli</i> nitroreductase, with half-lives between 2.9 and 11.9 min at pH 7.0 and 37 °C. Among these, compound <b>105</b> was found to be the most active, exhibiting selective activation by NTR with 170 000× selective cytotoxicity toward NTR-expressing V79 cells and an IC<sub>50</sub> of 0.4 nM. These results collectively indicated the future applicability of compound <b>105</b> in combination with <i>E. coli</i> nitroreductase in enzyme prodrug therapies (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(105)</a></div><div class="NLM_p">Reigan et al. reported aminoimidazolylmethyluracil analogs as potent inhibitors of thymidine phosphorylase in light of the overexpression of thymidine phosphorylase in the hypoxic regions of many tumors. This research group also reported the ability of their bioreductive nitroimidazolyl prodrugs to be converted to the amino analogs. Compound <b>106</b> (IC<sub>50</sub> ≈ 20 nM) significantly inhibited <i>E. coli</i> and human TP, with IC<sub>50</sub> values of ∼20 nM. The corresponding prodrug (<b>107</b>) of compound <b>106</b> was >1000-fold less active and underwent xanthine oxidase-mediated reduction to <b>106</b>. The results of the study clearly demonstrated the potential of the designed prodrugs to selectively deliver the potent 2′-aminoimidazol-1′-yl TP inhibitors into hypoxic solid tumors, because XO is highly expressed in many tumors (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(124)</a></div><div class="NLM_p">Wei et al. synthesized nitroimidazole-substituted 4-anilinoquinazoline derivatives as epidermal growth factor receptor (EGFR)/vascular endothelial growth factor (VEGF)-2 inhibitors. One of the synthesized compounds (<b>108</b>) exhibited a remarkable potential against A549 and H446 cells under hypoxic conditions (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(125)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thomas et al. synthesized glucuronide prodrugs of the histone deacetylase inhibitor CI-994 by incorporation of a nitrobenzylphenoxy carbamate linker. The prodrug (<b>109</b>) was hypothesized to release CI-994, enabling easy recognition by β-glucuronidase. Prodrug incubation with β-glucuronidase in the culture media efficiently released the parent drug CI-994, keeping the cell proliferation and the HDAC inhibitory and E-cadherin expression induction effects intact. The prodrug exhibited improved solubility and good stability under physiological conditions and is anticipated to be promising for use in tumor-targeting strategies such as ADEPT or PMT (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p last">Winn et al. synthesized bioreductively activated prodrug conjugates of phenstatin (<b>110</b>–<b>113</b>) that were designed to target tumor hypoxia. The results of biological evaluation revealed that dimethylnitrothiophene (<b>110</b>) and the gem-dimethylnitrofuran (<b>113</b>) underwent efficient enzymatic cleavage in the presence of NADPH cytochrome P450 oxidoreductase under anaerobic conditions. The majority of the synthesized prodrugs (<b>110</b>–<b>113</b>) were not tubulin polymerization inhibitors. This was a desirable feature of the study, as the bioreductively activatable prodrug conjugates were anticipated to be inactive prior to enzyme-mediated cleavage to release phenstatin (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.2.  Anticancer Agents Containing Nitro Groups</h3><div class="NLM_p">This section presents a recent update on agents containing nitro groups and exerting cytotoxic effects either via a mechanism different from the hypoxia-induced effects or without studies to ascertain their effects as prodrugs. The agents covered in this section do not act as prodrugs and possess significant cytotoxic effects.</div><div class="NLM_p">In view of the striking cytotoxic potential of muramyldipeptide or normuramyldipeptide analogs modified with acridine/acridone derivatives in their peptide, Dzierzbicka et al. reported two analogs (<b>114</b>, <b>115</b>) modified at the C-terminus and displaying potent in vitro cytotoxic activity against a panel of human prostate cancer cell lines. Analog <b>115</b> also demonstrated in vivo potential against sc UACC-62 melanoma in mice (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(126)</a></div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cholody et al. fused an imidazoacridone moiety to polycyclic heteroaromatics via linkers of diverse length and rigidity to accomplish the synthesis of unsymmetrical bifunctional antitumor agents. The most potent compound of the series (<b>116</b>, WMC79) induced substantial selective cytotoxic effects against colon cancers (GI<sub>50</sub> = 0.5 nM, LC<sub>50</sub> = 32 nM) and leukemias (GI<sub>50</sub> = 3.5 nM, LC<sub>50</sub> = 33 nM). The compounds also exhibited significant in vivo activity against HCT-116 colon cancer xenografts in nude mice (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>).<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(127)</a></div><div class="NLM_p">A group of researchers led by Hariprakasha et al. working on fused molecules containing different DNA binders included optimization of the unsymmetrical bifunctional antitumor agent WMC79 (<b>116</b>, previously reported)<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(128)</a> with a naphthalimide-imidazoacridone scaffold. The investigation led to the identification of compound <b>117</b>, which has significant inhibitory potential toward many tumor cell lines and is approximately 30-fold more active than <b>116</b> (median LC<sub>50</sub> = 0.67 μM compared to 19.9 μM for WMC79) and induced rapid apoptosis. Unlike <b>116</b>, compound <b>117</b> was toxic to both p53-positive and -negative cancer cells and had potent in vivo activity against xenografts of human colon and pancreatic tumors in athymic mice. Due to these results, compound <b>117</b> was advanced into clinical development (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>).<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(129)</a></div><div class="NLM_p">A series of flavone analogs was designed, synthesized, and evaluated against breast cancer cells by Yao et al. Some of the primary compounds bearing an imidazole ring attached to the flavone framework were moderately cytotoxic against breast cancer cells (MDA-MB-231 (ER−) and MCF-7 (ER+). Structural optimization studies involving the simplification of imidazole-containing compounds led to the discovery of compound <b>118</b>, which has striking cytotoxic potency (IC<sub>50</sub> = 1 μM) and binding to eEF1A2. In addition, it exhibited selective binding to eEF1A2 and appeared to be an excellent candidate with a novel mechanism of action against breast cancer (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(130)</a></div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The human selenoprotein, thioredoxin reductase, is a logical target for the development of cytostatic agents, as it is involved in antioxidant defense and DNA synthesis. This motivated Millet et al. to design <i>cis</i>-diamminedichloroplatinum complexes of the 5-nitro-2-furancarbohydrazide with the aim of overcoming the cisplatin resistance. The key fragments, 5-nitro-2-furancarbohydrazide and cisplatin, for the design of the target compounds were identified by kinetic studies, which indicated μM binding affinity of these fragments at two different subsites of the human enzyme. The tethering of the two fragments led to the design of nitrofuran-based <i>cis</i>-diamminedichloroplatinum complexes (<b>119</b>–<b>122</b>), which demonstrated irreversible inhibition of the human enzyme with nanomolar affinities (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>).<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(131)</a></div><div class="NLM_p">Novel mycophenolic acid (MPA) conjugates containing nitroacridine/acridone derivatives were designed and synthesized by Malachowska-Ugarte et al. The length of the linker between MPA and the heterocyclic units was varied, and it was observed that the heterocyclic section had a significant influence on the cytotoxic and antiproliferative properties. Conjugates <b>122a</b>–<b>e</b> displayed more potent cell-killing effects against the tested cell lines than the parent MPA. Mouse leukemia L1210 was the most sensitive to the exposure of the synthesized compounds, with IC<sub>50</sub> values in the range of 0.042–0.087 μM. Preliminary investigations revealed that the compounds acted as IMPDH inhibitors (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(132)</a></div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0028.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In view of the reported potential of SERT ligands to induce selective programmed cell death in Burkitt’s lymphoma, 1,3-bis(aryl)-2-nitro-1-propene derivatives bearing a structural resemblance to MTA were synthesized by McNamara et al. Remarkable antiproliferative potential was exhibited by a synthetic compound (<b>123</b>) against the malignant cell lines DG-75, MUTU-I, and SHSY-5Y, showing apparent selectivity for BL-derived cell lines. In addition, the compounds caused caspase activation, PARP cleavage, chromatin condensation, and membrane blebbing in a cell line derived from Burkitt’s lymphoma and induced apoptosis in vitro. The role of the nitro group in inducing apoptosis was confirmed by the remarkable activity of the most potent compound lacking the nitro functionality and failing to induce apoptosis. (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>).<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(133)</a></div><div class="NLM_p">In view of the dysregulation of human cathepsin B activity, a lysosomal cysteine protease that is associated with cancers, the research group led by Sosic et al. designed and synthesized nitroxoline derivatives. The most potent inhibitor (<b>124</b>) demonstrated improved catB endopeptidase inhibition and enhanced selectivity toward catB over catH and catL, in comparison with the parent nitroxoline (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(134)</a></div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0029.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Csuk et al. recently reported the potential of β-nitro-substituted carboxylic acids as a new class of cytotoxic agents. Among the series of synthesized compounds, <b>125</b>, 2-(4-chlorophenyl)-3-nitropropionic acid ethyl ester with IC<sub>50</sub> = 1.6 μM, displayed remarkable results against the human ovarian cancer cell line (A2780), suggesting the need for more detailed investigations (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(135)</a></div><div class="NLM_p">Tan et al. reported that 8-ethoxy-3-nitro-2<i>H</i>-chromene-based HDAC compounds have potent cell killing effects in K562, A549, MCF-7, PC3, and HeLa cell lines. The effects of the compounds were more potent than MS-275, with the majority of them exhibiting effects higher than or comparable to those of suberoylanilide hydroxamic acid (SAHA) against K562 cells. Compound <b>126</b> (IC<sub>50</sub> = 128 nM, HDAC1) and compound <b>127</b> (IC<sub>50</sub> = 179 nM, HDAC1) were endowed with more potent and selective inhibitory effects compared to HDAC2 than SAHA (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>).<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(136)</a></div><div class="NLM_p">A series of 1-indolyl acetate-5-nitroimidazole derivatives were designed, synthesized, and evaluated by Duan et al. as potential tubulin polymerization inhibitors. The most potent tubulin inhibitor (<b>128</b>) (IC<sub>50</sub> = 2.4 μM) induced significant inhibition against the growth of cancer cells, with IC<sub>50</sub> = 2.00, 1.05, 0.87 μM against A549, HeLa, and U251, respectively (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>).<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(137)</a></div><div class="NLM_p">Singh et al. synthesized 8-, 9-, and 10-nitro-5<i>H</i>-2,3-methylenedioxy-5-(2-<i>N</i>,<i>N</i>-dimethylaminoethyl)dibenzo[<i>c,h</i>][1,6]naphthyridin-6-ones and their amino derivatives as potent TOP1-targeting agents and anticancer agents. The results of the study were quite promising, as the 8- and 9-nitro analogs (<b>129</b> and <b>130</b>) displayed more pronounced TOP1-targeting activity and cytotoxicity than did camptothecin. A structure–activity relationship confirmed the importance of a nitro substituent at either the 8- or the 9-position of 5<i>H</i>-8,9-dimethoxy-5-(2-<i>N</i>,<i>N</i>-dimethylaminoethyl)-2,3-methylenedioxydibenzo[<i>c,h</i>][1,6]naphthyridin-6-one (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>) for activity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0030.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Morrell et al. synthesized indenoisoquinoline analogs employing a combination of nitro groups, methoxy groups, and hydrogen atoms. The results of the study demonstrated that the nitro group was of paramount importance for the TOP1 inhibitory potential. The electron-rich oxygen atoms of the nitro group of compound <b>131</b> complemented the electron-deficient outer edges of the scissile strand DNA base pair, and the nitro group induced electron deficiency in the indenoisoquinoline aromatic ring system, leading to good electrostatic complementarity with the DNA base pairs. Thus, the stabilization of the complex from π-stacking interactions was associated with the benefits of appropriate placement of nitro groups (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>).<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(138)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">4.  Recent Advances in Antitubercular Agents Containing Nitro Groups</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There have been several investigations conducted on antitubercular agents with nitro functionality, and most of them revolve around structure modification and attempts to enhance the potential of well-explored antitubercular prodrugs containing nitro groups, including delamanid (<b>13</b>)<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(87)</a> and pretomanid (<b>24</b>).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(98)</a> Pretomanid (<b>24</b>), possessing a 5-nitroimidazooxazine scaffold, and delamanid (<b>13</b>), bearing a 5-nitroimidazooxazole skeleton, are potent inhibitors of active replication and latent <i>Mycobacterium tuberculosis</i>. Pretomanid (<b>24</b>) is a prodrug that is metabolized by <i>Mycobacterium tuberculosis</i>. It undergoes the bioreduction of the aromatic nitro group to a reactive nitro radical anion intermediate within the cell and is thus activated. Inhibition of the synthesis of cell wall lipids and proteins is considered to be the primary mechanism of action of pretomanid (<b>24</b>), but its effect against nonreplicating bacteria indicates that inhibition of cell wall biosynthesis is not the only mode of action.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(98)</a> Delamanid (<b>13</b>) is also a prodrug that needs to be activated by <i>M. tuberculosis</i>.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(87)</a></div><div class="NLM_p">The selective attempts of medicinal chemists toward the exploration of antitubercular compounds containing nitro groups are presented in three categories: (1) structural engineering of prodrugs (pretomanid, <b>24</b>, and delamanid, (<b>13</b>) and related heterocycles, (2) antitubercular agents containing nitro group, (3) benzothiazinones and related heterocycles as antitubercular prodrugs. The insights revealed in these studies appear to be beneficial for the future design of antitubercular agents and have also identified the structural prerequisites for accomplishing target specificities, particularly for nitroimidazoles.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">4.1.  Structural Engineering of Prodrugs (Delamanid (<b>13</b>) and Pretomanid (<b>24</b>)) and Related Heterocycles</h3><div class="NLM_p">The variation in the activity profile of pretomanid (<b>24</b>) instigated the authors led by Kim et al. to explore its structural features by synthesizing 4- and 5-nitroimidazoles analogs (<b>132</b>) and evaluating their antitubercular activities. The results of the biological evaluation revealed that the nitro group was essential for both aerobic and anaerobic activity, and this was evidenced by the diminished activity of the des-nitro derivatives (<a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0031.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Antitubercular prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Kim et al., in a continuation of their study on pretomanid (<b>24</b>), investigated two areas of the nitroimidazooxazine pharmacophore for aerobic activity: the atom at the 2-position and the nature of the substituent at the 6-position on the oxazine ring. The key points regarding the SAR of <b>133</b> established that (1) a nitrogen or sulfur atom in place of oxygen at the 2-position yielded equipotent analogs; (2) a reduction in the activity profile was observed upon acylation of the amino functionality, oxidization of the thioether, or replacement of the ether oxygen with carbon; (3) <i>N</i>-benzylic functionality in place of <i>O</i>-benzylic functionality slightly elevated the potency and led to the more soluble 6-amino series; and (4) extending the length of the linker region between the 6-(S) position and the terminal hydrophobic aromatic substituent led to a significant improvement in the antitubercular potential (<a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Thompson et al. investigated the antitubercular activity of ring A/B analogs of pretomanid (<b>24</b>). The authors established synthetic protocols for the designed chromophore analogs (<b>134</b>) using imidazoles, pyrazoles, and triazoles with diverse heteroatoms at the 4/8-position of the adjacent fused ring. Evaluation of their reduction potential indicated that although the nitroheterocyclic compounds exhibited values close to those of <b>24</b> and the nitroimidazothiazines were similar to the nitroimidazooxazines, these compounds were endowed with substantial in vitro antitubercular activity (<a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>).<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(139)</a></div><div class="NLM_p">Palmer et al. developed a series of biphenyl analogs of pretomanid (<b>24</b>). Their evaluation indicated that the <i>para</i>-linked biaryls (<b>135</b>) were the most active, with several compounds endowed with improved efficacies (>10-fold) over that of <b>24</b> in a mouse model of acute Mtb infection. The most potent was >200-fold more effective.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(140)</a> In continuation of their program of investigation of <b>24</b>, the same research group reported heterobiaryl analogs replacing one of the phenyl rings with several five-membered heterocycles in anticipation of new candidates with improved aqueous solubility. Two compounds (<b>136</b>, <b>137</b>) displayed 4- to 41-fold higher efficacy than <b>24</b> in a mouse model of acute Mtb infection, and the pyrazole analog (<b>136</b>) also demonstrated 2-fold higher solubility than <b>24</b>.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(141)</a> Palmer et al. further attempted to improve the solubility and oral potential against chronic infection by <i>Mycobacterium tuberculosis</i> by designing novel nitroimidazooxazine analogs with extended side chains and the varying size, flexibility, and polarity of the linker. Several compounds exhibited good microsomal stabilities, but only compounds <b>138</b>, <b>139</b>, and <b>140</b> showed in vivo efficacies strikingly superior to that of <b>24</b> in an acute infection model.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(142)</a> The same research group designed new pretomanid (<b>24</b>) analogs by employing side chain ether linkers of varying size and flexibility to obtain compounds with enhanced metabolic stability and high efficacy. The biological evaluation showed that compound <b>141</b> demonstrated excellent antitubercular effects, and the propenyloxy, propynyloxy, and pentynyloxy groups, categorized as extended linkers, resulted in greater potencies against the monoaryl analogs of replicating Mtb, with propynyl ethers and mono/biaryl analogs (<b>142</b>) displaying the most potent effects under anaerobic, nonreplicating conditions. Maximal aerobic activity was observed with the original (-OCH<sub>2</sub>-) linker for the benzyloxybenzyl and biaryl derivatives.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(143)</a> Thompson et al., in a continuation of their backup program for the antitubercular drug pretomanid (<b>24</b>), prepared 6-nitro-2,3-dihydroimidazo[2,1-<i>b</i>][1,3]thiazoles and related 6-nitro-2,3-dihydroimidazo[2,1-<i>b</i>][1,3]oxazoles in high yields. A part of the structure–activity relationship was deduced and indicated that substitution of the methyl group at the second position and extended aryloxymethyl side chains favored the antitubercular activity, while S-oxidized thiazoles generally displayed negative trends. Among the synthetic compounds, <b>143</b> exhibited good microsomal stability and was found to be potent in an acute <i>Mycobacterium tuberculosis</i> mouse model.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(144)</a> Recently, while attempting to identify the two trace byproducts encountered during large-scale synthesis of pretomanid, Thompson et al. identified <b>144</b> (3′-methyl pretomanid) as a potent antitubercular agent, with 8-fold higher potency than pretomanid in the aerobic assay (<a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a></a>).<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(145)</a></div><figure id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0032.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Antitubercular prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Blaser et al. synthesized several analogs of compound <b>24</b> to address the issues of oxidative metabolism, minimal compound lipophilicity, and enhanced aqueous solubility by replacement of the -OCH<sub>2</sub>- linkage in <b>24</b> with an amide, carbamate, and urea functionality. The bioisosteric replacement of the biaryl moiety by arylpiperazine yielded a soluble, orally bioavailable carbamate analog (<b>145</b>) (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>).<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(146)</a></div><figure id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0033.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Antitubercular prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cherian et al. explored the influence of the linker and lipophilic tail of designed derivatives at three positions of the 4-(trifluoromethoxy)benzylamino tail against both replicating and nonreplicating Mtb. Out of three positions, modifications at R<sub>1</sub> and R<sub>3</sub> yielded an improved lead compound (<b>146</b>) in terms of both potency and solubility, and the third site, R<sub>2</sub>, was anticipated to be a site for modulation of the pharmacological properties of derivatives. The derivatives underwent deazaflavin-dependent nitroreductase (Ddn)-mediated reductive activation. Several active compounds displayed better activity than <b>24</b>, with 40 nM aerobic whole-cell activity and 1.6 μM anaerobic whole-cell activity. Quantum chemistry suggested the pseudoequatorial orientation of the linker and lipophilic tail as the conformational preference of these analogs (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>).<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(147)</a></div><div class="NLM_p">With an aim of improving the aqueous solubility and maintaining high metabolic stability and efficacy, aza- and diazabiphenyl analogs of pretomanid (<b>24</b>) were designed by Kmentova et al. The design strategy that was employed involved the synthesis of several heterocyclic analogs of the active biphenyl class derived from <b>24</b> and was accomplished by the replacement of phenyl groups by pyridine, pyridazine, pyrazine, or pyrimidine to decrease the lipophilicity. Some of the compounds demonstrated remarkable in vivo efficacies, for example, in an achronic infection model, along with high metabolic stabilities and excellent pharmacokinetics. The highlight of the study was the identification of the orally bioavailable pyridine analog (<b>147</b>), which is 3- to 4-fold more soluble than <b>24</b> at low pH values (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>).<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(148)</a></div><div class="NLM_p">Kang et al. attempted various modifications at the C-7 position of 2-nitroimidazooxazine pretomanid (<b>24</b>) analogs, such as placement of benzyl ether, phenyl ether, benzyl carbonate, and phenyl carbamate. Among the synthesized compounds, analog <b>148</b> bearing a trifluoromethoxy benzyl group (MIC = 0.078 μM) and analog <b>149</b> (phenyl ether-based analog, MIC = 0.050 μM) displayed striking antimycobacterial activity against Mtb in comparison to <b>24</b> (MIC = 0.390 μM) in the in vitro evaluation against the wild-type Mtb. Overall, the results were quite encouraging, and most of the compounds exhibited low toxicity (<a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">34</a></a>).<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(149)</a></div><figure id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0034.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Antitubercular agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">4.2.  Antitubercular Agents Containing Nitro Groups</h3><div class="NLM_p">This section presents studies that do not deal with structural modifications of the prodrugs (<b>13</b> and <b>24)</b> and thus have been separated from structures categorized as prodrugs in this perspective.</div><div class="NLM_p">Prompted by the positive preclinical outcomes attained with 2-nitroimidazole-linked chloroquinoline compounds, the research group led by Papadopoulou et al. investigated the antitubercular potential of 3-nitrotriazole-based and 2-nitroimidazole-based amides and sulfonamides against aerobic <i>Mycobacterium tuberculosis</i> H37Rv3 by using the BacTiter-Glo (BTG) microbial cell viability assay. Some of the sulfonamides (<b>150</b>) exhibited a positive trend with increasing lipophilicity; however, dependence of the antitubercular potential on one electron reduction potential was not observed. In general, the nitrotriazoles were endowed with unaltered antitubercular potential in the BTG assay against resistant strains (<a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">34</a></a>).<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(150)</a> Motivated by these fruitful results, Papadopoulou et al. also recently evaluated some nitro(triazole/imidazole)-based compounds (mostly amides) for antitubercular activity against <i>Mycobacterium tuberculosis</i> H37Rv (Mtb H37Rv) under aerobic or hypoxic conditions. This extensive program led by these authors resulted in the identification of compound <b>151</b> and <b>152</b>, which exhibited potential against aerobic and hypoxic Mtb and were also found to possess bactericidal and intracellular antitubercular activities. Compounds <b>153</b>, <b>154</b>, and <b>155</b> were found to be selectively active against aerobic Mtb. Compound <b>154</b> also exhibited good in vitro ADMET characteristics, demonstrating excellent caco-2 permeability, an efflux ratio of 0.39, good microsomal, and chemical stability and a lack of hepatotoxicity (<a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">34</a></a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0035.jpeg" id="gr35" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Antitubercular agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In view of the categorization of 1,3,4-oxadiazole as a privileged bioactive heterocycle, particularly for antitubercular agents, Rane et al. synthesized a series of novel 4-nitropyrrole-based 1,3,4-oxadiazole derivatives as antimicrobial and antitubercular agents. Compounds <b>156</b>, <b>157</b>, <b>158</b>, and <b>159</b> were endowed with significant antitubercular potential, with MIC values of 0.81 μg/mL, 0.46 μg/mL, 0.72 μg/mL, and 1.8 mg/mL, respectively. Among them, compound <b>156</b> was almost equipotent to the standard drug isoniazid (0.40 mg/mL). The results of the study were encouraging, as all the compounds were found to be nontoxic when tested for mammalian cell toxicity using the VERO cell line (<a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">35</a></a>).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(151)</a></div><div class="NLM_p">Working along similar lines and encouraged by the biopotential of bromopyrrole alkaloids and semicarbazide derivatives for antimicrobial activity, Rane et al. synthesized a series of 4-nitropyrrole-semicarbazide conjugates. Hybrids lacking a pyrrole-NH were more potent against <i>Mycobacterium tuberculosis</i> in comparison to the N-methylated analogs. Among the synthesized compounds, hybrids <b>160</b>, <b>161</b>, and <b>162</b> had MIC values of 0.50, 0.56, and 0.67 μM, respectively, against <i>Mycobacterium tuberculosis</i> H37RV (<a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">35</a></a>).<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(152)</a></div><div class="NLM_p">Kamal et al. synthesized the reported nitrofuramide-linked triazole hybrids and evaluated them for their antitubercular activity against a <i>Mycobacterium tuberculosis</i> H37Rv strain. The results of the investigation were encouraging, as a remarkable antitubercular potential was demonstrated by compound <b>163</b> (MIC = 0.25 μg/mL). Most of the other compounds synthesized in the study exhibited lower cytotoxicities (<a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">36</a></a>).<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(153)</a></div><figure id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0036.jpeg" id="gr36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Antitubercular agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Tangallapally et al. synthesized a series of nitrofuranylamides and screened them against <i>M. tuberculosis</i> UDP-Gal mutase inhibition. The biological evaluation indicated that the MIC values did not correlate with UDP-Gal mutase inhibition, indicating that the antitubercular potential of the compounds could be attributed to an alternative primary cellular target. On the basis of the in vitro results, the promising compounds were further evaluated in in vivo studies in a mouse model of tuberculosis infection. Among the tested compounds, compound <b>164</b> demonstrated substantial antitubercular effects (<a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">36</a></a>).<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(154)</a></div><div class="NLM_p last">Karabanovich et al. synthesized a series of 1,3,4-oxadiazole and 1,3,4-thiadiazole scaffolds in view of their role as bioisosteric surrogates for 2,5-disubstituted tetrazoles that had previously proven their antitubercular potential. Excellent activity against drug-susceptible and multidrug-resistant Mtb was demonstrated by a majority of the compounds, and the 3,5-dinitro substitution was found to be indispensable for antimycobacterial activity. In addition, a highly selective antimycobacterial effect was demonstrated by the compounds, as they possessed no inhibitory effects against other bacteria or fungi. Low in vitro toxicities against four proliferating mammalian cell lines and in isolated primary human hepatocytes, along with the absence of mutagenicity observed with the tested compounds, were among the salient features of the study. The active compound (<b>165</b>) had a favorable toxicity profile and exhibited a potency comparable to that of rifampicin against the nonreplicating streptomycin-starved <i>M. tuberculosis</i> 18b-Lux strain (<a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">36</a></a>).<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(155)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">4.3.  Benzothiazinones and Related Heterocycles as Antitubercular Prodrugs</h3><div class="NLM_p">1,3-Benzothiazin-4-ones (benzothiazinones, BTZs) have exhibited high activity against <i>Mycobacterium tuberculosis</i> both in vitro and in vivo. BTZ-043 (18), a benzothiazine analog, has demonstrated a remarkable potential to kill Mtb in vitro, ex vivo, and in mouse models of TB and induces its antitubercular effects at an MIC of 1 ng/mL against Mtb H37Rv. This is an extraordinary activity profile when compared to existing therapeutics such as isoniazid. Benzothiazines target the enzymes decaprenylphosphoryl-<span class="smallcaps smallerCapital">d</span>-ribose 2′-epimerase and DprE2 (Rv3791), which are critical for the synthesis of cell wall arabinans, and catalyze the epimerization of decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose to decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-arabinose.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(96,97)</a> Despite all these previous efforts, scope remains to fully investigate the detailed mechanism of BTZ-043 (<b>18</b>), and Trefzer et al. in their attempts to explore the mechanism of benzothiazine reported that BTZs act as suicide inhibitors, leading to enzyme inhibition by conversion of the nitro group to a nitroso and a subsequent covalent reaction with Cys387 of DprE1. The study also indicated that BTZ-043 (<b>18</b>) and the other related nitroaromatic compounds (<b>166</b>–<b>169</b>), despite their structural diversity, induce their effects via a common mechanism of action, thus representing an emerging family of antimycobacterial agents (<a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">37</a></a>A).<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(156)</a></div><div class="NLM_p">BTZ-043 (<b>18</b>) can be defined as a BTZ core, bearing three substituents (R1, R2, and R3). The well-established structure–activity relationship indicates that there is little scope for modifications around groups R1 and R2 but that a variation in the structure of the R3 group is feasible. Karoli et al. employed an in silico ligand-based model based on SAR studies from 170 BTZ compounds to design a new series of compounds. Groups at the R1 and R2 positions remained as NO<sub>2</sub> and CF<sub>3</sub>, and various alterations at position R3 were made. Biological assays led to the identification of several compounds with improved activity against MDR-TB. In addition, the compounds were endowed with favorable microsomal, metabolic, and plasma stability and low toxicity (<a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">37</a></a> B).<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(157)</a></div><figure id="fig37" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0037.jpeg" id="gr37" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. Benzothiazinones and related heterocycles as antitubercular prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Tiwari et al. designed nitroaromatic sulfonamide, reverse-amide, and ester classes of anti-TB agents by employing a scaffold simplification strategy. The substantial effects of BTZ-043 (<b>18</b>) led the authors to explore the influence of functional groups, such as sulfonamides, reverse-amides, and esters linked to the nitroaromatic rings, on anti-TB activity. Biological evaluation of the synthetic compounds against the H37Rv strain indicated that simple sulfonamides and nitrobenzoic acid ester analogs with dinitro substituents were more active than the reverse amides, but their potency was not close to that of BTZ043 (<b>18</b>). The difference in the activity profile was attributed to the electron-deficient aromatic ring in the nitroaromatics, as evidenced by the activity of compounds <b>170</b>-<b>172</b>. The study concluded that electron-deficient aromatic rings in, for example, the nitroaromatics were instrumental in potentiating the bioactivity (<a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">38</a></a>).<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(158)</a></div><figure id="fig38" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Figure 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0038.jpeg" id="gr38" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 38. Benzothiazinones and related heterocycles as antitubercular prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig38"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Tiwari et al. designed and synthesized novel anti-TB agents, successors to BTZs and other nitroaromatic compounds. The compounds synthesized displayed promising antitubercular potential and were nontoxic. An important revelation of the study was the susceptibility of the unsubstituted aromatic carbon between the electron withdrawing groups of compounds <b>173</b> and <b>18</b> to substitution by nucleophiles such as thiolates, cyanide, and even hydrides. This mediated the nonenzymatic reduction of the nitro groups to the corresponding nitroso intermediates by addition at the unsubstituted electron-deficient aromatic carbon present in these compounds. Overall, the study presents a possible alternative mechanism with which nitroaromatics might exert antitubercular effects. The mechanism proceeds via cysteine thiol(ate) or a hydride source at the active site of DprE1, triggering a nitro group reduction similar to the reaction proceedings in the von Richter reaction to the nitroso intermediates, thereby initiating the inhibition of DprE1 (<a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">38</a></a>).<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(159)</a></div><div class="NLM_p last">HisG (an ATP-phosphoribosyl transferase (ATPPRTase)) represents a potential drug target for tuberculosis owing to its role in the biosynthetic pathway for histidine. For this reason, Cho et al. performed virtual screening for the identification of novel inhibitors for <i>M. tuberculosis</i> HisG using both GOLD and FlexX. A nitrobenzothiazole moiety was found to be a key structural unit present in several hits, and one of the new compounds was found to be endowed with significant enzyme inhibitory activity (IC<sub>50</sub> = 6 μM). A docking study revealed that <b>174</b> occupies the PRPP binding site, and the nitro group forms a tight hydrogen-bonding network with the backbone nitrogen atoms of the P-loop, which leads to the stabilization of the molecule (<a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">38</a></a>).<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(160)</a></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">5.  Recent Advances in Antiparasitic Agents Containing Nitro Groups</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This section encompasses an overview of some selected findings in the field of antiparasitic agents that contain nitro groups. Preclinical investigations of these compounds have mostly focused on synthesizing antiparasitic agents based on the structural features of well-known nitroheterocyclic prodrugs, namely, nifurtimox (<b>2</b>), benzinidazole (<b>3</b>), metronidazole (<b>4</b>), and fexinidazole (<b>9</b>), as a part of drugs for neglected diseases programs. Nitroheterocycles are considered to be prodrugs that require bioactivation of the nitro group to exert an antimicrobial effect. It has been established that the trypanocidal activity of nitroheterocyclic drugs depends on a parasite type I nitroreductase (NTR), which is absent from mammalian cells. This particular difference forms the basis for the drug selectivity, and the enzyme catalyzes the two-electron reduction of nitroheterocycles within the parasite. The reduction leads to the generation of toxic metabolites that preferentially target the parasite.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(76)</a> Recent attempts toward the design of antiparasitic agents are presented in two categories: (1) triazoles, imidazoles and related heterocycles, (2) indazoles.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">5.1.  Nitrotriazoles, Imidazoles, and Related Heterocycles (Heterocycles as Prodrugs Containing Nitro Groups)</h3><div class="NLM_p">The quest to explore nitro group-containing heterocycles led Papadopoulou et al. to design and evaluate a series of 42 novel 2-nitro-1<i>H</i>-imidazole- and 3-nitro-1<i>H</i>-1,2,4-triazole-based aromatic and aliphatic amines. The results were quite good, as several compounds (<b>175</b>–<b>181</b>) were found to be endowed with significant growth inhibitory properties against <i>T. cruzi</i> amastigotes. IC<sub>50</sub> values ranged from 40 nM to 1.97 μM and selectivity indices (SI) from 44 to 1320, with the majority displaying 33.8-higher potency than the standard (<b>2</b>). The striking feature of the study was that the compounds failed to induce toxicity to the host cells (L6 cells) (<a data-tab="pane-pcw-Figures" href="#fig39" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig39" id="" class=" internalNav">39</a></a>).<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(161)</a></div><figure id="fig39" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Figure 39</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0039.jpeg" id="gr39" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 39. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig39"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In view of the shortcomings associated with benzinidazole (<b>3</b>) as a therapeutic for Chagas disease, which includes side effects and limited efficacy, Papadopoulou et al. synthesized a series of novel 3-nitro-1<i>H</i>-1,2,4-triazole-based and 2-nitro-1<i>H</i>-imidazole-based amides and sulfonamides. Several compounds (<b>182</b>–<b>184</b>) displayed striking activity against <i>Trypanosoma cruzi</i> intracellular amastigotes (IC<sub>50</sub> values ranged from 28 nM to 3.72 μM, SI ranged from 66 to 2782) without concomitant toxicity to the L6 host cells. A moderate activity profile was also demonstrated by some nitrotriazoles against the axenic form of <i>Leishmania donovani</i> (<a data-tab="pane-pcw-Figures" href="#fig39" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig39" id="" class=" internalNav">39</a></a>).<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(162)</a></div><div class="NLM_p">Continuing their investigations, Papadopoulou et al. attempted the synthesis of bioreducible 3-nitrotriazole-based compounds as CYP51 enzyme inhibitors. The study aimed to exploit the anticipated benefits of fusing the nitroheterocycles with the concomitant benefits of inhibiting the ergosterol biosynthesis inhibitors with a single molecule. Linear, rigid 3-nitrotriazole-based amides and 3-nitrotriazole-based carbinols, analogs of fluconazole, were synthesized and evaluated as potential antitrypanosomal/antichagasic agents, NTR substrates, and TcCYP51 inhibitors. The results of the investigation revealed that the synthetics were excellent substrates for type I nitroreductase (NTR), located in the mitochondria of trypanosomatids. Moreover, the compounds also exhibited inhibitory potential toward the sterol 14α-demethylase (<i>T. cruzi</i> CYP51) enzyme. Compounds <b>185</b> and <b>186</b> were found to be the most promising among all the synthetic compounds (<a data-tab="pane-pcw-Figures" href="#fig40" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig40" id="" class=" internalNav">40</a></a>).<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(163)</a> Papadopoulou et al. explored the potential of aminothiazole as a heterocyclic unit with an appropriately placed nitro group to induce antitrypanosomal activity by synthesizing a series of 5-nitro-2-aminothiazole-based amides containing arylpiperazine-, biphenyl-, or aryloxyphenyl functionalities. Compound <b>187</b> had a substantial activity profile (IC<sub>50</sub> = 0.571 μM) and demonstrated a 4-fold higher potential than did <b>2</b>. A moderate activity profile was also exhibited by some compounds against <i>L. donovani</i> axenic amastigotes (<a data-tab="pane-pcw-Figures" href="#fig40" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig40" id="" class=" internalNav">40</a></a>).<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(164)</a> In a continuation of their investigations on nitro-based heterocycles, Papadopoulou et al. explored 3-nitrotriazole- and 2-nitroimidazole-linked quinolines and quinazolines for in vitro antitrypanosomal and antitubercular activities. The biological evaluation indicated that 3-nitrotriazole-based compounds exhibited significant potency and parasite-selectivity in comparison to 2-nitroimidazole. Both of the classes demonstrated activity against <i>T. cruzi</i> amastigotes, with either similar or better activity than benzinidazole <b>(3)</b>. A selective activity potential against <i>T. b. rhodesiense</i> was also demonstrated by 3-nitrotriazole-based analogs. Among all the compounds, <b>188</b> was the most promising agent for the Chagas disease, with an IC<sub>50</sub> value of 0.038 μM and a selectivity index of 1937 against <i>T. b. rhodesiense</i>. Compound <b>189</b> was the most potent antitubercular agent, with an MIC value of 2.89 μM (<a data-tab="pane-pcw-Figures" href="#fig40" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig40" id="" class=" internalNav">40</a></a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(34)</a></div><figure id="fig40" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Figure 40</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0040.jpeg" id="gr40" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 40. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig40"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Papadopoulou et al. also reported the synthesis and evaluation of novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents. A striking inhibitory potential was demonstrated against <i>T. cruzi</i> at the nanomolar level by chlorothiophene-sulfonamides, benzothiophene-amides, and the benzothiazole-amide. The salient feature of the study was a 14-fold higher potential of these compounds than benzinidazole (<b>3</b>), with selectivity indices ranging from 216 to >1409. The structure of the most promising compound (<b>190</b>) is shown in <a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">41</a></a>. The compounds induced selective effects against <i>T. b. rhodesiense</i>. It was also observed that type I NTR activated most of the 3-nitrotriazoles, as the parasites overexpressing the enzyme were substantially more sensitive (up to 73-fold) to exposure to the synthesized compounds (<a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">41</a></a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(35)</a></div><figure id="fig41" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Figure 41</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0041.jpeg" id="gr41" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 41. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig41"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Extending their research program on heterocycles containing nitro groups with trypanocidal activity, Papadopoulou et al. investigated the in vitro trypanocidal activity of nitrotriazole-based piperazines and nitrotriazole-based 2-amino-1,3-benzothiazoles to ascertain the structure–activity relationship. The biological evaluation demonstrated a remarkable activity of the compounds against <i>T. cruzi</i> amastigotes at the nanomolar level. In addition, the compounds exhibited SI values of ≥200 and were found to be aligned with the Lipinski’s rule of 5, displaying drug-like characteristics. Among the synthesized compounds, <b>191</b>–<b>193</b> were identified as promising candidates for in vivo evaluation as anti-HAT agents (<a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">41</a></a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(36)</a> Papadopoulou et al. reported the in vitro and in vivo potential of 3-nitrotriazole-based aryloxyphenylamides as potently active and selective anti-<i>T. cruzi</i> agents. 3-Nitrotriazole-based aryloxyphenylamides (<b>194</b>, <b>195</b>) at 13 mg/kg/day (ip) reduced the parasite load after 5 days of treatment in infected mice. Metabolic stability and a good caco-2 permeability were demonstrated by these compounds, indicating a favorable profile for oral administration. Moreover, the compounds were found to be potential inhibitors of <i>T. cruzi</i> CYP51 and were excellent substrates for type I nitroreductase (NTR) (<a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">41</a></a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(37)</a></div><div class="NLM_p">Phenotypic investigation of 6-nitro-2,3-dihydroimidazo[2,1-<i>b</i>][1,3]oxazole derivatives led to the identification of a potential first-in-class drug candidate for visceral leishmaniasis: DNDI-VL-2098. Thompson et al. improved its solubility and safety profile and attempted several modifications of the 6-nitro-2,3-dihydroimidazo[2,1-<i>b</i>][1,3]oxazole scaffold. A structural engineering study indicated that the aryloxy side chain was open to modification, with attempts such as using nitrogen in place of the linking oxygen or the piperazine, biaryl extension, and a pyridine ring in place of phenyl rings leading to compounds that were well tolerated. However, the nitroheterocycle was extremely sensitive to modifications, as removal of the nitro group or switching its position and replacement of the imidazole ring by pyrazole or triazole all led to a diminished activity against VL. Compound <b>196</b> was identified as the most effective candidate, outshining DNDI-VL-2098 in the mouse model of acute <i>Leishmania donovani</i> infection (<a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">42</a></a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(38)</a> In view of previous work reporting the potential of delamanid analog DNDI-VL-2098 as a VL preclinical candidate, the 7-substituted 2-nitro-5,6-dihydroimidazo[2,1-<i>b</i>][1,3]oxazine class was investigated by Thompson et al. Attempts were made to develop compounds with enhanced efficacy and improved solubility and safety. A biological evaluation revealed that the two racemic phenylpyridines (<b>197</b>, <b>198</b>) had significant potential in the <i>Leishmania donovani</i> mouse model. Compound <b>198</b> induced >99% inhibition at 12.5 mg/kg (b.i.d., orally) in the <i>Leishmania infantum</i> hamster model. The configuration of compound <b>197</b> also had an influence on the activity profile, with the 7R enantiomer exhibiting more favorable pharmacokinetics, efficacy and safety (<a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">42</a></a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(39)</a></div><figure id="fig42" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Figure 42</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0042.jpeg" id="gr42" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 42. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig42"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thompson et al. screened a 900 compound nitroimidazole-based library established as a pretomanid backup program against human African trypanosomiasis (HAT) as a part of a drug for neglected diseases initiative. A stereoisomer (<b>199</b>) of the most potent compound (thiazine oxide) demonstrated substantial efficacy in the stage 1 HAT mouse model with once-daily oral dosing. The structure–activity relationship studies indicated that removal of the benzylic methylene reduced the activity, but the addition of a proximal pyridine ring enhanced the potency of compound <b>200</b> (<a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">42</a></a>).<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(165)</a></div><div class="NLM_p">Crozet et al., while attempting to improve the antiparasitic pharmacophore by lowering the mutagenicity, synthesized a series of 5-nitroimidazoles with an arylsulfonylmethyl group and evaluated them for antiparasitic activity against <i>Trichomonas vaginalis</i>. The study revealed that several derivatives had SI values that were better than metronidazole (<b>4</b>), and compounds bearing an additional methyl group placed at the second position demonstrated a lower mutagenicity than metronidazole (<b>4</b>). A lower mutagenicity and significant antitrichomonal activity was exhibited by compounds <b>201</b>–<b>203</b> (<a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">42</a></a>).<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(166)</a></div><div class="NLM_p">Hernandez-Nunez et al. in their delineation of the structural prerequisites for antiparasitic activities of <b>2</b> prepared novel <i>N</i>-acetamide (sulfonamide)-2-methyl-4-nitro-1<i>H</i>-imidazoles as benzinidazole (<b>3</b>) analogs. The design strategy that was employed involved moving the nitro group from position 2 to position 4 and the addition of an extra methyl group at position 2 in the metronidazole core. The resulting 2-methyl-4-nitroimidazole scaffold was fused with a sulfonamide pharmacophore in anticipation of an enhanced antiparasitic activity profile. The results of the biological evaluation indicated that compound <b>204</b> was 2-fold more potent than <b>2</b> against <i>T. vaginalis</i> and <i>G. intestinalis</i> and induced effects that were equipotent with those of <b>2</b> against <i>E. histolytica</i>. Selective toxicity was observed among sulfonamides against <i>E. histolytica</i>. Among the sulfonamides, compound <b>205</b> was the most active against <i>E. histolytica.</i> The compounds were found to be nontoxic in the MDCK cell line and merit a more detailed investigation (<a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">42</a></a>).<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(167)</a></div><div class="NLM_p">In view of the success of hybrid scaffolds that combine different pharmacophoric units to attain synergistic bioactivity, Colín-Lozano et al. synthesized and evaluated 5-nitrothiazole-NSAID chimeras as analogs of nitazoxanide and evaluated them against a panel of protozoa. The chemical architectures of the desired hybrid scaffolds were accomplished by fusion of the pharmacophore, 2-amino-5-nitrothiazole, with other NSAIDs. All the fused scaffolds (<b>206</b>–<b>210</b>) were endowed with more potent effects than either <b>4</b> or nitrozoxanide. Among all the hybrids, the indomethacin hybrid (<b>209</b>) was found to be the most potent, possessing a striking inhibitory potential toward the growth of <i>G. intestinalis</i>, with an IC<sub>50</sub> value of 0.145 μM. The effects of compound <b>206</b> were 38-fold higher than those of <b>4</b> and were 8-fold higher than those of nitazoxanide. The substantial giardicidal effect of <b>206</b> was also evidenced in in vivo studies in a CD-1 mouse model, with a median effective dose of 1.709 μg/kg (3.53 nmol/kg). In comparison to <b>4</b> and nitazoxanide, the in vivo potential of compound <b>206</b> is 321 times and 1015 times higher, respectively, after intragastric administration (<a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">42</a></a>).<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(168)</a></div><div class="NLM_p">Trunz et al. reported diverse 1-aryl-4-nitro-1<i>H</i>-imidazoles <b>211</b> and <b>212</b> with antitrypanosomal activity as compounds endowed with curative potential in mouse models of both acute and chronic African trypanosomiasis. The compounds were administered orally at doses of 25–50 mg/kg for 4 days in acute infection and 50–100 mg/kg (b.i.d.) for 5 days in the chronic model. There was no observed genotoxicity associated with these two compounds in mammalian cells. The structure–activity relationship delineated several structural features that led to increased or decreased activity. Of these, replacement of the 4-nitroimidazole moiety with 4-nitropyrazole reduced the activity potential (<a data-tab="pane-pcw-Figures" href="#fig43" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig43" id="" class=" internalNav">43</a></a>).<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(169)</a></div><figure id="fig43" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Figure 43</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0043.jpeg" id="gr43" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 43. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig43"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">5.2.  Nitroindazolines: Heterocycles Containing Nitro Groups as Prodrugs</h3><div class="NLM_p">In view of the reported antichagasic potential of the 5-nitroindazolin-3-one scaffold, Fonseca-Berzal et al. explored 1-substituted 2-benzyl-5-nitroindazolin-3-ones and 3-alkoxy-2-benzyl-5-nitro-2<i>H</i>-indazoles against the protozoan parasites <i>Trypanosoma cruzi</i> and <i>Trichomonas vaginalis</i>. Among the series of 1-substituted 2-benzyl-5-nitroindazolin-3-ones, compounds <b>213</b>–<b>215</b> demonstrated striking potential against amastigotes of the <i>T. cruzi</i> CL Brener strain (IC<sub>50</sub> < 1 μM, SI > 1000). Some compounds also exhibited activity against amastigotes from Tulahuen and Y strains of <i>T. cruzi</i> and was found to possess low toxicity toward cardiac cells (LC<sub>50</sub> > 100 μM). Delineation of the structural features indicated that electron-donating groups at position 1 of the indazolinone ring favored the activity. Among the 3-alkoxy-1-alkyl-2<i>H</i>-indazoles, compound <b>216</b> was endowed with similar activity profile against a metronidazole-sensitive (JH31A#4) or a metronidazole-resistant (IR78) isolate of <i>T. vaginalis</i> (IC<sub>50</sub> = 7.25 and 9.11 μM, respectively) (<a data-tab="pane-pcw-Figures" href="#fig44" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig44" id="" class=" internalNav">44</a></a>).<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(170)</a></div><figure id="fig44" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Figure 44</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0044.jpeg" id="gr44" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 44. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig44"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Boiani et al. explored the activity of a series of 5-nitroindazoles against <i>T. cruzi</i> bloodstream trypomastigotes and <i>Leishmania promastigotes</i> and reported compound <b>217</b> (general structure) to induce substantial trypanocidal potential (>80% lysis), equivalent to gentian violet. A complete lysis of promastigotes of Leishmania was caused by some compounds. The potent compounds were found to exert their effects via an oxidative stress-mediated mechanism of action against <i>T. cruzi</i> epimastigotes (<a data-tab="pane-pcw-Figures" href="#fig44" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig44" id="" class=" internalNav">44</a></a>).<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(171)</a></div><div class="NLM_p">Rodrıguez et al. investigated the 5-nitroindazole scaffold structural features that were mandatory for anti-<i>Trypanosoma cruzi</i> activity. The investigation revealed several ideas regarding the structure–activity relationship including 1) a 5-nitro substituent in the indazole ring is necessary for activity, as evidenced by the diminished activity potential of des-nitro-analogs of the potent compound; 2) a butylaminopentyl substituent at position 1 of the indazole ring favors the activity; 3) N-oxidation of the tertiary amino moiety leads to the loss of activity; 4) the substituent at position 3 was found to be critical, with 3-OH substitution leading to complete loss of activity; and 5) intramolecular cyclization of the side chain at position 1 is not favored. The study also revealed that trypanocidal nitro-anion radicals were generated by 5-nitroindazole derivatives through a one-electron process at physiological pH. The general structure of the potent compound (<b>218</b>) is shown in <a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">45</a></a>.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(172)</a></div><figure id="fig45" data-index="45" class="article__inlineFigure"><h2 class="fig-label">Figure 45</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0045.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0045.jpeg" id="gr45" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 45. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0045.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig45"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Rodríguez et al. synthesized various 5-nitroindazole derivatives with remarkable in vitro activity against <i>Trypanosoma cruzi</i>. The general structures of the most potent compounds are shown in <a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">45</a></a>. The active compound (e.g., <b>218</b>) did not exhibit significant unspecific cytotoxicity against macrophages. It was also observed that new derivatives with a quaternized amino moiety between the 5- and 6-CH<sub>2</sub> in their side chain resulted in an enhanced activity potential. The mechanism of action was associated with the generation of reduced species of the nitro moiety.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(173)</a></div><div class="NLM_p">Vega et al. synthesized a series of 1,2-disubstituted 5-nitroindazolinones and evaluated them against epimastigote forms of <i>Trypanosoma cruzi</i>. Among the synthesized compounds, compounds <b>219</b>, <b>220</b>, and <b>221</b> were found to have significant trypanocidal activity and low unspecific toxicity. The authors assumed that, apart from the lipophilicity of the compounds, trypanocidal activity was also influenced by the susceptibility to the parasite nitroreductases (<a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">45</a></a>).<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(174)</a></div><div class="NLM_p">Fonseca-Berzal et al. reported a series of 5-nitroindazole derivatives and evaluated their trypanocidal activity and unspecific cytotoxicity. Among this series, compounds with general structure <b>222</b> induced complete inhibition of the growth of amastigotes at concentrations of <8 μM (IC<sub>50</sub> = 5 μM), with remarkable selectivity indices with respect to the intracellular form of the parasite (SI > 30). The in vivo evaluation of potent compounds caused 52% and 77% reductions in parasitemia levels when administered orally to infected mice.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(175)</a> The potent compounds were further evaluated in diverse <i>Trypanosoma cruzi</i> strains belonging to two discrete typing units (DTUs) frequently associated with human infection (i.e., DTUs TcII and TcVI), and it was found that the compounds were endowed with high selectivity toward drug-sensitive (CL and Tulahuen) and drug-moderately resistant <i>T. cruzi</i> strains (<a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">45</a></a>).<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(176)</a></div><div class="NLM_p last">Muro et al. reported the synthesis of 3-alkoxy-1-alkyl-and 3-alkoxy-1-(ω-aminoalkyl)-5-nitroindazoles and tested them against the different morphological forms of <i>Trypanosoma cruzi</i>. The results of the biological evaluation identified some potent compounds, displaying striking in vitro potential, similar to or better than that of the reference drug (<b>2</b>) with low unspecific cytotoxicity against Vero cells and good selectivity indices (SI). Compounds <b>223</b> and <b>224</b> were the most potent of the series, and the metabolic changes induced by them evidenced by the complementary analyses and ultrastructural alterations indicate that they might, along with some glycosomal or mitochondrial enzymes, be involved in the catabolism of <i>T. cruzi</i> disease. The substantial activity profile of <b>223</b> and <b>224</b> against <i>T. cruzi</i> was supported by the results of in vitro infectivity assays and in an in vivo murine model of Chagas disease (<a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">45</a></a>).<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(177)</a></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">6.  Patent Survey on Anticancer Agents Containing Nitro Groups (Hypoxia-Activated Prodrugs)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This section presents a recent patent survey on hypoxia-activated prodrugs (HAPs) containing nitro groups that have displayed promising bioactivity as anticancer agents in in vitro and in vivo studies.</div><div class="NLM_p">In 2003, Longqin Hu et al. filed a patent describing the synthesis of nitroaryl-substituted phosphoramide compounds as potent cytotoxic agents. The results revealed that some of the compounds were substrates of <i>E. coli</i> nitroreductase, with <i>T</i><sub>1/2</sub> values of between 7 and 24 min and 2.9–6.4 min. The compounds were further assayed for cytotoxicity against T116 cells (<i>E. coli</i> nitroreductase) or hDT7 (human quinone oxidoreductase) using a maximum concentration of 100 μM. Compounds <b>225</b> and <b>226</b> demonstrated similar IC<sub>50</sub> values and indicated that <i>E. coli</i> nitroreductase reduction was important for enhanced cytotoxicity. All of the compounds were also tested against human ovarian cancer cell lines (SKOV3), and the results revealed that the compounds with a nitro group at the position <i>para</i> to the benzylic carbon (<b>227</b>–<b>233</b>) showed significant inhibition against the ovarian cancer cell line (<a data-tab="pane-pcw-Figures" href="#fig46" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig46" id="" class=" internalNav">46</a></a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(40)</a></div><figure id="fig46" data-index="46" class="article__inlineFigure"><h2 class="fig-label">Figure 46</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0046.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0046.jpeg" id="gr46" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 46. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig46"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Denny et al. filed a patent on the discovery of novel nitro-1,2-dihydro-3<i>H</i>-benzo[<i>e</i>]indoles and related analogs for the use of hypoxia-selective drugs and as radiosensitizing agents for cancer therapy. Almost all of the compounds showed selectivity values that were 200-fold greater for hypoxia against at least one cancer cell line. Most of the compounds bearing 7-SO<sub>2</sub>NHR or 7-CONHR substituents were found to be active. The selectivity of the compounds suggested that the compounds have possibilities as hypoxia-selective cytotoxins. Compounds <b>234</b>, <b>235</b>, <b>236</b>, and <b>237</b> were found to be promising, with significant IC<sub>50</sub> values against both of the tested cancer cell lines (<a data-tab="pane-pcw-Figures" href="#fig47" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig47" id="" class=" internalNav">47</a></a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(41)</a></div><figure id="fig47" data-index="47" class="article__inlineFigure"><h2 class="fig-label">Figure 47</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0047.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0047.jpeg" id="gr47" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 47. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0047.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig47"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Jiao et al. in 2008 filed a patent on hypoxia-activated prodrugs (HAPs) for the treatment of cancer. Their results demonstrated that prodrugs they produced were more cytotoxic under hypoxic conditions than under normoxia. Notably, nine of the compounds (<b>238</b>–<b>246</b>) exhibited potent cytotoxicity, with IC<sub>50</sub> values within the nanomolar range, and four compounds were found to be active against the Miapaca cancer cell line. Furthermore, the HAPs were equally cytotoxic against the parental, sensitive, and resistant cell lines, suggesting that the compounds were not susceptible to the various resistance mechanisms and thus could be useful in cancer treatment (<a data-tab="pane-pcw-Figures" href="#fig48" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig48" id="" class=" internalNav">48</a></a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(42)</a></div><figure id="fig48" data-index="48" class="article__inlineFigure"><h2 class="fig-label">Figure 48</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0048.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0048.jpeg" id="gr48" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 48. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0048.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig48"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Xiao-Hong Cai et al. filed a patent in 2009 on hypoxia-activated prodrug (HAP) compounds of anthracyclins. Four compounds (<b>247</b>–<b>250</b>) were found to be significantly active. Compound <b>248</b> was approximately 400 times more cytotoxic under hypoxic conditions than under normoxia, with the hypoxic IC<sub>50</sub> value in the nanomolar range. Compound <b>248</b> was also found to be less toxic to the normal cells under normoxic conditions and exhibited selective inhibition of cancer cells. Moreover, compound <b>248</b> was administered to mice; the pharmacokinetic profile is depicted in <a data-tab="pane-pcw-Figures" href="#fig49" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig49" id="" class=" internalNav">49</a></a>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(43)</a></div><figure id="fig49" data-index="49" class="article__inlineFigure"><h2 class="fig-label">Figure 49</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0049.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0049.jpeg" id="gr49" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 49. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0049.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig49"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2011, Li-Xi Yang et al. filed a patent on the discovery of camptothecin-based analogs for the treatment of tumors. Compound <b>251</b> emerged as a compound that significantly increased the radiosensitivity of cancer cells. The chemotherapeutic effect of <b>251</b> caused > 90% inhibition at 10 nM against human prostate cancer cell lines (PC-3 and DU-145). The toxicity profile in mice showed that compound <b>251</b> did not exert toxicity, even up to the dose level of 200 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig49" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig49" id="" class=" internalNav">49</a></a>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(44)</a></div><div class="NLM_p">Charles et al. filed a patent on HAPs in combination with checkpoint kinase 1 (Chk1) inhibitors for the treatment of cancer. The anticancer potential of the compounds was assessed individually against p53 and HT29 cells using Chk1 inhibitors PF477736, AZD7762 and LY2603618, and cell viability was observed by using alamarBlue. The results demonstrated that the activity of all the compounds was significantly enhanced in the presence of Chk1 inhibitors. Induction of apoptosis by the most potent compound (<b>252</b>) was assessed in HT29 cells. The treatment with <b>252</b> and AZD7762 in combination induced a 3-fold increase in apoptosis, which suggested that the Chk1 inhibitor sensitizes HT29 cells (<a data-tab="pane-pcw-Figures" href="#fig49" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig49" id="" class=" internalNav">49</a></a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(45)</a></div><div class="NLM_p">Smaill et al. published a patent in 2014 on the synthesis of prodrugs of nitrobenzamide mustards, nitrobenzamide mustard alcohol, and their corresponding phosphate esters. Wild-type HCT116, H460, H1299, and SiHa cells were used, in addition to HC116 cells. Compounds <b>253</b>, <b>254</b>, <b>255</b>, and <b>256</b> were found to exhibit increased cytotoxicity in cells under hypoxic conditions. Nearly all of the compounds tested provided a profound tumor growth delay following a single intraperitoneal dose (<a data-tab="pane-pcw-Figures" href="#fig50" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig50" id="" class=" internalNav">50</a></a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(46)</a></div><figure id="fig50" data-index="50" class="article__inlineFigure"><h2 class="fig-label">Figure 50</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0050.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0050.jpeg" id="gr50" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 50. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0050.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig50"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2014, Nagasaki et al. filed a patent on the synthesis of a prodrug of 2-nitro-1-imidazolepropionic acid containing an amino group, a cyclic amino group or a hydroxyl group in the basic pharmacophore. Compound <b>257</b> exhibited a significantly lower survival rate of human pancreatic cancer cells, even at a low oxygen concentration, compared to that of compound <b>258</b> (previously reported in WO 2009/018163 A1). These results revealed that compound <b>257</b> possessed higher cytotoxic activity against human pancreatic cancer cells (<a data-tab="pane-pcw-Figures" href="#fig50" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig50" id="" class=" internalNav">50</a></a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(47)</a></div><div class="NLM_p">Nordihydroguaiaretic acid (NDGA) is an antioxidant and acts as a lipoxygenase inhibitor. It is isolated from creosote bush (<i>Larrea tridentate</i>). Previously, it was reported that tetra-<i>O</i>-methylnordihydroguaiaretic acid suppresses the growth of a variety of mouse and human tumor cells. On the basis of these findings, Huang et al. published a patent in 2014 on the synthesis of nitroimidazole conjugates by incorporating tri-<i>O</i>-methyl NDGA (M3N) with a nitroimidazole moiety to increase the effectiveness of tetra-<i>O</i>-methyl nordihydroguaiaretic acid that targets the hypoxic cancer cells. Among the synthesized compounds, <b>259</b>–<b>262</b> showed better inhibitory activity than the parent compound against Hep3B human hepatocellular carcinoma cells. The results indicated that all the conjugates, as well as the parent compound, were active in hypoxic conditions (<a data-tab="pane-pcw-Figures" href="#fig51" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig51" id="" class=" internalNav">51</a></a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(48)</a> In 2014, Matteucci et al. filed a patent on the synthesis of phosphoramidate alkylator prodrugs. The results of the biological evaluation indicated that compounds <b>263</b>, <b>264</b>, and <b>265</b> were significantly active only against H460 cell lines in all conditions, whereas compound <b>266</b> (in N<sub>2</sub>, IC<sub>50</sub> = 2 μM; in O<sub>2</sub>, IC<sub>50</sub> = 25 μM; in air, IC<sub>50</sub> > 100 μM) showed activity against HT29 cell lines (<a data-tab="pane-pcw-Figures" href="#fig51" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig51" id="" class=" internalNav">51</a></a>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(49)</a></div><figure id="fig51" data-index="51" class="article__inlineFigure"><h2 class="fig-label">Figure 51</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0051.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0051.jpeg" id="gr51" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 51. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0051.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig51"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2014, Yang et al. published a patent on the synthesis of nitropyridinyl ethyleneimine compounds. The results revealed that most of the compounds (<b>267</b>–<b>271</b>) possessed more intensive hypoxia-selective antitumor activity, and their working mechanism was, in general, associated with human cytochrome P<sub>450</sub> reductase (CYPOR) but not with wild-type (WT) cell lines (<a data-tab="pane-pcw-Figures" href="#fig52" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig52" id="" class=" internalNav">52</a></a>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(50)</a></div><figure id="fig52" data-index="52" class="article__inlineFigure"><h2 class="fig-label">Figure 52</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0052.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0052.jpeg" id="gr52" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 52. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0052.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig52"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Duan et al. filed a patent in 2016 on the synthesis and biological evaluation of nitrobenzyl derivatives as anticancer agents. All the synthetic compounds were tested for their ability to inhibit cell proliferation in an H460 human cancer cell line in the presence and absence of a specific inhibitor of the AKR IC3 enzyme. The results of the cell proliferation data indicated that compounds <b>272</b> and <b>273</b> had potent inhibitory activity, with IC<sub>50</sub> values of ∼0.03 μM, even in the absence of a selective inhibitor of AKR IC3 (<a data-tab="pane-pcw-Figures" href="#fig53" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig53" id="" class=" internalNav">53</a></a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(51)</a></div><figure id="fig53" data-index="53" class="article__inlineFigure"><h2 class="fig-label">Figure 53</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0053.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0053.jpeg" id="gr53" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 53. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig53"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In 2016, Smaill et al. published a patent on the synthesis of various prodrug forms of kinase inhibitors. The results of the biological evaluation revealed that most of the compounds acted as reversible inhibitors of the erbB family and exhibited potent inhibitory activity against erbB1. It was also indicated that the quaternary ammonium salt prodrugs (<b>274</b>) of significant active compounds possessed potent inhibitory activity against erbB1, with IC<sub>50</sub> values ranging from 0.22 to 0.56 nM (<a data-tab="pane-pcw-Figures" href="#fig53" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig53" id="" class=" internalNav">53</a></a>).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(52)</a></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">7.  Future Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The investigation of drugs that contain nitro groups is an area of study with diverse opinions. A majority of the scientific community considers it to be a bioreductive trigger as well as a toxicophore. It often has been labeled as a structural alert, but this categorization has not hindered the focus of chemists on the exploration of nitro-group-based prodrugs. This Perspective presents the various aspects of agents that contain nitro groups, along with an overview of the recent advances in antitubercular, anticancer, and antiparasitic agents containing these groups. The anticancer effects of nitro-based compounds have been demonstrated to be induced via diverse mechanisms, but primarily the impact lies in its hypoxia-selective effects. The hypoxia-selective cell killing effects have been observed with chemically varied architectures including duocarmycins, isophosphoramide mustard, muramyldipeptide, imidazoacridone moiety, 2′-deoxyuridine, 2′-deoxycytidine, 5′-<i>O</i>-nitro-2′-deoxyuridines, nitrochloromethylbenzindolines, doxorubicin, gemcitabine, O6-benzylguanine, 6-<i>O</i>-glucoazomycin, campthothecin, quinazolines, phenstatins, and several hybrid scaffolds. This clearly indicates the feasible incorporation of aryl and heteroaryl functionalities containing a nitro group as the bioreductive arm or trigger in diverse scaffolds, ultimately leading to pronounced hypoxia-selective inhibitory effects. The research literature for antitubercular and antiparasitic agents also exemplifies the therapeutic benefits of bioreduction or induced fragmentation mediated by nitro groups in augmenting the biological effects. There have been a number of investigations conducted on antitubercular agents with nitro group functionality, and most of them revolve around the attempts involving structural engineering on PA-824 and OPC-67683. Several alterations have been attempted and explored in the 5-nitroimidazooxazole skeleton, along with the placement of several heteroaryl bioisosteric surrogates, and in most cases, the results have exhibited favorable trends. Nitrotriazoles, imidazoles, and several antitubercular leads have also been an area of investigation for the development of antiparasitic agents. The development of drugs for neglected disease initiative programs has been very efficient in developing libraries of nitro-based heterocyclic compounds, and the results have been quite optimistic, indicating a high probability of effectiveness replicated in clinical studies. The patent literature is in accordance with the research literature, showing the contribution of the bioreductive activation of nitro-based compounds to exert potent effects. The role of the nitro group in inducing these effects was often confirmed by researchers by comparing the activity profile with the des-nitro analogs or derivatives in a majority of the cases. The influence of nitro groups toward the stabilization of the compounds within the catalytic site by hydrogen bonding and other interactions, as indicated by molecular modeling studies, was also observed. Among the nitro heterocycles, the nitroimadozolyl ring has emerged as the most privileged and versatile heterocycle, exerting potent cell-killing effects in addition to its well-proven potential against infectious diseases. In view of the aforementioned evidence, along with the fact that hypoxic regions in tumors are often associated with invasiveness, metastasis, and resistance to radiotherapy and chemotherapy, the development of nitro-based hypoxia-activated prodrugs appears to be a most logical and urgently desired area of research.</div><div class="NLM_p">Despite the promising evidence of nitro-based bioreductive prodrugs targeting tumor hypoxia, it has not been possible to replicate and amplify their preclinical promise into clinical efficacy. Thus, several alternatives must be conceptualized to fully exploit the benefits of drugs containing nitro groups. One of the logical strategies could be the combination of radiation therapy and chemotherapy that employs bioreductive drugs containing nitro groups to induce synergistic effects. Previously reported evidence of such combinations has provided positive results for the rationalization of this approach, as prodrugs activated by hypoxia target radiation-resistant hypoxic cells. Furthermore, the potential of the role of nitroimidazoles as radiosensitizers should also be investigated in detail. It appears that solid tumors exhibiting extreme vulnerability to this combination can be substantially inhibited. Several agents covered in this Perspective have shown remarkable efficacy against solid tumors, and this further lays the foundation for the evaluation of these agents in combination with radiation.</div><div class="NLM_p">Another challenge associated with the use of drugs containing nitro groups concerns toxicity issues such as carcinogenicity, hepatotoxicity, mutagenicity, and bone-marrow suppression. In this context, future constructive attempts should be directed toward capitalizing the biopotential and reducing the toxicities of these drugs through structure genotoxicity/mutagenicity studies. A relevant approach could be the identification of the human enzymes that activate the nitro-containing drugs. Nifurtimox (<b>2</b>) excellently exemplifies this strategy, as the drug is an alcohol dehydrogenase 2 (ALDH2) substrate, and therefore the concomitant administration of ALDH2 inhibitors can reduce the toxicity issues. This approach presents enough scope in the fabrication of such strategies to reduce toxicity. Another way to combat such issues could be the establishment of tumor tissue selectivity, which evidence indicates can be achieved by bioreductive therapy. In this context, application of stimuli-responsive nanocarriers would appear to be a promising approach, particularly in view of the large number of nitro-based drugs that fail clinical trials due to toxicity issues. A formulation design program for the numerous drugs containing nitro groups covered in this review that can release the anticancer drugs in the tumor microenvironment (e.g., hypoxic regions) appears to be a practical approach that could lead to therapeutic benefits. The cleavage or reduction of hypoxia-responsive nitro functional groups at low oxygen levels is likely to induce conformational variations in hypoxia-responsive nanocarriers, which are required to be deeply explored for the efficient design of nanocarriers for the “drugs containing nitro groups” pipeline. Formulation chemists should also direct their attention to the antitubercular agents containing nitro groups, such as PA-824 (<b>24</b>) and OPC-67683 (<b>13</b>), which are not mutagenic and genotoxic but rather are handicapped by solubility issues, which are a barrier to their therapeutic utility.</div><div class="NLM_p last">In summary, agents containing nitro groups have been designed and employed as prodrugs. This is clear from recent advances in the fields of anticancer, antitubercular, and antiparasitic agents. It appears that controlling the bioactivation of nitro compounds could prove to be a genuine boon in the maximization of the bioactive potential of such compounds, with a concomitant minimization of toxicity issues. Toxicity related hindrance in the therapeutic growth of drugs containing nitro groups should be handled by finding ways to combat it rather than avoiding it.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00147" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00147" class="ext-link">10.1021/acs.jmedchem.8b00147</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Nitro containing drugs/agents and their clinical/preclinical update (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00147/suppl_file/jm8b00147_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00147/suppl_file/jm8b00147_si_001.pdf">jm8b00147_si_001.pdf (827.46 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00147" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71368" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71368" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing-Ping Liou</span> - <span class="hlFld-Affiliation affiliation">School of Pharmacy, College
of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3775-6405" title="Orcid link">http://orcid.org/0000-0002-3775-6405</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f59f8599b5819880db909180db8182"><span class="__cf_email__" data-cfemail="f69c869ab6829b83d8939283d88281">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kunal Nepali</span> - <span class="hlFld-Affiliation affiliation">School of Pharmacy, College
of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsueh-Yun Lee</span> - <span class="hlFld-Affiliation affiliation">School of Pharmacy, College
of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei 11031, Taiwan.</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48285" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48285" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="54" class="article__inlineFigure"><h2 class="fig-label">Kunal Nepali</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=BIO-d7e4271-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Kunal Nepali</b> obtained his Ph.D. degree in Pharmaceutical Chemistry in the year 2012 from ISF College of Pharmacy, Moga, Punjab, India, and is currently a postdoctoral researcher in the Department of Medicinal Chemistry, Taipei Medical University, Taiwan. His scientific interests are centered in the design and synthesis of novel molecular entities as future therapeutics to address pharmacological problems.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="55" class="article__inlineFigure"><h2 class="fig-label">Hsueh-Yun Lee</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=BIO-d7e4276-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hsueh-Yun Lee</b> received his Ph.D. from National Taiwan University in 2010. After 2 years of postdoctoral training, he joined in faculty at Taipei Medical University in 2012. His major scientific interests focus on the discovery of small molecules targeting epigenetic disorders, oncogenesis, and neurological diseases.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="56" class="article__inlineFigure"><h2 class="fig-label">Jing-Ping Liou</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=BIO-d7e4281-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jing-Ping Liou</b> has expertise spanning medicinal chemistry, natural product chemistry, and organic synthesis, with a >20-year experience in the development of cancer therapeutics. Presently, he is a Professor of Medicinal Chemistry in Taipei Medical University, Taiwan, and has a Ph.D. degree from the College of Medicine, National Taiwan University. His research work employs a rational structure based drug design approach that lies at the interface of chemistry and biology to treat cellular processes dealing with chronic molecular stress. His career as a medicinal chemist extends to the industrial sector also where he has advised several pharmaceutical companies and start-ups for developing novel clinical drug candidates. His publication profile includes 20 contributions to the <i>Journal of Medicinal Chemistry</i> along with numerous other publications and patents.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the Ministry of Science and Technology of the Republic of China (Grant MOST 106-2113-M-038-002).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Mtb</td><td class="NLM_def"><p class="first last"><i>Mycobacterium tuberculosis</i></p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term">MBC</td><td class="NLM_def"><p class="first last">minimum bactericidal concentration</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, toxicity</p></td></tr><tr><td class="NLM_term">BTZ</td><td class="NLM_def"><p class="first last">benzothiazine</p></td></tr><tr><td class="NLM_term">TB</td><td class="NLM_def"><p class="first last">tuberculosis</p></td></tr><tr><td class="NLM_term">MPA</td><td class="NLM_def"><p class="first last">mycophenolic acid</p></td></tr><tr><td class="NLM_term">TKI</td><td class="NLM_def"><p class="first last">tyrosine kinase inhibitor</p></td></tr><tr><td class="NLM_term">POR</td><td class="NLM_def"><p class="first last">cytochrome P450 oxidoreductase</p></td></tr><tr><td class="NLM_term">ADEPT</td><td class="NLM_def"><p class="first last">antibody-directed directed enzyme prodrug therapy</p></td></tr><tr><td class="NLM_term">GDEPT</td><td class="NLM_def"><p class="first last">gene-directed enzyme prodrug therapy</p></td></tr><tr><td class="NLM_term">AGT</td><td class="NLM_def"><p class="first last">O6-alkylguanine-DNA alkyltransferase</p></td></tr><tr><td class="NLM_term">CTA</td><td class="NLM_def"><p class="first last">clinical trial application</p></td></tr><tr><td class="NLM_term">IND</td><td class="NLM_def"><p class="first last">investigational new drug application</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">CLL</td><td class="NLM_def"><p class="first last">chronic lymphocytic leukemia</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">DNDi</td><td class="NLM_def"><p class="first last">drugs for neglected diseases initiative</p></td></tr><tr><td class="NLM_term">IMPDH</td><td class="NLM_def"><p class="first last">inosine 5′-monophosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">HAPS</td><td class="NLM_def"><p class="first last">hypoxia activated prodrug</p></td></tr><tr><td class="NLM_term">HAT</td><td class="NLM_def"><p class="first last">human African trypanosomiasis</p></td></tr><tr><td class="NLM_term">VL</td><td class="NLM_def"><p class="first last">visceral leishmaniasis</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 177 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, K.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parales, R. E.</span></span> <span> </span><span class="NLM_article-title">Nitroaromatic compounds, from synthesis to biodegradation</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1128/MMBR.00006-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1128%2FMMBR.00006-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=20508249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslKgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2010&pages=250-272&author=K.%0AS.+Juauthor=R.+E.+Parales&title=Nitroaromatic+compounds%2C+from+synthesis+to+biodegradation&doi=10.1128%2FMMBR.00006-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroaromatic compounds, from synthesis to biodegradation</span></div><div class="casAuthors">Ju, Kou-San; Parales, Rebecca E.</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">250-272</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Nitroarom. compds. are relatively rare in nature and have been introduced into the environment mainly by human activities.  This important class of industrial chems. is widely used in the synthesis of many diverse products, including dyes, polymers, pesticides, and explosives.  Unfortunately, their extensive use has led to environmental contamination of soil and groundwater.  The nitro group, which provides chem. and functional diversity in these mols., also contributes to the recalcitrance of these compds. to biodegrdn.  The electron-withdrawing nature of the nitro group, in concert with the stability of the benzene ring, makes nitroarom. compds. resistant to oxidative degrdn.  Recalcitrance is further compounded by their acute toxicity, mutagenicity, and easy redn. into carcinogenic arom. amines.  Nitroarom. compds. are hazardous to human health and are registered on the U.S. Environmental Protection Agency's list of priority pollutants for environmental remediation.  Although the majority of these compds. are synthetic in nature, microorganisms in contaminated environments have rapidly adapted to their presence by evolving new biodegrdn. pathways that take advantage of them as sources of carbon, nitrogen, and energy.  This review provides an overview of the synthesis of both man-made and biogenic nitroarom. compds., the bacteria that have been identified to grow on and completely mineralize nitroarom. compds., and the pathways that are present in these strains.  The possible evolutionary origins of the newly evolved pathways are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGocxxylLtq7Vg90H21EOLACvtfcHk0lil0Ie7DXAaUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslKgt7s%253D&md5=642bc57decfe2de3c705ba6cc9b2213c</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00006-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00006-10%26sid%3Dliteratum%253Aachs%26aulast%3DJu%26aufirst%3DK.%2BS.%26aulast%3DParales%26aufirst%3DR.%2BE.%26atitle%3DNitroaromatic%2520compounds%252C%2520from%2520synthesis%2520to%2520biodegradation%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2010%26volume%3D74%26spage%3D250%26epage%3D272%26doi%3D10.1128%2FMMBR.00006-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Noboru, O.</span></span> <i>The Nitro Group in Organic Synthesis</i>; <span class="NLM_publisher-name">Wiley VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2001</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">363</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=1-363&author=O.+Noboru&title=The+Nitro+Group+in+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNoboru%26aufirst%3DO.%26btitle%3DThe%2520Nitro%2520Group%2520in%2520Organic%2520Synthesis%26pub%3DWiley%2520VCH%26date%3D2001%26spage%3D1%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, M.</span></span> <span> </span><span class="NLM_article-title">The nitroaromatic group in drug design. Pharmacology (for nonpharmacologists)</span>. <i>Ind. Eng. Chem. Prod. Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1021/i360071a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/i360071a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1979&pages=158-166&author=M.+Strauss&title=The+nitroaromatic+group+in+drug+design.+Pharmacology+%28for+nonpharmacologists%29&doi=10.1021%2Fi360071a002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fi360071a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fi360071a002%26sid%3Dliteratum%253Aachs%26aulast%3DStrauss%26aufirst%3DM.%26atitle%3DThe%2520nitroaromatic%2520group%2520in%2520drug%2520design.%2520Pharmacology%2520%2528for%2520nonpharmacologists%2529%26jtitle%3DInd.%2520Eng.%2520Chem.%2520Prod.%2520Res.%2520Dev.%26date%3D1979%26volume%3D18%26spage%3D158%26epage%3D166%26doi%3D10.1021%2Fi360071a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gulley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, C. G.</span></span> <span> </span><span class="NLM_article-title">Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3884</span>– <span class="NLM_lpage">3891</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-10-2656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1158%2F1078-0432.CCR-10-2656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=21680544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFKgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3884-3891&author=J.+L.+Gulleyauthor=C.+G.+Drake&title=Immunotherapy+for+prostate+cancer%3A+recent+advances%2C+lessons+learned%2C+and+areas+for+further+research&doi=10.1158%2F1078-0432.CCR-10-2656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy for Prostate Cancer: Recent Advances, Lessons Learned, and Areas for Further Research</span></div><div class="casAuthors">Gulley, James L.; Drake, Charles G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3884-3891</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  A surge of interest in therapeutic cancer vaccines has arisen in the wake of recent clin. trials suggesting that such vaccines can result in statistically significant and clin. meaningful improvements in overall survival-with substantially limited side effects compared with chemotherapy-in patients with metastatic castration-resistant prostate cancer.  One of these trials led to the registration of sipuleucel-T, the first therapeutic vaccine to be approved for cancer patients.  In this review we highlight emerging patterns from clin. trials that suggest a need for more-appropriate patient populations (i.e., with lower tumor vol. and less-aggressive disease) and endpoints (i.e., overall survival) for studies of immunotherapy alone, as well as biol. plausible explanations for these findings.  We also explore the rationale for ongoing and planned studies combining therapeutic vaccines with other modalities.  Finally, we attempt to put these findings into a practical clin. context and suggest fertile areas for future study.  Although our discussion focuses on prostate cancer, the concepts we address most likely have broad applicability to immunotherapy for other cancers as well.  Clin Cancer Res; 17(12); 3884-91.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJcJeL25s4NrVg90H21EOLACvtfcHk0lidUo8LI6Nj4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFKgsLw%253D&md5=2dbf2f63f86d7ba7567d96af91c1fa47</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2656%26sid%3Dliteratum%253Aachs%26aulast%3DGulley%26aufirst%3DJ.%2BL.%26aulast%3DDrake%26aufirst%3DC.%2BG.%26atitle%3DImmunotherapy%2520for%2520prostate%2520cancer%253A%2520recent%2520advances%252C%2520lessons%2520learned%252C%2520and%2520areas%2520for%2520further%2520research%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D3884%26epage%3D3891%26doi%3D10.1158%2F1078-0432.CCR-10-2656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharifi, R.</span></span> <span> </span><span class="NLM_article-title">Benign prostatic hyperplasia: diagnosis and treatment guideline</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1177/106002809703100415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1177%2F106002809703100415" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1997&pages=481-486&author=M.+Leeauthor=R.+Sharifi&title=Benign+prostatic+hyperplasia%3A+diagnosis+and+treatment+guideline&doi=10.1177%2F106002809703100415"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1177%2F106002809703100415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F106002809703100415%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%26aulast%3DSharifi%26aufirst%3DR.%26atitle%3DBenign%2520prostatic%2520hyperplasia%253A%2520diagnosis%2520and%2520treatment%2520guideline%26jtitle%3DAnn.%2520Pharmacother.%26date%3D1997%26volume%3D31%26spage%3D481%26epage%3D486%26doi%3D10.1177%2F106002809703100415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span>DHHS/National
Toxicology Program; Eleventh Report on Carcinogens: Metronidazole
(443-48-1) (January 2005). <a href="http://www.jmcprl.net/PUBLICACIONES/F05/cancerigenos/eleventh/profiles/s112metr.pdf" class="extLink">http://www.jmcprl.net/PUBLICACIONES/F05/cancerigenos/eleventh/profiles/s112metr.pdf</a> (accessed December 14, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DHHS%2FNational%0AToxicology+Program%3B+Eleventh+Report+on+Carcinogens%3A+Metronidazole%0A%28443-48-1%29+%28January+2005%29.+http%3A%2F%2Fwww.jmcprl.net%2FPUBLICACIONES%2FF05%2Fcancerigenos%2Feleventh%2Fprofiles%2Fs112metr.pdf+%28accessed+December+14%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span>FDA Approves
Symbiomix Therapeutics’ Solosec (secnidazole) Oral Granules
for the Treatment of Bacterial Vaginosis in Adult Women, September
18, 2017. <a href="https://symbiomix.com/fda-approves-symbiomix-therapeutics-solosec-secnidazole-oral-granules-treatment-bacterial-vaginosis-adult-women/" class="extLink">https://symbiomix.com/fda-approves-symbiomix-therapeutics-solosec-secnidazole-oral-granules-treatment-bacterial-vaginosis-adult-women/</a> (accessed December 12, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA+Approves%0ASymbiomix+Therapeutics%E2%80%99+Solosec+%28secnidazole%29+Oral+Granules%0Afor+the+Treatment+of+Bacterial+Vaginosis+in+Adult+Women%2C+September%0A18%2C+2017.+https%3A%2F%2Fsymbiomix.com%2Ffda-approves-symbiomix-therapeutics-solosec-secnidazole-oral-granules-treatment-bacterial-vaginosis-adult-women%2F+%28accessed+December+12%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Nigro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballo, M. A.</span></span> <span> </span><span class="NLM_article-title">Genotoxicity and cell death induced by tinidazole (TNZ)</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2008.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.toxlet.2008.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18582545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=46-52&author=M.+M.+Lopez+Nigroauthor=M.+A.+Carballo&title=Genotoxicity+and+cell+death+induced+by+tinidazole+%28TNZ%29&doi=10.1016%2Fj.toxlet.2008.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Genotoxicity and cell death induced by tinidazole (TNZ)</span></div><div class="casAuthors">Lopez Nigro, M. M.; Carballo, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-52</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tinidazole (TNZ), a second-generation 5-nitroimidazole compd. chem. related to metronidazole (MTZ), has been widely used throughout Europe and developing countries for the treatment of amoebic and parasitic infections.  Despite TNZ's increasing use in therapeutics, scarce exptl. reports are available in literature on its potential genotoxicity in human cells.  Therefore, the aim of the present study was to achieve a precise characterization of the cytotoxic and genotoxic activities of this nitroimidazole in cultured human lymphocytes at therapeutic concns. (0.1, 1, 10 and 50 μg/mL of culture) and evaluate the possible cell death mechanism assocd. with it.  The endpoints analyzed included: mitotic index (MI), replication index (RI), sister chromatid exchange (SCE) and chromosomal aberrations (CA).  A significant decrease (p < 0.0001) in MI as well as an increase in SCE (p < 0.0001) and CA (p < 0.0001) frequencies were obsd.  No modifications in RI were found.  The results suggest a genotoxic and cytotoxic effect of TNZ related with cell death process.  Therefore, we evaluated this mechanism by DNA fragmentation (laddering), fluorescence microscopy using acridine orange/ethidium bromide (AO/EB) staining and flow cytometry propidium iodide (PI).  DNA exts. of TNZ-treated cells resulted in nucleosomal DNA ladder pattern after 48 h of cell treatment; meanwhile no differences were detected in untreated cells.  This pattern correlated with the obsd. decrease in cellular viability (p < 0.05), morphol. evidence of apoptosis and increase in the percentage of nuclei with hypodiploid DNA content of TNZ exposed cultures compared with control (p < 0.05).  We concluded that TNZ is genotoxic, cytotoxic and is able to modulate cell death through apoptotic mechanisms in the exptl. design employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyVTqYT7hs3LVg90H21EOLACvtfcHk0lidUo8LI6Nj4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D&md5=dbf7f9c371265bace4f736b0a475e1c9</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2008.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2008.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%2BNigro%26aufirst%3DM.%2BM.%26aulast%3DCarballo%26aufirst%3DM.%2BA.%26atitle%3DGenotoxicity%2520and%2520cell%2520death%2520induced%2520by%2520tinidazole%2520%2528TNZ%2529%26jtitle%3DToxicol.%2520Lett.%26date%3D2008%26volume%3D180%26spage%3D46%26epage%3D52%26doi%3D10.1016%2Fj.toxlet.2008.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, T. L.</span></span> <span> </span><span class="NLM_article-title">Tinidazole: a nitroimidazole antiprotozoal agent</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1859</span>– <span class="NLM_lpage">1884</span>, <span class="refDoi"> DOI: 10.1016/j.clinthera.2005.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.clinthera.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=16507373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1859-1884&author=H.+B.+Fungauthor=T.+L.+Doan&title=Tinidazole%3A+a+nitroimidazole+antiprotozoal+agent&doi=10.1016%2Fj.clinthera.2005.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Tinidazole: a nitroimidazole antiprotozoal agent</span></div><div class="casAuthors">Fung, Horatio B.; Doan, Thien-Ly</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1859-1884</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Tinidazole, a structural analog of metronidazole, is an antiprotozoal agent that has been widely used in Europe and developing countries for >2 decades with established efficacy and acceptable tolerability.  It was recently approved by the US Food and Drug Administration for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Objective: This article reviews the pharmacol. and pharmacokinetic properties and clin. usefulness of tinidazole.  Methods: Relevant information was identified through a search of MEDLINE (1966-August 2005), Iowa Drug Information Service (1966-August 2005), and International Pharmaceutical Abstrs. (1970-August 2005) using the terms tinidazole, Fasigyn, and nitroimidazole.  Results: In vitro, tinidazole exhibits activity against pathogenic protozoa (eg, Trichomonas vaginalis, Entamoeba histolytica, Giardia duodenalis), a wide range of clin. significant anaerobic bacteria (eg, Bacteroides fragilis, Clostridium difficile), and the microaerophilic bacterium Helicobacter pylori.  In susceptible protozoal and bacterial cells, tinidazole is reduced to cytotoxic intermediates that covalently bind to DNA, causing irreversible damage.  In human adults, tinidazole had a bioavailability of 100% and a Vd of 50.7 L, was minimally bound to plasma protein (12%), had a plasma elimination t1/2 of 12.3 h, and was eliminated primarily by hepatic metab. (∼63%).  Dose adjustment does not appear to be necessary on the basis of race, sex, or renal function.  No data were found on the disposition of tinidazole in patients with hepatic insufficiency; therefore, use of tinidazole in patients with severe hepatic impairment (Child-Pugh class C) is not recommended.  Clin. cure rates in patients with trichomoniasis, giardiasis, amebiasis, and amebic liver abscess were generally >90%.  In comparative trials, tinidazole was as effective as metronidazole in the treatment of trichomoniasis and was significantly more effective than metronidazole in the treatment of giardiasis (P < 0.05) and amebiasis (P < 0.05).  The most commonly reported (>1%) adverse effects included bitter taste, nausea, abdominal discomfort, anorexia, vomiting, and fatigue.  The recommended dosage of tinidazole is a single dose of 2 g for trichomoniasis and giardiasis, and 2 g/d for 3 to 5 days for amebiasis.  Conclusions: Tinidazole appears to be a promising agent for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Clin. studies are needed to evaluate the use of tinidazole against anaerobic bacteria and H pylori.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGwTnbff6nLbVg90H21EOLACvtfcHk0liTZnDF1cj6Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D&md5=cc1ef607c78b3cb9889d5425c4858f04</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DH.%2BB.%26aulast%3DDoan%26aufirst%3DT.%2BL.%26atitle%3DTinidazole%253A%2520a%2520nitroimidazole%2520antiprotozoal%2520agent%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1859%26epage%3D1884%26doi%3D10.1016%2Fj.clinthera.2005.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6"><span>Tinidazole News. <a href="https://www.drugs.com/answers/support-group/tinidazole/news/" class="extLink">https://www.drugs.com/answers/support-group/tinidazole/news/</a> (accessed December 21, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tinidazole+News.+https%3A%2F%2Fwww.drugs.com%2Fanswers%2Fsupport-group%2Ftinidazole%2Fnews%2F+%28accessed+December+21%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raether, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hänel, H.</span></span> <span> </span><span class="NLM_article-title">Nitroheterocyclic drugs with broad spectrum activity</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">S19</span>– <span class="NLM_lpage">S39</span>, <span class="refDoi"> DOI: 10.1007/s00436-002-0754-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1007%2Fs00436-002-0754-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=12811546" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2003&pages=S19-S39&issue=Suppl.+1&author=W.+Raetherauthor=H.+H%C3%A4nel&title=Nitroheterocyclic+drugs+with+broad+spectrum+activity&doi=10.1007%2Fs00436-002-0754-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00436-002-0754-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-002-0754-9%26sid%3Dliteratum%253Aachs%26aulast%3DRaether%26aufirst%3DW.%26aulast%3DH%25C3%25A4nel%26aufirst%3DH.%26atitle%3DNitroheterocyclic%2520drugs%2520with%2520broad%2520spectrum%2520activity%26jtitle%3DParasitol.%2520Res.%26date%3D2003%26volume%3D90%26issue%3DSuppl.%25201%26spage%3DS19%26epage%3DS39%26doi%3D10.1007%2Fs00436-002-0754-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. S.</span></span> <span> </span><span class="NLM_article-title">Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2072</span>– <span class="NLM_lpage">2084</span>, <span class="refDoi"> DOI: 10.2174/156802611796575894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.2174%2F156802611796575894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=21619510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=2072-2084&author=S.+R.+Wilkinsonauthor=C.+Botauthor=J.+M.+Kellyauthor=B.+S.+Hall&title=Trypanocidal+activity+of+nitroaromatic+prodrugs%3A+current+treatments+and+future+perspectives&doi=10.2174%2F156802611796575894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives</span></div><div class="casAuthors">Wilkinson, Shane R.; Bot, Christopher; Kelly, John M.; Hall, Belinda S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2072-2084</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chagas disease and African sleeping sickness are trypanosomal infections that represent important public health problems in Latin America and Africa, resp.  The restriction of these diseases to the poorer parts of the world has meant that they have been largely neglected and limited progress has been made in their treatment.  The nitroheterocyclic prodrugs nifurtimox and benznidazole, in use against Chagas disease for >40 years, remain the only agents available for this infection.  In the case of African sleeping sickness, nifurtimox has recently been added to the arsenal of medicines, with the nitroheterocycle fexinidazole currently under evaluation.  For a long time, the cytotoxic mechanisms of these drugs were poorly understood: nifurtimox was thought to act via prodn. of superoxide anions and nitro radicals, while the mode of benznidazole action was more obscure.  The trypanocidal activity of nitroheterocyclic drugs is now known to depend on a parasite type I nitroreductase (NTR).  This enzyme is absent from mammalian cells, a difference that forms the basis for the drug selectivity.  The role of this enzyme in drug activation has been genetically and biochem. validated.  It catalyzes the 2-electron redn. of nitroheterocyclic compds. within the parasite, producing toxic metabolites without significant generation of superoxide.  Recognition that this enzyme is responsible for activation of nitroheterocyclic prodrugs has allowed screening for compds. that preferentially target the parasite.  This approach has led to the identification of two new classes of anti-trypanosomal agents, nitrobenzylphosphoramide mustards and aziridinyl nitrobenzamides, and promises to yield new, safer, more effective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6vBQMwS_TY7Vg90H21EOLACvtfcHk0liTZnDF1cj6Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3L&md5=5976d05c6686ad8121c94b5da581f599</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F156802611796575894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611796575894%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DBot%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DHall%26aufirst%3DB.%2BS.%26atitle%3DTrypanocidal%2520activity%2520of%2520nitroaromatic%2520prodrugs%253A%2520current%2520treatments%2520and%2520future%2520perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D2072%26epage%3D2084%26doi%3D10.2174%2F156802611796575894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitmore, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, A. J.</span></span> <span> </span><span class="NLM_article-title">The biological properties of reduced nitroheterocycles and possible underlying biochemical mechanisms</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(86)90565-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2F0006-2952%2886%2990565-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1986&pages=97-103&author=G.+F.+Whitmoreauthor=A.+J.+Varghese&title=The+biological+properties+of+reduced+nitroheterocycles+and+possible+underlying+biochemical+mechanisms&doi=10.1016%2F0006-2952%2886%2990565-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2886%2990565-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252886%252990565-4%26sid%3Dliteratum%253Aachs%26aulast%3DWhitmore%26aufirst%3DG.%2BF.%26aulast%3DVarghese%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520biological%2520properties%2520of%2520reduced%2520nitroheterocycles%2520and%2520possible%2520underlying%2520biochemical%2520mechanisms%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1986%26volume%3D35%26spage%3D97%26epage%3D103%26doi%3D10.1016%2F0006-2952%2886%2990565-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boelsterli, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leow, K. Y.</span></span> <span> </span><span class="NLM_article-title">Bioactivation and hepatotoxicity of nitroaromatic drugs</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.2174/138920006778520606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.2174%2F138920006778520606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=17073576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWgt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=715-727&author=U.+A.+Boelsterliauthor=H.+K.+Hoauthor=S.+Zhouauthor=K.+Y.+Leow&title=Bioactivation+and+hepatotoxicity+of+nitroaromatic+drugs&doi=10.2174%2F138920006778520606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation and hepatotoxicity of nitroaromatic drugs</span></div><div class="casAuthors">Boelsterli, Urs A.; Ho, Han Kiat; Zhou, Shufeng; Leow, Koon Yeow</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">715-727</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Certain drugs contg. a nitroarom. moiety (e.g., tolcapone, nimesulide, nilutamide, flutamide, nitrofurantoin) have been assocd. with organ-selective toxicity including rare cases of idiosyncratic liver injury.  What they have in common is the potential for multistep nitroreductive bioactivation (6-electron transfer) that produces the potentially hazardous nitroanion radical, nitroso intermediate, and N-hydroxy deriv.  These intermediates have been assocd. with increased oxidant stress and targeting of nucleophilic residues on proteins and nucleic acids.  However, other mechanisms including the formation of oxidative metabolites and mitochondrial liability, as well as inherent toxicokinetic properties, also det. the drugs' overall potency.  Therefore, structural modification not only of the nitro moiety but also of ring substituents can greatly reduced toxicity.  Novel concepts have revealed that, besides the classical microsomal nitroreductases, cytosolic and mitochondrial enzymes including nitric oxide synthase can also bioactivate certain nitroarenes (nilutamide).  Furthermore, animal models of silent mitochondrial dysfunction have demonstrated that a mitochondrial oxidant stress posed by certain nitroarom. drugs (nimesulide) can produce significant mitochondrial injury if superimposed on a genetic mitochondrial abnormality.  Finally, there may be mechanisms for all nitroarom. drugs that do not involve bioactivation of the nitro group, e.g., AHR interactions with flutamide.  Taken together, the focus of research on the hepatic toxicity of nitroarene-contg. drugs has shifted over the past years from the identification of the reactive intermediates generated during the bioreductive pathway to the underlying biomechanisms of liver injury.  Most likely one of the next paradigm shifts will include the identification of determinants of susceptibility to nitroarom. drug-induced hepatotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbZw5d9MZTE7Vg90H21EOLACvtfcHk0lglzrleB08BRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWgt7rF&md5=21e155ba17d1ad097e7652a5d22728b3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138920006778520606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920006778520606%26sid%3Dliteratum%253Aachs%26aulast%3DBoelsterli%26aufirst%3DU.%2BA.%26aulast%3DHo%26aufirst%3DH.%2BK.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DLeow%26aufirst%3DK.%2BY.%26atitle%3DBioactivation%2520and%2520hepatotoxicity%2520of%2520nitroaromatic%2520drugs%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2006%26volume%3D7%26spage%3D715%26epage%3D727%26doi%3D10.2174%2F138920006778520606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wardman, P.</span></span> <span> </span><span class="NLM_article-title">Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.2174/0929867013372959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.2174%2F0929867013372959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=11375747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVChtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=739-761&author=P.+Wardman&title=Electron+transfer+and+oxidative+stress+as+key+factors+in+the+design+of+drugs+selectively+active+in+hypoxia&doi=10.2174%2F0929867013372959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia</span></div><div class="casAuthors">Wardman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">739-761</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 229 refs.  Hypoxia is a feature of some regions of many tumors, ischemic events, and arthritis.  Drugs activated in hypoxia have wide potential application, particularly in overcoming the resistance of hypoxic tumor cells to radiotherapy.  Key features of such drugs include redox properties appropriate for activation by reductase enzymes (typically flavoproteins), and oxygen-sensitive redn. chem. such that normal levels of oxygen inhibit or reverse redn.  In many cases this selectivity is achieved by a fast, free-radical reaction in which the drug radical (often an obligate intermediate in drug redn.) reduces oxygen to form superoxide radicals and thus "futile cycles" the drug in normoxic tissues.  However, this enhances cellular oxidative stress, which may be linked to normal tissue toxicity.  Appropriate redox properties are found with nitroarene, quinone, or arom. N-oxide moieties.  A particularly promising and versatile exploitation of bioreductive activation is for redn. of such "triggers" to activate release of an "effector", an agent that can obviously be active against diverse conditions assocd. with hypoxia.  The same approach can also be used in diagnosis of hypoxia.  Much information concerning the reactions of intermediates in drug action and the quant. prediction of redox properties of analogs has been accrued.  Drug design can be mechanism-led, with the wealth of literature quantifying redox properties of drug candidates a rich source of potential new leads.  There is a clear appreciation of the kinetic factors that limit drug efficacy or selectivity.  Thus the potential for rapid expansion of these concepts to diverse diseases is considerable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8yb0NnUNo6bVg90H21EOLACvtfcHk0lglzrleB08BRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVChtbg%253D&md5=71b7850f3858686974de41834ac7aa45</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F0929867013372959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867013372959%26sid%3Dliteratum%253Aachs%26aulast%3DWardman%26aufirst%3DP.%26atitle%3DElectron%2520transfer%2520and%2520oxidative%2520stress%2520as%2520key%2520factors%2520in%2520the%2520design%2520of%2520drugs%2520selectively%2520active%2520in%2520hypoxia%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D739%26epage%3D761%26doi%3D10.2174%2F0929867013372959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruchelman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoie, E. J.</span></span> <span> </span><span class="NLM_article-title">Diaza- and triazachrysenes: Potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDAMB-435</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3333</span>– <span class="NLM_lpage">3336</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00737-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FS0960-894X%2802%2900737-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3333-3336&author=A.+L.+Ruchelmanauthor=S.+K.+Singhauthor=X.+Wuauthor=A.+Rayauthor=J.-M.+Yangauthor=T.-K.+Liauthor=A.+Liuauthor=L.+F.+Liuauthor=E.+J.+LaVoie&title=Diaza-+and+triazachrysenes%3A+Potent+topoisomerase-targeting+agents+with+exceptional+antitumor+activity+against+the+human+tumor+xenograft%2C+MDAMB-435&doi=10.1016%2FS0960-894X%2802%2900737-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900737-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900737-0%26sid%3Dliteratum%253Aachs%26aulast%3DRuchelman%26aufirst%3DA.%2BL.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DJ.-M.%26aulast%3DLi%26aufirst%3DT.-K.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3DDiaza-%2520and%2520triazachrysenes%253A%2520Potent%2520topoisomerase-targeting%2520agents%2520with%2520exceptional%2520antitumor%2520activity%2520against%2520the%2520human%2520tumor%2520xenograft%252C%2520MDAMB-435%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3333%26epage%3D3336%26doi%3D10.1016%2FS0960-894X%2802%2900737-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruchelman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoie, E. J.</span></span> <span> </span><span class="NLM_article-title">5<i>H</i>-Dibenzo[<i>c,h</i>][1,6]naphthyridin-6-ones: Novel topoisomerase I-targeting anticancer agents with potent cytotoxic activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2061</span>– <span class="NLM_lpage">2073</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(03)00051-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FS0968-0896%2803%2900051-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2061-2073&author=A.+L.+Ruchelmanauthor=S.+K.+Singhauthor=A.+Rayauthor=X.+Wuauthor=J.-M.+Yangauthor=T.-K.+Liauthor=A.+Liuauthor=L.+F.+Liuauthor=E.+J.+LaVoie&title=5H-Dibenzo%5Bc%2Ch%5D%5B1%2C6%5Dnaphthyridin-6-ones%3A+Novel+topoisomerase+I-targeting+anticancer+agents+with+potent+cytotoxic+activity&doi=10.1016%2FS0968-0896%2803%2900051-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2803%2900051-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252803%252900051-8%26sid%3Dliteratum%253Aachs%26aulast%3DRuchelman%26aufirst%3DA.%2BL.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DJ.-M.%26aulast%3DLi%26aufirst%3DT.-K.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3D5H-Dibenzo%255Bc%252Ch%255D%255B1%252C6%255Dnaphthyridin-6-ones%253A%2520Novel%2520topoisomerase%2520I-targeting%2520anticancer%2520agents%2520with%2520potent%2520cytotoxic%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2061%26epage%3D2073%26doi%3D10.1016%2FS0968-0896%2803%2900051-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruchelman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoie, E. J.</span></span> <span> </span><span class="NLM_article-title">Nitro and amino substitution in the D-Ring of 5-(2-dimethylaminoethyl)-2,3-methylenedioxy-5<i>H</i>-dibenzo[<i>c,h</i>][1,6]naphthyridin-6-ones: Effect on topoisomerase-I targeting activity and cytotoxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2254</span>– <span class="NLM_lpage">2257</span>, <span class="refDoi"> DOI: 10.1021/jm020498a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020498a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2254-2257&author=S.+K.+Singhauthor=A.+L.+Ruchelmanauthor=T.+K.+Liauthor=A.+Liuauthor=L.+F.+Liuauthor=E.+J.+LaVoie&title=Nitro+and+amino+substitution+in+the+D-Ring+of+5-%282-dimethylaminoethyl%29-2%2C3-methylenedioxy-5H-dibenzo%5Bc%2Ch%5D%5B1%2C6%5Dnaphthyridin-6-ones%3A+Effect+on+topoisomerase-I+targeting+activity+and+cytotoxicity&doi=10.1021%2Fjm020498a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm020498a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020498a%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DRuchelman%26aufirst%3DA.%2BL.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3DNitro%2520and%2520amino%2520substitution%2520in%2520the%2520D-Ring%2520of%25205-%25282-dimethylaminoethyl%2529-2%252C3-methylenedioxy-5H-dibenzo%255Bc%252Ch%255D%255B1%252C6%255Dnaphthyridin-6-ones%253A%2520Effect%2520on%2520topoisomerase-I%2520targeting%2520activity%2520and%2520cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2254%26epage%3D2257%26doi%3D10.1021%2Fjm020498a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Placzek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Nitrated indenoisoquinolines as topoisomerase I inhibitors: a systematic study and optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4419</span>– <span class="NLM_lpage">4430</span>, <span class="refDoi"> DOI: 10.1021/jm070361q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070361q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4419-4430&author=A.+Morrellauthor=M.+Placzekauthor=S.+Parmleyauthor=S.+Antonyauthor=T.+S.+Dexheimerauthor=Y.+Pommierauthor=M.+Cushman&title=Nitrated+indenoisoquinolines+as+topoisomerase+I+inhibitors%3A+a+systematic+study+and+optimization&doi=10.1021%2Fjm070361q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm070361q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070361q%26sid%3Dliteratum%253Aachs%26aulast%3DMorrell%26aufirst%3DA.%26aulast%3DPlaczek%26aufirst%3DM.%26aulast%3DParmley%26aufirst%3DS.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DNitrated%2520indenoisoquinolines%2520as%2520topoisomerase%2520I%2520inhibitors%253A%2520a%2520systematic%2520study%2520and%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4419%26epage%3D4430%26doi%3D10.1021%2Fjm070361q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarhaut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranoy-Opalinski, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papot, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of glucuronide prodrugs of the histone deacetylase inhibitor CI-994 for application in selective cancer chemotherapy</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">8109</span>– <span class="NLM_lpage">8116</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.07.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2008.07.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8109-8116&author=M.+Thomasauthor=J.+Clarhautauthor=I.+Tranoy-Opalinskiauthor=J.+P.+Gessonauthor=J.+Rocheauthor=S.+Papot&title=Synthesis+and+biological+evaluation+of+glucuronide+prodrugs+of+the+histone+deacetylase+inhibitor+CI-994+for+application+in+selective+cancer+chemotherapy&doi=10.1016%2Fj.bmc.2008.07.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.048%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DClarhaut%26aufirst%3DJ.%26aulast%3DTranoy-Opalinski%26aufirst%3DI.%26aulast%3DGesson%26aufirst%3DJ.%2BP.%26aulast%3DRoche%26aufirst%3DJ.%26aulast%3DPapot%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520glucuronide%2520prodrugs%2520of%2520the%2520histone%2520deacetylase%2520inhibitor%2520CI-994%2520for%2520application%2520in%2520selective%2520cancer%2520chemotherapy%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8109%26epage%3D8116%26doi%3D10.1016%2Fj.bmc.2008.07.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-chromene derivatives as histone deacetylase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4123</span>– <span class="NLM_lpage">4132</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2017.05.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=4123-4132&author=S.+Tanauthor=F.+Heauthor=T.+Kongauthor=J.+Wuauthor=Z.+Liu&title=Design%2C+synthesis+and+tumor+cell+growth+inhibitory+activity+of+3-nitro-2H-chromene+derivatives+as+histone+deacetylase+inhibitors&doi=10.1016%2Fj.bmc.2017.05.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520tumor%2520cell%2520growth%2520inhibitory%2520activity%2520of%25203-nitro-2H-chromene%2520derivatives%2520as%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D4123%26epage%3D4132%26doi%3D10.1016%2Fj.bmc.2017.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penketh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartorelli, A. C.</span></span> <span> </span><span class="NLM_article-title">4-Nitrobenzyloxycarbonyl derivatives of O6-benzylguanine as hypoxia-activated prodrug inhibitors of O6-alkylguanine-DNA alkyltransferase (AGT), which produces resistance to agents targeting the O-6 position of DNA guanine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7720</span>– <span class="NLM_lpage">7728</span>, <span class="refDoi"> DOI: 10.1021/jm201115f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201115f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7720-7728&author=R.+Zhuauthor=M.+C.+Liuauthor=M.+Z.+Luoauthor=P.+G.+Penkethauthor=R.+P.+Baumannauthor=K.+Shyamauthor=A.+C.+Sartorelli&title=4-Nitrobenzyloxycarbonyl+derivatives+of+O6-benzylguanine+as+hypoxia-activated+prodrug+inhibitors+of+O6-alkylguanine-DNA+alkyltransferase+%28AGT%29%2C+which+produces+resistance+to+agents+targeting+the+O-6+position+of+DNA+guanine&doi=10.1021%2Fjm201115f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm201115f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201115f%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DM.%2BC.%26aulast%3DLuo%26aufirst%3DM.%2BZ.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D4-Nitrobenzyloxycarbonyl%2520derivatives%2520of%2520O6-benzylguanine%2520as%2520hypoxia-activated%2520prodrug%2520inhibitors%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%2520%2528AGT%2529%252C%2520which%2520produces%2520resistance%2520to%2520agents%2520targeting%2520the%2520O-6%2520position%2520of%2520DNA%2520guanine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7720%26epage%3D7728%26doi%3D10.1021%2Fjm201115f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, Y. S.</span></span> <span> </span><span class="NLM_article-title">A novel nitrobenzoate microtubule inhibitor that overcomes multidrug resistance exhibits antitumor activity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">31472</span>, <span class="refDoi"> DOI: 10.1038/srep31472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1038%2Fsrep31472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27510727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCitrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=31472&author=Y.+B.+Zhengauthor=J.+H.+Gongauthor=X.+J.+Liuauthor=S.+Y.+Wuauthor=Y.+Liauthor=X.+D.+Xuauthor=B.+Y.+Shangauthor=J.+M.+Zhouauthor=Z.+L.+Zhuauthor=S.+Y.+Siauthor=Y.+S.+Zhen&title=A+novel+nitrobenzoate+microtubule+inhibitor+that+overcomes+multidrug+resistance+exhibits+antitumor+activity&doi=10.1038%2Fsrep31472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity</span></div><div class="casAuthors">Zheng, Yan-Bo; Gong, Jian-Hua; Liu, Xiu-Jun; Wu, Shu-Ying; Li, Yi; Xu, Xian-Dong; Shang, Bo-Yang; Zhou, Jin-Ming; Zhu, Zhi-Ling; Si, Shu-Yi; Zhen, Yong-Su</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31472</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Multidrug resistance is a major limitation for microtubule-binding agents in cancer treatment.  Here we report a novel microtubule inhibitor (2-morpholin-4-yl-5-nitro-benzoic acid 4-methylsulfanyl-benzyl ester, IMB5046), its cytotoxicity against multidrug-resistant cell lines and its antitumor efficacy in animal models.  IMB5046 disrupted microtubule structures in cells and inhibited purified tubulin polymn. in vitro.  It bound to the colchicine pocket of tubulin.  IMB5046 displayed potent cytotoxicity against multiple tumor cell lines with an IC50 range of 0.037-0.426 μM.  Notably, several multidrug-resistant cell lines which were resistant to colchicine, vincristine and paclitaxel remained sensitive to IMB5046.  IMB5046 was not a P-glycoprotein substrate.  IMB5046 blocked cell cycle at G2/M phase and induced cell apoptosis.  Microarray assay indicated that the differentially expressed genes after IMB5046 treatment were highly related to immune system, cell death and cancer.  In a mouse xenograft model IMB5046 inhibited the growth of human lung tumor xenograft by 83% at a well-tolerated dose.  It is concluded that IMB5046 is a tubulin polymn. inhibitor with novel chem. structure and can overcome multidrug resistance.  It is a promising lead compd. for cancer chemotherapy, esp. for treatment of multidrug-resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSpeEJZPBQy7Vg90H21EOLACvtfcHk0lj2RFX3FduJlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCitrfF&md5=a7fab3ce717fbe2a2c7d3a952b94f8a7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsrep31472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep31472%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BB.%26aulast%3DGong%26aufirst%3DJ.%2BH.%26aulast%3DLiu%26aufirst%3DX.%2BJ.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%2BD.%26aulast%3DShang%26aufirst%3DB.%2BY.%26aulast%3DZhou%26aufirst%3DJ.%2BM.%26aulast%3DZhu%26aufirst%3DZ.%2BL.%26aulast%3DSi%26aufirst%3DS.%2BY.%26aulast%3DZhen%26aufirst%3DY.%2BS.%26atitle%3DA%2520novel%2520nitrobenzoate%2520microtubule%2520inhibitor%2520that%2520overcomes%2520multidrug%2520resistance%2520exhibits%2520antitumor%2520activity%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D31472%26doi%3D10.1038%2Fsrep31472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.11.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2016.11.093" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=636-641&author=B.+A.+Winnauthor=Z.+Shiauthor=G.+J.+Carlsonauthor=Y.+Wangauthor=B.+L.+Nguyenauthor=E.+M.+Kellyauthor=D.+Rossauthor=E.+Hamelauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Bioreductively+activatable+prodrug+conjugates+of+phenstatin+designed+to+target+tumor+hypoxia&doi=10.1016%2Fj.bmcl.2016.11.093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.093%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DB.%2BA.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DCarlson%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DB.%2BL.%26aulast%3DKelly%26aufirst%3DE.%2BM.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DBioreductively%2520activatable%2520prodrug%2520conjugates%2520of%2520phenstatin%2520designed%2520to%2520target%2520tumor%2520hypoxia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D636%26epage%3D641%26doi%3D10.1016%2Fj.bmcl.2016.11.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tercel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwell, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botting, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruijn, F. B.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-activated prodrugs: substituent effects on the properties of nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (nitrocbi) prodrugs of DNA minor groove alkylating agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7258</span>– <span class="NLM_lpage">7272</span>, <span class="refDoi"> DOI: 10.1021/jm901202b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901202b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7258-7272&author=M.+Tercelauthor=G.+J.+Atwellauthor=S.+Yangauthor=R.+J.+Stevensonauthor=K.+J.+Bottingauthor=M.+Boydauthor=E.+Smithauthor=R.+F.+Andersonauthor=W.+A.+Dennyauthor=W.+R.+Wilsonauthor=F.+B.+Pruijn&title=Hypoxia-activated+prodrugs%3A+substituent+effects+on+the+properties+of+nitro+seco-1%2C2%2C9%2C9a-tetrahydrocyclopropa%5Bc%5Dbenz%5Be%5Dindol-4-one+%28nitrocbi%29+prodrugs+of+DNA+minor+groove+alkylating+agents&doi=10.1021%2Fjm901202b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901202b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901202b%26sid%3Dliteratum%253Aachs%26aulast%3DTercel%26aufirst%3DM.%26aulast%3DAtwell%26aufirst%3DG.%2BJ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DStevenson%26aufirst%3DR.%2BJ.%26aulast%3DBotting%26aufirst%3DK.%2BJ.%26aulast%3DBoyd%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DPruijn%26aufirst%3DF.%2BB.%26atitle%3DHypoxia-activated%2520prodrugs%253A%2520substituent%2520effects%2520on%2520the%2520properties%2520of%2520nitro%2520seco-1%252C2%252C9%252C9a-tetrahydrocyclopropa%255Bc%255Dbenz%255Be%255Dindol-4-one%2520%2528nitrocbi%2529%2520prodrugs%2520of%2520DNA%2520minor%2520groove%2520alkylating%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7258%26epage%3D7272%26doi%3D10.1021%2Fjm901202b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaki, Y.</span></span> <span> </span><span class="NLM_article-title">Targeting and treatment of tumor hypoxia by newly designed prodrug possessing high permeability in solid tumors</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2283</span>– <span class="NLM_lpage">2289</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.6b00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.6b00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFKgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=2283-2289&author=Y.+Ikedaauthor=H.+Hisanoauthor=Y.+Nishikawaauthor=Y.+Nagasaki&title=Targeting+and+treatment+of+tumor+hypoxia+by+newly+designed+prodrug+possessing+high+permeability+in+solid+tumors&doi=10.1021%2Facs.molpharmaceut.6b00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting and Treatment of Tumor Hypoxia by Newly Designed Prodrug Possessing High Permeability in Solid Tumors</span></div><div class="casAuthors">Ikeda, Yutaka; Hisano, Hikaru; Nishikawa, Yuji; Nagasaki, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2283-2289</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumor hypoxia, which is assocd. with poor prognosis in cancer, is known to lead to resistance to radiotherapy and anticancer chemotherapy.  Impaired drug penetration in hypoxic regions has been recognized as an essential barrier to drug development in solid tumors.  Here, we propose novel hypoxia-activated prodrugs, which drastically improved the penetration property of commonly used anticancer drugs in the hypoxic region.  In this design, conventional anticancer drugs were modified with 2-nitroimidazole derivs.  The most important point of this study was that the prodrug designed formed a 6-membered cyclic structure to allow liberation of the active drug in the hypoxic region.  This design markedly increased the selectivity of the hypoxia-targeted prodrug, resulting in significant redn. of adverse effects in the normoxic region.  In vitro studies confirmed the selective activation under hypoxic conditions.  In vivo studies showed drastic redn. of adverse effects assocd. with conventional anticancer drugs and improvement of the survival rate of mice.  Immunofluorescence analyses confirmed that the designed prodrug had a tendency to localize at the hypoxic region, in contrast to conventional anticancer drugs, which localize only at the normoxic region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Ed6yVvSv0bVg90H21EOLACvtfcHk0lijyQ848Z9cVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFKgs74%253D&md5=aa62fca974fae7c0d5c9f002e6d05f5e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.6b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.6b00011%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DHisano%26aufirst%3DH.%26aulast%3DNishikawa%26aufirst%3DY.%26aulast%3DNagasaki%26aufirst%3DY.%26atitle%3DTargeting%2520and%2520treatment%2520of%2520tumor%2520hypoxia%2520by%2520newly%2520designed%2520prodrug%2520possessing%2520high%2520permeability%2520in%2520solid%2520tumors%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2016%26volume%3D13%26spage%3D2283%26epage%3D2289%26doi%3D10.1021%2Facs.molpharmaceut.6b00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parvathaneni, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alterio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuijk, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J. Y.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-targeting carbonic anhydrase IX Inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8512</span>– <span class="NLM_lpage">8520</span>, <span class="refDoi"> DOI: 10.1021/jm4009532</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4009532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8512-8520&author=M.+Ramiauthor=L.+Duboisauthor=N.+K.+Parvathaneniauthor=V.+Alterioauthor=S.+J.+van+Kuijkauthor=S.+M.+Montiauthor=P.+Lambinauthor=G.+De+Simoneauthor=C.+T.+Supuranauthor=J.+Y.+Winum&title=Hypoxia-targeting+carbonic+anhydrase+IX+Inhibitors+by+a+new+series+of+nitroimidazole-sulfonamides%2Fsulfamides%2Fsulfamates&doi=10.1021%2Fjm4009532"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm4009532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4009532%26sid%3Dliteratum%253Aachs%26aulast%3DRami%26aufirst%3DM.%26aulast%3DDubois%26aufirst%3DL.%26aulast%3DParvathaneni%26aufirst%3DN.%2BK.%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3Dvan%2BKuijk%26aufirst%3DS.%2BJ.%26aulast%3DMonti%26aufirst%3DS.%2BM.%26aulast%3DLambin%26aufirst%3DP.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26atitle%3DHypoxia-targeting%2520carbonic%2520anhydrase%2520IX%2520Inhibitors%2520by%2520a%2520new%2520series%2520of%2520nitroimidazole-sulfonamides%252Fsulfamides%252Fsulfamates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8512%26epage%3D8520%26doi%3D10.1021%2Fjm4009532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seow, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penketh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartorelli, A. C.</span></span> <span> </span><span class="NLM_article-title">Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6242</span>– <span class="NLM_lpage">6247</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2012.08.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6242-6247&author=R.+Zhuauthor=H.+A.+Seowauthor=R.+P.+Baumannauthor=K.+Ishiguroauthor=P.+G.+Penkethauthor=K.+Shyamauthor=A.+C.+Sartorelli&title=Design+of+a+hypoxia-activated+prodrug+inhibitor+of+O6-alkylguanine-DNA+alkyltransferase&doi=10.1016%2Fj.bmcl.2012.08.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DSeow%26aufirst%3DH.%2BA.%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DDesign%2520of%2520a%2520hypoxia-activated%2520prodrug%2520inhibitor%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6242%26epage%3D6247%26doi%3D10.1016%2Fj.bmcl.2012.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsberg, A.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurenzi, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouse, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spigelman, M. K.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3720</span>– <span class="NLM_lpage">3725</span>, <span class="refDoi"> DOI: 10.1128/AAC.00106-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1128%2FAAC.00106-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=19528280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3720-3725&author=A.%0AM.+Ginsbergauthor=M.+W.+Laurenziauthor=D.+J.+Rouseauthor=K.+D.+Whitneyauthor=M.+K.+Spigelman&title=Safety%2C+tolerability%2C+and+pharmacokinetics+of+PA-824+in+healthy+subjects&doi=10.1128%2FAAC.00106-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects</span></div><div class="casAuthors">Ginsberg, Ann M.; Laurenzi, Martino W.; Rouse, Doris J.; Whitney, Karl D.; Spigelman, Melvin K.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3720-3725</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">PA-824 is a novel antibacterial agent that has shown in vitro activity against both drug-sensitive and drug-resistant Mycobacterium tuberculosis.  The compd.'s MIC is between 0.015 and 0.25 μg/mL for drug-sensitive strains and between 0.03 and 0.53 μg/mL for drug-resistant strains.  In addn., it is active against nonreplicating anaerobic Mycobacterium tuberculosis.  The safety, tolerability, and pharmacokinetics of PA-824 were evaluated in two escalating-dose clin. studies, one a single-dose study and the other a multiple-dose study (up to 7 days of daily dosing).  In 58 healthy subjects dosed with PA-824 in these studies, the drug candidate was well tolerated, with no significant or serious adverse events.  In both studies, following oral administration PA-824 reached maximal plasma levels in 4 to 5 h independently of the dose.  Maximal blood levels averaged approx. 3 μg/mL (1,500-mg dose) in the single-dose study and 3.8 μg/mL (600-mg dose) in the multiple-dose study.  Steady state was achieved after 5 to 6 days of daily dosing, with an accumulation ratio of approx. 2.  The elimination half-life averaged 16 to 20 h.  Overall, PA-824 was well tolerated following oral doses once daily for up to 7 days, and pharmacokinetic parameters were consistent with a once-a-day regimen.  The results of these studies, combined with the demonstrated activity of PA-824 against drug-sensitive and multidrug-resistant Mycobacterium tuberculosis, support the investigation of this novel compd. for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqOz72SCeRarVg90H21EOLACvtfcHk0lgNbW_cJTZTEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsr7E&md5=b1a66b6df94526f21a3873747ad54487</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1128%2FAAC.00106-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00106-09%26sid%3Dliteratum%253Aachs%26aulast%3DGinsberg%26aufirst%3DA.%2BM.%26aulast%3DLaurenzi%26aufirst%3DM.%2BW.%26aulast%3DRouse%26aufirst%3DD.%2BJ.%26aulast%3DWhitney%26aufirst%3DK.%2BD.%26aulast%3DSpigelman%26aufirst%3DM.%2BK.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520of%2520PA-824%2520in%2520healthy%2520subjects%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3720%26epage%3D3725%26doi%3D10.1128%2FAAC.00106-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span> <span> </span><span class="NLM_article-title">The mechanism of action of PA-824</span>. <i>Commun. Integr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.4161/cib.2.3.7926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.4161%2Fcib.2.3.7926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=19641733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1yru7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=215-218&author=U.+Manjunathaauthor=H.+I.+Boshoffauthor=C.+E.+Barry&title=The+mechanism+of+action+of+PA-824&doi=10.4161%2Fcib.2.3.7926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of action of PA-824: novel insights from transcriptional profiling</span></div><div class="casAuthors">Manjunatha, Ujjini; Boshoff, Helena I. M.; Barry, Clifton E., III</div><div class="citationInfo"><span class="NLM_cas:title">Communicative & Integrative Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-218</span>CODEN:
                <span class="NLM_cas:coden">CIBOBQ</span>;
        ISSN:<span class="NLM_cas:issn">1942-0889</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">The bicyclic nitroimidazole PA-824 is a pro-drug with a very complex mechanism of action active against both replicating and hypoxic, non-replicating Mycobacterium tuberculosis.  Microarray anal. of the mode of action of PA-824 showed a puzzling mixed effect both on genes responsive to both cell wall inhibition (like isoniazid) and respiratory poisoning (like cyanide).  The aerobic killing mechanism of this drug appears to involve inhibition of cell wall mycolic acid biosynthesis through an as yet unknown mol. mechanism.  However, the structure-activity relationships governing aerobic activity do not parallel the relationships detg. anaerobic activity.  Based on the metabolite profiling of PA-824 and various derivs. by Ddn-mediated activation, we have shown that PA-824 acts directly as an NO donor.  This respiratory poisoning through nitric oxide release seemed to be a crucial element of anaerobic activity by PA-824.  The effect of PA-824 on the respiratory complex under hypoxic non-replicating conditions was also manifested in a rapid drop in intracellular ATP levels, again similar to that obsd. by cyanide treatment.  Thus, transcriptional profiling provided valuable clues to elucidating the mol. mechanism of mycobacterial killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRIjCfr9dB9bVg90H21EOLACvtfcHk0lgNbW_cJTZTEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1yru7bF&md5=b7b25a9c2c9b39ff446571c9a2d6d297</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.4161%2Fcib.2.3.7926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcib.2.3.7926%26sid%3Dliteratum%253Aachs%26aulast%3DManjunatha%26aufirst%3DU.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DThe%2520mechanism%2520of%2520action%2520of%2520PA-824%26jtitle%3DCommun.%2520Integr.%2520Biol.%26date%3D2009%26volume%3D2%26spage%3D215%26epage%3D218%26doi%3D10.4161%2Fcib.2.3.7926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowd, C. S.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1317</span>– <span class="NLM_lpage">1328</span>, <span class="refDoi"> DOI: 10.1021/jm801246z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801246z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVSnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1317-1328&author=P.+Kimauthor=L.+Zhangauthor=U.+H.+Manjunathaauthor=R.+Singhauthor=S.+Patelauthor=J.+Jiricekauthor=T.+H.+Kellerauthor=H.+I.+Boshoffauthor=C.+E.+Barryauthor=C.+S.+Dowd&title=Structure-activity+relationships+of+antitubercular+nitroimidazoles.+1.+Structural+features+associated+with+aerobic+and+anaerobic+activities+of+4-+and+5-nitroimidazoles&doi=10.1021%2Fjm801246z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Antitubercular Nitroimidazoles. 1. Structural Features Associated with Aerobic and Anaerobic Activities of 4- and 5-Nitroimidazoles</span></div><div class="casAuthors">Kim, Pilho; Zhang, Liang; Manjunatha, Ujjini H.; Singh, Ramandeep; Patel, Sejal; Jiricek, Jan; Keller, Thomas H.; Boshoff, Helena I.; Barry, Clifton E., III; Dowd, Cynthia S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1317-1328</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 4-nitroimidazole PA-824 is active against aerobic and anaerobic Mycobacterium tuberculosis (Mtb) while 5-nitroimidazoles like metronidazole are active against only anaerobic Mtb.  We have synthesized analogs of both 4- and 5-nitroimidazoles and explored their antitubercular activities.  The nitro group is required for both activities in all compds.  The key determinants of aerobic activity in the 4-nitroimidazoles include the bicyclic oxazine, the lipophilic tail, and the 2-position oxygen.  For the 5-nitroimidazoles, neither the corresponding bicyclic analog nor addn. of a lipophilic tail conveyed aerobic activity.  Incorporation of a 2-position oxygen atom into a rigid 5-nitroimidazooxazine provided the first 5-nitroimidazole with aerobic activity.  Across both series, anaerobic and aerobic activities were not correlated and Mtb mutants lacking the deazaflavin-dependent nitroreductase (Ddn) retained anaerobic sensitivity to some compds.  Aerobic activity appears to be correlated with efficiency as a substrate for Ddn, suggesting a means of structure-based optimization of improved nitroimidazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI5B8p1UDmi7Vg90H21EOLACvtfcHk0liReNYvf8bhcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVSnsrw%253D&md5=f06ae53ab31823ac2970d57c58f11a0e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm801246z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801246z%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DDowd%26aufirst%3DC.%2BS.%26atitle%3DStructure-activity%2520relationships%2520of%2520antitubercular%2520nitroimidazoles.%25201.%2520Structural%2520features%2520associated%2520with%2520aerobic%2520and%2520anaerobic%2520activities%2520of%25204-%2520and%25205-nitroimidazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1317%26epage%3D1328%26doi%3D10.1021%2Fjm801246z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niyomrattanakit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowd, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1329</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1021/jm801374t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801374t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1329-1344&author=P.+Kimauthor=S.+Kangauthor=H.+I.+Boshoffauthor=J.+Jiricekauthor=M.+Collinsauthor=R.+Singhauthor=U.+H.+Manjunathaauthor=P.+Niyomrattanakitauthor=L.+Zhangauthor=M.+Goodwinauthor=T.+Dickauthor=T.+H.+Kellerauthor=C.+S.+Dowdauthor=C.+E.+Barry&title=Structure-activity+relationships+of+antitubercular+nitroimidazoles.+2.+Determinants+of+aerobic+activity+and+quantitative+structure-activity+relationships&doi=10.1021%2Fjm801374t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm801374t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801374t%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DP.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DNiyomrattanakit%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGoodwin%26aufirst%3DM.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DDowd%26aufirst%3DC.%2BS.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DStructure-activity%2520relationships%2520of%2520antitubercular%2520nitroimidazoles.%25202.%2520Determinants%2520of%2520aerobic%2520activity%2520and%2520quantitative%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1329%26epage%3D1344%26doi%3D10.1021%2Fjm801374t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span> <span> </span><span class="NLM_article-title">The antitubercular activity of various nitro(triazole/imidazole)-based compounds</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">6039</span>– <span class="NLM_lpage">6048</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.09.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2017.09.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=6039-6048&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweig&title=The+antitubercular+activity+of+various+nitro%28triazole%2Fimidazole%29-based+compounds&doi=10.1016%2Fj.bmc.2017.09.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.09.037%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26atitle%3DThe%2520antitubercular%2520activity%2520of%2520various%2520nitro%2528triazole%252Fimidazole%2529-based%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D6039%26epage%3D6048%26doi%3D10.1016%2Fj.bmc.2017.09.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carter, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabarro, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiodini, P. L.</span></span> <span> </span><span class="NLM_article-title">Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions</span>. <i>Clin. Microbiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/j.cmi.2017.05.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.cmi.2017.05.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=28624613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BC1cnpt1OksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=37-42&author=E.+R.+Carterauthor=L.+E.+Nabarroauthor=L.+Hedleyauthor=P.+L.+Chiodini&title=Nitroimidazole-refractory+giardiasis%3A+a+growing+problem+requiring+rational+solutions&doi=10.1016%2Fj.cmi.2017.05.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions</span></div><div class="casAuthors">Carter E R; Nabarro L E; Chiodini P L; Hedley L</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Giardia intestinalis is microaerophilic diarrhoea-causing protozoan common in countries with suboptimal sanitation.  Standard treatment is with nitroimidazoles, but a growing number of refractory cases is being reported.  Treatment failure has become increasingly prevalent in travellers who contract giardiasis in Asia.  Clinicians are increasingly falling back on second-line and less well-known drugs to treat giardiasis.  AIMS:  To review nitroimidazole-refractory G. intestinalis infection, examine the current efficacy of standard therapeutic agents, consider potential resistance mechanisms which could cause treatment failure and describe the practical aspects of managing this emerging clinical problem.  SOURCES:  A PubMed search was conducted using combinations of the following terms: refractory, Giardia, giardiasis, resistance and treatment.  Articles on the pharmacotherapy, drug resistance mechanisms and use of alternative agents in nitroimidazole-refractory giardiasis were reviewed.  CONTENT:  We review the standard drugs for giardiasis, including their efficacy in initial treatment, mode of action and documented in vitro and in vivo drug resistance.  We assess the efficacy of alternative drugs in nitroimidazole-refractory disease.  Existing data suggest a potential advantage of combination treatment.  IMPLICATIONS:  An optimal treatment strategy for refractory giardiasis has still to be determined, so there is no standard treatment regimen for nitroimidazole-refractory giardiasis.  Further work on drug resistance mechanisms and the use of drug combinations in this condition is a priority.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHvG8MQO6nWOQ4Pl9hzjQhfW6udTcc2ea80MgGeB3OfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnpt1OksA%253D%253D&md5=14dcd9f24519c229d7d2bc0c3636692f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.cmi.2017.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmi.2017.05.028%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DE.%2BR.%26aulast%3DNabarro%26aufirst%3DL.%2BE.%26aulast%3DHedley%26aufirst%3DL.%26aulast%3DChiodini%26aufirst%3DP.%2BL.%26atitle%3DNitroimidazole-refractory%2520giardiasis%253A%2520a%2520growing%2520problem%2520requiring%2520rational%2520solutions%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2018%26volume%3D24%26spage%3D37%26epage%3D42%26doi%3D10.1016%2Fj.cmi.2017.05.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negrette, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parada, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basombrio, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, N. J.</span></span> <span> </span><span class="NLM_article-title">Hepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethyl nitro furazone: a comparison with Benznidazole</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e3231</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0003231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1371%2Fjournal.pntd.0003231" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=e3231&author=C.+Daviesauthor=N.+Deyauthor=O.+S.+Negretteauthor=L.+A.+Paradaauthor=M.+A.+Basombrioauthor=N.+J.+Garg&title=Hepatotoxicity+in+mice+of+a+novel+anti-parasite+drug+candidate+hydroxymethyl+nitro+furazone%3A+a+comparison+with+Benznidazole&doi=10.1371%2Fjournal.pntd.0003231"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003231%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DC.%26aulast%3DDey%26aufirst%3DN.%26aulast%3DNegrette%26aufirst%3DO.%2BS.%26aulast%3DParada%26aufirst%3DL.%2BA.%26aulast%3DBasombrio%26aufirst%3DM.%2BA.%26aulast%3DGarg%26aufirst%3DN.%2BJ.%26atitle%3DHepatotoxicity%2520in%2520mice%2520of%2520a%2520novel%2520anti-parasite%2520drug%2520candidate%2520hydroxymethyl%2520nitro%2520furazone%253A%2520a%2520comparison%2520with%2520Benznidazole%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26spage%3De3231%26doi%3D10.1371%2Fjournal.pntd.0003231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span>Metrinidazole:
An Overview. <a href="https://www.uptodate.com/contents/metronidazole-an-overview/" class="extLink">https://www.uptodate.com/contents/metronidazole-an-overview/</a> (accessed September 12, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Metrinidazole%3A%0AAn+Overview.+https%3A%2F%2Fwww.uptodate.com%2Fcontents%2Fmetronidazole-an-overview%2F+%28accessed+September+12%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Nigro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballo, M. A.</span></span> <span> </span><span class="NLM_article-title">Genotoxicity and cell death induced by tinidazole (TNZ)</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2008.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.toxlet.2008.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18582545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=46-52&author=M.+M.+Lopez+Nigroauthor=M.+A.+Carballo&title=Genotoxicity+and+cell+death+induced+by+tinidazole+%28TNZ%29&doi=10.1016%2Fj.toxlet.2008.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Genotoxicity and cell death induced by tinidazole (TNZ)</span></div><div class="casAuthors">Lopez Nigro, M. M.; Carballo, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-52</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tinidazole (TNZ), a second-generation 5-nitroimidazole compd. chem. related to metronidazole (MTZ), has been widely used throughout Europe and developing countries for the treatment of amoebic and parasitic infections.  Despite TNZ's increasing use in therapeutics, scarce exptl. reports are available in literature on its potential genotoxicity in human cells.  Therefore, the aim of the present study was to achieve a precise characterization of the cytotoxic and genotoxic activities of this nitroimidazole in cultured human lymphocytes at therapeutic concns. (0.1, 1, 10 and 50 μg/mL of culture) and evaluate the possible cell death mechanism assocd. with it.  The endpoints analyzed included: mitotic index (MI), replication index (RI), sister chromatid exchange (SCE) and chromosomal aberrations (CA).  A significant decrease (p < 0.0001) in MI as well as an increase in SCE (p < 0.0001) and CA (p < 0.0001) frequencies were obsd.  No modifications in RI were found.  The results suggest a genotoxic and cytotoxic effect of TNZ related with cell death process.  Therefore, we evaluated this mechanism by DNA fragmentation (laddering), fluorescence microscopy using acridine orange/ethidium bromide (AO/EB) staining and flow cytometry propidium iodide (PI).  DNA exts. of TNZ-treated cells resulted in nucleosomal DNA ladder pattern after 48 h of cell treatment; meanwhile no differences were detected in untreated cells.  This pattern correlated with the obsd. decrease in cellular viability (p < 0.05), morphol. evidence of apoptosis and increase in the percentage of nuclei with hypodiploid DNA content of TNZ exposed cultures compared with control (p < 0.05).  We concluded that TNZ is genotoxic, cytotoxic and is able to modulate cell death through apoptotic mechanisms in the exptl. design employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyVTqYT7hs3LVg90H21EOLACvtfcHk0lj2j_v08wIDzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D&md5=dbf7f9c371265bace4f736b0a475e1c9</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2008.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2008.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%2BNigro%26aufirst%3DM.%2BM.%26aulast%3DCarballo%26aufirst%3DM.%2BA.%26atitle%3DGenotoxicity%2520and%2520cell%2520death%2520induced%2520by%2520tinidazole%2520%2528TNZ%2529%26jtitle%3DToxicol.%2520Lett.%26date%3D2008%26volume%3D180%26spage%3D46%26epage%3D52%26doi%3D10.1016%2Fj.toxlet.2008.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, T. L.</span></span> <span> </span><span class="NLM_article-title">Tinidazole: a nitroimidazole antiprotozoal agent</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1859</span>– <span class="NLM_lpage">1884</span>, <span class="refDoi"> DOI: 10.1016/j.clinthera.2005.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.clinthera.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=16507373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1859-1884&author=H.+B.+Fungauthor=T.+L.+Doan&title=Tinidazole%3A+a+nitroimidazole+antiprotozoal+agent&doi=10.1016%2Fj.clinthera.2005.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Tinidazole: a nitroimidazole antiprotozoal agent</span></div><div class="casAuthors">Fung, Horatio B.; Doan, Thien-Ly</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1859-1884</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Tinidazole, a structural analog of metronidazole, is an antiprotozoal agent that has been widely used in Europe and developing countries for >2 decades with established efficacy and acceptable tolerability.  It was recently approved by the US Food and Drug Administration for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Objective: This article reviews the pharmacol. and pharmacokinetic properties and clin. usefulness of tinidazole.  Methods: Relevant information was identified through a search of MEDLINE (1966-August 2005), Iowa Drug Information Service (1966-August 2005), and International Pharmaceutical Abstrs. (1970-August 2005) using the terms tinidazole, Fasigyn, and nitroimidazole.  Results: In vitro, tinidazole exhibits activity against pathogenic protozoa (eg, Trichomonas vaginalis, Entamoeba histolytica, Giardia duodenalis), a wide range of clin. significant anaerobic bacteria (eg, Bacteroides fragilis, Clostridium difficile), and the microaerophilic bacterium Helicobacter pylori.  In susceptible protozoal and bacterial cells, tinidazole is reduced to cytotoxic intermediates that covalently bind to DNA, causing irreversible damage.  In human adults, tinidazole had a bioavailability of 100% and a Vd of 50.7 L, was minimally bound to plasma protein (12%), had a plasma elimination t1/2 of 12.3 h, and was eliminated primarily by hepatic metab. (∼63%).  Dose adjustment does not appear to be necessary on the basis of race, sex, or renal function.  No data were found on the disposition of tinidazole in patients with hepatic insufficiency; therefore, use of tinidazole in patients with severe hepatic impairment (Child-Pugh class C) is not recommended.  Clin. cure rates in patients with trichomoniasis, giardiasis, amebiasis, and amebic liver abscess were generally >90%.  In comparative trials, tinidazole was as effective as metronidazole in the treatment of trichomoniasis and was significantly more effective than metronidazole in the treatment of giardiasis (P < 0.05) and amebiasis (P < 0.05).  The most commonly reported (>1%) adverse effects included bitter taste, nausea, abdominal discomfort, anorexia, vomiting, and fatigue.  The recommended dosage of tinidazole is a single dose of 2 g for trichomoniasis and giardiasis, and 2 g/d for 3 to 5 days for amebiasis.  Conclusions: Tinidazole appears to be a promising agent for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Clin. studies are needed to evaluate the use of tinidazole against anaerobic bacteria and H pylori.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGwTnbff6nLbVg90H21EOLACvtfcHk0liKWA_K81kXtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D&md5=cc1ef607c78b3cb9889d5425c4858f04</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DH.%2BB.%26aulast%3DDoan%26aufirst%3DT.%2BL.%26atitle%3DTinidazole%253A%2520a%2520nitroimidazole%2520antiprotozoal%2520agent%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1859%26epage%3D1884%26doi%3D10.1016%2Fj.clinthera.2005.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33"><span>Tinidazole News. <a href="https://www.drugs.com/answers/support-group/tinidazole/news/" class="extLink">https://www.drugs.com/answers/support-group/tinidazole/news/</a> (accessed December 21, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tinidazole+News.+https%3A%2F%2Fwww.drugs.com%2Fanswers%2Fsupport-group%2Ftinidazole%2Fnews%2F+%28accessed+December+21%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit34"><span>Ornidazole. <a href="http://www.sanhome.com" class="extLink">http://www.sanhome.com</a>/ (accessed
December 31, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ornidazole.+http%3A%2F%2Fwww.sanhome.com%2F+%28accessed%0ADecember+31%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span> <span> </span><span class="NLM_article-title">The antitrypanosomal and antitubercular activity of some nitro(triazole/imidazole)-based aromatic amines</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">1106</span>– <span class="NLM_lpage">1113</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.07.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2017.07.060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=1106-1113&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=M.+Kaiser&title=The+antitrypanosomal+and+antitubercular+activity+of+some+nitro%28triazole%2Fimidazole%29-based+aromatic+amines&doi=10.1016%2Fj.ejmech.2017.07.060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.07.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.07.060%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DKaiser%26aufirst%3DM.%26atitle%3DThe%2520antitrypanosomal%2520and%2520antitubercular%2520activity%2520of%2520some%2520nitro%2528triazole%252Fimidazole%2529-based%2520aromatic%2520amines%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D1106%26epage%3D1113%26doi%3D10.1016%2Fj.ejmech.2017.07.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span> <span> </span><span class="NLM_article-title">Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2014.09.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=79-88&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=S.+R.+Wilkinsonauthor=M.+Kaiser&title=Novel+nitro%28triazole%2Fimidazole%29-based+heteroarylamides%2Fsulfonamides+as+potential+antitrypanosomal+agents&doi=10.1016%2Fj.ejmech.2014.09.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.045%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DKaiser%26aufirst%3DM.%26atitle%3DNovel%2520nitro%2528triazole%252Fimidazole%2529-based%2520heteroarylamides%252Fsulfonamides%2520as%2520potential%2520antitrypanosomal%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D79%26epage%3D88%26doi%3D10.1016%2Fj.ejmech.2014.09.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioset, J. R.</span></span> <span> </span><span class="NLM_article-title">Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1, 3-benzothiazoles as antichagasic agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6600</span>– <span class="NLM_lpage">6607</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.08.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2013.08.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6600-6607&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=M.+Kaiserauthor=E.+Chatelainauthor=J.+R.+Ioset&title=Novel+3-nitro-1H-1%2C2%2C4-triazole-based+piperazines+and+2-amino-1%2C+3-benzothiazoles+as+antichagasic+agents&doi=10.1016%2Fj.bmc.2013.08.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.08.022%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DIoset%26aufirst%3DJ.%2BR.%26atitle%3DNovel%25203-nitro-1H-1%252C2%252C4-triazole-based%2520piperazines%2520and%25202-amino-1%252C%25203-benzothiazoles%2520as%2520antichagasic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6600%26epage%3D6607%26doi%3D10.1016%2Fj.bmc.2013.08.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioset, J. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent nitrotriazole-based antitrypanosomal agents: <i>In vitro</i> and <i>in vivo</i> evaluation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6467</span>– <span class="NLM_lpage">6476</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2015.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=26344593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlylsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6467-6476&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=I.+P.+O%E2%80%99Sheaauthor=S.+R.+Wilkinsonauthor=M.+Kaiserauthor=E.+Chatelainauthor=J.+R.+Ioset&title=Discovery+of+potent+nitrotriazole-based+antitrypanosomal+agents%3A+In+vitro+and+in+vivo+evaluation&doi=10.1016%2Fj.bmc.2015.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation</span></div><div class="casAuthors">Papadopoulou, Maria V.; Bloomer, William D.; Rosenzweig, Howard S.; O'Shea, Ivan P.; Wilkinson, Shane R.; Kaiser, Marcel; Chatelain, Eric; Ioset, Jean-Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6467-6476</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">3-Nitro-1H-1,2,4-triazole- and 2-nitro-1H-imidazole-based amides with an aryloxy-Ph core were synthesized and evaluated as antitrypanosomal agents.  All 3-nitrotriazole-based derivs. were extremely potent anti-Trypanosoma cruzi agents at sub nM concns. and exhibited a high degree of selectivity for the parasite.  The 2-nitroimidazole analogs were only moderately active against T. cruzi amastigotes and exhibited low selectivity.  Both types of compd. were active against Leishmania donovani axenic amastigotes with excellent selectivity for the parasite, whereas three 2-nitroimidazole-based analogs were also moderately active against infected macrophages.  However, no compd. demonstrated selective activity against Trypanosoma brucei rhodesiense.  The most potent in vitro anti-T. cruzi compds. were tested in an acute murine model and reduced the parasites to an undetectable level after five days of treatment at 13 mg/kg/day.  Such compds. are potential inhibitors of T. cruzi CYP51 and, being excellent substrates for the type I nitroreductase, which is specific to trypanosomatids, work as prodrugs and constitute a new generation of effective and more affordable antitrypanosomal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6flda_B0eN7Vg90H21EOLACvtfcHk0lhHs0LaEMkuJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlylsLnI&md5=a52f3e97fcc84f3074464bdd74f6e209</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DI.%2BP.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DIoset%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520potent%2520nitrotriazole-based%2520antitrypanosomal%2520agents%253A%2520In%2520vitro%2520and%2520in%2520vivo%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6467%26epage%3D6476%26doi%3D10.1016%2Fj.bmc.2015.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Connor, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardley, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Repositioning antitubercular 6-nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for neglected tropical diseases:structure-activity studies on a preclinical candidate for visceral leishmaniasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2530</span>– <span class="NLM_lpage">2550</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01699</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01699" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2530-2550&author=A.+M.+Thompsonauthor=P.+D.+O%27Connorauthor=A.+Blaserauthor=V.+Yardleyauthor=L.+Maesauthor=S.+Guptaauthor=D.+Launayauthor=D.+Martinauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Denny&title=Repositioning+antitubercular+6-nitro-2%2C3-dihydroimidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazoles+for+neglected+tropical+diseases%3Astructure-activity+studies+on+a+preclinical+candidate+for+visceral+leishmaniasis&doi=10.1021%2Facs.jmedchem.5b01699"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01699%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DO%2527Connor%26aufirst%3DP.%2BD.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DYardley%26aufirst%3DV.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DRepositioning%2520antitubercular%25206-nitro-2%252C3-dihydroimidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazoles%2520for%2520neglected%2520tropical%2520diseases%253Astructure-activity%2520studies%2520on%2520a%2520preclinical%2520candidate%2520for%2520visceral%2520leishmaniasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2530%26epage%3D2550%26doi%3D10.1021%2Facs.jmedchem.5b01699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braillard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">7-Substituted 2-nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel antitubercular agents lead to a new preclinical candidate for visceral leishmaniasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4212</span>– <span class="NLM_lpage">4233</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVentbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4212-4233&author=A.+M.+Thompsonauthor=P.+D.+O%E2%80%99Connorauthor=A.+J.+Marshallauthor=A.+Yardleyauthor=O.+Maesauthor=U.+Guptaauthor=D.+Launayauthor=S.+Braillardauthor=E.+Chatelainauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=C.+B.+Cooperauthor=W.+A.+Denny&title=7-Substituted+2-nitro-5%2C6-dihydroimidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazines%3A+Novel+antitubercular+agents+lead+to+a+new+preclinical+candidate+for+visceral+leishmaniasis&doi=10.1021%2Facs.jmedchem.7b00034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis</span></div><div class="casAuthors">Thompson, Andrew M.; O'Connor, Patrick D.; Marshall, Andrew J.; Yardley, Vanessa; Maes, Louis; Gupta, Suman; Launay, Delphine; Braillard, Stephanie; Chatelain, Eric; Franzblau, Scott G.; Wan, Baojie; Wang, Yuehong; Ma, Zhenkun; Cooper, Christopher B.; Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4212-4233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Within a backup program for the clin. investigational agent pretomanid (PA-824), scaffold hopping from delamanid inspired the discovery of a novel class of potent antitubercular agents that unexpectedly possessed notable utility against the kinetoplastid disease visceral leishmaniasis (VL).  Following the identification of delamanid analog DNDI-VL-2098 as a VL preclin. candidate, this structurally related 7-substituted 2-nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazine class was further explored, seeking efficacious backup compds. with improved soly. and safety.  Commencing with a biphenyl lead, bioisosteres formed by replacing one Ph by pyridine or pyrimidine showed improved soly. and potency, whereas more hydrophilic side chains reduced VL activity.  In a Leishmania donovani mouse model, two racemic phenylpyridines (71 and 93) were superior, with the former providing >99% inhibition at 12.5 mg/kg (b.i.d., orally) in the Leishmania infantum hamster model.  Overall, the 7R enantiomer of 71 (79) displayed more optimal efficacy, pharmacokinetics, and safety, leading to its selection as the preferred development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZeHW7NJF-TrVg90H21EOLACvtfcHk0lgHJ_VqyW2kBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVentbw%253D&md5=ccb6e45ed81213d05527071e095bd651</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00034%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BD.%26aulast%3DMarshall%26aufirst%3DA.%2BJ.%26aulast%3DYardley%26aufirst%3DA.%26aulast%3DMaes%26aufirst%3DO.%26aulast%3DGupta%26aufirst%3DU.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DBraillard%26aufirst%3DS.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3D7-Substituted%25202-nitro-5%252C6-dihydroimidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazines%253A%2520Novel%2520antitubercular%2520agents%2520lead%2520to%2520a%2520new%2520preclinical%2520candidate%2520for%2520visceral%2520leishmaniasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4212%26epage%3D4233%26doi%3D10.1021%2Facs.jmedchem.7b00034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Nitro Phosphoramide Compositions and Methods for Targeting and Inhibiting Undesirable Cell Growth or Proliferation</span>. U.S. Patent <span class="NLM_patent">2004214798A1</span>, Oct 28, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=L.+Hu&title=Nitro+Phosphoramide+Compositions+and+Methods+for+Targeting+and+Inhibiting+Undesirable+Cell+Growth+or+Proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26atitle%3DNitro%2520Phosphoramide%2520Compositions%2520and%2520Methods%2520for%2520Targeting%2520and%2520Inhibiting%2520Undesirable%2520Cell%2520Growth%2520or%2520Proliferation%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span>; <span class="NLM_string-name">Wilson, W. R.</span>; <span class="NLM_string-name">Stevenson, R. J.</span>; <span class="NLM_string-name">Tercel, M.</span>; <span class="NLM_string-name">Atwell, G. J.</span>; <span class="NLM_string-name">Yang, S.</span>; <span class="NLM_string-name">Patterson, A. V.</span>; <span class="NLM_string-name">Pruijn, F. B.</span></span> <span> </span><span class="NLM_article-title">Nitrobenzindoles and Their Use in Cancer Therapy</span>. N.Z. Patent <span class="NLM_patent">WO 2006/043839 A1</span>, Apr 27, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=W.+A.+Denny&author=W.+R.+Wilson&author=R.+J.+Stevenson&author=M.+Tercel&author=G.+J.+Atwell&author=S.+Yang&author=A.+V.+Patterson&author=F.+B.+Pruijn&title=Nitrobenzindoles+and+Their+Use+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DNitrobenzindoles%2520and%2520Their%2520Use%2520in%2520Cancer%2520Therapy%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, H.</span>; <span class="NLM_string-name">Lewis, J.</span>; <span class="NLM_string-name">Matteucce, M.</span>; <span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">Hypoxia Activated Prodrugs of Antineoplastic Agents</span>. U.S. Patent <span class="NLM_patent">WO 2008/151253 A1</span>, Dec 11, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.+Jiao&author=J.+Lewis&author=M.+Matteucce&author=D.+Sun&title=Hypoxia+Activated+Prodrugs+of+Antineoplastic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DH.%26atitle%3DHypoxia%2520Activated%2520Prodrugs%2520of%2520Antineoplastic%2520Agents%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X. H.</span>; <span class="NLM_string-name">Duan, J. X.</span>; <span class="NLM_string-name">Matteucci, M.</span></span> <span> </span><span class="NLM_article-title">Hypoxia Activated Prodrugs of Anthracyclines</span>. U.S. Patent <span class="NLM_patent">WO 2009/018163 A1</span>, Feb 5, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=X.+H.+Cai&author=J.+X.+Duan&author=M.+Matteucci&title=Hypoxia+Activated+Prodrugs+of+Anthracyclines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%2BH.%26atitle%3DHypoxia%2520Activated%2520Prodrugs%2520of%2520Anthracyclines%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.-x.</span></span> <span> </span><span class="NLM_article-title">Camptothecin Derivatives as Chemoradiosensitizing Agents</span>. U.S. Patent <span class="NLM_patent">2011/0184009 A1</span>, Jul 28, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=L.-x.+Yang&title=Camptothecin+Derivatives+as+Chemoradiosensitizing+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.-x.%26atitle%3DCamptothecin%2520Derivatives%2520as%2520Chemoradiosensitizing%2520Agents%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hart, C.</span>; <span class="NLM_string-name">Meng, F.</span>; <span class="NLM_string-name">Sun, J.</span></span> <span> </span><span class="NLM_article-title">Administration of Hypoxia Activated Prodrugs in Combination with CHK1 Inhibitors for Treating Cancer</span>. U.S. Patent <span class="NLM_patent">WO 2013/096687 A1</span>, June 27, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Hart&author=F.+Meng&author=J.+Sun&title=Administration+of+Hypoxia+Activated+Prodrugs+in+Combination+with+CHK1+Inhibitors+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DC.%26atitle%3DAdministration%2520of%2520Hypoxia%2520Activated%2520Prodrugs%2520in%2520Combination%2520with%2520CHK1%2520Inhibitors%2520for%2520Treating%2520Cancer%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smaill, J. B.</span>; <span class="NLM_string-name">Patterson, A. V.</span>; <span class="NLM_string-name">Ashoorzadeh, A.</span>; <span class="NLM_string-name">Guise, C.
P.</span>; <span class="NLM_string-name">Mowday, A.
M.</span>; <span class="NLM_string-name">Ackerley, D. F.</span>; <span class="NLM_string-name">Williams, E. M.</span>; <span class="NLM_string-name">Copp, J. N.</span></span> <span> </span><span class="NLM_article-title">Novel Prodrugs and Methods of Use Thereof</span>. N.Z. Patent <span class="NLM_patent">WO 2014/031012 A1</span>, Feb 27, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+B.+Smaill&author=A.+V.+Patterson&author=A.+Ashoorzadeh&author=C.%0AP.+Guise&author=A.%0AM.+Mowday&author=D.+F.+Ackerley&author=E.+M.+Williams&author=J.+N.+Copp&title=Novel+Prodrugs+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DNovel%2520Prodrugs%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaki, Y.</span>; <span class="NLM_string-name">Ikeda, Y.</span>; <span class="NLM_string-name">Hisano, H.</span></span> <span> </span><span class="NLM_article-title">Prodrug Using Nitroimidazole</span>. U.S. Patent <span class="NLM_patent">2014/0378673 A1</span>, Dec 25, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.+Nagasaki&author=Y.+Ikeda&author=H.+Hisano&title=Prodrug+Using+Nitroimidazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNagasaki%26aufirst%3DY.%26atitle%3DProdrug%2520Using%2520Nitroimidazole%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R. C. C.</span>; <span class="NLM_string-name">Mold, D. E.</span>; <span class="NLM_string-name">Hwu, J. R.</span>; <span class="NLM_string-name">Hsu, M. H.</span>; <span class="NLM_string-name">Wu, S.
C.</span></span> <span> </span><span class="NLM_article-title">Conjugates of Nitroimidazole and their Use as Chemotherapeutic Agents</span>. U.S. Patent <span class="NLM_patent">2014/0186266 A1</span>, Jul 3, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+C.+C.+Huang&author=D.+E.+Mold&author=J.+R.+Hwu&author=M.+H.+Hsu&author=S.%0AC.+Wu&title=Conjugates+of+Nitroimidazole+and+their+Use+as+Chemotherapeutic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DR.%2BC.%2BC.%26atitle%3DConjugates%2520of%2520Nitroimidazole%2520and%2520their%2520Use%2520as%2520Chemotherapeutic%2520Agents%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, M.</span>; <span class="NLM_string-name">Duan, J.-X.</span>; <span class="NLM_string-name">Jiao, H.</span></span> <span> </span><span class="NLM_article-title">Phosphoramidate Alkylator Prodrugs</span>. U.S. Patent <span class="NLM_patent">2014/0170240 A1</span>, June 19, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Matteucci&author=J.-X.+Duan&author=H.+Jiao&title=Phosphoramidate+Alkylator+Prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMatteucci%26aufirst%3DM.%26atitle%3DPhosphoramidate%2520Alkylator%2520Prodrugs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span>; <span class="NLM_string-name">Yan, J.</span>; <span class="NLM_string-name">Wang, L.</span>; <span class="NLM_string-name">Guo, X.</span>; <span class="NLM_string-name">Li, S.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Zuo, R.</span>; <span class="NLM_string-name">Huang, X.</span>; <span class="NLM_string-name">Wang, H.</span>; <span class="NLM_string-name">Wang, L.</span>; <span class="NLM_string-name">Huang, W.</span>; <span class="NLM_string-name">Lu, H.</span>; <span class="NLM_string-name">Feng, K.</span>; <span class="NLM_string-name">Li, F.</span>; <span class="NLM_string-name">He, H.</span>; <span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Nitropyridinyl Ethyleneimine Compound, the Pharmaceutical Composition Containing it, the Preparation Method and Use Thereof</span>. U.S. Patent <span class="NLM_patent">2014/0073796 A1</span>, Mar 13, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Yang&author=J.+Yan&author=L.+Wang&author=X.+Guo&author=S.+Li&author=G.+Wu&author=R.+Zuo&author=X.+Huang&author=H.+Wang&author=L.+Wang&author=W.+Huang&author=H.+Lu&author=K.+Feng&author=F.+Li&author=H.+He&author=Y.+Liu&title=Nitropyridinyl+Ethyleneimine+Compound%2C+the+Pharmaceutical+Composition+Containing+it%2C+the+Preparation+Method+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%26atitle%3DNitropyridinyl%2520Ethyleneimine%2520Compound%252C%2520the%2520Pharmaceutical%2520Composition%2520Containing%2520it%252C%2520the%2520Preparation%2520Method%2520and%2520Use%2520Thereof%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. X.</span>; <span class="NLM_string-name">Cao, Y.</span>; <span class="NLM_string-name">Cai, X.</span>; <span class="NLM_string-name">Jiao, H.</span>; <span class="NLM_string-name">Jing, Y.</span>; <span class="NLM_string-name">Matteucci, M.</span></span> <span> </span><span class="NLM_article-title">Nitrobenzyl Derivatives of Anti-Cancer Agents</span>. U.S. Patent <span class="NLM_patent">WO2016/161342 A2</span>, Oct 6, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+X.+Duan&author=Y.+Cao&author=X.+Cai&author=H.+Jiao&author=Y.+Jing&author=M.+Matteucci&title=Nitrobenzyl+Derivatives+of+Anti-Cancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DJ.%2BX.%26atitle%3DNitrobenzyl%2520Derivatives%2520of%2520Anti-Cancer%2520Agents%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Small, J. B.</span>; <span class="NLM_string-name">Patterson, A. V.</span>; <span class="NLM_string-name">Hay, M. P.</span>; <span class="NLM_string-name">Denny, W. A.</span>; <span class="NLM_string-name">Wilson, W. R.</span>; <span class="NLM_string-name">Lu, G.-L.</span>; <span class="NLM_string-name">Anderson, R. F.</span>; <span class="NLM_string-name">Lee, H. H.</span>; <span class="NLM_string-name">Ashoorzadeh, A.</span></span> <span> </span><span class="NLM_article-title">Prodrug Forms of Kinase Inhibitors and Their Use in Therapy</span>. U.S. Patent <span class="NLM_patent">2016/0002222 A1</span>, Jan 7, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+B.+Small&author=A.+V.+Patterson&author=M.+P.+Hay&author=W.+A.+Denny&author=W.+R.+Wilson&author=G.-L.+Lu&author=R.+F.+Anderson&author=H.+H.+Lee&author=A.+Ashoorzadeh&title=Prodrug+Forms+of+Kinase+Inhibitors+and+Their+Use+in+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DJ.%2BB.%26atitle%3DProdrug%2520Forms%2520of%2520Kinase%2520Inhibitors%2520and%2520Their%2520Use%2520in%2520Therapy%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span> <span> </span><span class="NLM_article-title">Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2014.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.pt.2014.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=24776300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVWlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=289-298&author=S.+Pattersonauthor=S.+Wyllie&title=Nitro+drugs+for+the+treatment+of+trypanosomatid+diseases%3A+past%2C+present%2C+and+future+prospects&doi=10.1016%2Fj.pt.2014.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects</span></div><div class="casAuthors">Patterson, Stephen; Wyllie, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">289-298</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  There is an urgent need for new, safer, and effective treatments for the diseases caused by the protozoan parasites Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp.  In the search for more effective drugs to treat these 'neglected diseases' researchers have chosen to reassess the therapeutic value of nitroarom. compds.  Previously avoided in drug discovery programs owing to potential toxicity issues, a nitro drug is now being used successfully as part of a combination therapy for human African trypanosomiasis.  We describe here the rehabilitation of nitro drugs for the treatment of trypanosomatid diseases and discuss the future prospects for this compd. class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomh5yhGW-6mrVg90H21EOLACvtfcHk0lhrfYY__TPvsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVWlsL4%253D&md5=041606bd13d4f709723aa61f1100873b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2014.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2014.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DWyllie%26aufirst%3DS.%26atitle%3DNitro%2520drugs%2520for%2520the%2520treatment%2520of%2520trypanosomatid%2520diseases%253A%2520past%252C%2520present%252C%2520and%2520future%2520prospects%26jtitle%3DTrends%2520Parasitol.%26date%3D2014%26volume%3D30%26spage%3D289%26epage%3D298%26doi%3D10.1016%2Fj.pt.2014.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit55a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. P.</span></span> <span> </span><span class="NLM_article-title">Biologic activity of hydroxylamine: A review</span>. <i>Crit. Rev. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.3109/10408448509023765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.3109%2F10408448509023765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=3882333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADyaL2MXht1Klt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1985&pages=87-99&author=P.+Grossauthor=R.+P.+Smith&title=Biologic+activity+of+hydroxylamine%3A+A+review&doi=10.3109%2F10408448509023765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55aR"><div class="casContent"><span class="casTitleNuber">55a</span><div class="casTitle"><span class="NLM_cas:atitle">Biologic activity of hydroxylamine:  a review</span></div><div class="casAuthors">Gross, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-99</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">0045-6446</span>.
    </div><div class="casAbstract">A review with 119 refs. on the toxicity, teratogenicity, and carcinogenicity of hydroxylamine  [7803-49-8] in animals and humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4JvAuDoMmrbVg90H21EOLACvtfcHk0lhrfYY__TPvsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXht1Klt7Y%253D&md5=f1a4928e2c9c774182a813e9937ac712</span></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.3109%2F10408448509023765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10408448509023765%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DR.%2BP.%26atitle%3DBiologic%2520activity%2520of%2520hydroxylamine%253A%2520A%2520review%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D1985%26volume%3D14%26spage%3D87%26epage%3D99%26doi%3D10.3109%2F10408448509023765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit55b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Macherey, A. C.</span>; <span class="NLM_string-name">Dansette, P. M.</span></span> <span> </span><span class="NLM_article-title">Biotransformations Leading to Toxic Metabolites: Chemical Aspect</span>.  <i>The Practice of Medicinal Chemistry</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-417205-0.00025-0</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FB978-0-12-417205-0.00025-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=675-696&author=A.+C.+Macherey&author=P.+M.+Dansette&title=The+Practice+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-417205-0.00025-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-417205-0.00025-0%26sid%3Dliteratum%253Aachs%26aulast%3DMacherey%26aufirst%3DA.%2BC.%26atitle%3DBiotransformations%2520Leading%2520to%2520Toxic%2520Metabolites%253A%2520Chemical%2520Aspect%26btitle%3DThe%2520Practice%2520of%2520Medicinal%2520Chemistry%26pub%3DAcademic%2520Press%26date%3D2015%26spage%3D675%26epage%3D696%26doi%3D10.1016%2FB978-0-12-417205-0.00025-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plošnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vračko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Mutagenic and carcinogenic structural alerts and their mechanisms of action</span>. <i>Arh. Hig. Rada Toksikol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1515/aiht-2016-67-2801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1515%2Faiht-2016-67-2801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27749264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOjsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2016&pages=169-182&author=A.+Plo%C5%A1nikauthor=M.+Vra%C4%8Dkoauthor=M.+Sollner+Dolenc&title=Mutagenic+and+carcinogenic+structural+alerts+and+their+mechanisms+of+action&doi=10.1515%2Faiht-2016-67-2801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Mutagenic and carcinogenic structural alerts and their mechanisms of action</span></div><div class="casAuthors">Plosnik, Alja; Vracko, Marjan; Dolenc, Marija Sollner</div><div class="citationInfo"><span class="NLM_cas:title">Arhiv za Higijenu Rada i Toksikologiju</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-182</span>CODEN:
                <span class="NLM_cas:coden">AHRTAN</span>;
        ISSN:<span class="NLM_cas:issn">0004-1254</span>.
    
            (<span class="NLM_cas:orgname">Institute for Medical Research and Occupational Health</span>)
        </div><div class="casAbstract">Knowing the mutagenic and carcinogenic properties of chems. is very important for their hazard (and risk) assessment.  One of the crucial events that trigger genotoxic and sometimes carcinogenic effects is the forming of adducts between chem. compds. and nucleic acids and histones.  This review takes a look at the mechanisms related to specific functional groups (structural alerts or toxicophores) that may trigger genotoxic or epigenetic effects in the cells.  We present up-to-date information about defined structural alerts with their mechanisms and the software based on this knowledge (QSAR models and classification schemes).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdeqAFfj6rMbVg90H21EOLACvtfcHk0lj6Om1GWDEW6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOjsbnN&md5=dd7df61e62c220bd31592ec080b4a5e3</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1515%2Faiht-2016-67-2801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Faiht-2016-67-2801%26sid%3Dliteratum%253Aachs%26aulast%3DPlo%25C5%25A1nik%26aufirst%3DA.%26aulast%3DVra%25C4%258Dko%26aufirst%3DM.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DMutagenic%2520and%2520carcinogenic%2520structural%2520alerts%2520and%2520their%2520mechanisms%2520of%2520action%26jtitle%3DArh.%2520Hig.%2520Rada%2520Toksikol.%26date%3D2016%26volume%3D67%26spage%3D169%26epage%3D182%26doi%3D10.1515%2Faiht-2016-67-2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarrad, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaskovich, M. A. T.</span></span> <span> </span><span class="NLM_article-title">Nitroimidazoles: molecular fireworks that combat a broad spectrum of infectious diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7636</span>– <span class="NLM_lpage">7657</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00143</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntVGgtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7636-7657&author=C.+W.+Angauthor=A.+M.+Jarradauthor=M.+A.+Cooperauthor=M.+A.+T.+Blaskovich&title=Nitroimidazoles%3A+molecular+fireworks+that+combat+a+broad+spectrum+of+infectious+diseases&doi=10.1021%2Facs.jmedchem.7b00143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases</span></div><div class="casAuthors">Ang, Chee Wei; Jarrad, Angie M.; Cooper, Matthew A.; Blaskovich, Mark A. T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7636-7657</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Infectious diseases claim millions of lives every year, but with the advent of drug resistance, therapeutic options to treat infections are inadequate.  There is now an urgent need to develop new and effective treatments.  Nitroimidazoles are a class of antimicrobial drugs that have remarkable broad spectrum activity against parasites, mycobacteria, and anaerobic Gram-pos. and Gram-neg. bacteria.  While nitroimidazoles were discovered in the 1950s, there has been renewed interest in their therapeutic potential, particularly for the treatment of parasitic infections and tuberculosis.  In this review, we summarize different classes of nitroimidazoles that have been described in the literature in the past five years, from approved drugs and clin. candidates to examples undergoing preclin. or early stage development.  The relatively "nonspecific" mode of action and resistance mechanisms of nitromidazoles are discussed, and contemporary strategies to facilitate nitroimidazole drug development are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWN4dIzG5927Vg90H21EOLACvtfcHk0lj6Om1GWDEW6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntVGgtrw%253D&md5=7822bbe845bd6f1383ce09c62c5d5ac8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00143%26sid%3Dliteratum%253Aachs%26aulast%3DAng%26aufirst%3DC.%2BW.%26aulast%3DJarrad%26aufirst%3DA.%2BM.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%2BT.%26atitle%3DNitroimidazoles%253A%2520molecular%2520fireworks%2520that%2520combat%2520a%2520broad%2520spectrum%2520of%2520infectious%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7636%26epage%3D7657%26doi%3D10.1021%2Facs.jmedchem.7b00143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e09744</span>, <span class="refDoi"> DOI: 10.7554/eLife.09744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.7554%2FeLife.09744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27215734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsFamtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e09744&author=S.+Pattersonauthor=S.+Wyllieauthor=S.+Norvalauthor=L.+Stojanovskiauthor=F.+R.+C.+Simeonsauthor=J.+L.+Auerauthor=M.+Osuna-Cabelloauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=The+anti-tubercular+drug+delamanid+as+a+potential+oral+treatment+for+visceral+leishmaniasis&doi=10.7554%2FeLife.09744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis</span></div><div class="casAuthors">Patterson, Stephen; Wyllie, Susan; Norval, Suzanne; Stojanovski, Laste; Simeons, Frederick R. C.; Auer, Jennifer L.; Osuna-Cabello, Maria; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e09744/1-e09744/21</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">There is an urgent requirement for safe, oral and cost-effective drugs for the treatment of visceral leishmaniasis (VL).  We report that delamanid (OPC-67683), an approved drug for multi-drug resistant tuberculosis, is a potent inhibitor of Leishmaniadonovani both in vitro and in vivo.  Twice-daily oral dosing of delamanid at 30 mg kg-1 for 5 days resulted in sterile cures in a mouse model of VL.  Treatment with lower doses revealed a U-shaped (hormetic) dose-response curve with greater parasite suppression at 1 mg kg-1 than at 3 mg kg-1 (5 or 10 day dosing).  Dosing delamanid for 10 days confirmed the hormetic dose-response and improved the efficacy at all doses investigated.  Mechanistic studies reveal that delamanid is rapidly metabolised by parasites via an enzyme, distinct from the nitroreductase that activates fexinidazole.  Delamanid has the potential to be repurposed as a much-needed oral therapy for VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqepWvGUGZ0cbVg90H21EOLACvtfcHk0lg_9QSbPYBsXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsFamtLw%253D&md5=1a704d1acb52b08cae5f73cf625f293a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.7554%2FeLife.09744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.09744%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DAuer%26aufirst%3DJ.%2BL.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DThe%2520anti-tubercular%2520drug%2520delamanid%2520as%2520a%2520potential%2520oral%2520treatment%2520for%2520visceral%2520leishmaniasis%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De09744%26doi%3D10.7554%2FeLife.09744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit59"><span>DNDI-0690
Nitroimidazole; Drugs for Neglected Diseases Initiative, 2016. <a href="http://www.dndi.org/diseases-projects/portfolio/nitroimidazole/" class="extLink">http://www.dndi.org/diseases-projects/portfolio/nitroimidazole/</a> (accessed December 14, <span class="NLM_year">2016</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DNDI-0690%0ANitroimidazole%3B+Drugs+for+Neglected+Diseases+Initiative%2C+2016.+http%3A%2F%2Fwww.dndi.org%2Fdiseases-projects%2Fportfolio%2Fnitroimidazole%2F+%28accessed+December+14%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardley, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivahare, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, S. K.</span></span> <span> </span><span class="NLM_article-title">Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1093/jac/dku422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1093%2Fjac%2Fdku422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=25389223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFGmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=518-527&author=S.+Guptaauthor=V.+Yardleyauthor=P.+Vishwakarmaauthor=R.+Shivahareauthor=B.+Sharmaauthor=D.+Launayauthor=D.+Martinauthor=S.+K.+Puri&title=Nitroimidazo-oxazole+compound+DNDI-VL-2098%3A+an+orally+effective+preclinical+drug+candidate+for+the+treatment+of+visceral+leishmaniasis&doi=10.1093%2Fjac%2Fdku422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis</span></div><div class="casAuthors">Gupta, Suman; Yardley, Vanessa; Vishwakarma, Preeti; Shivahare, Rahul; Sharma, Bhawna; Launay, Delphine; Martin, Denis; Puri, Sunil K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">518-527</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: The objective of this study was to identify a nitroimidazo-oxazole lead mol. for the treatment of visceral leishmaniasis (VL).  Methods: A library of 72 nitroimidazo-oxazoles was evaluated in vitro for their antileishmanial activity against luciferase-transfected DD8 amastigotes of Leishmania donovani.  On the basis of their in vitro potency and pharmacokinetic properties, the promising compds. were tested in acute BALB/c mouse and chronic hamster models of VL via oral administration and efficacy was evaluated by microscopic counting of amastigotes after Giemsa staining.  The best antileishmanial candidates (racemate DNDI-VL-2001) and its R enantiomer (DNDI-VL-2098) were evaluated in vitro against a range of Leishmania strains.  These candidates were further studied in a hamster model using various dose regimens.  Cytokine and inducible nitric oxide synthase estns. by real-time PCR and nitric oxide generation by Griess assay were also carried out for DNDI-VL-2098.  Results: In vitro screening of nitroimidazo-oxazole compds. identified the racemate DNDI-VL-2001 (6-nitroimidazo-oxazole deriv.) and its enantiomers as candidates for further evaluation in in vivo models of VL.  DNDI-VL-2098 (IC50 of 0.03 μM for the DD8 strain) showed excellent in vivo activity in both mouse and hamster models, with an ED90 value of 3.7 and <25 mg/kg, resp., and was also found to be very effective against high-grade infection in the hamster model.  Our studies revealed that, along with leishmanicidal activity, DNDI-VL-2098 was also capable of inducing host-protective immune cells to suppress Leishmania parasites in hamsters.  Conclusions: These studies led to the identification of compd. DNDI-VL-2098 as a preclin. candidate for further drug development as an oral treatment for VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUxdrMAhWewLVg90H21EOLACvtfcHk0lg_9QSbPYBsXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFGmur8%253D&md5=179ae312a4efef99059577223650641a</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdku422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdku422%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DYardley%26aufirst%3DV.%26aulast%3DVishwakarma%26aufirst%3DP.%26aulast%3DShivahare%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DB.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DPuri%26aufirst%3DS.%2BK.%26atitle%3DNitroimidazo-oxazole%2520compound%2520DNDI-VL-2098%253A%2520an%2520orally%2520effective%2520preclinical%2520drug%2520candidate%2520for%2520the%2520treatment%2520of%2520visceral%2520leishmaniasis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2015%26volume%3D70%26spage%3D518%26epage%3D527%26doi%3D10.1093%2Fjac%2Fdku422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukkavilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinjari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengottuvelan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadekar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pothuri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashekar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koiram, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harisudhan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moinuddin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachharajani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2014.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejps.2014.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=25261338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Gms73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2014&pages=147-155&author=R.+Mukkavilliauthor=J.+Pinjariauthor=B.+Patelauthor=S.+Sengottuvelanauthor=S.+Mondalauthor=A.+Gadekarauthor=M.+Vermaauthor=J.+Patelauthor=L.+Pothuriauthor=G.+Chandrashekarauthor=P.+Koiramauthor=T.+Harisudhanauthor=A.+Moinuddinauthor=D.+Launayauthor=N.+Vachharajaniauthor=V.+Ramanathanauthor=D.+Martin&title=In+vitro+metabolism%2C+disposition%2C+preclinical+pharmacokinetics+and+prediction+of+human+pharmacokinetics+of+DNDI-VL-2098%2C+a+potential+oral+treatment+for+Visceral+Leishmaniasis&doi=10.1016%2Fj.ejps.2014.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis</span></div><div class="casAuthors">Mukkavilli, Rao; Pinjari, Jakir; Patel, Bhavesh; Sengottuvelan, Shankar; Mondal, Subodh; Gadekar, Ajit; Verma, Manas; Patel, Jignesh; Pothuri, Lavanya; Chandrashekar, Gopu; Koiram, Prabhakar; Harisudhan, Tanukrishnan; Moinuddin, Ansari; Launay, Delphine; Vachharajani, Nimish; Ramanathan, Vikram; Martin, Denis</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-155</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The in vitro metab. and in vivo pharmacokinetic (PK) properties of DNDI-VL-2098, a potential oral agent for Visceral Leishmaniasis (VL) were studied and used to predict its human pharmacokinetics.  DNDI-VL-2098 showed a low soly. (10 μM) and was highly permeable (>200 nm/s) in the Caco-2 model.  It was stable in vitro in liver microsomes and hepatocytes and no metabolite was detectable in circulating plasma from dosed animals suggesting very slow, if any, metab. of the compd.  DNDI-VL-2098 was moderate to highly bound to plasma proteins across the species tested (94-98%).  DNDI-VL-2098 showed satisfactory PK properties in mouse, hamster, rat and dog with a low blood clearance (<15% of hepatic blood flow except hamster), a vol. of distribution of about 3 times total body water, acceptable half-life (1-6 h across the species) and good oral bioavailability (37-100%).  Allometric scaling of the preclin. PK data to human gave a blood half-life of approx. 20 h suggesting that the compd. could be a once-a-day drug.  Based on the above assumptions, the min. efficacious dose predicted for a 50 kg human was 150 mg and 300 mg, using efficacy results in the mouse and hamster, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg5azRMLSQ37Vg90H21EOLACvtfcHk0lhizpbxdwP4lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Gms73N&md5=9d351c194ceba25f2dc23be54bb1ba33</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2014.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2014.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DMukkavilli%26aufirst%3DR.%26aulast%3DPinjari%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DB.%26aulast%3DSengottuvelan%26aufirst%3DS.%26aulast%3DMondal%26aufirst%3DS.%26aulast%3DGadekar%26aufirst%3DA.%26aulast%3DVerma%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DPothuri%26aufirst%3DL.%26aulast%3DChandrashekar%26aufirst%3DG.%26aulast%3DKoiram%26aufirst%3DP.%26aulast%3DHarisudhan%26aufirst%3DT.%26aulast%3DMoinuddin%26aufirst%3DA.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DVachharajani%26aufirst%3DN.%26aulast%3DRamanathan%26aufirst%3DV.%26aulast%3DMartin%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520metabolism%252C%2520disposition%252C%2520preclinical%2520pharmacokinetics%2520and%2520prediction%2520of%2520human%2520pharmacokinetics%2520of%2520DNDI-VL-2098%252C%2520a%2520potential%2520oral%2520treatment%2520for%2520Visceral%2520Leishmaniasis%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2014%26volume%3D65%26spage%3D147%26epage%3D155%26doi%3D10.1016%2Fj.ejps.2014.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel BET inhibitors by drug repurposing of nitroxoline and its analogues</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">9352</span>– <span class="NLM_lpage">9361</span>, <span class="refDoi"> DOI: 10.1039/C7OB02369C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1039%2FC7OB02369C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=29087414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSgsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=9352-9361&author=H.+Jiangauthor=J.+Xingauthor=C.+Wangauthor=H.+Zhangauthor=L.+Yueauthor=X.+Wanauthor=W.+Chenauthor=H.+Dingauthor=Y.+Xieauthor=H.+Taoauthor=Z.+Chenauthor=H.+Jiangauthor=K.+Chenauthor=S.+Chenauthor=M.+Zhengauthor=Y.+Zhangauthor=C.+Luo&title=Discovery+of+novel+BET+inhibitors+by+drug+repurposing+of+nitroxoline+and+its+analogues&doi=10.1039%2FC7OB02369C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel BET inhibitors by drug repurposing of nitroxoline and its analogues</span></div><div class="casAuthors">Jiang, Hao; Xing, Jing; Wang, Chen; Zhang, Hao; Yue, Liyan; Wan, Xiaozhe; Chen, Wei; Ding, Hong; Xie, Yiqian; Tao, Hongru; Chen, Zhifeng; Jiang, Hualiang; Chen, Kaixian; Chen, Shijie; Zheng, Mingyue; Zhang, Yuanyuan; Luo, Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">9352-9361</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The BET family of bromodomain-contg. proteins (BRDs) is believed to be a promising drug target for therapeutic intervention in a no. of diseases including cancer, inflammation and cardiovascular diseases.  Hence, there is a great demand for novel chemotypes of BET inhibitors.  The drug repurposing strategy offers great benefits to find inhibitors with known safety and pharmacokinetic profiles, thus increasing medicinal chemists' interest in recent years.  Using the drug repurposing strategy, a BRD4-specific score based virtual screening campaign on an inhouse drug library was conducted followed by the ALPHA screen assay test.  Nitroxoline, an FDA-approved antibiotic, was identified to effectively disrupt the interaction between the first bromodomain of BRD4 (bromodomain-contg. protein 4) and acetylated H4 peptide with IC50 of 0.98 μM.  Nitroxoline inhibited all BET family members with good selectivity against non-BET bromodomain-contg. proteins, thus it is defined as a selective BET inhibitor.  Based on the crystal structure of the nitroxoline-BRD4_BD1 complex, the mechanism of action as well as BET specificity of nitroxoline were detd.  Since the anticancer activity of nitroxoline against MLL leukemia, one of the BET related diseases, has not been studied before, we tested whether nitroxoline might serve as a potential repurposing drug candidate for MLL leukemia.  Nitroxoline effectively inhibited the proliferation of MLL leukemia cells by inducing cell cycle arrest and apoptosis.  The profound efficacy is, at least in part, due to the inhibition of BET and downregulation of target gene transcription.  Our discovery of nitroxoline as a BET inhibitor suggests potential application of nitroxoline and its derivs. for clin. translation in BET family related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwFY1iu1armbVg90H21EOLACvtfcHk0lhizpbxdwP4lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSgsbjF&md5=ca87955c1bd2b79fe073faef1e6ef149</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1039%2FC7OB02369C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7OB02369C%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DYue%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520BET%2520inhibitors%2520by%2520drug%2520repurposing%2520of%2520nitroxoline%2520and%2520its%2520analogues%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2017%26volume%3D15%26spage%3D9352%26epage%3D9361%26doi%3D10.1039%2FC7OB02369C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coe, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bammler, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farin, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plymate, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fausto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S. D.</span></span> <span> </span><span class="NLM_article-title">Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1290</span>, <span class="refDoi"> DOI: 10.1021/tx7001349</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx7001349" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1277-1290&author=K.+J.+Coeauthor=Y.+Jiaauthor=H.+K.+Hoauthor=P.+Rademacherauthor=T.+K.+Bammlerauthor=R.+P.+Beyerauthor=F.+M.+Farinauthor=L.+Woodkeauthor=S.+R.+Plymateauthor=N.+Faustoauthor=S.+D.+Nelson&title=Comparison+of+the+cytotoxicity+of+the+nitroaromatic+drug+flutamide+to+its+cyano+analogue+in+the+hepatocyte+cell+line+TAMH%3A+evidence+for+complex+I+inhibition+and+mitochondrial+dysfunction+using+toxicogenomic+screening&doi=10.1021%2Ftx7001349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Ftx7001349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx7001349%26sid%3Dliteratum%253Aachs%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DHo%26aufirst%3DH.%2BK.%26aulast%3DRademacher%26aufirst%3DP.%26aulast%3DBammler%26aufirst%3DT.%2BK.%26aulast%3DBeyer%26aufirst%3DR.%2BP.%26aulast%3DFarin%26aufirst%3DF.%2BM.%26aulast%3DWoodke%26aufirst%3DL.%26aulast%3DPlymate%26aufirst%3DS.%2BR.%26aulast%3DFausto%26aufirst%3DN.%26aulast%3DNelson%26aufirst%3DS.%2BD.%26atitle%3DComparison%2520of%2520the%2520cytotoxicity%2520of%2520the%2520nitroaromatic%2520drug%2520flutamide%2520to%2520its%2520cyano%2520analogue%2520in%2520the%2520hepatocyte%2520cell%2520line%2520TAMH%253A%2520evidence%2520for%2520complex%2520I%2520inhibition%2520and%2520mitochondrial%2520dysfunction%2520using%2520toxicogenomic%2520screening%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1277%26epage%3D1290%26doi%3D10.1021%2Ftx7001349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mook, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spasojevic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barak, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyerly, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span> <span> </span><span class="NLM_article-title">Structure–activity studies of Wnt/β-catenin inhibition in the niclosamide chemotype: Identification of derivatives with improved drug exposure</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5829</span>– <span class="NLM_lpage">5838</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2015.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=26272032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWls7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5829-5838&author=R.+A.+Mookauthor=J.+Wangauthor=X.+R.+Renauthor=M.+Chenauthor=I.+Spasojevicauthor=L.+S.+Barakauthor=H.+K.+Lyerlyauthor=W.+Chen&title=Structure%E2%80%93activity+studies+of+Wnt%2F%CE%B2-catenin+inhibition+in+the+niclosamide+chemotype%3A+Identification+of+derivatives+with+improved+drug+exposure&doi=10.1016%2Fj.bmc.2015.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure</span></div><div class="casAuthors">Mook, Robert A., Jr.; Wang, Jiangbo; Ren, Xiu-Rong; Chen, Minyong; Spasojevic, Ivan; Barak, Larry S.; Lyerly, H. Kim; Chen, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5829-5838</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Wnt signaling pathway plays a key role in regulation of organ development and tissue homeostasis.  Dysregulated Wnt activity is one of the major underlying mechanisms responsible for many diseases including cancer.  We previously reported the FDA-approved anthelmintic drug Niclosamide inhibits Wnt/β-catenin signaling and suppresses colon cancer cell growth in vitro and in vivo.  Niclosamide is a multi-functional drug that possesses important biol. activity in addn. to inhibition of Wnt/β-catenin signaling.  Here, we studied the SAR of Wnt signaling inhibition in the anilide and salicylamide region of Niclosamide.  We found that the 4'-nitro substituent can be effectively replaced by trifluoromethyl or chlorine and that the potency of inhibition was dependent on the substitution pattern in the anilide ring.  Non-anilide, N-Me amides and reverse amide derivs. lost significant potency, while acylated salicylamide derivs. inhibited signaling with potency similar to non-acyl derivs.  Niclosamide low systemic exposure when dosed orally may hinder its use to treat systemic disease.  To overcome this limitation we identified an acyl deriv. of Niclosamide, DK-520 (compd. 32), that significantly increased both the plasma concn. and the duration of exposure of Niclosamide when dosed orally.  The studies herein provide a medicinal chem. foundation to improve the pharmacokinetic exposure of Niclosamide and Wnt-signaling inhibitors based on the Niclosamide chemotype.  The identification of novel derivs. of Niclosamide that metabolize to Niclosamide and increase its drug exposure may provide important research tools for in vivo studies and provide drug candidates for treating cancers with dysregulated Wnt signaling including drug-resistant cancers.  Moreover, since Niclosamide is a multi-functional drug, new research tools such as DK520 could directly result in novel treatments against bacterial and viral infection, lupus, and metabolic diseases such as type II diabetes, NASH and NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmEUYAbB-zQrVg90H21EOLACvtfcHk0liN3rhS994A9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWls7%252FE&md5=bacff220c2336023d2854678058839c1</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DX.%2BR.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DSpasojevic%26aufirst%3DI.%26aulast%3DBarak%26aufirst%3DL.%2BS.%26aulast%3DLyerly%26aufirst%3DH.%2BK.%26aulast%3DChen%26aufirst%3DW.%26atitle%3DStructure%25E2%2580%2593activity%2520studies%2520of%2520Wnt%252F%25CE%25B2-catenin%2520inhibition%2520in%2520the%2520niclosamide%2520chemotype%253A%2520Identification%2520of%2520derivatives%2520with%2520improved%2520drug%2520exposure%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5829%26epage%3D5838%26doi%3D10.1016%2Fj.bmc.2015.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Purohit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, A. K.</span></span> <span> </span><span class="NLM_article-title">Mutagenicity of nitroaromatic compounds</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1021/tx000002x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx000002x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=673-692&author=V.+Purohitauthor=A.+K.+Basu&title=Mutagenicity+of+nitroaromatic+compounds&doi=10.1021%2Ftx000002x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Mutagenicity of Nitroaromatic Compounds</span></div><div class="casAuthors">Purohit, Vandana; Basu, Ashis K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">673-692</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review and discussion with 222 refs.  Metab. and DNA binding, mechanism of mutagenesis and repair in bacteria, mutagenesis in mammalian systems, and structure-activity relationship are discussed in relation to the title topic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpybDHR1RJ20rVg90H21EOLACvtfcHk0liN3rhS994A9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFSitLg%253D&md5=74477b2805d2365e208538cdce0dec39</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Ftx000002x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx000002x%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DV.%26aulast%3DBasu%26aufirst%3DA.%2BK.%26atitle%3DMutagenicity%2520of%2520nitroaromatic%2520compounds%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2000%26volume%3D13%26spage%3D673%26epage%3D692%26doi%3D10.1021%2Ftx000002x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit66a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span> <span> </span><span class="NLM_article-title">Delamanid is not metabolized by salmonella or human nitroreductases: a possible mechanism for the lack of mutagenicity</span>. <i>Regul. Toxicol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.yrtph.2016.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.yrtph.2016.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27988333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWltrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2017&pages=1-8&author=E.+Hanakiauthor=M.+Hayashiauthor=M.+Matsumoto&title=Delamanid+is+not+metabolized+by+salmonella+or+human+nitroreductases%3A+a+possible+mechanism+for+the+lack+of+mutagenicity&doi=10.1016%2Fj.yrtph.2016.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66aR"><div class="casContent"><span class="casTitleNuber">66a</span><div class="casTitle"><span class="NLM_cas:atitle">Delamanid is not metabolized by Salmonella or human nitroreductases: A possible mechanism for the lack of mutagenicity</span></div><div class="casAuthors">Hanaki, Erina; Hayashi, Mikayo; Matsumoto, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Toxicology and Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">RTOPDW</span>;
        ISSN:<span class="NLM_cas:issn">0273-2300</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Nitro-contg. compds. such as nitrofuran and nitroimidazole are drugs used for the treatment of infectious diseases.  However, many of these nitro-contg. drugs are pos. in the bacterial reverse mutation assay (Ames test).  The recently approved anti-multidrug-resistant tuberculosis (MDR-TB) drug, delamanid (Deltyba; OPC-67683), a deriv. of 4-nitroimidazole, was neg. for mutagenicity in the Ames assay.  In Salmonella typhimurium, mutagenicity of nitro compds. has been closely assocd. with the ability of nitroreductase to metabolize (degrdn.)these compds.  To explore the lack of mutagenicity for delamanid, we examd. the initial metabolic rate and mutagenic-specific activity of a series of nitro compds. in S. typhimurium TA100.  The order of max. mutagenic-activity was nitrofuran > 2-nitroimidazole > 5-nitroimidazole ≥ 4-nitroimidazole, which is very similar to the order of initial metabolic rate, i.e., the Pearson's correlation coeff. (r = 0.85) showed a correlation between metabolic rate and mutagenic-activity.  No metab. of delamanid was detected even after 60 h of treatment.  In addn., delamanid was not reduced by two human nitroreductases.  These facts may explain the absence of genotoxicity of delamanid in both in vitro and in vivo tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi9fPk3B4RcbVg90H21EOLACvtfcHk0lhfJssrDYB4pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWltrrK&md5=8fa327a744a5476a2a973c4b8ad2527c</span></div><a href="/servlet/linkout?suffix=cit66a&amp;dbid=16384&amp;doi=10.1016%2Fj.yrtph.2016.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yrtph.2016.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DHanaki%26aufirst%3DE.%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DM.%26atitle%3DDelamanid%2520is%2520not%2520metabolized%2520by%2520salmonella%2520or%2520human%2520nitroreductases%253A%2520a%2520possible%2520mechanism%2520for%2520the%2520lack%2520of%2520mutagenicity%26jtitle%3DRegul.%2520Toxicol.%2520Pharmacol.%26date%3D2017%26volume%3D84%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.yrtph.2016.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit66b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stover, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrener, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanDevanter, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arain, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langhorne, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiswirth, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, W. R.</span></span> <span> </span><span class="NLM_article-title">A small molecule nitroimidazopyran drug candidate for the treatment of tuberculosis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>405</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1038/35016103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1038%2F35016103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10879539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Wksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=962-966&author=C.+K.+Stoverauthor=P.+Warrenerauthor=D.+R.+VanDevanterauthor=D.+R.+Shermanauthor=T.+M.+Arainauthor=M.+H.+Langhorneauthor=S.+W.+Andersonauthor=J.+A.+Towellauthor=Y.+Yuanauthor=D.+N.+McMurrayauthor=B.+N.+Kreiswirthauthor=C.+E.+Barryauthor=W.+R.+Baker&title=A+small+molecule+nitroimidazopyran+drug+candidate+for+the+treatment+of+tuberculosis&doi=10.1038%2F35016103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66bR"><div class="casContent"><span class="casTitleNuber">66b</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis</span></div><div class="casAuthors">Stover, C. Kendall; Warrener, Paul; VanDevanter, Donald R.; Sherman, David R.; Arain, Taraq M.; Langhorne, Michael H.; Anderson, Scott W.; Towell, J. Andrew; Yuan, Ying; McMurray, David N.; Krelswirth, Barry N.; Barry, Clifton E.; Baker, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">6789</span>),
    <span class="NLM_cas:pages">962-966</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis, which causes tuberculosis, is the greatest single infectious cause of mortality worldwide, killing roughly; two million people annually.  Ests. indicate that one-third of the world population is infected with latent M. tuberculosis.  The synergy between tuberculosis and the AIDS epidemic, and the surge of multidrug-resistant clin. isolates of M. tuberculosis have reaffirmed tuberculosis as a primary public health threat.  However, new antitubercular drugs with new mechanisms of action have not been developed in over thirty years.  Here we report a series of compds. contg. a nitroimidazopyran nucleus that possess antitubercular activity.  After activation by a mechanism dependent on M. tuberculosis F420 cofactor, nitroimidazopyrans inhibited the synthesis of protein and cell wall lipid.  In contrast to current antitubercular drugs, nitroimidazopyrans exhibited bactericidal activity against both replicating and static M. tuberculosis.  Lead compd. PA-824 showed potent bactericidal activity against multidrug-resistant M. tuberculosis and promising oral activity in animal infection models.  We conclude that nitroimidazopyrans offer the practical qualities of a small mol. with the potential for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw41eD4TtVwbVg90H21EOLACvtfcHk0lhfJssrDYB4pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Wksb0%253D&md5=f5f6e2935928da72e328bddd4995515f</span></div><a href="/servlet/linkout?suffix=cit66b&amp;dbid=16384&amp;doi=10.1038%2F35016103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35016103%26sid%3Dliteratum%253Aachs%26aulast%3DStover%26aufirst%3DC.%2BK.%26aulast%3DWarrener%26aufirst%3DP.%26aulast%3DVanDevanter%26aufirst%3DD.%2BR.%26aulast%3DSherman%26aufirst%3DD.%2BR.%26aulast%3DArain%26aufirst%3DT.%2BM.%26aulast%3DLanghorne%26aufirst%3DM.%2BH.%26aulast%3DAnderson%26aufirst%3DS.%2BW.%26aulast%3DTowell%26aufirst%3DJ.%2BA.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DMcMurray%26aufirst%3DD.%2BN.%26aulast%3DKreiswirth%26aufirst%3DB.%2BN.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBaker%26aufirst%3DW.%2BR.%26atitle%3DA%2520small%2520molecule%2520nitroimidazopyran%2520drug%2520candidate%2520for%2520the%2520treatment%2520of%2520tuberculosis%26jtitle%3DNature%26date%3D2000%26volume%3D405%26spage%3D962%26epage%3D966%26doi%3D10.1038%2F35016103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellows, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachaspati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raichurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravishankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarkar, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandodkar, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span> <span> </span><span class="NLM_article-title">Nitroarenes as antitubercular agents: stereoelectronic modulation to mitigate mutagenicity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1002%2Fcmdc.201500462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=26751718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=331-339&author=S.+Landgeauthor=V.+Ramachandranauthor=A.+Kumarauthor=J.+Neresauthor=K.+Muruganauthor=C.+Sadlerauthor=M.+D.+Fellowsauthor=V.+Humnabadkarauthor=P.+Vachaspatiauthor=A.+Raichurkarauthor=S.+Sharmaauthor=S.+Ravishankarauthor=S.+Gupthaauthor=V.+K.+Sambandamurthyauthor=T.+S.+Balganeshauthor=B.+G.+Ugarkarauthor=V.+Balasubramanianauthor=B.+S.+Bandodkarauthor=M.+Panda&title=Nitroarenes+as+antitubercular+agents%3A+stereoelectronic+modulation+to+mitigate+mutagenicity&doi=10.1002%2Fcmdc.201500462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity</span></div><div class="casAuthors">Landge, Sudhir; Ramachandran, Vasanthi; Kumar, Anupriya; Neres, Joao; Murugan, Kannan; Sadler, Claire; Fellows, Mick D.; Humnabadkar, Vaishali; Vachaspati, Prakash; Raichurkar, Anandkumar; Sharma, Sreevalli; Ravishankar, Sudha; Guptha, Supreeth; Sambandamurthy, Vasan K.; Balganesh, Tanjore S.; Ugarkar, Bheemarao G.; Balasubramanian, V.; Bandodkar, Balachandra S.; Panda, Manoranjan</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-339</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Nitroarenes are less preferred in drug discovery due to their potential to be mutagenic.  However, several nitroarenes were shown to be promising antitubercular agents with specific modes of action, namely, nitroimidazoles and benzothiazinones.  The nitro group in these compds. is activated through different mechanisms, both enzymic and non-enzymic, in mycobacteria prior to binding to the target of interest.  From a whole-cell screening program, the authors identified a novel lead nitrobenzothiazole (BT) series that acts by inhibition of decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1) of Mycobacterium tuberculosis (Mtb).  The lead was found to be mutagenic to start with.  The authors' efforts to mitigate mutagenicity resulted in the identification of 6-methyl-7-nitro-5-(trifluoromethyl)-1,3-benzothiazoles (cBTs), a novel class of antitubercular agents that are non-mutagenic and exhibit an improved safety profile.  The Me group ortho to the nitro group decreases the electron affinity of the series, and is hence responsible for the non-mutagenic nature of these compds.  Addnl., the co-crystal structure of cBT in complex with Mtb DprE1 established the mode of binding.  This investigation led to a new non-mutagenic antitubercular agent and demonstrates that the mutagenic nature of nitroarenes can be solved by modulation of stereoelectronic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodER9QhnSYVbVg90H21EOLACvtfcHk0lgGXMXH8TEx7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVGmsA%253D%253D&md5=1210ad4dcfcb609da6a96b998f6eaf6d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500462%26sid%3Dliteratum%253Aachs%26aulast%3DLandge%26aufirst%3DS.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DMurugan%26aufirst%3DK.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DFellows%26aufirst%3DM.%2BD.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DVachaspati%26aufirst%3DP.%26aulast%3DRaichurkar%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DRavishankar%26aufirst%3DS.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DBalganesh%26aufirst%3DT.%2BS.%26aulast%3DUgarkar%26aufirst%3DB.%2BG.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBandodkar%26aufirst%3DB.%2BS.%26aulast%3DPanda%26aufirst%3DM.%26atitle%3DNitroarenes%2520as%2520antitubercular%2520agents%253A%2520stereoelectronic%2520modulation%2520to%2520mitigate%2520mutagenicity%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D331%26epage%3D339%26doi%3D10.1002%2Fcmdc.201500462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit68a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shamovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Börjesson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordén, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasselgren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjö, P.</span></span> <span> </span><span class="NLM_article-title">Explanation for main features of structure-genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">16168</span>– <span class="NLM_lpage">16185</span>, <span class="refDoi"> DOI: 10.1021/ja206427u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja206427u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=16168-16185&author=I.+Shamovskyauthor=L.+Ripaauthor=L.+B%C3%B6rjessonauthor=C.+Meeauthor=B.+Nord%C3%A9nauthor=P.+Hansenauthor=C.+Hasselgrenauthor=M.+O%E2%80%99Donovanauthor=P.+Sj%C3%B6&title=Explanation+for+main+features+of+structure-genotoxicity+relationships+of+aromatic+amines+by+theoretical+studies+of+their+activation+pathways+in+CYP1A2&doi=10.1021%2Fja206427u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68aR"><div class="casContent"><span class="casTitleNuber">68a</span><div class="casTitle"><span class="NLM_cas:atitle">Explanation for Main Features of Structure-Genotoxicity Relationships of Aromatic Amines by Theoretical Studies of Their Activation Pathways in CYP1A2</span></div><div class="casAuthors">Shamovsky, Igor; Ripa, Lena; Borjesson, Lena; Mee, Christine; Norden, Bo; Hansen, Peter; Hasselgren, Catrin; O'Donovan, Mike; Sjo, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">16168-16185</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arom. and heteroarom. amines (ArNH2) represent a class of potential mutagens that after being metabolically activated covalently modify DNA.  Activation of ArNH2 in many cases starts with N-hydroxylation by P 450 enzymes, primarily CYP1A2.  Poor understanding of structure-mutagenicity relationships of ArNH2 limits their use in drug discovery programs.  Key factors that facilitate activation of ArNH2 are revealed by exploring their reaction intermediates in CYP1A2 using DFT calcns.  On the basis of these calcns. and extensive anal. of structure-mutagenicity data, we suggest that mutagenic metabolites are generated by ferric peroxo intermediate, (CYP1A2)FeIII-OO-, in a three-step heterolytic mechanism.  First, the distal oxygen of the oxidant abstrs. proton from H-bonded ArNH2.  The subsequent proximal protonation of the resulting (CYP1A2)FeIII-OOH weakens both the O-O and the O-H bonds of the oxidant.  Heterolytic cleavage of the O-O bond leads to N-hydroxylation of ArNH- via SN2 mechanism, whereas cleavage of the O-H bond results in release of hydroperoxy radical.  Thus, our proposed reaction offers a mechanistic explanation for previous observations that metab. of arom. amines could cause oxidative stress.  The primary drivers for mutagenic potency of ArNH2 are (i) binding affinity of ArNH2 in the productive binding mode within the CYP1A2 substrate cavity, (ii) resonance stabilization of the anionic forms of ArNH2, and (iii) exothermicity of proton-assisted heterolytic cleavage of N-O bonds of hydroxylamines and their bioconjugates.  This leads to a strategy for designing mutagenicity free ArNH2: Structural alterations in ArNH2, which disrupt geometric compatibility with CYP1A2, hinder proton abstraction, or strongly destabilize the nitrenium ion, in this order of priority, prevent genotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrctr81IIN2trVg90H21EOLACvtfcHk0lgGXMXH8TEx7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvI&md5=9447ee2144a899b65e9350b712ca2a46</span></div><a href="/servlet/linkout?suffix=cit68a&amp;dbid=16384&amp;doi=10.1021%2Fja206427u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja206427u%26sid%3Dliteratum%253Aachs%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3DRipa%26aufirst%3DL.%26aulast%3DB%25C3%25B6rjesson%26aufirst%3DL.%26aulast%3DMee%26aufirst%3DC.%26aulast%3DNord%25C3%25A9n%26aufirst%3DB.%26aulast%3DHansen%26aufirst%3DP.%26aulast%3DHasselgren%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%26aulast%3DSj%25C3%25B6%26aufirst%3DP.%26atitle%3DExplanation%2520for%2520main%2520features%2520of%2520structure-genotoxicity%2520relationships%2520of%2520aromatic%2520amines%2520by%2520theoretical%2520studies%2520of%2520their%2520activation%2520pathways%2520in%2520CYP1A2%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D16168%26epage%3D16185%26doi%3D10.1021%2Fja206427u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit68b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shamovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomberg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjö, P.</span></span> <span> </span><span class="NLM_article-title">Theoretical studies of chemical reactivity of metabolically activated forms of aromatic amines toward DNA</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2236</span>– <span class="NLM_lpage">2252</span>, <span class="refDoi"> DOI: 10.1021/tx300313b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300313b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=2236-2252&issue=10&author=I.+Shamovskyauthor=L.+Ripaauthor=N.+Blombergauthor=L.+A.+Erikssonauthor=P.+Hansenauthor=C.+Meeauthor=C.+Tyrchanauthor=M.+O%E2%80%99Donovanauthor=P.+Sj%C3%B6&title=Theoretical+studies+of+chemical+reactivity+of+metabolically+activated+forms+of+aromatic+amines+toward+DNA&doi=10.1021%2Ftx300313b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68b&amp;dbid=16384&amp;doi=10.1021%2Ftx300313b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300313b%26sid%3Dliteratum%253Aachs%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3DRipa%26aufirst%3DL.%26aulast%3DBlomberg%26aufirst%3DN.%26aulast%3DEriksson%26aufirst%3DL.%2BA.%26aulast%3DHansen%26aufirst%3DP.%26aulast%3DMee%26aufirst%3DC.%26aulast%3DTyrchan%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%26aulast%3DSj%25C3%25B6%26aufirst%3DP.%26atitle%3DTheoretical%2520studies%2520of%2520chemical%2520reactivity%2520of%2520metabolically%2520activated%2520forms%2520of%2520aromatic%2520amines%2520toward%2520DNA%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26issue%3D10%26spage%3D2236%26epage%3D2252%26doi%3D10.1021%2Ftx300313b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit68c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ripa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjö, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamovsky, I.</span></span> <span> </span><span class="NLM_article-title">Theoretical studies of the mechanism of N-hydroxylation of primary aromatic amines by cytochrome P450 1A2: radicaloid or anionic?</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1021/tx400376u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx400376u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtl2gtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=265-278&issue=2&author=L.+Ripaauthor=C.+Meeauthor=P.+Sj%C3%B6author=I.+Shamovsky&title=Theoretical+studies+of+the+mechanism+of+N-hydroxylation+of+primary+aromatic+amines+by+cytochrome+P450+1A2%3A+radicaloid+or+anionic%3F&doi=10.1021%2Ftx400376u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68cR"><div class="casContent"><span class="casTitleNuber">68c</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical Studies of the Mechanism of N-Hydroxylation of Primary Aromatic Amines by Cytochrome P450 1A2: Radicaloid or Anionic?</span></div><div class="casAuthors">Ripa, Lena; Mee, Christine; Sjoe, Peter; Shamovsky, Igor</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">265-278</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Primary arom. and heteroarom. amines are notoriously known as potential mutagens and carcinogens.  The major event of the mechanism of their mutagenicity is N-hydroxylation by P 450 enzymes, primarily P 450 1A2 (CYP1A2), which leads to the formation of nitrenium ions that covalently modify nucleobases of DNA.  Energy profiles of the NH bond activation steps of two possible mechanisms of N-hydroxylation of a no. of arom. amines by CYP1A2, radicaloid and anionic, are studied by dispersion-cor. DFT calcns.  The classical radicaloid mechanism is mediated by H-atom transfer to the electrophilic ferryl-oxo intermediate of the P 450 catalytic cycle (called Compd. I or Cpd I), whereas the alternative anionic mechanism involves proton transfer to the preceding nucleophilic ferrous-peroxo species.  The key structural features of the catalytic site of human CYP1A2 revealed by X-ray crystallog. are maintained in calcns.  The obtained DFT reaction profiles and addnl. calcns. that account for nondynamical electron correlation suggest that Cpd I has higher thermodn. drive to activate arom. amines than the ferrous-peroxo species.  Nevertheless, the anionic mechanism is demonstrated to be consistent with a variety of exptl. observations.  Thus, energy of the proton transfer from arom. amines to the ferrous-peroxo dianion splits arom. amines into two classes with different mutagenicity mechanisms.  Favorable or slightly unfavorable barrier-free proton transfer is inherent in compds. that undergo nitrenium ion mediated mutagenicity.  Monocyclic electron-rich arom. amines that do not follow this mutagenicity mechanism show significantly unfavorable proton transfer.  Feasibility of the entire anionic mechanism is demonstrated by favorable Gibbs energy profiles of both chem. steps, NH bond activation, and NO bond formation.  Taken together, results suggest that the N-hydroxylation of arom. amines in CYP1A2 undergoes the anionic mechanism.  Possible reasons for the apparent inability of Cpd I to activate arom. amines in CYP1A2 are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQkB42GsCW7Vg90H21EOLACvtfcHk0lg28B_iK083YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtl2gtQ%253D%253D&md5=5aba1c841deea190a7b4170a824fc9ab</span></div><a href="/servlet/linkout?suffix=cit68c&amp;dbid=16384&amp;doi=10.1021%2Ftx400376u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx400376u%26sid%3Dliteratum%253Aachs%26aulast%3DRipa%26aufirst%3DL.%26aulast%3DMee%26aufirst%3DC.%26aulast%3DSj%25C3%25B6%26aufirst%3DP.%26aulast%3DShamovsky%26aufirst%3DI.%26atitle%3DTheoretical%2520studies%2520of%2520the%2520mechanism%2520of%2520N-hydroxylation%2520of%2520primary%2520aromatic%2520amines%2520by%2520cytochrome%2520P450%25201A2%253A%2520radicaloid%2520or%2520anionic%253F%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26issue%3D2%26spage%3D265%26epage%3D278%26doi%3D10.1021%2Ftx400376u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benigni, R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1767</span>– <span class="NLM_lpage">1800</span>, <span class="refDoi"> DOI: 10.1021/cr030049y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr030049y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=1767-1800&author=R.+Benigni&title=Structure-activity+relationship+studies+of+chemical+mutagens+and+carcinogens%3A+mechanistic+investigations+and+prediction+approaches&doi=10.1021%2Fcr030049y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fcr030049y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030049y%26sid%3Dliteratum%253Aachs%26aulast%3DBenigni%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520chemical%2520mutagens%2520and%2520carcinogens%253A%2520mechanistic%2520investigations%2520and%2520prediction%2520approaches%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D1767%26epage%3D1800%26doi%3D10.1021%2Fcr030049y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seger, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, L.</span></span> <span> </span><span class="NLM_article-title">Mechanism of the N-hydroxylation of primary and secondary amines by cytochrome P450</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">603</span>, <span class="refDoi"> DOI: 10.1021/tx500371a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx500371a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=597-603&author=S.+T.+Segerauthor=P.+Rydbergauthor=L.+Olsen&title=Mechanism+of+the+N-hydroxylation+of+primary+and+secondary+amines+by+cytochrome+P450&doi=10.1021%2Ftx500371a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of the N-Hydroxylation of Primary and Secondary Amines by Cytochrome P450</span></div><div class="casAuthors">Seger, Signe T.; Rydberg, Patrik; Olsen, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">597-603</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytochrome P 450 enzymes (CYPs) metabolize alkyl- and arylamines, generating several different products.  For the primary and secondary amines, some of these reactions result in hydroxylated amines, which may be toxic.  Thus, when designing new drugs contg. amine groups, it is important to be able to predict if a given compd. will be a substrate for CYPs, in order to avoid toxic metabolites, and hence to understand the mechanism that is utilized by CYPs.  Two possible mechanisms, for the N-hydroxylation of primary and secondary amines mediated by CYPs, are studied by d. functional theory (DFT) for four different amines (aniline, N-methylaniline, propan-2-amine, and dimethylamine).  The hydrogen atom transfer and rebound (HAT) mechanism is found to be preferred over the direct oxygen addn. rearrangement (OAR) mechanism for all four amines.  However, in contrast to the same mechanism for the hydroxylation of aliph. carbon atoms, the rebound step is shown to be rate-limiting in most cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgEFAA2ubocbVg90H21EOLACvtfcHk0lg28B_iK083YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrk%253D&md5=9f23608f2541a03110b90b2f5e6895fe</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Ftx500371a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx500371a%26sid%3Dliteratum%253Aachs%26aulast%3DSeger%26aufirst%3DS.%2BT.%26aulast%3DRydberg%26aufirst%3DP.%26aulast%3DOlsen%26aufirst%3DL.%26atitle%3DMechanism%2520of%2520the%2520N-hydroxylation%2520of%2520primary%2520and%2520secondary%2520amines%2520by%2520cytochrome%2520P450%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2015%26volume%3D28%26spage%3D597%26epage%3D603%26doi%3D10.1021%2Ftx500371a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boechat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomão, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo-Lima, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mello, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felzenszwalb, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiub, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamith, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skupin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haufe, G.</span></span> <span> </span><span class="NLM_article-title">Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group</span>. <i>Mem. Inst. Oswaldo Cruz</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1590/0074-02760140248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1590%2F0074-02760140248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=26018452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVChu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2015&pages=492-499&issue=4&author=N.+Boechatauthor=A.+S.+Carvalhoauthor=K.+Salom%C3%A3oauthor=S.+L.+Castroauthor=C.+F.+Araujo-Limaauthor=F.+V.+Melloauthor=I.+Felzenszwalbauthor=C.+A.+Aiubauthor=T.+R.+Condeauthor=H.+P.+Zamithauthor=R.+Skupinauthor=G.+Haufe&title=Studies+of+genotoxicity+and+mutagenicity+of+nitroimidazoles%3A+demystifying+this+critical+relationship+with+the+nitro+group&doi=10.1590%2F0074-02760140248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group</span></div><div class="casAuthors">Boechat, Nubia; Carvalho, Alcione S.; Salomao, Kelly; de Castro, Solange L.; Araujo-Lima, Carlos F.; Mello, Francisco V. C.; Felzenszwalb, Israel; Aiub, Claudia A. F.; Conde, Taline Ramos; Zamith, Helena P. S.; Skupin, Rolf; Haufe, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Memorias do Instituto Oswaldo Cruz</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">492-499</span>CODEN:
                <span class="NLM_cas:coden">MIOCAS</span>;
        ISSN:<span class="NLM_cas:issn">1678-8060</span>.
    
            (<span class="NLM_cas:orgname">Instituto Oswaldo Cruz</span>)
        </div><div class="casAbstract">Nitroimidazoles exhibit high microbicidal activity, but mutagenic, genotoxic and cytotoxic properties have been attributed to the presence of the nitro group.  However, we synthesized nitroimidazoles with activity against the trypomastigotes of Trypanosoma cruzi, but that were not genotoxic.  Herein, nitroimidazoles (11-19) bearing different substituent groups were investigated for their potential induction of genotoxicity (comet assay) and mutagenicity (Salmonella/Microsome assay) and the correlations of these effects with their trypanocidal effect and with megazol were investigated.  The compds. were designed to analyze the role played by the position of the nitro group in the imidazole nucleus (C-4 or C-5) and the presence of oxidisable groups at N-1 as an anion receptor group and the role of a Me group at C-2.  Nitroimidazoles bearing NO2 at C-4 and CH3 at C-2 were not genotoxic compared to those bearing NO2 at C-5.  However, when there was a CH3 at C-2, the position of the NO2 group had no influence on the genotoxic activity.  Fluorinated compds. exhibited higher genotoxicity regardless of the presence of CH3 at C-2 or NO2 at C-4 or C-5.  However, in compds. 11 (2-CH3; 4-NO2; N-CH2OHCH2Cl) and 12 (2-CH3; 4-NO2; N-CH2OHCH2F), the fluorine atom had no influence on genotoxicity.  This study contributes to the future search for new and safer prototypes and provide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_K_2K3FpFwLVg90H21EOLACvtfcHk0ljxdeSUdDGUhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVChu7Y%253D&md5=baa51b068dcb7e5c5ec680e458efc9c4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1590%2F0074-02760140248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252F0074-02760140248%26sid%3Dliteratum%253Aachs%26aulast%3DBoechat%26aufirst%3DN.%26aulast%3DCarvalho%26aufirst%3DA.%2BS.%26aulast%3DSalom%25C3%25A3o%26aufirst%3DK.%26aulast%3DCastro%26aufirst%3DS.%2BL.%26aulast%3DAraujo-Lima%26aufirst%3DC.%2BF.%26aulast%3DMello%26aufirst%3DF.%2BV.%26aulast%3DFelzenszwalb%26aufirst%3DI.%26aulast%3DAiub%26aufirst%3DC.%2BA.%26aulast%3DConde%26aufirst%3DT.%2BR.%26aulast%3DZamith%26aufirst%3DH.%2BP.%26aulast%3DSkupin%26aufirst%3DR.%26aulast%3DHaufe%26aufirst%3DG.%26atitle%3DStudies%2520of%2520genotoxicity%2520and%2520mutagenicity%2520of%2520nitroimidazoles%253A%2520demystifying%2520this%2520critical%2520relationship%2520with%2520the%2520nitro%2520group%26jtitle%3DMem.%2520Inst.%2520Oswaldo%2520Cruz%26date%3D2015%26volume%3D110%26issue%3D4%26spage%3D492%26epage%3D499%26doi%3D10.1590%2F0074-02760140248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit72"><span>Drug
information and side effects database. <a href="http://www.drugsdb.com/blog/fda-approved-drugs-pulled-from-market.html" class="extLink">http://www.drugsdb.com/blog/fda-approved-drugs-pulled-from-market.html</a> (accessed Dec 31, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Drug%0Ainformation+and+side+effects+database.+http%3A%2F%2Fwww.drugsdb.com%2Fblog%2Ffda-approved-drugs-pulled-from-market.html+%28accessed+Dec+31%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit73a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. J.</span>; <span class="NLM_string-name">Groundwater, P. W.</span>; <span class="NLM_string-name">Todd, A.</span>; <span class="NLM_string-name">Worsley, A. J.</span></span> <span> </span><span class="NLM_article-title">Nitroimidazole antibacterial agents</span>. In  <i>Antibacterial Agents: Chemistry, Mode of Action, Mechanisms of Resistance and Clinical Applications</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">John Wiley & Sons, Ltd.</span>: <span class="NLM_publisher-loc">Chichester, U.K.</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1002%2F9781118325421.ch4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=85-101&author=R.+J.+Anderson&author=P.+W.+Groundwater&author=A.+Todd&author=A.+J.+Worsley&title=Antibacterial+Agents%3A+Chemistry%2C+Mode+of+Action%2C+Mechanisms+of+Resistance+and+Clinical+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73a&amp;dbid=16384&amp;doi=10.1002%2F9781118325421.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118325421.ch4%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DR.%2BJ.%26atitle%3DNitroimidazole%2520antibacterial%2520agents%26btitle%3DAntibacterial%2520Agents%253A%2520Chemistry%252C%2520Mode%2520of%2520Action%252C%2520Mechanisms%2520of%2520Resistance%2520and%2520Clinical%2520Applications%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26date%3D2012%26spage%3D85%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit73b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Grigsby, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcial, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asbell, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T. L.</span></span> <span> </span><span class="NLM_article-title">Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80–05. Radiation Therapy Oncology Group</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1016/S0360-3016(99)00054-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FS0360-3016%2899%2900054-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10348279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADyaK1MXjsl2ku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1999&pages=513-517&author=P.+W.+Grigsbyauthor=K.+Winterauthor=T.+H.+Wassermanauthor=V.+Marcialauthor=M.+Rotmanauthor=J.+Cooperauthor=H.+Keysauthor=S.+O.+Asbellauthor=T.+L.+Phillips&title=Irradiation+with+or+without+misonidazole+for+patients+with+stages+IIIB+and+IVA+carcinoma+of+the+cervix%3A+final+results+of+RTOG+80%E2%80%9305.+Radiation+Therapy+Oncology+Group&doi=10.1016%2FS0360-3016%2899%2900054-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73bR"><div class="casContent"><span class="casTitleNuber">73b</span><div class="casTitle"><span class="NLM_cas:atitle">Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05</span></div><div class="casAuthors">Grigsby, Perry W.; Winter, Kathryn; Wasserman, Todd H.; Marcial, Victor; Rotman, Marvin; Cooper, Jay; Keys, Henry; Asbell, Sucha O.; Phillips, Theodore L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">513-517</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The purpose of this study was to evaluate tumor response, progression-free survival, local tumor control, patterns of relapse, and toxicity in patients with Stages IIIb and IVa squamous cell carcinoma of the uterine cervix treated with irradn. or irradn. and misonidazole.  This is a report of the final results of the study.  This study was a prospective randomized Phase III trial performed by the Radiation Therapy Oncol. Group (RTOG).  Between August 1980 and Nov. 1984, 120 patients with Stages IIIb and IVa squamous cell carcinoma of the cervix were randomized to receive either std. irradn. or std. irradn. and misonidazole.  Irradn. consisted of 46 Gy to the pelvis plus a 10 Gy parametrial boost followed by intracavitary brachytherapy or external irradn. boost to the primary tumor.  Misonidazole was administered at 400 mg/m2 daily, 2-4 h before irradn.  Patients in the 2 treatment groups were evenly distributed by stage, Karnofsky Performance Status, and pos. para-aortic lymph nodes.  Sixty-one patients were treated with irradn. alone, and 59 patients received irradn. and misonidazole.  Complete response in the pelvis occurred in 44 (75%) of those treated with irradn. and in 38 (64%) of those treated with irradn. and misonidazole.  The progression-free survivals were 22% at 5 yr for the control group, and 29% at 5 yr for the misonidazole group.  At the time of last follow-up, 18 patients in the control arm were free of disease, and in the exptl. arm, 19 were free of disease.  The patterns of failure for those treated with irradn. alone were local-only in 9 patients, distant-only in 8 patients, and local and distant in 11 patients.  The patterns of failure for those receiving irradn. and misonidazole were local-only in 3 patients, distant-only in 8 patients, and local and distant in 8 patients.  The max. toxicity experienced per patient was grade 3 in 18%, grade 4 in 8%, and no grade 5 toxicity for those treated with irradn. alone compared to 8%, 2%, and 2%, resp., for the exptl. arm.  There were no statistically significant differences in pelvic response, disease-free survivals, patterns of failure, or toxicity for the irradn. alone group or for the irradn. and misonidazole group as administered in this study for patients with Stages IIIb and IVa squamous cell carcinoma of the uterine cervix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRWPuOPW1XlbVg90H21EOLACvtfcHk0lhB7ixh0-7zbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsl2ku7g%253D&md5=329b2910e3d491d4a2a9e3cc92608374</span></div><a href="/servlet/linkout?suffix=cit73b&amp;dbid=16384&amp;doi=10.1016%2FS0360-3016%2899%2900054-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0360-3016%252899%252900054-1%26sid%3Dliteratum%253Aachs%26aulast%3DGrigsby%26aufirst%3DP.%2BW.%26aulast%3DWinter%26aufirst%3DK.%26aulast%3DWasserman%26aufirst%3DT.%2BH.%26aulast%3DMarcial%26aufirst%3DV.%26aulast%3DRotman%26aufirst%3DM.%26aulast%3DCooper%26aufirst%3DJ.%26aulast%3DKeys%26aufirst%3DH.%26aulast%3DAsbell%26aufirst%3DS.%2BO.%26aulast%3DPhillips%26aufirst%3DT.%2BL.%26atitle%3DIrradiation%2520with%2520or%2520without%2520misonidazole%2520for%2520patients%2520with%2520stages%2520IIIB%2520and%2520IVA%2520carcinoma%2520of%2520the%2520cervix%253A%2520final%2520results%2520of%2520RTOG%252080%25E2%2580%259305.%2520Radiation%2520Therapy%2520Oncology%2520Group%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D1999%26volume%3D44%26spage%3D513%26epage%3D517%26doi%3D10.1016%2FS0360-3016%2899%2900054-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit74"><span>Nitro
compounds-drug bank. <a href="https://www.drugbank.ca/categories/DBCAT000765/" class="extLink">https://www.drugbank.ca/categories/DBCAT000765/</a> (accessed Dec 29, <span class="NLM_year">2017</span>)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nitro%0Acompounds-drug+bank.+https%3A%2F%2Fwww.drugbank.ca%2Fcategories%2FDBCAT000765%2F+%28accessed+Dec+29%2C+2017%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit75"><span>NIH U.S.
National Library of Medicine, Clinical trials.gov. <a href="https://clinicaltrials.gov/" class="extLink">https://clinicaltrials.gov/</a> (accessed December 31, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=NIH+U.S.%0ANational+Library+of+Medicine%2C+Clinical+trials.gov.+https%3A%2F%2Fclinicaltrials.gov%2F+%28accessed+December+31%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit76"><span>The PubChem
Project. <a href="https://pubchem.ncbi.nlm.nih.gov/" class="extLink">https://pubchem.ncbi.nlm.nih.gov/</a> (accessed Dec 31, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+PubChem%0AProject.+https%3A%2F%2Fpubchem.ncbi.nlm.nih.gov%2F+%28accessed+Dec+31%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit77a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duaso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liempi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Droguett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galanti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maya, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Muñoz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmerling, U.</span></span> <span> </span><span class="NLM_article-title">Toxic and therapeutic effects of nifurtimox and benznidazole on Trypanosoma cruzi ex vivo infection of human placental chorionic villi explants</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1016/j.actatropica.2014.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.actatropica.2014.01.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2014&pages=112-118&author=G.+Rojoauthor=C.+Castilloauthor=J.+Duasoauthor=A.+Liempiauthor=D.+Droguettauthor=N.+Galantiauthor=J.+D.+Mayaauthor=R.+L%C3%B3pez-Mu%C3%B1ozauthor=U.+Kemmerling&title=Toxic+and+therapeutic+effects+of+nifurtimox+and+benznidazole+on+Trypanosoma+cruzi+ex+vivo+infection+of+human+placental+chorionic+villi+explants&doi=10.1016%2Fj.actatropica.2014.01.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77a&amp;dbid=16384&amp;doi=10.1016%2Fj.actatropica.2014.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.actatropica.2014.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DRojo%26aufirst%3DG.%26aulast%3DCastillo%26aufirst%3DC.%26aulast%3DDuaso%26aufirst%3DJ.%26aulast%3DLiempi%26aufirst%3DA.%26aulast%3DDroguett%26aufirst%3DD.%26aulast%3DGalanti%26aufirst%3DN.%26aulast%3DMaya%26aufirst%3DJ.%2BD.%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DR.%26aulast%3DKemmerling%26aufirst%3DU.%26atitle%3DToxic%2520and%2520therapeutic%2520effects%2520of%2520nifurtimox%2520and%2520benznidazole%2520on%2520Trypanosoma%2520cruzi%2520ex%2520vivo%2520infection%2520of%2520human%2520placental%2520chorionic%2520villi%2520explants%26jtitle%3DActa%2520Trop.%26date%3D2014%26volume%3D132%26spage%3D112%26epage%3D118%26doi%3D10.1016%2Fj.actatropica.2014.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit77b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. S.</span></span> <span> </span><span class="NLM_article-title">Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2072</span>– <span class="NLM_lpage">2084</span>, <span class="refDoi"> DOI: 10.2174/156802611796575894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.2174%2F156802611796575894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=21619510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=2072-2084&author=S.+R.+Wilkinsonauthor=C.+Botauthor=J.+M.+Kellyauthor=B.+S.+Hall&title=Trypanocidal+activity+of+nitroaromatic+prodrugs%3A+current+treatments+and+future+perspectives&doi=10.2174%2F156802611796575894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77bR"><div class="casContent"><span class="casTitleNuber">77b</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives</span></div><div class="casAuthors">Wilkinson, Shane R.; Bot, Christopher; Kelly, John M.; Hall, Belinda S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2072-2084</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chagas disease and African sleeping sickness are trypanosomal infections that represent important public health problems in Latin America and Africa, resp.  The restriction of these diseases to the poorer parts of the world has meant that they have been largely neglected and limited progress has been made in their treatment.  The nitroheterocyclic prodrugs nifurtimox and benznidazole, in use against Chagas disease for >40 years, remain the only agents available for this infection.  In the case of African sleeping sickness, nifurtimox has recently been added to the arsenal of medicines, with the nitroheterocycle fexinidazole currently under evaluation.  For a long time, the cytotoxic mechanisms of these drugs were poorly understood: nifurtimox was thought to act via prodn. of superoxide anions and nitro radicals, while the mode of benznidazole action was more obscure.  The trypanocidal activity of nitroheterocyclic drugs is now known to depend on a parasite type I nitroreductase (NTR).  This enzyme is absent from mammalian cells, a difference that forms the basis for the drug selectivity.  The role of this enzyme in drug activation has been genetically and biochem. validated.  It catalyzes the 2-electron redn. of nitroheterocyclic compds. within the parasite, producing toxic metabolites without significant generation of superoxide.  Recognition that this enzyme is responsible for activation of nitroheterocyclic prodrugs has allowed screening for compds. that preferentially target the parasite.  This approach has led to the identification of two new classes of anti-trypanosomal agents, nitrobenzylphosphoramide mustards and aziridinyl nitrobenzamides, and promises to yield new, safer, more effective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6vBQMwS_TY7Vg90H21EOLACvtfcHk0ligoYB-LhQ6ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3L&md5=5976d05c6686ad8121c94b5da581f599</span></div><a href="/servlet/linkout?suffix=cit77b&amp;dbid=16384&amp;doi=10.2174%2F156802611796575894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611796575894%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DBot%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DHall%26aufirst%3DB.%2BS.%26atitle%3DTrypanocidal%2520activity%2520of%2520nitroaromatic%2520prodrugs%253A%2520current%2520treatments%2520and%2520future%2520perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D2072%26epage%3D2084%26doi%3D10.2174%2F156802611796575894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit77c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alirol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrumpf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amici Heradi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Patoul, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappuis, F.</span></span> <span> </span><span class="NLM_article-title">Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1093/cid/cis886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1093%2Fcid%2Fcis886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=23074318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvV2ksLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=195-203&author=E.+Alirolauthor=D.+Schrumpfauthor=J.+Amici+Heradiauthor=A.+Riedelauthor=C.+de+Patoulauthor=M.+Quereauthor=F.+Chappuis&title=Nifurtimox-eflornithine+combination+therapy+for+second-stage+gambiense+human+African+trypanosomiasis%3A+M%C3%A9decins+Sans+Fronti%C3%A8res+experience+in+the+Democratic+Republic+of+the+Congo&doi=10.1093%2Fcid%2Fcis886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77cR"><div class="casContent"><span class="casTitleNuber">77c</span><div class="casTitle"><span class="NLM_cas:atitle">Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Medecins Sans Frontieres Experience in the Democratic Republic of the Congo</span></div><div class="casAuthors">Alirol, Emilie; Schrumpf, David; Amici Heradi, Josue; Riedel, Andrea; de Patoul, Catherine; Quere, Michel; Chappuis, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-203</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Since 2009, nifurtimox-eflornithine combination therapy (NECT) has raised great hopes for the treatment of second-stage human African trypanosomiasis.  Data from the first 18 mo of NECT use in Medecins Sans Frontieres programs in the Democratic Republic of the Congo confirm its good safety profile, esp. among children.  Background.  Existing diagnostic and treatment tools for human African trypanosomiasis (HAT) are limited.  The recent development of nifurtimox-eflornithine combination therapy (NECT) has brought new hopes for patients in the second stage.  While NECT has been rolled out in most endemic countries, safety data are scarce and derive only from clin. trials.  The World Health Organization (WHO) coordinates a pharmacovigilance program to collect addnl. data on NECT safety and efficacy.  We report here the results of 18 mo of experience of NECT use in treatment centers run by Medecins Sans Frontieres in the Democratic Republic of the Congo (DRC).  Methods. This cohort study included 684 second-stage HAT patients (including 120 children) treated with NECT in Doruma and Dingila hospitals, northeastern DRC, between Jan. 2010 and June 2011.  All treatment-emergent adverse events (AEs) were recorded and graded according to the Common Terminol. Criteria for Adverse Events version 3.0.  Safety and efficacy data were retrieved from the WHO pharmacovigilance forms and from Epitryps, a program monitoring database.  Results. Eighty-six percent of the patients experienced at least 1 AE during treatment.  On av., children experienced fewer AEs than adults.  Most AEs were mild (37.9%) or moderate (54.7%).  Severe AEs included vomiting (n = 32), dizziness (n = 16), headache (n = 11), and convulsions (n = 11).  The in-hospital case fatality rate was low (0.15%) and relapses were rare (n = 14).  Conclusions.  In comparison with previous treatments, NECT was effective, safe, and well tolerated in nontrial settings in DRC, further supporting the roll-out of NECT as first-line treatment in second-stage Trypanosoma brucei gambiense HAT.  Tolerance was particularly good in children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsb2XaO2Y1vrVg90H21EOLACvtfcHk0ligoYB-LhQ6ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvV2ksLvK&md5=78fa4f3ca3b109621a64a7d564414dea</span></div><a href="/servlet/linkout?suffix=cit77c&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcis886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcis886%26sid%3Dliteratum%253Aachs%26aulast%3DAlirol%26aufirst%3DE.%26aulast%3DSchrumpf%26aufirst%3DD.%26aulast%3DAmici%2BHeradi%26aufirst%3DJ.%26aulast%3DRiedel%26aufirst%3DA.%26aulast%3Dde%2BPatoul%26aufirst%3DC.%26aulast%3DQuere%26aufirst%3DM.%26aulast%3DChappuis%26aufirst%3DF.%26atitle%3DNifurtimox-eflornithine%2520combination%2520therapy%2520for%2520second-stage%2520gambiense%2520human%2520African%2520trypanosomiasis%253A%2520M%25C3%25A9decins%2520Sans%2520Fronti%25C3%25A8res%2520experience%2520in%2520the%2520Democratic%2520Republic%2520of%2520the%2520Congo%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D56%26spage%3D195%26epage%3D203%26doi%3D10.1093%2Fcid%2Fcis886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit78"><span>Benznidazole
(By Mouth). <a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0030625/" class="extLink">http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0030625/</a> (accessed December 26, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Benznidazole%0A%28By+Mouth%29.+http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmedhealth%2FPMHT0030625%2F+%28accessed+December+26%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit78b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez De Armas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eells, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traina, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meymandi, S. K.</span></span> <span> </span><span class="NLM_article-title">Tolerance of benznidazole in a United States Chagas Disease clinic</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1237</span>– <span class="NLM_lpage">1240</span>, <span class="refDoi"> DOI: 10.1093/cid/civ005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1093%2Fcid%2Fciv005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=25601454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BC2Mvns1eksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=1237-1240&author=D.+A.+Millerauthor=S.+Hernandezauthor=L.+Rodriguez+De+Armasauthor=S.+J.+Eellsauthor=M.+M.+Trainaauthor=L.+G.+Millerauthor=S.+K.+Meymandi&title=Tolerance+of+benznidazole+in+a+United+States+Chagas+Disease+clinic&doi=10.1093%2Fcid%2Fciv005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78bR"><div class="casContent"><span class="casTitleNuber">78b</span><div class="casTitle"><span class="NLM_cas:atitle">Tolerance of benznidazole in a United States Chagas Disease clinic</span></div><div class="casAuthors">Miller David A; Eells Samantha J; Miller Loren G; Hernandez Salvador; Rodriguez De Armas Lissette; Traina Mahmoud M; Meymandi Sheba K</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1237-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The US-based Center of Excellence for Chagas Disease performed an observational study on the safety and tolerance of benznidazole 5 mg/kg/day for 60 days in 30 adults with chronic Chagas disease.  The side-effect profile was suboptimal, including 5 cases of debilitating neuropathy and an unusually high angioedema rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoSEc0tthPZBFwe7cAcrfPfW6udTcc2eYkiOSbMhPzmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mvns1eksQ%253D%253D&md5=f247ffcd1f22c388bb82f2381111273d</span></div><a href="/servlet/linkout?suffix=cit78b&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciv005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciv005%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BA.%26aulast%3DHernandez%26aufirst%3DS.%26aulast%3DRodriguez%2BDe%2BArmas%26aufirst%3DL.%26aulast%3DEells%26aufirst%3DS.%2BJ.%26aulast%3DTraina%26aufirst%3DM.%2BM.%26aulast%3DMiller%26aufirst%3DL.%2BG.%26aulast%3DMeymandi%26aufirst%3DS.%2BK.%26atitle%3DTolerance%2520of%2520benznidazole%2520in%2520a%2520United%2520States%2520Chagas%2520Disease%2520clinic%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D60%26spage%3D1237%26epage%3D1240%26doi%3D10.1093%2Fcid%2Fciv005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negrette, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parada, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basombrio, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, N. J.</span></span> <span> </span><span class="NLM_article-title">Hepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethyl nitro furazone: a comparison with Benznidazole</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e3231</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0003231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1371%2Fjournal.pntd.0003231" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=e3231&author=C.+Daviesauthor=N.+Deyauthor=O.+S.+Negretteauthor=L.+A.+Paradaauthor=M.+A.+Basombrioauthor=N.+J.+Garg&title=Hepatotoxicity+in+mice+of+a+novel+anti-parasite+drug+candidate+hydroxymethyl+nitro+furazone%3A+a+comparison+with+Benznidazole&doi=10.1371%2Fjournal.pntd.0003231"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003231%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DC.%26aulast%3DDey%26aufirst%3DN.%26aulast%3DNegrette%26aufirst%3DO.%2BS.%26aulast%3DParada%26aufirst%3DL.%2BA.%26aulast%3DBasombrio%26aufirst%3DM.%2BA.%26aulast%3DGarg%26aufirst%3DN.%2BJ.%26atitle%3DHepatotoxicity%2520in%2520mice%2520of%2520a%2520novel%2520anti-parasite%2520drug%2520candidate%2520hydroxymethyl%2520nitro%2520furazone%253A%2520a%2520comparison%2520with%2520Benznidazole%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26spage%3De3231%26doi%3D10.1371%2Fjournal.pntd.0003231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit80"><span>Metronidazole
400 mg Tablets. <a href="https://www.medicines.org.uk/emc/product/538/smpc" class="extLink">https://www.medicines.org.uk/emc/product/538/smpc</a> (accessed Jan 14, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Metronidazole%0A400+mg+Tablets.+https%3A%2F%2Fwww.medicines.org.uk%2Femc%2Fproduct%2F538%2Fsmpc+%28accessed+Jan+14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit82a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Nigro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballo, M. A.</span></span> <span> </span><span class="NLM_article-title">Genotoxicity and cell death induced by tinidazole (TNZ)</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2008.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.toxlet.2008.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18582545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=46-52&author=M.+M.+Lopez+Nigroauthor=M.+A.+Carballo&title=Genotoxicity+and+cell+death+induced+by+tinidazole+%28TNZ%29&doi=10.1016%2Fj.toxlet.2008.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82aR"><div class="casContent"><span class="casTitleNuber">82a</span><div class="casTitle"><span class="NLM_cas:atitle">Genotoxicity and cell death induced by tinidazole (TNZ)</span></div><div class="casAuthors">Lopez Nigro, M. M.; Carballo, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-52</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tinidazole (TNZ), a second-generation 5-nitroimidazole compd. chem. related to metronidazole (MTZ), has been widely used throughout Europe and developing countries for the treatment of amoebic and parasitic infections.  Despite TNZ's increasing use in therapeutics, scarce exptl. reports are available in literature on its potential genotoxicity in human cells.  Therefore, the aim of the present study was to achieve a precise characterization of the cytotoxic and genotoxic activities of this nitroimidazole in cultured human lymphocytes at therapeutic concns. (0.1, 1, 10 and 50 μg/mL of culture) and evaluate the possible cell death mechanism assocd. with it.  The endpoints analyzed included: mitotic index (MI), replication index (RI), sister chromatid exchange (SCE) and chromosomal aberrations (CA).  A significant decrease (p < 0.0001) in MI as well as an increase in SCE (p < 0.0001) and CA (p < 0.0001) frequencies were obsd.  No modifications in RI were found.  The results suggest a genotoxic and cytotoxic effect of TNZ related with cell death process.  Therefore, we evaluated this mechanism by DNA fragmentation (laddering), fluorescence microscopy using acridine orange/ethidium bromide (AO/EB) staining and flow cytometry propidium iodide (PI).  DNA exts. of TNZ-treated cells resulted in nucleosomal DNA ladder pattern after 48 h of cell treatment; meanwhile no differences were detected in untreated cells.  This pattern correlated with the obsd. decrease in cellular viability (p < 0.05), morphol. evidence of apoptosis and increase in the percentage of nuclei with hypodiploid DNA content of TNZ exposed cultures compared with control (p < 0.05).  We concluded that TNZ is genotoxic, cytotoxic and is able to modulate cell death through apoptotic mechanisms in the exptl. design employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyVTqYT7hs3LVg90H21EOLACvtfcHk0liLrpmNVksHtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D&md5=dbf7f9c371265bace4f736b0a475e1c9</span></div><a href="/servlet/linkout?suffix=cit82a&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2008.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2008.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%2BNigro%26aufirst%3DM.%2BM.%26aulast%3DCarballo%26aufirst%3DM.%2BA.%26atitle%3DGenotoxicity%2520and%2520cell%2520death%2520induced%2520by%2520tinidazole%2520%2528TNZ%2529%26jtitle%3DToxicol.%2520Lett.%26date%3D2008%26volume%3D180%26spage%3D46%26epage%3D52%26doi%3D10.1016%2Fj.toxlet.2008.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit82b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, T. L.</span></span> <span> </span><span class="NLM_article-title">Tinidazole: a nitroimidazole antiprotozoal agent</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1859</span>– <span class="NLM_lpage">1884</span>, <span class="refDoi"> DOI: 10.1016/j.clinthera.2005.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.clinthera.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=16507373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1859-1884&author=H.+B.+Fungauthor=T.+L.+Doan&title=Tinidazole%3A+a+nitroimidazole+antiprotozoal+agent&doi=10.1016%2Fj.clinthera.2005.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82bR"><div class="casContent"><span class="casTitleNuber">82b</span><div class="casTitle"><span class="NLM_cas:atitle">Tinidazole: a nitroimidazole antiprotozoal agent</span></div><div class="casAuthors">Fung, Horatio B.; Doan, Thien-Ly</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1859-1884</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Tinidazole, a structural analog of metronidazole, is an antiprotozoal agent that has been widely used in Europe and developing countries for >2 decades with established efficacy and acceptable tolerability.  It was recently approved by the US Food and Drug Administration for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Objective: This article reviews the pharmacol. and pharmacokinetic properties and clin. usefulness of tinidazole.  Methods: Relevant information was identified through a search of MEDLINE (1966-August 2005), Iowa Drug Information Service (1966-August 2005), and International Pharmaceutical Abstrs. (1970-August 2005) using the terms tinidazole, Fasigyn, and nitroimidazole.  Results: In vitro, tinidazole exhibits activity against pathogenic protozoa (eg, Trichomonas vaginalis, Entamoeba histolytica, Giardia duodenalis), a wide range of clin. significant anaerobic bacteria (eg, Bacteroides fragilis, Clostridium difficile), and the microaerophilic bacterium Helicobacter pylori.  In susceptible protozoal and bacterial cells, tinidazole is reduced to cytotoxic intermediates that covalently bind to DNA, causing irreversible damage.  In human adults, tinidazole had a bioavailability of 100% and a Vd of 50.7 L, was minimally bound to plasma protein (12%), had a plasma elimination t1/2 of 12.3 h, and was eliminated primarily by hepatic metab. (∼63%).  Dose adjustment does not appear to be necessary on the basis of race, sex, or renal function.  No data were found on the disposition of tinidazole in patients with hepatic insufficiency; therefore, use of tinidazole in patients with severe hepatic impairment (Child-Pugh class C) is not recommended.  Clin. cure rates in patients with trichomoniasis, giardiasis, amebiasis, and amebic liver abscess were generally >90%.  In comparative trials, tinidazole was as effective as metronidazole in the treatment of trichomoniasis and was significantly more effective than metronidazole in the treatment of giardiasis (P < 0.05) and amebiasis (P < 0.05).  The most commonly reported (>1%) adverse effects included bitter taste, nausea, abdominal discomfort, anorexia, vomiting, and fatigue.  The recommended dosage of tinidazole is a single dose of 2 g for trichomoniasis and giardiasis, and 2 g/d for 3 to 5 days for amebiasis.  Conclusions: Tinidazole appears to be a promising agent for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Clin. studies are needed to evaluate the use of tinidazole against anaerobic bacteria and H pylori.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGwTnbff6nLbVg90H21EOLACvtfcHk0lgBOcgQ1wFYDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D&md5=cc1ef607c78b3cb9889d5425c4858f04</span></div><a href="/servlet/linkout?suffix=cit82b&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DH.%2BB.%26aulast%3DDoan%26aufirst%3DT.%2BL.%26atitle%3DTinidazole%253A%2520a%2520nitroimidazole%2520antiprotozoal%2520agent%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1859%26epage%3D1884%26doi%3D10.1016%2Fj.clinthera.2005.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit82"><span>Tinidazole News; <a href="https://www.drugs.com/answers/support-group/tinidazole/news/" class="extLink">https://www.drugs.com/answers/support-group/tinidazole/news/</a> (accessed Dec 21, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tinidazole+News%3B+https%3A%2F%2Fwww.drugs.com%2Fanswers%2Fsupport-group%2Ftinidazole%2Fnews%2F+%28accessed+Dec+21%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit83"><span>Ornidazole. <a href="http://www.sanhome.com/" class="extLink">http://www.sanhome.com/</a> (accessed
Dec 31, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ornidazole.+http%3A%2F%2Fwww.sanhome.com%2F+%28accessed%0ADec+31%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit84"><span>Fexinidazole.
Drugs for Neglected Diseases Initiative, 2016. <a href="https://www.dndi.org/diseases-projects/portfolio/fexinidazole/" class="extLink">https://www.dndi.org/diseases-projects/portfolio/fexinidazole/</a> (accessed Dec 25, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fexinidazole.%0ADrugs+for+Neglected+Diseases+Initiative%2C+2016.+https%3A%2F%2Fwww.dndi.org%2Fdiseases-projects%2Fportfolio%2Ffexinidazole%2F+%28accessed+Dec+25%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bleehen, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maughan, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenning, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R.</span></span> <span> </span><span class="NLM_article-title">The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic study</span>. <i>Radiother. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1016/0167-8140(91)90201-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2F0167-8140%2891%2990201-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1826962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADyaK3M3ht1KhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1991&pages=137-142&author=N.+M.+Bleehenauthor=T.+S.+Maughanauthor=P.+Workmanauthor=H.+F.+Newmanauthor=S.+Stenningauthor=R.+Ward&title=The+combination+of+multiple+doses+of+etanidazole+and+pimonidazole+in+48+patients%3A+a+toxicity+and+pharmacokinetic+study&doi=10.1016%2F0167-8140%2891%2990201-Q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic study</span></div><div class="casAuthors">Bleehen N M; Maughan T S; Workman P; Newman H F; Stenning S; Ward R</div><div class="citationInfo"><span class="NLM_cas:title">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">20 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">137-42</span>
        ISSN:<span class="NLM_cas:issn">0167-8140</span>.
    </div><div class="casAbstract">The two radiosensitizers etanidazole and pimonidazole, currently in clinical phase 3 trials, have different toxicities.  The former produces a peripheral neuropathy after cumulative doses and the latter presents an accurate but transient central nervous system syndrome after each dose.  A strategy for improving on the maximum radiosensitization achievable using either drug alone, has been investigated in the study reported in this paper.  Escalating doses of the two drugs were given together to determine toxicity up to a maximum of 15 doses of 2.0 g/m2 etanidazole and 0.75 g/m2 pimonidazole/dose. 25 neuropathies were seen in the total of 48 patients (48%).  This included 6 grade 2 neuropathies (12.5%) or 15% of those receiving 9 or more infusions.  There were no significant correlations between the incidence of neuropathy and various dose and AUC parameters for the 31 patients receiving 10 or more infusions.  However, in the selected group of 26 patients planned to receive multiple doses of etanidazole at 2 g/m2/dose with pimonidazole at 0.75 g/m2, significant correlations were seen with the cumulative dose, with single and cumulative AUCs for pimonidazole and also for the cumulative dose and the cumulative AUC for etanidazole, but not its single AUC.  In the light of these observations and the recent reports of higher peripheral neuropathy rates than previously reported in studies in the USA, it is concluded that it is not possible at this time to determine whether there is toxicity interaction between the two drugs.  There remains the possibility that, on the basis of the combined drug dosage achieved, an increased therapeutic efficacy can be reached with either drug alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQg7CNx5B92RHp3bfzSLaX5fW6udTcc2eaQVbvZwzYT6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3ht1KhsQ%253D%253D&md5=bd7a0bf8f2f2734a00a696c1f9580d01</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2F0167-8140%2891%2990201-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-8140%252891%252990201-Q%26sid%3Dliteratum%253Aachs%26aulast%3DBleehen%26aufirst%3DN.%2BM.%26aulast%3DMaughan%26aufirst%3DT.%2BS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DNewman%26aufirst%3DH.%2BF.%26aulast%3DStenning%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DR.%26atitle%3DThe%2520combination%2520of%2520multiple%2520doses%2520of%2520etanidazole%2520and%2520pimonidazole%2520in%252048%2520patients%253A%2520a%2520toxicity%2520and%2520pharmacokinetic%2520study%26jtitle%3DRadiother.%2520Oncol.%26date%3D1991%26volume%3D20%26spage%3D137%26epage%3D142%26doi%3D10.1016%2F0167-8140%2891%2990201-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span> <span> </span><span class="NLM_article-title">Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1128/AAC.05135-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1128%2FAAC.05135-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=22037852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Gksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=115-123&author=B.+S.+Hallauthor=S.+R.+Wilkinson&title=Activation+of+benznidazole+by+trypanosomal+type+I+nitroreductases+results+in+glyoxal+formation&doi=10.1128%2FAAC.05135-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation</span></div><div class="casAuthors">Hall, Belinda S.; Wilkinson, Shane R.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-123</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Benznidazole, a 2-nitroimidazole, is the front-line treatment used against American trypanosomiasis, a parasitic infection caused by Trypanosoma cruzi.  Despite nearly 40 years of use, the trypanocidal activity of this prodrug is not fully understood.  It has been proposed that benznidazole activation leads to the formation of reductive metabolites that can cause a series of deleterious effects, including DNA damage and thiol depletion.  Here, it is shown that the key step in benznidazole activation involves an NADH-dependent trypanosomal type I nitroreductase.  This catalyzes an oxygen-insensitive reaction with the interaction of enzyme, reductant, and prodrug occurring through a ping-pong mechanism.  Liq. chromatog./mass spectrometry (LC/MS) anal. of the resultant metabolites identified 4,5-dihydro-4,5-dihydroxyimidazole as the major product of a reductive pathway proceeding through hydroxylamine and hydroxy intermediates.  The breakdown of this product released the reactive dialdehyde glyoxal, which, in the presence of guanosine, generated guanosine-glyoxal adducts.  These expts. indicate that the redn. of benznidazole by type I nitroreductase activity leads to the formation of highly reactive metabolites and that the expression of this enzyme is key to the trypanocidal properties displayed by the prodrug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi5EttS3hz57Vg90H21EOLACvtfcHk0lhgGmuUz-Y-Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Gksg%253D%253D&md5=f8f175b6f7fd44904d49167bc5aa89ee</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1128%2FAAC.05135-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05135-11%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DB.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26atitle%3DActivation%2520of%2520benznidazole%2520by%2520trypanosomal%2520type%2520I%2520nitroreductases%2520results%2520in%2520glyoxal%2520formation%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D115%26epage%3D123%26doi%3D10.1128%2FAAC.05135-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Carvalho, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomão, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva Zamith, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffarena, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boechat, N.</span></span> <span> </span><span class="NLM_article-title">Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their <i>in vitro</i> and in silico interactions with the Trypanosoma brucei nitroreductase enzyme</span>. <i>Mem. Inst. Oswaldo Cruz</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1590/0074-0276140497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1590%2F0074-0276140497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=24676659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12jsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2014&pages=315-323&author=A.+S.+de%0ACarvalhoauthor=K.+Salom%C3%A3oauthor=S.+L.+de+Castroauthor=T.+R.+Condeauthor=H.+P.+da+Silva+Zamithauthor=E.+R.+Caffarenaauthor=B.+S.+Hallauthor=S.+R.+Wilkinsonauthor=N.+Boechat&title=Megazol+and+its+bioisostere+4H-1%2C2%2C4-triazole%3A+comparing+the+trypanocidal%2C+cytotoxic+and+genotoxic+activities+and+their+in+vitro+and+in+silico+interactions+with+the+Trypanosoma+brucei+nitroreductase+enzyme&doi=10.1590%2F0074-0276140497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico interactions with the Trypanosoma brucei nitroreductase enzyme</span></div><div class="casAuthors">de Carvalho, Alcione Silva; Salomao, Kelly; de Castro, Solange Lisboa; Conde, Taline Ramos; da Silva Zamith, Helena Pereira; Caffarena, Ernesto Raul; Hall, Belinda Suzette; Wilkinson, Shane Robert; Boechat, Nubia</div><div class="citationInfo"><span class="NLM_cas:title">Memorias do Instituto Oswaldo Cruz</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-323, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">MIOCAS</span>;
        ISSN:<span class="NLM_cas:issn">1678-8060</span>.
    
            (<span class="NLM_cas:orgname">Instituto Oswaldo Cruz</span>)
        </div><div class="casAbstract">Megazol (7) is a 5-nitroimidazole that is highly active against Trypanosoma cruzi and Trypanosoma brucei, as well as drug-resistant forms of trypanosomiasis.  Compd. 7 is not used clin. due to its mutagenic and genotoxic properties, but has been largely used as a lead compd.  Here, we compared the activity of 7 with its 4H-1,2,4-triazole bioisostere (8) in bloodstream forms of T. brucei and T. cruzi and evaluated their activation by T. brucei type I nitroreductase (TbNTR) enzyme.  We also analyzed the cytotoxic and genotoxic effects of these compds. in whole human blood using Comet and fluorescein diacetate/ethidium bromide assays.  Although the only difference between 7 and 8 is the substitution of sulfur (in the thiadiazole in 7) for nitrogen (in the triazole in 8), the results indicated that 8 had poorer antiparasitic activity than 7 and was not genotoxic, whereas 7 presented this effect.  The detn. of Vmax indicated that although 8 was metabolised more rapidly than 7, it bounds to the TbNTR with better affinity, resulting in equiv. kcat/KM values.  Docking assays of 7 and 8 performed within the active site of a homol. model of the TbNTR indicating that 8 had greater affinity than 7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBBZTNKUWViLVg90H21EOLACvtfcHk0lhgGmuUz-Y-Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12jsL7I&md5=90c08e9ec0d6d8a1fb5cca6f45c0b982</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1590%2F0074-0276140497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252F0074-0276140497%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCarvalho%26aufirst%3DA.%2BS.%26aulast%3DSalom%25C3%25A3o%26aufirst%3DK.%26aulast%3Dde%2BCastro%26aufirst%3DS.%2BL.%26aulast%3DConde%26aufirst%3DT.%2BR.%26aulast%3Dda%2BSilva%2BZamith%26aufirst%3DH.%2BP.%26aulast%3DCaffarena%26aufirst%3DE.%2BR.%26aulast%3DHall%26aufirst%3DB.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DBoechat%26aufirst%3DN.%26atitle%3DMegazol%2520and%2520its%2520bioisostere%25204H-1%252C2%252C4-triazole%253A%2520comparing%2520the%2520trypanocidal%252C%2520cytotoxic%2520and%2520genotoxic%2520activities%2520and%2520their%2520in%2520vitro%2520and%2520in%2520silico%2520interactions%2520with%2520the%2520Trypanosoma%2520brucei%2520nitroreductase%2520enzyme%26jtitle%3DMem.%2520Inst.%2520Oswaldo%2520Cruz%26date%3D2014%26volume%3D109%26spage%3D315%26epage%3D323%26doi%3D10.1590%2F0074-0276140497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit88a"><span>VENCLEXTA. <a href="https://www.venclexta.com/" class="extLink">https://www.venclexta.com/</a> (accessed Dec 31, <span class="NLM_year">2017</span>)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=VENCLEXTA.+https%3A%2F%2Fwww.venclexta.com%2F+%28accessed+Dec+31%2C+2017%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit88b"><span>AbbVie Announces Phase 3 Study
of VENCLEXTA/ VENCLYXTO (venetoclax) in Combination with Rituxan (rituximab)
Meets Its Primary Endpoint, December 12, 2017. <a href="https://news.abbvie.com/news/press-releases/" class="extLink">https://news.abbvie.com/news/press-releases/</a> (accessed Dec 29, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AbbVie+Announces+Phase+3+Study%0Aof+VENCLEXTA%2F+VENCLYXTO+%28venetoclax%29+in+Combination+with+Rituxan+%28rituximab%29%0AMeets+Its+Primary+Endpoint%2C+December+12%2C+2017.+https%3A%2F%2Fnews.abbvie.com%2Fnews%2Fpress-releases%2F+%28accessed+Dec+29%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit89"><span>Otsuka
and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba)
for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries,
August 24, 2017. <a href="https://www.venclexta.com/" class="extLink">https://www.venclexta.com/</a> (accessed Dec 27, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Otsuka%0Aand+Mylan+Announce+License+Agreement+to+Commercialize+Delamanid+%28Deltyba%29%0Afor+Multidrug-Resistant+Tuberculosis+%28MDR-TB%29+in+High-Burden+Countries%2C%0AAugust+24%2C+2017.+https%3A%2F%2Fwww.venclexta.com%2F+%28accessed+Dec+27%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit89b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishige, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubouchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis <i>in vitro</i> and in mice</span>. <i>PLoS Med</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e466</span>, <span class="refDoi"> DOI: 10.1371/journal.pmed.0030466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1371%2Fjournal.pmed.0030466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=17132069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BD28npsFKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=e466&author=M.+Matsumotoauthor=H.+Hashizumeauthor=T.+Tomishigeauthor=M.+Kawasakiauthor=H.+Tsubouchiauthor=H.+Sasakiauthor=Y.+Shimokawaauthor=M.+Komatsu&title=OPC-67683%2C+a+nitro-dihydro-imidazooxazole+derivative+with+promising+action+against+tuberculosis+in+vitro+and+in+mice&doi=10.1371%2Fjournal.pmed.0030466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89bR"><div class="casContent"><span class="casTitleNuber">89b</span><div class="casTitle"><span class="NLM_cas:atitle">OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice</span></div><div class="casAuthors">Matsumoto Makoto; Hashizume Hiroyuki; Tomishige Tatsuo; Kawasaki Masanori; Tsubouchi Hidetsugu; Sasaki Hirofumi; Shimokawa Yoshihiko; Komatsu Makoto</div><div class="citationInfo"><span class="NLM_cas:title">PLoS medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e466</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Tuberculosis (TB) is still a leading cause of death worldwide.  Almost a third of the world's population is infected with TB bacilli, and each year approximately 8 million people develop active TB and 2 million die as a result.  Today's TB treatment, which dates back to the 1970s, is long and burdensome, requiring at least 6 mo of multidrug chemotherapy.  The situation is further compounded by the emergence of multidrug-resistant TB (MDR-TB) and by the infection's lethal synergy with HIV/AIDS.  Global health and philanthropic organizations are now pleading for new drug interventions that can address these unmet needs in TB treatment.  METHODS AND FINDINGS:  Here we report OPC-67683, a nitro-dihydro-imidazooxazole derivative that was screened to help combat the unmet needs in TB treatment.  The compound is a mycolic acid biosynthesis inhibitor found to be free of mutagenicity and to possess highly potent activity against TB, including MDR-TB, as shown by its exceptionally low minimum inhibitory concentration (MIC) range of 0.006-0.024 microg/ml in vitro and highly effective therapeutic activity at low doses in vivo.  Additionally, the results of the post-antibiotic effect of OPC-67683 on intracellular Mycobacterium tuberculosis showed the agent to be highly and dose-dependently active also against intracellular M. tuberculosis H37Rv after a 4-h pulsed exposure, and this activity at a concentration of 0.1 microg/ml was similar to that of the first-line drug rifampicin (RFP) at a concentration of 3 microg/ml.  The combination of OPC-67683 with RFP and pyrazinamide (PZA) exhibited a remarkably quicker eradication (by at least 2 mo) of viable TB bacilli in the lung in comparison with the standard regimen consisting of RFP, isoniazid (INH), ethambutol (EB), and PZA.  Furthermore, OPC-67683 was not affected by nor did it affect the activity of liver microsome enzymes, suggesting the possibility for OPC-67683 to be used in combination with drugs, including anti-retrovirals, that induce or are metabolized by cytochrome P450 enzymes.  CONCLUSIONS:  We concluded that based on these properties OPC-67683 has the potential to be used as a TB drug to help combat the unmet needs in TB treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSF0z_BNLNYeRS7coPn-RtfW6udTcc2eb79PEpncfdcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28npsFKgug%253D%253D&md5=8a80560cc653b1c76ff4d47430317d18</span></div><a href="/servlet/linkout?suffix=cit89b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0030466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0030466%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DTomishige%26aufirst%3DT.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DTsubouchi%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DShimokawa%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DOPC-67683%252C%2520a%2520nitro-dihydro-imidazooxazole%2520derivative%2520with%2520promising%2520action%2520against%2520tuberculosis%2520in%2520vitro%2520and%2520in%2520mice%26jtitle%3DPLoS%2520Med%26date%3D2006%26volume%3D3%26spage%3De466%26doi%3D10.1371%2Fjournal.pmed.0030466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arend, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londoño-Joshi, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangrade, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katre, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurpad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samant, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landen, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straughn, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchsbaum, D. J.</span></span> <span> </span><span class="NLM_article-title">Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">86803</span>– <span class="NLM_lpage">86815</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.18632%2Foncotarget.13466" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=86803-86815&author=R.+C.+Arendauthor=A.+I.+Londo%C3%B1o-Joshiauthor=A.+Gangradeauthor=A.+A.+Katreauthor=C.+Kurpadauthor=Y.+Liauthor=R.+S.+Samantauthor=P.+K.+Liauthor=C.+N.+Landenauthor=E.+S.+Yangauthor=B.+Hidalgoauthor=R.+D.+Alvarezauthor=J.+M.+Straughnauthor=A.+Foreroauthor=D.+J.+Buchsbaum&title=Niclosamide+and+its+analogs+are+potent+inhibitors+of+Wnt%2F%CE%B2-catenin%2C+mTOR+and+STAT3+signaling+in+ovarian+cancer&doi=10.18632%2Foncotarget.13466"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13466%26sid%3Dliteratum%253Aachs%26aulast%3DArend%26aufirst%3DR.%2BC.%26aulast%3DLondo%25C3%25B1o-Joshi%26aufirst%3DA.%2BI.%26aulast%3DGangrade%26aufirst%3DA.%26aulast%3DKatre%26aufirst%3DA.%2BA.%26aulast%3DKurpad%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSamant%26aufirst%3DR.%2BS.%26aulast%3DLi%26aufirst%3DP.%2BK.%26aulast%3DLanden%26aufirst%3DC.%2BN.%26aulast%3DYang%26aufirst%3DE.%2BS.%26aulast%3DHidalgo%26aufirst%3DB.%26aulast%3DAlvarez%26aufirst%3DR.%2BD.%26aulast%3DStraughn%26aufirst%3DJ.%2BM.%26aulast%3DForero%26aufirst%3DA.%26aulast%3DBuchsbaum%26aufirst%3DD.%2BJ.%26atitle%3DNiclosamide%2520and%2520its%2520analogs%2520are%2520potent%2520inhibitors%2520of%2520Wnt%252F%25CE%25B2-catenin%252C%2520mTOR%2520and%2520STAT3%2520signaling%2520in%2520ovarian%2520cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D86803%26epage%3D86815%26doi%3D10.18632%2Foncotarget.13466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit91"><span>COMTAN
(entacapone) Tablets, December 2001. <a href="https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/comtan.pdf/" class="extLink">https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/comtan.pdf/</a> (accessed Dec 25, <span class="NLM_year">2017</span>)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=COMTAN%0A%28entacapone%29+Tablets%2C+December+2001.+https%3A%2F%2Fwww.pharma.us.novartis.com%2Fsites%2Fwww.pharma.us.novartis.com%2Ffiles%2Fcomtan.pdf%2F+%28accessed+Dec+25%2C+2017%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit91b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Najib, J.</span></span> <span> </span><span class="NLM_article-title">Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson’s disease</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">832</span>, <span class="refDoi"> DOI: 10.1016/S0149-2918(01)80071-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FS0149-2918%2801%2980071-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=11440283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltFWktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2001&pages=802-832&author=J.+Najib&title=Entacapone%3A+a+catechol-O-methyltransferase+inhibitor+for+the+adjunctive+treatment+of+Parkinson%E2%80%99s+disease&doi=10.1016%2FS0149-2918%2801%2980071-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91bR"><div class="casContent"><span class="casTitleNuber">91b</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of parkinson's disease</span></div><div class="casAuthors">Najib, Jadwiga</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">802-832</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review with refs.  When levodopa therapy is used in Parkinson's disease, degrdn. of the drug in the peripheral nervous system is assocd. with dyskinesias and motor fluctuations.  Much of this degrdn. is produced by catechol-O-methyltransferase (COMT), an enzyme involved in the metab. of catecholamines and catechol compds.  Inhibition of COMT activity prolongs the action of levodopa and reduces fluctuations in response.  Entacapone is a selective inhibitor of COMT whose activity is primarily in the peripheral nervous system, with little effect in the central nervous system.  This paper reviews the pharmacol. properties and clin. usefulness of entacapone in the treatment of Parkinson's disease.  Recent studies, abstrs., and reviews published in the English-language literature were identified through searches of MEDLINE (1966-Sept. 2000), International Pharmaceutical Abstrs. (1970-Sept. 2000), and PharmaProjects (Sept. 2000 version), and from the Web sites of Parkinson's disease conferences held from 1996 to Sept. 2000.  Relevant human studies provided further information on the pharmacol. properties and clin. usefulness of entacapone.  Entacapone is rapidly absorbed, with a time to max. concn. of ∼1 h.  Its plasma elimination half-life is 0.4 to 0.7 h in the beta phase and 2.4 h in the gamma phase, and it has 35% abs. bioavailability after oral administration, secondary to first-pass clearance.  Entacapone is 98% protein bound; thus, it is not distributed widely in tissues and is almost completely metabolized before excretion (0.1%-0.2% of dose unchanged in urine).  The drug inhibits erythrocyte-sol. COMT activity in a dose-dependent fashion (48% after a 400-mg dose, 82% after an 800-mg dose).  The inhibitory effect is reversible, with recovery of sol. COMT activity within 4 to 8 h.  In levodopa-treated patients with Parkinson's disease who experience motor fluctuations, clin. trials have demonstrated entacapone's effectiveness in increasing "on" time (the period during which medications relieve the symptoms of Parkinson's disease) by up to 1.2 h, decreasing "off" time (the period during which symptoms increase) by 0.9 to 1.3 h, and producing overall total improvement in scores on the Unified Parkinson's Disease Rating Scale.  The recommended dosage of entacapone is 200 mg administered orally with each dose of levodopa/carbidopa, up to 8 doses per day.  The drug is generally well tolerated, with most adverse effects attributed to levodopa-related dopaminergic effects, including dyskinesias and nausea.  In clin. trials, adjuvant treatment with entacapone appeared to be an effective and well-tolerated therapeutic strategy in patients with Parkinson's disease who experience fluctuations in the response to levodopa therapy.  The increased elimination half-life of levodopa with concomitant entacapone results in greater and more sustained plasma levodopa levels, with more const. dopaminergic stimulation in the brain and greater amelioration of parkinsonian symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTjPYcmpvhyLVg90H21EOLACvtfcHk0ljSvCmRh1T43g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltFWktbw%253D&md5=9a5219f190ae5b28908f73782b47ab9d</span></div><a href="/servlet/linkout?suffix=cit91b&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2801%2980071-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252801%252980071-0%26sid%3Dliteratum%253Aachs%26aulast%3DNajib%26aufirst%3DJ.%26atitle%3DEntacapone%253A%2520a%2520catechol-O-methyltransferase%2520inhibitor%2520for%2520the%2520adjunctive%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DClin.%2520Ther.%26date%3D2001%26volume%3D23%26spage%3D802%26epage%3D832%26doi%3D10.1016%2FS0149-2918%2801%2980071-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit91c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagar, H.</span></span> <span> </span><span class="NLM_article-title">Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson’s disease: a randomised, placebo controlled, double blind, six month study</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1136/jnnp.74.8.1071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1136%2Fjnnp.74.8.1071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=12876237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BD3szksVaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2003&pages=1071-1079&author=D.+J.+Brooksauthor=H.+Sagar&title=Entacapone+is+beneficial+in+both+fluctuating+and+non-fluctuating+patients+with+Parkinson%E2%80%99s+disease%3A+a+randomised%2C+placebo+controlled%2C+double+blind%2C+six+month+study&doi=10.1136%2Fjnnp.74.8.1071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91cR"><div class="casContent"><span class="casTitleNuber">91c</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study</span></div><div class="casAuthors">Brooks D J; Sagar H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1071-9</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">OBJECTIVE:  To study the effect of entacapone, a specific peripherally acting catechol-O-methyltransferase (COMT) inhibitor used in combination with levodopa treatment, in cases of Parkinson's disease with both fluctuating and non-fluctuating response to treatment.  METHODS:  A randomised, placebo controlled, double blind, six month study was undertaken in 172 fluctuating and 128 non-fluctuating patients.  The clinical efficacy and safety of 200 mg entacapone given with each daily levodopa dose was studied.  Efficacy was examined using home diaries, the unified Parkinson disease rating scale (UPDRS), and recording of daily levodopa dose.  RESULTS:  The primary efficacy variable for fluctuating patients-the proportion of daily ON time-showed a significant increase compared with placebo (p < 0.05).  The absolute ON time (mean (SD)) increased from 9.5 (2.5) to 10.8 (2.4) hours (p < 0.01), and the daily OFF time was correspondingly reduced from 7.0 (2.6) to 5.9 (2.5) hours (p < 0.05 v placebo).  This improvement was achieved despite a reduction in daily levodopa requirements.  The effect was rapidly lost on withdrawal of entacapone.  In non-fluctuating patients, the primary efficacy measure was part II of the UPDRS (activities of daily living; ADL).  In this group of patients, ADL scores improved in the entacapone group (p < 0.01 v placebo), and there was also a 40 mg reduction in levodopa requirement (p < 0.01 v placebo).  Entacapone was well tolerated by both fluctuating and non-fluctuating patients.  CONCLUSIONS:  The ability of entacapone to provide additional benefits to levodopa treatment in increasing ON time in fluctuating Parkinson's disease patients was confirmed.  A novel finding was that patients without fluctuations also obtained benefit from the addition of entacapone to their levodopa treatment, as evidenced by improved ADL scores and a relatively reduced levodopa requirement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQU23Nvq119lDDnmmyUf5qOfW6udTcc2eZ3wGtSSO9BV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szksVaisw%253D%253D&md5=cedbce79cf2e428f2f4a820e3fbbeca6</span></div><a href="/servlet/linkout?suffix=cit91c&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.74.8.1071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.74.8.1071%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DSagar%26aufirst%3DH.%26atitle%3DEntacapone%2520is%2520beneficial%2520in%2520both%2520fluctuating%2520and%2520non-fluctuating%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520randomised%252C%2520placebo%2520controlled%252C%2520double%2520blind%252C%2520six%2520month%2520study%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2003%26volume%3D74%26spage%3D1071%26epage%3D1079%26doi%3D10.1136%2Fjnnp.74.8.1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertout, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span> <span> </span><span class="NLM_article-title">The impact of O<sub>2</sub> availability on human cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1038/nrc2540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1038%2Fnrc2540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18987634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWhu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=967-975&author=J.+A.+Bertoutauthor=S.+A.+Patelauthor=M.+C.+Simon&title=The+impact+of+O2+availability+on+human+cancer&doi=10.1038%2Fnrc2540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of O2 availability on human cancer</span></div><div class="casAuthors">Bertout, Jessica A.; Patel, Shetal A.; Simon, M. Celeste</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">967-975</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  During the past century it has been established that regions within solid tumors experience mild to severe O2 deprivation owing to aberrant vascular function.  These hypoxic regions are assocd. with altered cellular metab., as well as increased resistance to radiation and chemotherapy.  As discussed in this Timeline, over the past decade work from many labs. has elucidated the mechanisms by which hypoxia-inducible factors (HIFs) modulate tumor cell metab., angiogenesis, growth and metastasis.  The central role played by intra-tumoral hypoxia and HIF in these processes has made them attractive therapeutic targets in the treatment of multiple human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofqTHqD6DAsLVg90H21EOLACvtfcHk0li3Zpjxyaeghw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWhu7fO&md5=0f5233f04781067ff184a8e9621293f4</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fnrc2540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2540%26sid%3Dliteratum%253Aachs%26aulast%3DBertout%26aufirst%3DJ.%2BA.%26aulast%3DPatel%26aufirst%3DS.%2BA.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26atitle%3DThe%2520impact%2520of%2520O2%2520availability%2520on%2520human%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D967%26epage%3D975%26doi%3D10.1038%2Fnrc2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, G. E.</span>; <span class="NLM_string-name">Michael, B. D.</span>; <span class="NLM_string-name">Asquith, J. C.</span>; <span class="NLM_string-name">Shenoy, M. A.</span>; <span class="NLM_string-name">Watts, M. E.</span>; <span class="NLM_string-name">Whillans, D. W.</span></span> <i>Radiation Research: Biomedical, Chemical and Physical Perspectives</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1975</span>; pp  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">492</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FB978-0-12-523350-7.50049-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1975&pages=478-492&author=G.+E.+Adams&author=B.+D.+Michael&author=J.+C.+Asquith&author=M.+A.+Shenoy&author=M.+E.+Watts&author=D.+W.+Whillans&title=Radiation+Research%3A+Biomedical%2C+Chemical+and+Physical+Perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-523350-7.50049-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-523350-7.50049-3%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DG.%2BE.%26btitle%3DRadiation%2520Research%253A%2520Biomedical%252C%2520Chemical%2520and%2520Physical%2520Perspectives%26pub%3DAcademic%2520Press%26date%3D1975%26spage%3D478%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kizaka-Kondoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konse-Nagasawa, H.</span></span> <span> </span><span class="NLM_article-title">Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">1366</span>– <span class="NLM_lpage">1373</span>, <span class="refDoi"> DOI: 10.1111/j.1349-7006.2009.01195.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1111%2Fj.1349-7006.2009.01195.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=19459851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2009&pages=1366-1373&author=S.+Kizaka-Kondohauthor=H.+Konse-Nagasawa&title=Significance+of+nitroimidazole+compounds+and+hypoxia-inducible+factor-1+for+imaging+tumor+hypoxia&doi=10.1111%2Fj.1349-7006.2009.01195.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia</span></div><div class="casAuthors">Kizaka-Kondoh, Shinae; Konse-Nagasawa, Hideko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1366-1373</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  A tumor-specific microenvironment is characterized by hypoxia, in which oxygen tension is considerably lower than in normal tissues.  The hypoxic status of various solid tumors has been attributed as an indicator of adverse prognosis due to tumor progression toward a more malignant phenotype with increased metastatic potential and resistance to treatment.  Various exogenous and endogenous markers for hypoxia are currently available and studied in relation to each other, tumor architecture, and tumor microenvironment.  Over the last few decades, various methods have been suggested to assess the level of oxygenation in solid tumors.  Among them, nitroimidazole compds. have provided promising information on tumor hypoxia.  To quantify the extent of hypoxia requires that nitroimidazole binding be primarily dependent on oxygen concn. as well as nitroreductase levels in the tumor cells.  Furthermore, recent progress in mol. biol. has highlighted a transcription factor, hypoxia-inducible factor (HIF)-1, whose activity is induced by hypoxia.  HIF-1 plays a central role in malignant progression by inducing the expression of various genes, whose functions are strongly assocd. with malignant alteration of the entire tumor.  The cellular changes induced by HIF-1 are extremely important therapeutic targets of cancer therapy, particularly in the therapy against refractory cancers.  In this review, we will discuss the significance of pimonidazole and HIF-1 as exogenous and endogenous hypoxia markers, resp., as well as their evaluation and imaging of tumor hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfR3S5xXQzw7Vg90H21EOLACvtfcHk0li3Zpjxyaeghw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnsLrM&md5=ce86e927966f2d0388d05eb6a930a398</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2009.01195.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2009.01195.x%26sid%3Dliteratum%253Aachs%26aulast%3DKizaka-Kondoh%26aufirst%3DS.%26aulast%3DKonse-Nagasawa%26aufirst%3DH.%26atitle%3DSignificance%2520of%2520nitroimidazole%2520compounds%2520and%2520hypoxia-inducible%2520factor-1%2520for%2520imaging%2520tumor%2520hypoxia%26jtitle%3DCancer%2520Sci.%26date%3D2009%26volume%3D100%26spage%3D1366%26epage%3D1373%26doi%3D10.1111%2Fj.1349-7006.2009.01195.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lunt, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudary, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R. P.</span></span> <span> </span><span class="NLM_article-title">The tumor microenvironment and metastatic disease</span>. <i>Clin. Exp. Metastasis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1007/s10585-008-9182-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1007%2Fs10585-008-9182-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18543068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FptF2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=19-34&author=S.+J.+Luntauthor=N.+Chaudaryauthor=R.+P.+Hill&title=The+tumor+microenvironment+and+metastatic+disease&doi=10.1007%2Fs10585-008-9182-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">The tumor microenvironment and metastatic disease</span></div><div class="casAuthors">Lunt Sarah Jane; Chaudary Naz; Hill Richard P</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & experimental metastasis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The microenvironment of solid tumors is a heterogeneous, complex milieu for tumor growth and survival that includes features such as acidic pH, low nutrient levels, elevated interstitial fluid pressure (IFP) and chronic and fluctuating levels of oxygenation that relate to the abnormal vascular network that exists in tumors.  The metastatic potential of tumor cells is believed to be regulated by interactions between the tumor cells and their extracellular environment (extracellular matrix (ECM)).  These interactions can be modified by the accumulation of genetic changes and by the transient alterations in gene expression induced by the local tumor microenvironment.  Clinical and experimental evidence suggests that altered gene expression in response to the hypoxic microenvironment is a contributing factor to increased metastatic efficiency.  A number of genes that have been implicated in the metastatic process, involving angiogenesis, intra/extravasation, survival and growth, have been found to be hypoxia-responsive.  The various metastatic determinants, genetic and epigenetic, somatic and inherited may serve as precedents for the future identification of more genes that are involved in metastasis.  Much research has focused on genetic and molecular properties of the tumor cells themselves.  In the present review we discuss the epigenetic and physiological regulation of metastasis and emphasize the need for further studies on the interactions between the pathophysiologic tumor microenvironment and the tumor extracellular matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZKUWZjAsBievW160gIxP_fW6udTcc2eZI5A2LR4xICrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FptF2hsw%253D%253D&md5=43511adf1ed4b463c08516af0f786f6b</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1007%2Fs10585-008-9182-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10585-008-9182-2%26sid%3Dliteratum%253Aachs%26aulast%3DLunt%26aufirst%3DS.%2BJ.%26aulast%3DChaudary%26aufirst%3DN.%26aulast%3DHill%26aufirst%3DR.%2BP.%26atitle%3DThe%2520tumor%2520microenvironment%2520and%2520metastatic%2520disease%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D2009%26volume%3D26%26spage%3D19%26epage%3D34%26doi%3D10.1007%2Fs10585-008-9182-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guise, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbattista, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holford, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dachs, G. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilford, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doñate, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. V.</span></span> <span> </span><span class="NLM_article-title">The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1573</span>– <span class="NLM_lpage">1584</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-3237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1158%2F0008-5472.CAN-09-3237" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1573-1584&author=C.+P.+Guiseauthor=M.+R.+Abbattistaauthor=R.+S.+Singletonauthor=S.+D.+Holfordauthor=J.+Connollyauthor=G.+U.+Dachsauthor=S.+B.+Foxauthor=R.+Pollockauthor=J.+Harveyauthor=P.+Guilfordauthor=F.+Do%C3%B1ateauthor=W.+R.+Wilsonauthor=A.+V.+Patterson&title=The+bioreductive+prodrug+PR-104A+is+activated+under+aerobic+conditions+by+human+aldo-keto+reductase+1C3&doi=10.1158%2F0008-5472.CAN-09-3237"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-3237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-3237%26sid%3Dliteratum%253Aachs%26aulast%3DGuise%26aufirst%3DC.%2BP.%26aulast%3DAbbattista%26aufirst%3DM.%2BR.%26aulast%3DSingleton%26aufirst%3DR.%2BS.%26aulast%3DHolford%26aufirst%3DS.%2BD.%26aulast%3DConnolly%26aufirst%3DJ.%26aulast%3DDachs%26aufirst%3DG.%2BU.%26aulast%3DFox%26aufirst%3DS.%2BB.%26aulast%3DPollock%26aufirst%3DR.%26aulast%3DHarvey%26aufirst%3DJ.%26aulast%3DGuilford%26aufirst%3DP.%26aulast%3DDo%25C3%25B1ate%26aufirst%3DF.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DPatterson%26aufirst%3DA.%2BV.%26atitle%3DThe%2520bioreductive%2520prodrug%2520PR-104A%2520is%2520activated%2520under%2520aerobic%2520conditions%2520by%2520human%2520aldo-keto%2520reductase%25201C3%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1573%26epage%3D1584%26doi%3D10.1158%2F0008-5472.CAN-09-3237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span> <span> </span><span class="NLM_article-title">Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1007/s00280-015-2920-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1007%2Fs00280-015-2920-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=26811177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2016&pages=441-457&author=R.+M.+Phillips&title=Targeting+the+hypoxic+fraction+of+tumours+using+hypoxia-activated+prodrugs&doi=10.1007%2Fs00280-015-2920-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the hypoxic fraction of tumors using hypoxia-activated prodrugs</span></div><div class="casAuthors">Phillips, Roger M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-457</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The presence of a microenvironment within most tumors contg. regions of low oxygen tension or hypoxia has profound biol. and therapeutic implications.  Tumor hypoxia is known to promote the development of an aggressive phenotype, resistance to both chemotherapy and radiotherapy and is strongly assocd. with poor clin. outcome.  Paradoxically, it is recognized as a high-priority target and one of the therapeutic strategies designed to eradicate hypoxic cells in tumors is a group of compds. known collectively as hypoxia-activated prodrugs (HAPs) or bioreductive drugs.  These drugs are inactive prodrugs that require enzymic activation (typically by 1 or 2 electron oxidoreductases) to generate cytotoxic species with selectivity for hypoxic cells being detd. by (1) the ability of oxygen to either reverse or inhibit the activation process and (2) the presence of elevated expression of oxidoreductases in tumors.  The concepts underpinning HAP development were established over 40 years ago and have been refined over the years to produce a new generation of HAPs that are under preclin. and clin. development.  The purpose of this article is to describe current progress in the development of HAPs focusing on the mechanisms of action, preclin. properties and clin. progress of leading examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT5Ciedj2i5LVg90H21EOLACvtfcHk0lhcd8osWFJTVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOht7g%253D&md5=0ddd0f1e4d2e4cb6af54e9b380624b5b</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1007%2Fs00280-015-2920-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-015-2920-7%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26atitle%3DTargeting%2520the%2520hypoxic%2520fraction%2520of%2520tumours%2520using%2520hypoxia-activated%2520prodrugs%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2016%26volume%3D77%26spage%3D441%26epage%3D457%26doi%3D10.1007%2Fs00280-015-2920-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möllmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Joanis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarelli, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dianiskova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordulakova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrethsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenkrands, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaonkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosset, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Benzothiazinones kill mycobacterium tuberculosis by blocking arabinan synthesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1126/science.1171583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1126%2Fscience.1171583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=19299584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=801-804&author=V.+Makarovauthor=G.+Maninaauthor=K.+Mikusovaauthor=U.+M%C3%B6llmannauthor=O.+Ryabovaauthor=B.+Saint-Joanisauthor=N.+Dharauthor=M.+R.+Pascaauthor=S.+Buroniauthor=A.+P.+Lucarelliauthor=A.+Milanoauthor=E.+De+Rossiauthor=M.+Belanovaauthor=A.+Bobovskaauthor=P.+Dianiskovaauthor=J.+Kordulakovaauthor=C.+Salaauthor=E.+Fullamauthor=P.+Schneiderauthor=J.+D.+McKinneyauthor=P.+Brodinauthor=T.+Christopheauthor=S.+Waddellauthor=P.+Butcherauthor=J.+Albrethsenauthor=I.+Rosenkrandsauthor=R.+Broschauthor=V.+Nandiauthor=S.+Bharathauthor=S.+Gaonkarauthor=R.+K.+Shandilauthor=V.+Balasubramanianauthor=T.+Balganeshauthor=S.+Tyagiauthor=J.+Grossetauthor=G.+Riccardiauthor=S.+T.+Cole&title=Benzothiazinones+kill+mycobacterium+tuberculosis+by+blocking+arabinan+synthesis&doi=10.1126%2Fscience.1171583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis</span></div><div class="casAuthors">Makarov, Vadim; Manina, Giulia; Mikusova, Katarina; Moellmann, Ute; Ryabova, Olga; Saint-Joanis, Brigitte; Dhar, Neeraj; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Brodin, Priscille; Christophe, Thierry; Waddell, Simon; Butcher, Philip; Albrethsen, Jakob; Rosenkrands, Ida; Brosch, Roland; Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore; Tyagi, Sandeep; Grosset, Jacques; Riccardi, Giovanna; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5928</span>),
    <span class="NLM_cas:pages">801-804</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">New drugs are required to counter the tuberculosis (TB) pandemic.  Here, we describe the synthesis and characterization of 1,3-benzothiazin-4-ones (BTZs), a new class of antimycobacterial agents that kill Mycobacterium tuberculosis in vitro, ex vivo, and in mouse models of TB.  Using genetics and biochem., we identified the enzyme decaprenylphosphoryl-β-D-ribose 2'-epimerase as a major BTZ target.  Inhibition of this enzymic activity abolishes the formation of decaprenylphosphoryl arabinose, a key precursor that is required for the synthesis of the cell-wall arabinans, thus provoking cell lysis and bacterial death.  The most advanced compd., BTZ043, is a candidate for inclusion in combination therapies for both drug-sensitive and extensively drug-resistant TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZiVvk0T_DOrVg90H21EOLACvtfcHk0lgcktMpluI4Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D&md5=1d80f14ba88460ef5c8ea31793dbb592</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1126%2Fscience.1171583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1171583%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DManina%26aufirst%3DG.%26aulast%3DMikusova%26aufirst%3DK.%26aulast%3DM%25C3%25B6llmann%26aufirst%3DU.%26aulast%3DRyabova%26aufirst%3DO.%26aulast%3DSaint-Joanis%26aufirst%3DB.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DLucarelli%26aufirst%3DA.%2BP.%26aulast%3DMilano%26aufirst%3DA.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DBelanova%26aufirst%3DM.%26aulast%3DBobovska%26aufirst%3DA.%26aulast%3DDianiskova%26aufirst%3DP.%26aulast%3DKordulakova%26aufirst%3DJ.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DFullam%26aufirst%3DE.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DWaddell%26aufirst%3DS.%26aulast%3DButcher%26aufirst%3DP.%26aulast%3DAlbrethsen%26aufirst%3DJ.%26aulast%3DRosenkrands%26aufirst%3DI.%26aulast%3DBrosch%26aufirst%3DR.%26aulast%3DNandi%26aufirst%3DV.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DGaonkar%26aufirst%3DS.%26aulast%3DShandil%26aufirst%3DR.%2BK.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBalganesh%26aufirst%3DT.%26aulast%3DTyagi%26aufirst%3DS.%26aulast%3DGrosset%26aufirst%3DJ.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DBenzothiazinones%2520kill%2520mycobacterium%2520tuberculosis%2520by%2520blocking%2520arabinan%2520synthesis%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D801%26epage%3D804%26doi%3D10.1126%2Fscience.1171583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Jesus Lopes Ribeiro, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degiacomi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Incandela, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras-Dominguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span> <span> </span><span class="NLM_article-title">Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e26675</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0026675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1371%2Fjournal.pone.0026675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=22069462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2lu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e26675&author=A.+L.+de%0AJesus+Lopes+Ribeiroauthor=G.+Degiacomiauthor=F.+Ewannauthor=S.+Buroniauthor=M.+L.+Incandelaauthor=L.+R.+Chiarelliauthor=G.+Moriauthor=J.+Kimauthor=M.+Contreras-Dominguezauthor=Y.-S.+Parkauthor=S.+J.+Hanauthor=P.+Brodinauthor=G.+Valentiniauthor=M.+Rizziauthor=G.+Riccardiauthor=M.+R.+Pasca&title=Analogous+mechanisms+of+resistance+to+benzothiazinones+and+dinitrobenzamides+in+Mycobacterium+smegmatis&doi=10.1371%2Fjournal.pone.0026675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis</span></div><div class="casAuthors">de Jesus Lopes Ribeiro, Ana Luisa; Degiacomi, Giulia; Ewann, Fanny; Buroni, Silvia; Incandela, Maria Loreto; Chiarelli, Laurent R.; Mori, Giorgia; Kim, Jaeseung; Contreras-Dominguez, Monica; Park, Young-Sam; Han, Sung-Jun; Brodin, Priscille; Valentini, Giovanna; Rizzi, Menico; Riccardi, Giovanna; Pasca, Maria Rosalia</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e26675</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Tuberculosis is still a leading cause of death worldwide.  The selection and spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem.  Recently, two different classes of chem. series, the benzothiazinones (BTZ) and the dinitrobenzamide (DNB) derivs. were found to be highly active against M. tuberculosis, including XDR-TB strains.  The target of BTZs is DprE1 protein which works in concert with DprE2 to form the heteromeric decaprenylphosphoryl-β-D-ribose 2'-epimerase, involved in Decaprenyl-Phospho-Arabinose (DPA) biosynthesis.  Interestingly, it was shown that the DNBs block the same pathway thus suggesting that both drugs could share the same target.  Moreover, in Mycobacterium smegmatis the overexpression of the NfnB nitroreductase led to the inactivation of the BTZs by redn. of a crit. nitro-group to an amino-group.  In this work several spontaneous M. smegmatis mutants resistant to DNBs were isolated.  Sixteen mutants, showing high levels of DNB resistance, exhibited a mutation in the Cys394 of DprE1.  Using fluorescence titrn. and mass spectrometry it was possible to monitor the binding between DprE1 and DNBs, achieving direct evidence that MSMEG_6382 is the cellular target of DNBs in mycobacteria.  Addnl., M. smegmatis mutants having low levels of resistance to DNBs harbor various mutations in MSMEG_6503 gene encoding the transcriptional repressor of the nitroreductase NfnB.  By LC/MS2 anal. it was demonstrated that NfnB is responsible for DNB inactivation.  Taken together, the authors' data demonstrate that both DNB and BTZ drugs share common resistance mechanisms in M. smegmatis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZRVZgf36h3rVg90H21EOLACvtfcHk0lhoDaQUB11fCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2lu7zL&md5=a33b887616575e8c97b7ad701bdeb4fc</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0026675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0026675%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJesus%2BLopes%2BRibeiro%26aufirst%3DA.%2BL.%26aulast%3DDegiacomi%26aufirst%3DG.%26aulast%3DEwann%26aufirst%3DF.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DIncandela%26aufirst%3DM.%2BL.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DMori%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DContreras-Dominguez%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DY.-S.%26aulast%3DHan%26aufirst%3DS.%2BJ.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DValentini%26aufirst%3DG.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26atitle%3DAnalogous%2520mechanisms%2520of%2520resistance%2520to%2520benzothiazinones%2520and%2520dinitrobenzamides%2520in%2520Mycobacterium%2520smegmatis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De26675%26doi%3D10.1371%2Fjournal.pone.0026675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit100a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stover, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrener, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanDevanter, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arain, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langhorne, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiswirth, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, W. R.</span></span> <span> </span><span class="NLM_article-title">A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>405</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1038/35016103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1038%2F35016103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10879539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Wksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=962-966&author=C.+K.+Stoverauthor=P.+Warrenerauthor=D.+R.+VanDevanterauthor=D.+R.+Shermanauthor=T.+M.+Arainauthor=M.+H.+Langhorneauthor=S.+W.+Andersonauthor=J.+A.+Towellauthor=Y.+Yuanauthor=D.+N.+McMurrayauthor=B.+N.+Kreiswirthauthor=C.+E.+Barryauthor=W.+R.+Baker&title=A+small-molecule+nitroimidazopyran+drug+candidate+for+the+treatment+of+tuberculosis&doi=10.1038%2F35016103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100aR"><div class="casContent"><span class="casTitleNuber">100a</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis</span></div><div class="casAuthors">Stover, C. Kendall; Warrener, Paul; VanDevanter, Donald R.; Sherman, David R.; Arain, Taraq M.; Langhorne, Michael H.; Anderson, Scott W.; Towell, J. Andrew; Yuan, Ying; McMurray, David N.; Krelswirth, Barry N.; Barry, Clifton E.; Baker, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">6789</span>),
    <span class="NLM_cas:pages">962-966</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis, which causes tuberculosis, is the greatest single infectious cause of mortality worldwide, killing roughly; two million people annually.  Ests. indicate that one-third of the world population is infected with latent M. tuberculosis.  The synergy between tuberculosis and the AIDS epidemic, and the surge of multidrug-resistant clin. isolates of M. tuberculosis have reaffirmed tuberculosis as a primary public health threat.  However, new antitubercular drugs with new mechanisms of action have not been developed in over thirty years.  Here we report a series of compds. contg. a nitroimidazopyran nucleus that possess antitubercular activity.  After activation by a mechanism dependent on M. tuberculosis F420 cofactor, nitroimidazopyrans inhibited the synthesis of protein and cell wall lipid.  In contrast to current antitubercular drugs, nitroimidazopyrans exhibited bactericidal activity against both replicating and static M. tuberculosis.  Lead compd. PA-824 showed potent bactericidal activity against multidrug-resistant M. tuberculosis and promising oral activity in animal infection models.  We conclude that nitroimidazopyrans offer the practical qualities of a small mol. with the potential for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw41eD4TtVwbVg90H21EOLACvtfcHk0lhoDaQUB11fCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Wksb0%253D&md5=f5f6e2935928da72e328bddd4995515f</span></div><a href="/servlet/linkout?suffix=cit100a&amp;dbid=16384&amp;doi=10.1038%2F35016103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35016103%26sid%3Dliteratum%253Aachs%26aulast%3DStover%26aufirst%3DC.%2BK.%26aulast%3DWarrener%26aufirst%3DP.%26aulast%3DVanDevanter%26aufirst%3DD.%2BR.%26aulast%3DSherman%26aufirst%3DD.%2BR.%26aulast%3DArain%26aufirst%3DT.%2BM.%26aulast%3DLanghorne%26aufirst%3DM.%2BH.%26aulast%3DAnderson%26aufirst%3DS.%2BW.%26aulast%3DTowell%26aufirst%3DJ.%2BA.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DMcMurray%26aufirst%3DD.%2BN.%26aulast%3DKreiswirth%26aufirst%3DB.%2BN.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBaker%26aufirst%3DW.%2BR.%26atitle%3DA%2520small-molecule%2520nitroimidazopyran%2520drug%2520candidate%2520for%2520the%2520treatment%2520of%2520tuberculosis%26jtitle%3DNature%26date%3D2000%26volume%3D405%26spage%3D962%26epage%3D966%26doi%3D10.1038%2F35016103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit100b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida Da
Silva, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, J. C.</span></span> <span> </span><span class="NLM_article-title">Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1417</span>– <span class="NLM_lpage">1430</span>, <span class="refDoi"> DOI: 10.1093/jac/dkr173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1093%2Fjac%2Fdkr173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=21558086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFWksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=1417-1430&author=P.+E.+Almeida+Da%0ASilvaauthor=J.+C.+Palomino&title=Molecular+basis+and+mechanisms+of+drug+resistance+in+Mycobacterium+tuberculosis%3A+classical+and+new+drugs&doi=10.1093%2Fjac%2Fdkr173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100bR"><div class="casContent"><span class="casTitleNuber">100b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs</span></div><div class="casAuthors">Almeida Da Silva, Pedro Eduardo; Palomino, Juan Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1417-1430</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Tuberculosis (TB) remains one of the leading public health problems worldwide.  Declared as a global emergency in 1993 by the WHO, its control is hampered by the emergence of multidrug resistance (MDR), defined as resistance to at least rifampicin and isoniazid, two key drugs in the treatment of the disease.  More recently, severe forms of drug resistance such as extensively drug-resistant (XDR) TB have been described.  After the discovery of several drugs with anti-TB activity, multidrug therapy became fundamental for control of the disease.  Major advances in mol. biol. and the availability of new information generated after sequencing the genome of Mycobacterium tuberculosis increased our knowledge of the mechanisms of resistance to the main anti-TB drugs.  Better knowledge of the mechanisms of drug resistance in TB and the mol. mechanisms involved will help us to improve current techniques for rapid detection and will also stimulate the exploration of new targets for drug activity and drug development.  This article presents an updated review of the mechanisms and mol. basis of drug resistance in M. tuberculosis.  It also comments on the several gaps in our current knowledge of the mol. mechanisms of drug resistance to the main classical and new anti-TB drugs and briefly discusses some implications of the development of drug resistance and fitness, transmission and pathogenicity of M. tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnautFX8QYVLVg90H21EOLACvtfcHk0lj1nV0Dm7Dq7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFWksL8%253D&md5=5d2d6af9192d73ecc1621ab94d910cfa</span></div><a href="/servlet/linkout?suffix=cit100b&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr173%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%2BDa%2BSilva%26aufirst%3DP.%2BE.%26aulast%3DPalomino%26aufirst%3DJ.%2BC.%26atitle%3DMolecular%2520basis%2520and%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520Mycobacterium%2520tuberculosis%253A%2520classical%2520and%2520new%2520drugs%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26spage%3D1417%26epage%3D1430%26doi%3D10.1093%2Fjac%2Fdkr173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of hypoxia-activated prodrugs of SN-38</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2017.03.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=28350997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltlKktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2017&pages=135-141&author=C.+Jinauthor=Q.+Zhangauthor=W.+Lu&title=Synthesis+and+biological+evaluation+of+hypoxia-activated+prodrugs+of+SN-38&doi=10.1016%2Fj.ejmech.2017.03.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of hypoxia-activated prodrugs of SN-38</span></div><div class="casAuthors">Jin, Chen; Zhang, Qiumeng; Lu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135-141</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We designed new hypoxia-activated prodrugs by conjugating (1-methyl-2-nitro-1H-imidazol-5-yl)methanol with 7-ethyl-10-hydroxy camptothecin (SN-38).  Initially, we improved the method of multi-gram scale synthesis of (1-methyl-2-nitro-1H-imidazol-5-yl)methanol, which increased the yield to 42% compared to 8% by the original synthesis method.  The improved method was used to synthesize evofosfamide (TH-302) and hypoxia-activated prodrugs of SN-38.  Two different linkages between (1-methyl-2-nitro-1H-imidazol-5-yl)methanol and SN-38 were evaluated that afforded different hypoxia-selectivity and toxicity.  Compd. 16 (I, IOS), contg. an ether linkage, was considered to be a promising hypoxia-selective antitumor agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP68ManJrK2LVg90H21EOLACvtfcHk0lj1nV0Dm7Dq7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltlKktLo%253D&md5=2cd96bd09d80396db5b50e70fa023652</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.040%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DW.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520hypoxia-activated%2520prodrugs%2520of%2520SN-38%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D132%26spage%3D135%26epage%3D141%26doi%3D10.1016%2Fj.ejmech.2017.03.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melton, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, P. J.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4179</span>– <span class="NLM_lpage">4186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10945627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFOkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=4179-4186&author=R.+J.+Knoxauthor=T.+C.+Jenkinsauthor=S.+M.+Hobbsauthor=S.+Chenauthor=R.+G.+Meltonauthor=P.+J.+Burke&title=Bioactivation+of+5-%28aziridin-1-yl%29-2%2C4-dinitrobenzamide+%28CB+1954%29+by+human+NAD%28P%29H+quinone+oxidoreductase+2%3A+a+novel+co-substrate-mediated+antitumor+prodrug+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy</span></div><div class="casAuthors">Knox, Richard J.; Jenkins, Terence C.; Hobbs, Stephen M.; Chen, Shiuan; Melton, Roger G.; Burke, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4179-4186</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A novel prodrug activation system, endogenous in human tumor cells, is described.  A latent enzyme-prodrug system is switched on by a simple synthetic, small mol. co-substrate.  This ternary system is inactive if any one of the components is absent.  CB 1954 [5-(aziridin-1-yl)-2,4-dinitrobenzamide] is an antitumor prodrug that is activated in certain rat tumors via its 4-hydroxylamine deriv. to a potent bifunctional alkylating agent.  However, human tumor cells are resistant to CB 1954 because they are unable to catalyze this bioactivation efficiently.  A human enzyme has been discovered that can activate CB 1954, and it has been shown to be commonly present in human tumor cells.  The enzyme is NQO2 [NAD(P)H quinone oxidoreductase 2], but its activity is normally latent, and a nonbiogenic co-substrate such as NRH [nicotinamide riboside (reduced)] is required for enzymic activity.  There is a very large (100-3000-fold) increase in CB 1954 cytotoxicity toward either NQO2-transfected rodent or nontransfected human tumor cell lines in the presence of NRH.  Other reduced pyridinium compds. can also act as co-substrates for NQO2.  Thus, the simplest quaternary salt of nicotinamide, 1-methyl-3-carboxyamidopyridinium iodide, was a co-substrate for NQO2 when reduced to the corresponding 1,4-dihydropyridine deriv.  Increased chain length and/or alkyl load at the 1-position of the dihydropyridine ring improved specific activity, and compds. more active than NRH were found.  However, little activity was seen with either the 1-benzyl or 1-(2-phenylethyl) derivs.  A neg. charged substituent at the 3-position of the reduced pyridine ring also negated the ability of these compds. to act as cosubstrates for NQO2.  In particular, 1-carbamoylmethyl-3-carbamoyl-1,4-dihydropyridine was shown to be a co-substrate for NQO2 with greater stability than NRH, with the ability to enter cells and potentiate the cytotoxicity of CB 1954.  Furthermore, this agent is synthetically accessible and suitable for further pharmaceutical development.  NQO2 activity appears to be related to expression of NQO1 (DT-diaphorase), an enzyme that is known to have a favorable distribution toward certain human cancers.  NQO2 is a novel target for prodrug therapy and has a unique activation mechanism that relies on a synthetic co-substrate to activate an apparently latent enzyme.  Our findings may reopen the use of CB 1954 for the direct therapy of human malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhX9EnyQ-gzLVg90H21EOLACvtfcHk0lj1nV0Dm7Dq7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFOkt7c%253D&md5=517e0177ac1945cb75b156145e0aad59</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DJenkins%26aufirst%3DT.%2BC.%26aulast%3DHobbs%26aufirst%3DS.%2BM.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMelton%26aufirst%3DR.%2BG.%26aulast%3DBurke%26aufirst%3DP.%2BJ.%26atitle%3DBioactivation%2520of%25205-%2528aziridin-1-yl%2529-2%252C4-dinitrobenzamide%2520%2528CB%25201954%2529%2520by%2520human%2520NAD%2528P%2529H%2520quinone%2520oxidoreductase%25202%253A%2520a%2520novel%2520co-substrate-mediated%2520antitumor%2520prodrug%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D4179%26epage%3D4186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mautner, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, P F.</span></span> <span> </span><span class="NLM_article-title">The nitroreductase/CB1954 enzyme-prodrug system</span>. <i>Methods Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1385/1-59259-429-8:459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1385%2F1-59259-429-8%3A459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=14657579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlKn" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=459-477&author=N.+K.+Greenauthor=D.+J.+Kerrauthor=V.+Mautnerauthor=P.+A.+Harrisauthor=P+F.+Searle&title=The+nitroreductase%2FCB1954+enzyme-prodrug+system&doi=10.1385%2F1-59259-429-8%3A459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">The nitroreductase/CB1954 enzyme-prodrug system</span></div><div class="casAuthors">Green, Nicola K.; Kerr, David J.; Mautner, Vivien; Harris, Peter A.; Searle, Peter F.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">Suicide Gene Therapy</span>),
    <span class="NLM_cas:pages">459-477</span>CODEN:
                <span class="NLM_cas:coden">MMMEFN</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">The construction and anal. of the retroviral and adenoviral vectors encoding nitroreductase (Ntr) are described along with their application in exptl. tumor models.  A summary of the clin. trial protocol that was designed to offer proof that the adenovirus can infect and lead to Ntr expression in colorectal cancer metastases is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDQeSqZbmev7Vg90H21EOLACvtfcHk0ligsMjTqlDmzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlKn&md5=d17b48f0762b5c7926b5b96834d2554a</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1385%2F1-59259-429-8%3A459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59259-429-8%253A459%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DN.%2BK.%26aulast%3DKerr%26aufirst%3DD.%2BJ.%26aulast%3DMautner%26aufirst%3DV.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DSearle%26aufirst%3DP%2BF.%26atitle%3DThe%2520nitroreductase%252FCB1954%2520enzyme-prodrug%2520system%26jtitle%3DMethods%2520Mol.%2520Med.%26date%3D2004%26volume%3D90%26spage%3D459%26epage%3D477%26doi%3D10.1385%2F1-59259-429-8%3A459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit104a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhupathi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahluwalia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, C. P.</span></span> <span> </span><span class="NLM_article-title">Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">422</span>, <span class="refDoi"> DOI: 10.1186/s12885-015-1387-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1186%2Fs12885-015-1387-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=25994202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BC2MfmtVCgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=422&author=F.+Mengauthor=D.+Bhupathiauthor=J.+D.+Sunauthor=Q.+Liuauthor=D.+Ahluwaliaauthor=Y.+Wangauthor=M.+D.+Matteucciauthor=C.+P.+Hart&title=Enhancement+of+hypoxia-activated+prodrug+TH-302+anti-tumor+activity+by+Chk1+inhibition&doi=10.1186%2Fs12885-015-1387-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104aR"><div class="casContent"><span class="casTitleNuber">104a</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition</span></div><div class="casAuthors">Meng Fanying; Bhupathi Deepthi; Sun Jessica D; Liu Qian; Ahluwalia Dharmendra; Wang Yan; Matteucci Mark D; Hart Charles P</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">422</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The hypoxia-activated prodrug TH-302 is reduced at its nitroimidazole group and selectively under hypoxic conditions releases the DNA cross-linker bromo-isophosphoramide mustard (Br-IPM).  Here, we have explored the effect of Chk1 inhibition on TH-302-mediated pharmacological activities.  METHODS:  We employed in vitro cell viability, DNA damage, cellular signaling assays and the in vivo HT29 human tumor xenograft model to study the effect of Chk1inhibition on TH-302 antitumor activities.  RESULTS:  TH-302 cytotoxicity is greatly enhanced by Chk1 inhibition in p53-deficient but not in p53-proficient human cancer cell lines.  Chk1 inhibitors reduced TH-302-induced cell cycle arrest via blocking TH-302-induced decrease of phosphorylation of histone H3 and increasing Cdc2-Y15 phosphorylation.  Employing the single-cell gel electrophoresis (comet) assay, we observed a potentiation of the TH-302 dependent tail moment.  TH-302 induced γH2AX and apoptosis were also increased upon the addition of Chk1 inhibitor.  Potentiation of TH-302 cytotoxicity by Chk1 inhibitor was only observed in cell lines proficient in, but not deficient in homology-directed DNA repair.  We also show that combination treatment led to lowering of Rad51 expression levels as compared to either agent alone.  In vivo data demonstrate that Chk1 inhibitor enhances TH-302 anti-tumor activity in p53 mutant HT-29 human tumor xenografts, supporting the hypothesis that these in vitro results can translate to enhanced in vivo efficacy of the combination.  CONCLUSIONS:  TH-302-mediated in vitro and in vivo anti-tumor activities were greatly enhanced by the addition of Chk1 inhibitors.  The preclinical data presented in this study support a new approach for the treatment of p53-deficient hypoxic cancers by combining Chk1 inhibitors with the hypoxia-activated prodrug TH-302.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT30BF8QReeFGHOrQ6qeX-mfW6udTcc2eYVcH_B5xXa6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfmtVCgtw%253D%253D&md5=454c21c1a27e22b745fe572f2eb24328</span></div><a href="/servlet/linkout?suffix=cit104a&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1387-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1387-6%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DBhupathi%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DAhluwalia%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMatteucci%26aufirst%3DM.%2BD.%26aulast%3DHart%26aufirst%3DC.%2BP.%26atitle%3DEnhancement%2520of%2520hypoxia-activated%2520prodrug%2520TH-302%2520anti-tumor%2520activity%2520by%2520Chk1%2520inhibition%26jtitle%3DBMC%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D422%26doi%3D10.1186%2Fs12885-015-1387-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit104b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtkowiak, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornnell, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillies, R.</span></span> <span> </span><span class="NLM_article-title">MR imaging biomarkers to monitor early response to hypoxia-activated prodrug TH-302 in pancreatic cancer xenografts</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_fpage">e0155289</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0155289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1371%2Fjournal.pone.0155289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSqsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=e0155289&author=X.+Zhangauthor=J.+W.+Wojtkowiakauthor=G.+V.+Martinezauthor=H.+H.+Cornnellauthor=C.+P.+Hartauthor=A.+F.+Bakerauthor=R.+Gillies&title=MR+imaging+biomarkers+to+monitor+early+response+to+hypoxia-activated+prodrug+TH-302+in+pancreatic+cancer+xenografts&doi=10.1371%2Fjournal.pone.0155289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104bR"><div class="casContent"><span class="casTitleNuber">104b</span><div class="casTitle"><span class="NLM_cas:atitle">MR imaging biomarkers to monitor early response to hypoxia-activated prodrug TH-302 in pancreatic cancer xenografts</span></div><div class="casAuthors">Zhang, Xiaomeng; Wojtkowiak, Jonathan W.; Martinez, Gary V.; Cornnell, Heather H.; Hart, Charles P.; Baker, Amanda F.; Gillies, Robert</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0155289/1-e0155289/13</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">TH-302 is a hypoxia-activated prodrug known to activate selectively under the hypoxic conditions commonly found in solid tumors.  It is currently being evaluated in clin. trials, including two trials in Pancreatic Ductal Adenocarcinomas (PDAC).  The current study was undertaken to evaluate imaging biomarkers for prediction and response monitoring of TH- 302 efficacy in xenograft models of PDAC.  Dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) were used to monitor acute effects on tumor vasculature and cellularity, resp.  Three human PDAC xenografts with known differential responses to TH-302 were imaged prior to, and at 24 h and 48 h following a single dose of TH-302 or vehicle to det. if imaging changes presaged changes in tumor vols.  DW-MRI was performed at five b-values to generate apparent diffusion coeff. of water (ADC) maps.  For DCE-MRI, a std. clin. available contrast reagent, Gd-DTPA, was used to det. blood flow into the tumor region of interest.  TH- 302 induced a dramatic decrease in the DCE transfer const. (Ktrans) within 48 h after treatment in the sensitive tumors, Hs766t and Mia PaCa-2, whereas TH-302 had no effect on the perfusion behavior of resistant SU.86.86 tumors.  Tumor cellularity, estd. from ADC, was significantly increased 24 and 48 h after treatment in Hs766t, but was not obsd. in the Mia PaCa-2 and SU.86.86 groups.  Notably, growth inhibition of Hs766t was obsd. immediately (day 3) following initiation of treatment, but was not obsd. in Mia- PaCa-2 tumors until 8 days after initiation of treatment.  Based on these preclin. findings, DCE-MRI measures of vascular perfusion dynamics and ADC measures of cell d. are suggested as potential TH-302 response biomarkers in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_VedTlVOkp7Vg90H21EOLACvtfcHk0lj7OptmrlxNVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSqsLvK&md5=c1e97f64bfe02d9fe2127274ba06614b</span></div><a href="/servlet/linkout?suffix=cit104b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0155289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0155289%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWojtkowiak%26aufirst%3DJ.%2BW.%26aulast%3DMartinez%26aufirst%3DG.%2BV.%26aulast%3DCornnell%26aufirst%3DH.%2BH.%26aulast%3DHart%26aufirst%3DC.%2BP.%26aulast%3DBaker%26aufirst%3DA.%2BF.%26aulast%3DGillies%26aufirst%3DR.%26atitle%3DMR%2520imaging%2520biomarkers%2520to%2520monitor%2520early%2520response%2520to%2520hypoxia-activated%2520prodrug%2520TH-302%2520in%2520pancreatic%2520cancer%2520xenografts%26jtitle%3DPLoS%2520One%26date%3D2016%26spage%3De0155289%26doi%3D10.1371%2Fjournal.pone.0155289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Damen, E. W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevalainen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den Bergh, T. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, F. M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheeren, H. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel paclitaxel prodrugs designed for bioreductive activation in hypoxic tumour tissue</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(01)00235-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FS0968-0896%2801%2900235-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=11738608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BD3MnptV2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=71-77&author=E.+W.+P.+Damenauthor=T.+J.+Nevalainenauthor=T.+J.+M.+Van+den+Berghauthor=F.+M.+H.+de+Grootauthor=H.+W.+Scheeren&title=Synthesis+of+novel+paclitaxel+prodrugs+designed+for+bioreductive+activation+in+hypoxic+tumour+tissue&doi=10.1016%2FS0968-0896%2801%2900235-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel paclitaxel prodrugs designed for bioreductive activation in hypoxic tumour tissue</span></div><div class="casAuthors">Damen Eric W P; Nevalainen Tapio J; van den Bergh Toine J M; de Groot Franciscus M H; Scheeren Hans W</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-7</span>
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    </div><div class="casAbstract">The syntheses and preliminary evaluation of the first potential bioreductive paclitaxel prodrugs are described.  These prodrugs were designed as potential candidates in more selective chemotherapy by targeting hypoxic tumour tissue.  Aromatic nitro and azide groups were used as the bioreductive trigger.  Generation of paclitaxel occurs after reduction and subsequent 1,6-elimination or 1,8-elimination.  All prodrugs are stable in buffer and indeed give paclitaxel after chemical reduction of the aromatic nitro or azide functionality.  In aerobic cytotoxicity assays several prodrugs exhibit diminished cytotoxicity.  These compounds are interesting candidates for further biological evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIlJcC9FrU-IqdXsLcGTEUfW6udTcc2eY5WLSNiGTeurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnptV2qsg%253D%253D&md5=e5ff3489b047b92ac28a59cd1eb09a83</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2801%2900235-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252801%252900235-8%26sid%3Dliteratum%253Aachs%26aulast%3DDamen%26aufirst%3DE.%2BW.%2BP.%26aulast%3DNevalainen%26aufirst%3DT.%2BJ.%26aulast%3DVan%2Bden%2BBergh%26aufirst%3DT.%2BJ.%2BM.%26aulast%3Dde%2BGroot%26aufirst%3DF.%2BM.%2BH.%26aulast%3DScheeren%26aufirst%3DH.%2BW.%26atitle%3DSynthesis%2520of%2520novel%2520paclitaxel%2520prodrugs%2520designed%2520for%2520bioreductive%2520activation%2520in%2520hypoxic%2520tumour%2520tissue%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D71%26epage%3D77%26doi%3D10.1016%2FS0968-0896%2801%2900235-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tercel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwell, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botting, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruijn, F. B.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-activated prodrugs: substituent effects on the properties of nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (nitroCBI) prodrugs of DNA minor groove alkylating agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7258</span>– <span class="NLM_lpage">7272</span>, <span class="refDoi"> DOI: 10.1021/jm901202b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901202b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7258-7272&author=M.+Tercelauthor=G.+J.+Atwellauthor=S.+Yangauthor=R.+J.+Stevensonauthor=K.+J.+Bottingauthor=M.+Boydauthor=E.+Smithauthor=R.+F.+Andersonauthor=W.+A.+Dennyauthor=W.+R.+Wilsonauthor=F.+B.+Pruijn&title=Hypoxia-activated+prodrugs%3A+substituent+effects+on+the+properties+of+nitro+seco-1%2C2%2C9%2C9a-tetrahydrocyclopropa%5Bc%5Dbenz%5Be%5Dindol-4-one+%28nitroCBI%29+prodrugs+of+DNA+minor+groove+alkylating+agents&doi=10.1021%2Fjm901202b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm901202b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901202b%26sid%3Dliteratum%253Aachs%26aulast%3DTercel%26aufirst%3DM.%26aulast%3DAtwell%26aufirst%3DG.%2BJ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DStevenson%26aufirst%3DR.%2BJ.%26aulast%3DBotting%26aufirst%3DK.%2BJ.%26aulast%3DBoyd%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DPruijn%26aufirst%3DF.%2BB.%26atitle%3DHypoxia-activated%2520prodrugs%253A%2520substituent%2520effects%2520on%2520the%2520properties%2520of%2520nitro%2520seco-1%252C2%252C9%252C9a-tetrahydrocyclopropa%255Bc%255Dbenz%255Be%255Dindol-4-one%2520%2528nitroCBI%2529%2520prodrugs%2520of%2520DNA%2520minor%2520groove%2520alkylating%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7258%26epage%3D7272%26doi%3D10.1021%2Fjm901202b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vass, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for <i>E. coli</i> nitroreductase activation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4333</span>– <span class="NLM_lpage">4343</span>, <span class="refDoi"> DOI: 10.1021/jm051246n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051246n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4333-4343&author=Y.+Jiangauthor=J.+Hanauthor=C.+Yuauthor=S.+O.+Vassauthor=P.+F.+Searleauthor=P.+Browneauthor=R.+J.+Knoxauthor=L.+Hu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+cyclic+and+acyclic+nitrobenzylphosphoramide+mustards+for+E.+coli+nitroreductase+activation&doi=10.1021%2Fjm051246n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm051246n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051246n%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DVass%26aufirst%3DS.%2BO.%26aulast%3DSearle%26aufirst%3DP.%2BF.%26aulast%3DBrowne%26aufirst%3DP.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520cyclic%2520and%2520acyclic%2520nitrobenzylphosphoramide%2520mustards%2520for%2520E.%2520coli%2520nitroreductase%2520activation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4333%26epage%3D4343%26doi%3D10.1021%2Fjm051246n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cazares-Korner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayer, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olcina, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E. M.</span></span> <span> </span><span class="NLM_article-title">CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1451</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.1021/cb4001537</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4001537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1451-1459&author=C.+Cazares-Kornerauthor=I.+M.+Piresauthor=I.+D.+Swallowauthor=S.+C.+Grayerauthor=L.+J.+O%E2%80%99Connorauthor=M.+M.+Olcinaauthor=M.+Christliebauthor=S.+J.+L.+Conwayauthor=E.+M.+Hammond&title=CH-01+is+a+hypoxia-activated+prodrug+that+sensitizes+cells+to+hypoxia%2Freoxygenation+through+inhibition+of+Chk1+and+Aurora+A&doi=10.1021%2Fcb4001537"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fcb4001537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4001537%26sid%3Dliteratum%253Aachs%26aulast%3DCazares-Korner%26aufirst%3DC.%26aulast%3DPires%26aufirst%3DI.%2BM.%26aulast%3DSwallow%26aufirst%3DI.%2BD.%26aulast%3DGrayer%26aufirst%3DS.%2BC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DL.%2BJ.%26aulast%3DOlcina%26aufirst%3DM.%2BM.%26aulast%3DChristlieb%26aufirst%3DM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%2BL.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26atitle%3DCH-01%2520is%2520a%2520hypoxia-activated%2520prodrug%2520that%2520sensitizes%2520cells%2520to%2520hypoxia%252Freoxygenation%2520through%2520inhibition%2520of%2520Chk1%2520and%2520Aurora%2520A%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1451%26epage%3D1459%26doi%3D10.1021%2Fcb4001537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penketh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, E. S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartorelli, A. C.</span></span> <span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4 nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): a cytotoxic prodrug with two stable conformations differing in biologicaland physical properties</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2011.01193.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1111%2Fj.1747-0285.2011.01193.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=21777394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2hsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2011&pages=513-526&author=P.+G.+Penkethauthor=R.+P.+Baumannauthor=K.+Shyamauthor=H.+S.+Williamsonauthor=K.+Ishiguroauthor=R.+Zhuauthor=E.+S.+E.+Erikssonauthor=L.+A.+Erikssonauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2-%5B%5B1-%284+nitrophenyl%29ethoxy%5Dcarbonyl%5Dhydrazine+%28KS119%29%3A+a+cytotoxic+prodrug+with+two+stable+conformations+differing+in+biologicaland+physical+properties&doi=10.1111%2Fj.1747-0285.2011.01193.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): a cytotoxic prodrug with two stable conformations differing in biological and physical properties</span></div><div class="casAuthors">Penketh, Philip G.; Baumann, Raymond P.; Shyam, Krishnamurthy; Williamson, Hugh S.; Ishiguro, Kimiko; Zhu, Rui; Eriksson, Emma S. E.; Eriksson, Leif A.; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-526</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The anticancer prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively releases a short-lived cytotoxin following enzymic redn. in hypoxic environments found in solid tumors.  KS119, in addn. to two enantiomers, has two stable atropisomers (conformers differing in structure owing to hindered bond rotation) that interconvert at 37 °C in aq. soln. by first-order kinetics with t1/2 values of ∼50 and ∼64 h.  The atropisomers differ in phys. properties such as partition coeffs. that allow their chromatog. sepn. on non-chiral columns.  A striking difference in the rate of metab. of the two atropisomers occurs in intact EMT6 murine mammary carcinoma cells under oxygen-deficient conditions.  A structurally related mol., 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(3-hydroxy-4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119WOH), was also found to exist in similar stable atropisomers.  The ratio of the atropisomers of KS119 and structurally related agents has the potential to impact the bioavailability, activation, and therapeutic activity.  Thus, thermally stable atropisomers/conformers in small mols. can result in chem. and enantiomerically pure compds. having differences in biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc5a2kVFjL_rVg90H21EOLACvtfcHk0liW1QmIoZhQAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2hsbrJ&md5=ccef646a2636361981991352191fd988</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01193.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01193.x%26sid%3Dliteratum%253Aachs%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DWilliamson%26aufirst%3DH.%2BS.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DEriksson%26aufirst%3DE.%2BS.%2BE.%26aulast%3DEriksson%26aufirst%3DL.%2BA.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2-%255B%255B1-%25284%2520nitrophenyl%2529ethoxy%255Dcarbonyl%255Dhydrazine%2520%2528KS119%2529%253A%2520a%2520cytotoxic%2520prodrug%2520with%2520two%2520stable%2520conformations%2520differing%2520in%2520biologicaland%2520physical%2520properties%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D78%26spage%3D513%26epage%3D526%26doi%3D10.1111%2Fj.1747-0285.2011.01193.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seow, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penketh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockwell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartorelli, A. C.</span></span> <span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): A novel agent with preferential cytotoxicity to hypoxic cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">9282</span>– <span class="NLM_lpage">9287</span>, <span class="refDoi"> DOI: 10.1073/pnas.0409013102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1073%2Fpnas.0409013102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=9282-9287&issue=26&author=A.+H.+Seowauthor=P.+G.+Penkethauthor=K.+Shyamauthor=S.+Rockwellauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2-%5B%5B1-%284-nitrophenyl%29ethoxy%5Dcarbonyl%5Dhydrazine+%28KS119%29%3A+A+novel+agent+with+preferential+cytotoxicity+to+hypoxic+cells&doi=10.1073%2Fpnas.0409013102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0409013102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0409013102%26sid%3Dliteratum%253Aachs%26aulast%3DSeow%26aufirst%3DA.%2BH.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DRockwell%26aufirst%3DS.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2-%255B%255B1-%25284-nitrophenyl%2529ethoxy%255Dcarbonyl%255Dhydrazine%2520%2528KS119%2529%253A%2520A%2520novel%2520agent%2520with%2520preferential%2520cytotoxicity%2520to%2520hypoxic%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26issue%3D26%26spage%3D9282%26epage%3D9287%26doi%3D10.1073%2Fpnas.0409013102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazares-Körner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, M. R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">794</span>, <span class="refDoi"> DOI: 10.1038/nprot.2016.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1038%2Fnprot.2016.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27010756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVKlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=781-794&author=L.+J.+O%E2%80%99Connorauthor=C.+Cazares-K%C3%B6rnerauthor=J.+Sahaauthor=C.+N.+Evansauthor=M.+R.+L.+Stratfordauthor=E.+M.+Hammondauthor=S.+J.+Conway&title=Design%2C+synthesis+and+evaluation+of+molecularly+targeted+hypoxia-activated+prodrugs&doi=10.1038%2Fnprot.2016.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs</span></div><div class="casAuthors">O'Connor, Liam J.; Cazares-Korner, Cindy; Saha, Jaideep; Evans, Charles N. G.; Stratford, Michael R. L.; Hammond, Ester M.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">781-794</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Regions of insufficient oxygen supply-hypoxia-occur in diverse contexts across biol. in both healthy and diseased organisms.  The difference in the chem. environment between a hypoxic biol. system and one with normal oxygen levels provides an opportunity for targeting compd. delivery to hypoxic regions by using bioreductive prodrugs.  Here we detail a protocol for the efficient synthesis of (1-methyl-2-nitro-1H-imidazol-5-yl)methanol, which is a key intermediate that can be converted into a range of 1-methyl-2-nitro-1H-imidazole-based precursors of bioreductive prodrugs.  We outline methods for attaching the bioreductive group to a range of functionalities, and we discuss the strategy for positioning of the group on the biol. active parent compd.  We have used two parent checkpoint kinase 1 (Chk1) inhibitors to exemplify the protocol.  The PROCEDURE also describes a suite of redn. assays, of increasing biol. relevance, to validate the bioreductive prodrug.  These assays are applied to an exemplar compd., CH-01, which is a bioreductive Chk1 inhibitor.  This protocol has broad applications to the development of hypoxia-targeted compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLVzieErJLfbVg90H21EOLACvtfcHk0liW1QmIoZhQAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVKlurg%253D&md5=12947657c27045fa89a1dc54f8cb9ef3</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2016.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2016.034%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DL.%2BJ.%26aulast%3DCazares-K%25C3%25B6rner%26aufirst%3DC.%26aulast%3DSaha%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DC.%2BN.%26aulast%3DStratford%26aufirst%3DM.%2BR.%2BL.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520molecularly%2520targeted%2520hypoxia-activated%2520prodrugs%26jtitle%3DNat.%2520Protoc.%26date%3D2016%26volume%3D11%26spage%3D781%26epage%3D794%26doi%3D10.1038%2Fnprot.2016.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, M. R.</span></span> <span> </span><span class="NLM_article-title">NLCQ-1 and NLCQ-2, two new agents with activity against dormant Mycobacterium tuberculosis</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1016/j.ijantimicag.2007.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ijantimicag.2007.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=17379483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=724-727&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=M.+R.+McNeil&title=NLCQ-1+and+NLCQ-2%2C+two+new+agents+with+activity+against+dormant+Mycobacterium+tuberculosis&doi=10.1016%2Fj.ijantimicag.2007.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">NLCQ-1 and NLCQ-2, two new agents with activity against dormant Mycobacterium tuberculosis</span></div><div class="casAuthors">Papadopoulou, Maria V.; Bloomer, William D.; McNeil, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">724-727</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">4-[3-(2-Nitro-1-imidazolyl)-propylamino]-7-chloroquinoline hydrochloride (NLCQ-1; NSC 709257) and 4-[4-(2-nitro-1-imidazolyl)-butylamino]-7-chloroquinoline hydrochloride (NLCQ-2), two weak DNA-intercalating nitroimidazole-based bioreductive prodrugs, have been tested against dormant Mycobacterium tuberculosis and demonstrated a significant activity comparable with that of the nitroimidazopyran PA-824.  Min. bactericidal concns. (MBCs) of 3.1 - 18.4 and 4.9 - 9.8 μg/mL were obtained for NLCQ-1 and NLCQ-2, resp.  In the same test setting; the corresponding MBC range for PA-824 was 6.4-12.8 μg/mL.  For rifampicin, isoniazid, minocycline, streptomycin, clarithromycin and capreomycin, the corresponding MBC values were 2.5, >100, >156.25, >12.5, >312.5 and 37.5 μg/mL, resp.  Toxicity against Vero cells provided 50% inhibitory concns. (IC50) of 146.7, >640 and >640 μg/mL for NLCQ-1, NLCQ-2 and PA-824, resp.  Therefore, the selectivity index (SI) was 8 - 47.3, >65.3 - 130.6 and >50 - 100 for NLCQ-1, NLCQ-2 and PA-824, resp.  These results suggest the potential usefulness of these compds. in the therapy of the latent form of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg14JaGLXDaLVg90H21EOLACvtfcHk0lh4Fy9omEKbGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1ans78%253D&md5=d99f8ae590d82da3a05b548e7b9fb2e7</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2007.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2007.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DMcNeil%26aufirst%3DM.%2BR.%26atitle%3DNLCQ-1%2520and%2520NLCQ-2%252C%2520two%2520new%2520agents%2520with%2520activity%2520against%2520dormant%2520Mycobacterium%2520tuberculosis%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2007%26volume%3D29%26spage%3D724%26epage%3D727%26doi%3D10.1016%2Fj.ijantimicag.2007.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cran, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minchinton, A. I.</span></span> <span> </span><span class="NLM_article-title">Selective radiosensitization of hypoxic cells using BCCA621C: a novel hypoxia activated prodrug targeting DNA-dependent protein kinase</span>. <i>Tumor Microenviron. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.2478/tumor-2013-0003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.2478%2Ftumor-2013-0003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=46-55&author=K.+E.+Lindquistauthor=J.+D.+Cranauthor=K.+Kordicauthor=P.+C.+Chuaauthor=G.+C.+Wintersauthor=J.+S.+Tanauthor=J.+Lozadaauthor=A.+H.+Kyleauthor=J.+W.+Evansauthor=A.+I.+Minchinton&title=Selective+radiosensitization+of+hypoxic+cells+using+BCCA621C%3A+a+novel+hypoxia+activated+prodrug+targeting+DNA-dependent+protein+kinase&doi=10.2478%2Ftumor-2013-0003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.2478%2Ftumor-2013-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Ftumor-2013-0003%26sid%3Dliteratum%253Aachs%26aulast%3DLindquist%26aufirst%3DK.%2BE.%26aulast%3DCran%26aufirst%3DJ.%2BD.%26aulast%3DKordic%26aufirst%3DK.%26aulast%3DChua%26aufirst%3DP.%2BC.%26aulast%3DWinters%26aufirst%3DG.%2BC.%26aulast%3DTan%26aufirst%3DJ.%2BS.%26aulast%3DLozada%26aufirst%3DJ.%26aulast%3DKyle%26aufirst%3DA.%2BH.%26aulast%3DEvans%26aufirst%3DJ.%2BW.%26aulast%3DMinchinton%26aufirst%3DA.%2BI.%26atitle%3DSelective%2520radiosensitization%2520of%2520hypoxic%2520cells%2520using%2520BCCA621C%253A%2520a%2520novel%2520hypoxia%2520activated%2520prodrug%2520targeting%2520DNA-dependent%2520protein%2520kinase%26jtitle%3DTumor%2520Microenviron.%2520Ther.%26date%3D2013%26volume%3D1%26spage%3D46%26epage%3D55%26doi%3D10.2478%2Ftumor-2013-0003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guise, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span> <span> </span><span class="NLM_article-title">FSL-61 is a 6-nitroquinolone fluorogenic probe for one-electron reductases in hypoxic cells</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>452</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1042/BJ20121695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1042%2FBJ20121695" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2013&pages=79-86&author=J.+Suauthor=C.+P.+Guiseauthor=W.+R.+Wilson&title=FSL-61+is+a+6-nitroquinolone+fluorogenic+probe+for+one-electron+reductases+in+hypoxic+cells&doi=10.1042%2FBJ20121695"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1042%2FBJ20121695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20121695%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DGuise%26aufirst%3DC.%2BP.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26atitle%3DFSL-61%2520is%2520a%25206-nitroquinolone%2520fluorogenic%2520probe%2520for%2520one-electron%2520reductases%2520in%2520hypoxic%2520cells%26jtitle%3DBiochem.%2520J.%26date%3D2013%26volume%3D452%26spage%3D79%26epage%3D86%26doi%3D10.1042%2FBJ20121695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tercel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youte
Tendoung, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liyanage, H. D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruijn, F. B.</span></span> <span> </span><span class="NLM_article-title">Influence of a basic side chain on the properties of hypoxia-selective nitro analogues of the duocarmycins: demonstration of substantial anticancer activity in combination with irradiation or chemotherapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5834</span>– <span class="NLM_lpage">5856</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00563</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00563" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCgs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5834-5856&author=M.+Tercelauthor=H.+H.+Leeauthor=S.+Y.+Mehtaauthor=J.+J.+Youte%0ATendoungauthor=S.+Y.+Baiauthor=H.+D.+S.+Liyanageauthor=F.+B.+Pruijn&title=Influence+of+a+basic+side+chain+on+the+properties+of+hypoxia-selective+nitro+analogues+of+the+duocarmycins%3A+demonstration+of+substantial+anticancer+activity+in+combination+with+irradiation+or+chemotherapy&doi=10.1021%2Facs.jmedchem.7b00563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of a Basic Side Chain on the Properties of Hypoxia-Selective Nitro Analogues of the Duocarmycins: Demonstration of Substantial Anticancer Activity in Combination with Irradiation or Chemotherapy</span></div><div class="casAuthors">Tercel, Moana; Lee, Ho H.; Mehta, Sunali Y.; Youte Tendoung, Jean-Jacques; Bai, Sally Y.; Liyanage, H. D. Sarath; Pruijn, Frederik B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5834-5856</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of nitro analogs of the duocarmycins was prepd. and evaluated for hypoxia-selective anticancer activity.  The compds. incorporate 13 different amine-contg. side chains designed to bind in the minor groove of DNA while spanning a wide range of base strength from pKa 9.64 to 5.24.  The most favorable in vitro properties were assocd. with strongly basic side chains, but the greatest in vivo antitumor activity was found for compds. contg. a weakly basic morpholine.  This applies to single-agent activity and for activity in combination with irradn. or chemotherapy (gemcitabine or docetaxel).  In combination with a single dose of γ irradn. I at 42 μmol/kg eliminated detectable clonogens in some SiHa cervical carcinoma xenografts, and in combination with gemcitabine using a well-tolerated multidose schedule, the same compd. caused regression of all treated A2780 ovarian tumor xenografts.  In the latter expt., three of seven animals receiving the combination treatment were completely tumor free at day 100.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI57WrxYeMHrVg90H21EOLACvtfcHk0liKrqF0gK3O5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCgs7fI&md5=645bd3b84acc9c13ba63128caeccd257</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00563%26sid%3Dliteratum%253Aachs%26aulast%3DTercel%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DH.%2BH.%26aulast%3DMehta%26aufirst%3DS.%2BY.%26aulast%3DYoute%2BTendoung%26aufirst%3DJ.%2BJ.%26aulast%3DBai%26aufirst%3DS.%2BY.%26aulast%3DLiyanage%26aufirst%3DH.%2BD.%2BS.%26aulast%3DPruijn%26aufirst%3DF.%2BB.%26atitle%3DInfluence%2520of%2520a%2520basic%2520side%2520chain%2520on%2520the%2520properties%2520of%2520hypoxia-selective%2520nitro%2520analogues%2520of%2520the%2520duocarmycins%253A%2520demonstration%2520of%2520substantial%2520anticancer%2520activity%2520in%2520combination%2520with%2520irradiation%2520or%2520chemotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5834%26epage%3D5856%26doi%3D10.1021%2Facs.jmedchem.7b00563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaizerman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorente, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banica, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammons, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, M.</span></span> <span> </span><span class="NLM_article-title">Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2412</span>– <span class="NLM_lpage">2420</span>, <span class="refDoi"> DOI: 10.1021/jm701028q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701028q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2412-2420&author=J.+X.+Duanauthor=H.+Jiaoauthor=J.+Kaizermanauthor=T.+Stantonauthor=J.+W.+Evansauthor=L.+Lanauthor=G.+Lorenteauthor=M.+Banicaauthor=D.+Jungauthor=J.+Wangauthor=H.+Maauthor=X.+Liauthor=Z.+Yangauthor=R.+M.+Hoffmanauthor=W.+S.+Ammonsauthor=C.+P.+Hartauthor=M.+Matteucci&title=Potent+and+highly+selective+hypoxia-activated+achiral+phosphoramidate+mustards+as+anticancer+drugs&doi=10.1021%2Fjm701028q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm701028q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701028q%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DJ.%2BX.%26aulast%3DJiao%26aufirst%3DH.%26aulast%3DKaizerman%26aufirst%3DJ.%26aulast%3DStanton%26aufirst%3DT.%26aulast%3DEvans%26aufirst%3DJ.%2BW.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLorente%26aufirst%3DG.%26aulast%3DBanica%26aufirst%3DM.%26aulast%3DJung%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHoffman%26aufirst%3DR.%2BM.%26aulast%3DAmmons%26aufirst%3DW.%2BS.%26aulast%3DHart%26aufirst%3DC.%2BP.%26aulast%3DMatteucci%26aufirst%3DM.%26atitle%3DPotent%2520and%2520highly%2520selective%2520hypoxia-activated%2520achiral%2520phosphoramidate%2520mustards%2520as%2520anticancer%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2412%26epage%3D2420%26doi%3D10.1021%2Fjm701028q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naimi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalili, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiebe, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, E. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 3′- and 5′-nitrooxy pyrimidine nucleoside nitrate esters: “nitric oxide donor” agents for evaluation as anticancer and antiviral agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1021/jm020299r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020299r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=995-1004&author=E.+Naimiauthor=A.+Zhouauthor=P.+Khaliliauthor=L.+I.+Wiebeauthor=J.+Balzariniauthor=E.+De+Clercqauthor=E.+E.+Knaus&title=Synthesis+of+3%E2%80%B2-+and+5%E2%80%B2-nitrooxy+pyrimidine+nucleoside+nitrate+esters%3A+%E2%80%9Cnitric+oxide+donor%E2%80%9D+agents+for+evaluation+as+anticancer+and+antiviral+agents&doi=10.1021%2Fjm020299r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fjm020299r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020299r%26sid%3Dliteratum%253Aachs%26aulast%3DNaimi%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DKhalili%26aufirst%3DP.%26aulast%3DWiebe%26aufirst%3DL.%2BI.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DKnaus%26aufirst%3DE.%2BE.%26atitle%3DSynthesis%2520of%25203%25E2%2580%25B2-%2520and%25205%25E2%2580%25B2-nitrooxy%2520pyrimidine%2520nucleoside%2520nitrate%2520esters%253A%2520%25E2%2580%259Cnitric%2520oxide%2520donor%25E2%2580%259D%2520agents%2520for%2520evaluation%2520as%2520anticancer%2520and%2520antiviral%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D995%26epage%3D1004%26doi%3D10.1021%2Fjm020299r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colón, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zayas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alegría, A. E.</span></span> <span> </span><span class="NLM_article-title">Role of the nitro functionality in the DNA binding of 3-nitro-10-methylbenzothiazolo[3,2-<i>a</i>]quinolinium chloride</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1706</span>– <span class="NLM_lpage">1715</span>, <span class="refDoi"> DOI: 10.1021/tx800076c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx800076c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1706-1715&author=I.+G.+Col%C3%B3nauthor=F.+A.+Gonz%C3%A1lezauthor=M.+Corderoauthor=B.+Zayasauthor=C.+Velezauthor=O.+Coxauthor=A.+Kumarauthor=A.+E.+Alegr%C3%ADa&title=Role+of+the+nitro+functionality+in+the+DNA+binding+of+3-nitro-10-methylbenzothiazolo%5B3%2C2-a%5Dquinolinium+chloride&doi=10.1021%2Ftx800076c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Ftx800076c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800076c%26sid%3Dliteratum%253Aachs%26aulast%3DCol%25C3%25B3n%26aufirst%3DI.%2BG.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DF.%2BA.%26aulast%3DCordero%26aufirst%3DM.%26aulast%3DZayas%26aufirst%3DB.%26aulast%3DVelez%26aufirst%3DC.%26aulast%3DCox%26aufirst%3DO.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DAlegr%25C3%25ADa%26aufirst%3DA.%2BE.%26atitle%3DRole%2520of%2520the%2520nitro%2520functionality%2520in%2520the%2520DNA%2520binding%2520of%25203-nitro-10-methylbenzothiazolo%255B3%252C2-a%255Dquinolinium%2520chloride%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1706%26epage%3D1715%26doi%3D10.1021%2Ftx800076c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karwa, A.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poreddy, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmelash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorshow, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopalan, R.</span></span> <span> </span><span class="NLM_article-title">Type 1 phototherapeutic agents, part i: preparation and cancer cell viability studies of novel photolabile sulfenamides</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">833</span>, <span class="refDoi"> DOI: 10.1021/ml2001483</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml2001483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=828-833&author=A.%0AS.+Karwaauthor=A.+R.+Poreddyauthor=B.+Asmelashauthor=T.+S.+Linauthor=R.+B.+Dorshowauthor=R.+Rajagopalan&title=Type+1+phototherapeutic+agents%2C+part+i%3A+preparation+and+cancer+cell+viability+studies+of+novel+photolabile+sulfenamides&doi=10.1021%2Fml2001483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fml2001483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2001483%26sid%3Dliteratum%253Aachs%26aulast%3DKarwa%26aufirst%3DA.%2BS.%26aulast%3DPoreddy%26aufirst%3DA.%2BR.%26aulast%3DAsmelash%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DT.%2BS.%26aulast%3DDorshow%26aufirst%3DR.%2BB.%26aulast%3DRajagopalan%26aufirst%3DR.%26atitle%3DType%25201%2520phototherapeutic%2520agents%252C%2520part%2520i%253A%2520preparation%2520and%2520cancer%2520cell%2520viability%2520studies%2520of%2520novel%2520photolabile%2520sulfenamides%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D828%26epage%3D833%26doi%3D10.1021%2Fml2001483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shustov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khlebnikov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheeseman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiebe, L. I.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6033</span>– <span class="NLM_lpage">6046</span>, <span class="refDoi"> DOI: 10.1021/jm2017336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2017336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38Xoslantbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6033-6046&author=P.+Kumarauthor=G.+Shustovauthor=H.+Liangauthor=V.+Khlebnikovauthor=W.+Zhengauthor=X.+H.+Yangauthor=C.+Cheesemanauthor=L.+I.+Wiebe&title=Design%2C+synthesis%2C+and+preliminary+biological+evaluation+of+6-O-glucose-azomycin+adducts+for+diagnosis+and+therapy+of+hypoxic+tumors&doi=10.1021%2Fjm2017336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Preliminary Biological Evaluation of 6-O-Glucose-Azomycin Adducts for Diagnosis and Therapy of Hypoxic Tumors</span></div><div class="casAuthors">Kumar, Piyush; Shustov, Gennady; Liang, Hong; Khlebnikov, Vladimir; Zheng, Weizhong; Yang, Xiao-Hong; Cheeseman, Chris; Wiebe, Leonard I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6033-6046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several 2-nitroimidazole-based mols. (NIs), e.g. I, are used as clin. hypoxic tumor radiodiagnostics, but they are not effective as radiosensitizers/radiochemotherapeutics.  These NIs permeate tumor cells non-selectively via diffusion, and in therapy, where high doses are required, their dose limiting toxicities preclude success.  The synthesis and preliminary in vitro evaluations of three glucoazomycins, members of a novel class of C6-O-glucose-linked-azomycin conjugates that are putative substrates of glucose transport proteins (GLUTs) and possess hypoxia-selective radiosensitization features, are now reported.  The hypoxia-dependent up-regulation of several GLUTs provides a rational basis to develop these glucoazomycins because more selective uptake in hypoxic cells would decrease systemic toxicities at EDs.  Calcd. partition coeffs. (ClogP, -1.70 to -2.99) predict rapid in vivo clearance for low systemic toxicity.  In vitro exptl. data show that glucoazomycins are radiosensitizers and that they competitively inhibit glucose uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0b8QbY1joMbVg90H21EOLACvtfcHk0ljCnmQ_195lDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xoslantbs%253D&md5=15fc3d15f417c8720b02c9bb0ea83e56</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Fjm2017336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2017336%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DShustov%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DKhlebnikov%26aufirst%3DV.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DX.%2BH.%26aulast%3DCheeseman%26aufirst%3DC.%26aulast%3DWiebe%26aufirst%3DL.%2BI.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520preliminary%2520biological%2520evaluation%2520of%25206-O-glucose-azomycin%2520adducts%2520for%2520diagnosis%2520and%2520therapy%2520of%2520hypoxic%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6033%26epage%3D6046%26doi%3D10.1021%2Fjm2017336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruijn, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, M. P.</span></span> <span> </span><span class="NLM_article-title">Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2123</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.02.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2014.02.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2123-2132&author=M.+Bonnetauthor=C.+R.+Hongauthor=Y.+Guauthor=R.+F.+Andersonauthor=W.+R.+Wilsonauthor=F.+B.+Pruijnauthor=J.+Wangauthor=K.+O.+Hicksauthor=M.+P.+Hay&title=Novel+nitroimidazole+alkylsulfonamides+as+hypoxic+cell+radiosensitisers&doi=10.1016%2Fj.bmc.2014.02.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.02.039%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DC.%2BR.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DPruijn%26aufirst%3DF.%2BB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHicks%26aufirst%3DK.%2BO.%26aulast%3DHay%26aufirst%3DM.%2BP.%26atitle%3DNovel%2520nitroimidazole%2520alkylsulfonamides%2520as%2520hypoxic%2520cell%2520radiosensitisers%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2123%26epage%3D2132%26doi%3D10.1016%2Fj.bmc.2014.02.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of 6-(nitroimidazole-1H-alkyloxyl)-4-anilinoquinazolines as efficient EGFR inhibitors exerting cytotoxic effects both under normoxia and hypoxia</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">826</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2014.11.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=826-834&author=W.+Chengauthor=S.+Zhuauthor=X.+Maauthor=N.+Qiuauthor=P.+Pengauthor=R.+Shengauthor=Y.+Hu&title=Design%2C+synthesis+and+biological+evaluation+of+6-%28nitroimidazole-1H-alkyloxyl%29-4-anilinoquinazolines+as+efficient+EGFR+inhibitors+exerting+cytotoxic+effects+both+under+normoxia+and+hypoxia&doi=10.1016%2Fj.ejmech.2014.11.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DN.%26aulast%3DPeng%26aufirst%3DP.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%25206-%2528nitroimidazole-1H-alkyloxyl%2529-4-anilinoquinazolines%2520as%2520efficient%2520EGFR%2520inhibitors%2520exerting%2520cytotoxic%2520effects%2520both%2520under%2520normoxia%2520and%2520hypoxia%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D826%26epage%3D834%26doi%3D10.1016%2Fj.ejmech.2014.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atwell, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruijn, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the <i>Escherichia coli nfsB</i> nitroreductase in gene therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1197</span>– <span class="NLM_lpage">1212</span>, <span class="refDoi"> DOI: 10.1021/jm061062o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061062o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1197-1212&author=G.+J.+Atwellauthor=S.+Yangauthor=F.+B.+Pruijnauthor=S.+M.+Pullenauthor=A.+Hoggauthor=A.+V.+Pattersonauthor=W.+R.+Wilsonauthor=W.+A.+Denny&title=Synthesis+and+structure-activity+relationships+for+2%2C4-dinitrobenzamide-5-mustards+as+prodrugs+for+the+Escherichia+coli+nfsB+nitroreductase+in+gene+therapy&doi=10.1021%2Fjm061062o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm061062o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061062o%26sid%3Dliteratum%253Aachs%26aulast%3DAtwell%26aufirst%3DG.%2BJ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DPruijn%26aufirst%3DF.%2BB.%26aulast%3DPullen%26aufirst%3DS.%2BM.%26aulast%3DHogg%26aufirst%3DA.%26aulast%3DPatterson%26aufirst%3DA.%2BV.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520for%25202%252C4-dinitrobenzamide-5-mustards%2520as%2520prodrugs%2520for%2520the%2520Escherichia%2520coli%2520nfsB%2520nitroreductase%2520in%2520gene%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1197%26epage%3D1212%26doi%3D10.1021%2Fjm061062o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayeh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheuermann, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longgood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Key, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frantz, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambar, U. K.</span></span> <span> </span><span class="NLM_article-title">Development of inhibitors of the PAS-B domain of the HIF-2α transcription factor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1747</span>, <span class="refDoi"> DOI: 10.1021/jm301847z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301847z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1739-1747&author=J.+L.+Rogersauthor=L.+Bayehauthor=T.+H.+Scheuermannauthor=J.+Longgoodauthor=J.+Keyauthor=J.+Naidooauthor=L.+Melitoauthor=C.+Shokriauthor=D.+E.+Frantzauthor=R.+K.+Bruickauthor=K.+H.+Gardnerauthor=J.+B.+MacMillanauthor=U.+K.+Tambar&title=Development+of+inhibitors+of+the+PAS-B+domain+of+the+HIF-2%CE%B1+transcription+factor&doi=10.1021%2Fjm301847z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Inhibitors of the PAS-B Domain of the HIF-2α Transcription Factor</span></div><div class="casAuthors">Rogers, Jamie L.; Bayeh, Liela; Scheuermann, Thomas H.; Longgood, Jamie; Key, Jason; Naidoo, Jacinth; Melito, Lisa; Shokri, Cameron; Frantz, Doug E.; Bruick, Richard K.; Gardner, Kevin H.; MacMillan, John B.; Tambar, Uttam K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1739-1747</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia inducible factors (HIFs) are heterodimeric transcription factors induced in a variety of pathophysiol. settings, including cancer.  The first detailed structure-activity relationship study of small mols. designed to inhibit HIF-2α-ARNT heterodimerization by binding an internal cavity of the HIF-2α PAS-B domain is described herein.  A series of benzoxadiazole derivs. was synthesized and evaluated for their inhibitory activity.  Through a series of biophys. characterizations of inhibitor-protein interactions [NMR and X-ray crystallog. for compds. I (R = H or Cl)], the structural requirements for artificial inhibitors of the HIF-2α-ARNT PAS-B interaction have been established.  These results may serve as a foundation for discovering therapeutic agents that function by a novel mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUwOF6FlDBrLVg90H21EOLACvtfcHk0ljTXdOyMUAllQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjsrs%253D&md5=03a967dcc64865633544f0973c806edc</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjm301847z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301847z%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DJ.%2BL.%26aulast%3DBayeh%26aufirst%3DL.%26aulast%3DScheuermann%26aufirst%3DT.%2BH.%26aulast%3DLonggood%26aufirst%3DJ.%26aulast%3DKey%26aufirst%3DJ.%26aulast%3DNaidoo%26aufirst%3DJ.%26aulast%3DMelito%26aufirst%3DL.%26aulast%3DShokri%26aufirst%3DC.%26aulast%3DFrantz%26aufirst%3DD.%2BE.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26aulast%3DMacMillan%26aufirst%3DJ.%2BB.%26aulast%3DTambar%26aufirst%3DU.%2BK.%26atitle%3DDevelopment%2520of%2520inhibitors%2520of%2520the%2520PAS-B%2520domain%2520of%2520the%2520HIF-2%25CE%25B1%2520transcription%2520factor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1739%26epage%3D1747%26doi%3D10.1021%2Fjm301847z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogné, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masereel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors: Bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3230</span>– <span class="NLM_lpage">3237</span>, <span class="refDoi"> DOI: 10.1021/jm800121c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800121c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3230-3237&author=K.+D%E2%80%99Ambrosioauthor=R.+M.+Vitaleauthor=J.+M.+Dogn%C3%A9author=B.+Masereelauthor=A.+Innocentiauthor=A.+Scozzafavaauthor=G.+De+Simoneauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors%3A+Bioreductive+nitro-containing+sulfonamides+with+selectivity+for+targeting+the+tumor+associated+isoforms+IX+and+XII&doi=10.1021%2Fjm800121c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm800121c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800121c%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DVitale%26aufirst%3DR.%2BM.%26aulast%3DDogn%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DInnocenti%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors%253A%2520Bioreductive%2520nitro-containing%2520sulfonamides%2520with%2520selectivity%2520for%2520targeting%2520the%2520tumor%2520associated%2520isoforms%2520IX%2520and%2520XII%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3230%26epage%3D3237%26doi%3D10.1021%2Fjm800121c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gbaj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luke, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryce, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, S.</span></span> <span> </span><span class="NLM_article-title">Aminoimidazolylmethyluracil analogues as potent inhibitors of thymidine phosphorylase and their bioreductive nitroimidazolyl prodrugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1021/jm049494r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049494r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=392-402&author=P.+Reiganauthor=P.+N.+Edwardsauthor=A.+Gbajauthor=C.+Coleauthor=S.+T.+Barryauthor=K.+M.+Pageauthor=S.+E.+Ashtonauthor=R.+W.+Lukeauthor=K.+T.+Douglasauthor=I.+J.+Stratfordauthor=M.+Jaffarauthor=R.+A.+Bryceauthor=S.+Freeman&title=Aminoimidazolylmethyluracil+analogues+as+potent+inhibitors+of+thymidine+phosphorylase+and+their+bioreductive+nitroimidazolyl+prodrugs&doi=10.1021%2Fjm049494r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm049494r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049494r%26sid%3Dliteratum%253Aachs%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DEdwards%26aufirst%3DP.%2BN.%26aulast%3DGbaj%26aufirst%3DA.%26aulast%3DCole%26aufirst%3DC.%26aulast%3DBarry%26aufirst%3DS.%2BT.%26aulast%3DPage%26aufirst%3DK.%2BM.%26aulast%3DAshton%26aufirst%3DS.%2BE.%26aulast%3DLuke%26aufirst%3DR.%2BW.%26aulast%3DDouglas%26aufirst%3DK.%2BT.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DJaffar%26aufirst%3DM.%26aulast%3DBryce%26aufirst%3DR.%2BA.%26aulast%3DFreeman%26aufirst%3DS.%26atitle%3DAminoimidazolylmethyluracil%2520analogues%2520as%2520potent%2520inhibitors%2520of%2520thymidine%2520phosphorylase%2520and%2520their%2520bioreductive%2520nitroimidazolyl%2520prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D392%26epage%3D402%26doi%3D10.1021%2Fjm049494r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of vandetanib derivatives containing nitroimidazole groups as tyrosine kinase inhibitors in normoxia and hypoxia</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">E1693</span>, <span class="refDoi"> DOI: 10.3390/molecules21121693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.3390%2Fmolecules21121693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27983649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlyqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=E1693&author=H.+Weiauthor=D.+Liauthor=X.+Yangauthor=H.+Shangauthor=S.+Fanauthor=Y.+Liauthor=D.+Song&title=Design+and+synthesis+of+vandetanib+derivatives+containing+nitroimidazole+groups+as+tyrosine+kinase+inhibitors+in+normoxia+and+hypoxia&doi=10.3390%2Fmolecules21121693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of vandetanib derivatives containing nitroimidazole groups as tyrosine kinase inhibitors in normoxia and hypoxia</span></div><div class="casAuthors">Wei, Huiqiang; Li, Deguan; Yang, Xiangbo; Shang, Haihua; Fan, Saijun; Li, Yiliang; Song, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1693/1-1693/15</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Sixteen novel epidermal growth factor receptor (EGFR)/vascular endothelial growth factor (VEGF)-2 inhibitors (nitroimidazole-substituted 4-anilinoquinazoline derivs.) I (R1 = H, CH3, NO2; R2 = H, NO2; X1 = H, F, Cl; X2 = H, F, Br, Cl; X3 = H, Br, F, Me, Cl; n = 1, 2, 3) were designed and prepd. via the introduction of a nitroimidazole group in the piperidine side chain and modification on the aniline moiety of vandetanib.  Preliminary biol. tests showed that comparing with vandetanib, some target compds. exhibited excellent EGFR inhibitory activities and anti-proliferative over A549/H446 cells in hypoxia.  Meanwhile, several of the above compds. demonstrated better bioactivity than vandetanib in VEGF gene expression inhibition.  Owing to the excellent IC50 value (1.64 μmol/L), the inhibition ratios of compd. I (R1 = H; R2 = NO2; X1 = F; X2 = H; X3 = Br; n = 1) over A549 and H446 cells were 62.01% and 59.86% at the concn. of 0.5 μM in hypoxia, resp.  All of these results indicated that compd. I (R1 = H; R2 = NO2; X1 = F; X2 = H; X3 = Br; n = 1) was a potential cancer therapeutic agent in hypoxia and was worthy of further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqObmsFvFJ3brVg90H21EOLACvtfcHk0limZvdMvxG9Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlyqu78%253D&md5=7368e8eea0a47483aad51f539e758ca3</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21121693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21121693%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShang%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520vandetanib%2520derivatives%2520containing%2520nitroimidazole%2520groups%2520as%2520tyrosine%2520kinase%2520inhibitors%2520in%2520normoxia%2520and%2520hypoxia%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3DE1693%26doi%3D10.3390%2Fmolecules21121693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dzierzbicka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kołodziejczyk, A.
M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antitumor activity of conjugates of muramyldipeptide or normuramyldipeptide with hydroxyacridine/acridone derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1021/jm020991m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020991m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=183-189&author=K.+Dzierzbickaauthor=A.%0AM.+Ko%C5%82odziejczyk&title=Synthesis+and+antitumor+activity+of+conjugates+of+muramyldipeptide+or+normuramyldipeptide+with+hydroxyacridine%2Facridone+derivatives&doi=10.1021%2Fjm020991m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm020991m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020991m%26sid%3Dliteratum%253Aachs%26aulast%3DDzierzbicka%26aufirst%3DK.%26aulast%3DKo%25C5%2582odziejczyk%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520and%2520antitumor%2520activity%2520of%2520conjugates%2520of%2520muramyldipeptide%2520or%2520normuramyldipeptide%2520with%2520hydroxyacridine%252Facridone%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D183%26epage%3D189%26doi%3D10.1021%2Fjm020991m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cholody, W.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosakowska-Cholody, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hariprakasha, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michejda, C. J.</span></span> <span> </span><span class="NLM_article-title">A new synthetic agent with potent but selective cytotoxic activity against cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4474</span>– <span class="NLM_lpage">4481</span>, <span class="refDoi"> DOI: 10.1021/jm048946x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm048946x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4474-4481&author=W.%0AM.+Cholodyauthor=T.+Kosakowska-Cholodyauthor=M.+G.+Hollingsheadauthor=H.+K.+Hariprakashaauthor=C.+J.+Michejda&title=A+new+synthetic+agent+with+potent+but+selective+cytotoxic+activity+against+cancer&doi=10.1021%2Fjm048946x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm048946x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm048946x%26sid%3Dliteratum%253Aachs%26aulast%3DCholody%26aufirst%3DW.%2BM.%26aulast%3DKosakowska-Cholody%26aufirst%3DT.%26aulast%3DHollingshead%26aufirst%3DM.%2BG.%26aulast%3DHariprakasha%26aufirst%3DH.%2BK.%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26atitle%3DA%2520new%2520synthetic%2520agent%2520with%2520potent%2520but%2520selective%2520cytotoxic%2520activity%2520against%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4474%26epage%3D4481%26doi%3D10.1021%2Fjm048946x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosakowska-Cholody, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cholody, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monks, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woynarowska, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michejda, C. J.</span></span> <span> </span><span class="NLM_article-title">WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1617</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-05-0170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1158%2F1535-7163.MCT-05-0170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=16227412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWhtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=1617-1627&author=T.+Kosakowska-Cholodyauthor=W.+M.+Cholodyauthor=A.+Monksauthor=B.+A.+Woynarowskaauthor=C.+J.+Michejda&title=WMC-79%2C+a+potent+agent+against+colon+cancers%2C+induces+apoptosis+through+a+p53-dependent+pathway&doi=10.1158%2F1535-7163.MCT-05-0170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway</span></div><div class="casAuthors">Kosakowska-Cholody, Teresa; Cholody, W. Marek; Monks, Anne; Woynarowska, Barbara A.; Michejda, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1617-1627</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">WMC-79 is a synthetic agent with potent activity against colon and hematopoietic tumors.  In vitro, the agent is most potent against colon cancer cells that carry the wild-type p53 tumor suppressor gene (HCT-116 and RKO cells: GI50 < 1 nmol/L, LC50 ∼ 40 nmol/L).  Growth arrest of HCT-116 and RKO cells occurs at the G1 and G2-M check points at sublethal concns. (10 nmol/L) but the entire cell population was killed at 100 nmol/L.  WMC-79 is localized to the nucleus where it binds to DNA.  We hypothesized that WMC-79 binding to DNA is recognized as an unrepairable damage in the tumor cells, which results in p53 activation.  This triggers transcriptional up-regulation of p53-dependent genes involved in replication, cell cycle progression, growth arrest, and apoptosis as evidenced by DNA microarrays.  The change in the transcriptional profile of HCT-116 cells is followed by a change in the levels of cell cycle regulatory proteins and apoptosis.  The recruitment of the p53-dependent apoptosis pathway was suggested by the up-regulation of p53, p21, Bax, DR-4, DR-5, and p53 phosphorylated on Ser15; down-regulation of Bcl-2; and activation of caspase-8, -9, -7, and -3 in cells treated with 100 nmol/L WMC-79.  Apoptosis was also evident from the flow cytometric studies of drug-treated HCT-116 cells as well as from the appearance of nuclear fragmentation.  However, whereas this pathway is important in wild-type p53 colon tumors, other pathways are also in operation because colon cancer cell lines in which the p53 gene is mutated are also affected by higher concns. of WMC-79.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwNiXJC_mixLVg90H21EOLACvtfcHk0lhIYtgKMaP82w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWhtLnE&md5=028cd1a31681063eed35ee1bebf45491</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0170%26sid%3Dliteratum%253Aachs%26aulast%3DKosakowska-Cholody%26aufirst%3DT.%26aulast%3DCholody%26aufirst%3DW.%2BM.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DWoynarowska%26aufirst%3DB.%2BA.%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26atitle%3DWMC-79%252C%2520a%2520potent%2520agent%2520against%2520colon%2520cancers%252C%2520induces%2520apoptosis%2520through%2520a%2520p53-dependent%2520pathway%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D1617%26epage%3D1627%26doi%3D10.1158%2F1535-7163.MCT-05-0170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hariprakasha, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosakowska-Cholody, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cholody, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinson, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarasova, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michejda, C. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of naphthalimide-imidazoacridone with potent antitumor activity leading to clinical candidate (HKH40A, RTA 502)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5557</span>– <span class="NLM_lpage">5560</span>, <span class="refDoi"> DOI: 10.1021/jm7009777</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009777" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5557-5560&author=H.+K.+Hariprakashaauthor=T.+Kosakowska-Cholodyauthor=C.+Meyerauthor=W.+M.+Cholodyauthor=S.+F.+Stinsonauthor=N.+I.+Tarasovaauthor=C.+J.+Michejda&title=Optimization+of+naphthalimide-imidazoacridone+with+potent+antitumor+activity+leading+to+clinical+candidate+%28HKH40A%2C+RTA+502%29&doi=10.1021%2Fjm7009777"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fjm7009777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009777%26sid%3Dliteratum%253Aachs%26aulast%3DHariprakasha%26aufirst%3DH.%2BK.%26aulast%3DKosakowska-Cholody%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DC.%26aulast%3DCholody%26aufirst%3DW.%2BM.%26aulast%3DStinson%26aufirst%3DS.%2BF.%26aulast%3DTarasova%26aufirst%3DN.%2BI.%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26atitle%3DOptimization%2520of%2520naphthalimide-imidazoacridone%2520with%2520potent%2520antitumor%2520activity%2520leading%2520to%2520clinical%2520candidate%2520%2528HKH40A%252C%2520RTA%2520502%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5557%26epage%3D5560%26doi%3D10.1021%2Fjm7009777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motonishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span> <span> </span><span class="NLM_article-title">Novel flavonoids with antiproliferative activities against breast cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4339</span>– <span class="NLM_lpage">4349</span>, <span class="refDoi"> DOI: 10.1021/jm101440r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101440r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1agtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4339-4349&author=N.+Yaoauthor=C.+Y.+Chenauthor=C.+Y.+Wuauthor=K.+Motonishiauthor=H.+J.+Kungauthor=K.+S.+Lam&title=Novel+flavonoids+with+antiproliferative+activities+against+breast+cancer+cells&doi=10.1021%2Fjm101440r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Novel flavonoids with antiproliferative activities against breast cancer cells</span></div><div class="casAuthors">Yao, Nianhuan; Chen, Chao-Yu; Wu, Chun-Yi; Motonishi, Kiyomi; Kung, Hsing-Jien; Lam, Kit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4339-4349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of flavone analogs were synthesized and evaluated for their antiproliferation activity against breast cancer cells.  The IC50 of compd. I and II were detd. to be at 5 μM.  These compds. were used as baits to screen breast cancer cDNA expression phage display proteome library.  DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for I and II.  Further optimization of these compds. led to the discovery of III with higher cytotoxic potency (IC50 = 1 μM) and binding to eEF1A2.  Biol. and biochem. data suggest that eEF1A2 might be a therapeutic target and that III is an excellent lead compd. for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_V-2ccXMkEbVg90H21EOLACvtfcHk0lhIYtgKMaP82w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1agtb4%253D&md5=7d674a8ab06c5decfd61270c37f47536</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fjm101440r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101440r%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DMotonishi%26aufirst%3DK.%26aulast%3DKung%26aufirst%3DH.%2BJ.%26aulast%3DLam%26aufirst%3DK.%2BS.%26atitle%3DNovel%2520flavonoids%2520with%2520antiproliferative%2520activities%2520against%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4339%26epage%3D4349%26doi%3D10.1021%2Fjm101440r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amtmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulinoux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gromer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davioud-Charvet, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7024</span>– <span class="NLM_lpage">7039</span>, <span class="refDoi"> DOI: 10.1021/jm050256l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050256l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOisbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7024-7039&author=R.+Milletauthor=S.+Urigauthor=J.+Jacobauthor=E.+Amtmannauthor=J.+P.+Moulinouxauthor=S.+Gromerauthor=K.+Beckerauthor=E.+Davioud-Charvet&title=Synthesis+of+5-nitro-2-furancarbohydrazides+and+their+cis-diamminedichloroplatinum+complexes+as+bitopic+and+irreversible+human+thioredoxin+reductase+inhibitors&doi=10.1021%2Fjm050256l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 5-Nitro-2-furancarbohydrazides and Their cis-Diamminedichloroplatinum Complexes as Bitopic and Irreversible Human Thioredoxin Reductase Inhibitors</span></div><div class="casAuthors">Millet, Regis; Urig, Sabine; Jacob, Judit; Amtmann, Eberhard; Moulinoux, Jacques-Philippe; Gromer, Stephan; Becker, Katja; Davioud-Charvet, Elisabeth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7024-7039</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The human selenoprotein thioredoxin reductase is involved in antioxidant defense and DNA synthesis.  As increased thioredoxin reductase levels are assocd. with drug sensitivity to cisplatin and drug resistance in tumor cells, this enzyme represents a promising target for the development of cytostatic agents.  To optimize the potential of the widely used cisplatin to inhibit the human thioredoxin reductase and therefore to overcome cisplatin resistance, the authors developed and synthesized four cis-diamminedichloroplatinum complexes of the lead 5-nitro-2-furancarbohydrazide (I) selected from high-throughput screening.  Detailed kinetics revealed that the isolated fragments, 5-nitro-2-furancarbohydrazide and cisplatin itself, bind with micromolar affinities at two different subsites of the human enzyme.  By tethering both fragments four nitrofuran-based cis-diamminedichloroplatinum complexes were synthesized and identified as biligand irreversible inhibitors of the human enzyme with nanomolar affinities.  Studies with mutant enzymes clearly demonstrate the penultimate selenocysteine residue as the prime target of the synthesized cis-diamminedichloroplatinum complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLrIL2NMZIu7Vg90H21EOLACvtfcHk0lglOx8JOyA2jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOisbbJ&md5=82553e697d0fbf88be7b02a65e25b4dc</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fjm050256l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050256l%26sid%3Dliteratum%253Aachs%26aulast%3DMillet%26aufirst%3DR.%26aulast%3DUrig%26aufirst%3DS.%26aulast%3DJacob%26aufirst%3DJ.%26aulast%3DAmtmann%26aufirst%3DE.%26aulast%3DMoulinoux%26aufirst%3DJ.%2BP.%26aulast%3DGromer%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DDavioud-Charvet%26aufirst%3DE.%26atitle%3DSynthesis%2520of%25205-nitro-2-furancarbohydrazides%2520and%2520their%2520cis-diamminedichloroplatinum%2520complexes%2520as%2520bitopic%2520and%2520irreversible%2520human%2520thioredoxin%2520reductase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7024%26epage%3D7039%26doi%3D10.1021%2Fjm050256l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malachowska-Ugarte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cholewinski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierzbicka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzonkowski, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of novel mycophenolic acid conjugates containing nitro-acridine/acridone derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2012.04.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2012&pages=197-201&author=M.+Malachowska-Ugarteauthor=G.+Cholewinskiauthor=K.+Dzierzbickaauthor=P.+Trzonkowski&title=Synthesis+and+biological+activity+of+novel+mycophenolic+acid+conjugates+containing+nitro-acridine%2Facridone+derivatives&doi=10.1016%2Fj.ejmech.2012.04.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DMalachowska-Ugarte%26aufirst%3DM.%26aulast%3DCholewinski%26aufirst%3DG.%26aulast%3DDzierzbicka%26aufirst%3DK.%26aulast%3DTrzonkowski%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520novel%2520mycophenolic%2520acid%2520conjugates%2520containing%2520nitro-acridine%252Facridone%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D54%26spage%3D197%26epage%3D201%26doi%3D10.1016%2Fj.ejmech.2012.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloonan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keating, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meegan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and serotonin transporter activity of 1,3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1328</span>– <span class="NLM_lpage">1348</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.11.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2010.11.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1328-1348&author=Y.+M.+McNamaraauthor=S.+M.+Cloonanauthor=A.+J.+Knoxauthor=J.+J.+Keatingauthor=S.+G.+Butlerauthor=G.+H.+Petersauthor=M.+J.+Meeganauthor=D.+C.+Williams&title=Synthesis+and+serotonin+transporter+activity+of+1%2C3-bis%28aryl%29-2-nitro-1-propenes+as+a+new+class+of+anticancer+agents&doi=10.1016%2Fj.bmc.2010.11.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.11.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.11.054%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamara%26aufirst%3DY.%2BM.%26aulast%3DCloonan%26aufirst%3DS.%2BM.%26aulast%3DKnox%26aufirst%3DA.%2BJ.%26aulast%3DKeating%26aufirst%3DJ.%2BJ.%26aulast%3DButler%26aufirst%3DS.%2BG.%26aulast%3DPeters%26aufirst%3DG.%2BH.%26aulast%3DMeegan%26aufirst%3DM.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BC.%26atitle%3DSynthesis%2520and%2520serotonin%2520transporter%2520activity%2520of%25201%252C3-bis%2528aryl%2529-2-nitro-1-propenes%2520as%2520a%2520new%2520class%2520of%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1328%26epage%3D1348%26doi%3D10.1016%2Fj.bmc.2010.11.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sosič, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirković, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefane, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Development of new cathepsin b inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1021/jm301544x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301544x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=521-533&author=I.+Sosi%C4%8Dauthor=B.+Mirkovi%C4%87author=K.+Arenzauthor=B.+Stefaneauthor=J.+Kosauthor=S.+Gobec&title=Development+of+new+cathepsin+b+inhibitors%3A+combining+bioisosteric+replacements+and+structure-based+design+to+explore+the+structure-activity+relationships+of+nitroxoline+derivatives&doi=10.1021%2Fjm301544x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm301544x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301544x%26sid%3Dliteratum%253Aachs%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3DMirkovi%25C4%2587%26aufirst%3DB.%26aulast%3DArenz%26aufirst%3DK.%26aulast%3DStefane%26aufirst%3DB.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520new%2520cathepsin%2520b%2520inhibitors%253A%2520combining%2520bioisosteric%2520replacements%2520and%2520structure-based%2520design%2520to%2520explore%2520the%2520structure-activity%2520relationships%2520of%2520nitroxoline%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D521%26epage%3D533%26doi%3D10.1021%2Fjm301544x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Csuk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siewert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutnov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidelmann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendisch, V.</span></span> <span> </span><span class="NLM_article-title">β-Nitro substituted carboxylic acids and their cytotoxicity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4011</span>– <span class="NLM_lpage">4013</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2014.06.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4011-4013&author=R.+Csukauthor=L.+Hellerauthor=B.+Siewertauthor=A.+Gutnovauthor=O.+Seidelmannauthor=V.+Wendisch&title=%CE%B2-Nitro+substituted+carboxylic+acids+and+their+cytotoxicity&doi=10.1016%2Fj.bmcl.2014.06.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DCsuk%26aufirst%3DR.%26aulast%3DHeller%26aufirst%3DL.%26aulast%3DSiewert%26aufirst%3DB.%26aulast%3DGutnov%26aufirst%3DA.%26aulast%3DSeidelmann%26aufirst%3DO.%26aulast%3DWendisch%26aufirst%3DV.%26atitle%3D%25CE%25B2-Nitro%2520substituted%2520carboxylic%2520acids%2520and%2520their%2520cytotoxicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4011%26epage%3D4013%26doi%3D10.1016%2Fj.bmcl.2014.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-cheromene derivatives as histone deacetylaes inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4123</span>– <span class="NLM_lpage">4132</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2017.05.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=4123-4132&author=S.+Tanauthor=F.+Heauthor=T.+Kongauthor=J.+Wuauthor=Z.+Liu&title=Design%2C+synthesis+and+tumor+cell+growth+inhibitory+activity+of+3-nitro-2H-cheromene+derivatives+as+histone+deacetylaes+inhibitors&doi=10.1016%2Fj.bmc.2017.05.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520tumor%2520cell%2520growth%2520inhibitory%2520activity%2520of%25203-nitro-2H-cheromene%2520derivatives%2520as%2520histone%2520deacetylaes%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D4123%26epage%3D4132%26doi%3D10.1016%2Fj.bmc.2017.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makawana, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teraiya, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and molecular modeling of novel 1-indolyl acetate 5-nitroimidazole targeting tubulin polymerization as antiproliferative agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2014.07.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=341-351&author=Y.+Duanauthor=Y.+L.+Sangauthor=J.+A.+Makawanaauthor=S.+B.+Teraiyaauthor=Y.+F.+Yaoauthor=D.+J.+Tangauthor=X.+X.+Taoauthor=H.+L.+Zhu&title=Discovery+and+molecular+modeling+of+novel+1-indolyl+acetate+5-nitroimidazole+targeting+tubulin+polymerization+as+antiproliferative+agents&doi=10.1016%2Fj.ejmech.2014.07.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.082%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DSang%26aufirst%3DY.%2BL.%26aulast%3DMakawana%26aufirst%3DJ.%2BA.%26aulast%3DTeraiya%26aufirst%3DS.%2BB.%26aulast%3DYao%26aufirst%3DY.%2BF.%26aulast%3DTang%26aufirst%3DD.%2BJ.%26aulast%3DTao%26aufirst%3DX.%2BX.%26aulast%3DZhu%26aufirst%3DH.%2BL.%26atitle%3DDiscovery%2520and%2520molecular%2520modeling%2520of%2520novel%25201-indolyl%2520acetate%25205-nitroimidazole%2520targeting%2520tubulin%2520polymerization%2520as%2520antiproliferative%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D341%26epage%3D351%26doi%3D10.1016%2Fj.ejmech.2014.07.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Placzek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Nitrated indenoisoquinolines as topoisomerase I inhibitors: A systematic study and optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4419</span>– <span class="NLM_lpage">4430</span>, <span class="refDoi"> DOI: 10.1021/jm070361q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070361q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4419-4430&author=A.+Morrellauthor=M.+Placzekauthor=S.+Parmleyauthor=S.+Antonyauthor=T.+S.+Dexheimerauthor=Y.+Pommierauthor=M.+Cushman&title=Nitrated+indenoisoquinolines+as+topoisomerase+I+inhibitors%3A+A+systematic+study+and+optimization&doi=10.1021%2Fjm070361q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fjm070361q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070361q%26sid%3Dliteratum%253Aachs%26aulast%3DMorrell%26aufirst%3DA.%26aulast%3DPlaczek%26aufirst%3DM.%26aulast%3DParmley%26aufirst%3DS.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DNitrated%2520indenoisoquinolines%2520as%2520topoisomerase%2520I%2520inhibitors%253A%2520A%2520systematic%2520study%2520and%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4419%26epage%3D4430%26doi%3D10.1021%2Fjm070361q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis, reduction potentials, and antitubercular activity of ring A/B analogues of the bioreductive drug (6<i>S</i>)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">645</span>, <span class="refDoi"> DOI: 10.1021/jm801087e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801087e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFais7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=637-645&author=A.+M.+Thompsonauthor=A.+Blaserauthor=R.+F.+Andersonauthor=S.+S.+Shindeauthor=S.+G.+Franzblauauthor=Z.+Maauthor=W.+A.+Dennyauthor=B.+D.+Palmer&title=Synthesis%2C+reduction+potentials%2C+and+antitubercular+activity+of+ring+A%2FB+analogues+of+the+bioreductive+drug+%286S%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm801087e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Reduction Potentials, and Antitubercular Activity of Ring A/B Analogues of the Bioreductive Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span></div><div class="casAuthors">Thompson, Andrew M.; Blaser, Adrian; Anderson, Robert F.; Shinde, Sujata S.; Franzblau, Scott G.; Ma, Zhenkun; Denny, William A.; Palmer, Brian D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">637-645</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nitroimidazooxazine I (PA-824) is a new class of bioreductive drug for tuberculosis.  A series of related bicyclic nitroheterocycles was synthesized, designed to have a wide range of one-electron redn. potentials E(1) (from -570 to -338 mV, compared with -534 mV for I).  The obsd. E(1) values closely correlated with the σm values of the heteroatom at the 4/8-position of the adjacent six-membered ring.  Although the compds. spanned a range of E(1) values around that of I, only the nitroimidazothiazines showed significant antitubercular activity (at a similar level of potency), suggesting that E(1) is not the main driver of efficacy.  Furthermore, there was a correlation between activity and the formation of imidazole ring-reduced products at the two-electron level, pointing to the potential importance of this redn. pathway, which is detd. by the nature of the substituent at the 2-position of the 4-nitroimidazole ring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoalNzH_DuAirVg90H21EOLACvtfcHk0liEXFybUp57kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFais7%252FK&md5=a9fe7edce4c538f14ddec49942a1e9a0</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fjm801087e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801087e%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26aulast%3DShinde%26aufirst%3DS.%2BS.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26atitle%3DSynthesis%252C%2520reduction%2520potentials%252C%2520and%2520antitubercular%2520activity%2520of%2520ring%2520A%252FB%2520analogues%2520of%2520the%2520bioreductive%2520drug%2520%25286S%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D637%26epage%3D645%26doi%3D10.1021%2Fjm801087e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6s)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1021/jm901207n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901207n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKhs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=282-294&author=B.+D.+Palmerauthor=A.+W.+Thompsonauthor=H.+S.+Sutherlandauthor=A.+Blaserauthor=I.+Kmentovaauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Denny&title=Synthesis+and+structure-activity+studies+of+biphenyl+analogues+of+the+tuberculosis+drug+%286s%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm901207n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span></div><div class="casAuthors">Palmer, Brian D.; Thompson, Andrew M.; Sutherland, Hamish S.; Blaser, Adrian; Kmentova, Iveta; Franzblau, Scott G.; Wan, Baojie; Wang, Yuehong; Ma, Zhenkun; Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">282-294</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of biphenyl analogs of the new tuberculosis drug PA-824 e. g. , I was prepd., primarily by coupling the known (6S)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-ol with iodobenzyl halides, followed by Suzuki coupling of these iodides with appropriate arylboronic acids or by assembly of the complete biaryl side chain prior to coupling with the above alc.  Antitubercular activity was detd. under both replicating (MABA) and nonreplicating (LORA) conditions.  Para-Linked biaryls were the most active, followed by meta-linked and then ortho-linked analogs.  A more detailed study of a larger group of para-linked analogs showed a significant correlation between potency (MABA) and both lipophilicity (CLOGP) and the electron-withdrawing properties of terminal ring substituents (.sum.σ).  Selected compds. were evaluated for their efficacy in a mouse model of acute Mycobacterium tuberculosis infection.  In vivo activity correlated well with the stability of compds. to microsomal metab.  Three compds. bearing combinations of lipophilic, electron-withdrawing groups achieved >200-fold higher efficacies than the parent drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5IcLLHAUDWbVg90H21EOLACvtfcHk0liEXFybUp57kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKhs7rL&md5=1ff5a8bd11f095f428898ec13f884259</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm901207n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901207n%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BW.%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520studies%2520of%2520biphenyl%2520analogues%2520of%2520the%2520tuberculosis%2520drug%2520%25286s%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D282%26epage%3D294%26doi%3D10.1021%2Fjm901207n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chains</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1021/jm901378u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901378u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=855-866&author=H.+S.+Sutherlandauthor=A.+Blaserauthor=I.+Kmentovaauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=B.+D.+Palmerauthor=W.+D.+Dennyauthor=A.+M.+Thompson&title=Synthesis+and+structure-activity+relationships+of+antitubercular+2-nitroimidazooxazines+bearing+heterocyclic+side+chains&doi=10.1021%2Fjm901378u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-activity Relationships of Antitubercular 2-Nitroimidazooxazines Bearing Heterocyclic Side Chains</span></div><div class="casAuthors">Sutherland, Hamish S.; Blaser, Adrian; Kmentova, Iveta; Franzblau, Scott G.; Wan, Baojie; Wang, Yuehong; Ma, Zhenkun; Palmer, Brian D.; Denny, William A.; Thompson, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">855-866</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previously, biphenyl analogs of the antituberculosis drug PA-824 were found to display improved potencies against M. tuberculosis but were poorly sol.  Heterobiaryl analogs of these, e.g., I (X = 2,5-thiophenediyl, R = 4-F), in which the first Ph ring was replaced with various 5-membered ring heterocycles, were prepd. with the aim of identifying potent new candidates with improved aq. soly.  The compds. were constructed by coupling the chiral 2-nitroimidazooxazine II with various halomethyl-substituted arylheterocycles, by cycloaddns. to a propargyl ether deriv. of this alc., or by Suzuki couplings on haloheterocyclic Me ether derivs.  The arylheterocyclic compds. were all more hydrophilic than their corresponding biphenyl analogs, and several showed soly. improvements.  1-Methylpyrazole, e.g., I (X = 1-methyl-3,5-pyrazolediyl, R = 4-F3C), 1,3-linked-pyrazole, e.g., I (X = 1,3-pyrazolediyl, R = 4-F), 2,4-linked-triazole, e.g., I [X = 1,2,3-triazole-2,4-diyl, R = 4-(CF3O)] and tetrazole analogs, e.g., I (X = 2,5-tetrazolediyl, R = H) had 3- to 7-fold higher MIC potencies against replicating M. tuberculosis than predicted by their lipophilicities.  Two pyrazole analogs were >10-fold more efficacious than the parent drug in a mouse model of acute M. tuberculosis infection, and one displayed a 2-fold higher soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ42rpfkuyeLVg90H21EOLACvtfcHk0lizH7m99smagA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrrN&md5=f9b6518612795cc55e5f9b8ad784c8c6</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fjm901378u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901378u%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DDenny%26aufirst%3DW.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520antitubercular%25202-nitroimidazooxazines%2520bearing%2520heterocyclic%2520side%2520chains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D855%26epage%3D866%26doi%3D10.1021%2Fjm901378u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7- dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3036</span>– <span class="NLM_lpage">3059</span>, <span class="refDoi"> DOI: 10.1021/jm501608q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501608q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3036-3059&author=B.+D.+Palmerauthor=H.+S.+Sutherlandauthor=A.+Blaserauthor=I.+Kmentovaauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Dennyauthor=A.+M.+Thompson&title=Synthesis+and+structure-activity+relationships+for+extended+side+chain+analogues+of+the+antitubercular+drug+%286S%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-+dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm501608q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm501608q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501608q%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520for%2520extended%2520side%2520chain%2520analogues%2520of%2520the%2520antitubercular%2520drug%2520%25286S%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-%2520dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3036%26epage%3D3059%26doi%3D10.1021%2Fjm501608q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of varied ether linker analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo-[2,1-b][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6563</span>– <span class="NLM_lpage">6585</span>, <span class="refDoi"> DOI: 10.1021/jm200377r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200377r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6563-6585&author=A.+M.+Thompsonauthor=H.+S.+Sutherlandauthor=B.+D.+Palmerauthor=I.+Kmentovaauthor=A.+Blaserauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Denny&title=Synthesis+and+structure-activity+relationships+of+varied+ether+linker+analogues+of+the+antitubercular+drug+%286S%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-dihydro-5H-imidazo-%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm200377r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm200377r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200377r%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520varied%2520ether%2520linker%2520analogues%2520of%2520the%2520antitubercular%2520drug%2520%25286S%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-dihydro-5H-imidazo-%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6563%26epage%3D6585%26doi%3D10.1021%2Fjm200377r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2583</span>– <span class="NLM_lpage">2589</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2017.03.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=28462832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFekt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2583-2589&author=A.+M.+Thompsonauthor=A.+Blaserauthor=B.+D.+Palmerauthor=R.+F.+Andersonauthor=S.+S.+Shindeauthor=D.+Launayauthor=E.+Chatelainauthor=L.+Maesauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Denny&title=6-Nitro-2%2C3-dihydroimidazo%5B2%2C1-b%5D%5B1%2C3%5Dthiazoles%3A+Facile+synthesis+and+comparative+appraisal+against+tuberculosis+and+neglected+tropical+diseases&doi=10.1016%2Fj.bmcl.2017.03.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases</span></div><div class="casAuthors">Thompson, Andrew M.; Blaser, Adrian; Palmer, Brian D.; Anderson, Robert F.; Shinde, Sujata S.; Launay, Delphine; Chatelain, Eric; Maes, Louis; Franzblau, Scott G.; Wan, Baojie; Wang, Yuehong; Ma, Zhenkun; Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2583-2589</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As part of a quest for backups to the antitubercular drug pretomanid (PA-824), we investigated the unexplored 6-nitro-2,3-dihydroimidazo[2,1-b][1,3]-thiazoles and related -oxazoles.  The nitroimidazothiazoles were prepd. in high yield from 2-bromo-4-nitroimidazole via heating with substituted thiiranes and diisopropylethylamine.  Equivalent examples of these two structural classes provided broadly comparable MICs, with 2-Me substitution and extended aryloxymethyl side chains preferred; albeit, S-oxidized thiazoles were ineffective for tuberculosis.  Favorable microsomal stability data for a biaryl thiazole I led to its assessment in an acute Mycobacterium tuberculosis mouse model, alongside the corresponding oxazole II, but the latter proved to be more efficacious.  In vitro screening against kinetoplastid diseases revealed that nitroimidazothiazoles were inactive vs. leishmaniasis but showed interesting activity, superior to that of the nitroimidazooxazoles, against Chagas disease.  Overall, "thio-delamanid" III is regarded as the best lead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSWR54W1PX6LVg90H21EOLACvtfcHk0lgWUfj7kmnHFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFekt78%253D&md5=3e747b90744e9d745cd77bd92f59b79c</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.069%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26aulast%3DShinde%26aufirst%3DS.%2BS.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3D6-Nitro-2%252C3-dihydroimidazo%255B2%252C1-b%255D%255B1%252C3%255Dthiazoles%253A%2520Facile%2520synthesis%2520and%2520comparative%2520appraisal%2520against%2520tuberculosis%2520and%2520neglected%2520tropical%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2583%26epage%3D2589%26doi%3D10.1016%2Fj.bmcl.2017.03.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Antitubercular nitroimidazoles revisited: synthesis and activity of the authentic 3-nitro isomer of pretomanid</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1280</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1275-1280&author=A.+M.+Thompsonauthor=M.+Bonnetauthor=H.+H.+Leeauthor=S.+G.+Franzblauauthor=B.+Wanauthor=G.+S.+Wongauthor=C.+B.+Cooperauthor=W.+A.+Denny&title=Antitubercular+nitroimidazoles+revisited%3A+synthesis+and+activity+of+the+authentic+3-nitro+isomer+of+pretomanid&doi=10.1021%2Facsmedchemlett.7b00356"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00356%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DBonnet%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DH.%2BH.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DG.%2BS.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DAntitubercular%2520nitroimidazoles%2520revisited%253A%2520synthesis%2520and%2520activity%2520of%2520the%2520authentic%25203-nitro%2520isomer%2520of%2520pretomanid%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1275%26epage%3D1280%26doi%3D10.1021%2Facsmedchemlett.7b00356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Structure–activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1021/jm2012276</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2012276" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=312-326&author=A.+Blaserauthor=B.+D.+Palmerauthor=H.+S.+Sutherlandauthor=I.+Kmentovaauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=A.+W.+Thompsonauthor=W.+A.+Denny&title=Structure%E2%80%93activity+relationships+for+amide-%2C+carbamate-%2C+and+urea-linked+analogues+of+the+tuberculosis+drug+%286S%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm2012276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships for Amide-, Carbamate-, And Urea-Linked Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span></div><div class="casAuthors">Blaser, Adrian; Palmer, Brian D.; Sutherland, Hamish S.; Kmentova, Iveta; Franzblau, Scott G.; Wan, Baojie; Wang, Yuehong; Ma, Zhenkun; Thompson, Andrew M.; Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">312-326</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Analogs of clin. tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824, I), in which the OCH2 linkage was replaced with amide, carbamate, and urea functionality, were investigated as an alternative approach to address oxidative metab., reduce lipophilicity, and improve aq. soly.  Several sol. monoaryl examples displayed moderately improved (∼2- to 4-fold) potencies against replicating Mycobacterium tuberculosis but were generally inferior inhibitors under anaerobic (nonreplicating) conditions.  More lipophilic biaryl derivs. mostly displayed similar or reduced potencies to these in contrast to the parent biaryl series.  The leading biaryl carbamate demonstrated exceptional metabolic stability and a 5-fold better efficacy than the parent drug in a mouse model of acute M. tuberculosis infection but was poorly sol.  Bioisosteric replacement of this biaryl moiety by arylpiperazine resulted in a sol., orally bioavailable carbamate analog providing identical activity in the acute model, comparable efficacy to OPC-67683 in a chronic infection model, favorable pharmacokinetic profiles across several species, and enhanced safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogqcEH6FbwO7Vg90H21EOLACvtfcHk0lgHrnZfcR9mxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurrE&md5=b515998cf44ca9998fc3434def6f82d4</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Fjm2012276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2012276%26sid%3Dliteratum%253Aachs%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DThompson%26aufirst%3DA.%2BW.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520for%2520amide-%252C%2520carbamate-%252C%2520and%2520urea-linked%2520analogues%2520of%2520the%2520tuberculosis%2520drug%2520%25286S%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D312%26epage%3D326%26doi%3D10.1021%2Fjm2012276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayyar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niyomrattanakit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravindran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dartois, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span> <span> </span><span class="NLM_article-title">Structure–activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((S)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3] oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-Amino PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5639</span>– <span class="NLM_lpage">5659</span>, <span class="refDoi"> DOI: 10.1021/jm1010644</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1010644" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5639-5659&author=J.+Cherianauthor=I.+Choiauthor=A.+Nayyarauthor=U.+H.+Manjunathaauthor=T.+Mukherjeeauthor=Y.+S.+Leeauthor=H.+I.+Boshoffauthor=R.+Singhauthor=Y.+H.+Haauthor=M.+Goodwinauthor=S.+B.+Lakshminarayanaauthor=P.+Niyomrattanakitauthor=J.+Jiricekauthor=S.+Ravindranauthor=T.+Dickauthor=T.+H.+Kellerauthor=V.+Dartoisauthor=C.+E.+Barry&title=Structure%E2%80%93activity+relationships+of+antitubercular+nitroimidazoles.+3.+Exploration+of+the+linker+and+lipophilic+tail+of+%28%28S%29-2-nitro-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5D+oxazin-6-yl%29-%284-trifluoromethoxybenzyl%29amine+%286-Amino+PA-824%29&doi=10.1021%2Fjm1010644"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm1010644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1010644%26sid%3Dliteratum%253Aachs%26aulast%3DCherian%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DI.%26aulast%3DNayyar%26aufirst%3DA.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DMukherjee%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DHa%26aufirst%3DY.%2BH.%26aulast%3DGoodwin%26aufirst%3DM.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DNiyomrattanakit%26aufirst%3DP.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DRavindran%26aufirst%3DS.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520antitubercular%2520nitroimidazoles.%25203.%2520Exploration%2520of%2520the%2520linker%2520and%2520lipophilic%2520tail%2520of%2520%2528%2528S%2529-2-nitro-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255D%2520oxazin-6-yl%2529-%25284-trifluoromethoxybenzyl%2529amine%2520%25286-Amino%2520PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5639%26epage%3D5659%26doi%3D10.1021%2Fjm1010644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8421</span>– <span class="NLM_lpage">8439</span>, <span class="refDoi"> DOI: 10.1021/jm101288t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101288t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8421-8439&author=I.+Kmentovaauthor=H.+S.+Sutherlandauthor=B.+D.+Palmerauthor=A.+Blaserauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Dennyauthor=A.+M.+Thompson&title=Synthesis+and+structure-activity+relationships+of+aza-+and+diazabiphenyl+analogues+of+the+antitubercular+drug+%286S%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm101288t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm101288t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101288t%26sid%3Dliteratum%253Aachs%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520aza-%2520and%2520diazabiphenyl%2520analogues%2520of%2520the%2520antitubercular%2520drug%2520%25286S%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8421%26epage%3D8439%26doi%3D10.1021%2Fjm101288t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3650</span>– <span class="NLM_lpage">3653</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2015.06.060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3650-3653&author=Y.+G.+Kangauthor=C.+Y.+Parkauthor=H.+Shinauthor=R.+Singhauthor=G.+Aroraauthor=C.+M.+Yuauthor=Y.+Lee&title=Synthesis+and+anti-tubercular+activity+of+2-nitroimidazooxazines+with+modification+at+the+C-7+position+as+PA-824+analogs&doi=10.1016%2Fj.bmcl.2015.06.060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.060%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DY.%2BG.%26aulast%3DPark%26aufirst%3DC.%2BY.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DArora%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DC.%2BM.%26aulast%3DLee%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520anti-tubercular%2520activity%2520of%25202-nitroimidazooxazines%2520with%2520modification%2520at%2520the%2520C-7%2520position%2520as%2520PA-824%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3650%26epage%3D3653%26doi%3D10.1016%2Fj.bmcl.2015.06.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrieta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebolledo, J. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. K.</span></span> <span> </span><span class="NLM_article-title">Nitrotriazole- and imidazole-based amides and sulfonamides as antitubercular agents</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6828</span>– <span class="NLM_lpage">6836</span>, <span class="refDoi"> DOI: 10.1128/AAC.03644-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1128%2FAAC.03644-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=6828-6836&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=A.+Arenaauthor=F.+Arrietaauthor=J.+C.+J.+Rebolledoauthor=D.+K.+Smith&title=Nitrotriazole-+and+imidazole-based+amides+and+sulfonamides+as+antitubercular+agents&doi=10.1128%2FAAC.03644-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1128%2FAAC.03644-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03644-14%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DArena%26aufirst%3DA.%26aulast%3DArrieta%26aufirst%3DF.%26aulast%3DRebolledo%26aufirst%3DJ.%2BC.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BK.%26atitle%3DNitrotriazole-%2520and%2520imidazole-based%2520amides%2520and%2520sulfonamides%2520as%2520antitubercular%2520agents%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D6828%26epage%3D6836%26doi%3D10.1128%2FAAC.03644-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rane, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangalore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borhade, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khandare, P. K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel 4-nitropyrrole-based 1,3,4-oxadiazole derivatives as antimicrobial and anti-tubercular agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2013.09.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=49-58&author=R.+A.+Raneauthor=P.+Bangaloreauthor=S.+D.+Borhadeauthor=P.+K.+Khandare&title=Synthesis+and+evaluation+of+novel+4-nitropyrrole-based+1%2C3%2C4-oxadiazole+derivatives+as+antimicrobial+and+anti-tubercular+agents&doi=10.1016%2Fj.ejmech.2013.09.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.039%26sid%3Dliteratum%253Aachs%26aulast%3DRane%26aufirst%3DR.%2BA.%26aulast%3DBangalore%26aufirst%3DP.%26aulast%3DBorhade%26aufirst%3DS.%2BD.%26aulast%3DKhandare%26aufirst%3DP.%2BK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%25204-nitropyrrole-based%25201%252C3%252C4-oxadiazole%2520derivatives%2520as%2520antimicrobial%2520and%2520anti-tubercular%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D70%26spage%3D49%26epage%3D58%26doi%3D10.1016%2Fj.ejmech.2013.09.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rane, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naphade, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangalore, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palkar, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpoormath, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel 4-nitropyrrole-based semicarbazide and thiosemicarbazide hybrids with antimicrobial and anti-tubercular</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3079</span>– <span class="NLM_lpage">3083</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2014.05.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3079-3083&author=R.+A.+Raneauthor=S.+S.+Naphadeauthor=P.+K.+Bangaloreauthor=M.+B.+Palkarauthor=M.+S.+Shaikhauthor=R.+Karpoormath&title=Synthesis+of+novel+4-nitropyrrole-based+semicarbazide+and+thiosemicarbazide+hybrids+with+antimicrobial+and+anti-tubercular&doi=10.1016%2Fj.bmcl.2014.05.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DRane%26aufirst%3DR.%2BA.%26aulast%3DNaphade%26aufirst%3DS.%2BS.%26aulast%3DBangalore%26aufirst%3DP.%2BK.%26aulast%3DPalkar%26aufirst%3DM.%2BB.%26aulast%3DShaikh%26aufirst%3DM.%2BS.%26aulast%3DKarpoormath%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520novel%25204-nitropyrrole-based%2520semicarbazide%2520and%2520thiosemicarbazide%2520hybrids%2520with%2520antimicrobial%2520and%2520anti-tubercular%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3079%26epage%3D3083%26doi%3D10.1016%2Fj.bmcl.2014.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussaini, S. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faazil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poornachandra, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajput, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, N. J.</span></span> <span> </span><span class="NLM_article-title">Anti-tubercular agents. Part 8: Synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6842</span>– <span class="NLM_lpage">6846</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2013.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=24206766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yqsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6842-6846&author=A.+Kamalauthor=S.+M.+A.+Hussainiauthor=S.+Faazilauthor=Y.+Poornachandraauthor=G.+N.+Reddyauthor=C.+G.+Kumarauthor=V.+S.+Rajputauthor=C.+Raniauthor=R.+Sharmaauthor=I.+A.+Khanauthor=N.+J.+Babu&title=Anti-tubercular+agents.+Part+8%3A+Synthesis%2C+antibacterial+and+antitubercular+activity+of+5-nitrofuran+based+1%2C2%2C3-triazoles&doi=10.1016%2Fj.bmcl.2013.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles</span></div><div class="casAuthors">Kamal, Ahmed; Hussaini, Syed Mohammed Ali; Faazil, Shaikh; Poornachandra, Y.; Narender Reddy, G.; Kumar, C. Ganesh; Rajput, Vikrant Singh; Rani, Chitra; Sharma, Rashmi; Khan, Inshad Ali; Jagadeesh Babu, N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6842-6846</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 5-nitrofuran-triazole conjugates were synthesized and evaluated for their antimicrobial activity against both Gram-pos. and Gram-neg. bacterial strains.  All the compds. exhibited promising inhibition towards Gram-pos. pathogenic strains, while mild inhibitory effects were obsd. towards Gram-neg. bacterial strains.  Compds. I (R1 = OH, R2 = OMe; R1 = H, R2 =NO2; R1 = F, F2 = Cl; R1 = CF3, R2 = H; R1 = F, R2 = OMe) are most active among the series exhibiting MIC value of 1.17 μg/mL against different bacterial strains.  The bactericidal activity is found to be in accordance with the bacterial growth inhibition data.  Compd. I (R1 = F, F2 = Cl) was found to be equipotent to the std. drug Ciprofloxacin displaying MBC value of 1.17 μg/mL against the bacterial strain Bacillus subtilis.  The compds. have also demonstrated promising antibacterial activity against the resistant strain MRSA and were found to be effective inhibitors of biofilm formation.  The compd. I (R1 = H, R2 =NO2) exhibited excellent anti-biofilm activity with IC50 value as low as 0.8 μg/mL.  These conjugates were also screened for antitubercular activity against Mycobacterium tuberculosis H37Rv strain.  Compd. I (R1 = F, F2 = Cl) showed promising antitubercular activity with MIC value of 0.25 μg/mL.  Most of these compds. are less toxic to normal mammalian cells than the widely used antibacterial drug Ciprofloxacin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8V2Tje3xTfLVg90H21EOLACvtfcHk0lgjbYhdURPhPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yqsLvM&md5=db5f25edbca83b237d335e1833fee991</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DHussaini%26aufirst%3DS.%2BM.%2BA.%26aulast%3DFaazil%26aufirst%3DS.%26aulast%3DPoornachandra%26aufirst%3DY.%26aulast%3DReddy%26aufirst%3DG.%2BN.%26aulast%3DKumar%26aufirst%3DC.%2BG.%26aulast%3DRajput%26aufirst%3DV.%2BS.%26aulast%3DRani%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26aulast%3DBabu%26aufirst%3DN.%2BJ.%26atitle%3DAnti-tubercular%2520agents.%2520Part%25208%253A%2520Synthesis%252C%2520antibacterial%2520and%2520antitubercular%2520activity%2520of%25205-nitrofuran%2520based%25201%252C2%252C3-triazoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6842%26epage%3D6846%26doi%3D10.1016%2Fj.bmcl.2013.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tangallapally, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yendapally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hevener, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaerts, A. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5276</span>– <span class="NLM_lpage">5283</span>, <span class="refDoi"> DOI: 10.1021/jm049972y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049972y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5276-5283&author=R.+P.+Tangallapallyauthor=R.+Yendapallyauthor=R.+E.+Leeauthor=K.+Hevenerauthor=V.+C.+Jonesauthor=A.+J.+M.+Lenaertsauthor=M.+R.+McNeilauthor=Y.+Wangauthor=S.+Franzblauauthor=R.+E.+Lee&title=Synthesis+and+evaluation+of+nitrofuranylamides+as+novel+antituberculosis+agents&doi=10.1021%2Fjm049972y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Fjm049972y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049972y%26sid%3Dliteratum%253Aachs%26aulast%3DTangallapally%26aufirst%3DR.%2BP.%26aulast%3DYendapally%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DR.%2BE.%26aulast%3DHevener%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DV.%2BC.%26aulast%3DLenaerts%26aufirst%3DA.%2BJ.%2BM.%26aulast%3DMcNeil%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFranzblau%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BE.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520nitrofuranylamides%2520as%2520novel%2520antituberculosis%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5276%26epage%3D5283%26doi%3D10.1021%2Fjm049972y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karabanovich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemanová, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smutný, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Székely, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šarkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centárová, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pávková, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Čonka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Němeček, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolaříková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vejsová, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vávrová, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimešová, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabálek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pávek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikušová, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, J.</span></span> <span> </span><span class="NLM_article-title">Development of 3,5-dinitrobenzylsulfanyl-1,3,4-oxadiazoles and thiadiazoles as selective antitubercular agents active against replicating and nonreplicating Mycobacterium tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2362</span>– <span class="NLM_lpage">2380</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00608</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00608" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2362-2380&author=G.+Karabanovichauthor=J.+Zemanov%C3%A1author=T.+Smutn%C3%BDauthor=R.+Sz%C3%A9kelyauthor=M.+%C5%A0arkanauthor=I.+Cent%C3%A1rov%C3%A1author=A.+Vocatauthor=I.+P%C3%A1vkov%C3%A1author=P.+%C4%8Conkaauthor=J.+N%C4%9Bme%C4%8Dekauthor=J.+Stola%C5%99%C3%ADkov%C3%A1author=M.+Vejsov%C3%A1author=K.+V%C3%A1vrov%C3%A1author=V.+Klime%C5%A1ov%C3%A1author=A.+Hrab%C3%A1lekauthor=P.+P%C3%A1vekauthor=S.+T.+Coleauthor=K.+Miku%C5%A1ov%C3%A1author=J.+Roh&title=Development+of+3%2C5-dinitrobenzylsulfanyl-1%2C3%2C4-oxadiazoles+and+thiadiazoles+as+selective+antitubercular+agents+active+against+replicating+and+nonreplicating+Mycobacterium+tuberculosis&doi=10.1021%2Facs.jmedchem.5b00608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis</span></div><div class="casAuthors">Karabanovich, Galina; Zemanova, Julia; Smutny, Tomas; Szekely, Rita; Sarkan, Michal; Centarova, Ivana; Vocat, Anthony; Pavkova, Ivona; Conka, Patrik; Nemecek, Jan; Stolarikova, Jirina; Vejsova, Marcela; Vavrova, Katerina; Klimesova, Vera; Hrabalek, Alexandr; Pavek, Petr; Cole, Stewart T.; Mikusova, Katarina; Roh, Jaroslav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2362-2380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we report the discovery and structure-activity relationships of 5-substituted-2-[(3,5-dinitrobenzyl)sulfanyl]-1,3,4-oxadiazoles and 1,3,4-thiadiazoles as a new class of antituberculosis agents.  The majority of these compds. exhibited outstanding in vitro activity against Mycobacterium tuberculosis CNCTC My 331/88 and six multidrug-resistant clin. isolated strains of M. tuberculosis, with min. inhibitory concn. values as low as 0.03 μM (0.011-0.026 μg/mL).  The investigated compds. had a highly selective antimycobacterial effect because they showed no activity against the other bacteria or fungi tested in this study.  Furthermore, the investigated compds. exhibited low in vitro toxicities in four proliferating mammalian cell lines and in isolated primary human hepatocytes.  Several in vitro genotoxicity assays indicated that the selected compds. have no mutagenic activity.  The oxadiazole and thiadiazole derivs. with the most favorable activity/toxicity profiles also showed potency comparable to that of rifampicin against the nonreplicating streptomycin-starved M. tuberculosis 18b-Lux strain, and therefore, these derivs., are of particular interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgBb0Hpi3vOrVg90H21EOLACvtfcHk0liDEssMA8mJiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yqt7Y%253D&md5=788b65627cfd13854c699c08ae7aa756</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00608%26sid%3Dliteratum%253Aachs%26aulast%3DKarabanovich%26aufirst%3DG.%26aulast%3DZemanov%25C3%25A1%26aufirst%3DJ.%26aulast%3DSmutn%25C3%25BD%26aufirst%3DT.%26aulast%3DSz%25C3%25A9kely%26aufirst%3DR.%26aulast%3D%25C5%25A0arkan%26aufirst%3DM.%26aulast%3DCent%25C3%25A1rov%25C3%25A1%26aufirst%3DI.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DP%25C3%25A1vkov%25C3%25A1%26aufirst%3DI.%26aulast%3D%25C4%258Conka%26aufirst%3DP.%26aulast%3DN%25C4%259Bme%25C4%258Dek%26aufirst%3DJ.%26aulast%3DStola%25C5%2599%25C3%25ADkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DVejsov%25C3%25A1%26aufirst%3DM.%26aulast%3DV%25C3%25A1vrov%25C3%25A1%26aufirst%3DK.%26aulast%3DKlime%25C5%25A1ov%25C3%25A1%26aufirst%3DV.%26aulast%3DHrab%25C3%25A1lek%26aufirst%3DA.%26aulast%3DP%25C3%25A1vek%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DMiku%25C5%25A1ov%25C3%25A1%26aufirst%3DK.%26aulast%3DRoh%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%25203%252C5-dinitrobenzylsulfanyl-1%252C3%252C4-oxadiazoles%2520and%2520thiadiazoles%2520as%2520selective%2520antitubercular%2520agents%2520active%2520against%2520replicating%2520and%2520nonreplicating%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2362%26epage%3D2380%26doi%3D10.1021%2Facs.jmedchem.5b00608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trefzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rengifo-Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinner, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, K.</span></span> <span> </span><span class="NLM_article-title">Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-<i>β</i>-D-ribose 2′-epimerase DprE1 of <i>Mycobacterium tuberculosis</i></span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">13663</span>– <span class="NLM_lpage">13665</span>, <span class="refDoi"> DOI: 10.1021/ja106357w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja106357w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=13663-13665&author=C.+Trefzerauthor=M.+Rengifo-Gonzalezauthor=M.+J.+Hinnerauthor=P.+Schneiderauthor=V.+Makarovauthor=S.+T.+Coleauthor=K.+Johnsson&title=Benzothiazinones%3A+prodrugs+that+covalently+modify+the+decaprenylphosphoryl-%CE%B2-D-ribose+2%E2%80%B2-epimerase+DprE1+of+Mycobacterium+tuberculosis&doi=10.1021%2Fja106357w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fja106357w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja106357w%26sid%3Dliteratum%253Aachs%26aulast%3DTrefzer%26aufirst%3DC.%26aulast%3DRengifo-Gonzalez%26aufirst%3DM.%26aulast%3DHinner%26aufirst%3DM.%2BJ.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DJohnsson%26aufirst%3DK.%26atitle%3DBenzothiazinones%253A%2520prodrugs%2520that%2520covalently%2520modify%2520the%2520decaprenylphosphoryl-%25CE%25B2-D-ribose%25202%25E2%2580%25B2-epimerase%2520DprE1%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D13663%26epage%3D13665%26doi%3D10.1021%2Fja106357w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karoli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuegg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möllmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Identification of antitubercular benzothiazinone compounds by ligand-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7940</span>– <span class="NLM_lpage">7944</span>, <span class="refDoi"> DOI: 10.1021/jm3008882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3008882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ghu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7940-7944&author=T.+Karoliauthor=B.+Beckerauthor=J.+Zueggauthor=U.+M%C3%B6llmannauthor=S.+Ramuauthor=J.+X.+Huangauthor=M.+A.+Cooper&title=Identification+of+antitubercular+benzothiazinone+compounds+by+ligand-based+design&doi=10.1021%2Fjm3008882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Antitubercular Benzothiazinone Compounds by Ligand-Based Design</span></div><div class="casAuthors">Karoli, Tomislav; Becker, Bernd; Zuegg, Johannes; Mollmann, Ute; Ramu, Soumya; Huang, Johnny X.; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7940-7944</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,3-Benzothiazin-4-ones (BTZs) are a novel class of TB drug candidates with potent activity against M. tuberculosis.  An in silico ligand-based model based on structure-activity data from 170 BTZ compds. was used to design a new series.  Compds. were tested against a panel of mycobacterial strains and were profiled for cytotoxicity, stability, and antiproliferative effects.  Several of the compds. showed improved activity against MDR-TB while retaining low toxicity with higher microsomal, metabolic, and plasma stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo55OwRcL9-ebVg90H21EOLACvtfcHk0liOJnFArsyiJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ghu73K&md5=8f9d6a494927943613d7cfc78b97a188</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fjm3008882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008882%26sid%3Dliteratum%253Aachs%26aulast%3DKaroli%26aufirst%3DT.%26aulast%3DBecker%26aufirst%3DB.%26aulast%3DZuegg%26aufirst%3DJ.%26aulast%3DM%25C3%25B6llmann%26aufirst%3DU.%26aulast%3DRamu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DJ.%2BX.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%2520antitubercular%2520benzothiazinone%2520compounds%2520by%2520ligand-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7940%26epage%3D7944%26doi%3D10.1021%2Fjm3008882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möllmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span> <span> </span><span class="NLM_article-title">Design and syntheses of anti-tuberculosis agents inspired by BTZ043 using a scaffold simplification strategy</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1021/ml500039g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500039g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVehtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=587-591&author=R.+Tiwariauthor=U.+M%C3%B6llmannauthor=S.+Choauthor=S.+G.+Franzblauauthor=P.+A.+Millerauthor=M.+J.+Miller&title=Design+and+syntheses+of+anti-tuberculosis+agents+inspired+by+BTZ043+using+a+scaffold+simplification+strategy&doi=10.1021%2Fml500039g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Syntheses of Anti-Tuberculosis Agents Inspired by BTZ043 Using a Scaffold Simplification Strategy</span></div><div class="casAuthors">Tiwari, Rohit; Mollmann, Ute; Cho, Sanghyun; Franzblau, Scott G.; Miller, Patricia A.; Miller, Marvin J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">587-591</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tuberculosis (TB), a disease caused by Mycobacterium tuberculosis (Mtb), is a global public health concern because of the emergence of various resistant strains.  Benzothiazin-4-ones (BTZs), represented by BTZ043, are a promising new class of agents for the treatment of tuberculosis and have been shown to kill Mtb in vitro, ex vivo, and in mouse models of TB.  Herein we report the design and syntheses of nitroarom. sulfonamide, reverse-amide, and ester classes of anti-TB agents using a scaffold simplification strategy based on BTZ043.  The presented work explores the effect of functional groups such as sulfonamides, reverse-amides, and esters that are attached to the nitroarom. rings on their anti-TB activity.  The in vitro activity of the compds. evaluated against the H37Rv strain of Mtb shows that nitroarom. sulfonamides, e.g. I, and nitrobenzoic acid esters, e.g. II, with two nitro substituents were most active and highlights the importance of the electronic character (electron deficient arom. ring) of the nitroarom. ring as a central theme in these types of nitroarom. anti-TB agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiXsl_Y9v5QrVg90H21EOLACvtfcHk0liOJnFArsyiJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVehtrg%253D&md5=138de42374225bafdca5435e9e6a0b60</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Fml500039g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500039g%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DM%25C3%25B6llmann%26aufirst%3DU.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DMiller%26aufirst%3DP.%2BA.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DDesign%2520and%2520syntheses%2520of%2520anti-tuberculosis%2520agents%2520inspired%2520by%2520BTZ043%2520using%2520a%2520scaffold%2520simplification%2520strategy%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D587%26epage%3D591%26doi%3D10.1021%2Fml500039g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraski, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krchňák, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colon-Martinez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span> <span> </span><span class="NLM_article-title">Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">3539</span>– <span class="NLM_lpage">3549</span>, <span class="refDoi"> DOI: 10.1021/ja311058q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja311058q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=3539-3549&author=R.+Tiwariauthor=G.+C.+Moraskiauthor=V.+Krch%C5%88%C3%A1kauthor=P.+A.+Millerauthor=M.+Colon-Martinezauthor=E.+Herreroauthor=A.+G.+Oliverauthor=M.+J.+Miller&title=Thiolates+chemically+induce+redox+activation+of+BTZ043+and+related+potent+nitroaromatic+anti-tuberculosis+agents&doi=10.1021%2Fja311058q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents</span></div><div class="casAuthors">Tiwari, Rohit; Moraski, Garrett C.; Krchnak, Viktor; Miller, Patricia A.; Colon-Martinez, Mariangelli; Herrero, Eliza; Oliver, Allen G.; Miller, Marvin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3539-3549</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of multidrug resistant (MDR) and extensively drug resistant (XDR) forms of tuberculosis (TB) has stimulated research efforts globally to expand the new drug pipeline.  Nitroarom. compds., including 1,3-benzothiazin-4-ones (BTZs) and related agents, are a promising new class for the treatment of TB.  Research has shown that the nitroso intermediates of BTZs that are generated in vivo cause suicide inhibition of decaprenylphosphoryl-β-d-ribose 2' oxidase (DprE1), which is responsible for cell wall arabinogalactan biosynthesis.  We have designed and synthesized novel anti-TB agents inspired from BTZs and other nitroarom. compds.  Computational studies indicated that the unsubstituted arom. carbons of BTZ043 and related nitroarom. compds. are the most electron-deficient and might be prone to nucleophilic attack.  Our chem. studies on BTZ043 and the addnl. nitroarom. compds. synthesized by us and others confirmed the postulated reactivity.  The results indicate that nucleophiles such as thiolates, cyanide, and hydride induce nonenzymic redn. of the nitro groups present in these compds. to the corresponding nitroso intermediates by addn. at the unsubstituted electron-deficient arom. carbon present in these compds.  Furthermore, we demonstrate here that these compds. are good candidates for the classical von Richter reaction.  These chem. studies offer an alternate hypothesis for the mechanism of action of nitroarom. anti-TB agents, in that the cysteine thiol(ate) or a hydride source at the active site of DprE1 may trigger the redn. of the nitro groups in a manner similar to the von Richter reaction to the nitroso intermediates, to initiate the inhibition of DprE1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEXS_ZRRGRArVg90H21EOLACvtfcHk0lj-ERoVaeUIfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D&md5=e3671cfef9ef47c15087e8299d9db64e</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fja311058q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja311058q%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DKrch%25C5%2588%25C3%25A1k%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DP.%2BA.%26aulast%3DColon-Martinez%26aufirst%3DM.%26aulast%3DHerrero%26aufirst%3DE.%26aulast%3DOliver%26aufirst%3DA.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DThiolates%2520chemically%2520induce%2520redox%2520activation%2520of%2520BTZ043%2520and%2520related%2520potent%2520nitroaromatic%2520anti-tuberculosis%2520agents%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D3539%26epage%3D3549%26doi%3D10.1021%2Fja311058q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5984</span>– <span class="NLM_lpage">5992</span>, <span class="refDoi"> DOI: 10.1021/jm800328v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800328v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5984-5992&author=Y.+Choauthor=T.+R.+Ioergerauthor=J.+C.+Sacchettini&title=Discovery+of+novel+nitrobenzothiazole+inhibitors+for+Mycobacterium+tuberculosis+ATP+phosphoribosyl+transferase+%28HisG%29+through+virtual+screening&doi=10.1021%2Fjm800328v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Nitrobenzothiazole Inhibitors for Mycobacterium tuberculosis ATP Phosphoribosyl Transferase (HisG) through Virtual Screening</span></div><div class="casAuthors">Cho, Yoonsang; Ioerger, Thomas R.; Sacchettini, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5984-5992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HisG is an ATP-phosphoribosyl transferase (ATPPRTase) that catalyzes the first step in the biosynthetic pathway for histidine.  Among the enzymes in this pathway, only HisG represents a potential drug target for tuberculosis.  Only a few inhibitors with limited potency for HisG are currently known.  To discover more potent and diverse inhibitors, virtual screening was performed.  The crystal structure of M. tuberculosis HisG has been solved and reveals a large, solvent-exposed active site with subsites for ATP and PRPP substrates.  Two docking algorithms, GOLD and FLEXX, were used to screen two large libraries, Chembridge and NCI, contg. over 500000 compds. combined.  An initial subset of top-ranked compds. were selected and assayed, and seven were found to have enzyme inhibition activity at micromolar concns.  Several of the hits contained a nitrobenzothiazole fragment, which was predicted to dock into the monophosphate-binding loop, and this binding mode was confirmed by crystallog. evidence.  A secondary screen was performed to identify compds. with similar structures.  Several of these also exhibited micromolar inhibition.  Furthermore, two of the compds. showed bacteriocidal activity in a whole-cell assay against Mycobacterium smegmatis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbgXaEKz2UCrVg90H21EOLACvtfcHk0lj-ERoVaeUIfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb3L&md5=dfec06f998fffff9c121e027616c1dbd</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Fjm800328v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800328v%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520novel%2520nitrobenzothiazole%2520inhibitors%2520for%2520Mycobacterium%2520tuberculosis%2520ATP%2520phosphoribosyl%2520transferase%2520%2528HisG%2529%2520through%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5984%26epage%3D5992%26doi%3D10.1021%2Fjm800328v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trunz, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasittichai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torreele, E.</span></span> <span> </span><span class="NLM_article-title">Novel 3-nitro-1h-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8214</span>– <span class="NLM_lpage">8223</span>, <span class="refDoi"> DOI: 10.1021/jm201215n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201215n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8214-8223&author=M.+V.+Papadopoulouauthor=B.+B.+Trunzauthor=W.+D.+Bloomerauthor=C.+McKenzieauthor=S.+R.+Wilkinsonauthor=C.+Prasittichaiauthor=R.+Brunauthor=M.+Kaiserauthor=E.+Torreele&title=Novel+3-nitro-1h-1%2C2%2C4-triazole-based+aliphatic+and+aromatic+amines+as+anti-chagasic+agents&doi=10.1021%2Fjm201215n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm201215n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201215n%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DTrunz%26aufirst%3DB.%2BB.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DMcKenzie%26aufirst%3DC.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DPrasittichai%26aufirst%3DC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DTorreele%26aufirst%3DE.%26atitle%3DNovel%25203-nitro-1h-1%252C2%252C4-triazole-based%2520aliphatic%2520and%2520aromatic%2520amines%2520as%2520anti-chagasic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8214%26epage%3D8223%26doi%3D10.1021%2Fjm201215n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioset, J. R.</span></span> <span> </span><span class="NLM_article-title">Novel 3-nitro-1h-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5554</span>– <span class="NLM_lpage">5565</span>, <span class="refDoi"> DOI: 10.1021/jm300508n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300508n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5554-5565&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=E.+Chatelainauthor=M.+Kaiserauthor=S.+R.+Wilkinsonauthor=C.+McKenzieauthor=J.+R.+Ioset&title=Novel+3-nitro-1h-1%2C2%2C4-triazole-based+amides+and+sulfonamides+as+potential+antitrypanosomal+agents&doi=10.1021%2Fjm300508n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Fjm300508n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300508n%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DMcKenzie%26aufirst%3DC.%26aulast%3DIoset%26aufirst%3DJ.%2BR.%26atitle%3DNovel%25203-nitro-1h-1%252C2%252C4-triazole-based%2520amides%2520and%2520sulfonamides%2520as%2520potential%2520antitrypanosomal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5554%26epage%3D5565%26doi%3D10.1021%2Fjm300508n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepesheva, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilera-Venegas, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioset, J. R.</span></span> <span> </span><span class="NLM_article-title">Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1307</span>– <span class="NLM_lpage">1319</span>, <span class="refDoi"> DOI: 10.1021/jm5015742</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5015742" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns12gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1307-1319&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=G.+I.+Lepeshevaauthor=H.+S.+Rosenzweigauthor=M.+Kaiserauthor=B.+A.+Aguilera-Venegasauthor=S.+R.+Wilkinsonauthor=E.+Chatelainauthor=J.+R.+Ioset&title=Novel+3-nitrotriazole-based+amides+and+carbinols+as+bifunctional+antichagasic+agents&doi=10.1021%2Fjm5015742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3-Nitrotriazole-Based Amides and Carbinols as Bifunctional Antichagasic Agents</span></div><div class="casAuthors">Papadopoulou, Maria V.; Bloomer, William D.; Lepesheva, Galina I.; Rosenzweig, Howard S.; Kaiser, Marcel; Aguilera-Venegas, Benjamin; Wilkinson, Shane R.; Chatelain, Eric; Ioset, Jean-Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1307-1319</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Nitro-1H-1,2,4-triazole-based amides with a linear, rigid core e. g., I, and 3-nitrotriazole-based fluconazole analogs e. g., II, were synthesized as dual functioning antitrypanosomal agents.  Such compds. are excellent substrates for type I nitroreductase (NTR) located in the mitochondrion of trypanosomatids and, at the same time, act as inhibitors of the sterol 14α-demethylase (T. cruzi CYP51) enzyme.  Because combination treatments against parasites are often superior to monotherapy, we believe that this emerging class of bifunctional compds. may introduce a new generation of antitrypanosomal drugs.  In the present work, the synthesis and in vitro and in vivo evaluation of such compds. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHujhVKJ6Sg7Vg90H21EOLACvtfcHk0lgt_yXwGh0rrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns12gug%253D%253D&md5=184bb84d8cee57c3ae3590bc387c6649</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Fjm5015742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5015742%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DLepesheva%26aufirst%3DG.%2BI.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DAguilera-Venegas%26aufirst%3DB.%2BA.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DIoset%26aufirst%3DJ.%2BR.%26atitle%3DNovel%25203-nitrotriazole-based%2520amides%2520and%2520carbinols%2520as%2520bifunctional%2520antichagasic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1307%26epage%3D1319%26doi%3D10.1021%2Fjm5015742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szular, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span> <span> </span><span class="NLM_article-title">Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2016.04.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=179-186&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=S.+R.+Wilkinsonauthor=J.+Szularauthor=M.+Kaiser&title=Antitrypanosomal+activity+of+5-nitro-2-aminothiazole-based+compounds&doi=10.1016%2Fj.ejmech.2016.04.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DSzular%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DM.%26atitle%3DAntitrypanosomal%2520activity%2520of%25205-nitro-2-aminothiazole-based%2520compounds%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D117%26spage%3D179%26epage%3D186%26doi%3D10.1016%2Fj.ejmech.2016.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaukel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braillard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowbray, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Assessment of a pretomanid analogue library for African trypanosomiasis: Hit-to-lead studies on 6-substituted 2-nitro-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]thiazine 8-oxides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2017.10.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=29191556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2lsr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=207-213&author=A.+M.+Thompsonauthor=A.+J.+Marshallauthor=L.+Maesauthor=N.+Yarlettauthor=C.+J.+Bacchiauthor=E.+Gaukelauthor=S.+A.+Wringauthor=D.+Launayauthor=S.+Braillardauthor=E.+Chatelainauthor=C.+E.+Mowbrayauthor=W.+A.+Denny&title=Assessment+of+a+pretomanid+analogue+library+for+African+trypanosomiasis%3A+Hit-to-lead+studies+on+6-substituted+2-nitro-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Dthiazine+8-oxides&doi=10.1016%2Fj.bmcl.2017.10.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of a pretomanid analogue library for African trypanosomiasis: Hit-to-lead studies on 6-substituted 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazine 8-oxides</span></div><div class="casAuthors">Thompson, Andrew M.; Marshall, Andrew J.; Maes, Louis; Yarlett, Nigel; Bacchi, Cyrus J.; Gaukel, Eric; Wring, Stephen A.; Launay, Delphine; Braillard, Stephanie; Chatelain, Eric; Mowbray, Charles E.; Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-213</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A 900 compd. nitroimidazole-based library derived from the authors' pretomanid backup program with TB Alliance was screened for utility against human African trypanosomiasis (HAT) by the Drugs for Neglected Diseases initiative.  Potent hits included 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazine 8-oxides, which surprisingly displayed good metabolic stability and excellent cell permeability.  Following comprehensive mouse pharmacokinetic assessments on four hits and detn. of the most active chiral form, a thiazine oxide counterpart of pretomanid (24 ((6S)-2-Nitro-6-[[4-(trifluoromethoxy)benzyl]oxy]-6,7-dihydro-5H-imidazo[2,1-6][1,3]thiazine 8-oxide)) was identified as the best lead.  With once daily oral dosing, this compd. delivered complete cures in an acute infection mouse model of HAT and increased survival times in a stage 2 model, implying the need for more prolonged CNS exposure.  In preliminary SAR findings, antitrypanosomal activity was reduced by removal of the benzylic methylene but enhanced through a phenylpyridine-based side chain, providing important direction for future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEuX9gwE1P1LVg90H21EOLACvtfcHk0lgcpsOCFK9FWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2lsr7N&md5=00573f41d0ae4882b316c5ed36199ef5</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.067%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DMarshall%26aufirst%3DA.%2BJ.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DBraillard%26aufirst%3DS.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DAssessment%2520of%2520a%2520pretomanid%2520analogue%2520library%2520for%2520African%2520trypanosomiasis%253A%2520Hit-to-lead%2520studies%2520on%25206-substituted%25202-nitro-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Dthiazine%25208-oxides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D207%26epage%3D213%26doi%3D10.1016%2Fj.bmcl.2017.10.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crozet, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasquet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rémusat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapelle, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Méo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanelle, P.</span></span> <span> </span><span class="NLM_article-title">Lowering of 5-nitroimidazole’s mutagenicity: Towards optimal antiparasitic pharmacophore</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">653</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2008.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2008.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18590939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlWjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=653-659&author=M.+D.+Crozetauthor=C.+Bottaauthor=M.+Gasquetauthor=C.+Curtiauthor=V.+R%C3%A9musatauthor=S.+Hutterauthor=O.+Chapelleauthor=N.+Azasauthor=M.+De+M%C3%A9oauthor=P.+Vanelle&title=Lowering+of+5-nitroimidazole%E2%80%99s+mutagenicity%3A+Towards+optimal+antiparasitic+pharmacophore&doi=10.1016%2Fj.ejmech.2008.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Lowering of 5-nitroimidazole's mutagenicity: Towards optimal antiparasitic pharmacophore</span></div><div class="casAuthors">Crozet, Maxime D.; Botta, Celine; Gasquet, Monique; Curti, Christophe; Remusat, Vincent; Hutter, Sebastien; Chapelle, Olivier; Azas, Nadine; De Meo, Michel; Vanelle, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">653-659</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To improve the antiparasitic pharmacophore, 20 5-nitroimidazoles bearing an arylsulfonylmethyl group I [R1 = Me, (CH2)OH, CH2CH(CH3)OH; R2 = H, Me; X = H, Me, Cl, Br, F] were prepd. from com. imidazoles.  The antiparasitic activity of these mols. was assessed against Trichomonas vaginalis, the in vitro cytotoxicity was evaluated on human monocytes and the mutagenicity was detd. by the Salmonella mutagenicity assay.  All IC50 on T. vaginalis were below the one of metronidazole.  The detn. of the specificity indexes (SIs), defined as the ratios of the cytotoxic activity and the antitrichomonas activity, indicated that 11 derivs. had a SI over the one of metronidazole.  Mols., bearing an addnl. Me group on the 2-position, showed a lower mutagenicity than metronidazole.  Moreover, three derivs. were characterized by a low mutagenicity and an efficient antitrichomonas activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYfgHS61Ra2LVg90H21EOLACvtfcHk0lh-cHVtmLdAcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlWjsL4%253D&md5=2e0745c81e59ce764ecc302bdca7a8e9</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DCrozet%26aufirst%3DM.%2BD.%26aulast%3DBotta%26aufirst%3DC.%26aulast%3DGasquet%26aufirst%3DM.%26aulast%3DCurti%26aufirst%3DC.%26aulast%3DR%25C3%25A9musat%26aufirst%3DV.%26aulast%3DHutter%26aufirst%3DS.%26aulast%3DChapelle%26aufirst%3DO.%26aulast%3DAzas%26aufirst%3DN.%26aulast%3DDe%2BM%25C3%25A9o%26aufirst%3DM.%26aulast%3DVanelle%26aufirst%3DP.%26atitle%3DLowering%2520of%25205-nitroimidazole%25E2%2580%2599s%2520mutagenicity%253A%2520Towards%2520optimal%2520antiparasitic%2520pharmacophore%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D653%26epage%3D659%26doi%3D10.1016%2Fj.ejmech.2008.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Núñez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tlahuext, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moo-Puc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres-Gómez, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes-Martínez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedillo-Rivera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nava-Zuazo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarrete-Vazquez, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and <i>in vitro</i> trichomonicidal, giardicidal and amebicidal activity of N-acetamide(sulfonamide)-2-methyl-4-nitro-1H-imidazolesq</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2975</span>– <span class="NLM_lpage">2984</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2009.01.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=2975-2984&author=E.+Hern%C3%A1ndez-N%C3%BA%C3%B1ezauthor=H.+Tlahuextauthor=R.+Moo-Pucauthor=H.+Torres-G%C3%B3mezauthor=R.+Reyes-Mart%C3%ADnezauthor=R.+Cedillo-Riveraauthor=C.+Nava-Zuazoauthor=G.+Navarrete-Vazquez&title=Synthesis+and+in+vitro+trichomonicidal%2C+giardicidal+and+amebicidal+activity+of+N-acetamide%28sulfonamide%29-2-methyl-4-nitro-1H-imidazolesq&doi=10.1016%2Fj.ejmech.2009.01.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez-N%25C3%25BA%25C3%25B1ez%26aufirst%3DE.%26aulast%3DTlahuext%26aufirst%3DH.%26aulast%3DMoo-Puc%26aufirst%3DR.%26aulast%3DTorres-G%25C3%25B3mez%26aufirst%3DH.%26aulast%3DReyes-Mart%25C3%25ADnez%26aufirst%3DR.%26aulast%3DCedillo-Rivera%26aufirst%3DR.%26aulast%3DNava-Zuazo%26aufirst%3DC.%26aulast%3DNavarrete-Vazquez%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520trichomonicidal%252C%2520giardicidal%2520and%2520amebicidal%2520activity%2520of%2520N-acetamide%2528sulfonamide%2529-2-methyl-4-nitro-1H-imidazolesq%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D2975%26epage%3D2984%26doi%3D10.1016%2Fj.ejmech.2009.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colín-Lozano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">León-Rivera, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan-Bacab, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Morales, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moo-Puc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Guerrero, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Núñez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argüello-Garcia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scior, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa-Cabrera, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarrete-Vázquez, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis, <i>in vitro</i> and <i>in vivo</i> giardicidal activity of nitrothiazole-NSAID chimeras displaying broad antiprotozoal spectrum</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3490</span>– <span class="NLM_lpage">3494</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.05.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2017.05.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=3490-3494&author=B.+Col%C3%ADn-Lozanoauthor=I.+Le%C3%B3n-Riveraauthor=M.+J.+Chan-Bacabauthor=B.+O.+Ortega-Moralesauthor=R.+Moo-Pucauthor=V.+L%C3%B3pez-Guerreroauthor=E.+Hern%C3%A1ndez-N%C3%BA%C3%B1ezauthor=R.+Arg%C3%BCello-Garciaauthor=T.+Sciorauthor=E.+Barbosa-Cabreraauthor=G.+Navarrete-V%C3%A1zquez&title=Synthesis%2C+in+vitro+and+in+vivo+giardicidal+activity+of+nitrothiazole-NSAID+chimeras+displaying+broad+antiprotozoal+spectrum&doi=10.1016%2Fj.bmcl.2017.05.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.05.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.05.071%26sid%3Dliteratum%253Aachs%26aulast%3DCol%25C3%25ADn-Lozano%26aufirst%3DB.%26aulast%3DLe%25C3%25B3n-Rivera%26aufirst%3DI.%26aulast%3DChan-Bacab%26aufirst%3DM.%2BJ.%26aulast%3DOrtega-Morales%26aufirst%3DB.%2BO.%26aulast%3DMoo-Puc%26aufirst%3DR.%26aulast%3DL%25C3%25B3pez-Guerrero%26aufirst%3DV.%26aulast%3DHern%25C3%25A1ndez-N%25C3%25BA%25C3%25B1ez%26aufirst%3DE.%26aulast%3DArg%25C3%25BCello-Garcia%26aufirst%3DR.%26aulast%3DScior%26aufirst%3DT.%26aulast%3DBarbosa-Cabrera%26aufirst%3DE.%26aulast%3DNavarrete-V%25C3%25A1zquez%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520giardicidal%2520activity%2520of%2520nitrothiazole-NSAID%2520chimeras%2520displaying%2520broad%2520antiprotozoal%2520spectrum%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D3490%26epage%3D3494%26doi%3D10.1016%2Fj.bmcl.2017.05.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trunz, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jędrysiak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweats, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwiński, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torreele, E.</span></span> <span> </span><span class="NLM_article-title">1-Aryl-4 nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1524</span>– <span class="NLM_lpage">1535</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.01.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2011.01.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1524-1535&author=B.+B.+Trunzauthor=R.+J%C4%99drysiakauthor=D.+Tweatsauthor=R.+Brunauthor=M.+Kaiserauthor=J.+Suwi%C5%84skiauthor=E.+Torreele&title=1-Aryl-4+nitro-1H-imidazoles%2C+a+new+promising+series+for+the+treatment+of+human+African+trypanosomiasis&doi=10.1016%2Fj.ejmech.2011.01.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.01.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.01.071%26sid%3Dliteratum%253Aachs%26aulast%3DTrunz%26aufirst%3DB.%2BB.%26aulast%3DJ%25C4%2599drysiak%26aufirst%3DR.%26aulast%3DTweats%26aufirst%3DD.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DSuwi%25C5%2584ski%26aufirst%3DJ.%26aulast%3DTorreele%26aufirst%3DE.%26atitle%3D1-Aryl-4%2520nitro-1H-imidazoles%252C%2520a%2520new%2520promising%2520series%2520for%2520the%2520treatment%2520of%2520human%2520African%2520trypanosomiasis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1524%26epage%3D1535%26doi%3D10.1016%2Fj.ejmech.2011.01.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca-Berzal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibáñez-Escribano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reviriego, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagerovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogal-Ruiz, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escario, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soeiro, M. d. N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Barrio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span> <span> </span><span class="NLM_article-title">Antichagasic and trichomonacidal activity of 1-substituted 2-benzyl- 5-nitroindazolin-3-ones and 3-alkoxy-2-benzyl-5-nitro-2Hindazoles</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2016.03.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=295-310&author=C.+Fonseca-Berzalauthor=A.+Ib%C3%A1%C3%B1ez-Escribanoauthor=F.+Reviriegoauthor=J.+Cumellaauthor=P.+Moralesauthor=N.+Jagerovicauthor=J.+J.+Nogal-Ruizauthor=J.+A.+Escarioauthor=P.+B.+da+Silvaauthor=M.+d.+N.+C.+Soeiroauthor=A.+G%C3%B3mez-Barrioauthor=V.+J.+Ar%C3%A1n&title=Antichagasic+and+trichomonacidal+activity+of+1-substituted+2-benzyl-+5-nitroindazolin-3-ones+and+3-alkoxy-2-benzyl-5-nitro-2Hindazoles&doi=10.1016%2Fj.ejmech.2016.03.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.036%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca-Berzal%26aufirst%3DC.%26aulast%3DIb%25C3%25A1%25C3%25B1ez-Escribano%26aufirst%3DA.%26aulast%3DReviriego%26aufirst%3DF.%26aulast%3DCumella%26aufirst%3DJ.%26aulast%3DMorales%26aufirst%3DP.%26aulast%3DJagerovic%26aufirst%3DN.%26aulast%3DNogal-Ruiz%26aufirst%3DJ.%2BJ.%26aulast%3DEscario%26aufirst%3DJ.%2BA.%26aulast%3Dda%2BSilva%26aufirst%3DP.%2BB.%26aulast%3DSoeiro%26aufirst%3DM.%2Bd.%2BN.%2BC.%26aulast%3DG%25C3%25B3mez-Barrio%26aufirst%3DA.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26atitle%3DAntichagasic%2520and%2520trichomonacidal%2520activity%2520of%25201-substituted%25202-benzyl-%25205-nitroindazolin-3-ones%2520and%25203-alkoxy-2-benzyl-5-nitro-2Hindazoles%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D295%26epage%3D310%26doi%3D10.1016%2Fj.ejmech.2016.03.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boiani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerpe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres de Ortiz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera de Bilbao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanabria, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaluff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas de
Arias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maya, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morello, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerecetto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, M.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> and <i>in vivo</i> antitrypanosomatid activity of 5-nitroindazoles</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1034</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2008.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2008.06.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=1034-1040&author=L.+Boianiauthor=A.+Gerpeauthor=V.+J.+Ar%C3%A1nauthor=S.+Torres+de+Ortizauthor=E.+Sernaauthor=N.+Vera+de+Bilbaoauthor=L.+Sanabriaauthor=G.+Yaluffauthor=H.+Nakayamaauthor=A.+Rojas+de%0AAriasauthor=J.+D.+Mayaauthor=J.+A.+Morelloauthor=H.+Cerecettoauthor=M.+Gonz%C3%A1lez&title=In+vitro+and+in+vivo+antitrypanosomatid+activity+of+5-nitroindazoles&doi=10.1016%2Fj.ejmech.2008.06.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DBoiani%26aufirst%3DL.%26aulast%3DGerpe%26aufirst%3DA.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DTorres%2Bde%2BOrtiz%26aufirst%3DS.%26aulast%3DSerna%26aufirst%3DE.%26aulast%3DVera%2Bde%2BBilbao%26aufirst%3DN.%26aulast%3DSanabria%26aufirst%3DL.%26aulast%3DYaluff%26aufirst%3DG.%26aulast%3DNakayama%26aufirst%3DH.%26aulast%3DRojas%2Bde%2BArias%26aufirst%3DA.%26aulast%3DMaya%26aufirst%3DJ.%2BD.%26aulast%3DMorello%26aufirst%3DJ.%2BA.%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitrypanosomatid%2520activity%2520of%25205-nitroindazoles%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D1034%26epage%3D1040%26doi%3D10.1016%2Fj.ejmech.2008.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerpe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmerling, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piro, O. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maya, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olea-Azar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerecetto, H.</span></span> <span> </span><span class="NLM_article-title">Study of 5-nitroindazoles’ anti-Trypanosoma cruzi mode of action: Electrochemical behaviour and ESR spectroscopic studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1545</span>– <span class="NLM_lpage">1553</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2008.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2008.07.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=1545-1553&author=J.+Rodr%C3%ADguezauthor=A.+Gerpeauthor=G.+Aguirreauthor=U.+Kemmerlingauthor=O.+E.+Piroauthor=V.+J.+Ar%C3%A1nauthor=J.+D.+Mayaauthor=C.+Olea-Azarauthor=M.+Gonz%C3%A1lezauthor=H.+Cerecetto&title=Study+of+5-nitroindazoles%E2%80%99+anti-Trypanosoma+cruzi+mode+of+action%3A+Electrochemical+behaviour+and+ESR+spectroscopic+studies&doi=10.1016%2Fj.ejmech.2008.07.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DJ.%26aulast%3DGerpe%26aufirst%3DA.%26aulast%3DAguirre%26aufirst%3DG.%26aulast%3DKemmerling%26aufirst%3DU.%26aulast%3DPiro%26aufirst%3DO.%2BE.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DMaya%26aufirst%3DJ.%2BD.%26aulast%3DOlea-Azar%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26atitle%3DStudy%2520of%25205-nitroindazoles%25E2%2580%2599%2520anti-Trypanosoma%2520cruzi%2520mode%2520of%2520action%253A%2520Electrochemical%2520behaviour%2520and%2520ESR%2520spectroscopic%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D1545%26epage%3D1553%26doi%3D10.1016%2Fj.ejmech.2008.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boiani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olea-Azar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavaggi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerecetto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maya, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco-Pozo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosoy, H. S.</span></span> <span> </span><span class="NLM_article-title">New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: Synthesis, biological evaluation, and mechanism of action studies</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">8186</span>– <span class="NLM_lpage">8196</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2009.10.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=8186-8196&author=J.+Rodr%C3%ADguezauthor=V.+J.+Ar%C3%A1nauthor=L.+Boianiauthor=C.+Olea-Azarauthor=M.+L.+Lavaggiauthor=M.+Gonz%C3%A1lezauthor=H.+Cerecettoauthor=J.+D.+Mayaauthor=C.+Carrasco-Pozoauthor=H.+S.+Cosoy&title=New+potent+5-nitroindazole+derivatives+as+inhibitors+of+Trypanosoma+cruzi+growth%3A+Synthesis%2C+biological+evaluation%2C+and+mechanism+of+action+studies&doi=10.1016%2Fj.bmc.2009.10.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DJ.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DBoiani%26aufirst%3DL.%26aulast%3DOlea-Azar%26aufirst%3DC.%26aulast%3DLavaggi%26aufirst%3DM.%2BL.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DMaya%26aufirst%3DJ.%2BD.%26aulast%3DCarrasco-Pozo%26aufirst%3DC.%26aulast%3DCosoy%26aufirst%3DH.%2BS.%26atitle%3DNew%2520potent%25205-nitroindazole%2520derivatives%2520as%2520inhibitors%2520of%2520Trypanosoma%2520cruzi%2520growth%253A%2520Synthesis%252C%2520biological%2520evaluation%252C%2520and%2520mechanism%2520of%2520action%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D8186%26epage%3D8196%26doi%3D10.1016%2Fj.bmc.2009.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vega, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolón, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero-Torres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca-Berzal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escario, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Barrio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gálvez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrero-Ponce, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2012.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=23124218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslOrsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=214-227&author=M.+C.+Vegaauthor=M.+Rol%C3%B3nauthor=A.+Montero-Torresauthor=C.+Fonseca-Berzalauthor=J.+A.+Escarioauthor=A.+G%C3%B3mez-Barrioauthor=J.+G%C3%A1lvezauthor=Y.+Marrero-Ponceauthor=V.+J.+Ar%C3%A1n&title=Synthesis%2C+biological+evaluation+and+chemometric+analysis+of+indazole+derivatives.+1%2C2-Disubstituted+5-nitroindazolinones%2C+new+prototypes+of+antichagasic+drug&doi=10.1016%2Fj.ejmech.2012.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</span></div><div class="casAuthors">Vega, Maria Celeste; Rolon, Miriam; Montero-Torres, Alina; Fonseca-Berzal, Cristina; Escario, Jose Antonio; Gomez-Barrio, Alicia; Galvez, Jorge; Marrero-Ponce, Yovani; Aran, Vicente J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">214-227</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compds. remains an important goal.  On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3-ones and in order to initiate the optimization of activity of this kind of compds., we have prepd. a series of related analogs and tested in vitro these products against epimastigote forms of Trypanosoma cruzi.  2-Benzyl-1-Pr (I), 2-benzyl-1-iso-Pr (II) and 2-benzyl-1-Bu (III) derivs. have shown high trypanocidal activity and low unspecific toxicity.  Other indazole derivs. with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prep. the mentioned indazolinones, have moderate to low effectiveness.  The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software.  We have also searched for structural similarities between 225 known antiprotozoan drugs and compd. I.  The results confirm that compds. I-III constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRbqmnzcyFhLVg90H21EOLACvtfcHk0limE_iME3uraQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslOrsr3E&md5=8922d27f24ff8cd9e0395fcc745f6100</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DVega%26aufirst%3DM.%2BC.%26aulast%3DRol%25C3%25B3n%26aufirst%3DM.%26aulast%3DMontero-Torres%26aufirst%3DA.%26aulast%3DFonseca-Berzal%26aufirst%3DC.%26aulast%3DEscario%26aufirst%3DJ.%2BA.%26aulast%3DG%25C3%25B3mez-Barrio%26aufirst%3DA.%26aulast%3DG%25C3%25A1lvez%26aufirst%3DJ.%26aulast%3DMarrero-Ponce%26aufirst%3DY.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520chemometric%2520analysis%2520of%2520indazole%2520derivatives.%25201%252C2-Disubstituted%25205-nitroindazolinones%252C%2520new%2520prototypes%2520of%2520antichagasic%2520drug%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D58%26spage%3D214%26epage%3D227%26doi%3D10.1016%2Fj.ejmech.2012.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca-Berzal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escario, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Barrio, A.</span></span> <span> </span><span class="NLM_article-title">Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1056</span>, <span class="refDoi"> DOI: 10.1007/s00436-013-3740-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1007%2Fs00436-013-3740-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=24435615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BC2czmt1eisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2014&pages=1049-1056&author=C.+Fonseca-Berzalauthor=J.+A.+Escarioauthor=V.+J.+Ar%C3%A1nauthor=A.+G%C3%B3mez-Barrio&title=Further+insights+into+biological+evaluation+of+new+anti-Trypanosoma+cruzi+5-nitroindazoles&doi=10.1007%2Fs00436-013-3740-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles</span></div><div class="casAuthors">Fonseca-Berzal Cristina; Escario Jose Antonio; Aran Vicente J; Gomez-Barrio Alicia</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1049-56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Twelve molecules from a series of 35 new 5-nitroindazole derivatives, selected from a successful primary screening on Trypanosoma cruzi epimastigotes, have been evaluated against intracellular amastigotes according to the previous results of their trypanocidal activity and unspecific cytotoxicity. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23), and 2-benzyl-1-butyl (24) 5-nitroindazolin-3-ones have inhibited the growth of amastigotes similarly to the reference drugs benznidazole and nifurtimox, inducing complete growth inhibition at concentrations lower than 8 μM (IC50 < 5 μM) and accomplishing great selectivity indexes on the intracellular form of the parasite (SI > 30).  Further in vivo assays were developed only for two of the most active molecules (22 and 24), reaching significant reductions in parasitemia levels (52 % and 77%, respectively) after their oral administration to infected mice.  In addition, none of the mice in experimental and benznidazole groups died, unlike in the control group which is only treated with the vehicle.  The trypanocidal properties found in some of the 5-nitroindazole derivatives assayed in the present work represent an interesting contribution to the urgent need for searching new antichagasic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCTUUnUpSgfijiVMCqkKxVfW6udTcc2ebpEt9MIYV-LLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czmt1eisg%253D%253D&md5=080ade604aeaa2acb4074b6a8d061f9e</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1007%2Fs00436-013-3740-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-013-3740-5%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca-Berzal%26aufirst%3DC.%26aulast%3DEscario%26aufirst%3DJ.%2BA.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DG%25C3%25B3mez-Barrio%26aufirst%3DA.%26atitle%3DFurther%2520insights%2520into%2520biological%2520evaluation%2520of%2520new%2520anti-Trypanosoma%2520cruzi%25205-nitroindazoles%26jtitle%3DParasitol.%2520Res.%26date%3D2014%26volume%3D113%26spage%3D1049%26epage%3D1056%26doi%3D10.1007%2Fs00436-013-3740-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca-Berzal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasconcelos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escario, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aran, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Barrio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soeiro, M.</span></span> <span> </span><span class="NLM_article-title">Exploring the potential activity spectrum of two 5-nitroindazolinone prototypes on different Trypanosoma cruzi strains</span>. <i>Parasitol. Open</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">e1</span>, <span class="refDoi"> DOI: 10.1017/pao.2015.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1017%2Fpao.2015.4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=e1&author=C.+Fonseca-Berzalauthor=P.+B.+Da+Silvaauthor=C.+F.+Da+Silvaauthor=M.+Vasconcelosauthor=M.+M.+Batistaauthor=J.+A.+Escarioauthor=V.+J.+Aranauthor=A.+Gomez-Barrioauthor=M.+Soeiro&title=Exploring+the+potential+activity+spectrum+of+two+5-nitroindazolinone+prototypes+on+different+Trypanosoma+cruzi+strains&doi=10.1017%2Fpao.2015.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1017%2Fpao.2015.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252Fpao.2015.4%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca-Berzal%26aufirst%3DC.%26aulast%3DDa%2BSilva%26aufirst%3DP.%2BB.%26aulast%3DDa%2BSilva%26aufirst%3DC.%2BF.%26aulast%3DVasconcelos%26aufirst%3DM.%26aulast%3DBatista%26aufirst%3DM.%2BM.%26aulast%3DEscario%26aufirst%3DJ.%2BA.%26aulast%3DAran%26aufirst%3DV.%2BJ.%26aulast%3DGomez-Barrio%26aufirst%3DA.%26aulast%3DSoeiro%26aufirst%3DM.%26atitle%3DExploring%2520the%2520potential%2520activity%2520spectrum%2520of%2520two%25205-nitroindazolinone%2520prototypes%2520on%2520different%2520Trypanosoma%2520cruzi%2520strains%26jtitle%3DParasitol.%2520Open%26date%3D2015%26volume%3D1%26spage%3De1%26doi%3D10.1017%2Fpao.2015.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reviriego, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marín, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramírez-Macías, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosales, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Moreno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span> <span> </span><span class="NLM_article-title">New perspectives on the synthesis and antichagasic activity of 3-alkoxy-1-alkyl-5-nitroindazoles</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.12.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2013.12.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=124-134&author=B.+Muroauthor=F.+Reviriegoauthor=P.+Navarroauthor=C.+Mar%C3%ADnauthor=I.+Ram%C3%ADrez-Mac%C3%ADasauthor=M.+J.+Rosalesauthor=M.+S%C3%A1nchez-Morenoauthor=V.+J.+Ar%C3%A1n&title=New+perspectives+on+the+synthesis+and+antichagasic+activity+of+3-alkoxy-1-alkyl-5-nitroindazoles&doi=10.1016%2Fj.ejmech.2013.12.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.12.025%26sid%3Dliteratum%253Aachs%26aulast%3DMuro%26aufirst%3DB.%26aulast%3DReviriego%26aufirst%3DF.%26aulast%3DNavarro%26aufirst%3DP.%26aulast%3DMar%25C3%25ADn%26aufirst%3DC.%26aulast%3DRam%25C3%25ADrez-Mac%25C3%25ADas%26aufirst%3DI.%26aulast%3DRosales%26aufirst%3DM.%2BJ.%26aulast%3DS%25C3%25A1nchez-Moreno%26aufirst%3DM.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26atitle%3DNew%2520perspectives%2520on%2520the%2520synthesis%2520and%2520antichagasic%2520activity%2520of%25203-alkoxy-1-alkyl-5-nitroindazoles%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D74%26spage%3D124%26epage%3D134%26doi%3D10.1016%2Fj.ejmech.2013.12.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref33':['cit33a','cit33b','cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55a','cit55b'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66a','cit66b'],'ref67':['cit67'],'ref68':['cit68a','cit68b','cit68c'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73a','cit73b'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77a','cit77b','cit77c'],'ref78':['cit78','cit78b'],'ref79':['cit79'],'ref80':['cit80'],'ref82':['cit82a','cit82b','cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88a','cit88b'],'ref89':['cit89','cit89b'],'ref90':['cit90'],'ref91':['cit91','cit91b','cit91c'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100a','cit100b'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104a','cit104b'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 121 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Marco Borgogno, Annalisa Savardi, Jacopo Manigrasso, Alessandra Turci, Corinne Portioli, Giuliana Ottonello, Sine Mandrup Bertozzi, Andrea Armirotti, Andrea Contestabile, Laura Cancedda, <span class="NLM_string-name hlFld-ContribAuthor">Marco De Vivo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, In Vitro and In Vivo Characterization of Selective NKCC1 Inhibitors for the Treatment of Core Symptoms in Down Syndrome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10203-10229. <a href="https://doi.org/10.1021/acs.jmedchem.1c00603" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00603</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00603%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BIn%252BVitro%252Band%252BIn%252BVivo%252BCharacterization%252Bof%252BSelective%252BNKCC1%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BCore%252BSymptoms%252Bin%252BDown%252BSyndrome%26aulast%3DBorgogno%26aufirst%3DMarco%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01042021%26date%3D17062021%26volume%3D64%26issue%3D14%26spage%3D10203%26epage%3D10229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrew V. Stachulski, Joshua Taujanskas, Sophie L. Pate, Rajith K. R. Rajoli, Ghaith Aljayyoussi, Shaun H. Pennington, Stephen A. Ward, Weiqian David Hong, Giancarlo A. Biagini, Andrew Owen, Gemma L. Nixon, Suet C. Leung, <span class="NLM_string-name hlFld-ContribAuthor">Paul M. O’Neill</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (6)
                                     , 1317-1331. <a href="https://doi.org/10.1021/acsinfecdis.0c00478" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00478%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DTherapeutic%252BPotential%252Bof%252BNitazoxanide%25253A%252BAn%252BAppropriate%252BChoice%252Bfor%252BRepurposing%252Bversus%252BSARS-CoV-2%25253F%26aulast%3DStachulski%26aufirst%3DAndrew%2BV.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D08072020%26date%3D22122020%26volume%3D7%26issue%3D6%26spage%3D1317%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liwei Xu, Xinxin Xu, Lingling Guo, Zhongxing Wang, Xiaoling Wu, Hua Kuang, <span class="NLM_string-name hlFld-ContribAuthor">Chuanlai Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Environmental Health Risk Analysis of Neonicotinoids and a Synergist. </span><span class="cited-content_cbyCitation_journal-name">Environmental Science & Technology</span><span> <strong>2021,</strong> <em>55 </em>
                                    (11)
                                     , 7541-7550. <a href="https://doi.org/10.1021/acs.est.1c00872" title="DOI URL">https://doi.org/10.1021/acs.est.1c00872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.est.1c00872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.est.1c00872%26sid%3Dliteratum%253Aachs%26jtitle%3DEnvironmental%2520Science%2520%2526%2520Technology%26atitle%3DPotential%252BEnvironmental%252BHealth%252BRisk%252BAnalysis%252Bof%252BNeonicotinoids%252Band%252Ba%252BSynergist%26aulast%3DXu%26aufirst%3DLiwei%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D06022021%26date%3D29042021%26date%3D29042021%26date%3D13052021%26volume%3D55%26issue%3D11%26spage%3D7541%26epage%3D7550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhuo Wang, Tao Chen, Hua Liu, Xiao-Li Zhao, Wei-Bo Hu, Hui Yang, Yahu A. Liu, <span class="NLM_string-name hlFld-ContribAuthor">Ke Wen</span>. </span><span class="cited-content_cbyCitation_article-title">Pillar[5]arene-Derived endo-Functionalized Molecular Tube for Mimicking Protein–Ligand Interactions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (9)
                                     , 6467-6477. <a href="https://doi.org/10.1021/acs.joc.1c00314" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00314%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPillar%25255B5%25255Darene-Derived%252Bendo-Functionalized%252BMolecular%252BTube%252Bfor%252BMimicking%252BProtein%2525E2%252580%252593Ligand%252BInteractions%26aulast%3DWang%26aufirst%3DZhuo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08022021%26date%3D19042021%26volume%3D86%26issue%3D9%26spage%3D6467%26epage%3D6477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Priyadeep Bhutani, Gaurav Joshi, Nivethitha Raja, Namrata Bachhav, Prabhakar K. Rajanna, Hemant Bhutani, Atish T. Paul, <span class="NLM_string-name hlFld-ContribAuthor">Raj Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">U.S. FDA Approved Drugs from 2015–June 2020: A Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2339-2381. <a href="https://doi.org/10.1021/acs.jmedchem.0c01786" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01786%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DU.S.%252BFDA%252BApproved%252BDrugs%252Bfrom%252B2015%2525E2%252580%252593June%252B2020%25253A%252BA%252BPerspective%26aulast%3DBhutani%26aufirst%3DPriyadeep%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12102020%26date%3D22022021%26volume%3D64%26issue%3D5%26spage%3D2339%26epage%3D2381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yelena Mostinski, Guus J. J. E. Heynen, Maria Pascual López-Alberca, Jerome Paul, Sandra Miksche, Silke Radetzki, David Schaller, Elena Shanina, Carola Seyffarth, Yuliya Kolomeets, Nandor Ziebart, Judith de Schryver, Sylvia Oestreich, Martin Neuenschwander, Yvette Roske, Udo Heinemann, Christoph Rademacher, Andrea Volkamer, Jens Peter von Kries, Walter Birchmeier, <span class="NLM_string-name hlFld-ContribAuthor">Marc Nazaré</span>. </span><span class="cited-content_cbyCitation_article-title">From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14780-14804. <a href="https://doi.org/10.1021/acs.jmedchem.0c01265" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01265%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BPyrazolones%252Bto%252BAzaindoles%25253A%252BEvolution%252Bof%252BActive-Site%252BSHP2%252BInhibitors%252BBased%252Bon%252BScaffold%252BHopping%252Band%252BBioisosteric%252BReplacement%26aulast%3DMostinski%26aufirst%3DYelena%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28072020%26date%3D19112020%26volume%3D63%26issue%3D23%26spage%3D14780%26epage%3D14804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jimin Xu, Judith Berastegui-Cabrera, Na Ye, Marta Carretero-Ledesma, Jerónimo Pachón-Díaz, Haiying Chen, Maria Eugenia Pachón-Ibáñez, Javier Sánchez-Céspedes, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Substituted N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues as Potent Human Adenovirus Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12830-12852. <a href="https://doi.org/10.1021/acs.jmedchem.0c01226" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01226%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BSubstituted%252BN-%2525284-Amino-2-chlorophenyl%252529-5-chloro-2-hydroxybenzamide%252BAnalogues%252Bas%252BPotent%252BHuman%252BAdenovirus%252BInhibitors%26aulast%3DXu%26aufirst%3DJimin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14072020%26date%3D28102020%26volume%3D63%26issue%3D21%26spage%3D12830%26epage%3D12852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vagelis Rinotas, Athanasios Papakyriakou, Foteini Violitzi, Christos Papaneophytou, Maria-Dimitra Ouzouni, Polyxeni Alexiou, Alexandros Strongilos, Elias Couladouros, George Kontopidis, Elias Eliopoulos, <span class="NLM_string-name hlFld-ContribAuthor">Eleni Douni</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Small-Molecule Inhibitors of Receptor Activator of Nuclear Factor-κB Ligand with a Superior Therapeutic Index. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 12043-12059. <a href="https://doi.org/10.1021/acs.jmedchem.0c01316" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01316%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSmall-Molecule%252BInhibitors%252Bof%252BReceptor%252BActivator%252Bof%252BNuclear%252BFactor-%2525CE%2525BAB%252BLigand%252Bwith%252Ba%252BSuperior%252BTherapeutic%252BIndex%26aulast%3DRinotas%26aufirst%3DVagelis%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29072020%26date%3D02102020%26date%3D21092020%26volume%3D63%26issue%3D20%26spage%3D12043%26epage%3D12059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yue Gui, Xin Yao, Ilia A. Guzei, Michael M. Aristov, Junguang Yu, <span class="NLM_string-name hlFld-ContribAuthor">Lian Yu</span>. </span><span class="cited-content_cbyCitation_article-title">A Mechanism for Reversible Solid-State Transitions Involving Nitro Torsion. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Materials</span><span> <strong>2020,</strong> <em>32 </em>
                                    (18)
                                     , 7754-7765. <a href="https://doi.org/10.1021/acs.chemmater.0c02209" title="DOI URL">https://doi.org/10.1021/acs.chemmater.0c02209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemmater.0c02209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemmater.0c02209%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Materials%26atitle%3DA%252BMechanism%252Bfor%252BReversible%252BSolid-State%252BTransitions%252BInvolving%252BNitro%252BTorsion%26aulast%3DGui%26aufirst%3DYue%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26052020%26date%3D16082020%26date%3D08092020%26volume%3D32%26issue%3D18%26spage%3D7754%26epage%3D7765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jing Wang, Yunqian Ding, Chenxi Li, Nan Zheng, Zengqi Xie, Zaifei Ma, Yan Lu, Xiangjian Wan, <span class="NLM_string-name hlFld-ContribAuthor">Yongsheng Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of Nitro-Substituted Ending Groups on the Photovoltaic Properties of Nonfullerene Acceptors. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2020,</strong> <em>12 </em>
                                    (37)
                                     , 41861-41868. <a href="https://doi.org/10.1021/acsami.0c11698" title="DOI URL">https://doi.org/10.1021/acsami.0c11698</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.0c11698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.0c11698%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DEffect%252Bof%252BNitro-Substituted%252BEnding%252BGroups%252Bon%252Bthe%252BPhotovoltaic%252BProperties%252Bof%252BNonfullerene%252BAcceptors%26aulast%3DWang%26aufirst%3DJing%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02072020%26date%3D21082020%26date%3D03092020%26date%3D21082020%26volume%3D12%26issue%3D37%26spage%3D41861%26epage%3D41868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jordan L. Woehl, Seiya Kitamura, Nicholas Dillon, Zhen Han, Landon J. Edgar, Victor Nizet, <span class="NLM_string-name hlFld-ContribAuthor">Dennis W. Wolan</span>. </span><span class="cited-content_cbyCitation_article-title">An Irreversible Inhibitor to Probe the Role of Streptococcus pyogenes Cysteine Protease SpeB in Evasion of Host Complement Defenses. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (8)
                                     , 2060-2069. <a href="https://doi.org/10.1021/acschembio.0c00191" title="DOI URL">https://doi.org/10.1021/acschembio.0c00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.0c00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.0c00191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DAn%252BIrreversible%252BInhibitor%252Bto%252BProbe%252Bthe%252BRole%252Bof%252BStreptococcus%252Bpyogenes%252BCysteine%252BProtease%252BSpeB%252Bin%252BEvasion%252Bof%252BHost%252BComplement%252BDefenses%26aulast%3DWoehl%26aufirst%3DJordan%2BL.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15032020%26date%3D14072020%26date%3D28072020%26date%3D14072020%26volume%3D15%26issue%3D8%26spage%3D2060%26epage%3D2069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peng Gao, Huai-Juan Chen, Zi-Jing Bai, Mi-Na Zhao, Desuo Yang, Juan Wang, Ning Wang, Lele Du, <span class="NLM_string-name hlFld-ContribAuthor">Zheng-Hui Guan</span>. </span><span class="cited-content_cbyCitation_article-title">IBX-Promoted Oxidative Cyclization of N-Hydroxyalkyl Enamines: A Metal-Free Approach toward 2,3-Disubstituted Pyrroles and Pyridines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (12)
                                     , 7939-7951. <a href="https://doi.org/10.1021/acs.joc.0c00625" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00625%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIBX-Promoted%252BOxidative%252BCyclization%252Bof%252BN-Hydroxyalkyl%252BEnamines%25253A%252BA%252BMetal-Free%252BApproach%252Btoward%252B2%25252C3-Disubstituted%252BPyrroles%252Band%252BPyridines%26aulast%3DGao%26aufirst%3DPeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09032020%26date%3D08062020%26date%3D22052020%26volume%3D85%26issue%3D12%26spage%3D7939%26epage%3D7951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sheng Han, Yali Sang, Yan Wu, Yuan Tao, Christophe Pannecouque, Erik De Clercq, Chunlin Zhuang, <span class="NLM_string-name hlFld-ContribAuthor">Fen-Er Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (5)
                                     , 787-801. <a href="https://doi.org/10.1021/acsinfecdis.9b00229" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00229%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DMolecular%252BHybridization-Inspired%252BOptimization%252Bof%252BDiarylbenzopyrimidines%252Bas%252BHIV-1%252BNonnucleoside%252BReverse%252BTranscriptase%252BInhibitors%252Bwith%252BImproved%252BActivity%252Bagainst%252BK103N%252Band%252BE138K%252BMutants%252Band%252BPharmacokinetic%252BProfiles%26aulast%3DHan%26aufirst%3DSheng%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D19062019%26date%3D24102019%26date%3D10102019%26volume%3D6%26issue%3D5%26spage%3D787%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mohmmad Younus Wani, Aijaz Ahmad, Faisal Mohammed Aqlan, <span class="NLM_string-name hlFld-ContribAuthor">Abdullah Saad Al-Bogami</span>. </span><span class="cited-content_cbyCitation_article-title">Azole Based Acetohydrazide Derivatives of Cinnamaldehyde Target and Kill Candida albicans by Causing Cellular Apoptosis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 566-574. <a href="https://doi.org/10.1021/acsmedchemlett.0c00030" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00030%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAzole%252BBased%252BAcetohydrazide%252BDerivatives%252Bof%252BCinnamaldehyde%252BTarget%252Band%252BKill%252BCandida%252Balbicans%252Bby%252BCausing%252BCellular%252BApoptosis%26aulast%3DWani%26aufirst%3DMohmmad%2BYounus%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20012020%26date%3D05022020%26date%3D10022020%26date%3D05022020%26volume%3D11%26issue%3D4%26spage%3D566%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Julien Pedron, Clotilde Boudot, Jean-Yves Brossas, Emilie Pinault, Sandra Bourgeade-Delmas, Alix Sournia-Saquet, Elisa Boutet-Robinet, Alexandre Destere, Antoine Tronnet, Justine Bergé, Colin Bonduelle, Céline Deraeve, Geneviève Pratviel, Jean-Luc Stigliani, Luc Paris, Dominique Mazier, Sophie Corvaisier, Marc Since, Aurélie Malzert-Fréon, Susan Wyllie, Rachel Milne, Alan H. Fairlamb, Alexis Valentin, Bertrand Courtioux, <span class="NLM_string-name hlFld-ContribAuthor">Pierre Verhaeghe</span>. </span><span class="cited-content_cbyCitation_article-title">New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma brucei and cruzi. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 464-472. <a href="https://doi.org/10.1021/acsmedchemlett.9b00566" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00566%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252B8-Nitroquinolinone%252BDerivative%252BDisplaying%252BSubmicromolar%252Bin%252BVitro%252BActivities%252Bagainst%252BBoth%252BTrypanosoma%252Bbrucei%252Band%252Bcruzi%26aulast%3DPedron%26aufirst%3DJulien%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D02122019%26date%3D06022020%26date%3D11022020%26date%3D06022020%26volume%3D11%26issue%3D4%26spage%3D464%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kun Zhang, Alena Budinská, Alessandro Passera, <span class="NLM_string-name hlFld-ContribAuthor">Dmitry Katayev</span>. </span><span class="cited-content_cbyCitation_article-title">N-Nitroheterocycles: Bench-Stable Organic Reagents for Catalytic Ipso-Nitration of Aryl- and Heteroarylboronic Acids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (7)
                                     , 2714-2719. <a href="https://doi.org/10.1021/acs.orglett.0c00671" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00671%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DN-Nitroheterocycles%25253A%252BBench-Stable%252BOrganic%252BReagents%252Bfor%252BCatalytic%252BIpso-Nitration%252Bof%252BAryl-%252Band%252BHeteroarylboronic%252BAcids%26aulast%3DZhang%26aufirst%3DKun%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20022020%26date%3D20032020%26volume%3D22%26issue%3D7%26spage%3D2714%26epage%3D2719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Laurent R. Chiarelli, Elena G. Salina, Giorgia Mori, Tatyana Azhikina, Olga Riabova, Alexander Lepioshkin, Artem Grigorov, Martin Forbak, Jan Madacki, Beatrice Silvia Orena, Marcello Manfredi, Fabio Gosetti, Arianna Buzzi, Giulia Degiacomi, José Camilla Sammartino, Emilio Marengo, Jana Korduláková, Giovanna Riccardi, Katarína Mikušová, Vadim Makarov, <span class="NLM_string-name hlFld-ContribAuthor">Maria Rosalia Pasca</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (2)
                                     , 313-323. <a href="https://doi.org/10.1021/acsinfecdis.9b00388" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00388%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DNew%252BInsights%252Binto%252Bthe%252BMechanism%252Bof%252BAction%252Bof%252Bthe%252BThienopyrimidine%252BAntitubercular%252BProdrug%252BTP053%26aulast%3DChiarelli%26aufirst%3DLaurent%2BR.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D04102019%26date%3D02122019%26date%3D15112019%26volume%3D6%26issue%3D2%26spage%3D313%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benedikt Millies, Franziska von Hammerstein, Andrea Gellert, Stefan Hammerschmidt, Fabian Barthels, Ulrike Göppel, Melissa Immerheiser, Fabian Elgner, Nathalie Jung, Michael Basic, Christian Kersten, Werner Kiefer, Jochen Bodem, Eberhard Hildt, Maike Windbergs, Ute A. Hellmich, <span class="NLM_string-name hlFld-ContribAuthor">Tanja Schirmeister</span>. </span><span class="cited-content_cbyCitation_article-title">Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 11359-11382. <a href="https://doi.org/10.1021/acs.jmedchem.9b01697" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01697%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProline-Based%252BAllosteric%252BInhibitors%252Bof%252BZika%252Band%252BDengue%252BVirus%252BNS2B%25252FNS3%252BProteases%26aulast%3DMillies%26aufirst%3DBenedikt%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14102019%26date%3D13122019%26date%3D26112019%26volume%3D62%26issue%3D24%26spage%3D11359%26epage%3D11382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Huang-Chi Du, Nicholas Simmons, John C. Faver, Zhifeng Yu, Murugesan Palaniappan, Kevin Riehle, <span class="NLM_string-name hlFld-ContribAuthor">Martin M. Matzuk</span>. </span><span class="cited-content_cbyCitation_article-title">A Mild, DNA-Compatible Nitro Reduction Using B2(OH)4. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (7)
                                     , 2194-2199. <a href="https://doi.org/10.1021/acs.orglett.9b00497" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b00497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b00497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b00497%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BMild%25252C%252BDNA-Compatible%252BNitro%252BReduction%252BUsing%252BB2%252528OH%2525294%26aulast%3DDu%26aufirst%3DHuang-Chi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06022019%26date%3D12032019%26volume%3D21%26issue%3D7%26spage%3D2194%26epage%3D2199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gargi Chakraborty, Rina Sikari, Siuli Das, Rakesh Mondal, Suman Sinha, Seemika Banerjee, <span class="NLM_string-name hlFld-ContribAuthor">Nanda D. Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Dehydrogenative Synthesis of Quinolines, 2-Aminoquinolines, and Quinazolines Using Singlet Diradical Ni(II)-Catalysts. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (5)
                                     , 2626-2641. <a href="https://doi.org/10.1021/acs.joc.8b03070" title="DOI URL">https://doi.org/10.1021/acs.joc.8b03070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b03070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b03070%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDehydrogenative%252BSynthesis%252Bof%252BQuinolines%25252C%252B2-Aminoquinolines%25252C%252Band%252BQuinazolines%252BUsing%252BSinglet%252BDiradical%252BNi%252528II%252529-Catalysts%26aulast%3DChakraborty%26aufirst%3DGargi%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30112018%26date%3D11022019%26date%3D28012019%26volume%3D84%26issue%3D5%26spage%3D2626%26epage%3D2641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh Kumar  Sahoo</span>, <span class="hlFld-ContribAuthor ">Bandela  Rani</span>, <span class="hlFld-ContribAuthor ">Nikhil Baliram  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Mohammad Naiyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Grace  Kaul</span>, <span class="hlFld-ContribAuthor ">Manjulika  Shukla</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>, <span class="hlFld-ContribAuthor ">Arunava  Dasgupta</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>, <span class="hlFld-ContribAuthor ">Venkata Madhavi  Yaddanapudi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure-activity relationship of new chalcone linked 5-phenyl-3-isoxazolecarboxylic acid methyl esters potentially active against drug resistant Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113580. <a href="https://doi.org/10.1016/j.ejmech.2021.113580" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113580%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure-activity%252Brelationship%252Bof%252Bnew%252Bchalcone%252Blinked%252B5-phenyl-3-isoxazolecarboxylic%252Bacid%252Bmethyl%252Besters%252Bpotentially%252Bactive%252Bagainst%252Bdrug%252Bresistant%252BMycobacterium%252Btuberculosis%26aulast%3DSahoo%26aufirst%3DSantosh%2BKumar%26date%3D2021%26volume%3D222%26spage%3D113580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Talita A.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Erik  Machado-Ferreira</span>, <span class="hlFld-ContribAuthor ">Lohaine F.  Guimarães</span>, <span class="hlFld-ContribAuthor ">Jéssica  Cavaleiro</span>, <span class="hlFld-ContribAuthor ">Alan Messala A.  Britto</span>, <span class="hlFld-ContribAuthor ">Nátaly  Redua</span>, <span class="hlFld-ContribAuthor ">Lucas Miguel Pereira  de Souza</span>, <span class="hlFld-ContribAuthor ">André S.  Pimentel</span>, <span class="hlFld-ContribAuthor ">Paulo H.S.  Picciani</span>, <span class="hlFld-ContribAuthor ">Osvaldo N.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Cléber Bonfim  Barreto</span>, <span class="hlFld-ContribAuthor ">Carlos Augusto G.  Soares</span>. </span><span class="cited-content_cbyCitation_article-title">Novel cytotoxic amphiphilic nitro-compounds derived from a synthetic route for paraconic acids. </span><span class="cited-content_cbyCitation_journal-name">Colloids and Surfaces A: Physicochemical and Engineering Aspects</span><span> <strong>2021,</strong> <em>626 </em>, 126984. <a href="https://doi.org/10.1016/j.colsurfa.2021.126984" title="DOI URL">https://doi.org/10.1016/j.colsurfa.2021.126984</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.colsurfa.2021.126984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.colsurfa.2021.126984%26sid%3Dliteratum%253Aachs%26jtitle%3DColloids%2520and%2520Surfaces%2520A%253A%2520Physicochemical%2520and%2520Engineering%2520Aspects%26atitle%3DNovel%252Bcytotoxic%252Bamphiphilic%252Bnitro-compounds%252Bderived%252Bfrom%252Ba%252Bsynthetic%252Broute%252Bfor%252Bparaconic%252Bacids%26aulast%3DRibeiro%26aufirst%3DTalita%2BA.%26date%3D2021%26volume%3D626%26spage%3D126984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilamuni H.  de Silva</span>, <span class="hlFld-ContribAuthor ">Suneela  Pyreddy</span>, <span class="hlFld-ContribAuthor ">Ewan W.  Blanch</span>, <span class="hlFld-ContribAuthor ">Helmut M.  Hügel</span>, <span class="hlFld-ContribAuthor ">Subashani  Maniam</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted rapid synthesis of spirooxindole-pyrrolizidine analogues and their activity as anti-amyloidogenic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105128. <a href="https://doi.org/10.1016/j.bioorg.2021.105128" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105128%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DMicrowave-assisted%252Brapid%252Bsynthesis%252Bof%252Bspirooxindole-pyrrolizidine%252Banalogues%252Band%252Btheir%252Bactivity%252Bas%252Banti-amyloidogenic%252Bagents%26aulast%3Dde%2BSilva%26aufirst%3DNilamuni%2BH.%26date%3D2021%26volume%3D114%26spage%3D105128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer L.  Goeckeler-Fried</span>, <span class="hlFld-ContribAuthor ">Rajiah  Aldrin Denny</span>, <span class="hlFld-ContribAuthor ">Disha  Joshi</span>, <span class="hlFld-ContribAuthor ">Clare  Hill</span>, <span class="hlFld-ContribAuthor ">Mads B.  Larsen</span>, <span class="hlFld-ContribAuthor ">Annette N.  Chiang</span>, <span class="hlFld-ContribAuthor ">Raymond A.  Frizzell</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Eric J.  Sorscher</span>, <span class="hlFld-ContribAuthor ">Jeffrey L.  Brodsky</span>. </span><span class="cited-content_cbyCitation_article-title">Improved correction of F508del-CFTR biogenesis with a folding facilitator and an inhibitor of protein ubiquitination. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>48 </em>, 128243. <a href="https://doi.org/10.1016/j.bmcl.2021.128243" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128243%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImproved%252Bcorrection%252Bof%252BF508del-CFTR%252Bbiogenesis%252Bwith%252Ba%252Bfolding%252Bfacilitator%252Band%252Ban%252Binhibitor%252Bof%252Bprotein%252Bubiquitination%26aulast%3DGoeckeler-Fried%26aufirst%3DJennifer%2BL.%26date%3D2021%26volume%3D48%26spage%3D128243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zuleima  Blanco</span>, <span class="hlFld-ContribAuthor ">Michael R.  Mijares</span>, <span class="hlFld-ContribAuthor ">Hegira  Ramírez</span>, <span class="hlFld-ContribAuthor ">Esteban  Fernandez-Moreira</span>, <span class="hlFld-ContribAuthor ">Henry J.  Oviedo</span>, <span class="hlFld-ContribAuthor ">Noris M.  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Jaime E.  Charris</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro evaluation and in vivo efficacy of nitroimidazole-sulfanyl ethyl derivatives against Leishmania (V.) braziliensis and Leishmania (L.) mexicana. </span><span class="cited-content_cbyCitation_journal-name">Parasitology Research</span><span> <strong>2021,</strong> <em>62 </em><a href="https://doi.org/10.1007/s00436-021-07266-w" title="DOI URL">https://doi.org/10.1007/s00436-021-07266-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00436-021-07266-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00436-021-07266-w%26sid%3Dliteratum%253Aachs%26jtitle%3DParasitology%2520Research%26atitle%3DIn%252Bvitro%252Bevaluation%252Band%252Bin%252Bvivo%252Befficacy%252Bof%252Bnitroimidazole-sulfanyl%252Bethyl%252Bderivatives%252Bagainst%252BLeishmania%252B%252528V.%252529%252Bbraziliensis%252Band%252BLeishmania%252B%252528L.%252529%252Bmexicana%26aulast%3DBlanco%26aufirst%3DZuleima%26date%3D2021%26date%3D2021%26volume%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaio Maciel de  Santiago-Silva</span>, <span class="hlFld-ContribAuthor ">Bruna Taciane da Silva  Bortoleti</span>, <span class="hlFld-ContribAuthor ">Tiago de Oliveira  Brito</span>, <span class="hlFld-ContribAuthor ">Ivete Conchon  Costa</span>, <span class="hlFld-ContribAuthor ">Camilo Henrique da Silva  Lima</span>, <span class="hlFld-ContribAuthor ">Fernando  Macedo</span>, <span class="hlFld-ContribAuthor ">Milena Menegazzo  Miranda-Sapla</span>, <span class="hlFld-ContribAuthor ">Wander Rogério  Pavanelli</span>, <span class="hlFld-ContribAuthor ">Marcelle de Lima Ferreira  Bispo</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the antileishmanial activity of
              N
              1
              ,
              N
              2
              -disubstituted-benzoylguanidines: synthesis and molecular modeling studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>85 </em>, 1-16. <a href="https://doi.org/10.1080/07391102.2021.1959403" title="DOI URL">https://doi.org/10.1080/07391102.2021.1959403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1959403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1959403%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DExploring%252Bthe%252Bantileishmanial%252Bactivity%252Bof%252BN%252B1%252B%25252C%252BN%252B2%252B-disubstituted-benzoylguanidines%25253A%252Bsynthesis%252Band%252Bmolecular%252Bmodeling%252Bstudies%26aulast%3DSantiago-Silva%26aufirst%3DKaio%2BMaciel%2Bde%26date%3D2021%26date%3D2021%26volume%3D85%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilie  Anduran</span>, <span class="hlFld-ContribAuthor ">Ludwig L  Dubois</span>, <span class="hlFld-ContribAuthor ">Philippe  Lambin</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Winum</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 – 2021. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>15 </em>, 1-12. <a href="https://doi.org/10.1080/13543776.2021.1954617" title="DOI URL">https://doi.org/10.1080/13543776.2021.1954617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1954617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1954617%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DHypoxia-activated%252Bprodrug%252Bderivatives%252Bof%252Banti-cancer%252Bdrugs%25253A%252Ba%252Bpatent%252Breview%252B2006%252B%2525E2%252580%252593%252B2021%26aulast%3DAnduran%26aufirst%3DEmilie%26date%3D2021%26date%3D2021%26volume%3D15%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandr K.  Kharchenko</span>, <span class="hlFld-ContribAuthor ">Ruslan V.  Fauziev</span>, <span class="hlFld-ContribAuthor ">Mikhail N.  Zharkov</span>, <span class="hlFld-ContribAuthor ">Ilya V.  Kuchurov</span>, <span class="hlFld-ContribAuthor ">Sergei G.  Zlotin</span>. </span><span class="cited-content_cbyCitation_article-title">Nitration of aromatics with dinitrogen pentoxide in a liquefied 1,1,1,2-tetrafluoroethane medium. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (42)
                                     , 25841-25847. <a href="https://doi.org/10.1039/D1RA04536A" title="DOI URL">https://doi.org/10.1039/D1RA04536A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA04536A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA04536A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DNitration%252Bof%252Baromatics%252Bwith%252Bdinitrogen%252Bpentoxide%252Bin%252Ba%252Bliquefied%252B1%25252C1%25252C1%25252C2-tetrafluoroethane%252Bmedium%26aulast%3DKharchenko%26aufirst%3DAlexandr%2BK.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D42%26spage%3D25841%26epage%3D25847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manpreet  Kaur</span>, <span class="hlFld-ContribAuthor ">Vikrant  Mehta</span>, <span class="hlFld-ContribAuthor ">Sahil  Arora</span>, <span class="hlFld-ContribAuthor ">Anjana  Munshi</span>, <span class="hlFld-ContribAuthor ">Sandeep  Singh</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of New 5‐(2‐Nitrophenyl)‐1‐aryl‐1
              H
              ‐pyrazoles as Topoisomerase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (26)
                                     , 6644-6651. <a href="https://doi.org/10.1002/slct.202101459" title="DOI URL">https://doi.org/10.1002/slct.202101459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202101459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202101459%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNew%252B5%2525E2%252580%252590%2525282%2525E2%252580%252590Nitrophenyl%252529%2525E2%252580%2525901%2525E2%252580%252590aryl%2525E2%252580%2525901%252BH%252B%2525E2%252580%252590pyrazoles%252Bas%252BTopoisomerase%252BInhibitors%26aulast%3DKaur%26aufirst%3DManpreet%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D26%26spage%3D6644%26epage%3D6651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Hyejin  Kim</span>, <span class="hlFld-ContribAuthor ">Pingyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Doerte R.  Fricke</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Tianzhi  Wang</span>, <span class="hlFld-ContribAuthor ">Qiang  Shen</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113427. <a href="https://doi.org/10.1016/j.ejmech.2021.113427" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113427%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFurther%252Blead%252Boptimization%252Bon%252BBax%252Bactivators%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252B2-fluoro-fluorene%252Bderivatives%252Bfor%252Bthe%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DLiu%26aufirst%3DGang%26date%3D2021%26volume%3D219%26spage%3D113427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haoran  Xue</span>, <span class="hlFld-ContribAuthor ">Haleigh  Svatek</span>, <span class="hlFld-ContribAuthor ">Ariane F.  Bertonha</span>, <span class="hlFld-ContribAuthor ">Keighley  Reisenauer</span>, <span class="hlFld-ContribAuthor ">Joshua  Robinson</span>, <span class="hlFld-ContribAuthor ">Minwoo  Kim</span>, <span class="hlFld-ContribAuthor ">Alec  Ingros</span>, <span class="hlFld-ContribAuthor ">Matthew  Ho</span>, <span class="hlFld-ContribAuthor ">Joseph  Taube</span>, <span class="hlFld-ContribAuthor ">Daniel  Romo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of agelastatin A and derivatives premised on a hidden symmetry element leading to analogs displaying anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>28 </em>, 132340. <a href="https://doi.org/10.1016/j.tet.2021.132340" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132340%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bagelastatin%252BA%252Band%252Bderivatives%252Bpremised%252Bon%252Ba%252Bhidden%252Bsymmetry%252Belement%252Bleading%252Bto%252Banalogs%252Bdisplaying%252Banticancer%252Bactivity%26aulast%3DXue%26aufirst%3DHaoran%26date%3D2021%26volume%3D28%26spage%3D132340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allison M.  Rice</span>, <span class="hlFld-ContribAuthor ">Allison  Faig</span>, <span class="hlFld-ContribAuthor ">David E.  Wolff</span>, <span class="hlFld-ContribAuthor ">S.  Bruce King</span>. </span><span class="cited-content_cbyCitation_article-title">Sodium borohydride and thiol mediated nitrite release from nitroaromatic antibiotics. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>30 </em>, 128245. <a href="https://doi.org/10.1016/j.bmcl.2021.128245" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128245%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSodium%252Bborohydride%252Band%252Bthiol%252Bmediated%252Bnitrite%252Brelease%252Bfrom%252Bnitroaromatic%252Bantibiotics%26aulast%3DRice%26aufirst%3DAllison%2BM.%26date%3D2021%26volume%3D30%26spage%3D128245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balungile  Madikizela</span>, <span class="hlFld-ContribAuthor ">Tamira  Eckhardt</span>, <span class="hlFld-ContribAuthor ">Richard  Goddard</span>, <span class="hlFld-ContribAuthor ">Adrian  Richter</span>, <span class="hlFld-ContribAuthor ">Anika  Lins</span>, <span class="hlFld-ContribAuthor ">Christoph  Lehmann</span>, <span class="hlFld-ContribAuthor ">Peter  Imming</span>, <span class="hlFld-ContribAuthor ">Rüdiger W.  Seidel</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>23 </em><a href="https://doi.org/10.1007/s00044-021-02735-4" title="DOI URL">https://doi.org/10.1007/s00044-021-02735-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02735-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02735-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%25252C%252Bstructural%252Bcharacterization%252Band%252Bantimycobacterial%252Bevaluation%252Bof%252Bseveral%252Bhalogenated%252Bnon-nitro%252Bbenzothiazinones%26aulast%3DMadikizela%26aufirst%3DBalungile%26date%3D2021%26date%3D2021%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-En  Qian</span>, <span class="hlFld-ContribAuthor ">Lan  Zheng</span>, <span class="hlFld-ContribAuthor ">Hao-Yue  Xiang</span>, <span class="hlFld-ContribAuthor ">Hua  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in the nitration of arenes and alkenes. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (22)
                                     , 4835-4851. <a href="https://doi.org/10.1039/D1OB00384D" title="DOI URL">https://doi.org/10.1039/D1OB00384D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00384D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00384D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252Bthe%252Bnitration%252Bof%252Barenes%252Band%252Balkenes%26aulast%3DQian%26aufirst%3DYu-En%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D22%26spage%3D4835%26epage%3D4851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young-Hwan  Jung</span>, <span class="hlFld-ContribAuthor ">Shanu  Jain</span>, <span class="hlFld-ContribAuthor ">Varun  Gopinatth</span>, <span class="hlFld-ContribAuthor ">Ngan B.  Phung</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Structure activity relationship of 3-nitro-2-(trifluoromethyl)-2H-chromene derivatives as P2Y6 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>41 </em>, 128008. <a href="https://doi.org/10.1016/j.bmcl.2021.128008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Bactivity%252Brelationship%252Bof%252B3-nitro-2-%252528trifluoromethyl%252529-2H-chromene%252Bderivatives%252Bas%252BP2Y6%252Breceptor%252Bantagonists%26aulast%3DJung%26aufirst%3DYoung-Hwan%26date%3D2021%26volume%3D41%26spage%3D128008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia M.  Toro</span>, <span class="hlFld-ContribAuthor ">Francisco  Peralta</span>, <span class="hlFld-ContribAuthor ">Juan  Oyarzo</span>, <span class="hlFld-ContribAuthor ">Shane R.  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Mónica  Zavala</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Arancibia</span>, <span class="hlFld-ContribAuthor ">Mauricio  Moncada-Basualto</span>, <span class="hlFld-ContribAuthor ">Iván  Brito</span>, <span class="hlFld-ContribAuthor ">Jonathan  Cisterna</span>, <span class="hlFld-ContribAuthor ">A. Hugo  Klahn</span>, <span class="hlFld-ContribAuthor ">Concepción  López</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of trypanocidal properties of ferrocenyl and cyrhetrenyl N-acylhydrazones with pendant 5-nitrofuryl group. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2021,</strong> <em>219 </em>, 111428. <a href="https://doi.org/10.1016/j.jinorgbio.2021.111428" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2021.111428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2021.111428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2021.111428%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DEvaluation%252Bof%252Btrypanocidal%252Bproperties%252Bof%252Bferrocenyl%252Band%252Bcyrhetrenyl%252BN-acylhydrazones%252Bwith%252Bpendant%252B5-nitrofuryl%252Bgroup%26aulast%3DToro%26aufirst%3DPatricia%2BM.%26date%3D2021%26volume%3D219%26spage%3D111428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nanami  Shirakami</span>, <span class="hlFld-ContribAuthor ">Sayuri L.  Higashi</span>, <span class="hlFld-ContribAuthor ">Yugo  Kawaki</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Kitamura</span>, <span class="hlFld-ContribAuthor ">Aya  Shibata</span>, <span class="hlFld-ContribAuthor ">Masato  Ikeda</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of a reduction-responsive oligonucleotide via a post-modification approach utilizing 4-nitrophenyl diazomethane. </span><span class="cited-content_cbyCitation_journal-name">Polymer Journal</span><span> <strong>2021,</strong> <em>53 </em>
                                    (6)
                                     , 741-746. <a href="https://doi.org/10.1038/s41428-021-00464-4" title="DOI URL">https://doi.org/10.1038/s41428-021-00464-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41428-021-00464-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41428-021-00464-4%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymer%2520Journal%26atitle%3DConstruction%252Bof%252Ba%252Breduction-responsive%252Boligonucleotide%252Bvia%252Ba%252Bpost-modification%252Bapproach%252Butilizing%252B4-nitrophenyl%252Bdiazomethane%26aulast%3DShirakami%26aufirst%3DNanami%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D6%26spage%3D741%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elvan  Üstün</span>, <span class="hlFld-ContribAuthor ">Mutlu S.  Çelebi</span>, <span class="hlFld-ContribAuthor ">Melek Ç.  Ayvaz</span>, <span class="hlFld-ContribAuthor ">Neslihan  Şahin</span>. </span><span class="cited-content_cbyCitation_article-title">PEPPSI complexes as potential prodrugs: enzyme inhibition, antioxidant activity, electrochemical characterization, molecular docking analysis. </span><span class="cited-content_cbyCitation_journal-name">Zeitschrift für Naturforschung C</span><span> <strong>2021,</strong> <em>76 </em>
                                    (5-6)
                                     , 219-227. <a href="https://doi.org/10.1515/znc-2020-0295" title="DOI URL">https://doi.org/10.1515/znc-2020-0295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/znc-2020-0295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fznc-2020-0295%26sid%3Dliteratum%253Aachs%26jtitle%3DZeitschrift%2520f%25C3%25BCr%2520Naturforschung%2520C%26atitle%3DPEPPSI%252Bcomplexes%252Bas%252Bpotential%252Bprodrugs%25253A%252Benzyme%252Binhibition%25252C%252Bantioxidant%252Bactivity%25252C%252Belectrochemical%252Bcharacterization%25252C%252Bmolecular%252Bdocking%252Banalysis%26aulast%3D%25C3%259Cst%25C3%25BCn%26aufirst%3DElvan%26date%3D2021%26date%3D2021%26volume%3D76%26issue%3D5-6%26spage%3D219%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Filia  Stephanie</span>, <span class="hlFld-ContribAuthor ">Mutiara  Saragih</span>, <span class="hlFld-ContribAuthor ">Usman Sumo Friend  Tambunan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (5)
                                     , 592. <a href="https://doi.org/10.3390/pharmaceutics13050592" title="DOI URL">https://doi.org/10.3390/pharmaceutics13050592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13050592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13050592%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DRecent%252BProgress%252Band%252BChallenges%252Bfor%252BDrug-Resistant%252BTuberculosis%252BTreatment%26aulast%3DStephanie%26aufirst%3DFilia%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D5%26spage%3D592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carol  Thomas</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Gwenin</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Nitroreductases in Resistance to Nitroimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Biology</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 388. <a href="https://doi.org/10.3390/biology10050388" title="DOI URL">https://doi.org/10.3390/biology10050388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biology10050388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiology10050388%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%26atitle%3DThe%252BRole%252Bof%252BNitroreductases%252Bin%252BResistance%252Bto%252BNitroimidazoles%26aulast%3DThomas%26aufirst%3DCarol%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D5%26spage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yudha P.  Budiman</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Westcott</span>, <span class="hlFld-ContribAuthor ">Udo  Radius</span>, <span class="hlFld-ContribAuthor ">Todd B.  Marder</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated Aryl Boronates as Building Blocks in Organic Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (9)
                                     , 2224-2255. <a href="https://doi.org/10.1002/adsc.202001291" title="DOI URL">https://doi.org/10.1002/adsc.202001291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202001291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202001291%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DFluorinated%252BAryl%252BBoronates%252Bas%252BBuilding%252BBlocks%252Bin%252BOrganic%252BSynthesis%26aulast%3DBudiman%26aufirst%3DYudha%2BP.%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D9%26spage%3D2224%26epage%3D2255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shushu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Wu</span>, <span class="hlFld-ContribAuthor ">Yuqing  Zhang</span>, <span class="hlFld-ContribAuthor ">Dong  Zhang</span>, <span class="hlFld-ContribAuthor ">Boyu  Xie</span>, <span class="hlFld-ContribAuthor ">Zhixiang  Pan</span>, <span class="hlFld-ContribAuthor ">Kunfu  Ouyang</span>, <span class="hlFld-ContribAuthor ">Tao  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a highly efficient nitroaryl group for detection of nitroreductase and imaging of hypoxic tumor cells. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (15)
                                     , 3469-3478. <a href="https://doi.org/10.1039/D1OB00356A" title="DOI URL">https://doi.org/10.1039/D1OB00356A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00356A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00356A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bhighly%252Befficient%252Bnitroaryl%252Bgroup%252Bfor%252Bdetection%252Bof%252Bnitroreductase%252Band%252Bimaging%252Bof%252Bhypoxic%252Btumor%252Bcells%26aulast%3DWang%26aufirst%3DShushu%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D15%26spage%3D3469%26epage%3D3478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Conor R.  Caffrey</span>, <span class="hlFld-ContribAuthor ">Dietmar  Steverding</span>, <span class="hlFld-ContribAuthor ">Rafaela S.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Renata B.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Anthony J.  O'Donoghue</span>, <span class="hlFld-ContribAuthor ">Ludovica  Monti</span>, <span class="hlFld-ContribAuthor ">Carlo  Ballatore</span>, <span class="hlFld-ContribAuthor ">Kelly A.  Bachovchin</span>, <span class="hlFld-ContribAuthor ">Lori  Ferrins</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>, <span class="hlFld-ContribAuthor ">Kimberley M.  Zorn</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Foil</span>, <span class="hlFld-ContribAuthor ">Alex M.  Clark</span>, <span class="hlFld-ContribAuthor ">Melina  Mottin</span>, <span class="hlFld-ContribAuthor ">Carolina H.  Andrade</span>, <span class="hlFld-ContribAuthor ">Jair L.  Siqueira‐Neto</span>, <span class="hlFld-ContribAuthor ">Sean  Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery and Development for Kinetoplastid Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-79. <a href="https://doi.org/10.1002/0471266949.bmc235.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc235.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc235.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc235.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BDiscovery%252Band%252BDevelopment%252Bfor%252BKinetoplastid%252BDiseases%26aulast%3DCaffrey%26aufirst%3DConor%2BR.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D79%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Korkit  Korvorapun</span>, <span class="hlFld-ContribAuthor ">Ramesh C.  Samanta</span>, <span class="hlFld-ContribAuthor ">Torben  Rogge</span>, <span class="hlFld-ContribAuthor ">Lutz  Ackermann</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium‐Catalyzed Remote
              C
              –
              H
              Functionalizations. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 137-167. <a href="https://doi.org/10.1002/9783527824137.ch5" title="DOI URL">https://doi.org/10.1002/9783527824137.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527824137.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527824137.ch5%26sid%3Dliteratum%253Aachs%26atitle%3DRuthenium%2525E2%252580%252590Catalyzed%252BRemote%252BC%252B%2525E2%252580%252593%252BH%252BFunctionalizations%26aulast%3DKorvorapun%26aufirst%3DKorkit%26date%3D2021%26date%3D2021%26spage%3D137%26epage%3D167%26pub%3DWiley%26atitle%3DRemote%252BC%2525EF%2525A3%2525BFH%252BBond%252BFunctionalizations%26aulast%3DMaiti%26aufirst%3DDebabrata%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huajian  Zhu</span>, <span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Shuai</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Limei  Yang</span>, <span class="hlFld-ContribAuthor ">Yuchen  Tan</span>, <span class="hlFld-ContribAuthor ">Tiandong  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong  Yao</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Dong-Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113316. <a href="https://doi.org/10.1016/j.ejmech.2021.113316" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113316%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BN-benzylbenzamide%252Bderivatives%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%252Bwith%252Bpotent%252Bantitumor%252Bactivities%26aulast%3DZhu%26aufirst%3DHuajian%26date%3D2021%26volume%3D216%26spage%3D113316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jadriane  de Almeida Xavier</span>, <span class="hlFld-ContribAuthor ">Thaissa L.  Silva</span>, <span class="hlFld-ContribAuthor ">Eduardo Caio  Torres-Santos</span>, <span class="hlFld-ContribAuthor ">Camila Calado  de Vasconcelos</span>, <span class="hlFld-ContribAuthor ">Anastacio  Boane</span>, <span class="hlFld-ContribAuthor ">Ricardo Alexandre  dos Santos</span>, <span class="hlFld-ContribAuthor ">Andre Felippe A.  Xavier</span>, <span class="hlFld-ContribAuthor ">Marília O.F.  Goulart</span>. </span><span class="cited-content_cbyCitation_article-title">Unveiling the relevance of the redox character of nitroaromatic and nitroheteroaromatic compounds as potential medicines. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Electrochemistry</span><span> <strong>2021,</strong> <em>23 </em>, 100740. <a href="https://doi.org/10.1016/j.coelec.2021.100740" title="DOI URL">https://doi.org/10.1016/j.coelec.2021.100740</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coelec.2021.100740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coelec.2021.100740%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Electrochemistry%26atitle%3DUnveiling%252Bthe%252Brelevance%252Bof%252Bthe%252Bredox%252Bcharacter%252Bof%252Bnitroaromatic%252Band%252Bnitroheteroaromatic%252Bcompounds%252Bas%252Bpotential%252Bmedicines%26aulast%3Dde%2BAlmeida%2BXavier%26aufirst%3DJadriane%26date%3D2021%26volume%3D23%26spage%3D100740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatu  Rimpilauinen</span>, <span class="hlFld-ContribAuthor ">Alexandra  Nunes</span>, <span class="hlFld-ContribAuthor ">Rita  Calado</span>, <span class="hlFld-ContribAuthor ">Ana S.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Joana  Andrade</span>, <span class="hlFld-ContribAuthor ">Epole  Ntungwe</span>, <span class="hlFld-ContribAuthor ">Gabriella  Spengler</span>, <span class="hlFld-ContribAuthor ">Nikoletta  Szemerédi</span>, <span class="hlFld-ContribAuthor ">Joao  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Joao Paulo  Gomes</span>, <span class="hlFld-ContribAuthor ">Patricia  Rijo</span>, <span class="hlFld-ContribAuthor ">Nuno R.  Candeias</span>. </span><span class="cited-content_cbyCitation_article-title">Increased antibacterial properties of indoline-derived phenolic Mannich bases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>18 </em>, 113459. <a href="https://doi.org/10.1016/j.ejmech.2021.113459" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113459%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIncreased%252Bantibacterial%252Bproperties%252Bof%252Bindoline-derived%252Bphenolic%252BMannich%252Bbases%26aulast%3DRimpilauinen%26aufirst%3DTatu%26date%3D2021%26volume%3D18%26spage%3D113459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phelelisiwe S.  Dube</span>, <span class="hlFld-ContribAuthor ">Lesetja J.  Legoabe</span>, <span class="hlFld-ContribAuthor ">Audrey  Jordaan</span>, <span class="hlFld-ContribAuthor ">Omobolanle J.  Jesumoroti</span>, <span class="hlFld-ContribAuthor ">Tendamudzimu  Tshiwawa</span>, <span class="hlFld-ContribAuthor ">Digby F.  Warner</span>, <span class="hlFld-ContribAuthor ">Richard M.  Beteck</span>. </span><span class="cited-content_cbyCitation_article-title">Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113207. <a href="https://doi.org/10.1016/j.ejmech.2021.113207" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113207%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEasily%252Baccessed%252Bnitroquinolones%252Bexhibiting%252Bpotent%252Band%252Bselective%252Banti-tubercular%252Bactivity%26aulast%3DDube%26aufirst%3DPhelelisiwe%2BS.%26date%3D2021%26volume%3D213%26spage%3D113207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelyne  Haroun</span>, <span class="hlFld-ContribAuthor ">Christophe  Tratrat</span>, <span class="hlFld-ContribAuthor ">Aggeliki  Kolokotroni</span>, <span class="hlFld-ContribAuthor ">Anthi  Petrou</span>, <span class="hlFld-ContribAuthor ">Athina  Geronikaki</span>, <span class="hlFld-ContribAuthor ">Marija  Ivanov</span>, <span class="hlFld-ContribAuthor ">Marina  Kostic</span>, <span class="hlFld-ContribAuthor ">Marina  Sokovic</span>, <span class="hlFld-ContribAuthor ">Alejandro  Carazo</span>, <span class="hlFld-ContribAuthor ">Přemysl  Mladěnka</span>, <span class="hlFld-ContribAuthor ">Nagaraja  Sreeharsha</span>, <span class="hlFld-ContribAuthor ">Katharigatta N.  Venugopala</span>, <span class="hlFld-ContribAuthor ">Anroop B.  Nair</span>, <span class="hlFld-ContribAuthor ">Heba S.  Elsewedy</span>. </span><span class="cited-content_cbyCitation_article-title">5-Benzyliden-2-(5-methylthiazol-2-ylimino)thiazolidin-4-ones as Antimicrobial Agents. Design, Synthesis, Biological Evaluation and Molecular Docking Studies. </span><span class="cited-content_cbyCitation_journal-name">Antibiotics</span><span> <strong>2021,</strong> <em>10 </em>
                                    (3)
                                     , 309. <a href="https://doi.org/10.3390/antibiotics10030309" title="DOI URL">https://doi.org/10.3390/antibiotics10030309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antibiotics10030309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantibiotics10030309%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%26atitle%3D5-Benzyliden-2-%2525285-methylthiazol-2-ylimino%252529thiazolidin-4-ones%252Bas%252BAntimicrobial%252BAgents.%252BDesign%25252C%252BSynthesis%25252C%252BBiological%252BEvaluation%252Band%252BMolecular%252BDocking%252BStudies%26aulast%3DHaroun%26aufirst%3DMichelyne%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D3%26spage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Žan  Toplak</span>, <span class="hlFld-ContribAuthor ">Louise Antonia  Hendrickx</span>, <span class="hlFld-ContribAuthor ">Špela  Gubič</span>, <span class="hlFld-ContribAuthor ">Štefan  Možina</span>, <span class="hlFld-ContribAuthor ">Bojana  Žegura</span>, <span class="hlFld-ContribAuthor ">Alja  Štern</span>, <span class="hlFld-ContribAuthor ">Matjaž  Novak</span>, <span class="hlFld-ContribAuthor ">Xiaoyi  Shi</span>, <span class="hlFld-ContribAuthor ">Steve  Peigneur</span>, <span class="hlFld-ContribAuthor ">Jan  Tytgat</span>, <span class="hlFld-ContribAuthor ">Tihomir  Tomašič</span>, <span class="hlFld-ContribAuthor ">Luis A.  Pardo</span>, <span class="hlFld-ContribAuthor ">Lucija Peterlin  Mašič</span>. </span><span class="cited-content_cbyCitation_article-title">3D Pharmacophore-Based Discovery of Novel KV10.1 Inhibitors with Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (6)
                                     , 1244. <a href="https://doi.org/10.3390/cancers13061244" title="DOI URL">https://doi.org/10.3390/cancers13061244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13061244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13061244%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3D3D%252BPharmacophore-Based%252BDiscovery%252Bof%252BNovel%252BKV10.1%252BInhibitors%252Bwith%252BAntiproliferative%252BActivity%26aulast%3DToplak%26aufirst%3D%25C5%25BDan%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D6%26spage%3D1244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Li</span>, <span class="hlFld-ContribAuthor ">Liu  Yang</span>, <span class="hlFld-ContribAuthor ">Jian‐Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Rui  Cao</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Zunting  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianliang  Xiao</span>, <span class="hlFld-ContribAuthor ">Dong  Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Light‐Promoted C–N Coupling of Aryl Halides with Nitroarenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (10)
                                     , 5290-5294. <a href="https://doi.org/10.1002/ange.202012877" title="DOI URL">https://doi.org/10.1002/ange.202012877</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202012877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202012877%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DLight%2525E2%252580%252590Promoted%252BC%2525E2%252580%252593N%252BCoupling%252Bof%252BAryl%252BHalides%252Bwith%252BNitroarenes%26aulast%3DLi%26aufirst%3DGang%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D10%26spage%3D5290%26epage%3D5294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Li</span>, <span class="hlFld-ContribAuthor ">Liu  Yang</span>, <span class="hlFld-ContribAuthor ">Jian‐Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Rui  Cao</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Zunting  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianliang  Xiao</span>, <span class="hlFld-ContribAuthor ">Dong  Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Light‐Promoted C–N Coupling of Aryl Halides with Nitroarenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (10)
                                     , 5230-5234. <a href="https://doi.org/10.1002/anie.202012877" title="DOI URL">https://doi.org/10.1002/anie.202012877</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202012877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202012877%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DLight%2525E2%252580%252590Promoted%252BC%2525E2%252580%252593N%252BCoupling%252Bof%252BAryl%252BHalides%252Bwith%252BNitroarenes%26aulast%3DLi%26aufirst%3DGang%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D10%26spage%3D5230%26epage%3D5234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sangwoon  Park</span>, <span class="hlFld-ContribAuthor ">Seungri  Yoon</span>, <span class="hlFld-ContribAuthor ">Sun‐Joon  Min</span>. </span><span class="cited-content_cbyCitation_article-title">Metal‐free Synthesis of
              β‐Nitrostyrenes
              via
              DDQ‐Catalyzed
              Nitration. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2021,</strong> <em>42 </em>
                                    (3)
                                     , 525-528. <a href="https://doi.org/10.1002/bkcs.12232" title="DOI URL">https://doi.org/10.1002/bkcs.12232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.12232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.12232%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DMetal%2525E2%252580%252590free%252BSynthesis%252Bof%252B%2525CE%2525B2%2525E2%252580%252590Nitrostyrenes%252Bvia%252BDDQ%2525E2%252580%252590Catalyzed%252BNitration%26aulast%3DPark%26aufirst%3DSangwoon%26date%3D2021%26date%3D2021%26volume%3D42%26issue%3D3%26spage%3D525%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siddharth S.  Patel</span>, <span class="hlFld-ContribAuthor ">Dhaval B.  Patel</span>, <span class="hlFld-ContribAuthor ">Hitesh D.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Protocols for Aromatic Nitration: A Review. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (6)
                                     , 1337-1356. <a href="https://doi.org/10.1002/slct.202004695" title="DOI URL">https://doi.org/10.1002/slct.202004695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202004695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202004695%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthetic%252BProtocols%252Bfor%252BAromatic%252BNitration%25253A%252BA%252BReview%26aulast%3DPatel%26aufirst%3DSiddharth%2BS.%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D6%26spage%3D1337%26epage%3D1356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Lowell  Markley</span>, <span class="hlFld-ContribAuthor ">Patricia A.  Miller</span>, <span class="hlFld-ContribAuthor ">Scott  Franzblau</span>, <span class="hlFld-ContribAuthor ">Gauri  Shetye</span>, <span class="hlFld-ContribAuthor ">Rui  Ma</span>, <span class="hlFld-ContribAuthor ">Karin  Savková</span>, <span class="hlFld-ContribAuthor ">Katarína  Mikušová</span>, <span class="hlFld-ContribAuthor ">Bei Shi  Lee</span>, <span class="hlFld-ContribAuthor ">Kevin  Pethe</span>, <span class="hlFld-ContribAuthor ">Garrett C.  Moraski</span>, <span class="hlFld-ContribAuthor ">Marvin J.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 62-72. <a href="https://doi.org/10.1039/D0MD00390E" title="DOI URL">https://doi.org/10.1039/D0MD00390E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00390E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00390E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DHydride-induced%252BMeisenheimer%252Bcomplex%252Bformation%252Breflects%252Bactivity%252Bof%252Bnitro%252Baromatic%252Banti-tuberculosis%252Bcompounds%26aulast%3DLiu%26aufirst%3DRui%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D62%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Bing‐jie  Hou</span>, <span class="hlFld-ContribAuthor ">Yan‐yan  Li</span>, <span class="hlFld-ContribAuthor ">Wen‐yuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia‐cheng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">DNA interactive and selective anticancer activity studies of copper(II) complexes decorated water‐soluble porphyrin. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2021,</strong> <em>35 </em>
                                    (2)
                                     <a href="https://doi.org/10.1002/aoc.6094" title="DOI URL">https://doi.org/10.1002/aoc.6094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.6094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.6094%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DDNA%252Binteractive%252Band%252Bselective%252Banticancer%252Bactivity%252Bstudies%252Bof%252Bcopper%252528II%252529%252Bcomplexes%252Bdecorated%252Bwater%2525E2%252580%252590soluble%252Bporphyrin%26aulast%3DZhang%26aufirst%3DQian%26date%3D2021%26date%3D2020%26volume%3D35%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W.M.A.  Niessen</span>. </span><span class="cited-content_cbyCitation_article-title">Tandem mass spectrometry of organic nitro and halogen compounds: Competition between losses of molecules and of radicals. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Mass Spectrometry</span><span> <strong>2021,</strong> <em>460 </em>, 116496. <a href="https://doi.org/10.1016/j.ijms.2020.116496" title="DOI URL">https://doi.org/10.1016/j.ijms.2020.116496</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijms.2020.116496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijms.2020.116496%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Mass%2520Spectrometry%26atitle%3DTandem%252Bmass%252Bspectrometry%252Bof%252Borganic%252Bnitro%252Band%252Bhalogen%252Bcompounds%25253A%252BCompetition%252Bbetween%252Blosses%252Bof%252Bmolecules%252Band%252Bof%252Bradicals%26aulast%3DNiessen%26aufirst%3DW.M.A.%26date%3D2021%26volume%3D460%26spage%3D116496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allison M.  Rice</span>, <span class="hlFld-ContribAuthor ">Yueming  Long</span>, <span class="hlFld-ContribAuthor ">S. Bruce  King</span>. </span><span class="cited-content_cbyCitation_article-title">Nitroaromatic Antibiotics as Nitrogen Oxide Sources. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 267. <a href="https://doi.org/10.3390/biom11020267" title="DOI URL">https://doi.org/10.3390/biom11020267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11020267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11020267%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DNitroaromatic%252BAntibiotics%252Bas%252BNitrogen%252BOxide%252BSources%26aulast%3DRice%26aufirst%3DAllison%2BM.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando de  Moura Gatti</span>, <span class="hlFld-ContribAuthor ">Renan Augusto  Gomes</span>, <span class="hlFld-ContribAuthor ">Amanda Luisa  da Fonseca</span>, <span class="hlFld-ContribAuthor ">Elys Juliane  Cardoso Lima</span>, <span class="hlFld-ContribAuthor ">Drielli Gomes  Vital-Fujii</span>, <span class="hlFld-ContribAuthor ">Alex Guterres  Taranto</span>, <span class="hlFld-ContribAuthor ">Fernando de  Pilla Varotti</span>, <span class="hlFld-ContribAuthor ">Gustavo Henrique  Goulart Trossini</span>. </span><span class="cited-content_cbyCitation_article-title">Antiplasmodial activity of sulfonylhydrazones:
              in vitro
              and
              in silico
              approaches. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 233-250. <a href="https://doi.org/10.4155/fmc-2020-0229" title="DOI URL">https://doi.org/10.4155/fmc-2020-0229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0229%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAntiplasmodial%252Bactivity%252Bof%252Bsulfonylhydrazones%25253A%252Bin%252Bvitro%252Band%252Bin%252Bsilico%252Bapproaches%26aulast%3DMoura%2BGatti%26aufirst%3DFernando%2Bde%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D233%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxim A.  Bastrakov</span>, <span class="hlFld-ContribAuthor ">Alexey M.  Starosotnikov</span>, <span class="hlFld-ContribAuthor ">Ivan V.  Fedyanin</span>, <span class="hlFld-ContribAuthor ">Igor L.  Dalinger</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new 2-substituted 6,8-dinitro[1,2,4]triazolo[1,5-a]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2021,</strong> <em>57 </em>
                                    (1)
                                     , 95-98. <a href="https://doi.org/10.1007/s10593-021-02873-y" title="DOI URL">https://doi.org/10.1007/s10593-021-02873-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-021-02873-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-021-02873-y%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Bof%252Bnew%252B2-substituted%252B6%25252C8-dinitro%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyridines%26aulast%3DBastrakov%26aufirst%3DMaxim%2BA.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D1%26spage%3D95%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Om P.S.  Patel</span>, <span class="hlFld-ContribAuthor ">Omobolanle Janet  Jesumoroti</span>, <span class="hlFld-ContribAuthor ">Lesetja J.  Legoabe</span>, <span class="hlFld-ContribAuthor ">Richard M.  Beteck</span>. </span><span class="cited-content_cbyCitation_article-title">Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112994. <a href="https://doi.org/10.1016/j.ejmech.2020.112994" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112994</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112994%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetronidazole-conjugates%25253A%252BA%252Bcomprehensive%252Breview%252Bof%252Brecent%252Bdevelopments%252Btowards%252Bsynthesis%252Band%252Bmedicinal%252Bperspective%26aulast%3DPatel%26aufirst%3DOm%2BP.S.%26date%3D2021%26volume%3D210%26spage%3D112994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia M.  Toro</span>, <span class="hlFld-ContribAuthor ">Juan  Oyarzo</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Arancibia</span>, <span class="hlFld-ContribAuthor ">Shane  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Vania  Artigas</span>, <span class="hlFld-ContribAuthor ">Mauricio  Fuentealba</span>, <span class="hlFld-ContribAuthor ">Mauricio  Moncada-Basualto</span>, <span class="hlFld-ContribAuthor ">Claudio  Olea-Azar</span>, <span class="hlFld-ContribAuthor ">Andrés  Vega</span>, <span class="hlFld-ContribAuthor ">A.  Hugo Klahn</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of chemical and biological properties of organometallic complexes containing 4- and 5-nitrothienyl groups. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2021,</strong> <em>193 </em>, 114872. <a href="https://doi.org/10.1016/j.poly.2020.114872" title="DOI URL">https://doi.org/10.1016/j.poly.2020.114872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2020.114872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2020.114872%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DComparison%252Bof%252Bchemical%252Band%252Bbiological%252Bproperties%252Bof%252Borganometallic%252Bcomplexes%252Bcontaining%252B4-%252Band%252B5-nitrothienyl%252Bgroups%26aulast%3DToro%26aufirst%3DPatricia%2BM.%26date%3D2021%26volume%3D193%26spage%3D114872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Songuigama  Coulibaly</span>, <span class="hlFld-ContribAuthor ">Mena  Cimino</span>, <span class="hlFld-ContribAuthor ">Mahama  Ouattara</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Maria V.  Buchieri</span>, <span class="hlFld-ContribAuthor ">Noelia  Alonso-Rodriguez</span>, <span class="hlFld-ContribAuthor ">Julien  Briffotaux</span>, <span class="hlFld-ContribAuthor ">Damien  Mornico</span>, <span class="hlFld-ContribAuthor ">Brigitte  Gicquel</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Phenanthrolinic analogs of quinolones show antibacterial activity against M. tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>207 </em>, 112821. <a href="https://doi.org/10.1016/j.ejmech.2020.112821" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112821%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhenanthrolinic%252Banalogs%252Bof%252Bquinolones%252Bshow%252Bantibacterial%252Bactivity%252Bagainst%252BM.%2525C2%2525A0tuberculosis%26aulast%3DCoulibaly%26aufirst%3DSonguigama%26date%3D2020%26volume%3D207%26spage%3D112821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Saqib</span>, <span class="hlFld-ContribAuthor ">Eugene  Arthur-Baidoo</span>, <span class="hlFld-ContribAuthor ">Milan  Ončák</span>, <span class="hlFld-ContribAuthor ">Stephan  Denifl</span>. </span><span class="cited-content_cbyCitation_article-title">Electron Attachment Studies with the Potential Radiosensitizer 2-Nitrofuran. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 8906. <a href="https://doi.org/10.3390/ijms21238906" title="DOI URL">https://doi.org/10.3390/ijms21238906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21238906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21238906%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DElectron%252BAttachment%252BStudies%252Bwith%252Bthe%252BPotential%252BRadiosensitizer%252B2-Nitrofuran%26aulast%3DSaqib%26aufirst%3DMuhammad%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D8906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manvinder  Kaur</span>, <span class="hlFld-ContribAuthor ">Mohamad  Yusuf</span>, <span class="hlFld-ContribAuthor ">Dharambeer Singh  Malhi</span>, <span class="hlFld-ContribAuthor ">Harvinder Singh  Sohal</span>. </span><span class="cited-content_cbyCitation_article-title">Bis-dihydroisoxazolines: Synthesis, Structural Elucidation, Antimicrobial Evaluation, and DNA Photocleavage Assay. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Synthesis</span><span> <strong>2020,</strong> <em>17 </em>
                                    (8)
                                     , 671-678. <a href="https://doi.org/10.2174/1570179417666200713181959" title="DOI URL">https://doi.org/10.2174/1570179417666200713181959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570179417666200713181959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570179417666200713181959%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Synthesis%26atitle%3DBis-dihydroisoxazolines%25253A%252BSynthesis%25252C%252BStructural%252BElucidation%25252C%252BAntimicrobial%252BEvaluation%25252C%252Band%252BDNA%252BPhotocleavage%252BAssay%26aulast%3DKaur%26aufirst%3DManvinder%26date%3D2020%26volume%3D17%26issue%3D8%26spage%3D671%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniil N.  Lyapustin</span>, <span class="hlFld-ContribAuthor ">Evgeny N.  Ulomsky</span>, <span class="hlFld-ContribAuthor ">Vladimir L.  Rusinov</span>. </span><span class="cited-content_cbyCitation_article-title">6-Nitro-4,7-dihydroazolo [1,5-a]pyrimidines: an alternative mechanism of formation and studies of alkylation. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (11)
                                     , 1465-1472. <a href="https://doi.org/10.1007/s10593-020-02839-6" title="DOI URL">https://doi.org/10.1007/s10593-020-02839-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-020-02839-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-020-02839-6%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3D6-Nitro-4%25252C7-dihydroazolo%252B%25255B1%25252C5-a%25255Dpyrimidines%25253A%252Ban%252Balternative%252Bmechanism%252Bof%252Bformation%252Band%252Bstudies%252Bof%252Balkylation%26aulast%3DLyapustin%26aufirst%3DDaniil%2BN.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D11%26spage%3D1465%26epage%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mckayla  Stevens</span>, <span class="hlFld-ContribAuthor ">Chris  Howe</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Ray</span>, <span class="hlFld-ContribAuthor ">Alex  Washburn</span>, <span class="hlFld-ContribAuthor ">Siddhi  Chitre</span>, <span class="hlFld-ContribAuthor ">Jared  Sivinski</span>, <span class="hlFld-ContribAuthor ">Yangshin  Park</span>, <span class="hlFld-ContribAuthor ">Quyen Q.  Hoang</span>, <span class="hlFld-ContribAuthor ">Eli  Chapman</span>, <span class="hlFld-ContribAuthor ">Steven M.  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Analogs of nitrofuran antibiotics are potent GroEL/ES inhibitor pro-drugs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (22)
                                     , 115710. <a href="https://doi.org/10.1016/j.bmc.2020.115710" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115710%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAnalogs%252Bof%252Bnitrofuran%252Bantibiotics%252Bare%252Bpotent%252BGroEL%25252FES%252Binhibitor%252Bpro-drugs%26aulast%3DStevens%26aufirst%3DMckayla%26date%3D2020%26volume%3D28%26issue%3D22%26spage%3D115710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cyril  Fersing</span>, <span class="hlFld-ContribAuthor ">Clotilde  Boudot</span>, <span class="hlFld-ContribAuthor ">Romain  Paoli-Lombardo</span>, <span class="hlFld-ContribAuthor ">Nicolas  Primas</span>, <span class="hlFld-ContribAuthor ">Emilie  Pinault</span>, <span class="hlFld-ContribAuthor ">Sébastien  Hutter</span>, <span class="hlFld-ContribAuthor ">Caroline  Castera-Ducros</span>, <span class="hlFld-ContribAuthor ">Youssef  Kabri</span>, <span class="hlFld-ContribAuthor ">Julien  Pedron</span>, <span class="hlFld-ContribAuthor ">Sandra  Bourgeade-Delmas</span>, <span class="hlFld-ContribAuthor ">Alix  Sournia-Saquet</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Stigliani</span>, <span class="hlFld-ContribAuthor ">Alexis  Valentin</span>, <span class="hlFld-ContribAuthor ">Amaya  Azqueta</span>, <span class="hlFld-ContribAuthor ">Damián  Muruzabal</span>, <span class="hlFld-ContribAuthor ">Alexandre  Destere</span>, <span class="hlFld-ContribAuthor ">Susan  Wyllie</span>, <span class="hlFld-ContribAuthor ">Alan H.  Fairlamb</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Aurélie  Malzert-Fréon</span>, <span class="hlFld-ContribAuthor ">Carole  Di Giorgio</span>, <span class="hlFld-ContribAuthor ">Pascal  Rathelot</span>, <span class="hlFld-ContribAuthor ">Nadine  Azas</span>, <span class="hlFld-ContribAuthor ">Bertrand  Courtioux</span>, <span class="hlFld-ContribAuthor ">Patrice  Vanelle</span>, <span class="hlFld-ContribAuthor ">Pierre  Verhaeghe</span>. </span><span class="cited-content_cbyCitation_article-title">Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112668. <a href="https://doi.org/10.1016/j.ejmech.2020.112668" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112668</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112668%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntikinetoplastid%252BSAR%252Bstudy%252Bin%252B3-nitroimidazopyridine%252Bseries%25253A%252BIdentification%252Bof%252Ba%252Bnovel%252Bnon-genotoxic%252Band%252Bpotent%252Banti-T.%2525C2%2525A0b.%252Bbrucei%252Bhit-compound%252Bwith%252Bimproved%252Bpharmacokinetic%252Bproperties%26aulast%3DFersing%26aufirst%3DCyril%26date%3D2020%26volume%3D206%26spage%3D112668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christina  Kannigadu</span>, <span class="hlFld-ContribAuthor ">David. D.  N'Da</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Synthesis and Development of Nitroaromatics as Anti-Infective Drugs. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2020,</strong> <em>26 </em>
                                    (36)
                                     , 4658-4674. <a href="https://doi.org/10.2174/1381612826666200331091853" title="DOI URL">https://doi.org/10.2174/1381612826666200331091853</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612826666200331091853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612826666200331091853%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BSynthesis%252Band%252BDevelopment%252Bof%252BNitroaromatics%252Bas%252BAnti-Infective%252BDrugs%26aulast%3DKannigadu%26aufirst%3DChristina%26date%3D2020%26volume%3D26%26issue%3D36%26spage%3D4658%26epage%3D4674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rambabu  Pamarthi</span>, <span class="hlFld-ContribAuthor ">Ram  Kumar</span>, <span class="hlFld-ContribAuthor ">Chennikkayala Siva  Sankara</span>, <span class="hlFld-ContribAuthor ">Gabrielle J.  Lowe</span>, <span class="hlFld-ContribAuthor ">Johannes  Zuegg</span>, <span class="hlFld-ContribAuthor ">Sudheer Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Madhu  Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">α
              ‐Iodonitroalkenes as Potential Antifungal and Antitubercular Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (39)
                                     , 12272-12277. <a href="https://doi.org/10.1002/slct.202003251" title="DOI URL">https://doi.org/10.1002/slct.202003251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202003251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202003251%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3D%2525CE%2525B1%252B%2525E2%252580%252590Iodonitroalkenes%252Bas%252BPotential%252BAntifungal%252Band%252BAntitubercular%252BAgents%26aulast%3DPamarthi%26aufirst%3DRambabu%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D39%26spage%3D12272%26epage%3D12277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe  Zhang</span>, <span class="hlFld-ContribAuthor ">Kang  Li</span>, <span class="hlFld-ContribAuthor ">Guang-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">You-Zhi  Tang</span>, <span class="hlFld-ContribAuthor ">Zhen  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112604. <a href="https://doi.org/10.1016/j.ejmech.2020.112604" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112604%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bnovel%252Bpleuromutilin%252Bderivatives%252Bwith%252Ba%252Bsubstituted%252Btriazole%252Bmoiety%252Bas%252Bpotent%252Bantibacterial%252Bagents%26aulast%3DZhang%26aufirst%3DZhe%26date%3D2020%26volume%3D204%26spage%3D112604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Dominguez-Tello</span>, <span class="hlFld-ContribAuthor ">A.  Dominguez-Alfaro</span>, <span class="hlFld-ContribAuthor ">J.L.  Gómez-Ariza</span>, <span class="hlFld-ContribAuthor ">A.  Arias-Borrego</span>, <span class="hlFld-ContribAuthor ">T.  García-Barrera</span>. </span><span class="cited-content_cbyCitation_article-title">Effervescence-assisted spiral hollow-fibre liquid-phase microextraction of trihalomethanes, halonitromethanes, haloacetonitriles, and haloketones in drinking water. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hazardous Materials</span><span> <strong>2020,</strong> <em>397 </em>, 122790. <a href="https://doi.org/10.1016/j.jhazmat.2020.122790" title="DOI URL">https://doi.org/10.1016/j.jhazmat.2020.122790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jhazmat.2020.122790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jhazmat.2020.122790%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hazardous%2520Materials%26atitle%3DEffervescence-assisted%252Bspiral%252Bhollow-fibre%252Bliquid-phase%252Bmicroextraction%252Bof%252Btrihalomethanes%25252C%252Bhalonitromethanes%25252C%252Bhaloacetonitriles%25252C%252Band%252Bhaloketones%252Bin%252Bdrinking%252Bwater%26aulast%3DDominguez-Tello%26aufirst%3DA.%26date%3D2020%26volume%3D397%26spage%3D122790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergey  Chuprun</span>, <span class="hlFld-ContribAuthor ">Dmitry  Dar’in</span>, <span class="hlFld-ContribAuthor ">Elizaveta  Rogacheva</span>, <span class="hlFld-ContribAuthor ">Liudmila  Kraeva</span>, <span class="hlFld-ContribAuthor ">Oleg  Levin</span>, <span class="hlFld-ContribAuthor ">Olga  Manicheva</span>, <span class="hlFld-ContribAuthor ">Marine  Dogonadze</span>, <span class="hlFld-ContribAuthor ">Tatiana  Vinogradova</span>, <span class="hlFld-ContribAuthor ">Olga  Bakulina</span>, <span class="hlFld-ContribAuthor ">Mikhail  Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Mutually Isomeric 2- and 4-(3-Nitro-1,2,4-triazol-1-yl)pyrimidines Inspired by an Antimycobacterial Screening Hit: Synthesis and Biological Activity against the ESKAPE Panel of Pathogens. </span><span class="cited-content_cbyCitation_journal-name">Antibiotics</span><span> <strong>2020,</strong> <em>9 </em>
                                    (10)
                                     , 666. <a href="https://doi.org/10.3390/antibiotics9100666" title="DOI URL">https://doi.org/10.3390/antibiotics9100666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antibiotics9100666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantibiotics9100666%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%26atitle%3DMutually%252BIsomeric%252B2-%252Band%252B4-%2525283-Nitro-1%25252C2%25252C4-triazol-1-yl%252529pyrimidines%252BInspired%252Bby%252Ban%252BAntimycobacterial%252BScreening%252BHit%25253A%252BSynthesis%252Band%252BBiological%252BActivity%252Bagainst%252Bthe%252BESKAPE%252BPanel%252Bof%252BPathogens%26aulast%3DChuprun%26aufirst%3DSergey%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D10%26spage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bingjie  Hou</span>, <span class="hlFld-ContribAuthor ">Zhenzhen  Li</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Peiyu  Chen</span>, <span class="hlFld-ContribAuthor ">Jiacheng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel water-soluble Cu(
              ii
              ) complexes based on acylhydrazone porphyrin ligands for DNA binding and
              in vitro
              anticancer activity as potential therapeutic targeting candidates. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (36)
                                     , 15387-15395. <a href="https://doi.org/10.1039/D0NJ02842H" title="DOI URL">https://doi.org/10.1039/D0NJ02842H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ02842H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ02842H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DNovel%252Bwater-soluble%252BCu%252528%252Bii%252B%252529%252Bcomplexes%252Bbased%252Bon%252Bacylhydrazone%252Bporphyrin%252Bligands%252Bfor%252BDNA%252Bbinding%252Band%252Bin%252Bvitro%252Banticancer%252Bactivity%252Bas%252Bpotential%252Btherapeutic%252Btargeting%252Bcandidates%26aulast%3DHou%26aufirst%3DBingjie%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D36%26spage%3D15387%26epage%3D15395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cyril  Fersing</span>, <span class="hlFld-ContribAuthor ">Clotilde  Boudot</span>, <span class="hlFld-ContribAuthor ">Caroline  Castera-Ducros</span>, <span class="hlFld-ContribAuthor ">Emilie  Pinault</span>, <span class="hlFld-ContribAuthor ">Sébastien  Hutter</span>, <span class="hlFld-ContribAuthor ">Romain  Paoli-Lombardo</span>, <span class="hlFld-ContribAuthor ">Nicolas  Primas</span>, <span class="hlFld-ContribAuthor ">Julien  Pedron</span>, <span class="hlFld-ContribAuthor ">Line  Seguy</span>, <span class="hlFld-ContribAuthor ">Sandra  Bourgeade-Delmas</span>, <span class="hlFld-ContribAuthor ">Alix  Sournia-Saquet</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Stigliani</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Brossas</span>, <span class="hlFld-ContribAuthor ">Luc  Paris</span>, <span class="hlFld-ContribAuthor ">Alexis  Valentin</span>, <span class="hlFld-ContribAuthor ">Susan  Wyllie</span>, <span class="hlFld-ContribAuthor ">Alan H.  Fairlamb</span>, <span class="hlFld-ContribAuthor ">Élisa  Boutet-Robinet</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Aurélie  Malzert-Fréon</span>, <span class="hlFld-ContribAuthor ">Alexandre  Destere</span>, <span class="hlFld-ContribAuthor ">Dominique  Mazier</span>, <span class="hlFld-ContribAuthor ">Pascal  Rathelot</span>, <span class="hlFld-ContribAuthor ">Bertrand  Courtioux</span>, <span class="hlFld-ContribAuthor ">Nadine  Azas</span>, <span class="hlFld-ContribAuthor ">Pierre  Verhaeghe</span>, <span class="hlFld-ContribAuthor ">Patrice  Vanelle</span>. </span><span class="cited-content_cbyCitation_article-title">8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112558. <a href="https://doi.org/10.1016/j.ejmech.2020.112558" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112558</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112558%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D8-Alkynyl-3-nitroimidazopyridines%252Bdisplay%252Bpotent%252Bantitrypanosomal%252Bactivity%252Bagainst%252Bboth%252BT.%2525C2%2525A0b.%252Bbrucei%252Band%252Bcruzi%26aulast%3DFersing%26aufirst%3DCyril%26date%3D2020%26volume%3D202%26spage%3D112558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan R.  Birchall</span>, <span class="hlFld-ContribAuthor ">Mohammad S. H.  Kabir</span>, <span class="hlFld-ContribAuthor ">Oleg G.  Salnikov</span>, <span class="hlFld-ContribAuthor ">Nikita V.  Chukanov</span>, <span class="hlFld-ContribAuthor ">Alexandra  Svyatova</span>, <span class="hlFld-ContribAuthor ">Kirill V.  Kovtunov</span>, <span class="hlFld-ContribAuthor ">Igor V.  Koptyug</span>, <span class="hlFld-ContribAuthor ">Juri G.  Gelovani</span>, <span class="hlFld-ContribAuthor ">Boyd M.  Goodson</span>, <span class="hlFld-ContribAuthor ">Wellington  Pham</span>, <span class="hlFld-ContribAuthor ">Eduard Y.  Chekmenev</span>. </span><span class="cited-content_cbyCitation_article-title">Quantifying the effects of quadrupolar sinks
              via
              15
              N relaxation dynamics in metronidazoles hyperpolarized
              via
              SABRE-SHEATH. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (64)
                                     , 9098-9101. <a href="https://doi.org/10.1039/D0CC03994B" title="DOI URL">https://doi.org/10.1039/D0CC03994B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC03994B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC03994B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DQuantifying%252Bthe%252Beffects%252Bof%252Bquadrupolar%252Bsinks%252Bvia%252B15%252BN%252Brelaxation%252Bdynamics%252Bin%252Bmetronidazoles%252Bhyperpolarized%252Bvia%252BSABRE-SHEATH%26aulast%3DBirchall%26aufirst%3DJonathan%2BR.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D64%26spage%3D9098%26epage%3D9101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angel H.  Romero</span>, <span class="hlFld-ContribAuthor ">Felipe  Sojo</span>, <span class="hlFld-ContribAuthor ">Francisco  Arvelo</span>, <span class="hlFld-ContribAuthor ">Christian  Calderón</span>, <span class="hlFld-ContribAuthor ">Alvaro  Morales</span>, <span class="hlFld-ContribAuthor ">Simón E.  López</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer potential of new 3-nitroaryl-6-(N-methyl)piperazin-1,2,4-triazolo[3,4-a]phthalazines targeting voltage-gated K+ channel: Copper-catalyzed one-pot synthesis from 4-chloro-1-phthalazinyl-arylhydrazones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>101 </em>, 104031. <a href="https://doi.org/10.1016/j.bioorg.2020.104031" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAnticancer%252Bpotential%252Bof%252Bnew%252B3-nitroaryl-6-%252528N-methyl%252529piperazin-1%25252C2%25252C4-triazolo%25255B3%25252C4-a%25255Dphthalazines%252Btargeting%252Bvoltage-gated%252BK%25252B%252Bchannel%25253A%252BCopper-catalyzed%252Bone-pot%252Bsynthesis%252Bfrom%252B4-chloro-1-phthalazinyl-arylhydrazones%26aulast%3DRomero%26aufirst%3DAngel%2BH.%26date%3D2020%26volume%3D101%26spage%3D104031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suresh  Palanivel</span>, <span class="hlFld-ContribAuthor ">Akshaya  Murugesan</span>, <span class="hlFld-ContribAuthor ">Kumar  Subramanian</span>, <span class="hlFld-ContribAuthor ">Olli  Yli-Harja</span>, <span class="hlFld-ContribAuthor ">Meenakshisundaram  Kandhavelu</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative and apoptotic effects of indole derivative, N-(2-hydroxy-5-nitrophenyl (4′-methylphenyl) methyl) indoline in breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2020,</strong> <em>881 </em>, 173195. <a href="https://doi.org/10.1016/j.ejphar.2020.173195" title="DOI URL">https://doi.org/10.1016/j.ejphar.2020.173195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2020.173195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2020.173195%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DAntiproliferative%252Band%252Bapoptotic%252Beffects%252Bof%252Bindole%252Bderivative%25252C%252BN-%2525282-hydroxy-5-nitrophenyl%252B%2525284%2525E2%252580%2525B2-methylphenyl%252529%252Bmethyl%252529%252Bindoline%252Bin%252Bbreast%252Bcancer%252Bcells%26aulast%3DPalanivel%26aufirst%3DSuresh%26date%3D2020%26volume%3D881%26spage%3D173195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranjana  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Suresh  Kumar</span>, <span class="hlFld-ContribAuthor ">Ashwani  Mittal</span>, <span class="hlFld-ContribAuthor ">Rachna  Sadana</span>, <span class="hlFld-ContribAuthor ">Vikas  Dutt</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, in vitro DNA photocleavage and cytotoxicity studies of 4-arylazo-1-phenyl-3-(2-thienyl)-5-hydroxy-5-trifluoromethylpyrazolines and regioisomeric 4-arylazo-1-phenyl-5(3)-(2-thienyl)-3(5)-trifluoromethylpyrazoles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2020,</strong> <em>236 </em>, 109573. <a href="https://doi.org/10.1016/j.jfluchem.2020.109573" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2020.109573</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2020.109573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2020.109573%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Bin%252Bvitro%252BDNA%252Bphotocleavage%252Band%252Bcytotoxicity%252Bstudies%252Bof%252B4-arylazo-1-phenyl-3-%2525282-thienyl%252529-5-hydroxy-5-trifluoromethylpyrazolines%252Band%252Bregioisomeric%252B4-arylazo-1-phenyl-5%2525283%252529-%2525282-thienyl%252529-3%2525285%252529-trifluoromethylpyrazoles%26aulast%3DAggarwal%26aufirst%3DRanjana%26date%3D2020%26volume%3D236%26spage%3D109573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagatoshi  Nishiwaki</span>. </span><span class="cited-content_cbyCitation_article-title">A Walk through Recent Nitro Chemistry Advances. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (16)
                                     , 3680. <a href="https://doi.org/10.3390/molecules25163680" title="DOI URL">https://doi.org/10.3390/molecules25163680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25163680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25163680%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DA%252BWalk%252Bthrough%252BRecent%252BNitro%252BChemistry%252BAdvances%26aulast%3DNishiwaki%26aufirst%3DNagatoshi%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D16%26spage%3D3680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Léo  Bucher</span>, <span class="hlFld-ContribAuthor ">Sandrine  Kappler-Gratias</span>, <span class="hlFld-ContribAuthor ">Nicolas  Desbois</span>, <span class="hlFld-ContribAuthor ">Kerstin  Bystricky</span>, <span class="hlFld-ContribAuthor ">Franck  Gallardo</span>, <span class="hlFld-ContribAuthor ">Claude P.  Gros</span>. </span><span class="cited-content_cbyCitation_article-title">A
              3
              - and A
              2
              B-nitrocorroles: synthesis and antiviral activity evaluation against human cytomegalovirus infection. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (7)
                                     , 771-782. <a href="https://doi.org/10.1039/D0MD00034E" title="DOI URL">https://doi.org/10.1039/D0MD00034E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00034E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00034E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DA%252B3%252B-%252Band%252BA%252B2%252BB-nitrocorroles%25253A%252Bsynthesis%252Band%252Bantiviral%252Bactivity%252Bevaluation%252Bagainst%252Bhuman%252Bcytomegalovirus%252Binfection%26aulast%3DBucher%26aufirst%3DL%25C3%25A9o%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D7%26spage%3D771%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer  Hemmerich</span>, <span class="hlFld-ContribAuthor ">Gerhard F.  Ecker</span>. </span><span class="cited-content_cbyCitation_article-title">In silico toxicology: From structure–activity relationships towards deep learning and adverse outcome pathways. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2020,</strong> <em>10 </em>
                                    (4)
                                     <a href="https://doi.org/10.1002/wcms.1475" title="DOI URL">https://doi.org/10.1002/wcms.1475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1475%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DIn%252Bsilico%252Btoxicology%25253A%252BFrom%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Btowards%252Bdeep%252Blearning%252Band%252Badverse%252Boutcome%252Bpathways%26aulast%3DHemmerich%26aufirst%3DJennifer%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priscila Teixeira da  Silva</span>, <span class="hlFld-ContribAuthor ">Thiago Sampaio de  Freitas</span>, <span class="hlFld-ContribAuthor ">Diniz Maciel  Sena</span>, <span class="hlFld-ContribAuthor ">Paulo Nogueira  Bandeira</span>, <span class="hlFld-ContribAuthor ">Murilo Ségio da Silva  Julião</span>, <span class="hlFld-ContribAuthor ">Emmanuel Silva  Marinho</span>, <span class="hlFld-ContribAuthor ">Ana Aline Coêlho  Alcanfor</span>, <span class="hlFld-ContribAuthor ">Emanuelle Machado  Marinho</span>, <span class="hlFld-ContribAuthor ">Pedro de  Lima-Neto</span>, <span class="hlFld-ContribAuthor ">Carlos Emídio Sampaio  Nogueira</span>, <span class="hlFld-ContribAuthor ">Henrique Douglas Melo  Coutinho</span>, <span class="hlFld-ContribAuthor ">Antonio Linkoln Alves Borges  Leal</span>, <span class="hlFld-ContribAuthor ">Humberto Medeiros  Barreto</span>, <span class="hlFld-ContribAuthor ">Natália  Martins</span>, <span class="hlFld-ContribAuthor ">Alexandre Magno  Rodrigues Teixeira</span>, <span class="hlFld-ContribAuthor ">Hélcio Silva dos  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Structural, Vibrational and Electrochemical Analysis and Antibacterial Potential of Isomeric Chalcones Derived from Natural Acetophenone. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2020,</strong> <em>10 </em>
                                    (14)
                                     , 4713. <a href="https://doi.org/10.3390/app10144713" title="DOI URL">https://doi.org/10.3390/app10144713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app10144713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp10144713%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DStructural%25252C%252BVibrational%252Band%252BElectrochemical%252BAnalysis%252Band%252BAntibacterial%252BPotential%252Bof%252BIsomeric%252BChalcones%252BDerived%252Bfrom%252BNatural%252BAcetophenone%26aulast%3DSilva%26aufirst%3DPriscila%2BTeixeira%2Bda%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D14%26spage%3D4713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ingrida  Tumosienė</span>, <span class="hlFld-ContribAuthor ">Kristina  Kantminienė</span>, <span class="hlFld-ContribAuthor ">Arnas  Klevinskas</span>, <span class="hlFld-ContribAuthor ">Vilma  Petrikaitė</span>, <span class="hlFld-ContribAuthor ">Ilona  Jonuškienė</span>, <span class="hlFld-ContribAuthor ">Vytautas  Mickevičius</span>. </span><span class="cited-content_cbyCitation_article-title">Antioxidant and Anticancer Activity of Novel Derivatives of 3-[(4-Methoxyphenyl)amino]propanehydrazide. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (13)
                                     , 2980. <a href="https://doi.org/10.3390/molecules25132980" title="DOI URL">https://doi.org/10.3390/molecules25132980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25132980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25132980%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAntioxidant%252Band%252BAnticancer%252BActivity%252Bof%252BNovel%252BDerivatives%252Bof%252B3-%25255B%2525284-Methoxyphenyl%252529amino%25255Dpropanehydrazide%26aulast%3DTumosien%25C4%2597%26aufirst%3DIngrida%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D13%26spage%3D2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huaisheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jasmine  Collins</span>, <span class="hlFld-ContribAuthor ">Rogers  Nyamwihura</span>, <span class="hlFld-ContribAuthor ">Olamide  Crown</span>, <span class="hlFld-ContribAuthor ">Oluwatomi  Ajayi</span>, <span class="hlFld-ContribAuthor ">Ifedayo Victor  Ogungbe</span>. </span><span class="cited-content_cbyCitation_article-title">Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (14)
                                     , 127217. <a href="https://doi.org/10.1016/j.bmcl.2020.127217" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127217%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DVinyl%252Bsulfone-based%252Binhibitors%252Bof%252Btrypanosomal%252Bcysteine%252Bprotease%252Brhodesain%252Bwith%252Bimproved%252Bantitrypanosomal%252Bactivities%26aulast%3DZhang%26aufirst%3DHuaisheng%26date%3D2020%26volume%3D30%26issue%3D14%26spage%3D127217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Structural Alerts for Toxicity. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 305-379. <a href="https://doi.org/10.1002/9781119607311.ch5" title="DOI URL">https://doi.org/10.1002/9781119607311.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch5%26sid%3Dliteratum%253Aachs%26atitle%3DStructural%252BAlerts%252Bfor%252BToxicity%26date%3D2020%26date%3D2020%26spage%3D305%26epage%3D379%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengjiao  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuqi  Xie</span>, <span class="hlFld-ContribAuthor ">Shujun  Xu</span>, <span class="hlFld-ContribAuthor ">Jingqi  Xin</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Ting</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Feifei  An</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-activated nanomedicines for effective cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112274. <a href="https://doi.org/10.1016/j.ejmech.2020.112274" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112274%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHypoxia-activated%252Bnanomedicines%252Bfor%252Beffective%252Bcancer%252Btherapy%26aulast%3DZhou%26aufirst%3DMengjiao%26date%3D2020%26volume%3D195%26spage%3D112274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Shentong  Xie</span>, <span class="hlFld-ContribAuthor ">Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Peipei  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Mild and Regioselective Three‐component Heteroarylation‐Nitration of Alkenes with Imidazo[1,2‐
              a
              ]pyridines and
              tert
              ‐Butyl Nitrite. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (11)
                                     , 2173-2177. <a href="https://doi.org/10.1002/adsc.202000078" title="DOI URL">https://doi.org/10.1002/adsc.202000078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000078%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DMild%252Band%252BRegioselective%252BThree%2525E2%252580%252590component%252BHeteroarylation%2525E2%252580%252590Nitration%252Bof%252BAlkenes%252Bwith%252BImidazo%25255B1%25252C2%2525E2%252580%252590%252Ba%252B%25255Dpyridines%252Band%252Btert%252B%2525E2%252580%252590Butyl%252BNitrite%26aulast%3DZhang%26aufirst%3DJie%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D11%26spage%3D2173%26epage%3D2177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-Chao  Lu</span>, <span class="hlFld-ContribAuthor ">Botao  Wu</span>, <span class="hlFld-ContribAuthor ">Shi-Peng  Zhang</span>, <span class="hlFld-ContribAuthor ">Ya-Ling  Gong</span>, <span class="hlFld-ContribAuthor ">Shu  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">K
              2
              S
              2
              O
              8
              -mediated radical cyclisation of 2-alkynylthioanisoles or -selenoanisoles: a green and regioselective route to 3-nitrobenzothiophenes and benzoselenophenes. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (32)
                                     , 19083-19087. <a href="https://doi.org/10.1039/D0RA03894F" title="DOI URL">https://doi.org/10.1039/D0RA03894F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA03894F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA03894F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DK%252B2%252BS%252B2%252BO%252B8%252B-mediated%252Bradical%252Bcyclisation%252Bof%252B2-alkynylthioanisoles%252Bor%252B-selenoanisoles%25253A%252Ba%252Bgreen%252Band%252Bregioselective%252Broute%252Bto%252B3-nitrobenzothiophenes%252Band%252Bbenzoselenophenes%26aulast%3DLu%26aufirst%3DShi-Chao%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D32%26spage%3D19083%26epage%3D19087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beatriz Cardoso  Roriz</span>, <span class="hlFld-ContribAuthor ">Danieli Fernanda  Buccini</span>, <span class="hlFld-ContribAuthor ">Beatriz Fuzinato dos  Santos</span>, <span class="hlFld-ContribAuthor ">Suellen Rolon de Sousa  Silva</span>, <span class="hlFld-ContribAuthor ">Nelson Luís de Campos  Domingues</span>, <span class="hlFld-ContribAuthor ">Susana Elisa  Moreno</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activities of a nitro-shiff base compound as a potential anti-inflammatory agent. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2020,</strong> <em>148 </em>, 105300. <a href="https://doi.org/10.1016/j.ejps.2020.105300" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105300%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Ba%252Bnitro-shiff%252Bbase%252Bcompound%252Bas%252Ba%252Bpotential%252Banti-inflammatory%252Bagent%26aulast%3DRoriz%26aufirst%3DBeatriz%2BCardoso%26date%3D2020%26volume%3D148%26spage%3D105300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumit  Sharma</span>, <span class="hlFld-ContribAuthor ">Radhika  Anand</span>, <span class="hlFld-ContribAuthor ">Pankaj Singh  Cham</span>, <span class="hlFld-ContribAuthor ">Sushil  Raina</span>, <span class="hlFld-ContribAuthor ">Ram. A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Parvinder Pal  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">A concise and sequential synthesis of the nitroimidazooxazole based drug, Delamanid and related compounds. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (29)
                                     , 17085-17093. <a href="https://doi.org/10.1039/D0RA01662D" title="DOI URL">https://doi.org/10.1039/D0RA01662D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA01662D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA01662D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bconcise%252Band%252Bsequential%252Bsynthesis%252Bof%252Bthe%252Bnitroimidazooxazole%252Bbased%252Bdrug%25252C%252BDelamanid%252Band%252Brelated%252Bcompounds%26aulast%3DSharma%26aufirst%3DSumit%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D29%26spage%3D17085%26epage%3D17093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxim A.  Bastrakov</span>, <span class="hlFld-ContribAuthor ">Alexey K.  Fedorenko</span>, <span class="hlFld-ContribAuthor ">Alexey M.  Starosotnikov</span>, <span class="hlFld-ContribAuthor ">Ivan V.  Fedyanin</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Kokorekin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Facile Dearomatization of Highly Electrophilic Nitroisoxazolo[4,3-b]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 2194. <a href="https://doi.org/10.3390/molecules25092194" title="DOI URL">https://doi.org/10.3390/molecules25092194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25092194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25092194%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BFacile%252BDearomatization%252Bof%252BHighly%252BElectrophilic%252BNitroisoxazolo%25255B4%25252C3-b%25255Dpyridines%26aulast%3DBastrakov%26aufirst%3DMaxim%2BA.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D9%26spage%3D2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent R.  Chiarelli</span>, <span class="hlFld-ContribAuthor ">Viola Camilla  Scoffone</span>, <span class="hlFld-ContribAuthor ">Gabriele  Trespidi</span>, <span class="hlFld-ContribAuthor ">Giulia  Barbieri</span>, <span class="hlFld-ContribAuthor ">Olga  Riabova</span>, <span class="hlFld-ContribAuthor ">Natalia  Monakhova</span>, <span class="hlFld-ContribAuthor ">Alessio  Porta</span>, <span class="hlFld-ContribAuthor ">Giulia  Manina</span>, <span class="hlFld-ContribAuthor ">Giovanna  Riccardi</span>, <span class="hlFld-ContribAuthor ">Vadim  Makarov</span>, <span class="hlFld-ContribAuthor ">Silvia  Buroni</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fmicb.2020.00562" title="DOI URL">https://doi.org/10.3389/fmicb.2020.00562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2020.00562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2020.00562%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DChemical%25252C%252BMetabolic%25252C%252Band%252BCellular%252BCharacterization%252Bof%252Ba%252BFtsZ%252BInhibitor%252BEffective%252BAgainst%252BBurkholderia%252Bcenocepacia%26aulast%3DChiarelli%26aufirst%3DLaurent%2BR.%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elana  Shaw</span>, <span class="hlFld-ContribAuthor ">William M.  Wuest</span>. </span><span class="cited-content_cbyCitation_article-title">Virulence attenuating combination therapy: a potential multi-target synergy approach to treat
              Pseudomonas aeruginosa
              infections in cystic fibrosis patients. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 358-369. <a href="https://doi.org/10.1039/C9MD00566H" title="DOI URL">https://doi.org/10.1039/C9MD00566H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00566H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00566H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DVirulence%252Battenuating%252Bcombination%252Btherapy%25253A%252Ba%252Bpotential%252Bmulti-target%252Bsynergy%252Bapproach%252Bto%252Btreat%252BPseudomonas%252Baeruginosa%252Binfections%252Bin%252Bcystic%252Bfibrosis%252Bpatients%26aulast%3DShaw%26aufirst%3DElana%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D3%26spage%3D358%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yixuan  Huang</span>, <span class="hlFld-ContribAuthor ">Hao  Lin</span>, <span class="hlFld-ContribAuthor ">Yanhui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of MIL-101(Fe)/SiO2 composites with improved catalytic activity for reduction of nitroaromatic compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Solid State Chemistry</span><span> <strong>2020,</strong> <em>283 </em>, 121150. <a href="https://doi.org/10.1016/j.jssc.2019.121150" title="DOI URL">https://doi.org/10.1016/j.jssc.2019.121150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jssc.2019.121150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jssc.2019.121150%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Solid%2520State%2520Chemistry%26atitle%3DSynthesis%252Bof%252BMIL-101%252528Fe%252529%25252FSiO2%252Bcomposites%252Bwith%252Bimproved%252Bcatalytic%252Bactivity%252Bfor%252Breduction%252Bof%252Bnitroaromatic%252Bcompounds%26aulast%3DHuang%26aufirst%3DYixuan%26date%3D2020%26volume%3D283%26spage%3D121150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sriram  Mahesh</span>, <span class="hlFld-ContribAuthor ">Victor  Adebomi</span>, <span class="hlFld-ContribAuthor ">Zilma P.  Muneeswaran</span>, <span class="hlFld-ContribAuthor ">Monika  Raj</span>. </span><span class="cited-content_cbyCitation_article-title">Bioinspired Nitroalkylation for Selective Protein Modification and Peptide Stapling. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (7)
                                     , 2793-2801. <a href="https://doi.org/10.1002/anie.201908593" title="DOI URL">https://doi.org/10.1002/anie.201908593</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201908593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201908593%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DBioinspired%252BNitroalkylation%252Bfor%252BSelective%252BProtein%252BModification%252Band%252BPeptide%252BStapling%26aulast%3DMahesh%26aufirst%3DSriram%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D7%26spage%3D2793%26epage%3D2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sriram  Mahesh</span>, <span class="hlFld-ContribAuthor ">Victor  Adebomi</span>, <span class="hlFld-ContribAuthor ">Zilma P.  Muneeswaran</span>, <span class="hlFld-ContribAuthor ">Monika  Raj</span>. </span><span class="cited-content_cbyCitation_article-title">Bioinspired Nitroalkylation for Selective Protein Modification and Peptide Stapling. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (7)
                                     , 2815-2823. <a href="https://doi.org/10.1002/ange.201908593" title="DOI URL">https://doi.org/10.1002/ange.201908593</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201908593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201908593%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DBioinspired%252BNitroalkylation%252Bfor%252BSelective%252BProtein%252BModification%252Band%252BPeptide%252BStapling%26aulast%3DMahesh%26aufirst%3DSriram%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D7%26spage%3D2815%26epage%3D2823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucy  Chappel</span>, <span class="hlFld-ContribAuthor ">Lai Chun  Wong</span>, <span class="hlFld-ContribAuthor ">Chee-Onn  Leong</span>, <span class="hlFld-ContribAuthor ">Chun-Wai  Mai</span>, <span class="hlFld-ContribAuthor ">Ian T.  Meikle</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Stanforth</span>, <span class="hlFld-ContribAuthor ">Thang V.  Truong</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis of trifluoromethylated N-nitroaryl-2-amino-1,3-dichloropropane derivatives and their evaluation as potential anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126910. <a href="https://doi.org/10.1016/j.bmcl.2019.126910" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126910%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bsynthesis%252Bof%252Btrifluoromethylated%252BN-nitroaryl-2-amino-1%25252C3-dichloropropane%252Bderivatives%252Band%252Btheir%252Bevaluation%252Bas%252Bpotential%252Banti-cancer%252Bagents%26aulast%3DChappel%26aufirst%3DLucy%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robin  Wray</span>, <span class="hlFld-ContribAuthor ">Junmei  Wang</span>, <span class="hlFld-ContribAuthor ">Irene  Iscla</span>, <span class="hlFld-ContribAuthor ">Paul  Blount</span>, . </span><span class="cited-content_cbyCitation_article-title">Novel MscL agonists that allow multiple antibiotics cytoplasmic access activate the channel through a common binding site. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2020,</strong> <em>15 </em>
                                    (1)
                                     , e0228153. <a href="https://doi.org/10.1371/journal.pone.0228153" title="DOI URL">https://doi.org/10.1371/journal.pone.0228153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0228153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0228153%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DNovel%252BMscL%252Bagonists%252Bthat%252Ballow%252Bmultiple%252Bantibiotics%252Bcytoplasmic%252Baccess%252Bactivate%252Bthe%252Bchannel%252Bthrough%252Ba%252Bcommon%252Bbinding%252Bsite%26aulast%3DWray%26aufirst%3DRobin%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D1%26spage%3De0228153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amandeep  Thakur</span>, <span class="hlFld-ContribAuthor ">Arshdeep  Singh</span>, <span class="hlFld-ContribAuthor ">Navdeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Ritu  Ojha</span>, <span class="hlFld-ContribAuthor ">Kunal  Nepali</span>. </span><span class="cited-content_cbyCitation_article-title">Steering the antitumor drug discovery campaign towards structurally diverse indolines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103436. <a href="https://doi.org/10.1016/j.bioorg.2019.103436" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103436%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSteering%252Bthe%252Bantitumor%252Bdrug%252Bdiscovery%252Bcampaign%252Btowards%252Bstructurally%252Bdiverse%252Bindolines%26aulast%3DThakur%26aufirst%3DAmandeep%26date%3D2020%26volume%3D94%26spage%3D103436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Facs.jmedchem.8b00147&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00147%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=121&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0054.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0054.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mutagenic pathway of nitroarenes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Drugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Agents containing nitro groups with bioreductive potential.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Bioreductive activation of PR104.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Bioreductive activation of TH-4000.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Bioreductive activation of BTZ-043.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Bioreductive activation of paclitaxel prodrug.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Bioreductive activation of nitroCBI as hypoxia activated prodrug.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Bioreductive activation of nitrobenzylphosphoramide mustards.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Bioreductive activation of 4-nitrobenzyloxycarbonyl derivatives of O6-benzylguanine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Bioreductive activation of protected chk1 inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Bioreductive activation of PA-824.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Bioreductive activation of CB-1954.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Bioreductive activation of TH-302.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Bioreductive activation of SN-38 prodrug activated via enzymatic metabolism under hypoxic conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Bioreductive activation of KS119 prodrug activated via enzymatic metabolism under hypoxic conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Bioreductive agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0028.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0029.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0030.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0031.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Antitubercular prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0032.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Antitubercular prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0033.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Antitubercular prodrugs containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0034.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Antitubercular agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0035.jpeg" id="rightTab-gr35" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Antitubercular agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0036.jpeg" id="rightTab-gr36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Antitubercular agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig37" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0037.jpeg" id="rightTab-gr37" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. Benzothiazinones and related heterocycles as antitubercular prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig38" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Figure 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0038.jpeg" id="rightTab-gr38" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 38. Benzothiazinones and related heterocycles as antitubercular prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig38"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig39" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Figure 39</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0039.jpeg" id="rightTab-gr39" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 39. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig39"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig40" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Figure 40</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0040.jpeg" id="rightTab-gr40" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 40. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig40"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig41" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Figure 41</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0041.jpeg" id="rightTab-gr41" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 41. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig41"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig42" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Figure 42</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0042.jpeg" id="rightTab-gr42" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 42. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig42"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig43" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Figure 43</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0043.jpeg" id="rightTab-gr43" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 43. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig43"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig44" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Figure 44</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0044.jpeg" id="rightTab-gr44" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 44. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig44"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig45" data-index="45" class="article__inlineFigure"><h2 class="fig-label">Figure 45</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0045.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0045.jpeg" id="rightTab-gr45" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 45. Antiparasitic agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0045.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig45"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig46" data-index="46" class="article__inlineFigure"><h2 class="fig-label">Figure 46</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0046.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0046.jpeg" id="rightTab-gr46" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 46. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig46"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig47" data-index="47" class="article__inlineFigure"><h2 class="fig-label">Figure 47</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0047.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0047.jpeg" id="rightTab-gr47" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 47. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0047.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig47"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig48" data-index="48" class="article__inlineFigure"><h2 class="fig-label">Figure 48</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0048.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0048.jpeg" id="rightTab-gr48" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 48. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0048.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig48"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig49" data-index="49" class="article__inlineFigure"><h2 class="fig-label">Figure 49</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0049.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0049.jpeg" id="rightTab-gr49" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 49. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0049.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig49"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig50" data-index="50" class="article__inlineFigure"><h2 class="fig-label">Figure 50</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0050.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0050.jpeg" id="rightTab-gr50" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 50. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0050.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig50"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig51" data-index="51" class="article__inlineFigure"><h2 class="fig-label">Figure 51</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0051.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0051.jpeg" id="rightTab-gr51" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 51. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0051.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig51"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig52" data-index="52" class="article__inlineFigure"><h2 class="fig-label">Figure 52</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0052.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0052.jpeg" id="rightTab-gr52" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 52. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0052.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig52"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig53" data-index="53" class="article__inlineFigure"><h2 class="fig-label">Figure 53</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/medium/jm-2018-001479_0053.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0053.jpeg" id="rightTab-gr53" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 53. Patented agents containing nitro groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-6/acs.jmedchem.8b00147/20190321/images/large/jm-2018-001479_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00147&amp;id=fig53"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 177 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, K.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parales, R. E.</span></span> <span> </span><span class="NLM_article-title">Nitroaromatic compounds, from synthesis to biodegradation</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1128/MMBR.00006-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1128%2FMMBR.00006-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=20508249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslKgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2010&pages=250-272&author=K.%0AS.+Juauthor=R.+E.+Parales&title=Nitroaromatic+compounds%2C+from+synthesis+to+biodegradation&doi=10.1128%2FMMBR.00006-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroaromatic compounds, from synthesis to biodegradation</span></div><div class="casAuthors">Ju, Kou-San; Parales, Rebecca E.</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">250-272</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Nitroarom. compds. are relatively rare in nature and have been introduced into the environment mainly by human activities.  This important class of industrial chems. is widely used in the synthesis of many diverse products, including dyes, polymers, pesticides, and explosives.  Unfortunately, their extensive use has led to environmental contamination of soil and groundwater.  The nitro group, which provides chem. and functional diversity in these mols., also contributes to the recalcitrance of these compds. to biodegrdn.  The electron-withdrawing nature of the nitro group, in concert with the stability of the benzene ring, makes nitroarom. compds. resistant to oxidative degrdn.  Recalcitrance is further compounded by their acute toxicity, mutagenicity, and easy redn. into carcinogenic arom. amines.  Nitroarom. compds. are hazardous to human health and are registered on the U.S. Environmental Protection Agency's list of priority pollutants for environmental remediation.  Although the majority of these compds. are synthetic in nature, microorganisms in contaminated environments have rapidly adapted to their presence by evolving new biodegrdn. pathways that take advantage of them as sources of carbon, nitrogen, and energy.  This review provides an overview of the synthesis of both man-made and biogenic nitroarom. compds., the bacteria that have been identified to grow on and completely mineralize nitroarom. compds., and the pathways that are present in these strains.  The possible evolutionary origins of the newly evolved pathways are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGocxxylLtq7Vg90H21EOLACvtfcHk0lgQ8UQ-aGVdoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslKgt7s%253D&md5=642bc57decfe2de3c705ba6cc9b2213c</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00006-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00006-10%26sid%3Dliteratum%253Aachs%26aulast%3DJu%26aufirst%3DK.%2BS.%26aulast%3DParales%26aufirst%3DR.%2BE.%26atitle%3DNitroaromatic%2520compounds%252C%2520from%2520synthesis%2520to%2520biodegradation%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2010%26volume%3D74%26spage%3D250%26epage%3D272%26doi%3D10.1128%2FMMBR.00006-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Noboru, O.</span></span> <i>The Nitro Group in Organic Synthesis</i>; <span class="NLM_publisher-name">Wiley VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2001</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">363</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=1-363&author=O.+Noboru&title=The+Nitro+Group+in+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNoboru%26aufirst%3DO.%26btitle%3DThe%2520Nitro%2520Group%2520in%2520Organic%2520Synthesis%26pub%3DWiley%2520VCH%26date%3D2001%26spage%3D1%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, M.</span></span> <span> </span><span class="NLM_article-title">The nitroaromatic group in drug design. Pharmacology (for nonpharmacologists)</span>. <i>Ind. Eng. Chem. Prod. Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1021/i360071a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/i360071a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1979&pages=158-166&author=M.+Strauss&title=The+nitroaromatic+group+in+drug+design.+Pharmacology+%28for+nonpharmacologists%29&doi=10.1021%2Fi360071a002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fi360071a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fi360071a002%26sid%3Dliteratum%253Aachs%26aulast%3DStrauss%26aufirst%3DM.%26atitle%3DThe%2520nitroaromatic%2520group%2520in%2520drug%2520design.%2520Pharmacology%2520%2528for%2520nonpharmacologists%2529%26jtitle%3DInd.%2520Eng.%2520Chem.%2520Prod.%2520Res.%2520Dev.%26date%3D1979%26volume%3D18%26spage%3D158%26epage%3D166%26doi%3D10.1021%2Fi360071a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gulley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, C. G.</span></span> <span> </span><span class="NLM_article-title">Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3884</span>– <span class="NLM_lpage">3891</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-10-2656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1158%2F1078-0432.CCR-10-2656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=21680544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFKgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3884-3891&author=J.+L.+Gulleyauthor=C.+G.+Drake&title=Immunotherapy+for+prostate+cancer%3A+recent+advances%2C+lessons+learned%2C+and+areas+for+further+research&doi=10.1158%2F1078-0432.CCR-10-2656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy for Prostate Cancer: Recent Advances, Lessons Learned, and Areas for Further Research</span></div><div class="casAuthors">Gulley, James L.; Drake, Charles G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3884-3891</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  A surge of interest in therapeutic cancer vaccines has arisen in the wake of recent clin. trials suggesting that such vaccines can result in statistically significant and clin. meaningful improvements in overall survival-with substantially limited side effects compared with chemotherapy-in patients with metastatic castration-resistant prostate cancer.  One of these trials led to the registration of sipuleucel-T, the first therapeutic vaccine to be approved for cancer patients.  In this review we highlight emerging patterns from clin. trials that suggest a need for more-appropriate patient populations (i.e., with lower tumor vol. and less-aggressive disease) and endpoints (i.e., overall survival) for studies of immunotherapy alone, as well as biol. plausible explanations for these findings.  We also explore the rationale for ongoing and planned studies combining therapeutic vaccines with other modalities.  Finally, we attempt to put these findings into a practical clin. context and suggest fertile areas for future study.  Although our discussion focuses on prostate cancer, the concepts we address most likely have broad applicability to immunotherapy for other cancers as well.  Clin Cancer Res; 17(12); 3884-91.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJcJeL25s4NrVg90H21EOLACvtfcHk0lgQ8UQ-aGVdoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFKgsLw%253D&md5=2dbf2f63f86d7ba7567d96af91c1fa47</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-2656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-2656%26sid%3Dliteratum%253Aachs%26aulast%3DGulley%26aufirst%3DJ.%2BL.%26aulast%3DDrake%26aufirst%3DC.%2BG.%26atitle%3DImmunotherapy%2520for%2520prostate%2520cancer%253A%2520recent%2520advances%252C%2520lessons%2520learned%252C%2520and%2520areas%2520for%2520further%2520research%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D3884%26epage%3D3891%26doi%3D10.1158%2F1078-0432.CCR-10-2656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharifi, R.</span></span> <span> </span><span class="NLM_article-title">Benign prostatic hyperplasia: diagnosis and treatment guideline</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1177/106002809703100415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1177%2F106002809703100415" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1997&pages=481-486&author=M.+Leeauthor=R.+Sharifi&title=Benign+prostatic+hyperplasia%3A+diagnosis+and+treatment+guideline&doi=10.1177%2F106002809703100415"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1177%2F106002809703100415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F106002809703100415%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%26aulast%3DSharifi%26aufirst%3DR.%26atitle%3DBenign%2520prostatic%2520hyperplasia%253A%2520diagnosis%2520and%2520treatment%2520guideline%26jtitle%3DAnn.%2520Pharmacother.%26date%3D1997%26volume%3D31%26spage%3D481%26epage%3D486%26doi%3D10.1177%2F106002809703100415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span>DHHS/National
Toxicology Program; Eleventh Report on Carcinogens: Metronidazole
(443-48-1) (January 2005). <a href="http://www.jmcprl.net/PUBLICACIONES/F05/cancerigenos/eleventh/profiles/s112metr.pdf" class="extLink">http://www.jmcprl.net/PUBLICACIONES/F05/cancerigenos/eleventh/profiles/s112metr.pdf</a> (accessed December 14, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DHHS%2FNational%0AToxicology+Program%3B+Eleventh+Report+on+Carcinogens%3A+Metronidazole%0A%28443-48-1%29+%28January+2005%29.+http%3A%2F%2Fwww.jmcprl.net%2FPUBLICACIONES%2FF05%2Fcancerigenos%2Feleventh%2Fprofiles%2Fs112metr.pdf+%28accessed+December+14%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span>FDA Approves
Symbiomix Therapeutics’ Solosec (secnidazole) Oral Granules
for the Treatment of Bacterial Vaginosis in Adult Women, September
18, 2017. <a href="https://symbiomix.com/fda-approves-symbiomix-therapeutics-solosec-secnidazole-oral-granules-treatment-bacterial-vaginosis-adult-women/" class="extLink">https://symbiomix.com/fda-approves-symbiomix-therapeutics-solosec-secnidazole-oral-granules-treatment-bacterial-vaginosis-adult-women/</a> (accessed December 12, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA+Approves%0ASymbiomix+Therapeutics%E2%80%99+Solosec+%28secnidazole%29+Oral+Granules%0Afor+the+Treatment+of+Bacterial+Vaginosis+in+Adult+Women%2C+September%0A18%2C+2017.+https%3A%2F%2Fsymbiomix.com%2Ffda-approves-symbiomix-therapeutics-solosec-secnidazole-oral-granules-treatment-bacterial-vaginosis-adult-women%2F+%28accessed+December+12%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Nigro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballo, M. A.</span></span> <span> </span><span class="NLM_article-title">Genotoxicity and cell death induced by tinidazole (TNZ)</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2008.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.toxlet.2008.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18582545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=46-52&author=M.+M.+Lopez+Nigroauthor=M.+A.+Carballo&title=Genotoxicity+and+cell+death+induced+by+tinidazole+%28TNZ%29&doi=10.1016%2Fj.toxlet.2008.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Genotoxicity and cell death induced by tinidazole (TNZ)</span></div><div class="casAuthors">Lopez Nigro, M. M.; Carballo, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-52</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tinidazole (TNZ), a second-generation 5-nitroimidazole compd. chem. related to metronidazole (MTZ), has been widely used throughout Europe and developing countries for the treatment of amoebic and parasitic infections.  Despite TNZ's increasing use in therapeutics, scarce exptl. reports are available in literature on its potential genotoxicity in human cells.  Therefore, the aim of the present study was to achieve a precise characterization of the cytotoxic and genotoxic activities of this nitroimidazole in cultured human lymphocytes at therapeutic concns. (0.1, 1, 10 and 50 μg/mL of culture) and evaluate the possible cell death mechanism assocd. with it.  The endpoints analyzed included: mitotic index (MI), replication index (RI), sister chromatid exchange (SCE) and chromosomal aberrations (CA).  A significant decrease (p < 0.0001) in MI as well as an increase in SCE (p < 0.0001) and CA (p < 0.0001) frequencies were obsd.  No modifications in RI were found.  The results suggest a genotoxic and cytotoxic effect of TNZ related with cell death process.  Therefore, we evaluated this mechanism by DNA fragmentation (laddering), fluorescence microscopy using acridine orange/ethidium bromide (AO/EB) staining and flow cytometry propidium iodide (PI).  DNA exts. of TNZ-treated cells resulted in nucleosomal DNA ladder pattern after 48 h of cell treatment; meanwhile no differences were detected in untreated cells.  This pattern correlated with the obsd. decrease in cellular viability (p < 0.05), morphol. evidence of apoptosis and increase in the percentage of nuclei with hypodiploid DNA content of TNZ exposed cultures compared with control (p < 0.05).  We concluded that TNZ is genotoxic, cytotoxic and is able to modulate cell death through apoptotic mechanisms in the exptl. design employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyVTqYT7hs3LVg90H21EOLACvtfcHk0liIc-9mcafr_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D&md5=dbf7f9c371265bace4f736b0a475e1c9</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2008.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2008.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%2BNigro%26aufirst%3DM.%2BM.%26aulast%3DCarballo%26aufirst%3DM.%2BA.%26atitle%3DGenotoxicity%2520and%2520cell%2520death%2520induced%2520by%2520tinidazole%2520%2528TNZ%2529%26jtitle%3DToxicol.%2520Lett.%26date%3D2008%26volume%3D180%26spage%3D46%26epage%3D52%26doi%3D10.1016%2Fj.toxlet.2008.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, T. L.</span></span> <span> </span><span class="NLM_article-title">Tinidazole: a nitroimidazole antiprotozoal agent</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1859</span>– <span class="NLM_lpage">1884</span>, <span class="refDoi"> DOI: 10.1016/j.clinthera.2005.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.clinthera.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=16507373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1859-1884&author=H.+B.+Fungauthor=T.+L.+Doan&title=Tinidazole%3A+a+nitroimidazole+antiprotozoal+agent&doi=10.1016%2Fj.clinthera.2005.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Tinidazole: a nitroimidazole antiprotozoal agent</span></div><div class="casAuthors">Fung, Horatio B.; Doan, Thien-Ly</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1859-1884</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Tinidazole, a structural analog of metronidazole, is an antiprotozoal agent that has been widely used in Europe and developing countries for >2 decades with established efficacy and acceptable tolerability.  It was recently approved by the US Food and Drug Administration for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Objective: This article reviews the pharmacol. and pharmacokinetic properties and clin. usefulness of tinidazole.  Methods: Relevant information was identified through a search of MEDLINE (1966-August 2005), Iowa Drug Information Service (1966-August 2005), and International Pharmaceutical Abstrs. (1970-August 2005) using the terms tinidazole, Fasigyn, and nitroimidazole.  Results: In vitro, tinidazole exhibits activity against pathogenic protozoa (eg, Trichomonas vaginalis, Entamoeba histolytica, Giardia duodenalis), a wide range of clin. significant anaerobic bacteria (eg, Bacteroides fragilis, Clostridium difficile), and the microaerophilic bacterium Helicobacter pylori.  In susceptible protozoal and bacterial cells, tinidazole is reduced to cytotoxic intermediates that covalently bind to DNA, causing irreversible damage.  In human adults, tinidazole had a bioavailability of 100% and a Vd of 50.7 L, was minimally bound to plasma protein (12%), had a plasma elimination t1/2 of 12.3 h, and was eliminated primarily by hepatic metab. (∼63%).  Dose adjustment does not appear to be necessary on the basis of race, sex, or renal function.  No data were found on the disposition of tinidazole in patients with hepatic insufficiency; therefore, use of tinidazole in patients with severe hepatic impairment (Child-Pugh class C) is not recommended.  Clin. cure rates in patients with trichomoniasis, giardiasis, amebiasis, and amebic liver abscess were generally >90%.  In comparative trials, tinidazole was as effective as metronidazole in the treatment of trichomoniasis and was significantly more effective than metronidazole in the treatment of giardiasis (P < 0.05) and amebiasis (P < 0.05).  The most commonly reported (>1%) adverse effects included bitter taste, nausea, abdominal discomfort, anorexia, vomiting, and fatigue.  The recommended dosage of tinidazole is a single dose of 2 g for trichomoniasis and giardiasis, and 2 g/d for 3 to 5 days for amebiasis.  Conclusions: Tinidazole appears to be a promising agent for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Clin. studies are needed to evaluate the use of tinidazole against anaerobic bacteria and H pylori.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGwTnbff6nLbVg90H21EOLACvtfcHk0lg5tYfKixZepg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D&md5=cc1ef607c78b3cb9889d5425c4858f04</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DH.%2BB.%26aulast%3DDoan%26aufirst%3DT.%2BL.%26atitle%3DTinidazole%253A%2520a%2520nitroimidazole%2520antiprotozoal%2520agent%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1859%26epage%3D1884%26doi%3D10.1016%2Fj.clinthera.2005.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6"><span>Tinidazole News. <a href="https://www.drugs.com/answers/support-group/tinidazole/news/" class="extLink">https://www.drugs.com/answers/support-group/tinidazole/news/</a> (accessed December 21, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tinidazole+News.+https%3A%2F%2Fwww.drugs.com%2Fanswers%2Fsupport-group%2Ftinidazole%2Fnews%2F+%28accessed+December+21%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raether, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hänel, H.</span></span> <span> </span><span class="NLM_article-title">Nitroheterocyclic drugs with broad spectrum activity</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">S19</span>– <span class="NLM_lpage">S39</span>, <span class="refDoi"> DOI: 10.1007/s00436-002-0754-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1007%2Fs00436-002-0754-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=12811546" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2003&pages=S19-S39&issue=Suppl.+1&author=W.+Raetherauthor=H.+H%C3%A4nel&title=Nitroheterocyclic+drugs+with+broad+spectrum+activity&doi=10.1007%2Fs00436-002-0754-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00436-002-0754-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-002-0754-9%26sid%3Dliteratum%253Aachs%26aulast%3DRaether%26aufirst%3DW.%26aulast%3DH%25C3%25A4nel%26aufirst%3DH.%26atitle%3DNitroheterocyclic%2520drugs%2520with%2520broad%2520spectrum%2520activity%26jtitle%3DParasitol.%2520Res.%26date%3D2003%26volume%3D90%26issue%3DSuppl.%25201%26spage%3DS19%26epage%3DS39%26doi%3D10.1007%2Fs00436-002-0754-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. S.</span></span> <span> </span><span class="NLM_article-title">Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2072</span>– <span class="NLM_lpage">2084</span>, <span class="refDoi"> DOI: 10.2174/156802611796575894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.2174%2F156802611796575894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=21619510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=2072-2084&author=S.+R.+Wilkinsonauthor=C.+Botauthor=J.+M.+Kellyauthor=B.+S.+Hall&title=Trypanocidal+activity+of+nitroaromatic+prodrugs%3A+current+treatments+and+future+perspectives&doi=10.2174%2F156802611796575894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives</span></div><div class="casAuthors">Wilkinson, Shane R.; Bot, Christopher; Kelly, John M.; Hall, Belinda S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2072-2084</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chagas disease and African sleeping sickness are trypanosomal infections that represent important public health problems in Latin America and Africa, resp.  The restriction of these diseases to the poorer parts of the world has meant that they have been largely neglected and limited progress has been made in their treatment.  The nitroheterocyclic prodrugs nifurtimox and benznidazole, in use against Chagas disease for >40 years, remain the only agents available for this infection.  In the case of African sleeping sickness, nifurtimox has recently been added to the arsenal of medicines, with the nitroheterocycle fexinidazole currently under evaluation.  For a long time, the cytotoxic mechanisms of these drugs were poorly understood: nifurtimox was thought to act via prodn. of superoxide anions and nitro radicals, while the mode of benznidazole action was more obscure.  The trypanocidal activity of nitroheterocyclic drugs is now known to depend on a parasite type I nitroreductase (NTR).  This enzyme is absent from mammalian cells, a difference that forms the basis for the drug selectivity.  The role of this enzyme in drug activation has been genetically and biochem. validated.  It catalyzes the 2-electron redn. of nitroheterocyclic compds. within the parasite, producing toxic metabolites without significant generation of superoxide.  Recognition that this enzyme is responsible for activation of nitroheterocyclic prodrugs has allowed screening for compds. that preferentially target the parasite.  This approach has led to the identification of two new classes of anti-trypanosomal agents, nitrobenzylphosphoramide mustards and aziridinyl nitrobenzamides, and promises to yield new, safer, more effective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6vBQMwS_TY7Vg90H21EOLACvtfcHk0lg5tYfKixZepg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3L&md5=5976d05c6686ad8121c94b5da581f599</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F156802611796575894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611796575894%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DBot%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DHall%26aufirst%3DB.%2BS.%26atitle%3DTrypanocidal%2520activity%2520of%2520nitroaromatic%2520prodrugs%253A%2520current%2520treatments%2520and%2520future%2520perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D2072%26epage%3D2084%26doi%3D10.2174%2F156802611796575894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitmore, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, A. J.</span></span> <span> </span><span class="NLM_article-title">The biological properties of reduced nitroheterocycles and possible underlying biochemical mechanisms</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(86)90565-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2F0006-2952%2886%2990565-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1986&pages=97-103&author=G.+F.+Whitmoreauthor=A.+J.+Varghese&title=The+biological+properties+of+reduced+nitroheterocycles+and+possible+underlying+biochemical+mechanisms&doi=10.1016%2F0006-2952%2886%2990565-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2886%2990565-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252886%252990565-4%26sid%3Dliteratum%253Aachs%26aulast%3DWhitmore%26aufirst%3DG.%2BF.%26aulast%3DVarghese%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520biological%2520properties%2520of%2520reduced%2520nitroheterocycles%2520and%2520possible%2520underlying%2520biochemical%2520mechanisms%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1986%26volume%3D35%26spage%3D97%26epage%3D103%26doi%3D10.1016%2F0006-2952%2886%2990565-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boelsterli, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leow, K. Y.</span></span> <span> </span><span class="NLM_article-title">Bioactivation and hepatotoxicity of nitroaromatic drugs</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.2174/138920006778520606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.2174%2F138920006778520606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=17073576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWgt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=715-727&author=U.+A.+Boelsterliauthor=H.+K.+Hoauthor=S.+Zhouauthor=K.+Y.+Leow&title=Bioactivation+and+hepatotoxicity+of+nitroaromatic+drugs&doi=10.2174%2F138920006778520606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation and hepatotoxicity of nitroaromatic drugs</span></div><div class="casAuthors">Boelsterli, Urs A.; Ho, Han Kiat; Zhou, Shufeng; Leow, Koon Yeow</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">715-727</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Certain drugs contg. a nitroarom. moiety (e.g., tolcapone, nimesulide, nilutamide, flutamide, nitrofurantoin) have been assocd. with organ-selective toxicity including rare cases of idiosyncratic liver injury.  What they have in common is the potential for multistep nitroreductive bioactivation (6-electron transfer) that produces the potentially hazardous nitroanion radical, nitroso intermediate, and N-hydroxy deriv.  These intermediates have been assocd. with increased oxidant stress and targeting of nucleophilic residues on proteins and nucleic acids.  However, other mechanisms including the formation of oxidative metabolites and mitochondrial liability, as well as inherent toxicokinetic properties, also det. the drugs' overall potency.  Therefore, structural modification not only of the nitro moiety but also of ring substituents can greatly reduced toxicity.  Novel concepts have revealed that, besides the classical microsomal nitroreductases, cytosolic and mitochondrial enzymes including nitric oxide synthase can also bioactivate certain nitroarenes (nilutamide).  Furthermore, animal models of silent mitochondrial dysfunction have demonstrated that a mitochondrial oxidant stress posed by certain nitroarom. drugs (nimesulide) can produce significant mitochondrial injury if superimposed on a genetic mitochondrial abnormality.  Finally, there may be mechanisms for all nitroarom. drugs that do not involve bioactivation of the nitro group, e.g., AHR interactions with flutamide.  Taken together, the focus of research on the hepatic toxicity of nitroarene-contg. drugs has shifted over the past years from the identification of the reactive intermediates generated during the bioreductive pathway to the underlying biomechanisms of liver injury.  Most likely one of the next paradigm shifts will include the identification of determinants of susceptibility to nitroarom. drug-induced hepatotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbZw5d9MZTE7Vg90H21EOLACvtfcHk0lgtmXyNuveMDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWgt7rF&md5=21e155ba17d1ad097e7652a5d22728b3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138920006778520606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920006778520606%26sid%3Dliteratum%253Aachs%26aulast%3DBoelsterli%26aufirst%3DU.%2BA.%26aulast%3DHo%26aufirst%3DH.%2BK.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DLeow%26aufirst%3DK.%2BY.%26atitle%3DBioactivation%2520and%2520hepatotoxicity%2520of%2520nitroaromatic%2520drugs%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2006%26volume%3D7%26spage%3D715%26epage%3D727%26doi%3D10.2174%2F138920006778520606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wardman, P.</span></span> <span> </span><span class="NLM_article-title">Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.2174/0929867013372959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.2174%2F0929867013372959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=11375747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVChtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=739-761&author=P.+Wardman&title=Electron+transfer+and+oxidative+stress+as+key+factors+in+the+design+of+drugs+selectively+active+in+hypoxia&doi=10.2174%2F0929867013372959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia</span></div><div class="casAuthors">Wardman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">739-761</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 229 refs.  Hypoxia is a feature of some regions of many tumors, ischemic events, and arthritis.  Drugs activated in hypoxia have wide potential application, particularly in overcoming the resistance of hypoxic tumor cells to radiotherapy.  Key features of such drugs include redox properties appropriate for activation by reductase enzymes (typically flavoproteins), and oxygen-sensitive redn. chem. such that normal levels of oxygen inhibit or reverse redn.  In many cases this selectivity is achieved by a fast, free-radical reaction in which the drug radical (often an obligate intermediate in drug redn.) reduces oxygen to form superoxide radicals and thus "futile cycles" the drug in normoxic tissues.  However, this enhances cellular oxidative stress, which may be linked to normal tissue toxicity.  Appropriate redox properties are found with nitroarene, quinone, or arom. N-oxide moieties.  A particularly promising and versatile exploitation of bioreductive activation is for redn. of such "triggers" to activate release of an "effector", an agent that can obviously be active against diverse conditions assocd. with hypoxia.  The same approach can also be used in diagnosis of hypoxia.  Much information concerning the reactions of intermediates in drug action and the quant. prediction of redox properties of analogs has been accrued.  Drug design can be mechanism-led, with the wealth of literature quantifying redox properties of drug candidates a rich source of potential new leads.  There is a clear appreciation of the kinetic factors that limit drug efficacy or selectivity.  Thus the potential for rapid expansion of these concepts to diverse diseases is considerable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8yb0NnUNo6bVg90H21EOLACvtfcHk0lgtmXyNuveMDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVChtbg%253D&md5=71b7850f3858686974de41834ac7aa45</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F0929867013372959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867013372959%26sid%3Dliteratum%253Aachs%26aulast%3DWardman%26aufirst%3DP.%26atitle%3DElectron%2520transfer%2520and%2520oxidative%2520stress%2520as%2520key%2520factors%2520in%2520the%2520design%2520of%2520drugs%2520selectively%2520active%2520in%2520hypoxia%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D739%26epage%3D761%26doi%3D10.2174%2F0929867013372959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruchelman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoie, E. J.</span></span> <span> </span><span class="NLM_article-title">Diaza- and triazachrysenes: Potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDAMB-435</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3333</span>– <span class="NLM_lpage">3336</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00737-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FS0960-894X%2802%2900737-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3333-3336&author=A.+L.+Ruchelmanauthor=S.+K.+Singhauthor=X.+Wuauthor=A.+Rayauthor=J.-M.+Yangauthor=T.-K.+Liauthor=A.+Liuauthor=L.+F.+Liuauthor=E.+J.+LaVoie&title=Diaza-+and+triazachrysenes%3A+Potent+topoisomerase-targeting+agents+with+exceptional+antitumor+activity+against+the+human+tumor+xenograft%2C+MDAMB-435&doi=10.1016%2FS0960-894X%2802%2900737-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900737-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900737-0%26sid%3Dliteratum%253Aachs%26aulast%3DRuchelman%26aufirst%3DA.%2BL.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DJ.-M.%26aulast%3DLi%26aufirst%3DT.-K.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3DDiaza-%2520and%2520triazachrysenes%253A%2520Potent%2520topoisomerase-targeting%2520agents%2520with%2520exceptional%2520antitumor%2520activity%2520against%2520the%2520human%2520tumor%2520xenograft%252C%2520MDAMB-435%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3333%26epage%3D3336%26doi%3D10.1016%2FS0960-894X%2802%2900737-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruchelman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoie, E. J.</span></span> <span> </span><span class="NLM_article-title">5<i>H</i>-Dibenzo[<i>c,h</i>][1,6]naphthyridin-6-ones: Novel topoisomerase I-targeting anticancer agents with potent cytotoxic activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2061</span>– <span class="NLM_lpage">2073</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(03)00051-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FS0968-0896%2803%2900051-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2061-2073&author=A.+L.+Ruchelmanauthor=S.+K.+Singhauthor=A.+Rayauthor=X.+Wuauthor=J.-M.+Yangauthor=T.-K.+Liauthor=A.+Liuauthor=L.+F.+Liuauthor=E.+J.+LaVoie&title=5H-Dibenzo%5Bc%2Ch%5D%5B1%2C6%5Dnaphthyridin-6-ones%3A+Novel+topoisomerase+I-targeting+anticancer+agents+with+potent+cytotoxic+activity&doi=10.1016%2FS0968-0896%2803%2900051-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2803%2900051-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252803%252900051-8%26sid%3Dliteratum%253Aachs%26aulast%3DRuchelman%26aufirst%3DA.%2BL.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DJ.-M.%26aulast%3DLi%26aufirst%3DT.-K.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3D5H-Dibenzo%255Bc%252Ch%255D%255B1%252C6%255Dnaphthyridin-6-ones%253A%2520Novel%2520topoisomerase%2520I-targeting%2520anticancer%2520agents%2520with%2520potent%2520cytotoxic%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2061%26epage%3D2073%26doi%3D10.1016%2FS0968-0896%2803%2900051-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruchelman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoie, E. J.</span></span> <span> </span><span class="NLM_article-title">Nitro and amino substitution in the D-Ring of 5-(2-dimethylaminoethyl)-2,3-methylenedioxy-5<i>H</i>-dibenzo[<i>c,h</i>][1,6]naphthyridin-6-ones: Effect on topoisomerase-I targeting activity and cytotoxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2254</span>– <span class="NLM_lpage">2257</span>, <span class="refDoi"> DOI: 10.1021/jm020498a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020498a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2254-2257&author=S.+K.+Singhauthor=A.+L.+Ruchelmanauthor=T.+K.+Liauthor=A.+Liuauthor=L.+F.+Liuauthor=E.+J.+LaVoie&title=Nitro+and+amino+substitution+in+the+D-Ring+of+5-%282-dimethylaminoethyl%29-2%2C3-methylenedioxy-5H-dibenzo%5Bc%2Ch%5D%5B1%2C6%5Dnaphthyridin-6-ones%3A+Effect+on+topoisomerase-I+targeting+activity+and+cytotoxicity&doi=10.1021%2Fjm020498a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm020498a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020498a%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DRuchelman%26aufirst%3DA.%2BL.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3DNitro%2520and%2520amino%2520substitution%2520in%2520the%2520D-Ring%2520of%25205-%25282-dimethylaminoethyl%2529-2%252C3-methylenedioxy-5H-dibenzo%255Bc%252Ch%255D%255B1%252C6%255Dnaphthyridin-6-ones%253A%2520Effect%2520on%2520topoisomerase-I%2520targeting%2520activity%2520and%2520cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2254%26epage%3D2257%26doi%3D10.1021%2Fjm020498a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Placzek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Nitrated indenoisoquinolines as topoisomerase I inhibitors: a systematic study and optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4419</span>– <span class="NLM_lpage">4430</span>, <span class="refDoi"> DOI: 10.1021/jm070361q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070361q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4419-4430&author=A.+Morrellauthor=M.+Placzekauthor=S.+Parmleyauthor=S.+Antonyauthor=T.+S.+Dexheimerauthor=Y.+Pommierauthor=M.+Cushman&title=Nitrated+indenoisoquinolines+as+topoisomerase+I+inhibitors%3A+a+systematic+study+and+optimization&doi=10.1021%2Fjm070361q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm070361q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070361q%26sid%3Dliteratum%253Aachs%26aulast%3DMorrell%26aufirst%3DA.%26aulast%3DPlaczek%26aufirst%3DM.%26aulast%3DParmley%26aufirst%3DS.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DNitrated%2520indenoisoquinolines%2520as%2520topoisomerase%2520I%2520inhibitors%253A%2520a%2520systematic%2520study%2520and%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4419%26epage%3D4430%26doi%3D10.1021%2Fjm070361q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarhaut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranoy-Opalinski, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papot, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of glucuronide prodrugs of the histone deacetylase inhibitor CI-994 for application in selective cancer chemotherapy</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">8109</span>– <span class="NLM_lpage">8116</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.07.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2008.07.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8109-8116&author=M.+Thomasauthor=J.+Clarhautauthor=I.+Tranoy-Opalinskiauthor=J.+P.+Gessonauthor=J.+Rocheauthor=S.+Papot&title=Synthesis+and+biological+evaluation+of+glucuronide+prodrugs+of+the+histone+deacetylase+inhibitor+CI-994+for+application+in+selective+cancer+chemotherapy&doi=10.1016%2Fj.bmc.2008.07.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.07.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.07.048%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DClarhaut%26aufirst%3DJ.%26aulast%3DTranoy-Opalinski%26aufirst%3DI.%26aulast%3DGesson%26aufirst%3DJ.%2BP.%26aulast%3DRoche%26aufirst%3DJ.%26aulast%3DPapot%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520glucuronide%2520prodrugs%2520of%2520the%2520histone%2520deacetylase%2520inhibitor%2520CI-994%2520for%2520application%2520in%2520selective%2520cancer%2520chemotherapy%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8109%26epage%3D8116%26doi%3D10.1016%2Fj.bmc.2008.07.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-chromene derivatives as histone deacetylase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4123</span>– <span class="NLM_lpage">4132</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2017.05.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=4123-4132&author=S.+Tanauthor=F.+Heauthor=T.+Kongauthor=J.+Wuauthor=Z.+Liu&title=Design%2C+synthesis+and+tumor+cell+growth+inhibitory+activity+of+3-nitro-2H-chromene+derivatives+as+histone+deacetylase+inhibitors&doi=10.1016%2Fj.bmc.2017.05.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520tumor%2520cell%2520growth%2520inhibitory%2520activity%2520of%25203-nitro-2H-chromene%2520derivatives%2520as%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D4123%26epage%3D4132%26doi%3D10.1016%2Fj.bmc.2017.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penketh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartorelli, A. C.</span></span> <span> </span><span class="NLM_article-title">4-Nitrobenzyloxycarbonyl derivatives of O6-benzylguanine as hypoxia-activated prodrug inhibitors of O6-alkylguanine-DNA alkyltransferase (AGT), which produces resistance to agents targeting the O-6 position of DNA guanine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7720</span>– <span class="NLM_lpage">7728</span>, <span class="refDoi"> DOI: 10.1021/jm201115f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201115f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7720-7728&author=R.+Zhuauthor=M.+C.+Liuauthor=M.+Z.+Luoauthor=P.+G.+Penkethauthor=R.+P.+Baumannauthor=K.+Shyamauthor=A.+C.+Sartorelli&title=4-Nitrobenzyloxycarbonyl+derivatives+of+O6-benzylguanine+as+hypoxia-activated+prodrug+inhibitors+of+O6-alkylguanine-DNA+alkyltransferase+%28AGT%29%2C+which+produces+resistance+to+agents+targeting+the+O-6+position+of+DNA+guanine&doi=10.1021%2Fjm201115f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm201115f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201115f%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DM.%2BC.%26aulast%3DLuo%26aufirst%3DM.%2BZ.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D4-Nitrobenzyloxycarbonyl%2520derivatives%2520of%2520O6-benzylguanine%2520as%2520hypoxia-activated%2520prodrug%2520inhibitors%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%2520%2528AGT%2529%252C%2520which%2520produces%2520resistance%2520to%2520agents%2520targeting%2520the%2520O-6%2520position%2520of%2520DNA%2520guanine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7720%26epage%3D7728%26doi%3D10.1021%2Fjm201115f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, Y. S.</span></span> <span> </span><span class="NLM_article-title">A novel nitrobenzoate microtubule inhibitor that overcomes multidrug resistance exhibits antitumor activity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">31472</span>, <span class="refDoi"> DOI: 10.1038/srep31472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1038%2Fsrep31472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27510727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCitrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=31472&author=Y.+B.+Zhengauthor=J.+H.+Gongauthor=X.+J.+Liuauthor=S.+Y.+Wuauthor=Y.+Liauthor=X.+D.+Xuauthor=B.+Y.+Shangauthor=J.+M.+Zhouauthor=Z.+L.+Zhuauthor=S.+Y.+Siauthor=Y.+S.+Zhen&title=A+novel+nitrobenzoate+microtubule+inhibitor+that+overcomes+multidrug+resistance+exhibits+antitumor+activity&doi=10.1038%2Fsrep31472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity</span></div><div class="casAuthors">Zheng, Yan-Bo; Gong, Jian-Hua; Liu, Xiu-Jun; Wu, Shu-Ying; Li, Yi; Xu, Xian-Dong; Shang, Bo-Yang; Zhou, Jin-Ming; Zhu, Zhi-Ling; Si, Shu-Yi; Zhen, Yong-Su</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31472</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Multidrug resistance is a major limitation for microtubule-binding agents in cancer treatment.  Here we report a novel microtubule inhibitor (2-morpholin-4-yl-5-nitro-benzoic acid 4-methylsulfanyl-benzyl ester, IMB5046), its cytotoxicity against multidrug-resistant cell lines and its antitumor efficacy in animal models.  IMB5046 disrupted microtubule structures in cells and inhibited purified tubulin polymn. in vitro.  It bound to the colchicine pocket of tubulin.  IMB5046 displayed potent cytotoxicity against multiple tumor cell lines with an IC50 range of 0.037-0.426 μM.  Notably, several multidrug-resistant cell lines which were resistant to colchicine, vincristine and paclitaxel remained sensitive to IMB5046.  IMB5046 was not a P-glycoprotein substrate.  IMB5046 blocked cell cycle at G2/M phase and induced cell apoptosis.  Microarray assay indicated that the differentially expressed genes after IMB5046 treatment were highly related to immune system, cell death and cancer.  In a mouse xenograft model IMB5046 inhibited the growth of human lung tumor xenograft by 83% at a well-tolerated dose.  It is concluded that IMB5046 is a tubulin polymn. inhibitor with novel chem. structure and can overcome multidrug resistance.  It is a promising lead compd. for cancer chemotherapy, esp. for treatment of multidrug-resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSpeEJZPBQy7Vg90H21EOLACvtfcHk0lihB7Lh795uUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCitrfF&md5=a7fab3ce717fbe2a2c7d3a952b94f8a7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsrep31472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep31472%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%2BB.%26aulast%3DGong%26aufirst%3DJ.%2BH.%26aulast%3DLiu%26aufirst%3DX.%2BJ.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%2BD.%26aulast%3DShang%26aufirst%3DB.%2BY.%26aulast%3DZhou%26aufirst%3DJ.%2BM.%26aulast%3DZhu%26aufirst%3DZ.%2BL.%26aulast%3DSi%26aufirst%3DS.%2BY.%26aulast%3DZhen%26aufirst%3DY.%2BS.%26atitle%3DA%2520novel%2520nitrobenzoate%2520microtubule%2520inhibitor%2520that%2520overcomes%2520multidrug%2520resistance%2520exhibits%2520antitumor%2520activity%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D31472%26doi%3D10.1038%2Fsrep31472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.11.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2016.11.093" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=636-641&author=B.+A.+Winnauthor=Z.+Shiauthor=G.+J.+Carlsonauthor=Y.+Wangauthor=B.+L.+Nguyenauthor=E.+M.+Kellyauthor=D.+Rossauthor=E.+Hamelauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Bioreductively+activatable+prodrug+conjugates+of+phenstatin+designed+to+target+tumor+hypoxia&doi=10.1016%2Fj.bmcl.2016.11.093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.093%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DB.%2BA.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DCarlson%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DB.%2BL.%26aulast%3DKelly%26aufirst%3DE.%2BM.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DBioreductively%2520activatable%2520prodrug%2520conjugates%2520of%2520phenstatin%2520designed%2520to%2520target%2520tumor%2520hypoxia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D636%26epage%3D641%26doi%3D10.1016%2Fj.bmcl.2016.11.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tercel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwell, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botting, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruijn, F. B.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-activated prodrugs: substituent effects on the properties of nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (nitrocbi) prodrugs of DNA minor groove alkylating agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7258</span>– <span class="NLM_lpage">7272</span>, <span class="refDoi"> DOI: 10.1021/jm901202b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901202b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7258-7272&author=M.+Tercelauthor=G.+J.+Atwellauthor=S.+Yangauthor=R.+J.+Stevensonauthor=K.+J.+Bottingauthor=M.+Boydauthor=E.+Smithauthor=R.+F.+Andersonauthor=W.+A.+Dennyauthor=W.+R.+Wilsonauthor=F.+B.+Pruijn&title=Hypoxia-activated+prodrugs%3A+substituent+effects+on+the+properties+of+nitro+seco-1%2C2%2C9%2C9a-tetrahydrocyclopropa%5Bc%5Dbenz%5Be%5Dindol-4-one+%28nitrocbi%29+prodrugs+of+DNA+minor+groove+alkylating+agents&doi=10.1021%2Fjm901202b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901202b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901202b%26sid%3Dliteratum%253Aachs%26aulast%3DTercel%26aufirst%3DM.%26aulast%3DAtwell%26aufirst%3DG.%2BJ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DStevenson%26aufirst%3DR.%2BJ.%26aulast%3DBotting%26aufirst%3DK.%2BJ.%26aulast%3DBoyd%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DPruijn%26aufirst%3DF.%2BB.%26atitle%3DHypoxia-activated%2520prodrugs%253A%2520substituent%2520effects%2520on%2520the%2520properties%2520of%2520nitro%2520seco-1%252C2%252C9%252C9a-tetrahydrocyclopropa%255Bc%255Dbenz%255Be%255Dindol-4-one%2520%2528nitrocbi%2529%2520prodrugs%2520of%2520DNA%2520minor%2520groove%2520alkylating%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7258%26epage%3D7272%26doi%3D10.1021%2Fjm901202b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaki, Y.</span></span> <span> </span><span class="NLM_article-title">Targeting and treatment of tumor hypoxia by newly designed prodrug possessing high permeability in solid tumors</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2283</span>– <span class="NLM_lpage">2289</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.6b00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.6b00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFKgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=2283-2289&author=Y.+Ikedaauthor=H.+Hisanoauthor=Y.+Nishikawaauthor=Y.+Nagasaki&title=Targeting+and+treatment+of+tumor+hypoxia+by+newly+designed+prodrug+possessing+high+permeability+in+solid+tumors&doi=10.1021%2Facs.molpharmaceut.6b00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting and Treatment of Tumor Hypoxia by Newly Designed Prodrug Possessing High Permeability in Solid Tumors</span></div><div class="casAuthors">Ikeda, Yutaka; Hisano, Hikaru; Nishikawa, Yuji; Nagasaki, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2283-2289</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumor hypoxia, which is assocd. with poor prognosis in cancer, is known to lead to resistance to radiotherapy and anticancer chemotherapy.  Impaired drug penetration in hypoxic regions has been recognized as an essential barrier to drug development in solid tumors.  Here, we propose novel hypoxia-activated prodrugs, which drastically improved the penetration property of commonly used anticancer drugs in the hypoxic region.  In this design, conventional anticancer drugs were modified with 2-nitroimidazole derivs.  The most important point of this study was that the prodrug designed formed a 6-membered cyclic structure to allow liberation of the active drug in the hypoxic region.  This design markedly increased the selectivity of the hypoxia-targeted prodrug, resulting in significant redn. of adverse effects in the normoxic region.  In vitro studies confirmed the selective activation under hypoxic conditions.  In vivo studies showed drastic redn. of adverse effects assocd. with conventional anticancer drugs and improvement of the survival rate of mice.  Immunofluorescence analyses confirmed that the designed prodrug had a tendency to localize at the hypoxic region, in contrast to conventional anticancer drugs, which localize only at the normoxic region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Ed6yVvSv0bVg90H21EOLACvtfcHk0lgVDugOCcv70w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFKgs74%253D&md5=aa62fca974fae7c0d5c9f002e6d05f5e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.6b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.6b00011%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DHisano%26aufirst%3DH.%26aulast%3DNishikawa%26aufirst%3DY.%26aulast%3DNagasaki%26aufirst%3DY.%26atitle%3DTargeting%2520and%2520treatment%2520of%2520tumor%2520hypoxia%2520by%2520newly%2520designed%2520prodrug%2520possessing%2520high%2520permeability%2520in%2520solid%2520tumors%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2016%26volume%3D13%26spage%3D2283%26epage%3D2289%26doi%3D10.1021%2Facs.molpharmaceut.6b00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parvathaneni, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alterio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuijk, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winum, J. Y.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-targeting carbonic anhydrase IX Inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8512</span>– <span class="NLM_lpage">8520</span>, <span class="refDoi"> DOI: 10.1021/jm4009532</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4009532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8512-8520&author=M.+Ramiauthor=L.+Duboisauthor=N.+K.+Parvathaneniauthor=V.+Alterioauthor=S.+J.+van+Kuijkauthor=S.+M.+Montiauthor=P.+Lambinauthor=G.+De+Simoneauthor=C.+T.+Supuranauthor=J.+Y.+Winum&title=Hypoxia-targeting+carbonic+anhydrase+IX+Inhibitors+by+a+new+series+of+nitroimidazole-sulfonamides%2Fsulfamides%2Fsulfamates&doi=10.1021%2Fjm4009532"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm4009532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4009532%26sid%3Dliteratum%253Aachs%26aulast%3DRami%26aufirst%3DM.%26aulast%3DDubois%26aufirst%3DL.%26aulast%3DParvathaneni%26aufirst%3DN.%2BK.%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3Dvan%2BKuijk%26aufirst%3DS.%2BJ.%26aulast%3DMonti%26aufirst%3DS.%2BM.%26aulast%3DLambin%26aufirst%3DP.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26atitle%3DHypoxia-targeting%2520carbonic%2520anhydrase%2520IX%2520Inhibitors%2520by%2520a%2520new%2520series%2520of%2520nitroimidazole-sulfonamides%252Fsulfamides%252Fsulfamates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8512%26epage%3D8520%26doi%3D10.1021%2Fjm4009532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seow, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penketh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartorelli, A. C.</span></span> <span> </span><span class="NLM_article-title">Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6242</span>– <span class="NLM_lpage">6247</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2012.08.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6242-6247&author=R.+Zhuauthor=H.+A.+Seowauthor=R.+P.+Baumannauthor=K.+Ishiguroauthor=P.+G.+Penkethauthor=K.+Shyamauthor=A.+C.+Sartorelli&title=Design+of+a+hypoxia-activated+prodrug+inhibitor+of+O6-alkylguanine-DNA+alkyltransferase&doi=10.1016%2Fj.bmcl.2012.08.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DSeow%26aufirst%3DH.%2BA.%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DDesign%2520of%2520a%2520hypoxia-activated%2520prodrug%2520inhibitor%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6242%26epage%3D6247%26doi%3D10.1016%2Fj.bmcl.2012.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ginsberg, A.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurenzi, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouse, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spigelman, M. K.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3720</span>– <span class="NLM_lpage">3725</span>, <span class="refDoi"> DOI: 10.1128/AAC.00106-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1128%2FAAC.00106-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=19528280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3720-3725&author=A.%0AM.+Ginsbergauthor=M.+W.+Laurenziauthor=D.+J.+Rouseauthor=K.+D.+Whitneyauthor=M.+K.+Spigelman&title=Safety%2C+tolerability%2C+and+pharmacokinetics+of+PA-824+in+healthy+subjects&doi=10.1128%2FAAC.00106-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects</span></div><div class="casAuthors">Ginsberg, Ann M.; Laurenzi, Martino W.; Rouse, Doris J.; Whitney, Karl D.; Spigelman, Melvin K.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3720-3725</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">PA-824 is a novel antibacterial agent that has shown in vitro activity against both drug-sensitive and drug-resistant Mycobacterium tuberculosis.  The compd.'s MIC is between 0.015 and 0.25 μg/mL for drug-sensitive strains and between 0.03 and 0.53 μg/mL for drug-resistant strains.  In addn., it is active against nonreplicating anaerobic Mycobacterium tuberculosis.  The safety, tolerability, and pharmacokinetics of PA-824 were evaluated in two escalating-dose clin. studies, one a single-dose study and the other a multiple-dose study (up to 7 days of daily dosing).  In 58 healthy subjects dosed with PA-824 in these studies, the drug candidate was well tolerated, with no significant or serious adverse events.  In both studies, following oral administration PA-824 reached maximal plasma levels in 4 to 5 h independently of the dose.  Maximal blood levels averaged approx. 3 μg/mL (1,500-mg dose) in the single-dose study and 3.8 μg/mL (600-mg dose) in the multiple-dose study.  Steady state was achieved after 5 to 6 days of daily dosing, with an accumulation ratio of approx. 2.  The elimination half-life averaged 16 to 20 h.  Overall, PA-824 was well tolerated following oral doses once daily for up to 7 days, and pharmacokinetic parameters were consistent with a once-a-day regimen.  The results of these studies, combined with the demonstrated activity of PA-824 against drug-sensitive and multidrug-resistant Mycobacterium tuberculosis, support the investigation of this novel compd. for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqOz72SCeRarVg90H21EOLACvtfcHk0lhyinBK7P3SQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsr7E&md5=b1a66b6df94526f21a3873747ad54487</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1128%2FAAC.00106-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00106-09%26sid%3Dliteratum%253Aachs%26aulast%3DGinsberg%26aufirst%3DA.%2BM.%26aulast%3DLaurenzi%26aufirst%3DM.%2BW.%26aulast%3DRouse%26aufirst%3DD.%2BJ.%26aulast%3DWhitney%26aufirst%3DK.%2BD.%26aulast%3DSpigelman%26aufirst%3DM.%2BK.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520of%2520PA-824%2520in%2520healthy%2520subjects%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3720%26epage%3D3725%26doi%3D10.1128%2FAAC.00106-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span> <span> </span><span class="NLM_article-title">The mechanism of action of PA-824</span>. <i>Commun. Integr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.4161/cib.2.3.7926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.4161%2Fcib.2.3.7926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=19641733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1yru7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=215-218&author=U.+Manjunathaauthor=H.+I.+Boshoffauthor=C.+E.+Barry&title=The+mechanism+of+action+of+PA-824&doi=10.4161%2Fcib.2.3.7926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of action of PA-824: novel insights from transcriptional profiling</span></div><div class="casAuthors">Manjunatha, Ujjini; Boshoff, Helena I. M.; Barry, Clifton E., III</div><div class="citationInfo"><span class="NLM_cas:title">Communicative & Integrative Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-218</span>CODEN:
                <span class="NLM_cas:coden">CIBOBQ</span>;
        ISSN:<span class="NLM_cas:issn">1942-0889</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">The bicyclic nitroimidazole PA-824 is a pro-drug with a very complex mechanism of action active against both replicating and hypoxic, non-replicating Mycobacterium tuberculosis.  Microarray anal. of the mode of action of PA-824 showed a puzzling mixed effect both on genes responsive to both cell wall inhibition (like isoniazid) and respiratory poisoning (like cyanide).  The aerobic killing mechanism of this drug appears to involve inhibition of cell wall mycolic acid biosynthesis through an as yet unknown mol. mechanism.  However, the structure-activity relationships governing aerobic activity do not parallel the relationships detg. anaerobic activity.  Based on the metabolite profiling of PA-824 and various derivs. by Ddn-mediated activation, we have shown that PA-824 acts directly as an NO donor.  This respiratory poisoning through nitric oxide release seemed to be a crucial element of anaerobic activity by PA-824.  The effect of PA-824 on the respiratory complex under hypoxic non-replicating conditions was also manifested in a rapid drop in intracellular ATP levels, again similar to that obsd. by cyanide treatment.  Thus, transcriptional profiling provided valuable clues to elucidating the mol. mechanism of mycobacterial killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRIjCfr9dB9bVg90H21EOLACvtfcHk0lgZYCWqPgl3Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1yru7bF&md5=b7b25a9c2c9b39ff446571c9a2d6d297</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.4161%2Fcib.2.3.7926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcib.2.3.7926%26sid%3Dliteratum%253Aachs%26aulast%3DManjunatha%26aufirst%3DU.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DThe%2520mechanism%2520of%2520action%2520of%2520PA-824%26jtitle%3DCommun.%2520Integr.%2520Biol.%26date%3D2009%26volume%3D2%26spage%3D215%26epage%3D218%26doi%3D10.4161%2Fcib.2.3.7926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowd, C. S.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1317</span>– <span class="NLM_lpage">1328</span>, <span class="refDoi"> DOI: 10.1021/jm801246z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801246z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVSnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1317-1328&author=P.+Kimauthor=L.+Zhangauthor=U.+H.+Manjunathaauthor=R.+Singhauthor=S.+Patelauthor=J.+Jiricekauthor=T.+H.+Kellerauthor=H.+I.+Boshoffauthor=C.+E.+Barryauthor=C.+S.+Dowd&title=Structure-activity+relationships+of+antitubercular+nitroimidazoles.+1.+Structural+features+associated+with+aerobic+and+anaerobic+activities+of+4-+and+5-nitroimidazoles&doi=10.1021%2Fjm801246z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Antitubercular Nitroimidazoles. 1. Structural Features Associated with Aerobic and Anaerobic Activities of 4- and 5-Nitroimidazoles</span></div><div class="casAuthors">Kim, Pilho; Zhang, Liang; Manjunatha, Ujjini H.; Singh, Ramandeep; Patel, Sejal; Jiricek, Jan; Keller, Thomas H.; Boshoff, Helena I.; Barry, Clifton E., III; Dowd, Cynthia S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1317-1328</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 4-nitroimidazole PA-824 is active against aerobic and anaerobic Mycobacterium tuberculosis (Mtb) while 5-nitroimidazoles like metronidazole are active against only anaerobic Mtb.  We have synthesized analogs of both 4- and 5-nitroimidazoles and explored their antitubercular activities.  The nitro group is required for both activities in all compds.  The key determinants of aerobic activity in the 4-nitroimidazoles include the bicyclic oxazine, the lipophilic tail, and the 2-position oxygen.  For the 5-nitroimidazoles, neither the corresponding bicyclic analog nor addn. of a lipophilic tail conveyed aerobic activity.  Incorporation of a 2-position oxygen atom into a rigid 5-nitroimidazooxazine provided the first 5-nitroimidazole with aerobic activity.  Across both series, anaerobic and aerobic activities were not correlated and Mtb mutants lacking the deazaflavin-dependent nitroreductase (Ddn) retained anaerobic sensitivity to some compds.  Aerobic activity appears to be correlated with efficiency as a substrate for Ddn, suggesting a means of structure-based optimization of improved nitroimidazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI5B8p1UDmi7Vg90H21EOLACvtfcHk0lgZYCWqPgl3Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVSnsrw%253D&md5=f06ae53ab31823ac2970d57c58f11a0e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm801246z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801246z%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DDowd%26aufirst%3DC.%2BS.%26atitle%3DStructure-activity%2520relationships%2520of%2520antitubercular%2520nitroimidazoles.%25201.%2520Structural%2520features%2520associated%2520with%2520aerobic%2520and%2520anaerobic%2520activities%2520of%25204-%2520and%25205-nitroimidazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1317%26epage%3D1328%26doi%3D10.1021%2Fjm801246z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niyomrattanakit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowd, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1329</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1021/jm801374t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801374t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1329-1344&author=P.+Kimauthor=S.+Kangauthor=H.+I.+Boshoffauthor=J.+Jiricekauthor=M.+Collinsauthor=R.+Singhauthor=U.+H.+Manjunathaauthor=P.+Niyomrattanakitauthor=L.+Zhangauthor=M.+Goodwinauthor=T.+Dickauthor=T.+H.+Kellerauthor=C.+S.+Dowdauthor=C.+E.+Barry&title=Structure-activity+relationships+of+antitubercular+nitroimidazoles.+2.+Determinants+of+aerobic+activity+and+quantitative+structure-activity+relationships&doi=10.1021%2Fjm801374t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm801374t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801374t%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DP.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DNiyomrattanakit%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGoodwin%26aufirst%3DM.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DDowd%26aufirst%3DC.%2BS.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DStructure-activity%2520relationships%2520of%2520antitubercular%2520nitroimidazoles.%25202.%2520Determinants%2520of%2520aerobic%2520activity%2520and%2520quantitative%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1329%26epage%3D1344%26doi%3D10.1021%2Fjm801374t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span> <span> </span><span class="NLM_article-title">The antitubercular activity of various nitro(triazole/imidazole)-based compounds</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">6039</span>– <span class="NLM_lpage">6048</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.09.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2017.09.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=6039-6048&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweig&title=The+antitubercular+activity+of+various+nitro%28triazole%2Fimidazole%29-based+compounds&doi=10.1016%2Fj.bmc.2017.09.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.09.037%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26atitle%3DThe%2520antitubercular%2520activity%2520of%2520various%2520nitro%2528triazole%252Fimidazole%2529-based%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D6039%26epage%3D6048%26doi%3D10.1016%2Fj.bmc.2017.09.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carter, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabarro, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiodini, P. L.</span></span> <span> </span><span class="NLM_article-title">Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions</span>. <i>Clin. Microbiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/j.cmi.2017.05.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.cmi.2017.05.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=28624613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BC1cnpt1OksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=37-42&author=E.+R.+Carterauthor=L.+E.+Nabarroauthor=L.+Hedleyauthor=P.+L.+Chiodini&title=Nitroimidazole-refractory+giardiasis%3A+a+growing+problem+requiring+rational+solutions&doi=10.1016%2Fj.cmi.2017.05.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions</span></div><div class="casAuthors">Carter E R; Nabarro L E; Chiodini P L; Hedley L</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Giardia intestinalis is microaerophilic diarrhoea-causing protozoan common in countries with suboptimal sanitation.  Standard treatment is with nitroimidazoles, but a growing number of refractory cases is being reported.  Treatment failure has become increasingly prevalent in travellers who contract giardiasis in Asia.  Clinicians are increasingly falling back on second-line and less well-known drugs to treat giardiasis.  AIMS:  To review nitroimidazole-refractory G. intestinalis infection, examine the current efficacy of standard therapeutic agents, consider potential resistance mechanisms which could cause treatment failure and describe the practical aspects of managing this emerging clinical problem.  SOURCES:  A PubMed search was conducted using combinations of the following terms: refractory, Giardia, giardiasis, resistance and treatment.  Articles on the pharmacotherapy, drug resistance mechanisms and use of alternative agents in nitroimidazole-refractory giardiasis were reviewed.  CONTENT:  We review the standard drugs for giardiasis, including their efficacy in initial treatment, mode of action and documented in vitro and in vivo drug resistance.  We assess the efficacy of alternative drugs in nitroimidazole-refractory disease.  Existing data suggest a potential advantage of combination treatment.  IMPLICATIONS:  An optimal treatment strategy for refractory giardiasis has still to be determined, so there is no standard treatment regimen for nitroimidazole-refractory giardiasis.  Further work on drug resistance mechanisms and the use of drug combinations in this condition is a priority.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHvG8MQO6nWOQ4Pl9hzjQhfW6udTcc2ebCyFTYomaZuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnpt1OksA%253D%253D&md5=14dcd9f24519c229d7d2bc0c3636692f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.cmi.2017.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmi.2017.05.028%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DE.%2BR.%26aulast%3DNabarro%26aufirst%3DL.%2BE.%26aulast%3DHedley%26aufirst%3DL.%26aulast%3DChiodini%26aufirst%3DP.%2BL.%26atitle%3DNitroimidazole-refractory%2520giardiasis%253A%2520a%2520growing%2520problem%2520requiring%2520rational%2520solutions%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2018%26volume%3D24%26spage%3D37%26epage%3D42%26doi%3D10.1016%2Fj.cmi.2017.05.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negrette, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parada, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basombrio, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, N. J.</span></span> <span> </span><span class="NLM_article-title">Hepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethyl nitro furazone: a comparison with Benznidazole</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e3231</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0003231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1371%2Fjournal.pntd.0003231" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=e3231&author=C.+Daviesauthor=N.+Deyauthor=O.+S.+Negretteauthor=L.+A.+Paradaauthor=M.+A.+Basombrioauthor=N.+J.+Garg&title=Hepatotoxicity+in+mice+of+a+novel+anti-parasite+drug+candidate+hydroxymethyl+nitro+furazone%3A+a+comparison+with+Benznidazole&doi=10.1371%2Fjournal.pntd.0003231"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003231%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DC.%26aulast%3DDey%26aufirst%3DN.%26aulast%3DNegrette%26aufirst%3DO.%2BS.%26aulast%3DParada%26aufirst%3DL.%2BA.%26aulast%3DBasombrio%26aufirst%3DM.%2BA.%26aulast%3DGarg%26aufirst%3DN.%2BJ.%26atitle%3DHepatotoxicity%2520in%2520mice%2520of%2520a%2520novel%2520anti-parasite%2520drug%2520candidate%2520hydroxymethyl%2520nitro%2520furazone%253A%2520a%2520comparison%2520with%2520Benznidazole%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26spage%3De3231%26doi%3D10.1371%2Fjournal.pntd.0003231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span>Metrinidazole:
An Overview. <a href="https://www.uptodate.com/contents/metronidazole-an-overview/" class="extLink">https://www.uptodate.com/contents/metronidazole-an-overview/</a> (accessed September 12, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Metrinidazole%3A%0AAn+Overview.+https%3A%2F%2Fwww.uptodate.com%2Fcontents%2Fmetronidazole-an-overview%2F+%28accessed+September+12%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Nigro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballo, M. A.</span></span> <span> </span><span class="NLM_article-title">Genotoxicity and cell death induced by tinidazole (TNZ)</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2008.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.toxlet.2008.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18582545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=46-52&author=M.+M.+Lopez+Nigroauthor=M.+A.+Carballo&title=Genotoxicity+and+cell+death+induced+by+tinidazole+%28TNZ%29&doi=10.1016%2Fj.toxlet.2008.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Genotoxicity and cell death induced by tinidazole (TNZ)</span></div><div class="casAuthors">Lopez Nigro, M. M.; Carballo, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-52</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tinidazole (TNZ), a second-generation 5-nitroimidazole compd. chem. related to metronidazole (MTZ), has been widely used throughout Europe and developing countries for the treatment of amoebic and parasitic infections.  Despite TNZ's increasing use in therapeutics, scarce exptl. reports are available in literature on its potential genotoxicity in human cells.  Therefore, the aim of the present study was to achieve a precise characterization of the cytotoxic and genotoxic activities of this nitroimidazole in cultured human lymphocytes at therapeutic concns. (0.1, 1, 10 and 50 μg/mL of culture) and evaluate the possible cell death mechanism assocd. with it.  The endpoints analyzed included: mitotic index (MI), replication index (RI), sister chromatid exchange (SCE) and chromosomal aberrations (CA).  A significant decrease (p < 0.0001) in MI as well as an increase in SCE (p < 0.0001) and CA (p < 0.0001) frequencies were obsd.  No modifications in RI were found.  The results suggest a genotoxic and cytotoxic effect of TNZ related with cell death process.  Therefore, we evaluated this mechanism by DNA fragmentation (laddering), fluorescence microscopy using acridine orange/ethidium bromide (AO/EB) staining and flow cytometry propidium iodide (PI).  DNA exts. of TNZ-treated cells resulted in nucleosomal DNA ladder pattern after 48 h of cell treatment; meanwhile no differences were detected in untreated cells.  This pattern correlated with the obsd. decrease in cellular viability (p < 0.05), morphol. evidence of apoptosis and increase in the percentage of nuclei with hypodiploid DNA content of TNZ exposed cultures compared with control (p < 0.05).  We concluded that TNZ is genotoxic, cytotoxic and is able to modulate cell death through apoptotic mechanisms in the exptl. design employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyVTqYT7hs3LVg90H21EOLACvtfcHk0lixEo6TmGKp3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D&md5=dbf7f9c371265bace4f736b0a475e1c9</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2008.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2008.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%2BNigro%26aufirst%3DM.%2BM.%26aulast%3DCarballo%26aufirst%3DM.%2BA.%26atitle%3DGenotoxicity%2520and%2520cell%2520death%2520induced%2520by%2520tinidazole%2520%2528TNZ%2529%26jtitle%3DToxicol.%2520Lett.%26date%3D2008%26volume%3D180%26spage%3D46%26epage%3D52%26doi%3D10.1016%2Fj.toxlet.2008.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, T. L.</span></span> <span> </span><span class="NLM_article-title">Tinidazole: a nitroimidazole antiprotozoal agent</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1859</span>– <span class="NLM_lpage">1884</span>, <span class="refDoi"> DOI: 10.1016/j.clinthera.2005.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.clinthera.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=16507373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1859-1884&author=H.+B.+Fungauthor=T.+L.+Doan&title=Tinidazole%3A+a+nitroimidazole+antiprotozoal+agent&doi=10.1016%2Fj.clinthera.2005.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Tinidazole: a nitroimidazole antiprotozoal agent</span></div><div class="casAuthors">Fung, Horatio B.; Doan, Thien-Ly</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1859-1884</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Tinidazole, a structural analog of metronidazole, is an antiprotozoal agent that has been widely used in Europe and developing countries for >2 decades with established efficacy and acceptable tolerability.  It was recently approved by the US Food and Drug Administration for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Objective: This article reviews the pharmacol. and pharmacokinetic properties and clin. usefulness of tinidazole.  Methods: Relevant information was identified through a search of MEDLINE (1966-August 2005), Iowa Drug Information Service (1966-August 2005), and International Pharmaceutical Abstrs. (1970-August 2005) using the terms tinidazole, Fasigyn, and nitroimidazole.  Results: In vitro, tinidazole exhibits activity against pathogenic protozoa (eg, Trichomonas vaginalis, Entamoeba histolytica, Giardia duodenalis), a wide range of clin. significant anaerobic bacteria (eg, Bacteroides fragilis, Clostridium difficile), and the microaerophilic bacterium Helicobacter pylori.  In susceptible protozoal and bacterial cells, tinidazole is reduced to cytotoxic intermediates that covalently bind to DNA, causing irreversible damage.  In human adults, tinidazole had a bioavailability of 100% and a Vd of 50.7 L, was minimally bound to plasma protein (12%), had a plasma elimination t1/2 of 12.3 h, and was eliminated primarily by hepatic metab. (∼63%).  Dose adjustment does not appear to be necessary on the basis of race, sex, or renal function.  No data were found on the disposition of tinidazole in patients with hepatic insufficiency; therefore, use of tinidazole in patients with severe hepatic impairment (Child-Pugh class C) is not recommended.  Clin. cure rates in patients with trichomoniasis, giardiasis, amebiasis, and amebic liver abscess were generally >90%.  In comparative trials, tinidazole was as effective as metronidazole in the treatment of trichomoniasis and was significantly more effective than metronidazole in the treatment of giardiasis (P < 0.05) and amebiasis (P < 0.05).  The most commonly reported (>1%) adverse effects included bitter taste, nausea, abdominal discomfort, anorexia, vomiting, and fatigue.  The recommended dosage of tinidazole is a single dose of 2 g for trichomoniasis and giardiasis, and 2 g/d for 3 to 5 days for amebiasis.  Conclusions: Tinidazole appears to be a promising agent for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Clin. studies are needed to evaluate the use of tinidazole against anaerobic bacteria and H pylori.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGwTnbff6nLbVg90H21EOLACvtfcHk0lixEo6TmGKp3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D&md5=cc1ef607c78b3cb9889d5425c4858f04</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DH.%2BB.%26aulast%3DDoan%26aufirst%3DT.%2BL.%26atitle%3DTinidazole%253A%2520a%2520nitroimidazole%2520antiprotozoal%2520agent%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1859%26epage%3D1884%26doi%3D10.1016%2Fj.clinthera.2005.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33"><span>Tinidazole News. <a href="https://www.drugs.com/answers/support-group/tinidazole/news/" class="extLink">https://www.drugs.com/answers/support-group/tinidazole/news/</a> (accessed December 21, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tinidazole+News.+https%3A%2F%2Fwww.drugs.com%2Fanswers%2Fsupport-group%2Ftinidazole%2Fnews%2F+%28accessed+December+21%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit34"><span>Ornidazole. <a href="http://www.sanhome.com" class="extLink">http://www.sanhome.com</a>/ (accessed
December 31, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ornidazole.+http%3A%2F%2Fwww.sanhome.com%2F+%28accessed%0ADecember+31%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span> <span> </span><span class="NLM_article-title">The antitrypanosomal and antitubercular activity of some nitro(triazole/imidazole)-based aromatic amines</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">1106</span>– <span class="NLM_lpage">1113</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.07.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2017.07.060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=1106-1113&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=M.+Kaiser&title=The+antitrypanosomal+and+antitubercular+activity+of+some+nitro%28triazole%2Fimidazole%29-based+aromatic+amines&doi=10.1016%2Fj.ejmech.2017.07.060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.07.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.07.060%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DKaiser%26aufirst%3DM.%26atitle%3DThe%2520antitrypanosomal%2520and%2520antitubercular%2520activity%2520of%2520some%2520nitro%2528triazole%252Fimidazole%2529-based%2520aromatic%2520amines%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D1106%26epage%3D1113%26doi%3D10.1016%2Fj.ejmech.2017.07.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span> <span> </span><span class="NLM_article-title">Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2014.09.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=79-88&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=S.+R.+Wilkinsonauthor=M.+Kaiser&title=Novel+nitro%28triazole%2Fimidazole%29-based+heteroarylamides%2Fsulfonamides+as+potential+antitrypanosomal+agents&doi=10.1016%2Fj.ejmech.2014.09.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.045%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DKaiser%26aufirst%3DM.%26atitle%3DNovel%2520nitro%2528triazole%252Fimidazole%2529-based%2520heteroarylamides%252Fsulfonamides%2520as%2520potential%2520antitrypanosomal%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D79%26epage%3D88%26doi%3D10.1016%2Fj.ejmech.2014.09.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioset, J. R.</span></span> <span> </span><span class="NLM_article-title">Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1, 3-benzothiazoles as antichagasic agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6600</span>– <span class="NLM_lpage">6607</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.08.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2013.08.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6600-6607&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=M.+Kaiserauthor=E.+Chatelainauthor=J.+R.+Ioset&title=Novel+3-nitro-1H-1%2C2%2C4-triazole-based+piperazines+and+2-amino-1%2C+3-benzothiazoles+as+antichagasic+agents&doi=10.1016%2Fj.bmc.2013.08.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.08.022%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DIoset%26aufirst%3DJ.%2BR.%26atitle%3DNovel%25203-nitro-1H-1%252C2%252C4-triazole-based%2520piperazines%2520and%25202-amino-1%252C%25203-benzothiazoles%2520as%2520antichagasic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6600%26epage%3D6607%26doi%3D10.1016%2Fj.bmc.2013.08.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioset, J. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent nitrotriazole-based antitrypanosomal agents: <i>In vitro</i> and <i>in vivo</i> evaluation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6467</span>– <span class="NLM_lpage">6476</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2015.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=26344593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlylsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6467-6476&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=I.+P.+O%E2%80%99Sheaauthor=S.+R.+Wilkinsonauthor=M.+Kaiserauthor=E.+Chatelainauthor=J.+R.+Ioset&title=Discovery+of+potent+nitrotriazole-based+antitrypanosomal+agents%3A+In+vitro+and+in+vivo+evaluation&doi=10.1016%2Fj.bmc.2015.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation</span></div><div class="casAuthors">Papadopoulou, Maria V.; Bloomer, William D.; Rosenzweig, Howard S.; O'Shea, Ivan P.; Wilkinson, Shane R.; Kaiser, Marcel; Chatelain, Eric; Ioset, Jean-Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6467-6476</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">3-Nitro-1H-1,2,4-triazole- and 2-nitro-1H-imidazole-based amides with an aryloxy-Ph core were synthesized and evaluated as antitrypanosomal agents.  All 3-nitrotriazole-based derivs. were extremely potent anti-Trypanosoma cruzi agents at sub nM concns. and exhibited a high degree of selectivity for the parasite.  The 2-nitroimidazole analogs were only moderately active against T. cruzi amastigotes and exhibited low selectivity.  Both types of compd. were active against Leishmania donovani axenic amastigotes with excellent selectivity for the parasite, whereas three 2-nitroimidazole-based analogs were also moderately active against infected macrophages.  However, no compd. demonstrated selective activity against Trypanosoma brucei rhodesiense.  The most potent in vitro anti-T. cruzi compds. were tested in an acute murine model and reduced the parasites to an undetectable level after five days of treatment at 13 mg/kg/day.  Such compds. are potential inhibitors of T. cruzi CYP51 and, being excellent substrates for the type I nitroreductase, which is specific to trypanosomatids, work as prodrugs and constitute a new generation of effective and more affordable antitrypanosomal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6flda_B0eN7Vg90H21EOLACvtfcHk0ljli_yEjWOVPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlylsLnI&md5=a52f3e97fcc84f3074464bdd74f6e209</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DI.%2BP.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DIoset%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520potent%2520nitrotriazole-based%2520antitrypanosomal%2520agents%253A%2520In%2520vitro%2520and%2520in%2520vivo%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6467%26epage%3D6476%26doi%3D10.1016%2Fj.bmc.2015.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Connor, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardley, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Repositioning antitubercular 6-nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for neglected tropical diseases:structure-activity studies on a preclinical candidate for visceral leishmaniasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2530</span>– <span class="NLM_lpage">2550</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01699</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01699" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2530-2550&author=A.+M.+Thompsonauthor=P.+D.+O%27Connorauthor=A.+Blaserauthor=V.+Yardleyauthor=L.+Maesauthor=S.+Guptaauthor=D.+Launayauthor=D.+Martinauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Denny&title=Repositioning+antitubercular+6-nitro-2%2C3-dihydroimidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazoles+for+neglected+tropical+diseases%3Astructure-activity+studies+on+a+preclinical+candidate+for+visceral+leishmaniasis&doi=10.1021%2Facs.jmedchem.5b01699"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01699%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DO%2527Connor%26aufirst%3DP.%2BD.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DYardley%26aufirst%3DV.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DRepositioning%2520antitubercular%25206-nitro-2%252C3-dihydroimidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazoles%2520for%2520neglected%2520tropical%2520diseases%253Astructure-activity%2520studies%2520on%2520a%2520preclinical%2520candidate%2520for%2520visceral%2520leishmaniasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2530%26epage%3D2550%26doi%3D10.1021%2Facs.jmedchem.5b01699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braillard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">7-Substituted 2-nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel antitubercular agents lead to a new preclinical candidate for visceral leishmaniasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4212</span>– <span class="NLM_lpage">4233</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVentbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4212-4233&author=A.+M.+Thompsonauthor=P.+D.+O%E2%80%99Connorauthor=A.+J.+Marshallauthor=A.+Yardleyauthor=O.+Maesauthor=U.+Guptaauthor=D.+Launayauthor=S.+Braillardauthor=E.+Chatelainauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=C.+B.+Cooperauthor=W.+A.+Denny&title=7-Substituted+2-nitro-5%2C6-dihydroimidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazines%3A+Novel+antitubercular+agents+lead+to+a+new+preclinical+candidate+for+visceral+leishmaniasis&doi=10.1021%2Facs.jmedchem.7b00034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis</span></div><div class="casAuthors">Thompson, Andrew M.; O'Connor, Patrick D.; Marshall, Andrew J.; Yardley, Vanessa; Maes, Louis; Gupta, Suman; Launay, Delphine; Braillard, Stephanie; Chatelain, Eric; Franzblau, Scott G.; Wan, Baojie; Wang, Yuehong; Ma, Zhenkun; Cooper, Christopher B.; Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4212-4233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Within a backup program for the clin. investigational agent pretomanid (PA-824), scaffold hopping from delamanid inspired the discovery of a novel class of potent antitubercular agents that unexpectedly possessed notable utility against the kinetoplastid disease visceral leishmaniasis (VL).  Following the identification of delamanid analog DNDI-VL-2098 as a VL preclin. candidate, this structurally related 7-substituted 2-nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazine class was further explored, seeking efficacious backup compds. with improved soly. and safety.  Commencing with a biphenyl lead, bioisosteres formed by replacing one Ph by pyridine or pyrimidine showed improved soly. and potency, whereas more hydrophilic side chains reduced VL activity.  In a Leishmania donovani mouse model, two racemic phenylpyridines (71 and 93) were superior, with the former providing >99% inhibition at 12.5 mg/kg (b.i.d., orally) in the Leishmania infantum hamster model.  Overall, the 7R enantiomer of 71 (79) displayed more optimal efficacy, pharmacokinetics, and safety, leading to its selection as the preferred development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZeHW7NJF-TrVg90H21EOLACvtfcHk0lgmyZt9LM_tVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVentbw%253D&md5=ccb6e45ed81213d05527071e095bd651</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00034%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BD.%26aulast%3DMarshall%26aufirst%3DA.%2BJ.%26aulast%3DYardley%26aufirst%3DA.%26aulast%3DMaes%26aufirst%3DO.%26aulast%3DGupta%26aufirst%3DU.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DBraillard%26aufirst%3DS.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3D7-Substituted%25202-nitro-5%252C6-dihydroimidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazines%253A%2520Novel%2520antitubercular%2520agents%2520lead%2520to%2520a%2520new%2520preclinical%2520candidate%2520for%2520visceral%2520leishmaniasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4212%26epage%3D4233%26doi%3D10.1021%2Facs.jmedchem.7b00034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Nitro Phosphoramide Compositions and Methods for Targeting and Inhibiting Undesirable Cell Growth or Proliferation</span>. U.S. Patent <span class="NLM_patent">2004214798A1</span>, Oct 28, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=L.+Hu&title=Nitro+Phosphoramide+Compositions+and+Methods+for+Targeting+and+Inhibiting+Undesirable+Cell+Growth+or+Proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26atitle%3DNitro%2520Phosphoramide%2520Compositions%2520and%2520Methods%2520for%2520Targeting%2520and%2520Inhibiting%2520Undesirable%2520Cell%2520Growth%2520or%2520Proliferation%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span>; <span class="NLM_string-name">Wilson, W. R.</span>; <span class="NLM_string-name">Stevenson, R. J.</span>; <span class="NLM_string-name">Tercel, M.</span>; <span class="NLM_string-name">Atwell, G. J.</span>; <span class="NLM_string-name">Yang, S.</span>; <span class="NLM_string-name">Patterson, A. V.</span>; <span class="NLM_string-name">Pruijn, F. B.</span></span> <span> </span><span class="NLM_article-title">Nitrobenzindoles and Their Use in Cancer Therapy</span>. N.Z. Patent <span class="NLM_patent">WO 2006/043839 A1</span>, Apr 27, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=W.+A.+Denny&author=W.+R.+Wilson&author=R.+J.+Stevenson&author=M.+Tercel&author=G.+J.+Atwell&author=S.+Yang&author=A.+V.+Patterson&author=F.+B.+Pruijn&title=Nitrobenzindoles+and+Their+Use+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DNitrobenzindoles%2520and%2520Their%2520Use%2520in%2520Cancer%2520Therapy%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, H.</span>; <span class="NLM_string-name">Lewis, J.</span>; <span class="NLM_string-name">Matteucce, M.</span>; <span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">Hypoxia Activated Prodrugs of Antineoplastic Agents</span>. U.S. Patent <span class="NLM_patent">WO 2008/151253 A1</span>, Dec 11, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.+Jiao&author=J.+Lewis&author=M.+Matteucce&author=D.+Sun&title=Hypoxia+Activated+Prodrugs+of+Antineoplastic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DH.%26atitle%3DHypoxia%2520Activated%2520Prodrugs%2520of%2520Antineoplastic%2520Agents%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X. H.</span>; <span class="NLM_string-name">Duan, J. X.</span>; <span class="NLM_string-name">Matteucci, M.</span></span> <span> </span><span class="NLM_article-title">Hypoxia Activated Prodrugs of Anthracyclines</span>. U.S. Patent <span class="NLM_patent">WO 2009/018163 A1</span>, Feb 5, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=X.+H.+Cai&author=J.+X.+Duan&author=M.+Matteucci&title=Hypoxia+Activated+Prodrugs+of+Anthracyclines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%2BH.%26atitle%3DHypoxia%2520Activated%2520Prodrugs%2520of%2520Anthracyclines%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.-x.</span></span> <span> </span><span class="NLM_article-title">Camptothecin Derivatives as Chemoradiosensitizing Agents</span>. U.S. Patent <span class="NLM_patent">2011/0184009 A1</span>, Jul 28, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=L.-x.+Yang&title=Camptothecin+Derivatives+as+Chemoradiosensitizing+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.-x.%26atitle%3DCamptothecin%2520Derivatives%2520as%2520Chemoradiosensitizing%2520Agents%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hart, C.</span>; <span class="NLM_string-name">Meng, F.</span>; <span class="NLM_string-name">Sun, J.</span></span> <span> </span><span class="NLM_article-title">Administration of Hypoxia Activated Prodrugs in Combination with CHK1 Inhibitors for Treating Cancer</span>. U.S. Patent <span class="NLM_patent">WO 2013/096687 A1</span>, June 27, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Hart&author=F.+Meng&author=J.+Sun&title=Administration+of+Hypoxia+Activated+Prodrugs+in+Combination+with+CHK1+Inhibitors+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DC.%26atitle%3DAdministration%2520of%2520Hypoxia%2520Activated%2520Prodrugs%2520in%2520Combination%2520with%2520CHK1%2520Inhibitors%2520for%2520Treating%2520Cancer%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smaill, J. B.</span>; <span class="NLM_string-name">Patterson, A. V.</span>; <span class="NLM_string-name">Ashoorzadeh, A.</span>; <span class="NLM_string-name">Guise, C.
P.</span>; <span class="NLM_string-name">Mowday, A.
M.</span>; <span class="NLM_string-name">Ackerley, D. F.</span>; <span class="NLM_string-name">Williams, E. M.</span>; <span class="NLM_string-name">Copp, J. N.</span></span> <span> </span><span class="NLM_article-title">Novel Prodrugs and Methods of Use Thereof</span>. N.Z. Patent <span class="NLM_patent">WO 2014/031012 A1</span>, Feb 27, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+B.+Smaill&author=A.+V.+Patterson&author=A.+Ashoorzadeh&author=C.%0AP.+Guise&author=A.%0AM.+Mowday&author=D.+F.+Ackerley&author=E.+M.+Williams&author=J.+N.+Copp&title=Novel+Prodrugs+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DNovel%2520Prodrugs%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaki, Y.</span>; <span class="NLM_string-name">Ikeda, Y.</span>; <span class="NLM_string-name">Hisano, H.</span></span> <span> </span><span class="NLM_article-title">Prodrug Using Nitroimidazole</span>. U.S. Patent <span class="NLM_patent">2014/0378673 A1</span>, Dec 25, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.+Nagasaki&author=Y.+Ikeda&author=H.+Hisano&title=Prodrug+Using+Nitroimidazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNagasaki%26aufirst%3DY.%26atitle%3DProdrug%2520Using%2520Nitroimidazole%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R. C. C.</span>; <span class="NLM_string-name">Mold, D. E.</span>; <span class="NLM_string-name">Hwu, J. R.</span>; <span class="NLM_string-name">Hsu, M. H.</span>; <span class="NLM_string-name">Wu, S.
C.</span></span> <span> </span><span class="NLM_article-title">Conjugates of Nitroimidazole and their Use as Chemotherapeutic Agents</span>. U.S. Patent <span class="NLM_patent">2014/0186266 A1</span>, Jul 3, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+C.+C.+Huang&author=D.+E.+Mold&author=J.+R.+Hwu&author=M.+H.+Hsu&author=S.%0AC.+Wu&title=Conjugates+of+Nitroimidazole+and+their+Use+as+Chemotherapeutic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DR.%2BC.%2BC.%26atitle%3DConjugates%2520of%2520Nitroimidazole%2520and%2520their%2520Use%2520as%2520Chemotherapeutic%2520Agents%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, M.</span>; <span class="NLM_string-name">Duan, J.-X.</span>; <span class="NLM_string-name">Jiao, H.</span></span> <span> </span><span class="NLM_article-title">Phosphoramidate Alkylator Prodrugs</span>. U.S. Patent <span class="NLM_patent">2014/0170240 A1</span>, June 19, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Matteucci&author=J.-X.+Duan&author=H.+Jiao&title=Phosphoramidate+Alkylator+Prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMatteucci%26aufirst%3DM.%26atitle%3DPhosphoramidate%2520Alkylator%2520Prodrugs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span>; <span class="NLM_string-name">Yan, J.</span>; <span class="NLM_string-name">Wang, L.</span>; <span class="NLM_string-name">Guo, X.</span>; <span class="NLM_string-name">Li, S.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Zuo, R.</span>; <span class="NLM_string-name">Huang, X.</span>; <span class="NLM_string-name">Wang, H.</span>; <span class="NLM_string-name">Wang, L.</span>; <span class="NLM_string-name">Huang, W.</span>; <span class="NLM_string-name">Lu, H.</span>; <span class="NLM_string-name">Feng, K.</span>; <span class="NLM_string-name">Li, F.</span>; <span class="NLM_string-name">He, H.</span>; <span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Nitropyridinyl Ethyleneimine Compound, the Pharmaceutical Composition Containing it, the Preparation Method and Use Thereof</span>. U.S. Patent <span class="NLM_patent">2014/0073796 A1</span>, Mar 13, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Yang&author=J.+Yan&author=L.+Wang&author=X.+Guo&author=S.+Li&author=G.+Wu&author=R.+Zuo&author=X.+Huang&author=H.+Wang&author=L.+Wang&author=W.+Huang&author=H.+Lu&author=K.+Feng&author=F.+Li&author=H.+He&author=Y.+Liu&title=Nitropyridinyl+Ethyleneimine+Compound%2C+the+Pharmaceutical+Composition+Containing+it%2C+the+Preparation+Method+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%26atitle%3DNitropyridinyl%2520Ethyleneimine%2520Compound%252C%2520the%2520Pharmaceutical%2520Composition%2520Containing%2520it%252C%2520the%2520Preparation%2520Method%2520and%2520Use%2520Thereof%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. X.</span>; <span class="NLM_string-name">Cao, Y.</span>; <span class="NLM_string-name">Cai, X.</span>; <span class="NLM_string-name">Jiao, H.</span>; <span class="NLM_string-name">Jing, Y.</span>; <span class="NLM_string-name">Matteucci, M.</span></span> <span> </span><span class="NLM_article-title">Nitrobenzyl Derivatives of Anti-Cancer Agents</span>. U.S. Patent <span class="NLM_patent">WO2016/161342 A2</span>, Oct 6, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+X.+Duan&author=Y.+Cao&author=X.+Cai&author=H.+Jiao&author=Y.+Jing&author=M.+Matteucci&title=Nitrobenzyl+Derivatives+of+Anti-Cancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DJ.%2BX.%26atitle%3DNitrobenzyl%2520Derivatives%2520of%2520Anti-Cancer%2520Agents%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Small, J. B.</span>; <span class="NLM_string-name">Patterson, A. V.</span>; <span class="NLM_string-name">Hay, M. P.</span>; <span class="NLM_string-name">Denny, W. A.</span>; <span class="NLM_string-name">Wilson, W. R.</span>; <span class="NLM_string-name">Lu, G.-L.</span>; <span class="NLM_string-name">Anderson, R. F.</span>; <span class="NLM_string-name">Lee, H. H.</span>; <span class="NLM_string-name">Ashoorzadeh, A.</span></span> <span> </span><span class="NLM_article-title">Prodrug Forms of Kinase Inhibitors and Their Use in Therapy</span>. U.S. Patent <span class="NLM_patent">2016/0002222 A1</span>, Jan 7, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+B.+Small&author=A.+V.+Patterson&author=M.+P.+Hay&author=W.+A.+Denny&author=W.+R.+Wilson&author=G.-L.+Lu&author=R.+F.+Anderson&author=H.+H.+Lee&author=A.+Ashoorzadeh&title=Prodrug+Forms+of+Kinase+Inhibitors+and+Their+Use+in+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DJ.%2BB.%26atitle%3DProdrug%2520Forms%2520of%2520Kinase%2520Inhibitors%2520and%2520Their%2520Use%2520in%2520Therapy%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span> <span> </span><span class="NLM_article-title">Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2014.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.pt.2014.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=24776300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVWlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=289-298&author=S.+Pattersonauthor=S.+Wyllie&title=Nitro+drugs+for+the+treatment+of+trypanosomatid+diseases%3A+past%2C+present%2C+and+future+prospects&doi=10.1016%2Fj.pt.2014.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects</span></div><div class="casAuthors">Patterson, Stephen; Wyllie, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">289-298</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  There is an urgent need for new, safer, and effective treatments for the diseases caused by the protozoan parasites Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp.  In the search for more effective drugs to treat these 'neglected diseases' researchers have chosen to reassess the therapeutic value of nitroarom. compds.  Previously avoided in drug discovery programs owing to potential toxicity issues, a nitro drug is now being used successfully as part of a combination therapy for human African trypanosomiasis.  We describe here the rehabilitation of nitro drugs for the treatment of trypanosomatid diseases and discuss the future prospects for this compd. class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomh5yhGW-6mrVg90H21EOLACvtfcHk0ljZR05D1Mcr1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVWlsL4%253D&md5=041606bd13d4f709723aa61f1100873b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2014.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2014.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DWyllie%26aufirst%3DS.%26atitle%3DNitro%2520drugs%2520for%2520the%2520treatment%2520of%2520trypanosomatid%2520diseases%253A%2520past%252C%2520present%252C%2520and%2520future%2520prospects%26jtitle%3DTrends%2520Parasitol.%26date%3D2014%26volume%3D30%26spage%3D289%26epage%3D298%26doi%3D10.1016%2Fj.pt.2014.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit55a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. P.</span></span> <span> </span><span class="NLM_article-title">Biologic activity of hydroxylamine: A review</span>. <i>Crit. Rev. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.3109/10408448509023765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.3109%2F10408448509023765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=3882333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADyaL2MXht1Klt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1985&pages=87-99&author=P.+Grossauthor=R.+P.+Smith&title=Biologic+activity+of+hydroxylamine%3A+A+review&doi=10.3109%2F10408448509023765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55aR"><div class="casContent"><span class="casTitleNuber">55a</span><div class="casTitle"><span class="NLM_cas:atitle">Biologic activity of hydroxylamine:  a review</span></div><div class="casAuthors">Gross, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-99</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">0045-6446</span>.
    </div><div class="casAbstract">A review with 119 refs. on the toxicity, teratogenicity, and carcinogenicity of hydroxylamine  [7803-49-8] in animals and humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4JvAuDoMmrbVg90H21EOLACvtfcHk0lgAGSJNOPqlZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXht1Klt7Y%253D&md5=f1a4928e2c9c774182a813e9937ac712</span></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.3109%2F10408448509023765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10408448509023765%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DR.%2BP.%26atitle%3DBiologic%2520activity%2520of%2520hydroxylamine%253A%2520A%2520review%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D1985%26volume%3D14%26spage%3D87%26epage%3D99%26doi%3D10.3109%2F10408448509023765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit55b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Macherey, A. C.</span>; <span class="NLM_string-name">Dansette, P. M.</span></span> <span> </span><span class="NLM_article-title">Biotransformations Leading to Toxic Metabolites: Chemical Aspect</span>.  <i>The Practice of Medicinal Chemistry</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-417205-0.00025-0</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FB978-0-12-417205-0.00025-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=675-696&author=A.+C.+Macherey&author=P.+M.+Dansette&title=The+Practice+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-417205-0.00025-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-417205-0.00025-0%26sid%3Dliteratum%253Aachs%26aulast%3DMacherey%26aufirst%3DA.%2BC.%26atitle%3DBiotransformations%2520Leading%2520to%2520Toxic%2520Metabolites%253A%2520Chemical%2520Aspect%26btitle%3DThe%2520Practice%2520of%2520Medicinal%2520Chemistry%26pub%3DAcademic%2520Press%26date%3D2015%26spage%3D675%26epage%3D696%26doi%3D10.1016%2FB978-0-12-417205-0.00025-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plošnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vračko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Mutagenic and carcinogenic structural alerts and their mechanisms of action</span>. <i>Arh. Hig. Rada Toksikol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1515/aiht-2016-67-2801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1515%2Faiht-2016-67-2801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27749264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOjsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2016&pages=169-182&author=A.+Plo%C5%A1nikauthor=M.+Vra%C4%8Dkoauthor=M.+Sollner+Dolenc&title=Mutagenic+and+carcinogenic+structural+alerts+and+their+mechanisms+of+action&doi=10.1515%2Faiht-2016-67-2801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Mutagenic and carcinogenic structural alerts and their mechanisms of action</span></div><div class="casAuthors">Plosnik, Alja; Vracko, Marjan; Dolenc, Marija Sollner</div><div class="citationInfo"><span class="NLM_cas:title">Arhiv za Higijenu Rada i Toksikologiju</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-182</span>CODEN:
                <span class="NLM_cas:coden">AHRTAN</span>;
        ISSN:<span class="NLM_cas:issn">0004-1254</span>.
    
            (<span class="NLM_cas:orgname">Institute for Medical Research and Occupational Health</span>)
        </div><div class="casAbstract">Knowing the mutagenic and carcinogenic properties of chems. is very important for their hazard (and risk) assessment.  One of the crucial events that trigger genotoxic and sometimes carcinogenic effects is the forming of adducts between chem. compds. and nucleic acids and histones.  This review takes a look at the mechanisms related to specific functional groups (structural alerts or toxicophores) that may trigger genotoxic or epigenetic effects in the cells.  We present up-to-date information about defined structural alerts with their mechanisms and the software based on this knowledge (QSAR models and classification schemes).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdeqAFfj6rMbVg90H21EOLACvtfcHk0lgAGSJNOPqlZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOjsbnN&md5=dd7df61e62c220bd31592ec080b4a5e3</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1515%2Faiht-2016-67-2801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Faiht-2016-67-2801%26sid%3Dliteratum%253Aachs%26aulast%3DPlo%25C5%25A1nik%26aufirst%3DA.%26aulast%3DVra%25C4%258Dko%26aufirst%3DM.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DMutagenic%2520and%2520carcinogenic%2520structural%2520alerts%2520and%2520their%2520mechanisms%2520of%2520action%26jtitle%3DArh.%2520Hig.%2520Rada%2520Toksikol.%26date%3D2016%26volume%3D67%26spage%3D169%26epage%3D182%26doi%3D10.1515%2Faiht-2016-67-2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarrad, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaskovich, M. A. T.</span></span> <span> </span><span class="NLM_article-title">Nitroimidazoles: molecular fireworks that combat a broad spectrum of infectious diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7636</span>– <span class="NLM_lpage">7657</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00143</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntVGgtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7636-7657&author=C.+W.+Angauthor=A.+M.+Jarradauthor=M.+A.+Cooperauthor=M.+A.+T.+Blaskovich&title=Nitroimidazoles%3A+molecular+fireworks+that+combat+a+broad+spectrum+of+infectious+diseases&doi=10.1021%2Facs.jmedchem.7b00143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases</span></div><div class="casAuthors">Ang, Chee Wei; Jarrad, Angie M.; Cooper, Matthew A.; Blaskovich, Mark A. T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7636-7657</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Infectious diseases claim millions of lives every year, but with the advent of drug resistance, therapeutic options to treat infections are inadequate.  There is now an urgent need to develop new and effective treatments.  Nitroimidazoles are a class of antimicrobial drugs that have remarkable broad spectrum activity against parasites, mycobacteria, and anaerobic Gram-pos. and Gram-neg. bacteria.  While nitroimidazoles were discovered in the 1950s, there has been renewed interest in their therapeutic potential, particularly for the treatment of parasitic infections and tuberculosis.  In this review, we summarize different classes of nitroimidazoles that have been described in the literature in the past five years, from approved drugs and clin. candidates to examples undergoing preclin. or early stage development.  The relatively "nonspecific" mode of action and resistance mechanisms of nitromidazoles are discussed, and contemporary strategies to facilitate nitroimidazole drug development are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWN4dIzG5927Vg90H21EOLACvtfcHk0lipYNz9wtQSIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntVGgtrw%253D&md5=7822bbe845bd6f1383ce09c62c5d5ac8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00143%26sid%3Dliteratum%253Aachs%26aulast%3DAng%26aufirst%3DC.%2BW.%26aulast%3DJarrad%26aufirst%3DA.%2BM.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%2BT.%26atitle%3DNitroimidazoles%253A%2520molecular%2520fireworks%2520that%2520combat%2520a%2520broad%2520spectrum%2520of%2520infectious%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7636%26epage%3D7657%26doi%3D10.1021%2Facs.jmedchem.7b00143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e09744</span>, <span class="refDoi"> DOI: 10.7554/eLife.09744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.7554%2FeLife.09744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27215734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsFamtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e09744&author=S.+Pattersonauthor=S.+Wyllieauthor=S.+Norvalauthor=L.+Stojanovskiauthor=F.+R.+C.+Simeonsauthor=J.+L.+Auerauthor=M.+Osuna-Cabelloauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=The+anti-tubercular+drug+delamanid+as+a+potential+oral+treatment+for+visceral+leishmaniasis&doi=10.7554%2FeLife.09744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis</span></div><div class="casAuthors">Patterson, Stephen; Wyllie, Susan; Norval, Suzanne; Stojanovski, Laste; Simeons, Frederick R. C.; Auer, Jennifer L.; Osuna-Cabello, Maria; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e09744/1-e09744/21</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">There is an urgent requirement for safe, oral and cost-effective drugs for the treatment of visceral leishmaniasis (VL).  We report that delamanid (OPC-67683), an approved drug for multi-drug resistant tuberculosis, is a potent inhibitor of Leishmaniadonovani both in vitro and in vivo.  Twice-daily oral dosing of delamanid at 30 mg kg-1 for 5 days resulted in sterile cures in a mouse model of VL.  Treatment with lower doses revealed a U-shaped (hormetic) dose-response curve with greater parasite suppression at 1 mg kg-1 than at 3 mg kg-1 (5 or 10 day dosing).  Dosing delamanid for 10 days confirmed the hormetic dose-response and improved the efficacy at all doses investigated.  Mechanistic studies reveal that delamanid is rapidly metabolised by parasites via an enzyme, distinct from the nitroreductase that activates fexinidazole.  Delamanid has the potential to be repurposed as a much-needed oral therapy for VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqepWvGUGZ0cbVg90H21EOLACvtfcHk0lipYNz9wtQSIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsFamtLw%253D&md5=1a704d1acb52b08cae5f73cf625f293a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.7554%2FeLife.09744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.09744%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DAuer%26aufirst%3DJ.%2BL.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DThe%2520anti-tubercular%2520drug%2520delamanid%2520as%2520a%2520potential%2520oral%2520treatment%2520for%2520visceral%2520leishmaniasis%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De09744%26doi%3D10.7554%2FeLife.09744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit59"><span>DNDI-0690
Nitroimidazole; Drugs for Neglected Diseases Initiative, 2016. <a href="http://www.dndi.org/diseases-projects/portfolio/nitroimidazole/" class="extLink">http://www.dndi.org/diseases-projects/portfolio/nitroimidazole/</a> (accessed December 14, <span class="NLM_year">2016</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DNDI-0690%0ANitroimidazole%3B+Drugs+for+Neglected+Diseases+Initiative%2C+2016.+http%3A%2F%2Fwww.dndi.org%2Fdiseases-projects%2Fportfolio%2Fnitroimidazole%2F+%28accessed+December+14%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardley, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivahare, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, S. K.</span></span> <span> </span><span class="NLM_article-title">Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1093/jac/dku422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1093%2Fjac%2Fdku422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=25389223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFGmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=518-527&author=S.+Guptaauthor=V.+Yardleyauthor=P.+Vishwakarmaauthor=R.+Shivahareauthor=B.+Sharmaauthor=D.+Launayauthor=D.+Martinauthor=S.+K.+Puri&title=Nitroimidazo-oxazole+compound+DNDI-VL-2098%3A+an+orally+effective+preclinical+drug+candidate+for+the+treatment+of+visceral+leishmaniasis&doi=10.1093%2Fjac%2Fdku422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis</span></div><div class="casAuthors">Gupta, Suman; Yardley, Vanessa; Vishwakarma, Preeti; Shivahare, Rahul; Sharma, Bhawna; Launay, Delphine; Martin, Denis; Puri, Sunil K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">518-527</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: The objective of this study was to identify a nitroimidazo-oxazole lead mol. for the treatment of visceral leishmaniasis (VL).  Methods: A library of 72 nitroimidazo-oxazoles was evaluated in vitro for their antileishmanial activity against luciferase-transfected DD8 amastigotes of Leishmania donovani.  On the basis of their in vitro potency and pharmacokinetic properties, the promising compds. were tested in acute BALB/c mouse and chronic hamster models of VL via oral administration and efficacy was evaluated by microscopic counting of amastigotes after Giemsa staining.  The best antileishmanial candidates (racemate DNDI-VL-2001) and its R enantiomer (DNDI-VL-2098) were evaluated in vitro against a range of Leishmania strains.  These candidates were further studied in a hamster model using various dose regimens.  Cytokine and inducible nitric oxide synthase estns. by real-time PCR and nitric oxide generation by Griess assay were also carried out for DNDI-VL-2098.  Results: In vitro screening of nitroimidazo-oxazole compds. identified the racemate DNDI-VL-2001 (6-nitroimidazo-oxazole deriv.) and its enantiomers as candidates for further evaluation in in vivo models of VL.  DNDI-VL-2098 (IC50 of 0.03 μM for the DD8 strain) showed excellent in vivo activity in both mouse and hamster models, with an ED90 value of 3.7 and <25 mg/kg, resp., and was also found to be very effective against high-grade infection in the hamster model.  Our studies revealed that, along with leishmanicidal activity, DNDI-VL-2098 was also capable of inducing host-protective immune cells to suppress Leishmania parasites in hamsters.  Conclusions: These studies led to the identification of compd. DNDI-VL-2098 as a preclin. candidate for further drug development as an oral treatment for VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUxdrMAhWewLVg90H21EOLACvtfcHk0liaQbWvumQs-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFGmur8%253D&md5=179ae312a4efef99059577223650641a</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdku422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdku422%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DYardley%26aufirst%3DV.%26aulast%3DVishwakarma%26aufirst%3DP.%26aulast%3DShivahare%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DB.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DPuri%26aufirst%3DS.%2BK.%26atitle%3DNitroimidazo-oxazole%2520compound%2520DNDI-VL-2098%253A%2520an%2520orally%2520effective%2520preclinical%2520drug%2520candidate%2520for%2520the%2520treatment%2520of%2520visceral%2520leishmaniasis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2015%26volume%3D70%26spage%3D518%26epage%3D527%26doi%3D10.1093%2Fjac%2Fdku422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukkavilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinjari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengottuvelan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadekar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pothuri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashekar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koiram, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harisudhan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moinuddin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachharajani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2014.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejps.2014.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=25261338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Gms73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2014&pages=147-155&author=R.+Mukkavilliauthor=J.+Pinjariauthor=B.+Patelauthor=S.+Sengottuvelanauthor=S.+Mondalauthor=A.+Gadekarauthor=M.+Vermaauthor=J.+Patelauthor=L.+Pothuriauthor=G.+Chandrashekarauthor=P.+Koiramauthor=T.+Harisudhanauthor=A.+Moinuddinauthor=D.+Launayauthor=N.+Vachharajaniauthor=V.+Ramanathanauthor=D.+Martin&title=In+vitro+metabolism%2C+disposition%2C+preclinical+pharmacokinetics+and+prediction+of+human+pharmacokinetics+of+DNDI-VL-2098%2C+a+potential+oral+treatment+for+Visceral+Leishmaniasis&doi=10.1016%2Fj.ejps.2014.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis</span></div><div class="casAuthors">Mukkavilli, Rao; Pinjari, Jakir; Patel, Bhavesh; Sengottuvelan, Shankar; Mondal, Subodh; Gadekar, Ajit; Verma, Manas; Patel, Jignesh; Pothuri, Lavanya; Chandrashekar, Gopu; Koiram, Prabhakar; Harisudhan, Tanukrishnan; Moinuddin, Ansari; Launay, Delphine; Vachharajani, Nimish; Ramanathan, Vikram; Martin, Denis</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-155</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The in vitro metab. and in vivo pharmacokinetic (PK) properties of DNDI-VL-2098, a potential oral agent for Visceral Leishmaniasis (VL) were studied and used to predict its human pharmacokinetics.  DNDI-VL-2098 showed a low soly. (10 μM) and was highly permeable (>200 nm/s) in the Caco-2 model.  It was stable in vitro in liver microsomes and hepatocytes and no metabolite was detectable in circulating plasma from dosed animals suggesting very slow, if any, metab. of the compd.  DNDI-VL-2098 was moderate to highly bound to plasma proteins across the species tested (94-98%).  DNDI-VL-2098 showed satisfactory PK properties in mouse, hamster, rat and dog with a low blood clearance (<15% of hepatic blood flow except hamster), a vol. of distribution of about 3 times total body water, acceptable half-life (1-6 h across the species) and good oral bioavailability (37-100%).  Allometric scaling of the preclin. PK data to human gave a blood half-life of approx. 20 h suggesting that the compd. could be a once-a-day drug.  Based on the above assumptions, the min. efficacious dose predicted for a 50 kg human was 150 mg and 300 mg, using efficacy results in the mouse and hamster, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg5azRMLSQ37Vg90H21EOLACvtfcHk0liaQbWvumQs-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Gms73N&md5=9d351c194ceba25f2dc23be54bb1ba33</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2014.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2014.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DMukkavilli%26aufirst%3DR.%26aulast%3DPinjari%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DB.%26aulast%3DSengottuvelan%26aufirst%3DS.%26aulast%3DMondal%26aufirst%3DS.%26aulast%3DGadekar%26aufirst%3DA.%26aulast%3DVerma%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DPothuri%26aufirst%3DL.%26aulast%3DChandrashekar%26aufirst%3DG.%26aulast%3DKoiram%26aufirst%3DP.%26aulast%3DHarisudhan%26aufirst%3DT.%26aulast%3DMoinuddin%26aufirst%3DA.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DVachharajani%26aufirst%3DN.%26aulast%3DRamanathan%26aufirst%3DV.%26aulast%3DMartin%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520metabolism%252C%2520disposition%252C%2520preclinical%2520pharmacokinetics%2520and%2520prediction%2520of%2520human%2520pharmacokinetics%2520of%2520DNDI-VL-2098%252C%2520a%2520potential%2520oral%2520treatment%2520for%2520Visceral%2520Leishmaniasis%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2014%26volume%3D65%26spage%3D147%26epage%3D155%26doi%3D10.1016%2Fj.ejps.2014.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel BET inhibitors by drug repurposing of nitroxoline and its analogues</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">9352</span>– <span class="NLM_lpage">9361</span>, <span class="refDoi"> DOI: 10.1039/C7OB02369C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1039%2FC7OB02369C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=29087414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSgsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=9352-9361&author=H.+Jiangauthor=J.+Xingauthor=C.+Wangauthor=H.+Zhangauthor=L.+Yueauthor=X.+Wanauthor=W.+Chenauthor=H.+Dingauthor=Y.+Xieauthor=H.+Taoauthor=Z.+Chenauthor=H.+Jiangauthor=K.+Chenauthor=S.+Chenauthor=M.+Zhengauthor=Y.+Zhangauthor=C.+Luo&title=Discovery+of+novel+BET+inhibitors+by+drug+repurposing+of+nitroxoline+and+its+analogues&doi=10.1039%2FC7OB02369C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel BET inhibitors by drug repurposing of nitroxoline and its analogues</span></div><div class="casAuthors">Jiang, Hao; Xing, Jing; Wang, Chen; Zhang, Hao; Yue, Liyan; Wan, Xiaozhe; Chen, Wei; Ding, Hong; Xie, Yiqian; Tao, Hongru; Chen, Zhifeng; Jiang, Hualiang; Chen, Kaixian; Chen, Shijie; Zheng, Mingyue; Zhang, Yuanyuan; Luo, Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">9352-9361</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The BET family of bromodomain-contg. proteins (BRDs) is believed to be a promising drug target for therapeutic intervention in a no. of diseases including cancer, inflammation and cardiovascular diseases.  Hence, there is a great demand for novel chemotypes of BET inhibitors.  The drug repurposing strategy offers great benefits to find inhibitors with known safety and pharmacokinetic profiles, thus increasing medicinal chemists' interest in recent years.  Using the drug repurposing strategy, a BRD4-specific score based virtual screening campaign on an inhouse drug library was conducted followed by the ALPHA screen assay test.  Nitroxoline, an FDA-approved antibiotic, was identified to effectively disrupt the interaction between the first bromodomain of BRD4 (bromodomain-contg. protein 4) and acetylated H4 peptide with IC50 of 0.98 μM.  Nitroxoline inhibited all BET family members with good selectivity against non-BET bromodomain-contg. proteins, thus it is defined as a selective BET inhibitor.  Based on the crystal structure of the nitroxoline-BRD4_BD1 complex, the mechanism of action as well as BET specificity of nitroxoline were detd.  Since the anticancer activity of nitroxoline against MLL leukemia, one of the BET related diseases, has not been studied before, we tested whether nitroxoline might serve as a potential repurposing drug candidate for MLL leukemia.  Nitroxoline effectively inhibited the proliferation of MLL leukemia cells by inducing cell cycle arrest and apoptosis.  The profound efficacy is, at least in part, due to the inhibition of BET and downregulation of target gene transcription.  Our discovery of nitroxoline as a BET inhibitor suggests potential application of nitroxoline and its derivs. for clin. translation in BET family related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwFY1iu1armbVg90H21EOLACvtfcHk0liU6grLHrVtdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSgsbjF&md5=ca87955c1bd2b79fe073faef1e6ef149</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1039%2FC7OB02369C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7OB02369C%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DYue%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520BET%2520inhibitors%2520by%2520drug%2520repurposing%2520of%2520nitroxoline%2520and%2520its%2520analogues%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2017%26volume%3D15%26spage%3D9352%26epage%3D9361%26doi%3D10.1039%2FC7OB02369C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coe, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bammler, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farin, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plymate, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fausto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, S. D.</span></span> <span> </span><span class="NLM_article-title">Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1290</span>, <span class="refDoi"> DOI: 10.1021/tx7001349</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx7001349" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1277-1290&author=K.+J.+Coeauthor=Y.+Jiaauthor=H.+K.+Hoauthor=P.+Rademacherauthor=T.+K.+Bammlerauthor=R.+P.+Beyerauthor=F.+M.+Farinauthor=L.+Woodkeauthor=S.+R.+Plymateauthor=N.+Faustoauthor=S.+D.+Nelson&title=Comparison+of+the+cytotoxicity+of+the+nitroaromatic+drug+flutamide+to+its+cyano+analogue+in+the+hepatocyte+cell+line+TAMH%3A+evidence+for+complex+I+inhibition+and+mitochondrial+dysfunction+using+toxicogenomic+screening&doi=10.1021%2Ftx7001349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Ftx7001349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx7001349%26sid%3Dliteratum%253Aachs%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DHo%26aufirst%3DH.%2BK.%26aulast%3DRademacher%26aufirst%3DP.%26aulast%3DBammler%26aufirst%3DT.%2BK.%26aulast%3DBeyer%26aufirst%3DR.%2BP.%26aulast%3DFarin%26aufirst%3DF.%2BM.%26aulast%3DWoodke%26aufirst%3DL.%26aulast%3DPlymate%26aufirst%3DS.%2BR.%26aulast%3DFausto%26aufirst%3DN.%26aulast%3DNelson%26aufirst%3DS.%2BD.%26atitle%3DComparison%2520of%2520the%2520cytotoxicity%2520of%2520the%2520nitroaromatic%2520drug%2520flutamide%2520to%2520its%2520cyano%2520analogue%2520in%2520the%2520hepatocyte%2520cell%2520line%2520TAMH%253A%2520evidence%2520for%2520complex%2520I%2520inhibition%2520and%2520mitochondrial%2520dysfunction%2520using%2520toxicogenomic%2520screening%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1277%26epage%3D1290%26doi%3D10.1021%2Ftx7001349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mook, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spasojevic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barak, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyerly, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span> <span> </span><span class="NLM_article-title">Structure–activity studies of Wnt/β-catenin inhibition in the niclosamide chemotype: Identification of derivatives with improved drug exposure</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5829</span>– <span class="NLM_lpage">5838</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2015.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=26272032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWls7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5829-5838&author=R.+A.+Mookauthor=J.+Wangauthor=X.+R.+Renauthor=M.+Chenauthor=I.+Spasojevicauthor=L.+S.+Barakauthor=H.+K.+Lyerlyauthor=W.+Chen&title=Structure%E2%80%93activity+studies+of+Wnt%2F%CE%B2-catenin+inhibition+in+the+niclosamide+chemotype%3A+Identification+of+derivatives+with+improved+drug+exposure&doi=10.1016%2Fj.bmc.2015.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure</span></div><div class="casAuthors">Mook, Robert A., Jr.; Wang, Jiangbo; Ren, Xiu-Rong; Chen, Minyong; Spasojevic, Ivan; Barak, Larry S.; Lyerly, H. Kim; Chen, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5829-5838</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Wnt signaling pathway plays a key role in regulation of organ development and tissue homeostasis.  Dysregulated Wnt activity is one of the major underlying mechanisms responsible for many diseases including cancer.  We previously reported the FDA-approved anthelmintic drug Niclosamide inhibits Wnt/β-catenin signaling and suppresses colon cancer cell growth in vitro and in vivo.  Niclosamide is a multi-functional drug that possesses important biol. activity in addn. to inhibition of Wnt/β-catenin signaling.  Here, we studied the SAR of Wnt signaling inhibition in the anilide and salicylamide region of Niclosamide.  We found that the 4'-nitro substituent can be effectively replaced by trifluoromethyl or chlorine and that the potency of inhibition was dependent on the substitution pattern in the anilide ring.  Non-anilide, N-Me amides and reverse amide derivs. lost significant potency, while acylated salicylamide derivs. inhibited signaling with potency similar to non-acyl derivs.  Niclosamide low systemic exposure when dosed orally may hinder its use to treat systemic disease.  To overcome this limitation we identified an acyl deriv. of Niclosamide, DK-520 (compd. 32), that significantly increased both the plasma concn. and the duration of exposure of Niclosamide when dosed orally.  The studies herein provide a medicinal chem. foundation to improve the pharmacokinetic exposure of Niclosamide and Wnt-signaling inhibitors based on the Niclosamide chemotype.  The identification of novel derivs. of Niclosamide that metabolize to Niclosamide and increase its drug exposure may provide important research tools for in vivo studies and provide drug candidates for treating cancers with dysregulated Wnt signaling including drug-resistant cancers.  Moreover, since Niclosamide is a multi-functional drug, new research tools such as DK520 could directly result in novel treatments against bacterial and viral infection, lupus, and metabolic diseases such as type II diabetes, NASH and NAFLD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmEUYAbB-zQrVg90H21EOLACvtfcHk0liU6grLHrVtdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWls7%252FE&md5=bacff220c2336023d2854678058839c1</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DX.%2BR.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DSpasojevic%26aufirst%3DI.%26aulast%3DBarak%26aufirst%3DL.%2BS.%26aulast%3DLyerly%26aufirst%3DH.%2BK.%26aulast%3DChen%26aufirst%3DW.%26atitle%3DStructure%25E2%2580%2593activity%2520studies%2520of%2520Wnt%252F%25CE%25B2-catenin%2520inhibition%2520in%2520the%2520niclosamide%2520chemotype%253A%2520Identification%2520of%2520derivatives%2520with%2520improved%2520drug%2520exposure%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5829%26epage%3D5838%26doi%3D10.1016%2Fj.bmc.2015.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Purohit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, A. K.</span></span> <span> </span><span class="NLM_article-title">Mutagenicity of nitroaromatic compounds</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1021/tx000002x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx000002x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=673-692&author=V.+Purohitauthor=A.+K.+Basu&title=Mutagenicity+of+nitroaromatic+compounds&doi=10.1021%2Ftx000002x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Mutagenicity of Nitroaromatic Compounds</span></div><div class="casAuthors">Purohit, Vandana; Basu, Ashis K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">673-692</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review and discussion with 222 refs.  Metab. and DNA binding, mechanism of mutagenesis and repair in bacteria, mutagenesis in mammalian systems, and structure-activity relationship are discussed in relation to the title topic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpybDHR1RJ20rVg90H21EOLACvtfcHk0lhmswppfwq2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFSitLg%253D&md5=74477b2805d2365e208538cdce0dec39</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Ftx000002x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx000002x%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DV.%26aulast%3DBasu%26aufirst%3DA.%2BK.%26atitle%3DMutagenicity%2520of%2520nitroaromatic%2520compounds%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2000%26volume%3D13%26spage%3D673%26epage%3D692%26doi%3D10.1021%2Ftx000002x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit66a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span> <span> </span><span class="NLM_article-title">Delamanid is not metabolized by salmonella or human nitroreductases: a possible mechanism for the lack of mutagenicity</span>. <i>Regul. Toxicol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.yrtph.2016.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.yrtph.2016.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27988333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWltrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2017&pages=1-8&author=E.+Hanakiauthor=M.+Hayashiauthor=M.+Matsumoto&title=Delamanid+is+not+metabolized+by+salmonella+or+human+nitroreductases%3A+a+possible+mechanism+for+the+lack+of+mutagenicity&doi=10.1016%2Fj.yrtph.2016.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66aR"><div class="casContent"><span class="casTitleNuber">66a</span><div class="casTitle"><span class="NLM_cas:atitle">Delamanid is not metabolized by Salmonella or human nitroreductases: A possible mechanism for the lack of mutagenicity</span></div><div class="casAuthors">Hanaki, Erina; Hayashi, Mikayo; Matsumoto, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Toxicology and Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">RTOPDW</span>;
        ISSN:<span class="NLM_cas:issn">0273-2300</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Nitro-contg. compds. such as nitrofuran and nitroimidazole are drugs used for the treatment of infectious diseases.  However, many of these nitro-contg. drugs are pos. in the bacterial reverse mutation assay (Ames test).  The recently approved anti-multidrug-resistant tuberculosis (MDR-TB) drug, delamanid (Deltyba; OPC-67683), a deriv. of 4-nitroimidazole, was neg. for mutagenicity in the Ames assay.  In Salmonella typhimurium, mutagenicity of nitro compds. has been closely assocd. with the ability of nitroreductase to metabolize (degrdn.)these compds.  To explore the lack of mutagenicity for delamanid, we examd. the initial metabolic rate and mutagenic-specific activity of a series of nitro compds. in S. typhimurium TA100.  The order of max. mutagenic-activity was nitrofuran > 2-nitroimidazole > 5-nitroimidazole ≥ 4-nitroimidazole, which is very similar to the order of initial metabolic rate, i.e., the Pearson's correlation coeff. (r = 0.85) showed a correlation between metabolic rate and mutagenic-activity.  No metab. of delamanid was detected even after 60 h of treatment.  In addn., delamanid was not reduced by two human nitroreductases.  These facts may explain the absence of genotoxicity of delamanid in both in vitro and in vivo tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi9fPk3B4RcbVg90H21EOLACvtfcHk0lhmswppfwq2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWltrrK&md5=8fa327a744a5476a2a973c4b8ad2527c</span></div><a href="/servlet/linkout?suffix=cit66a&amp;dbid=16384&amp;doi=10.1016%2Fj.yrtph.2016.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yrtph.2016.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DHanaki%26aufirst%3DE.%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DM.%26atitle%3DDelamanid%2520is%2520not%2520metabolized%2520by%2520salmonella%2520or%2520human%2520nitroreductases%253A%2520a%2520possible%2520mechanism%2520for%2520the%2520lack%2520of%2520mutagenicity%26jtitle%3DRegul.%2520Toxicol.%2520Pharmacol.%26date%3D2017%26volume%3D84%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.yrtph.2016.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit66b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stover, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrener, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanDevanter, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arain, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langhorne, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiswirth, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, W. R.</span></span> <span> </span><span class="NLM_article-title">A small molecule nitroimidazopyran drug candidate for the treatment of tuberculosis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>405</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1038/35016103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1038%2F35016103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10879539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Wksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=962-966&author=C.+K.+Stoverauthor=P.+Warrenerauthor=D.+R.+VanDevanterauthor=D.+R.+Shermanauthor=T.+M.+Arainauthor=M.+H.+Langhorneauthor=S.+W.+Andersonauthor=J.+A.+Towellauthor=Y.+Yuanauthor=D.+N.+McMurrayauthor=B.+N.+Kreiswirthauthor=C.+E.+Barryauthor=W.+R.+Baker&title=A+small+molecule+nitroimidazopyran+drug+candidate+for+the+treatment+of+tuberculosis&doi=10.1038%2F35016103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66bR"><div class="casContent"><span class="casTitleNuber">66b</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis</span></div><div class="casAuthors">Stover, C. Kendall; Warrener, Paul; VanDevanter, Donald R.; Sherman, David R.; Arain, Taraq M.; Langhorne, Michael H.; Anderson, Scott W.; Towell, J. Andrew; Yuan, Ying; McMurray, David N.; Krelswirth, Barry N.; Barry, Clifton E.; Baker, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">6789</span>),
    <span class="NLM_cas:pages">962-966</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis, which causes tuberculosis, is the greatest single infectious cause of mortality worldwide, killing roughly; two million people annually.  Ests. indicate that one-third of the world population is infected with latent M. tuberculosis.  The synergy between tuberculosis and the AIDS epidemic, and the surge of multidrug-resistant clin. isolates of M. tuberculosis have reaffirmed tuberculosis as a primary public health threat.  However, new antitubercular drugs with new mechanisms of action have not been developed in over thirty years.  Here we report a series of compds. contg. a nitroimidazopyran nucleus that possess antitubercular activity.  After activation by a mechanism dependent on M. tuberculosis F420 cofactor, nitroimidazopyrans inhibited the synthesis of protein and cell wall lipid.  In contrast to current antitubercular drugs, nitroimidazopyrans exhibited bactericidal activity against both replicating and static M. tuberculosis.  Lead compd. PA-824 showed potent bactericidal activity against multidrug-resistant M. tuberculosis and promising oral activity in animal infection models.  We conclude that nitroimidazopyrans offer the practical qualities of a small mol. with the potential for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw41eD4TtVwbVg90H21EOLACvtfcHk0lgbHZsUlHccCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Wksb0%253D&md5=f5f6e2935928da72e328bddd4995515f</span></div><a href="/servlet/linkout?suffix=cit66b&amp;dbid=16384&amp;doi=10.1038%2F35016103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35016103%26sid%3Dliteratum%253Aachs%26aulast%3DStover%26aufirst%3DC.%2BK.%26aulast%3DWarrener%26aufirst%3DP.%26aulast%3DVanDevanter%26aufirst%3DD.%2BR.%26aulast%3DSherman%26aufirst%3DD.%2BR.%26aulast%3DArain%26aufirst%3DT.%2BM.%26aulast%3DLanghorne%26aufirst%3DM.%2BH.%26aulast%3DAnderson%26aufirst%3DS.%2BW.%26aulast%3DTowell%26aufirst%3DJ.%2BA.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DMcMurray%26aufirst%3DD.%2BN.%26aulast%3DKreiswirth%26aufirst%3DB.%2BN.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBaker%26aufirst%3DW.%2BR.%26atitle%3DA%2520small%2520molecule%2520nitroimidazopyran%2520drug%2520candidate%2520for%2520the%2520treatment%2520of%2520tuberculosis%26jtitle%3DNature%26date%3D2000%26volume%3D405%26spage%3D962%26epage%3D966%26doi%3D10.1038%2F35016103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellows, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachaspati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raichurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravishankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarkar, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandodkar, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span> <span> </span><span class="NLM_article-title">Nitroarenes as antitubercular agents: stereoelectronic modulation to mitigate mutagenicity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1002%2Fcmdc.201500462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=26751718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=331-339&author=S.+Landgeauthor=V.+Ramachandranauthor=A.+Kumarauthor=J.+Neresauthor=K.+Muruganauthor=C.+Sadlerauthor=M.+D.+Fellowsauthor=V.+Humnabadkarauthor=P.+Vachaspatiauthor=A.+Raichurkarauthor=S.+Sharmaauthor=S.+Ravishankarauthor=S.+Gupthaauthor=V.+K.+Sambandamurthyauthor=T.+S.+Balganeshauthor=B.+G.+Ugarkarauthor=V.+Balasubramanianauthor=B.+S.+Bandodkarauthor=M.+Panda&title=Nitroarenes+as+antitubercular+agents%3A+stereoelectronic+modulation+to+mitigate+mutagenicity&doi=10.1002%2Fcmdc.201500462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity</span></div><div class="casAuthors">Landge, Sudhir; Ramachandran, Vasanthi; Kumar, Anupriya; Neres, Joao; Murugan, Kannan; Sadler, Claire; Fellows, Mick D.; Humnabadkar, Vaishali; Vachaspati, Prakash; Raichurkar, Anandkumar; Sharma, Sreevalli; Ravishankar, Sudha; Guptha, Supreeth; Sambandamurthy, Vasan K.; Balganesh, Tanjore S.; Ugarkar, Bheemarao G.; Balasubramanian, V.; Bandodkar, Balachandra S.; Panda, Manoranjan</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-339</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Nitroarenes are less preferred in drug discovery due to their potential to be mutagenic.  However, several nitroarenes were shown to be promising antitubercular agents with specific modes of action, namely, nitroimidazoles and benzothiazinones.  The nitro group in these compds. is activated through different mechanisms, both enzymic and non-enzymic, in mycobacteria prior to binding to the target of interest.  From a whole-cell screening program, the authors identified a novel lead nitrobenzothiazole (BT) series that acts by inhibition of decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1) of Mycobacterium tuberculosis (Mtb).  The lead was found to be mutagenic to start with.  The authors' efforts to mitigate mutagenicity resulted in the identification of 6-methyl-7-nitro-5-(trifluoromethyl)-1,3-benzothiazoles (cBTs), a novel class of antitubercular agents that are non-mutagenic and exhibit an improved safety profile.  The Me group ortho to the nitro group decreases the electron affinity of the series, and is hence responsible for the non-mutagenic nature of these compds.  Addnl., the co-crystal structure of cBT in complex with Mtb DprE1 established the mode of binding.  This investigation led to a new non-mutagenic antitubercular agent and demonstrates that the mutagenic nature of nitroarenes can be solved by modulation of stereoelectronic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodER9QhnSYVbVg90H21EOLACvtfcHk0lgbHZsUlHccCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVGmsA%253D%253D&md5=1210ad4dcfcb609da6a96b998f6eaf6d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500462%26sid%3Dliteratum%253Aachs%26aulast%3DLandge%26aufirst%3DS.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DMurugan%26aufirst%3DK.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DFellows%26aufirst%3DM.%2BD.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DVachaspati%26aufirst%3DP.%26aulast%3DRaichurkar%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DRavishankar%26aufirst%3DS.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DBalganesh%26aufirst%3DT.%2BS.%26aulast%3DUgarkar%26aufirst%3DB.%2BG.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBandodkar%26aufirst%3DB.%2BS.%26aulast%3DPanda%26aufirst%3DM.%26atitle%3DNitroarenes%2520as%2520antitubercular%2520agents%253A%2520stereoelectronic%2520modulation%2520to%2520mitigate%2520mutagenicity%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D331%26epage%3D339%26doi%3D10.1002%2Fcmdc.201500462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit68a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shamovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Börjesson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordén, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasselgren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjö, P.</span></span> <span> </span><span class="NLM_article-title">Explanation for main features of structure-genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">16168</span>– <span class="NLM_lpage">16185</span>, <span class="refDoi"> DOI: 10.1021/ja206427u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja206427u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=16168-16185&author=I.+Shamovskyauthor=L.+Ripaauthor=L.+B%C3%B6rjessonauthor=C.+Meeauthor=B.+Nord%C3%A9nauthor=P.+Hansenauthor=C.+Hasselgrenauthor=M.+O%E2%80%99Donovanauthor=P.+Sj%C3%B6&title=Explanation+for+main+features+of+structure-genotoxicity+relationships+of+aromatic+amines+by+theoretical+studies+of+their+activation+pathways+in+CYP1A2&doi=10.1021%2Fja206427u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68aR"><div class="casContent"><span class="casTitleNuber">68a</span><div class="casTitle"><span class="NLM_cas:atitle">Explanation for Main Features of Structure-Genotoxicity Relationships of Aromatic Amines by Theoretical Studies of Their Activation Pathways in CYP1A2</span></div><div class="casAuthors">Shamovsky, Igor; Ripa, Lena; Borjesson, Lena; Mee, Christine; Norden, Bo; Hansen, Peter; Hasselgren, Catrin; O'Donovan, Mike; Sjo, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">16168-16185</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arom. and heteroarom. amines (ArNH2) represent a class of potential mutagens that after being metabolically activated covalently modify DNA.  Activation of ArNH2 in many cases starts with N-hydroxylation by P 450 enzymes, primarily CYP1A2.  Poor understanding of structure-mutagenicity relationships of ArNH2 limits their use in drug discovery programs.  Key factors that facilitate activation of ArNH2 are revealed by exploring their reaction intermediates in CYP1A2 using DFT calcns.  On the basis of these calcns. and extensive anal. of structure-mutagenicity data, we suggest that mutagenic metabolites are generated by ferric peroxo intermediate, (CYP1A2)FeIII-OO-, in a three-step heterolytic mechanism.  First, the distal oxygen of the oxidant abstrs. proton from H-bonded ArNH2.  The subsequent proximal protonation of the resulting (CYP1A2)FeIII-OOH weakens both the O-O and the O-H bonds of the oxidant.  Heterolytic cleavage of the O-O bond leads to N-hydroxylation of ArNH- via SN2 mechanism, whereas cleavage of the O-H bond results in release of hydroperoxy radical.  Thus, our proposed reaction offers a mechanistic explanation for previous observations that metab. of arom. amines could cause oxidative stress.  The primary drivers for mutagenic potency of ArNH2 are (i) binding affinity of ArNH2 in the productive binding mode within the CYP1A2 substrate cavity, (ii) resonance stabilization of the anionic forms of ArNH2, and (iii) exothermicity of proton-assisted heterolytic cleavage of N-O bonds of hydroxylamines and their bioconjugates.  This leads to a strategy for designing mutagenicity free ArNH2: Structural alterations in ArNH2, which disrupt geometric compatibility with CYP1A2, hinder proton abstraction, or strongly destabilize the nitrenium ion, in this order of priority, prevent genotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrctr81IIN2trVg90H21EOLACvtfcHk0lgZ8mAXDAFN0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SrsrvI&md5=9447ee2144a899b65e9350b712ca2a46</span></div><a href="/servlet/linkout?suffix=cit68a&amp;dbid=16384&amp;doi=10.1021%2Fja206427u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja206427u%26sid%3Dliteratum%253Aachs%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3DRipa%26aufirst%3DL.%26aulast%3DB%25C3%25B6rjesson%26aufirst%3DL.%26aulast%3DMee%26aufirst%3DC.%26aulast%3DNord%25C3%25A9n%26aufirst%3DB.%26aulast%3DHansen%26aufirst%3DP.%26aulast%3DHasselgren%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%26aulast%3DSj%25C3%25B6%26aufirst%3DP.%26atitle%3DExplanation%2520for%2520main%2520features%2520of%2520structure-genotoxicity%2520relationships%2520of%2520aromatic%2520amines%2520by%2520theoretical%2520studies%2520of%2520their%2520activation%2520pathways%2520in%2520CYP1A2%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D16168%26epage%3D16185%26doi%3D10.1021%2Fja206427u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit68b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shamovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomberg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjö, P.</span></span> <span> </span><span class="NLM_article-title">Theoretical studies of chemical reactivity of metabolically activated forms of aromatic amines toward DNA</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2236</span>– <span class="NLM_lpage">2252</span>, <span class="refDoi"> DOI: 10.1021/tx300313b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300313b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=2236-2252&issue=10&author=I.+Shamovskyauthor=L.+Ripaauthor=N.+Blombergauthor=L.+A.+Erikssonauthor=P.+Hansenauthor=C.+Meeauthor=C.+Tyrchanauthor=M.+O%E2%80%99Donovanauthor=P.+Sj%C3%B6&title=Theoretical+studies+of+chemical+reactivity+of+metabolically+activated+forms+of+aromatic+amines+toward+DNA&doi=10.1021%2Ftx300313b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68b&amp;dbid=16384&amp;doi=10.1021%2Ftx300313b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300313b%26sid%3Dliteratum%253Aachs%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3DRipa%26aufirst%3DL.%26aulast%3DBlomberg%26aufirst%3DN.%26aulast%3DEriksson%26aufirst%3DL.%2BA.%26aulast%3DHansen%26aufirst%3DP.%26aulast%3DMee%26aufirst%3DC.%26aulast%3DTyrchan%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%26aulast%3DSj%25C3%25B6%26aufirst%3DP.%26atitle%3DTheoretical%2520studies%2520of%2520chemical%2520reactivity%2520of%2520metabolically%2520activated%2520forms%2520of%2520aromatic%2520amines%2520toward%2520DNA%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26issue%3D10%26spage%3D2236%26epage%3D2252%26doi%3D10.1021%2Ftx300313b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit68c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ripa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjö, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamovsky, I.</span></span> <span> </span><span class="NLM_article-title">Theoretical studies of the mechanism of N-hydroxylation of primary aromatic amines by cytochrome P450 1A2: radicaloid or anionic?</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1021/tx400376u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx400376u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtl2gtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=265-278&issue=2&author=L.+Ripaauthor=C.+Meeauthor=P.+Sj%C3%B6author=I.+Shamovsky&title=Theoretical+studies+of+the+mechanism+of+N-hydroxylation+of+primary+aromatic+amines+by+cytochrome+P450+1A2%3A+radicaloid+or+anionic%3F&doi=10.1021%2Ftx400376u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68cR"><div class="casContent"><span class="casTitleNuber">68c</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical Studies of the Mechanism of N-Hydroxylation of Primary Aromatic Amines by Cytochrome P450 1A2: Radicaloid or Anionic?</span></div><div class="casAuthors">Ripa, Lena; Mee, Christine; Sjoe, Peter; Shamovsky, Igor</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">265-278</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Primary arom. and heteroarom. amines are notoriously known as potential mutagens and carcinogens.  The major event of the mechanism of their mutagenicity is N-hydroxylation by P 450 enzymes, primarily P 450 1A2 (CYP1A2), which leads to the formation of nitrenium ions that covalently modify nucleobases of DNA.  Energy profiles of the NH bond activation steps of two possible mechanisms of N-hydroxylation of a no. of arom. amines by CYP1A2, radicaloid and anionic, are studied by dispersion-cor. DFT calcns.  The classical radicaloid mechanism is mediated by H-atom transfer to the electrophilic ferryl-oxo intermediate of the P 450 catalytic cycle (called Compd. I or Cpd I), whereas the alternative anionic mechanism involves proton transfer to the preceding nucleophilic ferrous-peroxo species.  The key structural features of the catalytic site of human CYP1A2 revealed by X-ray crystallog. are maintained in calcns.  The obtained DFT reaction profiles and addnl. calcns. that account for nondynamical electron correlation suggest that Cpd I has higher thermodn. drive to activate arom. amines than the ferrous-peroxo species.  Nevertheless, the anionic mechanism is demonstrated to be consistent with a variety of exptl. observations.  Thus, energy of the proton transfer from arom. amines to the ferrous-peroxo dianion splits arom. amines into two classes with different mutagenicity mechanisms.  Favorable or slightly unfavorable barrier-free proton transfer is inherent in compds. that undergo nitrenium ion mediated mutagenicity.  Monocyclic electron-rich arom. amines that do not follow this mutagenicity mechanism show significantly unfavorable proton transfer.  Feasibility of the entire anionic mechanism is demonstrated by favorable Gibbs energy profiles of both chem. steps, NH bond activation, and NO bond formation.  Taken together, results suggest that the N-hydroxylation of arom. amines in CYP1A2 undergoes the anionic mechanism.  Possible reasons for the apparent inability of Cpd I to activate arom. amines in CYP1A2 are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQkB42GsCW7Vg90H21EOLACvtfcHk0lhfh_g44gbGtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtl2gtQ%253D%253D&md5=5aba1c841deea190a7b4170a824fc9ab</span></div><a href="/servlet/linkout?suffix=cit68c&amp;dbid=16384&amp;doi=10.1021%2Ftx400376u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx400376u%26sid%3Dliteratum%253Aachs%26aulast%3DRipa%26aufirst%3DL.%26aulast%3DMee%26aufirst%3DC.%26aulast%3DSj%25C3%25B6%26aufirst%3DP.%26aulast%3DShamovsky%26aufirst%3DI.%26atitle%3DTheoretical%2520studies%2520of%2520the%2520mechanism%2520of%2520N-hydroxylation%2520of%2520primary%2520aromatic%2520amines%2520by%2520cytochrome%2520P450%25201A2%253A%2520radicaloid%2520or%2520anionic%253F%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26issue%3D2%26spage%3D265%26epage%3D278%26doi%3D10.1021%2Ftx400376u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benigni, R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1767</span>– <span class="NLM_lpage">1800</span>, <span class="refDoi"> DOI: 10.1021/cr030049y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr030049y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=1767-1800&author=R.+Benigni&title=Structure-activity+relationship+studies+of+chemical+mutagens+and+carcinogens%3A+mechanistic+investigations+and+prediction+approaches&doi=10.1021%2Fcr030049y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fcr030049y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr030049y%26sid%3Dliteratum%253Aachs%26aulast%3DBenigni%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520chemical%2520mutagens%2520and%2520carcinogens%253A%2520mechanistic%2520investigations%2520and%2520prediction%2520approaches%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D1767%26epage%3D1800%26doi%3D10.1021%2Fcr030049y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seger, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, L.</span></span> <span> </span><span class="NLM_article-title">Mechanism of the N-hydroxylation of primary and secondary amines by cytochrome P450</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">603</span>, <span class="refDoi"> DOI: 10.1021/tx500371a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx500371a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=597-603&author=S.+T.+Segerauthor=P.+Rydbergauthor=L.+Olsen&title=Mechanism+of+the+N-hydroxylation+of+primary+and+secondary+amines+by+cytochrome+P450&doi=10.1021%2Ftx500371a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of the N-Hydroxylation of Primary and Secondary Amines by Cytochrome P450</span></div><div class="casAuthors">Seger, Signe T.; Rydberg, Patrik; Olsen, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">597-603</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytochrome P 450 enzymes (CYPs) metabolize alkyl- and arylamines, generating several different products.  For the primary and secondary amines, some of these reactions result in hydroxylated amines, which may be toxic.  Thus, when designing new drugs contg. amine groups, it is important to be able to predict if a given compd. will be a substrate for CYPs, in order to avoid toxic metabolites, and hence to understand the mechanism that is utilized by CYPs.  Two possible mechanisms, for the N-hydroxylation of primary and secondary amines mediated by CYPs, are studied by d. functional theory (DFT) for four different amines (aniline, N-methylaniline, propan-2-amine, and dimethylamine).  The hydrogen atom transfer and rebound (HAT) mechanism is found to be preferred over the direct oxygen addn. rearrangement (OAR) mechanism for all four amines.  However, in contrast to the same mechanism for the hydroxylation of aliph. carbon atoms, the rebound step is shown to be rate-limiting in most cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgEFAA2ubocbVg90H21EOLACvtfcHk0lhfh_g44gbGtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrk%253D&md5=9f23608f2541a03110b90b2f5e6895fe</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Ftx500371a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx500371a%26sid%3Dliteratum%253Aachs%26aulast%3DSeger%26aufirst%3DS.%2BT.%26aulast%3DRydberg%26aufirst%3DP.%26aulast%3DOlsen%26aufirst%3DL.%26atitle%3DMechanism%2520of%2520the%2520N-hydroxylation%2520of%2520primary%2520and%2520secondary%2520amines%2520by%2520cytochrome%2520P450%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2015%26volume%3D28%26spage%3D597%26epage%3D603%26doi%3D10.1021%2Ftx500371a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boechat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomão, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo-Lima, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mello, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felzenszwalb, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiub, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamith, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skupin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haufe, G.</span></span> <span> </span><span class="NLM_article-title">Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group</span>. <i>Mem. Inst. Oswaldo Cruz</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1590/0074-02760140248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1590%2F0074-02760140248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=26018452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVChu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2015&pages=492-499&issue=4&author=N.+Boechatauthor=A.+S.+Carvalhoauthor=K.+Salom%C3%A3oauthor=S.+L.+Castroauthor=C.+F.+Araujo-Limaauthor=F.+V.+Melloauthor=I.+Felzenszwalbauthor=C.+A.+Aiubauthor=T.+R.+Condeauthor=H.+P.+Zamithauthor=R.+Skupinauthor=G.+Haufe&title=Studies+of+genotoxicity+and+mutagenicity+of+nitroimidazoles%3A+demystifying+this+critical+relationship+with+the+nitro+group&doi=10.1590%2F0074-02760140248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group</span></div><div class="casAuthors">Boechat, Nubia; Carvalho, Alcione S.; Salomao, Kelly; de Castro, Solange L.; Araujo-Lima, Carlos F.; Mello, Francisco V. C.; Felzenszwalb, Israel; Aiub, Claudia A. F.; Conde, Taline Ramos; Zamith, Helena P. S.; Skupin, Rolf; Haufe, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Memorias do Instituto Oswaldo Cruz</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">492-499</span>CODEN:
                <span class="NLM_cas:coden">MIOCAS</span>;
        ISSN:<span class="NLM_cas:issn">1678-8060</span>.
    
            (<span class="NLM_cas:orgname">Instituto Oswaldo Cruz</span>)
        </div><div class="casAbstract">Nitroimidazoles exhibit high microbicidal activity, but mutagenic, genotoxic and cytotoxic properties have been attributed to the presence of the nitro group.  However, we synthesized nitroimidazoles with activity against the trypomastigotes of Trypanosoma cruzi, but that were not genotoxic.  Herein, nitroimidazoles (11-19) bearing different substituent groups were investigated for their potential induction of genotoxicity (comet assay) and mutagenicity (Salmonella/Microsome assay) and the correlations of these effects with their trypanocidal effect and with megazol were investigated.  The compds. were designed to analyze the role played by the position of the nitro group in the imidazole nucleus (C-4 or C-5) and the presence of oxidisable groups at N-1 as an anion receptor group and the role of a Me group at C-2.  Nitroimidazoles bearing NO2 at C-4 and CH3 at C-2 were not genotoxic compared to those bearing NO2 at C-5.  However, when there was a CH3 at C-2, the position of the NO2 group had no influence on the genotoxic activity.  Fluorinated compds. exhibited higher genotoxicity regardless of the presence of CH3 at C-2 or NO2 at C-4 or C-5.  However, in compds. 11 (2-CH3; 4-NO2; N-CH2OHCH2Cl) and 12 (2-CH3; 4-NO2; N-CH2OHCH2F), the fluorine atom had no influence on genotoxicity.  This study contributes to the future search for new and safer prototypes and provide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_K_2K3FpFwLVg90H21EOLACvtfcHk0line-Gh3CjO4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVChu7Y%253D&md5=baa51b068dcb7e5c5ec680e458efc9c4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1590%2F0074-02760140248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252F0074-02760140248%26sid%3Dliteratum%253Aachs%26aulast%3DBoechat%26aufirst%3DN.%26aulast%3DCarvalho%26aufirst%3DA.%2BS.%26aulast%3DSalom%25C3%25A3o%26aufirst%3DK.%26aulast%3DCastro%26aufirst%3DS.%2BL.%26aulast%3DAraujo-Lima%26aufirst%3DC.%2BF.%26aulast%3DMello%26aufirst%3DF.%2BV.%26aulast%3DFelzenszwalb%26aufirst%3DI.%26aulast%3DAiub%26aufirst%3DC.%2BA.%26aulast%3DConde%26aufirst%3DT.%2BR.%26aulast%3DZamith%26aufirst%3DH.%2BP.%26aulast%3DSkupin%26aufirst%3DR.%26aulast%3DHaufe%26aufirst%3DG.%26atitle%3DStudies%2520of%2520genotoxicity%2520and%2520mutagenicity%2520of%2520nitroimidazoles%253A%2520demystifying%2520this%2520critical%2520relationship%2520with%2520the%2520nitro%2520group%26jtitle%3DMem.%2520Inst.%2520Oswaldo%2520Cruz%26date%3D2015%26volume%3D110%26issue%3D4%26spage%3D492%26epage%3D499%26doi%3D10.1590%2F0074-02760140248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit72"><span>Drug
information and side effects database. <a href="http://www.drugsdb.com/blog/fda-approved-drugs-pulled-from-market.html" class="extLink">http://www.drugsdb.com/blog/fda-approved-drugs-pulled-from-market.html</a> (accessed Dec 31, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Drug%0Ainformation+and+side+effects+database.+http%3A%2F%2Fwww.drugsdb.com%2Fblog%2Ffda-approved-drugs-pulled-from-market.html+%28accessed+Dec+31%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit73a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. J.</span>; <span class="NLM_string-name">Groundwater, P. W.</span>; <span class="NLM_string-name">Todd, A.</span>; <span class="NLM_string-name">Worsley, A. J.</span></span> <span> </span><span class="NLM_article-title">Nitroimidazole antibacterial agents</span>. In  <i>Antibacterial Agents: Chemistry, Mode of Action, Mechanisms of Resistance and Clinical Applications</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">John Wiley & Sons, Ltd.</span>: <span class="NLM_publisher-loc">Chichester, U.K.</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1002%2F9781118325421.ch4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=85-101&author=R.+J.+Anderson&author=P.+W.+Groundwater&author=A.+Todd&author=A.+J.+Worsley&title=Antibacterial+Agents%3A+Chemistry%2C+Mode+of+Action%2C+Mechanisms+of+Resistance+and+Clinical+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73a&amp;dbid=16384&amp;doi=10.1002%2F9781118325421.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118325421.ch4%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DR.%2BJ.%26atitle%3DNitroimidazole%2520antibacterial%2520agents%26btitle%3DAntibacterial%2520Agents%253A%2520Chemistry%252C%2520Mode%2520of%2520Action%252C%2520Mechanisms%2520of%2520Resistance%2520and%2520Clinical%2520Applications%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26date%3D2012%26spage%3D85%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit73b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Grigsby, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcial, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asbell, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T. L.</span></span> <span> </span><span class="NLM_article-title">Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80–05. Radiation Therapy Oncology Group</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1016/S0360-3016(99)00054-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FS0360-3016%2899%2900054-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10348279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADyaK1MXjsl2ku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1999&pages=513-517&author=P.+W.+Grigsbyauthor=K.+Winterauthor=T.+H.+Wassermanauthor=V.+Marcialauthor=M.+Rotmanauthor=J.+Cooperauthor=H.+Keysauthor=S.+O.+Asbellauthor=T.+L.+Phillips&title=Irradiation+with+or+without+misonidazole+for+patients+with+stages+IIIB+and+IVA+carcinoma+of+the+cervix%3A+final+results+of+RTOG+80%E2%80%9305.+Radiation+Therapy+Oncology+Group&doi=10.1016%2FS0360-3016%2899%2900054-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73bR"><div class="casContent"><span class="casTitleNuber">73b</span><div class="casTitle"><span class="NLM_cas:atitle">Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05</span></div><div class="casAuthors">Grigsby, Perry W.; Winter, Kathryn; Wasserman, Todd H.; Marcial, Victor; Rotman, Marvin; Cooper, Jay; Keys, Henry; Asbell, Sucha O.; Phillips, Theodore L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">513-517</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The purpose of this study was to evaluate tumor response, progression-free survival, local tumor control, patterns of relapse, and toxicity in patients with Stages IIIb and IVa squamous cell carcinoma of the uterine cervix treated with irradn. or irradn. and misonidazole.  This is a report of the final results of the study.  This study was a prospective randomized Phase III trial performed by the Radiation Therapy Oncol. Group (RTOG).  Between August 1980 and Nov. 1984, 120 patients with Stages IIIb and IVa squamous cell carcinoma of the cervix were randomized to receive either std. irradn. or std. irradn. and misonidazole.  Irradn. consisted of 46 Gy to the pelvis plus a 10 Gy parametrial boost followed by intracavitary brachytherapy or external irradn. boost to the primary tumor.  Misonidazole was administered at 400 mg/m2 daily, 2-4 h before irradn.  Patients in the 2 treatment groups were evenly distributed by stage, Karnofsky Performance Status, and pos. para-aortic lymph nodes.  Sixty-one patients were treated with irradn. alone, and 59 patients received irradn. and misonidazole.  Complete response in the pelvis occurred in 44 (75%) of those treated with irradn. and in 38 (64%) of those treated with irradn. and misonidazole.  The progression-free survivals were 22% at 5 yr for the control group, and 29% at 5 yr for the misonidazole group.  At the time of last follow-up, 18 patients in the control arm were free of disease, and in the exptl. arm, 19 were free of disease.  The patterns of failure for those treated with irradn. alone were local-only in 9 patients, distant-only in 8 patients, and local and distant in 11 patients.  The patterns of failure for those receiving irradn. and misonidazole were local-only in 3 patients, distant-only in 8 patients, and local and distant in 8 patients.  The max. toxicity experienced per patient was grade 3 in 18%, grade 4 in 8%, and no grade 5 toxicity for those treated with irradn. alone compared to 8%, 2%, and 2%, resp., for the exptl. arm.  There were no statistically significant differences in pelvic response, disease-free survivals, patterns of failure, or toxicity for the irradn. alone group or for the irradn. and misonidazole group as administered in this study for patients with Stages IIIb and IVa squamous cell carcinoma of the uterine cervix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRWPuOPW1XlbVg90H21EOLACvtfcHk0line-Gh3CjO4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsl2ku7g%253D&md5=329b2910e3d491d4a2a9e3cc92608374</span></div><a href="/servlet/linkout?suffix=cit73b&amp;dbid=16384&amp;doi=10.1016%2FS0360-3016%2899%2900054-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0360-3016%252899%252900054-1%26sid%3Dliteratum%253Aachs%26aulast%3DGrigsby%26aufirst%3DP.%2BW.%26aulast%3DWinter%26aufirst%3DK.%26aulast%3DWasserman%26aufirst%3DT.%2BH.%26aulast%3DMarcial%26aufirst%3DV.%26aulast%3DRotman%26aufirst%3DM.%26aulast%3DCooper%26aufirst%3DJ.%26aulast%3DKeys%26aufirst%3DH.%26aulast%3DAsbell%26aufirst%3DS.%2BO.%26aulast%3DPhillips%26aufirst%3DT.%2BL.%26atitle%3DIrradiation%2520with%2520or%2520without%2520misonidazole%2520for%2520patients%2520with%2520stages%2520IIIB%2520and%2520IVA%2520carcinoma%2520of%2520the%2520cervix%253A%2520final%2520results%2520of%2520RTOG%252080%25E2%2580%259305.%2520Radiation%2520Therapy%2520Oncology%2520Group%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D1999%26volume%3D44%26spage%3D513%26epage%3D517%26doi%3D10.1016%2FS0360-3016%2899%2900054-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit74"><span>Nitro
compounds-drug bank. <a href="https://www.drugbank.ca/categories/DBCAT000765/" class="extLink">https://www.drugbank.ca/categories/DBCAT000765/</a> (accessed Dec 29, <span class="NLM_year">2017</span>)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nitro%0Acompounds-drug+bank.+https%3A%2F%2Fwww.drugbank.ca%2Fcategories%2FDBCAT000765%2F+%28accessed+Dec+29%2C+2017%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit75"><span>NIH U.S.
National Library of Medicine, Clinical trials.gov. <a href="https://clinicaltrials.gov/" class="extLink">https://clinicaltrials.gov/</a> (accessed December 31, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=NIH+U.S.%0ANational+Library+of+Medicine%2C+Clinical+trials.gov.+https%3A%2F%2Fclinicaltrials.gov%2F+%28accessed+December+31%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit76"><span>The PubChem
Project. <a href="https://pubchem.ncbi.nlm.nih.gov/" class="extLink">https://pubchem.ncbi.nlm.nih.gov/</a> (accessed Dec 31, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+PubChem%0AProject.+https%3A%2F%2Fpubchem.ncbi.nlm.nih.gov%2F+%28accessed+Dec+31%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit77a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duaso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liempi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Droguett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galanti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maya, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Muñoz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmerling, U.</span></span> <span> </span><span class="NLM_article-title">Toxic and therapeutic effects of nifurtimox and benznidazole on Trypanosoma cruzi ex vivo infection of human placental chorionic villi explants</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1016/j.actatropica.2014.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.actatropica.2014.01.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2014&pages=112-118&author=G.+Rojoauthor=C.+Castilloauthor=J.+Duasoauthor=A.+Liempiauthor=D.+Droguettauthor=N.+Galantiauthor=J.+D.+Mayaauthor=R.+L%C3%B3pez-Mu%C3%B1ozauthor=U.+Kemmerling&title=Toxic+and+therapeutic+effects+of+nifurtimox+and+benznidazole+on+Trypanosoma+cruzi+ex+vivo+infection+of+human+placental+chorionic+villi+explants&doi=10.1016%2Fj.actatropica.2014.01.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77a&amp;dbid=16384&amp;doi=10.1016%2Fj.actatropica.2014.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.actatropica.2014.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DRojo%26aufirst%3DG.%26aulast%3DCastillo%26aufirst%3DC.%26aulast%3DDuaso%26aufirst%3DJ.%26aulast%3DLiempi%26aufirst%3DA.%26aulast%3DDroguett%26aufirst%3DD.%26aulast%3DGalanti%26aufirst%3DN.%26aulast%3DMaya%26aufirst%3DJ.%2BD.%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DR.%26aulast%3DKemmerling%26aufirst%3DU.%26atitle%3DToxic%2520and%2520therapeutic%2520effects%2520of%2520nifurtimox%2520and%2520benznidazole%2520on%2520Trypanosoma%2520cruzi%2520ex%2520vivo%2520infection%2520of%2520human%2520placental%2520chorionic%2520villi%2520explants%26jtitle%3DActa%2520Trop.%26date%3D2014%26volume%3D132%26spage%3D112%26epage%3D118%26doi%3D10.1016%2Fj.actatropica.2014.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit77b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. S.</span></span> <span> </span><span class="NLM_article-title">Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2072</span>– <span class="NLM_lpage">2084</span>, <span class="refDoi"> DOI: 10.2174/156802611796575894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.2174%2F156802611796575894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=21619510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=2072-2084&author=S.+R.+Wilkinsonauthor=C.+Botauthor=J.+M.+Kellyauthor=B.+S.+Hall&title=Trypanocidal+activity+of+nitroaromatic+prodrugs%3A+current+treatments+and+future+perspectives&doi=10.2174%2F156802611796575894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77bR"><div class="casContent"><span class="casTitleNuber">77b</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives</span></div><div class="casAuthors">Wilkinson, Shane R.; Bot, Christopher; Kelly, John M.; Hall, Belinda S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2072-2084</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chagas disease and African sleeping sickness are trypanosomal infections that represent important public health problems in Latin America and Africa, resp.  The restriction of these diseases to the poorer parts of the world has meant that they have been largely neglected and limited progress has been made in their treatment.  The nitroheterocyclic prodrugs nifurtimox and benznidazole, in use against Chagas disease for >40 years, remain the only agents available for this infection.  In the case of African sleeping sickness, nifurtimox has recently been added to the arsenal of medicines, with the nitroheterocycle fexinidazole currently under evaluation.  For a long time, the cytotoxic mechanisms of these drugs were poorly understood: nifurtimox was thought to act via prodn. of superoxide anions and nitro radicals, while the mode of benznidazole action was more obscure.  The trypanocidal activity of nitroheterocyclic drugs is now known to depend on a parasite type I nitroreductase (NTR).  This enzyme is absent from mammalian cells, a difference that forms the basis for the drug selectivity.  The role of this enzyme in drug activation has been genetically and biochem. validated.  It catalyzes the 2-electron redn. of nitroheterocyclic compds. within the parasite, producing toxic metabolites without significant generation of superoxide.  Recognition that this enzyme is responsible for activation of nitroheterocyclic prodrugs has allowed screening for compds. that preferentially target the parasite.  This approach has led to the identification of two new classes of anti-trypanosomal agents, nitrobenzylphosphoramide mustards and aziridinyl nitrobenzamides, and promises to yield new, safer, more effective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6vBQMwS_TY7Vg90H21EOLACvtfcHk0lgJa3MqMDaRAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2gsL3L&md5=5976d05c6686ad8121c94b5da581f599</span></div><a href="/servlet/linkout?suffix=cit77b&amp;dbid=16384&amp;doi=10.2174%2F156802611796575894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611796575894%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DBot%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DHall%26aufirst%3DB.%2BS.%26atitle%3DTrypanocidal%2520activity%2520of%2520nitroaromatic%2520prodrugs%253A%2520current%2520treatments%2520and%2520future%2520perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D2072%26epage%3D2084%26doi%3D10.2174%2F156802611796575894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit77c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alirol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrumpf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amici Heradi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Patoul, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappuis, F.</span></span> <span> </span><span class="NLM_article-title">Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1093/cid/cis886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1093%2Fcid%2Fcis886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=23074318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvV2ksLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=195-203&author=E.+Alirolauthor=D.+Schrumpfauthor=J.+Amici+Heradiauthor=A.+Riedelauthor=C.+de+Patoulauthor=M.+Quereauthor=F.+Chappuis&title=Nifurtimox-eflornithine+combination+therapy+for+second-stage+gambiense+human+African+trypanosomiasis%3A+M%C3%A9decins+Sans+Fronti%C3%A8res+experience+in+the+Democratic+Republic+of+the+Congo&doi=10.1093%2Fcid%2Fcis886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77cR"><div class="casContent"><span class="casTitleNuber">77c</span><div class="casTitle"><span class="NLM_cas:atitle">Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Medecins Sans Frontieres Experience in the Democratic Republic of the Congo</span></div><div class="casAuthors">Alirol, Emilie; Schrumpf, David; Amici Heradi, Josue; Riedel, Andrea; de Patoul, Catherine; Quere, Michel; Chappuis, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-203</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Since 2009, nifurtimox-eflornithine combination therapy (NECT) has raised great hopes for the treatment of second-stage human African trypanosomiasis.  Data from the first 18 mo of NECT use in Medecins Sans Frontieres programs in the Democratic Republic of the Congo confirm its good safety profile, esp. among children.  Background.  Existing diagnostic and treatment tools for human African trypanosomiasis (HAT) are limited.  The recent development of nifurtimox-eflornithine combination therapy (NECT) has brought new hopes for patients in the second stage.  While NECT has been rolled out in most endemic countries, safety data are scarce and derive only from clin. trials.  The World Health Organization (WHO) coordinates a pharmacovigilance program to collect addnl. data on NECT safety and efficacy.  We report here the results of 18 mo of experience of NECT use in treatment centers run by Medecins Sans Frontieres in the Democratic Republic of the Congo (DRC).  Methods. This cohort study included 684 second-stage HAT patients (including 120 children) treated with NECT in Doruma and Dingila hospitals, northeastern DRC, between Jan. 2010 and June 2011.  All treatment-emergent adverse events (AEs) were recorded and graded according to the Common Terminol. Criteria for Adverse Events version 3.0.  Safety and efficacy data were retrieved from the WHO pharmacovigilance forms and from Epitryps, a program monitoring database.  Results. Eighty-six percent of the patients experienced at least 1 AE during treatment.  On av., children experienced fewer AEs than adults.  Most AEs were mild (37.9%) or moderate (54.7%).  Severe AEs included vomiting (n = 32), dizziness (n = 16), headache (n = 11), and convulsions (n = 11).  The in-hospital case fatality rate was low (0.15%) and relapses were rare (n = 14).  Conclusions.  In comparison with previous treatments, NECT was effective, safe, and well tolerated in nontrial settings in DRC, further supporting the roll-out of NECT as first-line treatment in second-stage Trypanosoma brucei gambiense HAT.  Tolerance was particularly good in children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsb2XaO2Y1vrVg90H21EOLACvtfcHk0lhZgFotEeyg0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvV2ksLvK&md5=78fa4f3ca3b109621a64a7d564414dea</span></div><a href="/servlet/linkout?suffix=cit77c&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcis886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcis886%26sid%3Dliteratum%253Aachs%26aulast%3DAlirol%26aufirst%3DE.%26aulast%3DSchrumpf%26aufirst%3DD.%26aulast%3DAmici%2BHeradi%26aufirst%3DJ.%26aulast%3DRiedel%26aufirst%3DA.%26aulast%3Dde%2BPatoul%26aufirst%3DC.%26aulast%3DQuere%26aufirst%3DM.%26aulast%3DChappuis%26aufirst%3DF.%26atitle%3DNifurtimox-eflornithine%2520combination%2520therapy%2520for%2520second-stage%2520gambiense%2520human%2520African%2520trypanosomiasis%253A%2520M%25C3%25A9decins%2520Sans%2520Fronti%25C3%25A8res%2520experience%2520in%2520the%2520Democratic%2520Republic%2520of%2520the%2520Congo%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D56%26spage%3D195%26epage%3D203%26doi%3D10.1093%2Fcid%2Fcis886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit78"><span>Benznidazole
(By Mouth). <a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0030625/" class="extLink">http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0030625/</a> (accessed December 26, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Benznidazole%0A%28By+Mouth%29.+http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmedhealth%2FPMHT0030625%2F+%28accessed+December+26%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit78b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez De Armas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eells, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traina, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meymandi, S. K.</span></span> <span> </span><span class="NLM_article-title">Tolerance of benznidazole in a United States Chagas Disease clinic</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1237</span>– <span class="NLM_lpage">1240</span>, <span class="refDoi"> DOI: 10.1093/cid/civ005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1093%2Fcid%2Fciv005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=25601454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BC2Mvns1eksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=1237-1240&author=D.+A.+Millerauthor=S.+Hernandezauthor=L.+Rodriguez+De+Armasauthor=S.+J.+Eellsauthor=M.+M.+Trainaauthor=L.+G.+Millerauthor=S.+K.+Meymandi&title=Tolerance+of+benznidazole+in+a+United+States+Chagas+Disease+clinic&doi=10.1093%2Fcid%2Fciv005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78bR"><div class="casContent"><span class="casTitleNuber">78b</span><div class="casTitle"><span class="NLM_cas:atitle">Tolerance of benznidazole in a United States Chagas Disease clinic</span></div><div class="casAuthors">Miller David A; Eells Samantha J; Miller Loren G; Hernandez Salvador; Rodriguez De Armas Lissette; Traina Mahmoud M; Meymandi Sheba K</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1237-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The US-based Center of Excellence for Chagas Disease performed an observational study on the safety and tolerance of benznidazole 5 mg/kg/day for 60 days in 30 adults with chronic Chagas disease.  The side-effect profile was suboptimal, including 5 cases of debilitating neuropathy and an unusually high angioedema rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoSEc0tthPZBFwe7cAcrfPfW6udTcc2eZPKWRDEPQCgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mvns1eksQ%253D%253D&md5=f247ffcd1f22c388bb82f2381111273d</span></div><a href="/servlet/linkout?suffix=cit78b&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciv005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciv005%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BA.%26aulast%3DHernandez%26aufirst%3DS.%26aulast%3DRodriguez%2BDe%2BArmas%26aufirst%3DL.%26aulast%3DEells%26aufirst%3DS.%2BJ.%26aulast%3DTraina%26aufirst%3DM.%2BM.%26aulast%3DMiller%26aufirst%3DL.%2BG.%26aulast%3DMeymandi%26aufirst%3DS.%2BK.%26atitle%3DTolerance%2520of%2520benznidazole%2520in%2520a%2520United%2520States%2520Chagas%2520Disease%2520clinic%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D60%26spage%3D1237%26epage%3D1240%26doi%3D10.1093%2Fcid%2Fciv005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negrette, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parada, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basombrio, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, N. J.</span></span> <span> </span><span class="NLM_article-title">Hepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethyl nitro furazone: a comparison with Benznidazole</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e3231</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0003231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1371%2Fjournal.pntd.0003231" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=e3231&author=C.+Daviesauthor=N.+Deyauthor=O.+S.+Negretteauthor=L.+A.+Paradaauthor=M.+A.+Basombrioauthor=N.+J.+Garg&title=Hepatotoxicity+in+mice+of+a+novel+anti-parasite+drug+candidate+hydroxymethyl+nitro+furazone%3A+a+comparison+with+Benznidazole&doi=10.1371%2Fjournal.pntd.0003231"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003231%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DC.%26aulast%3DDey%26aufirst%3DN.%26aulast%3DNegrette%26aufirst%3DO.%2BS.%26aulast%3DParada%26aufirst%3DL.%2BA.%26aulast%3DBasombrio%26aufirst%3DM.%2BA.%26aulast%3DGarg%26aufirst%3DN.%2BJ.%26atitle%3DHepatotoxicity%2520in%2520mice%2520of%2520a%2520novel%2520anti-parasite%2520drug%2520candidate%2520hydroxymethyl%2520nitro%2520furazone%253A%2520a%2520comparison%2520with%2520Benznidazole%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26spage%3De3231%26doi%3D10.1371%2Fjournal.pntd.0003231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit80"><span>Metronidazole
400 mg Tablets. <a href="https://www.medicines.org.uk/emc/product/538/smpc" class="extLink">https://www.medicines.org.uk/emc/product/538/smpc</a> (accessed Jan 14, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Metronidazole%0A400+mg+Tablets.+https%3A%2F%2Fwww.medicines.org.uk%2Femc%2Fproduct%2F538%2Fsmpc+%28accessed+Jan+14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit82a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Nigro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballo, M. A.</span></span> <span> </span><span class="NLM_article-title">Genotoxicity and cell death induced by tinidazole (TNZ)</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2008.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.toxlet.2008.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18582545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=46-52&author=M.+M.+Lopez+Nigroauthor=M.+A.+Carballo&title=Genotoxicity+and+cell+death+induced+by+tinidazole+%28TNZ%29&doi=10.1016%2Fj.toxlet.2008.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82aR"><div class="casContent"><span class="casTitleNuber">82a</span><div class="casTitle"><span class="NLM_cas:atitle">Genotoxicity and cell death induced by tinidazole (TNZ)</span></div><div class="casAuthors">Lopez Nigro, M. M.; Carballo, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-52</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tinidazole (TNZ), a second-generation 5-nitroimidazole compd. chem. related to metronidazole (MTZ), has been widely used throughout Europe and developing countries for the treatment of amoebic and parasitic infections.  Despite TNZ's increasing use in therapeutics, scarce exptl. reports are available in literature on its potential genotoxicity in human cells.  Therefore, the aim of the present study was to achieve a precise characterization of the cytotoxic and genotoxic activities of this nitroimidazole in cultured human lymphocytes at therapeutic concns. (0.1, 1, 10 and 50 μg/mL of culture) and evaluate the possible cell death mechanism assocd. with it.  The endpoints analyzed included: mitotic index (MI), replication index (RI), sister chromatid exchange (SCE) and chromosomal aberrations (CA).  A significant decrease (p < 0.0001) in MI as well as an increase in SCE (p < 0.0001) and CA (p < 0.0001) frequencies were obsd.  No modifications in RI were found.  The results suggest a genotoxic and cytotoxic effect of TNZ related with cell death process.  Therefore, we evaluated this mechanism by DNA fragmentation (laddering), fluorescence microscopy using acridine orange/ethidium bromide (AO/EB) staining and flow cytometry propidium iodide (PI).  DNA exts. of TNZ-treated cells resulted in nucleosomal DNA ladder pattern after 48 h of cell treatment; meanwhile no differences were detected in untreated cells.  This pattern correlated with the obsd. decrease in cellular viability (p < 0.05), morphol. evidence of apoptosis and increase in the percentage of nuclei with hypodiploid DNA content of TNZ exposed cultures compared with control (p < 0.05).  We concluded that TNZ is genotoxic, cytotoxic and is able to modulate cell death through apoptotic mechanisms in the exptl. design employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyVTqYT7hs3LVg90H21EOLACvtfcHk0lheisoPLYMbdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWrsrs%253D&md5=dbf7f9c371265bace4f736b0a475e1c9</span></div><a href="/servlet/linkout?suffix=cit82a&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2008.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2008.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%2BNigro%26aufirst%3DM.%2BM.%26aulast%3DCarballo%26aufirst%3DM.%2BA.%26atitle%3DGenotoxicity%2520and%2520cell%2520death%2520induced%2520by%2520tinidazole%2520%2528TNZ%2529%26jtitle%3DToxicol.%2520Lett.%26date%3D2008%26volume%3D180%26spage%3D46%26epage%3D52%26doi%3D10.1016%2Fj.toxlet.2008.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit82b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, T. L.</span></span> <span> </span><span class="NLM_article-title">Tinidazole: a nitroimidazole antiprotozoal agent</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1859</span>– <span class="NLM_lpage">1884</span>, <span class="refDoi"> DOI: 10.1016/j.clinthera.2005.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.clinthera.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=16507373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1859-1884&author=H.+B.+Fungauthor=T.+L.+Doan&title=Tinidazole%3A+a+nitroimidazole+antiprotozoal+agent&doi=10.1016%2Fj.clinthera.2005.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82bR"><div class="casContent"><span class="casTitleNuber">82b</span><div class="casTitle"><span class="NLM_cas:atitle">Tinidazole: a nitroimidazole antiprotozoal agent</span></div><div class="casAuthors">Fung, Horatio B.; Doan, Thien-Ly</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1859-1884</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Tinidazole, a structural analog of metronidazole, is an antiprotozoal agent that has been widely used in Europe and developing countries for >2 decades with established efficacy and acceptable tolerability.  It was recently approved by the US Food and Drug Administration for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Objective: This article reviews the pharmacol. and pharmacokinetic properties and clin. usefulness of tinidazole.  Methods: Relevant information was identified through a search of MEDLINE (1966-August 2005), Iowa Drug Information Service (1966-August 2005), and International Pharmaceutical Abstrs. (1970-August 2005) using the terms tinidazole, Fasigyn, and nitroimidazole.  Results: In vitro, tinidazole exhibits activity against pathogenic protozoa (eg, Trichomonas vaginalis, Entamoeba histolytica, Giardia duodenalis), a wide range of clin. significant anaerobic bacteria (eg, Bacteroides fragilis, Clostridium difficile), and the microaerophilic bacterium Helicobacter pylori.  In susceptible protozoal and bacterial cells, tinidazole is reduced to cytotoxic intermediates that covalently bind to DNA, causing irreversible damage.  In human adults, tinidazole had a bioavailability of 100% and a Vd of 50.7 L, was minimally bound to plasma protein (12%), had a plasma elimination t1/2 of 12.3 h, and was eliminated primarily by hepatic metab. (∼63%).  Dose adjustment does not appear to be necessary on the basis of race, sex, or renal function.  No data were found on the disposition of tinidazole in patients with hepatic insufficiency; therefore, use of tinidazole in patients with severe hepatic impairment (Child-Pugh class C) is not recommended.  Clin. cure rates in patients with trichomoniasis, giardiasis, amebiasis, and amebic liver abscess were generally >90%.  In comparative trials, tinidazole was as effective as metronidazole in the treatment of trichomoniasis and was significantly more effective than metronidazole in the treatment of giardiasis (P < 0.05) and amebiasis (P < 0.05).  The most commonly reported (>1%) adverse effects included bitter taste, nausea, abdominal discomfort, anorexia, vomiting, and fatigue.  The recommended dosage of tinidazole is a single dose of 2 g for trichomoniasis and giardiasis, and 2 g/d for 3 to 5 days for amebiasis.  Conclusions: Tinidazole appears to be a promising agent for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.  Clin. studies are needed to evaluate the use of tinidazole against anaerobic bacteria and H pylori.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGwTnbff6nLbVg90H21EOLACvtfcHk0lh0W0YWOeZ-kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVenu7c%253D&md5=cc1ef607c78b3cb9889d5425c4858f04</span></div><a href="/servlet/linkout?suffix=cit82b&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DH.%2BB.%26aulast%3DDoan%26aufirst%3DT.%2BL.%26atitle%3DTinidazole%253A%2520a%2520nitroimidazole%2520antiprotozoal%2520agent%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1859%26epage%3D1884%26doi%3D10.1016%2Fj.clinthera.2005.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit82"><span>Tinidazole News; <a href="https://www.drugs.com/answers/support-group/tinidazole/news/" class="extLink">https://www.drugs.com/answers/support-group/tinidazole/news/</a> (accessed Dec 21, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tinidazole+News%3B+https%3A%2F%2Fwww.drugs.com%2Fanswers%2Fsupport-group%2Ftinidazole%2Fnews%2F+%28accessed+Dec+21%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit83"><span>Ornidazole. <a href="http://www.sanhome.com/" class="extLink">http://www.sanhome.com/</a> (accessed
Dec 31, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ornidazole.+http%3A%2F%2Fwww.sanhome.com%2F+%28accessed%0ADec+31%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit84"><span>Fexinidazole.
Drugs for Neglected Diseases Initiative, 2016. <a href="https://www.dndi.org/diseases-projects/portfolio/fexinidazole/" class="extLink">https://www.dndi.org/diseases-projects/portfolio/fexinidazole/</a> (accessed Dec 25, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fexinidazole.%0ADrugs+for+Neglected+Diseases+Initiative%2C+2016.+https%3A%2F%2Fwww.dndi.org%2Fdiseases-projects%2Fportfolio%2Ffexinidazole%2F+%28accessed+Dec+25%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bleehen, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maughan, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenning, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R.</span></span> <span> </span><span class="NLM_article-title">The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic study</span>. <i>Radiother. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1016/0167-8140(91)90201-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2F0167-8140%2891%2990201-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1826962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADyaK3M3ht1KhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1991&pages=137-142&author=N.+M.+Bleehenauthor=T.+S.+Maughanauthor=P.+Workmanauthor=H.+F.+Newmanauthor=S.+Stenningauthor=R.+Ward&title=The+combination+of+multiple+doses+of+etanidazole+and+pimonidazole+in+48+patients%3A+a+toxicity+and+pharmacokinetic+study&doi=10.1016%2F0167-8140%2891%2990201-Q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic study</span></div><div class="casAuthors">Bleehen N M; Maughan T S; Workman P; Newman H F; Stenning S; Ward R</div><div class="citationInfo"><span class="NLM_cas:title">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">20 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">137-42</span>
        ISSN:<span class="NLM_cas:issn">0167-8140</span>.
    </div><div class="casAbstract">The two radiosensitizers etanidazole and pimonidazole, currently in clinical phase 3 trials, have different toxicities.  The former produces a peripheral neuropathy after cumulative doses and the latter presents an accurate but transient central nervous system syndrome after each dose.  A strategy for improving on the maximum radiosensitization achievable using either drug alone, has been investigated in the study reported in this paper.  Escalating doses of the two drugs were given together to determine toxicity up to a maximum of 15 doses of 2.0 g/m2 etanidazole and 0.75 g/m2 pimonidazole/dose. 25 neuropathies were seen in the total of 48 patients (48%).  This included 6 grade 2 neuropathies (12.5%) or 15% of those receiving 9 or more infusions.  There were no significant correlations between the incidence of neuropathy and various dose and AUC parameters for the 31 patients receiving 10 or more infusions.  However, in the selected group of 26 patients planned to receive multiple doses of etanidazole at 2 g/m2/dose with pimonidazole at 0.75 g/m2, significant correlations were seen with the cumulative dose, with single and cumulative AUCs for pimonidazole and also for the cumulative dose and the cumulative AUC for etanidazole, but not its single AUC.  In the light of these observations and the recent reports of higher peripheral neuropathy rates than previously reported in studies in the USA, it is concluded that it is not possible at this time to determine whether there is toxicity interaction between the two drugs.  There remains the possibility that, on the basis of the combined drug dosage achieved, an increased therapeutic efficacy can be reached with either drug alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQg7CNx5B92RHp3bfzSLaX5fW6udTcc2ebU9qHSAZPuSbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3ht1KhsQ%253D%253D&md5=bd7a0bf8f2f2734a00a696c1f9580d01</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2F0167-8140%2891%2990201-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-8140%252891%252990201-Q%26sid%3Dliteratum%253Aachs%26aulast%3DBleehen%26aufirst%3DN.%2BM.%26aulast%3DMaughan%26aufirst%3DT.%2BS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DNewman%26aufirst%3DH.%2BF.%26aulast%3DStenning%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DR.%26atitle%3DThe%2520combination%2520of%2520multiple%2520doses%2520of%2520etanidazole%2520and%2520pimonidazole%2520in%252048%2520patients%253A%2520a%2520toxicity%2520and%2520pharmacokinetic%2520study%26jtitle%3DRadiother.%2520Oncol.%26date%3D1991%26volume%3D20%26spage%3D137%26epage%3D142%26doi%3D10.1016%2F0167-8140%2891%2990201-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span> <span> </span><span class="NLM_article-title">Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1128/AAC.05135-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1128%2FAAC.05135-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=22037852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Gksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=115-123&author=B.+S.+Hallauthor=S.+R.+Wilkinson&title=Activation+of+benznidazole+by+trypanosomal+type+I+nitroreductases+results+in+glyoxal+formation&doi=10.1128%2FAAC.05135-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation</span></div><div class="casAuthors">Hall, Belinda S.; Wilkinson, Shane R.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-123</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Benznidazole, a 2-nitroimidazole, is the front-line treatment used against American trypanosomiasis, a parasitic infection caused by Trypanosoma cruzi.  Despite nearly 40 years of use, the trypanocidal activity of this prodrug is not fully understood.  It has been proposed that benznidazole activation leads to the formation of reductive metabolites that can cause a series of deleterious effects, including DNA damage and thiol depletion.  Here, it is shown that the key step in benznidazole activation involves an NADH-dependent trypanosomal type I nitroreductase.  This catalyzes an oxygen-insensitive reaction with the interaction of enzyme, reductant, and prodrug occurring through a ping-pong mechanism.  Liq. chromatog./mass spectrometry (LC/MS) anal. of the resultant metabolites identified 4,5-dihydro-4,5-dihydroxyimidazole as the major product of a reductive pathway proceeding through hydroxylamine and hydroxy intermediates.  The breakdown of this product released the reactive dialdehyde glyoxal, which, in the presence of guanosine, generated guanosine-glyoxal adducts.  These expts. indicate that the redn. of benznidazole by type I nitroreductase activity leads to the formation of highly reactive metabolites and that the expression of this enzyme is key to the trypanocidal properties displayed by the prodrug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi5EttS3hz57Vg90H21EOLACvtfcHk0lgfhzscaQhN6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Gksg%253D%253D&md5=f8f175b6f7fd44904d49167bc5aa89ee</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1128%2FAAC.05135-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05135-11%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DB.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26atitle%3DActivation%2520of%2520benznidazole%2520by%2520trypanosomal%2520type%2520I%2520nitroreductases%2520results%2520in%2520glyoxal%2520formation%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D115%26epage%3D123%26doi%3D10.1128%2FAAC.05135-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Carvalho, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomão, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva Zamith, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffarena, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boechat, N.</span></span> <span> </span><span class="NLM_article-title">Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their <i>in vitro</i> and in silico interactions with the Trypanosoma brucei nitroreductase enzyme</span>. <i>Mem. Inst. Oswaldo Cruz</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1590/0074-0276140497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1590%2F0074-0276140497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=24676659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12jsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2014&pages=315-323&author=A.+S.+de%0ACarvalhoauthor=K.+Salom%C3%A3oauthor=S.+L.+de+Castroauthor=T.+R.+Condeauthor=H.+P.+da+Silva+Zamithauthor=E.+R.+Caffarenaauthor=B.+S.+Hallauthor=S.+R.+Wilkinsonauthor=N.+Boechat&title=Megazol+and+its+bioisostere+4H-1%2C2%2C4-triazole%3A+comparing+the+trypanocidal%2C+cytotoxic+and+genotoxic+activities+and+their+in+vitro+and+in+silico+interactions+with+the+Trypanosoma+brucei+nitroreductase+enzyme&doi=10.1590%2F0074-0276140497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico interactions with the Trypanosoma brucei nitroreductase enzyme</span></div><div class="casAuthors">de Carvalho, Alcione Silva; Salomao, Kelly; de Castro, Solange Lisboa; Conde, Taline Ramos; da Silva Zamith, Helena Pereira; Caffarena, Ernesto Raul; Hall, Belinda Suzette; Wilkinson, Shane Robert; Boechat, Nubia</div><div class="citationInfo"><span class="NLM_cas:title">Memorias do Instituto Oswaldo Cruz</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-323, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">MIOCAS</span>;
        ISSN:<span class="NLM_cas:issn">1678-8060</span>.
    
            (<span class="NLM_cas:orgname">Instituto Oswaldo Cruz</span>)
        </div><div class="casAbstract">Megazol (7) is a 5-nitroimidazole that is highly active against Trypanosoma cruzi and Trypanosoma brucei, as well as drug-resistant forms of trypanosomiasis.  Compd. 7 is not used clin. due to its mutagenic and genotoxic properties, but has been largely used as a lead compd.  Here, we compared the activity of 7 with its 4H-1,2,4-triazole bioisostere (8) in bloodstream forms of T. brucei and T. cruzi and evaluated their activation by T. brucei type I nitroreductase (TbNTR) enzyme.  We also analyzed the cytotoxic and genotoxic effects of these compds. in whole human blood using Comet and fluorescein diacetate/ethidium bromide assays.  Although the only difference between 7 and 8 is the substitution of sulfur (in the thiadiazole in 7) for nitrogen (in the triazole in 8), the results indicated that 8 had poorer antiparasitic activity than 7 and was not genotoxic, whereas 7 presented this effect.  The detn. of Vmax indicated that although 8 was metabolised more rapidly than 7, it bounds to the TbNTR with better affinity, resulting in equiv. kcat/KM values.  Docking assays of 7 and 8 performed within the active site of a homol. model of the TbNTR indicating that 8 had greater affinity than 7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBBZTNKUWViLVg90H21EOLACvtfcHk0lgfhzscaQhN6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12jsL7I&md5=90c08e9ec0d6d8a1fb5cca6f45c0b982</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1590%2F0074-0276140497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252F0074-0276140497%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCarvalho%26aufirst%3DA.%2BS.%26aulast%3DSalom%25C3%25A3o%26aufirst%3DK.%26aulast%3Dde%2BCastro%26aufirst%3DS.%2BL.%26aulast%3DConde%26aufirst%3DT.%2BR.%26aulast%3Dda%2BSilva%2BZamith%26aufirst%3DH.%2BP.%26aulast%3DCaffarena%26aufirst%3DE.%2BR.%26aulast%3DHall%26aufirst%3DB.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DBoechat%26aufirst%3DN.%26atitle%3DMegazol%2520and%2520its%2520bioisostere%25204H-1%252C2%252C4-triazole%253A%2520comparing%2520the%2520trypanocidal%252C%2520cytotoxic%2520and%2520genotoxic%2520activities%2520and%2520their%2520in%2520vitro%2520and%2520in%2520silico%2520interactions%2520with%2520the%2520Trypanosoma%2520brucei%2520nitroreductase%2520enzyme%26jtitle%3DMem.%2520Inst.%2520Oswaldo%2520Cruz%26date%3D2014%26volume%3D109%26spage%3D315%26epage%3D323%26doi%3D10.1590%2F0074-0276140497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit88a"><span>VENCLEXTA. <a href="https://www.venclexta.com/" class="extLink">https://www.venclexta.com/</a> (accessed Dec 31, <span class="NLM_year">2017</span>)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=VENCLEXTA.+https%3A%2F%2Fwww.venclexta.com%2F+%28accessed+Dec+31%2C+2017%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit88b"><span>AbbVie Announces Phase 3 Study
of VENCLEXTA/ VENCLYXTO (venetoclax) in Combination with Rituxan (rituximab)
Meets Its Primary Endpoint, December 12, 2017. <a href="https://news.abbvie.com/news/press-releases/" class="extLink">https://news.abbvie.com/news/press-releases/</a> (accessed Dec 29, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AbbVie+Announces+Phase+3+Study%0Aof+VENCLEXTA%2F+VENCLYXTO+%28venetoclax%29+in+Combination+with+Rituxan+%28rituximab%29%0AMeets+Its+Primary+Endpoint%2C+December+12%2C+2017.+https%3A%2F%2Fnews.abbvie.com%2Fnews%2Fpress-releases%2F+%28accessed+Dec+29%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit89"><span>Otsuka
and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba)
for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries,
August 24, 2017. <a href="https://www.venclexta.com/" class="extLink">https://www.venclexta.com/</a> (accessed Dec 27, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Otsuka%0Aand+Mylan+Announce+License+Agreement+to+Commercialize+Delamanid+%28Deltyba%29%0Afor+Multidrug-Resistant+Tuberculosis+%28MDR-TB%29+in+High-Burden+Countries%2C%0AAugust+24%2C+2017.+https%3A%2F%2Fwww.venclexta.com%2F+%28accessed+Dec+27%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit89b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishige, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubouchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span> <span> </span><span class="NLM_article-title">OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis <i>in vitro</i> and in mice</span>. <i>PLoS Med</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e466</span>, <span class="refDoi"> DOI: 10.1371/journal.pmed.0030466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1371%2Fjournal.pmed.0030466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=17132069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BD28npsFKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=e466&author=M.+Matsumotoauthor=H.+Hashizumeauthor=T.+Tomishigeauthor=M.+Kawasakiauthor=H.+Tsubouchiauthor=H.+Sasakiauthor=Y.+Shimokawaauthor=M.+Komatsu&title=OPC-67683%2C+a+nitro-dihydro-imidazooxazole+derivative+with+promising+action+against+tuberculosis+in+vitro+and+in+mice&doi=10.1371%2Fjournal.pmed.0030466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89bR"><div class="casContent"><span class="casTitleNuber">89b</span><div class="casTitle"><span class="NLM_cas:atitle">OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice</span></div><div class="casAuthors">Matsumoto Makoto; Hashizume Hiroyuki; Tomishige Tatsuo; Kawasaki Masanori; Tsubouchi Hidetsugu; Sasaki Hirofumi; Shimokawa Yoshihiko; Komatsu Makoto</div><div class="citationInfo"><span class="NLM_cas:title">PLoS medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e466</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Tuberculosis (TB) is still a leading cause of death worldwide.  Almost a third of the world's population is infected with TB bacilli, and each year approximately 8 million people develop active TB and 2 million die as a result.  Today's TB treatment, which dates back to the 1970s, is long and burdensome, requiring at least 6 mo of multidrug chemotherapy.  The situation is further compounded by the emergence of multidrug-resistant TB (MDR-TB) and by the infection's lethal synergy with HIV/AIDS.  Global health and philanthropic organizations are now pleading for new drug interventions that can address these unmet needs in TB treatment.  METHODS AND FINDINGS:  Here we report OPC-67683, a nitro-dihydro-imidazooxazole derivative that was screened to help combat the unmet needs in TB treatment.  The compound is a mycolic acid biosynthesis inhibitor found to be free of mutagenicity and to possess highly potent activity against TB, including MDR-TB, as shown by its exceptionally low minimum inhibitory concentration (MIC) range of 0.006-0.024 microg/ml in vitro and highly effective therapeutic activity at low doses in vivo.  Additionally, the results of the post-antibiotic effect of OPC-67683 on intracellular Mycobacterium tuberculosis showed the agent to be highly and dose-dependently active also against intracellular M. tuberculosis H37Rv after a 4-h pulsed exposure, and this activity at a concentration of 0.1 microg/ml was similar to that of the first-line drug rifampicin (RFP) at a concentration of 3 microg/ml.  The combination of OPC-67683 with RFP and pyrazinamide (PZA) exhibited a remarkably quicker eradication (by at least 2 mo) of viable TB bacilli in the lung in comparison with the standard regimen consisting of RFP, isoniazid (INH), ethambutol (EB), and PZA.  Furthermore, OPC-67683 was not affected by nor did it affect the activity of liver microsome enzymes, suggesting the possibility for OPC-67683 to be used in combination with drugs, including anti-retrovirals, that induce or are metabolized by cytochrome P450 enzymes.  CONCLUSIONS:  We concluded that based on these properties OPC-67683 has the potential to be used as a TB drug to help combat the unmet needs in TB treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSF0z_BNLNYeRS7coPn-RtfW6udTcc2eb84Lj5LAFzfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28npsFKgug%253D%253D&md5=8a80560cc653b1c76ff4d47430317d18</span></div><a href="/servlet/linkout?suffix=cit89b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0030466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0030466%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DTomishige%26aufirst%3DT.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DTsubouchi%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DShimokawa%26aufirst%3DY.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DOPC-67683%252C%2520a%2520nitro-dihydro-imidazooxazole%2520derivative%2520with%2520promising%2520action%2520against%2520tuberculosis%2520in%2520vitro%2520and%2520in%2520mice%26jtitle%3DPLoS%2520Med%26date%3D2006%26volume%3D3%26spage%3De466%26doi%3D10.1371%2Fjournal.pmed.0030466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arend, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londoño-Joshi, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangrade, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katre, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurpad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samant, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landen, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straughn, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchsbaum, D. J.</span></span> <span> </span><span class="NLM_article-title">Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">86803</span>– <span class="NLM_lpage">86815</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.18632%2Foncotarget.13466" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=86803-86815&author=R.+C.+Arendauthor=A.+I.+Londo%C3%B1o-Joshiauthor=A.+Gangradeauthor=A.+A.+Katreauthor=C.+Kurpadauthor=Y.+Liauthor=R.+S.+Samantauthor=P.+K.+Liauthor=C.+N.+Landenauthor=E.+S.+Yangauthor=B.+Hidalgoauthor=R.+D.+Alvarezauthor=J.+M.+Straughnauthor=A.+Foreroauthor=D.+J.+Buchsbaum&title=Niclosamide+and+its+analogs+are+potent+inhibitors+of+Wnt%2F%CE%B2-catenin%2C+mTOR+and+STAT3+signaling+in+ovarian+cancer&doi=10.18632%2Foncotarget.13466"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13466%26sid%3Dliteratum%253Aachs%26aulast%3DArend%26aufirst%3DR.%2BC.%26aulast%3DLondo%25C3%25B1o-Joshi%26aufirst%3DA.%2BI.%26aulast%3DGangrade%26aufirst%3DA.%26aulast%3DKatre%26aufirst%3DA.%2BA.%26aulast%3DKurpad%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSamant%26aufirst%3DR.%2BS.%26aulast%3DLi%26aufirst%3DP.%2BK.%26aulast%3DLanden%26aufirst%3DC.%2BN.%26aulast%3DYang%26aufirst%3DE.%2BS.%26aulast%3DHidalgo%26aufirst%3DB.%26aulast%3DAlvarez%26aufirst%3DR.%2BD.%26aulast%3DStraughn%26aufirst%3DJ.%2BM.%26aulast%3DForero%26aufirst%3DA.%26aulast%3DBuchsbaum%26aufirst%3DD.%2BJ.%26atitle%3DNiclosamide%2520and%2520its%2520analogs%2520are%2520potent%2520inhibitors%2520of%2520Wnt%252F%25CE%25B2-catenin%252C%2520mTOR%2520and%2520STAT3%2520signaling%2520in%2520ovarian%2520cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D86803%26epage%3D86815%26doi%3D10.18632%2Foncotarget.13466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit91"><span>COMTAN
(entacapone) Tablets, December 2001. <a href="https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/comtan.pdf/" class="extLink">https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/comtan.pdf/</a> (accessed Dec 25, <span class="NLM_year">2017</span>)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=COMTAN%0A%28entacapone%29+Tablets%2C+December+2001.+https%3A%2F%2Fwww.pharma.us.novartis.com%2Fsites%2Fwww.pharma.us.novartis.com%2Ffiles%2Fcomtan.pdf%2F+%28accessed+Dec+25%2C+2017%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit91b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Najib, J.</span></span> <span> </span><span class="NLM_article-title">Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson’s disease</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">832</span>, <span class="refDoi"> DOI: 10.1016/S0149-2918(01)80071-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FS0149-2918%2801%2980071-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=11440283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltFWktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2001&pages=802-832&author=J.+Najib&title=Entacapone%3A+a+catechol-O-methyltransferase+inhibitor+for+the+adjunctive+treatment+of+Parkinson%E2%80%99s+disease&doi=10.1016%2FS0149-2918%2801%2980071-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91bR"><div class="casContent"><span class="casTitleNuber">91b</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of parkinson's disease</span></div><div class="casAuthors">Najib, Jadwiga</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">802-832</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review with refs.  When levodopa therapy is used in Parkinson's disease, degrdn. of the drug in the peripheral nervous system is assocd. with dyskinesias and motor fluctuations.  Much of this degrdn. is produced by catechol-O-methyltransferase (COMT), an enzyme involved in the metab. of catecholamines and catechol compds.  Inhibition of COMT activity prolongs the action of levodopa and reduces fluctuations in response.  Entacapone is a selective inhibitor of COMT whose activity is primarily in the peripheral nervous system, with little effect in the central nervous system.  This paper reviews the pharmacol. properties and clin. usefulness of entacapone in the treatment of Parkinson's disease.  Recent studies, abstrs., and reviews published in the English-language literature were identified through searches of MEDLINE (1966-Sept. 2000), International Pharmaceutical Abstrs. (1970-Sept. 2000), and PharmaProjects (Sept. 2000 version), and from the Web sites of Parkinson's disease conferences held from 1996 to Sept. 2000.  Relevant human studies provided further information on the pharmacol. properties and clin. usefulness of entacapone.  Entacapone is rapidly absorbed, with a time to max. concn. of ∼1 h.  Its plasma elimination half-life is 0.4 to 0.7 h in the beta phase and 2.4 h in the gamma phase, and it has 35% abs. bioavailability after oral administration, secondary to first-pass clearance.  Entacapone is 98% protein bound; thus, it is not distributed widely in tissues and is almost completely metabolized before excretion (0.1%-0.2% of dose unchanged in urine).  The drug inhibits erythrocyte-sol. COMT activity in a dose-dependent fashion (48% after a 400-mg dose, 82% after an 800-mg dose).  The inhibitory effect is reversible, with recovery of sol. COMT activity within 4 to 8 h.  In levodopa-treated patients with Parkinson's disease who experience motor fluctuations, clin. trials have demonstrated entacapone's effectiveness in increasing "on" time (the period during which medications relieve the symptoms of Parkinson's disease) by up to 1.2 h, decreasing "off" time (the period during which symptoms increase) by 0.9 to 1.3 h, and producing overall total improvement in scores on the Unified Parkinson's Disease Rating Scale.  The recommended dosage of entacapone is 200 mg administered orally with each dose of levodopa/carbidopa, up to 8 doses per day.  The drug is generally well tolerated, with most adverse effects attributed to levodopa-related dopaminergic effects, including dyskinesias and nausea.  In clin. trials, adjuvant treatment with entacapone appeared to be an effective and well-tolerated therapeutic strategy in patients with Parkinson's disease who experience fluctuations in the response to levodopa therapy.  The increased elimination half-life of levodopa with concomitant entacapone results in greater and more sustained plasma levodopa levels, with more const. dopaminergic stimulation in the brain and greater amelioration of parkinsonian symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTjPYcmpvhyLVg90H21EOLACvtfcHk0lhT5h0RHCmskg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltFWktbw%253D&md5=9a5219f190ae5b28908f73782b47ab9d</span></div><a href="/servlet/linkout?suffix=cit91b&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2801%2980071-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252801%252980071-0%26sid%3Dliteratum%253Aachs%26aulast%3DNajib%26aufirst%3DJ.%26atitle%3DEntacapone%253A%2520a%2520catechol-O-methyltransferase%2520inhibitor%2520for%2520the%2520adjunctive%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DClin.%2520Ther.%26date%3D2001%26volume%3D23%26spage%3D802%26epage%3D832%26doi%3D10.1016%2FS0149-2918%2801%2980071-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit91c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagar, H.</span></span> <span> </span><span class="NLM_article-title">Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson’s disease: a randomised, placebo controlled, double blind, six month study</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1136/jnnp.74.8.1071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1136%2Fjnnp.74.8.1071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=12876237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BD3szksVaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2003&pages=1071-1079&author=D.+J.+Brooksauthor=H.+Sagar&title=Entacapone+is+beneficial+in+both+fluctuating+and+non-fluctuating+patients+with+Parkinson%E2%80%99s+disease%3A+a+randomised%2C+placebo+controlled%2C+double+blind%2C+six+month+study&doi=10.1136%2Fjnnp.74.8.1071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91cR"><div class="casContent"><span class="casTitleNuber">91c</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study</span></div><div class="casAuthors">Brooks D J; Sagar H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1071-9</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">OBJECTIVE:  To study the effect of entacapone, a specific peripherally acting catechol-O-methyltransferase (COMT) inhibitor used in combination with levodopa treatment, in cases of Parkinson's disease with both fluctuating and non-fluctuating response to treatment.  METHODS:  A randomised, placebo controlled, double blind, six month study was undertaken in 172 fluctuating and 128 non-fluctuating patients.  The clinical efficacy and safety of 200 mg entacapone given with each daily levodopa dose was studied.  Efficacy was examined using home diaries, the unified Parkinson disease rating scale (UPDRS), and recording of daily levodopa dose.  RESULTS:  The primary efficacy variable for fluctuating patients-the proportion of daily ON time-showed a significant increase compared with placebo (p < 0.05).  The absolute ON time (mean (SD)) increased from 9.5 (2.5) to 10.8 (2.4) hours (p < 0.01), and the daily OFF time was correspondingly reduced from 7.0 (2.6) to 5.9 (2.5) hours (p < 0.05 v placebo).  This improvement was achieved despite a reduction in daily levodopa requirements.  The effect was rapidly lost on withdrawal of entacapone.  In non-fluctuating patients, the primary efficacy measure was part II of the UPDRS (activities of daily living; ADL).  In this group of patients, ADL scores improved in the entacapone group (p < 0.01 v placebo), and there was also a 40 mg reduction in levodopa requirement (p < 0.01 v placebo).  Entacapone was well tolerated by both fluctuating and non-fluctuating patients.  CONCLUSIONS:  The ability of entacapone to provide additional benefits to levodopa treatment in increasing ON time in fluctuating Parkinson's disease patients was confirmed.  A novel finding was that patients without fluctuations also obtained benefit from the addition of entacapone to their levodopa treatment, as evidenced by improved ADL scores and a relatively reduced levodopa requirement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQU23Nvq119lDDnmmyUf5qOfW6udTcc2ebywhpMgFYxlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szksVaisw%253D%253D&md5=cedbce79cf2e428f2f4a820e3fbbeca6</span></div><a href="/servlet/linkout?suffix=cit91c&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.74.8.1071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.74.8.1071%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DSagar%26aufirst%3DH.%26atitle%3DEntacapone%2520is%2520beneficial%2520in%2520both%2520fluctuating%2520and%2520non-fluctuating%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520randomised%252C%2520placebo%2520controlled%252C%2520double%2520blind%252C%2520six%2520month%2520study%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2003%26volume%3D74%26spage%3D1071%26epage%3D1079%26doi%3D10.1136%2Fjnnp.74.8.1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertout, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span> <span> </span><span class="NLM_article-title">The impact of O<sub>2</sub> availability on human cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1038/nrc2540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1038%2Fnrc2540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18987634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWhu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=967-975&author=J.+A.+Bertoutauthor=S.+A.+Patelauthor=M.+C.+Simon&title=The+impact+of+O2+availability+on+human+cancer&doi=10.1038%2Fnrc2540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of O2 availability on human cancer</span></div><div class="casAuthors">Bertout, Jessica A.; Patel, Shetal A.; Simon, M. Celeste</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">967-975</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  During the past century it has been established that regions within solid tumors experience mild to severe O2 deprivation owing to aberrant vascular function.  These hypoxic regions are assocd. with altered cellular metab., as well as increased resistance to radiation and chemotherapy.  As discussed in this Timeline, over the past decade work from many labs. has elucidated the mechanisms by which hypoxia-inducible factors (HIFs) modulate tumor cell metab., angiogenesis, growth and metastasis.  The central role played by intra-tumoral hypoxia and HIF in these processes has made them attractive therapeutic targets in the treatment of multiple human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofqTHqD6DAsLVg90H21EOLACvtfcHk0lhT5h0RHCmskg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWhu7fO&md5=0f5233f04781067ff184a8e9621293f4</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fnrc2540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2540%26sid%3Dliteratum%253Aachs%26aulast%3DBertout%26aufirst%3DJ.%2BA.%26aulast%3DPatel%26aufirst%3DS.%2BA.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26atitle%3DThe%2520impact%2520of%2520O2%2520availability%2520on%2520human%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D967%26epage%3D975%26doi%3D10.1038%2Fnrc2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, G. E.</span>; <span class="NLM_string-name">Michael, B. D.</span>; <span class="NLM_string-name">Asquith, J. C.</span>; <span class="NLM_string-name">Shenoy, M. A.</span>; <span class="NLM_string-name">Watts, M. E.</span>; <span class="NLM_string-name">Whillans, D. W.</span></span> <i>Radiation Research: Biomedical, Chemical and Physical Perspectives</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1975</span>; pp  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">492</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FB978-0-12-523350-7.50049-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1975&pages=478-492&author=G.+E.+Adams&author=B.+D.+Michael&author=J.+C.+Asquith&author=M.+A.+Shenoy&author=M.+E.+Watts&author=D.+W.+Whillans&title=Radiation+Research%3A+Biomedical%2C+Chemical+and+Physical+Perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-523350-7.50049-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-523350-7.50049-3%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DG.%2BE.%26btitle%3DRadiation%2520Research%253A%2520Biomedical%252C%2520Chemical%2520and%2520Physical%2520Perspectives%26pub%3DAcademic%2520Press%26date%3D1975%26spage%3D478%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kizaka-Kondoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konse-Nagasawa, H.</span></span> <span> </span><span class="NLM_article-title">Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">1366</span>– <span class="NLM_lpage">1373</span>, <span class="refDoi"> DOI: 10.1111/j.1349-7006.2009.01195.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1111%2Fj.1349-7006.2009.01195.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=19459851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2009&pages=1366-1373&author=S.+Kizaka-Kondohauthor=H.+Konse-Nagasawa&title=Significance+of+nitroimidazole+compounds+and+hypoxia-inducible+factor-1+for+imaging+tumor+hypoxia&doi=10.1111%2Fj.1349-7006.2009.01195.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia</span></div><div class="casAuthors">Kizaka-Kondoh, Shinae; Konse-Nagasawa, Hideko</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1366-1373</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  A tumor-specific microenvironment is characterized by hypoxia, in which oxygen tension is considerably lower than in normal tissues.  The hypoxic status of various solid tumors has been attributed as an indicator of adverse prognosis due to tumor progression toward a more malignant phenotype with increased metastatic potential and resistance to treatment.  Various exogenous and endogenous markers for hypoxia are currently available and studied in relation to each other, tumor architecture, and tumor microenvironment.  Over the last few decades, various methods have been suggested to assess the level of oxygenation in solid tumors.  Among them, nitroimidazole compds. have provided promising information on tumor hypoxia.  To quantify the extent of hypoxia requires that nitroimidazole binding be primarily dependent on oxygen concn. as well as nitroreductase levels in the tumor cells.  Furthermore, recent progress in mol. biol. has highlighted a transcription factor, hypoxia-inducible factor (HIF)-1, whose activity is induced by hypoxia.  HIF-1 plays a central role in malignant progression by inducing the expression of various genes, whose functions are strongly assocd. with malignant alteration of the entire tumor.  The cellular changes induced by HIF-1 are extremely important therapeutic targets of cancer therapy, particularly in the therapy against refractory cancers.  In this review, we will discuss the significance of pimonidazole and HIF-1 as exogenous and endogenous hypoxia markers, resp., as well as their evaluation and imaging of tumor hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfR3S5xXQzw7Vg90H21EOLACvtfcHk0ljSF1KX5qMJIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnsLrM&md5=ce86e927966f2d0388d05eb6a930a398</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2009.01195.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2009.01195.x%26sid%3Dliteratum%253Aachs%26aulast%3DKizaka-Kondoh%26aufirst%3DS.%26aulast%3DKonse-Nagasawa%26aufirst%3DH.%26atitle%3DSignificance%2520of%2520nitroimidazole%2520compounds%2520and%2520hypoxia-inducible%2520factor-1%2520for%2520imaging%2520tumor%2520hypoxia%26jtitle%3DCancer%2520Sci.%26date%3D2009%26volume%3D100%26spage%3D1366%26epage%3D1373%26doi%3D10.1111%2Fj.1349-7006.2009.01195.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lunt, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudary, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R. P.</span></span> <span> </span><span class="NLM_article-title">The tumor microenvironment and metastatic disease</span>. <i>Clin. Exp. Metastasis</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1007/s10585-008-9182-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1007%2Fs10585-008-9182-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18543068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FptF2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=19-34&author=S.+J.+Luntauthor=N.+Chaudaryauthor=R.+P.+Hill&title=The+tumor+microenvironment+and+metastatic+disease&doi=10.1007%2Fs10585-008-9182-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">The tumor microenvironment and metastatic disease</span></div><div class="casAuthors">Lunt Sarah Jane; Chaudary Naz; Hill Richard P</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & experimental metastasis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The microenvironment of solid tumors is a heterogeneous, complex milieu for tumor growth and survival that includes features such as acidic pH, low nutrient levels, elevated interstitial fluid pressure (IFP) and chronic and fluctuating levels of oxygenation that relate to the abnormal vascular network that exists in tumors.  The metastatic potential of tumor cells is believed to be regulated by interactions between the tumor cells and their extracellular environment (extracellular matrix (ECM)).  These interactions can be modified by the accumulation of genetic changes and by the transient alterations in gene expression induced by the local tumor microenvironment.  Clinical and experimental evidence suggests that altered gene expression in response to the hypoxic microenvironment is a contributing factor to increased metastatic efficiency.  A number of genes that have been implicated in the metastatic process, involving angiogenesis, intra/extravasation, survival and growth, have been found to be hypoxia-responsive.  The various metastatic determinants, genetic and epigenetic, somatic and inherited may serve as precedents for the future identification of more genes that are involved in metastasis.  Much research has focused on genetic and molecular properties of the tumor cells themselves.  In the present review we discuss the epigenetic and physiological regulation of metastasis and emphasize the need for further studies on the interactions between the pathophysiologic tumor microenvironment and the tumor extracellular matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZKUWZjAsBievW160gIxP_fW6udTcc2ebIBKKoYy_vKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FptF2hsw%253D%253D&md5=43511adf1ed4b463c08516af0f786f6b</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1007%2Fs10585-008-9182-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10585-008-9182-2%26sid%3Dliteratum%253Aachs%26aulast%3DLunt%26aufirst%3DS.%2BJ.%26aulast%3DChaudary%26aufirst%3DN.%26aulast%3DHill%26aufirst%3DR.%2BP.%26atitle%3DThe%2520tumor%2520microenvironment%2520and%2520metastatic%2520disease%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D2009%26volume%3D26%26spage%3D19%26epage%3D34%26doi%3D10.1007%2Fs10585-008-9182-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guise, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbattista, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holford, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dachs, G. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guilford, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doñate, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. V.</span></span> <span> </span><span class="NLM_article-title">The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1573</span>– <span class="NLM_lpage">1584</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-3237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1158%2F0008-5472.CAN-09-3237" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1573-1584&author=C.+P.+Guiseauthor=M.+R.+Abbattistaauthor=R.+S.+Singletonauthor=S.+D.+Holfordauthor=J.+Connollyauthor=G.+U.+Dachsauthor=S.+B.+Foxauthor=R.+Pollockauthor=J.+Harveyauthor=P.+Guilfordauthor=F.+Do%C3%B1ateauthor=W.+R.+Wilsonauthor=A.+V.+Patterson&title=The+bioreductive+prodrug+PR-104A+is+activated+under+aerobic+conditions+by+human+aldo-keto+reductase+1C3&doi=10.1158%2F0008-5472.CAN-09-3237"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-3237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-3237%26sid%3Dliteratum%253Aachs%26aulast%3DGuise%26aufirst%3DC.%2BP.%26aulast%3DAbbattista%26aufirst%3DM.%2BR.%26aulast%3DSingleton%26aufirst%3DR.%2BS.%26aulast%3DHolford%26aufirst%3DS.%2BD.%26aulast%3DConnolly%26aufirst%3DJ.%26aulast%3DDachs%26aufirst%3DG.%2BU.%26aulast%3DFox%26aufirst%3DS.%2BB.%26aulast%3DPollock%26aufirst%3DR.%26aulast%3DHarvey%26aufirst%3DJ.%26aulast%3DGuilford%26aufirst%3DP.%26aulast%3DDo%25C3%25B1ate%26aufirst%3DF.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DPatterson%26aufirst%3DA.%2BV.%26atitle%3DThe%2520bioreductive%2520prodrug%2520PR-104A%2520is%2520activated%2520under%2520aerobic%2520conditions%2520by%2520human%2520aldo-keto%2520reductase%25201C3%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1573%26epage%3D1584%26doi%3D10.1158%2F0008-5472.CAN-09-3237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span> <span> </span><span class="NLM_article-title">Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1007/s00280-015-2920-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1007%2Fs00280-015-2920-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=26811177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2016&pages=441-457&author=R.+M.+Phillips&title=Targeting+the+hypoxic+fraction+of+tumours+using+hypoxia-activated+prodrugs&doi=10.1007%2Fs00280-015-2920-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the hypoxic fraction of tumors using hypoxia-activated prodrugs</span></div><div class="casAuthors">Phillips, Roger M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-457</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The presence of a microenvironment within most tumors contg. regions of low oxygen tension or hypoxia has profound biol. and therapeutic implications.  Tumor hypoxia is known to promote the development of an aggressive phenotype, resistance to both chemotherapy and radiotherapy and is strongly assocd. with poor clin. outcome.  Paradoxically, it is recognized as a high-priority target and one of the therapeutic strategies designed to eradicate hypoxic cells in tumors is a group of compds. known collectively as hypoxia-activated prodrugs (HAPs) or bioreductive drugs.  These drugs are inactive prodrugs that require enzymic activation (typically by 1 or 2 electron oxidoreductases) to generate cytotoxic species with selectivity for hypoxic cells being detd. by (1) the ability of oxygen to either reverse or inhibit the activation process and (2) the presence of elevated expression of oxidoreductases in tumors.  The concepts underpinning HAP development were established over 40 years ago and have been refined over the years to produce a new generation of HAPs that are under preclin. and clin. development.  The purpose of this article is to describe current progress in the development of HAPs focusing on the mechanisms of action, preclin. properties and clin. progress of leading examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT5Ciedj2i5LVg90H21EOLACvtfcHk0li140e5DSZt9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOht7g%253D&md5=0ddd0f1e4d2e4cb6af54e9b380624b5b</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1007%2Fs00280-015-2920-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-015-2920-7%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26atitle%3DTargeting%2520the%2520hypoxic%2520fraction%2520of%2520tumours%2520using%2520hypoxia-activated%2520prodrugs%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2016%26volume%3D77%26spage%3D441%26epage%3D457%26doi%3D10.1007%2Fs00280-015-2920-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möllmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Joanis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarelli, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dianiskova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordulakova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrethsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenkrands, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaonkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosset, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Benzothiazinones kill mycobacterium tuberculosis by blocking arabinan synthesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1126/science.1171583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1126%2Fscience.1171583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=19299584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=801-804&author=V.+Makarovauthor=G.+Maninaauthor=K.+Mikusovaauthor=U.+M%C3%B6llmannauthor=O.+Ryabovaauthor=B.+Saint-Joanisauthor=N.+Dharauthor=M.+R.+Pascaauthor=S.+Buroniauthor=A.+P.+Lucarelliauthor=A.+Milanoauthor=E.+De+Rossiauthor=M.+Belanovaauthor=A.+Bobovskaauthor=P.+Dianiskovaauthor=J.+Kordulakovaauthor=C.+Salaauthor=E.+Fullamauthor=P.+Schneiderauthor=J.+D.+McKinneyauthor=P.+Brodinauthor=T.+Christopheauthor=S.+Waddellauthor=P.+Butcherauthor=J.+Albrethsenauthor=I.+Rosenkrandsauthor=R.+Broschauthor=V.+Nandiauthor=S.+Bharathauthor=S.+Gaonkarauthor=R.+K.+Shandilauthor=V.+Balasubramanianauthor=T.+Balganeshauthor=S.+Tyagiauthor=J.+Grossetauthor=G.+Riccardiauthor=S.+T.+Cole&title=Benzothiazinones+kill+mycobacterium+tuberculosis+by+blocking+arabinan+synthesis&doi=10.1126%2Fscience.1171583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis</span></div><div class="casAuthors">Makarov, Vadim; Manina, Giulia; Mikusova, Katarina; Moellmann, Ute; Ryabova, Olga; Saint-Joanis, Brigitte; Dhar, Neeraj; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Brodin, Priscille; Christophe, Thierry; Waddell, Simon; Butcher, Philip; Albrethsen, Jakob; Rosenkrands, Ida; Brosch, Roland; Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore; Tyagi, Sandeep; Grosset, Jacques; Riccardi, Giovanna; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5928</span>),
    <span class="NLM_cas:pages">801-804</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">New drugs are required to counter the tuberculosis (TB) pandemic.  Here, we describe the synthesis and characterization of 1,3-benzothiazin-4-ones (BTZs), a new class of antimycobacterial agents that kill Mycobacterium tuberculosis in vitro, ex vivo, and in mouse models of TB.  Using genetics and biochem., we identified the enzyme decaprenylphosphoryl-β-D-ribose 2'-epimerase as a major BTZ target.  Inhibition of this enzymic activity abolishes the formation of decaprenylphosphoryl arabinose, a key precursor that is required for the synthesis of the cell-wall arabinans, thus provoking cell lysis and bacterial death.  The most advanced compd., BTZ043, is a candidate for inclusion in combination therapies for both drug-sensitive and extensively drug-resistant TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZiVvk0T_DOrVg90H21EOLACvtfcHk0ljds1wxvxM_0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D&md5=1d80f14ba88460ef5c8ea31793dbb592</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1126%2Fscience.1171583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1171583%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DManina%26aufirst%3DG.%26aulast%3DMikusova%26aufirst%3DK.%26aulast%3DM%25C3%25B6llmann%26aufirst%3DU.%26aulast%3DRyabova%26aufirst%3DO.%26aulast%3DSaint-Joanis%26aufirst%3DB.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DLucarelli%26aufirst%3DA.%2BP.%26aulast%3DMilano%26aufirst%3DA.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DBelanova%26aufirst%3DM.%26aulast%3DBobovska%26aufirst%3DA.%26aulast%3DDianiskova%26aufirst%3DP.%26aulast%3DKordulakova%26aufirst%3DJ.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DFullam%26aufirst%3DE.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DWaddell%26aufirst%3DS.%26aulast%3DButcher%26aufirst%3DP.%26aulast%3DAlbrethsen%26aufirst%3DJ.%26aulast%3DRosenkrands%26aufirst%3DI.%26aulast%3DBrosch%26aufirst%3DR.%26aulast%3DNandi%26aufirst%3DV.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DGaonkar%26aufirst%3DS.%26aulast%3DShandil%26aufirst%3DR.%2BK.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBalganesh%26aufirst%3DT.%26aulast%3DTyagi%26aufirst%3DS.%26aulast%3DGrosset%26aufirst%3DJ.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DBenzothiazinones%2520kill%2520mycobacterium%2520tuberculosis%2520by%2520blocking%2520arabinan%2520synthesis%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D801%26epage%3D804%26doi%3D10.1126%2Fscience.1171583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Jesus Lopes Ribeiro, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degiacomi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Incandela, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras-Dominguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span> <span> </span><span class="NLM_article-title">Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e26675</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0026675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1371%2Fjournal.pone.0026675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=22069462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2lu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e26675&author=A.+L.+de%0AJesus+Lopes+Ribeiroauthor=G.+Degiacomiauthor=F.+Ewannauthor=S.+Buroniauthor=M.+L.+Incandelaauthor=L.+R.+Chiarelliauthor=G.+Moriauthor=J.+Kimauthor=M.+Contreras-Dominguezauthor=Y.-S.+Parkauthor=S.+J.+Hanauthor=P.+Brodinauthor=G.+Valentiniauthor=M.+Rizziauthor=G.+Riccardiauthor=M.+R.+Pasca&title=Analogous+mechanisms+of+resistance+to+benzothiazinones+and+dinitrobenzamides+in+Mycobacterium+smegmatis&doi=10.1371%2Fjournal.pone.0026675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis</span></div><div class="casAuthors">de Jesus Lopes Ribeiro, Ana Luisa; Degiacomi, Giulia; Ewann, Fanny; Buroni, Silvia; Incandela, Maria Loreto; Chiarelli, Laurent R.; Mori, Giorgia; Kim, Jaeseung; Contreras-Dominguez, Monica; Park, Young-Sam; Han, Sung-Jun; Brodin, Priscille; Valentini, Giovanna; Rizzi, Menico; Riccardi, Giovanna; Pasca, Maria Rosalia</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e26675</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Tuberculosis is still a leading cause of death worldwide.  The selection and spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem.  Recently, two different classes of chem. series, the benzothiazinones (BTZ) and the dinitrobenzamide (DNB) derivs. were found to be highly active against M. tuberculosis, including XDR-TB strains.  The target of BTZs is DprE1 protein which works in concert with DprE2 to form the heteromeric decaprenylphosphoryl-β-D-ribose 2'-epimerase, involved in Decaprenyl-Phospho-Arabinose (DPA) biosynthesis.  Interestingly, it was shown that the DNBs block the same pathway thus suggesting that both drugs could share the same target.  Moreover, in Mycobacterium smegmatis the overexpression of the NfnB nitroreductase led to the inactivation of the BTZs by redn. of a crit. nitro-group to an amino-group.  In this work several spontaneous M. smegmatis mutants resistant to DNBs were isolated.  Sixteen mutants, showing high levels of DNB resistance, exhibited a mutation in the Cys394 of DprE1.  Using fluorescence titrn. and mass spectrometry it was possible to monitor the binding between DprE1 and DNBs, achieving direct evidence that MSMEG_6382 is the cellular target of DNBs in mycobacteria.  Addnl., M. smegmatis mutants having low levels of resistance to DNBs harbor various mutations in MSMEG_6503 gene encoding the transcriptional repressor of the nitroreductase NfnB.  By LC/MS2 anal. it was demonstrated that NfnB is responsible for DNB inactivation.  Taken together, the authors' data demonstrate that both DNB and BTZ drugs share common resistance mechanisms in M. smegmatis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZRVZgf36h3rVg90H21EOLACvtfcHk0ljds1wxvxM_0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2lu7zL&md5=a33b887616575e8c97b7ad701bdeb4fc</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0026675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0026675%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJesus%2BLopes%2BRibeiro%26aufirst%3DA.%2BL.%26aulast%3DDegiacomi%26aufirst%3DG.%26aulast%3DEwann%26aufirst%3DF.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DIncandela%26aufirst%3DM.%2BL.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DMori%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DContreras-Dominguez%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DY.-S.%26aulast%3DHan%26aufirst%3DS.%2BJ.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DValentini%26aufirst%3DG.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26atitle%3DAnalogous%2520mechanisms%2520of%2520resistance%2520to%2520benzothiazinones%2520and%2520dinitrobenzamides%2520in%2520Mycobacterium%2520smegmatis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De26675%26doi%3D10.1371%2Fjournal.pone.0026675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit100a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stover, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrener, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanDevanter, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arain, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langhorne, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiswirth, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, W. R.</span></span> <span> </span><span class="NLM_article-title">A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>405</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1038/35016103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1038%2F35016103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10879539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Wksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=962-966&author=C.+K.+Stoverauthor=P.+Warrenerauthor=D.+R.+VanDevanterauthor=D.+R.+Shermanauthor=T.+M.+Arainauthor=M.+H.+Langhorneauthor=S.+W.+Andersonauthor=J.+A.+Towellauthor=Y.+Yuanauthor=D.+N.+McMurrayauthor=B.+N.+Kreiswirthauthor=C.+E.+Barryauthor=W.+R.+Baker&title=A+small-molecule+nitroimidazopyran+drug+candidate+for+the+treatment+of+tuberculosis&doi=10.1038%2F35016103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100aR"><div class="casContent"><span class="casTitleNuber">100a</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis</span></div><div class="casAuthors">Stover, C. Kendall; Warrener, Paul; VanDevanter, Donald R.; Sherman, David R.; Arain, Taraq M.; Langhorne, Michael H.; Anderson, Scott W.; Towell, J. Andrew; Yuan, Ying; McMurray, David N.; Krelswirth, Barry N.; Barry, Clifton E.; Baker, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">6789</span>),
    <span class="NLM_cas:pages">962-966</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis, which causes tuberculosis, is the greatest single infectious cause of mortality worldwide, killing roughly; two million people annually.  Ests. indicate that one-third of the world population is infected with latent M. tuberculosis.  The synergy between tuberculosis and the AIDS epidemic, and the surge of multidrug-resistant clin. isolates of M. tuberculosis have reaffirmed tuberculosis as a primary public health threat.  However, new antitubercular drugs with new mechanisms of action have not been developed in over thirty years.  Here we report a series of compds. contg. a nitroimidazopyran nucleus that possess antitubercular activity.  After activation by a mechanism dependent on M. tuberculosis F420 cofactor, nitroimidazopyrans inhibited the synthesis of protein and cell wall lipid.  In contrast to current antitubercular drugs, nitroimidazopyrans exhibited bactericidal activity against both replicating and static M. tuberculosis.  Lead compd. PA-824 showed potent bactericidal activity against multidrug-resistant M. tuberculosis and promising oral activity in animal infection models.  We conclude that nitroimidazopyrans offer the practical qualities of a small mol. with the potential for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw41eD4TtVwbVg90H21EOLACvtfcHk0lgdRSSzX80t2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Wksb0%253D&md5=f5f6e2935928da72e328bddd4995515f</span></div><a href="/servlet/linkout?suffix=cit100a&amp;dbid=16384&amp;doi=10.1038%2F35016103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35016103%26sid%3Dliteratum%253Aachs%26aulast%3DStover%26aufirst%3DC.%2BK.%26aulast%3DWarrener%26aufirst%3DP.%26aulast%3DVanDevanter%26aufirst%3DD.%2BR.%26aulast%3DSherman%26aufirst%3DD.%2BR.%26aulast%3DArain%26aufirst%3DT.%2BM.%26aulast%3DLanghorne%26aufirst%3DM.%2BH.%26aulast%3DAnderson%26aufirst%3DS.%2BW.%26aulast%3DTowell%26aufirst%3DJ.%2BA.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DMcMurray%26aufirst%3DD.%2BN.%26aulast%3DKreiswirth%26aufirst%3DB.%2BN.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBaker%26aufirst%3DW.%2BR.%26atitle%3DA%2520small-molecule%2520nitroimidazopyran%2520drug%2520candidate%2520for%2520the%2520treatment%2520of%2520tuberculosis%26jtitle%3DNature%26date%3D2000%26volume%3D405%26spage%3D962%26epage%3D966%26doi%3D10.1038%2F35016103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit100b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida Da
Silva, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, J. C.</span></span> <span> </span><span class="NLM_article-title">Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1417</span>– <span class="NLM_lpage">1430</span>, <span class="refDoi"> DOI: 10.1093/jac/dkr173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1093%2Fjac%2Fdkr173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=21558086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFWksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2011&pages=1417-1430&author=P.+E.+Almeida+Da%0ASilvaauthor=J.+C.+Palomino&title=Molecular+basis+and+mechanisms+of+drug+resistance+in+Mycobacterium+tuberculosis%3A+classical+and+new+drugs&doi=10.1093%2Fjac%2Fdkr173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100bR"><div class="casContent"><span class="casTitleNuber">100b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs</span></div><div class="casAuthors">Almeida Da Silva, Pedro Eduardo; Palomino, Juan Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1417-1430</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Tuberculosis (TB) remains one of the leading public health problems worldwide.  Declared as a global emergency in 1993 by the WHO, its control is hampered by the emergence of multidrug resistance (MDR), defined as resistance to at least rifampicin and isoniazid, two key drugs in the treatment of the disease.  More recently, severe forms of drug resistance such as extensively drug-resistant (XDR) TB have been described.  After the discovery of several drugs with anti-TB activity, multidrug therapy became fundamental for control of the disease.  Major advances in mol. biol. and the availability of new information generated after sequencing the genome of Mycobacterium tuberculosis increased our knowledge of the mechanisms of resistance to the main anti-TB drugs.  Better knowledge of the mechanisms of drug resistance in TB and the mol. mechanisms involved will help us to improve current techniques for rapid detection and will also stimulate the exploration of new targets for drug activity and drug development.  This article presents an updated review of the mechanisms and mol. basis of drug resistance in M. tuberculosis.  It also comments on the several gaps in our current knowledge of the mol. mechanisms of drug resistance to the main classical and new anti-TB drugs and briefly discusses some implications of the development of drug resistance and fitness, transmission and pathogenicity of M. tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnautFX8QYVLVg90H21EOLACvtfcHk0lgdRSSzX80t2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFWksL8%253D&md5=5d2d6af9192d73ecc1621ab94d910cfa</span></div><a href="/servlet/linkout?suffix=cit100b&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkr173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkr173%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%2BDa%2BSilva%26aufirst%3DP.%2BE.%26aulast%3DPalomino%26aufirst%3DJ.%2BC.%26atitle%3DMolecular%2520basis%2520and%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520Mycobacterium%2520tuberculosis%253A%2520classical%2520and%2520new%2520drugs%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2011%26volume%3D66%26spage%3D1417%26epage%3D1430%26doi%3D10.1093%2Fjac%2Fdkr173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of hypoxia-activated prodrugs of SN-38</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2017.03.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=28350997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltlKktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2017&pages=135-141&author=C.+Jinauthor=Q.+Zhangauthor=W.+Lu&title=Synthesis+and+biological+evaluation+of+hypoxia-activated+prodrugs+of+SN-38&doi=10.1016%2Fj.ejmech.2017.03.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of hypoxia-activated prodrugs of SN-38</span></div><div class="casAuthors">Jin, Chen; Zhang, Qiumeng; Lu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135-141</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We designed new hypoxia-activated prodrugs by conjugating (1-methyl-2-nitro-1H-imidazol-5-yl)methanol with 7-ethyl-10-hydroxy camptothecin (SN-38).  Initially, we improved the method of multi-gram scale synthesis of (1-methyl-2-nitro-1H-imidazol-5-yl)methanol, which increased the yield to 42% compared to 8% by the original synthesis method.  The improved method was used to synthesize evofosfamide (TH-302) and hypoxia-activated prodrugs of SN-38.  Two different linkages between (1-methyl-2-nitro-1H-imidazol-5-yl)methanol and SN-38 were evaluated that afforded different hypoxia-selectivity and toxicity.  Compd. 16 (I, IOS), contg. an ether linkage, was considered to be a promising hypoxia-selective antitumor agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP68ManJrK2LVg90H21EOLACvtfcHk0ljkNfIk2AyhNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltlKktLo%253D&md5=2cd96bd09d80396db5b50e70fa023652</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.040%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DW.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520hypoxia-activated%2520prodrugs%2520of%2520SN-38%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D132%26spage%3D135%26epage%3D141%26doi%3D10.1016%2Fj.ejmech.2017.03.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melton, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, P. J.</span></span> <span> </span><span class="NLM_article-title">Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4179</span>– <span class="NLM_lpage">4186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10945627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFOkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=4179-4186&author=R.+J.+Knoxauthor=T.+C.+Jenkinsauthor=S.+M.+Hobbsauthor=S.+Chenauthor=R.+G.+Meltonauthor=P.+J.+Burke&title=Bioactivation+of+5-%28aziridin-1-yl%29-2%2C4-dinitrobenzamide+%28CB+1954%29+by+human+NAD%28P%29H+quinone+oxidoreductase+2%3A+a+novel+co-substrate-mediated+antitumor+prodrug+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy</span></div><div class="casAuthors">Knox, Richard J.; Jenkins, Terence C.; Hobbs, Stephen M.; Chen, Shiuan; Melton, Roger G.; Burke, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4179-4186</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A novel prodrug activation system, endogenous in human tumor cells, is described.  A latent enzyme-prodrug system is switched on by a simple synthetic, small mol. co-substrate.  This ternary system is inactive if any one of the components is absent.  CB 1954 [5-(aziridin-1-yl)-2,4-dinitrobenzamide] is an antitumor prodrug that is activated in certain rat tumors via its 4-hydroxylamine deriv. to a potent bifunctional alkylating agent.  However, human tumor cells are resistant to CB 1954 because they are unable to catalyze this bioactivation efficiently.  A human enzyme has been discovered that can activate CB 1954, and it has been shown to be commonly present in human tumor cells.  The enzyme is NQO2 [NAD(P)H quinone oxidoreductase 2], but its activity is normally latent, and a nonbiogenic co-substrate such as NRH [nicotinamide riboside (reduced)] is required for enzymic activity.  There is a very large (100-3000-fold) increase in CB 1954 cytotoxicity toward either NQO2-transfected rodent or nontransfected human tumor cell lines in the presence of NRH.  Other reduced pyridinium compds. can also act as co-substrates for NQO2.  Thus, the simplest quaternary salt of nicotinamide, 1-methyl-3-carboxyamidopyridinium iodide, was a co-substrate for NQO2 when reduced to the corresponding 1,4-dihydropyridine deriv.  Increased chain length and/or alkyl load at the 1-position of the dihydropyridine ring improved specific activity, and compds. more active than NRH were found.  However, little activity was seen with either the 1-benzyl or 1-(2-phenylethyl) derivs.  A neg. charged substituent at the 3-position of the reduced pyridine ring also negated the ability of these compds. to act as cosubstrates for NQO2.  In particular, 1-carbamoylmethyl-3-carbamoyl-1,4-dihydropyridine was shown to be a co-substrate for NQO2 with greater stability than NRH, with the ability to enter cells and potentiate the cytotoxicity of CB 1954.  Furthermore, this agent is synthetically accessible and suitable for further pharmaceutical development.  NQO2 activity appears to be related to expression of NQO1 (DT-diaphorase), an enzyme that is known to have a favorable distribution toward certain human cancers.  NQO2 is a novel target for prodrug therapy and has a unique activation mechanism that relies on a synthetic co-substrate to activate an apparently latent enzyme.  Our findings may reopen the use of CB 1954 for the direct therapy of human malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhX9EnyQ-gzLVg90H21EOLACvtfcHk0ljkNfIk2AyhNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFOkt7c%253D&md5=517e0177ac1945cb75b156145e0aad59</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DJenkins%26aufirst%3DT.%2BC.%26aulast%3DHobbs%26aufirst%3DS.%2BM.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMelton%26aufirst%3DR.%2BG.%26aulast%3DBurke%26aufirst%3DP.%2BJ.%26atitle%3DBioactivation%2520of%25205-%2528aziridin-1-yl%2529-2%252C4-dinitrobenzamide%2520%2528CB%25201954%2529%2520by%2520human%2520NAD%2528P%2529H%2520quinone%2520oxidoreductase%25202%253A%2520a%2520novel%2520co-substrate-mediated%2520antitumor%2520prodrug%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D4179%26epage%3D4186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mautner, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, P F.</span></span> <span> </span><span class="NLM_article-title">The nitroreductase/CB1954 enzyme-prodrug system</span>. <i>Methods Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1385/1-59259-429-8:459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1385%2F1-59259-429-8%3A459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=14657579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlKn" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=459-477&author=N.+K.+Greenauthor=D.+J.+Kerrauthor=V.+Mautnerauthor=P.+A.+Harrisauthor=P+F.+Searle&title=The+nitroreductase%2FCB1954+enzyme-prodrug+system&doi=10.1385%2F1-59259-429-8%3A459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">The nitroreductase/CB1954 enzyme-prodrug system</span></div><div class="casAuthors">Green, Nicola K.; Kerr, David J.; Mautner, Vivien; Harris, Peter A.; Searle, Peter F.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">Suicide Gene Therapy</span>),
    <span class="NLM_cas:pages">459-477</span>CODEN:
                <span class="NLM_cas:coden">MMMEFN</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">The construction and anal. of the retroviral and adenoviral vectors encoding nitroreductase (Ntr) are described along with their application in exptl. tumor models.  A summary of the clin. trial protocol that was designed to offer proof that the adenovirus can infect and lead to Ntr expression in colorectal cancer metastases is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDQeSqZbmev7Vg90H21EOLACvtfcHk0ljkNfIk2AyhNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlKn&md5=d17b48f0762b5c7926b5b96834d2554a</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1385%2F1-59259-429-8%3A459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1-59259-429-8%253A459%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DN.%2BK.%26aulast%3DKerr%26aufirst%3DD.%2BJ.%26aulast%3DMautner%26aufirst%3DV.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DSearle%26aufirst%3DP%2BF.%26atitle%3DThe%2520nitroreductase%252FCB1954%2520enzyme-prodrug%2520system%26jtitle%3DMethods%2520Mol.%2520Med.%26date%3D2004%26volume%3D90%26spage%3D459%26epage%3D477%26doi%3D10.1385%2F1-59259-429-8%3A459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit104a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhupathi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahluwalia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, C. P.</span></span> <span> </span><span class="NLM_article-title">Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">422</span>, <span class="refDoi"> DOI: 10.1186/s12885-015-1387-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1186%2Fs12885-015-1387-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=25994202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BC2MfmtVCgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=422&author=F.+Mengauthor=D.+Bhupathiauthor=J.+D.+Sunauthor=Q.+Liuauthor=D.+Ahluwaliaauthor=Y.+Wangauthor=M.+D.+Matteucciauthor=C.+P.+Hart&title=Enhancement+of+hypoxia-activated+prodrug+TH-302+anti-tumor+activity+by+Chk1+inhibition&doi=10.1186%2Fs12885-015-1387-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104aR"><div class="casContent"><span class="casTitleNuber">104a</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition</span></div><div class="casAuthors">Meng Fanying; Bhupathi Deepthi; Sun Jessica D; Liu Qian; Ahluwalia Dharmendra; Wang Yan; Matteucci Mark D; Hart Charles P</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">422</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The hypoxia-activated prodrug TH-302 is reduced at its nitroimidazole group and selectively under hypoxic conditions releases the DNA cross-linker bromo-isophosphoramide mustard (Br-IPM).  Here, we have explored the effect of Chk1 inhibition on TH-302-mediated pharmacological activities.  METHODS:  We employed in vitro cell viability, DNA damage, cellular signaling assays and the in vivo HT29 human tumor xenograft model to study the effect of Chk1inhibition on TH-302 antitumor activities.  RESULTS:  TH-302 cytotoxicity is greatly enhanced by Chk1 inhibition in p53-deficient but not in p53-proficient human cancer cell lines.  Chk1 inhibitors reduced TH-302-induced cell cycle arrest via blocking TH-302-induced decrease of phosphorylation of histone H3 and increasing Cdc2-Y15 phosphorylation.  Employing the single-cell gel electrophoresis (comet) assay, we observed a potentiation of the TH-302 dependent tail moment.  TH-302 induced γH2AX and apoptosis were also increased upon the addition of Chk1 inhibitor.  Potentiation of TH-302 cytotoxicity by Chk1 inhibitor was only observed in cell lines proficient in, but not deficient in homology-directed DNA repair.  We also show that combination treatment led to lowering of Rad51 expression levels as compared to either agent alone.  In vivo data demonstrate that Chk1 inhibitor enhances TH-302 anti-tumor activity in p53 mutant HT-29 human tumor xenografts, supporting the hypothesis that these in vitro results can translate to enhanced in vivo efficacy of the combination.  CONCLUSIONS:  TH-302-mediated in vitro and in vivo anti-tumor activities were greatly enhanced by the addition of Chk1 inhibitors.  The preclinical data presented in this study support a new approach for the treatment of p53-deficient hypoxic cancers by combining Chk1 inhibitors with the hypoxia-activated prodrug TH-302.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT30BF8QReeFGHOrQ6qeX-mfW6udTcc2eZQ3VUT5f4sGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfmtVCgtw%253D%253D&md5=454c21c1a27e22b745fe572f2eb24328</span></div><a href="/servlet/linkout?suffix=cit104a&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1387-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1387-6%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DBhupathi%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DAhluwalia%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMatteucci%26aufirst%3DM.%2BD.%26aulast%3DHart%26aufirst%3DC.%2BP.%26atitle%3DEnhancement%2520of%2520hypoxia-activated%2520prodrug%2520TH-302%2520anti-tumor%2520activity%2520by%2520Chk1%2520inhibition%26jtitle%3DBMC%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D422%26doi%3D10.1186%2Fs12885-015-1387-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit104b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtkowiak, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornnell, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillies, R.</span></span> <span> </span><span class="NLM_article-title">MR imaging biomarkers to monitor early response to hypoxia-activated prodrug TH-302 in pancreatic cancer xenografts</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_fpage">e0155289</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0155289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1371%2Fjournal.pone.0155289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSqsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=e0155289&author=X.+Zhangauthor=J.+W.+Wojtkowiakauthor=G.+V.+Martinezauthor=H.+H.+Cornnellauthor=C.+P.+Hartauthor=A.+F.+Bakerauthor=R.+Gillies&title=MR+imaging+biomarkers+to+monitor+early+response+to+hypoxia-activated+prodrug+TH-302+in+pancreatic+cancer+xenografts&doi=10.1371%2Fjournal.pone.0155289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104bR"><div class="casContent"><span class="casTitleNuber">104b</span><div class="casTitle"><span class="NLM_cas:atitle">MR imaging biomarkers to monitor early response to hypoxia-activated prodrug TH-302 in pancreatic cancer xenografts</span></div><div class="casAuthors">Zhang, Xiaomeng; Wojtkowiak, Jonathan W.; Martinez, Gary V.; Cornnell, Heather H.; Hart, Charles P.; Baker, Amanda F.; Gillies, Robert</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0155289/1-e0155289/13</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">TH-302 is a hypoxia-activated prodrug known to activate selectively under the hypoxic conditions commonly found in solid tumors.  It is currently being evaluated in clin. trials, including two trials in Pancreatic Ductal Adenocarcinomas (PDAC).  The current study was undertaken to evaluate imaging biomarkers for prediction and response monitoring of TH- 302 efficacy in xenograft models of PDAC.  Dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) were used to monitor acute effects on tumor vasculature and cellularity, resp.  Three human PDAC xenografts with known differential responses to TH-302 were imaged prior to, and at 24 h and 48 h following a single dose of TH-302 or vehicle to det. if imaging changes presaged changes in tumor vols.  DW-MRI was performed at five b-values to generate apparent diffusion coeff. of water (ADC) maps.  For DCE-MRI, a std. clin. available contrast reagent, Gd-DTPA, was used to det. blood flow into the tumor region of interest.  TH- 302 induced a dramatic decrease in the DCE transfer const. (Ktrans) within 48 h after treatment in the sensitive tumors, Hs766t and Mia PaCa-2, whereas TH-302 had no effect on the perfusion behavior of resistant SU.86.86 tumors.  Tumor cellularity, estd. from ADC, was significantly increased 24 and 48 h after treatment in Hs766t, but was not obsd. in the Mia PaCa-2 and SU.86.86 groups.  Notably, growth inhibition of Hs766t was obsd. immediately (day 3) following initiation of treatment, but was not obsd. in Mia- PaCa-2 tumors until 8 days after initiation of treatment.  Based on these preclin. findings, DCE-MRI measures of vascular perfusion dynamics and ADC measures of cell d. are suggested as potential TH-302 response biomarkers in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_VedTlVOkp7Vg90H21EOLACvtfcHk0ljTs5gjg0Oq-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSqsLvK&md5=c1e97f64bfe02d9fe2127274ba06614b</span></div><a href="/servlet/linkout?suffix=cit104b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0155289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0155289%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWojtkowiak%26aufirst%3DJ.%2BW.%26aulast%3DMartinez%26aufirst%3DG.%2BV.%26aulast%3DCornnell%26aufirst%3DH.%2BH.%26aulast%3DHart%26aufirst%3DC.%2BP.%26aulast%3DBaker%26aufirst%3DA.%2BF.%26aulast%3DGillies%26aufirst%3DR.%26atitle%3DMR%2520imaging%2520biomarkers%2520to%2520monitor%2520early%2520response%2520to%2520hypoxia-activated%2520prodrug%2520TH-302%2520in%2520pancreatic%2520cancer%2520xenografts%26jtitle%3DPLoS%2520One%26date%3D2016%26spage%3De0155289%26doi%3D10.1371%2Fjournal.pone.0155289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Damen, E. W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevalainen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den Bergh, T. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, F. M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheeren, H. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel paclitaxel prodrugs designed for bioreductive activation in hypoxic tumour tissue</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(01)00235-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2FS0968-0896%2801%2900235-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=11738608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BD3MnptV2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=71-77&author=E.+W.+P.+Damenauthor=T.+J.+Nevalainenauthor=T.+J.+M.+Van+den+Berghauthor=F.+M.+H.+de+Grootauthor=H.+W.+Scheeren&title=Synthesis+of+novel+paclitaxel+prodrugs+designed+for+bioreductive+activation+in+hypoxic+tumour+tissue&doi=10.1016%2FS0968-0896%2801%2900235-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel paclitaxel prodrugs designed for bioreductive activation in hypoxic tumour tissue</span></div><div class="casAuthors">Damen Eric W P; Nevalainen Tapio J; van den Bergh Toine J M; de Groot Franciscus M H; Scheeren Hans W</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-7</span>
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    </div><div class="casAbstract">The syntheses and preliminary evaluation of the first potential bioreductive paclitaxel prodrugs are described.  These prodrugs were designed as potential candidates in more selective chemotherapy by targeting hypoxic tumour tissue.  Aromatic nitro and azide groups were used as the bioreductive trigger.  Generation of paclitaxel occurs after reduction and subsequent 1,6-elimination or 1,8-elimination.  All prodrugs are stable in buffer and indeed give paclitaxel after chemical reduction of the aromatic nitro or azide functionality.  In aerobic cytotoxicity assays several prodrugs exhibit diminished cytotoxicity.  These compounds are interesting candidates for further biological evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIlJcC9FrU-IqdXsLcGTEUfW6udTcc2eYV7v0encXP2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnptV2qsg%253D%253D&md5=e5ff3489b047b92ac28a59cd1eb09a83</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2801%2900235-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252801%252900235-8%26sid%3Dliteratum%253Aachs%26aulast%3DDamen%26aufirst%3DE.%2BW.%2BP.%26aulast%3DNevalainen%26aufirst%3DT.%2BJ.%26aulast%3DVan%2Bden%2BBergh%26aufirst%3DT.%2BJ.%2BM.%26aulast%3Dde%2BGroot%26aufirst%3DF.%2BM.%2BH.%26aulast%3DScheeren%26aufirst%3DH.%2BW.%26atitle%3DSynthesis%2520of%2520novel%2520paclitaxel%2520prodrugs%2520designed%2520for%2520bioreductive%2520activation%2520in%2520hypoxic%2520tumour%2520tissue%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D71%26epage%3D77%26doi%3D10.1016%2FS0968-0896%2801%2900235-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tercel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwell, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botting, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruijn, F. B.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-activated prodrugs: substituent effects on the properties of nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (nitroCBI) prodrugs of DNA minor groove alkylating agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7258</span>– <span class="NLM_lpage">7272</span>, <span class="refDoi"> DOI: 10.1021/jm901202b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901202b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7258-7272&author=M.+Tercelauthor=G.+J.+Atwellauthor=S.+Yangauthor=R.+J.+Stevensonauthor=K.+J.+Bottingauthor=M.+Boydauthor=E.+Smithauthor=R.+F.+Andersonauthor=W.+A.+Dennyauthor=W.+R.+Wilsonauthor=F.+B.+Pruijn&title=Hypoxia-activated+prodrugs%3A+substituent+effects+on+the+properties+of+nitro+seco-1%2C2%2C9%2C9a-tetrahydrocyclopropa%5Bc%5Dbenz%5Be%5Dindol-4-one+%28nitroCBI%29+prodrugs+of+DNA+minor+groove+alkylating+agents&doi=10.1021%2Fjm901202b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm901202b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901202b%26sid%3Dliteratum%253Aachs%26aulast%3DTercel%26aufirst%3DM.%26aulast%3DAtwell%26aufirst%3DG.%2BJ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DStevenson%26aufirst%3DR.%2BJ.%26aulast%3DBotting%26aufirst%3DK.%2BJ.%26aulast%3DBoyd%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DPruijn%26aufirst%3DF.%2BB.%26atitle%3DHypoxia-activated%2520prodrugs%253A%2520substituent%2520effects%2520on%2520the%2520properties%2520of%2520nitro%2520seco-1%252C2%252C9%252C9a-tetrahydrocyclopropa%255Bc%255Dbenz%255Be%255Dindol-4-one%2520%2528nitroCBI%2529%2520prodrugs%2520of%2520DNA%2520minor%2520groove%2520alkylating%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7258%26epage%3D7272%26doi%3D10.1021%2Fjm901202b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vass, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for <i>E. coli</i> nitroreductase activation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4333</span>– <span class="NLM_lpage">4343</span>, <span class="refDoi"> DOI: 10.1021/jm051246n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051246n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4333-4343&author=Y.+Jiangauthor=J.+Hanauthor=C.+Yuauthor=S.+O.+Vassauthor=P.+F.+Searleauthor=P.+Browneauthor=R.+J.+Knoxauthor=L.+Hu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+cyclic+and+acyclic+nitrobenzylphosphoramide+mustards+for+E.+coli+nitroreductase+activation&doi=10.1021%2Fjm051246n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm051246n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051246n%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DVass%26aufirst%3DS.%2BO.%26aulast%3DSearle%26aufirst%3DP.%2BF.%26aulast%3DBrowne%26aufirst%3DP.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DHu%26aufirst%3DL.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520cyclic%2520and%2520acyclic%2520nitrobenzylphosphoramide%2520mustards%2520for%2520E.%2520coli%2520nitroreductase%2520activation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4333%26epage%3D4343%26doi%3D10.1021%2Fjm051246n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cazares-Korner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayer, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olcina, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E. M.</span></span> <span> </span><span class="NLM_article-title">CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1451</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.1021/cb4001537</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4001537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1451-1459&author=C.+Cazares-Kornerauthor=I.+M.+Piresauthor=I.+D.+Swallowauthor=S.+C.+Grayerauthor=L.+J.+O%E2%80%99Connorauthor=M.+M.+Olcinaauthor=M.+Christliebauthor=S.+J.+L.+Conwayauthor=E.+M.+Hammond&title=CH-01+is+a+hypoxia-activated+prodrug+that+sensitizes+cells+to+hypoxia%2Freoxygenation+through+inhibition+of+Chk1+and+Aurora+A&doi=10.1021%2Fcb4001537"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fcb4001537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4001537%26sid%3Dliteratum%253Aachs%26aulast%3DCazares-Korner%26aufirst%3DC.%26aulast%3DPires%26aufirst%3DI.%2BM.%26aulast%3DSwallow%26aufirst%3DI.%2BD.%26aulast%3DGrayer%26aufirst%3DS.%2BC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DL.%2BJ.%26aulast%3DOlcina%26aufirst%3DM.%2BM.%26aulast%3DChristlieb%26aufirst%3DM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%2BL.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26atitle%3DCH-01%2520is%2520a%2520hypoxia-activated%2520prodrug%2520that%2520sensitizes%2520cells%2520to%2520hypoxia%252Freoxygenation%2520through%2520inhibition%2520of%2520Chk1%2520and%2520Aurora%2520A%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1451%26epage%3D1459%26doi%3D10.1021%2Fcb4001537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penketh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, E. S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartorelli, A. C.</span></span> <span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4 nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): a cytotoxic prodrug with two stable conformations differing in biologicaland physical properties</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2011.01193.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1111%2Fj.1747-0285.2011.01193.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=21777394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2hsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2011&pages=513-526&author=P.+G.+Penkethauthor=R.+P.+Baumannauthor=K.+Shyamauthor=H.+S.+Williamsonauthor=K.+Ishiguroauthor=R.+Zhuauthor=E.+S.+E.+Erikssonauthor=L.+A.+Erikssonauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2-%5B%5B1-%284+nitrophenyl%29ethoxy%5Dcarbonyl%5Dhydrazine+%28KS119%29%3A+a+cytotoxic+prodrug+with+two+stable+conformations+differing+in+biologicaland+physical+properties&doi=10.1111%2Fj.1747-0285.2011.01193.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): a cytotoxic prodrug with two stable conformations differing in biological and physical properties</span></div><div class="casAuthors">Penketh, Philip G.; Baumann, Raymond P.; Shyam, Krishnamurthy; Williamson, Hugh S.; Ishiguro, Kimiko; Zhu, Rui; Eriksson, Emma S. E.; Eriksson, Leif A.; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-526</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The anticancer prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively releases a short-lived cytotoxin following enzymic redn. in hypoxic environments found in solid tumors.  KS119, in addn. to two enantiomers, has two stable atropisomers (conformers differing in structure owing to hindered bond rotation) that interconvert at 37 °C in aq. soln. by first-order kinetics with t1/2 values of ∼50 and ∼64 h.  The atropisomers differ in phys. properties such as partition coeffs. that allow their chromatog. sepn. on non-chiral columns.  A striking difference in the rate of metab. of the two atropisomers occurs in intact EMT6 murine mammary carcinoma cells under oxygen-deficient conditions.  A structurally related mol., 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(3-hydroxy-4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119WOH), was also found to exist in similar stable atropisomers.  The ratio of the atropisomers of KS119 and structurally related agents has the potential to impact the bioavailability, activation, and therapeutic activity.  Thus, thermally stable atropisomers/conformers in small mols. can result in chem. and enantiomerically pure compds. having differences in biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc5a2kVFjL_rVg90H21EOLACvtfcHk0lhfwJRP8VMrjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2hsbrJ&md5=ccef646a2636361981991352191fd988</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01193.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01193.x%26sid%3Dliteratum%253Aachs%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DWilliamson%26aufirst%3DH.%2BS.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DEriksson%26aufirst%3DE.%2BS.%2BE.%26aulast%3DEriksson%26aufirst%3DL.%2BA.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2-%255B%255B1-%25284%2520nitrophenyl%2529ethoxy%255Dcarbonyl%255Dhydrazine%2520%2528KS119%2529%253A%2520a%2520cytotoxic%2520prodrug%2520with%2520two%2520stable%2520conformations%2520differing%2520in%2520biologicaland%2520physical%2520properties%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D78%26spage%3D513%26epage%3D526%26doi%3D10.1111%2Fj.1747-0285.2011.01193.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seow, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penketh, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockwell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartorelli, A. C.</span></span> <span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): A novel agent with preferential cytotoxicity to hypoxic cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">9282</span>– <span class="NLM_lpage">9287</span>, <span class="refDoi"> DOI: 10.1073/pnas.0409013102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1073%2Fpnas.0409013102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=9282-9287&issue=26&author=A.+H.+Seowauthor=P.+G.+Penkethauthor=K.+Shyamauthor=S.+Rockwellauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2-%5B%5B1-%284-nitrophenyl%29ethoxy%5Dcarbonyl%5Dhydrazine+%28KS119%29%3A+A+novel+agent+with+preferential+cytotoxicity+to+hypoxic+cells&doi=10.1073%2Fpnas.0409013102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0409013102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0409013102%26sid%3Dliteratum%253Aachs%26aulast%3DSeow%26aufirst%3DA.%2BH.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DRockwell%26aufirst%3DS.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2-%255B%255B1-%25284-nitrophenyl%2529ethoxy%255Dcarbonyl%255Dhydrazine%2520%2528KS119%2529%253A%2520A%2520novel%2520agent%2520with%2520preferential%2520cytotoxicity%2520to%2520hypoxic%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26issue%3D26%26spage%3D9282%26epage%3D9287%26doi%3D10.1073%2Fpnas.0409013102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazares-Körner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, M. R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">794</span>, <span class="refDoi"> DOI: 10.1038/nprot.2016.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1038%2Fnprot.2016.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27010756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVKlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=781-794&author=L.+J.+O%E2%80%99Connorauthor=C.+Cazares-K%C3%B6rnerauthor=J.+Sahaauthor=C.+N.+Evansauthor=M.+R.+L.+Stratfordauthor=E.+M.+Hammondauthor=S.+J.+Conway&title=Design%2C+synthesis+and+evaluation+of+molecularly+targeted+hypoxia-activated+prodrugs&doi=10.1038%2Fnprot.2016.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs</span></div><div class="casAuthors">O'Connor, Liam J.; Cazares-Korner, Cindy; Saha, Jaideep; Evans, Charles N. G.; Stratford, Michael R. L.; Hammond, Ester M.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">781-794</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Regions of insufficient oxygen supply-hypoxia-occur in diverse contexts across biol. in both healthy and diseased organisms.  The difference in the chem. environment between a hypoxic biol. system and one with normal oxygen levels provides an opportunity for targeting compd. delivery to hypoxic regions by using bioreductive prodrugs.  Here we detail a protocol for the efficient synthesis of (1-methyl-2-nitro-1H-imidazol-5-yl)methanol, which is a key intermediate that can be converted into a range of 1-methyl-2-nitro-1H-imidazole-based precursors of bioreductive prodrugs.  We outline methods for attaching the bioreductive group to a range of functionalities, and we discuss the strategy for positioning of the group on the biol. active parent compd.  We have used two parent checkpoint kinase 1 (Chk1) inhibitors to exemplify the protocol.  The PROCEDURE also describes a suite of redn. assays, of increasing biol. relevance, to validate the bioreductive prodrug.  These assays are applied to an exemplar compd., CH-01, which is a bioreductive Chk1 inhibitor.  This protocol has broad applications to the development of hypoxia-targeted compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLVzieErJLfbVg90H21EOLACvtfcHk0ljXuf7wZ8IEbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVKlurg%253D&md5=12947657c27045fa89a1dc54f8cb9ef3</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2016.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2016.034%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DL.%2BJ.%26aulast%3DCazares-K%25C3%25B6rner%26aufirst%3DC.%26aulast%3DSaha%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DC.%2BN.%26aulast%3DStratford%26aufirst%3DM.%2BR.%2BL.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520molecularly%2520targeted%2520hypoxia-activated%2520prodrugs%26jtitle%3DNat.%2520Protoc.%26date%3D2016%26volume%3D11%26spage%3D781%26epage%3D794%26doi%3D10.1038%2Fnprot.2016.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, M. R.</span></span> <span> </span><span class="NLM_article-title">NLCQ-1 and NLCQ-2, two new agents with activity against dormant Mycobacterium tuberculosis</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1016/j.ijantimicag.2007.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ijantimicag.2007.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=17379483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=724-727&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=M.+R.+McNeil&title=NLCQ-1+and+NLCQ-2%2C+two+new+agents+with+activity+against+dormant+Mycobacterium+tuberculosis&doi=10.1016%2Fj.ijantimicag.2007.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">NLCQ-1 and NLCQ-2, two new agents with activity against dormant Mycobacterium tuberculosis</span></div><div class="casAuthors">Papadopoulou, Maria V.; Bloomer, William D.; McNeil, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">724-727</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">4-[3-(2-Nitro-1-imidazolyl)-propylamino]-7-chloroquinoline hydrochloride (NLCQ-1; NSC 709257) and 4-[4-(2-nitro-1-imidazolyl)-butylamino]-7-chloroquinoline hydrochloride (NLCQ-2), two weak DNA-intercalating nitroimidazole-based bioreductive prodrugs, have been tested against dormant Mycobacterium tuberculosis and demonstrated a significant activity comparable with that of the nitroimidazopyran PA-824.  Min. bactericidal concns. (MBCs) of 3.1 - 18.4 and 4.9 - 9.8 μg/mL were obtained for NLCQ-1 and NLCQ-2, resp.  In the same test setting; the corresponding MBC range for PA-824 was 6.4-12.8 μg/mL.  For rifampicin, isoniazid, minocycline, streptomycin, clarithromycin and capreomycin, the corresponding MBC values were 2.5, >100, >156.25, >12.5, >312.5 and 37.5 μg/mL, resp.  Toxicity against Vero cells provided 50% inhibitory concns. (IC50) of 146.7, >640 and >640 μg/mL for NLCQ-1, NLCQ-2 and PA-824, resp.  Therefore, the selectivity index (SI) was 8 - 47.3, >65.3 - 130.6 and >50 - 100 for NLCQ-1, NLCQ-2 and PA-824, resp.  These results suggest the potential usefulness of these compds. in the therapy of the latent form of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg14JaGLXDaLVg90H21EOLACvtfcHk0ljXuf7wZ8IEbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1ans78%253D&md5=d99f8ae590d82da3a05b548e7b9fb2e7</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2007.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2007.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DMcNeil%26aufirst%3DM.%2BR.%26atitle%3DNLCQ-1%2520and%2520NLCQ-2%252C%2520two%2520new%2520agents%2520with%2520activity%2520against%2520dormant%2520Mycobacterium%2520tuberculosis%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2007%26volume%3D29%26spage%3D724%26epage%3D727%26doi%3D10.1016%2Fj.ijantimicag.2007.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cran, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minchinton, A. I.</span></span> <span> </span><span class="NLM_article-title">Selective radiosensitization of hypoxic cells using BCCA621C: a novel hypoxia activated prodrug targeting DNA-dependent protein kinase</span>. <i>Tumor Microenviron. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.2478/tumor-2013-0003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.2478%2Ftumor-2013-0003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=46-55&author=K.+E.+Lindquistauthor=J.+D.+Cranauthor=K.+Kordicauthor=P.+C.+Chuaauthor=G.+C.+Wintersauthor=J.+S.+Tanauthor=J.+Lozadaauthor=A.+H.+Kyleauthor=J.+W.+Evansauthor=A.+I.+Minchinton&title=Selective+radiosensitization+of+hypoxic+cells+using+BCCA621C%3A+a+novel+hypoxia+activated+prodrug+targeting+DNA-dependent+protein+kinase&doi=10.2478%2Ftumor-2013-0003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.2478%2Ftumor-2013-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Ftumor-2013-0003%26sid%3Dliteratum%253Aachs%26aulast%3DLindquist%26aufirst%3DK.%2BE.%26aulast%3DCran%26aufirst%3DJ.%2BD.%26aulast%3DKordic%26aufirst%3DK.%26aulast%3DChua%26aufirst%3DP.%2BC.%26aulast%3DWinters%26aufirst%3DG.%2BC.%26aulast%3DTan%26aufirst%3DJ.%2BS.%26aulast%3DLozada%26aufirst%3DJ.%26aulast%3DKyle%26aufirst%3DA.%2BH.%26aulast%3DEvans%26aufirst%3DJ.%2BW.%26aulast%3DMinchinton%26aufirst%3DA.%2BI.%26atitle%3DSelective%2520radiosensitization%2520of%2520hypoxic%2520cells%2520using%2520BCCA621C%253A%2520a%2520novel%2520hypoxia%2520activated%2520prodrug%2520targeting%2520DNA-dependent%2520protein%2520kinase%26jtitle%3DTumor%2520Microenviron.%2520Ther.%26date%3D2013%26volume%3D1%26spage%3D46%26epage%3D55%26doi%3D10.2478%2Ftumor-2013-0003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guise, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span> <span> </span><span class="NLM_article-title">FSL-61 is a 6-nitroquinolone fluorogenic probe for one-electron reductases in hypoxic cells</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>452</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1042/BJ20121695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1042%2FBJ20121695" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2013&pages=79-86&author=J.+Suauthor=C.+P.+Guiseauthor=W.+R.+Wilson&title=FSL-61+is+a+6-nitroquinolone+fluorogenic+probe+for+one-electron+reductases+in+hypoxic+cells&doi=10.1042%2FBJ20121695"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1042%2FBJ20121695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20121695%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DGuise%26aufirst%3DC.%2BP.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26atitle%3DFSL-61%2520is%2520a%25206-nitroquinolone%2520fluorogenic%2520probe%2520for%2520one-electron%2520reductases%2520in%2520hypoxic%2520cells%26jtitle%3DBiochem.%2520J.%26date%3D2013%26volume%3D452%26spage%3D79%26epage%3D86%26doi%3D10.1042%2FBJ20121695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tercel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youte
Tendoung, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liyanage, H. D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruijn, F. B.</span></span> <span> </span><span class="NLM_article-title">Influence of a basic side chain on the properties of hypoxia-selective nitro analogues of the duocarmycins: demonstration of substantial anticancer activity in combination with irradiation or chemotherapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5834</span>– <span class="NLM_lpage">5856</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00563</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00563" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCgs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5834-5856&author=M.+Tercelauthor=H.+H.+Leeauthor=S.+Y.+Mehtaauthor=J.+J.+Youte%0ATendoungauthor=S.+Y.+Baiauthor=H.+D.+S.+Liyanageauthor=F.+B.+Pruijn&title=Influence+of+a+basic+side+chain+on+the+properties+of+hypoxia-selective+nitro+analogues+of+the+duocarmycins%3A+demonstration+of+substantial+anticancer+activity+in+combination+with+irradiation+or+chemotherapy&doi=10.1021%2Facs.jmedchem.7b00563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of a Basic Side Chain on the Properties of Hypoxia-Selective Nitro Analogues of the Duocarmycins: Demonstration of Substantial Anticancer Activity in Combination with Irradiation or Chemotherapy</span></div><div class="casAuthors">Tercel, Moana; Lee, Ho H.; Mehta, Sunali Y.; Youte Tendoung, Jean-Jacques; Bai, Sally Y.; Liyanage, H. D. Sarath; Pruijn, Frederik B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5834-5856</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of nitro analogs of the duocarmycins was prepd. and evaluated for hypoxia-selective anticancer activity.  The compds. incorporate 13 different amine-contg. side chains designed to bind in the minor groove of DNA while spanning a wide range of base strength from pKa 9.64 to 5.24.  The most favorable in vitro properties were assocd. with strongly basic side chains, but the greatest in vivo antitumor activity was found for compds. contg. a weakly basic morpholine.  This applies to single-agent activity and for activity in combination with irradn. or chemotherapy (gemcitabine or docetaxel).  In combination with a single dose of γ irradn. I at 42 μmol/kg eliminated detectable clonogens in some SiHa cervical carcinoma xenografts, and in combination with gemcitabine using a well-tolerated multidose schedule, the same compd. caused regression of all treated A2780 ovarian tumor xenografts.  In the latter expt., three of seven animals receiving the combination treatment were completely tumor free at day 100.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI57WrxYeMHrVg90H21EOLACvtfcHk0lhntmvBbeifUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCgs7fI&md5=645bd3b84acc9c13ba63128caeccd257</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00563%26sid%3Dliteratum%253Aachs%26aulast%3DTercel%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DH.%2BH.%26aulast%3DMehta%26aufirst%3DS.%2BY.%26aulast%3DYoute%2BTendoung%26aufirst%3DJ.%2BJ.%26aulast%3DBai%26aufirst%3DS.%2BY.%26aulast%3DLiyanage%26aufirst%3DH.%2BD.%2BS.%26aulast%3DPruijn%26aufirst%3DF.%2BB.%26atitle%3DInfluence%2520of%2520a%2520basic%2520side%2520chain%2520on%2520the%2520properties%2520of%2520hypoxia-selective%2520nitro%2520analogues%2520of%2520the%2520duocarmycins%253A%2520demonstration%2520of%2520substantial%2520anticancer%2520activity%2520in%2520combination%2520with%2520irradiation%2520or%2520chemotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5834%26epage%3D5856%26doi%3D10.1021%2Facs.jmedchem.7b00563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaizerman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorente, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banica, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammons, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matteucci, M.</span></span> <span> </span><span class="NLM_article-title">Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2412</span>– <span class="NLM_lpage">2420</span>, <span class="refDoi"> DOI: 10.1021/jm701028q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701028q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2412-2420&author=J.+X.+Duanauthor=H.+Jiaoauthor=J.+Kaizermanauthor=T.+Stantonauthor=J.+W.+Evansauthor=L.+Lanauthor=G.+Lorenteauthor=M.+Banicaauthor=D.+Jungauthor=J.+Wangauthor=H.+Maauthor=X.+Liauthor=Z.+Yangauthor=R.+M.+Hoffmanauthor=W.+S.+Ammonsauthor=C.+P.+Hartauthor=M.+Matteucci&title=Potent+and+highly+selective+hypoxia-activated+achiral+phosphoramidate+mustards+as+anticancer+drugs&doi=10.1021%2Fjm701028q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm701028q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701028q%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DJ.%2BX.%26aulast%3DJiao%26aufirst%3DH.%26aulast%3DKaizerman%26aufirst%3DJ.%26aulast%3DStanton%26aufirst%3DT.%26aulast%3DEvans%26aufirst%3DJ.%2BW.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLorente%26aufirst%3DG.%26aulast%3DBanica%26aufirst%3DM.%26aulast%3DJung%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DHoffman%26aufirst%3DR.%2BM.%26aulast%3DAmmons%26aufirst%3DW.%2BS.%26aulast%3DHart%26aufirst%3DC.%2BP.%26aulast%3DMatteucci%26aufirst%3DM.%26atitle%3DPotent%2520and%2520highly%2520selective%2520hypoxia-activated%2520achiral%2520phosphoramidate%2520mustards%2520as%2520anticancer%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2412%26epage%3D2420%26doi%3D10.1021%2Fjm701028q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naimi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalili, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiebe, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaus, E. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 3′- and 5′-nitrooxy pyrimidine nucleoside nitrate esters: “nitric oxide donor” agents for evaluation as anticancer and antiviral agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1021/jm020299r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020299r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=995-1004&author=E.+Naimiauthor=A.+Zhouauthor=P.+Khaliliauthor=L.+I.+Wiebeauthor=J.+Balzariniauthor=E.+De+Clercqauthor=E.+E.+Knaus&title=Synthesis+of+3%E2%80%B2-+and+5%E2%80%B2-nitrooxy+pyrimidine+nucleoside+nitrate+esters%3A+%E2%80%9Cnitric+oxide+donor%E2%80%9D+agents+for+evaluation+as+anticancer+and+antiviral+agents&doi=10.1021%2Fjm020299r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fjm020299r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020299r%26sid%3Dliteratum%253Aachs%26aulast%3DNaimi%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DKhalili%26aufirst%3DP.%26aulast%3DWiebe%26aufirst%3DL.%2BI.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DKnaus%26aufirst%3DE.%2BE.%26atitle%3DSynthesis%2520of%25203%25E2%2580%25B2-%2520and%25205%25E2%2580%25B2-nitrooxy%2520pyrimidine%2520nucleoside%2520nitrate%2520esters%253A%2520%25E2%2580%259Cnitric%2520oxide%2520donor%25E2%2580%259D%2520agents%2520for%2520evaluation%2520as%2520anticancer%2520and%2520antiviral%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D995%26epage%3D1004%26doi%3D10.1021%2Fjm020299r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colón, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zayas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alegría, A. E.</span></span> <span> </span><span class="NLM_article-title">Role of the nitro functionality in the DNA binding of 3-nitro-10-methylbenzothiazolo[3,2-<i>a</i>]quinolinium chloride</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1706</span>– <span class="NLM_lpage">1715</span>, <span class="refDoi"> DOI: 10.1021/tx800076c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx800076c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1706-1715&author=I.+G.+Col%C3%B3nauthor=F.+A.+Gonz%C3%A1lezauthor=M.+Corderoauthor=B.+Zayasauthor=C.+Velezauthor=O.+Coxauthor=A.+Kumarauthor=A.+E.+Alegr%C3%ADa&title=Role+of+the+nitro+functionality+in+the+DNA+binding+of+3-nitro-10-methylbenzothiazolo%5B3%2C2-a%5Dquinolinium+chloride&doi=10.1021%2Ftx800076c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Ftx800076c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800076c%26sid%3Dliteratum%253Aachs%26aulast%3DCol%25C3%25B3n%26aufirst%3DI.%2BG.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DF.%2BA.%26aulast%3DCordero%26aufirst%3DM.%26aulast%3DZayas%26aufirst%3DB.%26aulast%3DVelez%26aufirst%3DC.%26aulast%3DCox%26aufirst%3DO.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DAlegr%25C3%25ADa%26aufirst%3DA.%2BE.%26atitle%3DRole%2520of%2520the%2520nitro%2520functionality%2520in%2520the%2520DNA%2520binding%2520of%25203-nitro-10-methylbenzothiazolo%255B3%252C2-a%255Dquinolinium%2520chloride%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1706%26epage%3D1715%26doi%3D10.1021%2Ftx800076c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karwa, A.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poreddy, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmelash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorshow, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopalan, R.</span></span> <span> </span><span class="NLM_article-title">Type 1 phototherapeutic agents, part i: preparation and cancer cell viability studies of novel photolabile sulfenamides</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">833</span>, <span class="refDoi"> DOI: 10.1021/ml2001483</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml2001483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=828-833&author=A.%0AS.+Karwaauthor=A.+R.+Poreddyauthor=B.+Asmelashauthor=T.+S.+Linauthor=R.+B.+Dorshowauthor=R.+Rajagopalan&title=Type+1+phototherapeutic+agents%2C+part+i%3A+preparation+and+cancer+cell+viability+studies+of+novel+photolabile+sulfenamides&doi=10.1021%2Fml2001483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fml2001483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2001483%26sid%3Dliteratum%253Aachs%26aulast%3DKarwa%26aufirst%3DA.%2BS.%26aulast%3DPoreddy%26aufirst%3DA.%2BR.%26aulast%3DAsmelash%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DT.%2BS.%26aulast%3DDorshow%26aufirst%3DR.%2BB.%26aulast%3DRajagopalan%26aufirst%3DR.%26atitle%3DType%25201%2520phototherapeutic%2520agents%252C%2520part%2520i%253A%2520preparation%2520and%2520cancer%2520cell%2520viability%2520studies%2520of%2520novel%2520photolabile%2520sulfenamides%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D828%26epage%3D833%26doi%3D10.1021%2Fml2001483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shustov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khlebnikov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheeseman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiebe, L. I.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6033</span>– <span class="NLM_lpage">6046</span>, <span class="refDoi"> DOI: 10.1021/jm2017336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2017336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38Xoslantbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6033-6046&author=P.+Kumarauthor=G.+Shustovauthor=H.+Liangauthor=V.+Khlebnikovauthor=W.+Zhengauthor=X.+H.+Yangauthor=C.+Cheesemanauthor=L.+I.+Wiebe&title=Design%2C+synthesis%2C+and+preliminary+biological+evaluation+of+6-O-glucose-azomycin+adducts+for+diagnosis+and+therapy+of+hypoxic+tumors&doi=10.1021%2Fjm2017336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Preliminary Biological Evaluation of 6-O-Glucose-Azomycin Adducts for Diagnosis and Therapy of Hypoxic Tumors</span></div><div class="casAuthors">Kumar, Piyush; Shustov, Gennady; Liang, Hong; Khlebnikov, Vladimir; Zheng, Weizhong; Yang, Xiao-Hong; Cheeseman, Chris; Wiebe, Leonard I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6033-6046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several 2-nitroimidazole-based mols. (NIs), e.g. I, are used as clin. hypoxic tumor radiodiagnostics, but they are not effective as radiosensitizers/radiochemotherapeutics.  These NIs permeate tumor cells non-selectively via diffusion, and in therapy, where high doses are required, their dose limiting toxicities preclude success.  The synthesis and preliminary in vitro evaluations of three glucoazomycins, members of a novel class of C6-O-glucose-linked-azomycin conjugates that are putative substrates of glucose transport proteins (GLUTs) and possess hypoxia-selective radiosensitization features, are now reported.  The hypoxia-dependent up-regulation of several GLUTs provides a rational basis to develop these glucoazomycins because more selective uptake in hypoxic cells would decrease systemic toxicities at EDs.  Calcd. partition coeffs. (ClogP, -1.70 to -2.99) predict rapid in vivo clearance for low systemic toxicity.  In vitro exptl. data show that glucoazomycins are radiosensitizers and that they competitively inhibit glucose uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0b8QbY1joMbVg90H21EOLACvtfcHk0ljMoHa3EstVow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xoslantbs%253D&md5=15fc3d15f417c8720b02c9bb0ea83e56</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Fjm2017336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2017336%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DShustov%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DKhlebnikov%26aufirst%3DV.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DX.%2BH.%26aulast%3DCheeseman%26aufirst%3DC.%26aulast%3DWiebe%26aufirst%3DL.%2BI.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520preliminary%2520biological%2520evaluation%2520of%25206-O-glucose-azomycin%2520adducts%2520for%2520diagnosis%2520and%2520therapy%2520of%2520hypoxic%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6033%26epage%3D6046%26doi%3D10.1021%2Fjm2017336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruijn, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, M. P.</span></span> <span> </span><span class="NLM_article-title">Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2123</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.02.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2014.02.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2123-2132&author=M.+Bonnetauthor=C.+R.+Hongauthor=Y.+Guauthor=R.+F.+Andersonauthor=W.+R.+Wilsonauthor=F.+B.+Pruijnauthor=J.+Wangauthor=K.+O.+Hicksauthor=M.+P.+Hay&title=Novel+nitroimidazole+alkylsulfonamides+as+hypoxic+cell+radiosensitisers&doi=10.1016%2Fj.bmc.2014.02.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.02.039%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DC.%2BR.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DPruijn%26aufirst%3DF.%2BB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHicks%26aufirst%3DK.%2BO.%26aulast%3DHay%26aufirst%3DM.%2BP.%26atitle%3DNovel%2520nitroimidazole%2520alkylsulfonamides%2520as%2520hypoxic%2520cell%2520radiosensitisers%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2123%26epage%3D2132%26doi%3D10.1016%2Fj.bmc.2014.02.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of 6-(nitroimidazole-1H-alkyloxyl)-4-anilinoquinazolines as efficient EGFR inhibitors exerting cytotoxic effects both under normoxia and hypoxia</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">826</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2014.11.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=826-834&author=W.+Chengauthor=S.+Zhuauthor=X.+Maauthor=N.+Qiuauthor=P.+Pengauthor=R.+Shengauthor=Y.+Hu&title=Design%2C+synthesis+and+biological+evaluation+of+6-%28nitroimidazole-1H-alkyloxyl%29-4-anilinoquinazolines+as+efficient+EGFR+inhibitors+exerting+cytotoxic+effects+both+under+normoxia+and+hypoxia&doi=10.1016%2Fj.ejmech.2014.11.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DN.%26aulast%3DPeng%26aufirst%3DP.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%25206-%2528nitroimidazole-1H-alkyloxyl%2529-4-anilinoquinazolines%2520as%2520efficient%2520EGFR%2520inhibitors%2520exerting%2520cytotoxic%2520effects%2520both%2520under%2520normoxia%2520and%2520hypoxia%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D826%26epage%3D834%26doi%3D10.1016%2Fj.ejmech.2014.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atwell, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruijn, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the <i>Escherichia coli nfsB</i> nitroreductase in gene therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1197</span>– <span class="NLM_lpage">1212</span>, <span class="refDoi"> DOI: 10.1021/jm061062o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061062o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1197-1212&author=G.+J.+Atwellauthor=S.+Yangauthor=F.+B.+Pruijnauthor=S.+M.+Pullenauthor=A.+Hoggauthor=A.+V.+Pattersonauthor=W.+R.+Wilsonauthor=W.+A.+Denny&title=Synthesis+and+structure-activity+relationships+for+2%2C4-dinitrobenzamide-5-mustards+as+prodrugs+for+the+Escherichia+coli+nfsB+nitroreductase+in+gene+therapy&doi=10.1021%2Fjm061062o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm061062o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061062o%26sid%3Dliteratum%253Aachs%26aulast%3DAtwell%26aufirst%3DG.%2BJ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DPruijn%26aufirst%3DF.%2BB.%26aulast%3DPullen%26aufirst%3DS.%2BM.%26aulast%3DHogg%26aufirst%3DA.%26aulast%3DPatterson%26aufirst%3DA.%2BV.%26aulast%3DWilson%26aufirst%3DW.%2BR.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520for%25202%252C4-dinitrobenzamide-5-mustards%2520as%2520prodrugs%2520for%2520the%2520Escherichia%2520coli%2520nfsB%2520nitroreductase%2520in%2520gene%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1197%26epage%3D1212%26doi%3D10.1021%2Fjm061062o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayeh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheuermann, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longgood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Key, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frantz, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambar, U. K.</span></span> <span> </span><span class="NLM_article-title">Development of inhibitors of the PAS-B domain of the HIF-2α transcription factor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1747</span>, <span class="refDoi"> DOI: 10.1021/jm301847z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301847z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1739-1747&author=J.+L.+Rogersauthor=L.+Bayehauthor=T.+H.+Scheuermannauthor=J.+Longgoodauthor=J.+Keyauthor=J.+Naidooauthor=L.+Melitoauthor=C.+Shokriauthor=D.+E.+Frantzauthor=R.+K.+Bruickauthor=K.+H.+Gardnerauthor=J.+B.+MacMillanauthor=U.+K.+Tambar&title=Development+of+inhibitors+of+the+PAS-B+domain+of+the+HIF-2%CE%B1+transcription+factor&doi=10.1021%2Fjm301847z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Inhibitors of the PAS-B Domain of the HIF-2α Transcription Factor</span></div><div class="casAuthors">Rogers, Jamie L.; Bayeh, Liela; Scheuermann, Thomas H.; Longgood, Jamie; Key, Jason; Naidoo, Jacinth; Melito, Lisa; Shokri, Cameron; Frantz, Doug E.; Bruick, Richard K.; Gardner, Kevin H.; MacMillan, John B.; Tambar, Uttam K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1739-1747</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia inducible factors (HIFs) are heterodimeric transcription factors induced in a variety of pathophysiol. settings, including cancer.  The first detailed structure-activity relationship study of small mols. designed to inhibit HIF-2α-ARNT heterodimerization by binding an internal cavity of the HIF-2α PAS-B domain is described herein.  A series of benzoxadiazole derivs. was synthesized and evaluated for their inhibitory activity.  Through a series of biophys. characterizations of inhibitor-protein interactions [NMR and X-ray crystallog. for compds. I (R = H or Cl)], the structural requirements for artificial inhibitors of the HIF-2α-ARNT PAS-B interaction have been established.  These results may serve as a foundation for discovering therapeutic agents that function by a novel mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUwOF6FlDBrLVg90H21EOLACvtfcHk0lh6mz0dw5F7Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjsrs%253D&md5=03a967dcc64865633544f0973c806edc</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjm301847z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301847z%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DJ.%2BL.%26aulast%3DBayeh%26aufirst%3DL.%26aulast%3DScheuermann%26aufirst%3DT.%2BH.%26aulast%3DLonggood%26aufirst%3DJ.%26aulast%3DKey%26aufirst%3DJ.%26aulast%3DNaidoo%26aufirst%3DJ.%26aulast%3DMelito%26aufirst%3DL.%26aulast%3DShokri%26aufirst%3DC.%26aulast%3DFrantz%26aufirst%3DD.%2BE.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26aulast%3DMacMillan%26aufirst%3DJ.%2BB.%26aulast%3DTambar%26aufirst%3DU.%2BK.%26atitle%3DDevelopment%2520of%2520inhibitors%2520of%2520the%2520PAS-B%2520domain%2520of%2520the%2520HIF-2%25CE%25B1%2520transcription%2520factor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1739%26epage%3D1747%26doi%3D10.1021%2Fjm301847z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogné, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masereel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scozzafava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors: Bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3230</span>– <span class="NLM_lpage">3237</span>, <span class="refDoi"> DOI: 10.1021/jm800121c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800121c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3230-3237&author=K.+D%E2%80%99Ambrosioauthor=R.+M.+Vitaleauthor=J.+M.+Dogn%C3%A9author=B.+Masereelauthor=A.+Innocentiauthor=A.+Scozzafavaauthor=G.+De+Simoneauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors%3A+Bioreductive+nitro-containing+sulfonamides+with+selectivity+for+targeting+the+tumor+associated+isoforms+IX+and+XII&doi=10.1021%2Fjm800121c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm800121c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800121c%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DVitale%26aufirst%3DR.%2BM.%26aulast%3DDogn%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DInnocenti%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors%253A%2520Bioreductive%2520nitro-containing%2520sulfonamides%2520with%2520selectivity%2520for%2520targeting%2520the%2520tumor%2520associated%2520isoforms%2520IX%2520and%2520XII%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3230%26epage%3D3237%26doi%3D10.1021%2Fjm800121c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gbaj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luke, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryce, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, S.</span></span> <span> </span><span class="NLM_article-title">Aminoimidazolylmethyluracil analogues as potent inhibitors of thymidine phosphorylase and their bioreductive nitroimidazolyl prodrugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1021/jm049494r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049494r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=392-402&author=P.+Reiganauthor=P.+N.+Edwardsauthor=A.+Gbajauthor=C.+Coleauthor=S.+T.+Barryauthor=K.+M.+Pageauthor=S.+E.+Ashtonauthor=R.+W.+Lukeauthor=K.+T.+Douglasauthor=I.+J.+Stratfordauthor=M.+Jaffarauthor=R.+A.+Bryceauthor=S.+Freeman&title=Aminoimidazolylmethyluracil+analogues+as+potent+inhibitors+of+thymidine+phosphorylase+and+their+bioreductive+nitroimidazolyl+prodrugs&doi=10.1021%2Fjm049494r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm049494r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049494r%26sid%3Dliteratum%253Aachs%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DEdwards%26aufirst%3DP.%2BN.%26aulast%3DGbaj%26aufirst%3DA.%26aulast%3DCole%26aufirst%3DC.%26aulast%3DBarry%26aufirst%3DS.%2BT.%26aulast%3DPage%26aufirst%3DK.%2BM.%26aulast%3DAshton%26aufirst%3DS.%2BE.%26aulast%3DLuke%26aufirst%3DR.%2BW.%26aulast%3DDouglas%26aufirst%3DK.%2BT.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DJaffar%26aufirst%3DM.%26aulast%3DBryce%26aufirst%3DR.%2BA.%26aulast%3DFreeman%26aufirst%3DS.%26atitle%3DAminoimidazolylmethyluracil%2520analogues%2520as%2520potent%2520inhibitors%2520of%2520thymidine%2520phosphorylase%2520and%2520their%2520bioreductive%2520nitroimidazolyl%2520prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D392%26epage%3D402%26doi%3D10.1021%2Fjm049494r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of vandetanib derivatives containing nitroimidazole groups as tyrosine kinase inhibitors in normoxia and hypoxia</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">E1693</span>, <span class="refDoi"> DOI: 10.3390/molecules21121693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.3390%2Fmolecules21121693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=27983649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlyqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=E1693&author=H.+Weiauthor=D.+Liauthor=X.+Yangauthor=H.+Shangauthor=S.+Fanauthor=Y.+Liauthor=D.+Song&title=Design+and+synthesis+of+vandetanib+derivatives+containing+nitroimidazole+groups+as+tyrosine+kinase+inhibitors+in+normoxia+and+hypoxia&doi=10.3390%2Fmolecules21121693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of vandetanib derivatives containing nitroimidazole groups as tyrosine kinase inhibitors in normoxia and hypoxia</span></div><div class="casAuthors">Wei, Huiqiang; Li, Deguan; Yang, Xiangbo; Shang, Haihua; Fan, Saijun; Li, Yiliang; Song, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1693/1-1693/15</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Sixteen novel epidermal growth factor receptor (EGFR)/vascular endothelial growth factor (VEGF)-2 inhibitors (nitroimidazole-substituted 4-anilinoquinazoline derivs.) I (R1 = H, CH3, NO2; R2 = H, NO2; X1 = H, F, Cl; X2 = H, F, Br, Cl; X3 = H, Br, F, Me, Cl; n = 1, 2, 3) were designed and prepd. via the introduction of a nitroimidazole group in the piperidine side chain and modification on the aniline moiety of vandetanib.  Preliminary biol. tests showed that comparing with vandetanib, some target compds. exhibited excellent EGFR inhibitory activities and anti-proliferative over A549/H446 cells in hypoxia.  Meanwhile, several of the above compds. demonstrated better bioactivity than vandetanib in VEGF gene expression inhibition.  Owing to the excellent IC50 value (1.64 μmol/L), the inhibition ratios of compd. I (R1 = H; R2 = NO2; X1 = F; X2 = H; X3 = Br; n = 1) over A549 and H446 cells were 62.01% and 59.86% at the concn. of 0.5 μM in hypoxia, resp.  All of these results indicated that compd. I (R1 = H; R2 = NO2; X1 = F; X2 = H; X3 = Br; n = 1) was a potential cancer therapeutic agent in hypoxia and was worthy of further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqObmsFvFJ3brVg90H21EOLACvtfcHk0lglW19sE52aiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlyqu78%253D&md5=7368e8eea0a47483aad51f539e758ca3</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21121693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21121693%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShang%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520vandetanib%2520derivatives%2520containing%2520nitroimidazole%2520groups%2520as%2520tyrosine%2520kinase%2520inhibitors%2520in%2520normoxia%2520and%2520hypoxia%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3DE1693%26doi%3D10.3390%2Fmolecules21121693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dzierzbicka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kołodziejczyk, A.
M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antitumor activity of conjugates of muramyldipeptide or normuramyldipeptide with hydroxyacridine/acridone derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1021/jm020991m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020991m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=183-189&author=K.+Dzierzbickaauthor=A.%0AM.+Ko%C5%82odziejczyk&title=Synthesis+and+antitumor+activity+of+conjugates+of+muramyldipeptide+or+normuramyldipeptide+with+hydroxyacridine%2Facridone+derivatives&doi=10.1021%2Fjm020991m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm020991m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020991m%26sid%3Dliteratum%253Aachs%26aulast%3DDzierzbicka%26aufirst%3DK.%26aulast%3DKo%25C5%2582odziejczyk%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520and%2520antitumor%2520activity%2520of%2520conjugates%2520of%2520muramyldipeptide%2520or%2520normuramyldipeptide%2520with%2520hydroxyacridine%252Facridone%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D183%26epage%3D189%26doi%3D10.1021%2Fjm020991m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cholody, W.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosakowska-Cholody, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hariprakasha, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michejda, C. J.</span></span> <span> </span><span class="NLM_article-title">A new synthetic agent with potent but selective cytotoxic activity against cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">4474</span>– <span class="NLM_lpage">4481</span>, <span class="refDoi"> DOI: 10.1021/jm048946x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm048946x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4474-4481&author=W.%0AM.+Cholodyauthor=T.+Kosakowska-Cholodyauthor=M.+G.+Hollingsheadauthor=H.+K.+Hariprakashaauthor=C.+J.+Michejda&title=A+new+synthetic+agent+with+potent+but+selective+cytotoxic+activity+against+cancer&doi=10.1021%2Fjm048946x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm048946x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm048946x%26sid%3Dliteratum%253Aachs%26aulast%3DCholody%26aufirst%3DW.%2BM.%26aulast%3DKosakowska-Cholody%26aufirst%3DT.%26aulast%3DHollingshead%26aufirst%3DM.%2BG.%26aulast%3DHariprakasha%26aufirst%3DH.%2BK.%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26atitle%3DA%2520new%2520synthetic%2520agent%2520with%2520potent%2520but%2520selective%2520cytotoxic%2520activity%2520against%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4474%26epage%3D4481%26doi%3D10.1021%2Fjm048946x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosakowska-Cholody, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cholody, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monks, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woynarowska, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michejda, C. J.</span></span> <span> </span><span class="NLM_article-title">WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1617</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-05-0170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1158%2F1535-7163.MCT-05-0170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=16227412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWhtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=1617-1627&author=T.+Kosakowska-Cholodyauthor=W.+M.+Cholodyauthor=A.+Monksauthor=B.+A.+Woynarowskaauthor=C.+J.+Michejda&title=WMC-79%2C+a+potent+agent+against+colon+cancers%2C+induces+apoptosis+through+a+p53-dependent+pathway&doi=10.1158%2F1535-7163.MCT-05-0170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway</span></div><div class="casAuthors">Kosakowska-Cholody, Teresa; Cholody, W. Marek; Monks, Anne; Woynarowska, Barbara A.; Michejda, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1617-1627</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">WMC-79 is a synthetic agent with potent activity against colon and hematopoietic tumors.  In vitro, the agent is most potent against colon cancer cells that carry the wild-type p53 tumor suppressor gene (HCT-116 and RKO cells: GI50 < 1 nmol/L, LC50 ∼ 40 nmol/L).  Growth arrest of HCT-116 and RKO cells occurs at the G1 and G2-M check points at sublethal concns. (10 nmol/L) but the entire cell population was killed at 100 nmol/L.  WMC-79 is localized to the nucleus where it binds to DNA.  We hypothesized that WMC-79 binding to DNA is recognized as an unrepairable damage in the tumor cells, which results in p53 activation.  This triggers transcriptional up-regulation of p53-dependent genes involved in replication, cell cycle progression, growth arrest, and apoptosis as evidenced by DNA microarrays.  The change in the transcriptional profile of HCT-116 cells is followed by a change in the levels of cell cycle regulatory proteins and apoptosis.  The recruitment of the p53-dependent apoptosis pathway was suggested by the up-regulation of p53, p21, Bax, DR-4, DR-5, and p53 phosphorylated on Ser15; down-regulation of Bcl-2; and activation of caspase-8, -9, -7, and -3 in cells treated with 100 nmol/L WMC-79.  Apoptosis was also evident from the flow cytometric studies of drug-treated HCT-116 cells as well as from the appearance of nuclear fragmentation.  However, whereas this pathway is important in wild-type p53 colon tumors, other pathways are also in operation because colon cancer cell lines in which the p53 gene is mutated are also affected by higher concns. of WMC-79.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwNiXJC_mixLVg90H21EOLACvtfcHk0lhaGIAZ4ThzsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWhtLnE&md5=028cd1a31681063eed35ee1bebf45491</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0170%26sid%3Dliteratum%253Aachs%26aulast%3DKosakowska-Cholody%26aufirst%3DT.%26aulast%3DCholody%26aufirst%3DW.%2BM.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DWoynarowska%26aufirst%3DB.%2BA.%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26atitle%3DWMC-79%252C%2520a%2520potent%2520agent%2520against%2520colon%2520cancers%252C%2520induces%2520apoptosis%2520through%2520a%2520p53-dependent%2520pathway%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D1617%26epage%3D1627%26doi%3D10.1158%2F1535-7163.MCT-05-0170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hariprakasha, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosakowska-Cholody, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cholody, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinson, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarasova, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michejda, C. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of naphthalimide-imidazoacridone with potent antitumor activity leading to clinical candidate (HKH40A, RTA 502)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5557</span>– <span class="NLM_lpage">5560</span>, <span class="refDoi"> DOI: 10.1021/jm7009777</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009777" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5557-5560&author=H.+K.+Hariprakashaauthor=T.+Kosakowska-Cholodyauthor=C.+Meyerauthor=W.+M.+Cholodyauthor=S.+F.+Stinsonauthor=N.+I.+Tarasovaauthor=C.+J.+Michejda&title=Optimization+of+naphthalimide-imidazoacridone+with+potent+antitumor+activity+leading+to+clinical+candidate+%28HKH40A%2C+RTA+502%29&doi=10.1021%2Fjm7009777"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fjm7009777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009777%26sid%3Dliteratum%253Aachs%26aulast%3DHariprakasha%26aufirst%3DH.%2BK.%26aulast%3DKosakowska-Cholody%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DC.%26aulast%3DCholody%26aufirst%3DW.%2BM.%26aulast%3DStinson%26aufirst%3DS.%2BF.%26aulast%3DTarasova%26aufirst%3DN.%2BI.%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26atitle%3DOptimization%2520of%2520naphthalimide-imidazoacridone%2520with%2520potent%2520antitumor%2520activity%2520leading%2520to%2520clinical%2520candidate%2520%2528HKH40A%252C%2520RTA%2520502%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5557%26epage%3D5560%26doi%3D10.1021%2Fjm7009777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motonishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span> <span> </span><span class="NLM_article-title">Novel flavonoids with antiproliferative activities against breast cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4339</span>– <span class="NLM_lpage">4349</span>, <span class="refDoi"> DOI: 10.1021/jm101440r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101440r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1agtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4339-4349&author=N.+Yaoauthor=C.+Y.+Chenauthor=C.+Y.+Wuauthor=K.+Motonishiauthor=H.+J.+Kungauthor=K.+S.+Lam&title=Novel+flavonoids+with+antiproliferative+activities+against+breast+cancer+cells&doi=10.1021%2Fjm101440r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Novel flavonoids with antiproliferative activities against breast cancer cells</span></div><div class="casAuthors">Yao, Nianhuan; Chen, Chao-Yu; Wu, Chun-Yi; Motonishi, Kiyomi; Kung, Hsing-Jien; Lam, Kit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4339-4349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of flavone analogs were synthesized and evaluated for their antiproliferation activity against breast cancer cells.  The IC50 of compd. I and II were detd. to be at 5 μM.  These compds. were used as baits to screen breast cancer cDNA expression phage display proteome library.  DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for I and II.  Further optimization of these compds. led to the discovery of III with higher cytotoxic potency (IC50 = 1 μM) and binding to eEF1A2.  Biol. and biochem. data suggest that eEF1A2 might be a therapeutic target and that III is an excellent lead compd. for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_V-2ccXMkEbVg90H21EOLACvtfcHk0lj7DoRBIhMsQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1agtb4%253D&md5=7d674a8ab06c5decfd61270c37f47536</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fjm101440r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101440r%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DMotonishi%26aufirst%3DK.%26aulast%3DKung%26aufirst%3DH.%2BJ.%26aulast%3DLam%26aufirst%3DK.%2BS.%26atitle%3DNovel%2520flavonoids%2520with%2520antiproliferative%2520activities%2520against%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4339%26epage%3D4349%26doi%3D10.1021%2Fjm101440r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amtmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulinoux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gromer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davioud-Charvet, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7024</span>– <span class="NLM_lpage">7039</span>, <span class="refDoi"> DOI: 10.1021/jm050256l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050256l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOisbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7024-7039&author=R.+Milletauthor=S.+Urigauthor=J.+Jacobauthor=E.+Amtmannauthor=J.+P.+Moulinouxauthor=S.+Gromerauthor=K.+Beckerauthor=E.+Davioud-Charvet&title=Synthesis+of+5-nitro-2-furancarbohydrazides+and+their+cis-diamminedichloroplatinum+complexes+as+bitopic+and+irreversible+human+thioredoxin+reductase+inhibitors&doi=10.1021%2Fjm050256l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 5-Nitro-2-furancarbohydrazides and Their cis-Diamminedichloroplatinum Complexes as Bitopic and Irreversible Human Thioredoxin Reductase Inhibitors</span></div><div class="casAuthors">Millet, Regis; Urig, Sabine; Jacob, Judit; Amtmann, Eberhard; Moulinoux, Jacques-Philippe; Gromer, Stephan; Becker, Katja; Davioud-Charvet, Elisabeth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7024-7039</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The human selenoprotein thioredoxin reductase is involved in antioxidant defense and DNA synthesis.  As increased thioredoxin reductase levels are assocd. with drug sensitivity to cisplatin and drug resistance in tumor cells, this enzyme represents a promising target for the development of cytostatic agents.  To optimize the potential of the widely used cisplatin to inhibit the human thioredoxin reductase and therefore to overcome cisplatin resistance, the authors developed and synthesized four cis-diamminedichloroplatinum complexes of the lead 5-nitro-2-furancarbohydrazide (I) selected from high-throughput screening.  Detailed kinetics revealed that the isolated fragments, 5-nitro-2-furancarbohydrazide and cisplatin itself, bind with micromolar affinities at two different subsites of the human enzyme.  By tethering both fragments four nitrofuran-based cis-diamminedichloroplatinum complexes were synthesized and identified as biligand irreversible inhibitors of the human enzyme with nanomolar affinities.  Studies with mutant enzymes clearly demonstrate the penultimate selenocysteine residue as the prime target of the synthesized cis-diamminedichloroplatinum complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLrIL2NMZIu7Vg90H21EOLACvtfcHk0lj7DoRBIhMsQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOisbbJ&md5=82553e697d0fbf88be7b02a65e25b4dc</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fjm050256l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050256l%26sid%3Dliteratum%253Aachs%26aulast%3DMillet%26aufirst%3DR.%26aulast%3DUrig%26aufirst%3DS.%26aulast%3DJacob%26aufirst%3DJ.%26aulast%3DAmtmann%26aufirst%3DE.%26aulast%3DMoulinoux%26aufirst%3DJ.%2BP.%26aulast%3DGromer%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DDavioud-Charvet%26aufirst%3DE.%26atitle%3DSynthesis%2520of%25205-nitro-2-furancarbohydrazides%2520and%2520their%2520cis-diamminedichloroplatinum%2520complexes%2520as%2520bitopic%2520and%2520irreversible%2520human%2520thioredoxin%2520reductase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7024%26epage%3D7039%26doi%3D10.1021%2Fjm050256l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malachowska-Ugarte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cholewinski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierzbicka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzonkowski, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of novel mycophenolic acid conjugates containing nitro-acridine/acridone derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2012.04.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2012&pages=197-201&author=M.+Malachowska-Ugarteauthor=G.+Cholewinskiauthor=K.+Dzierzbickaauthor=P.+Trzonkowski&title=Synthesis+and+biological+activity+of+novel+mycophenolic+acid+conjugates+containing+nitro-acridine%2Facridone+derivatives&doi=10.1016%2Fj.ejmech.2012.04.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DMalachowska-Ugarte%26aufirst%3DM.%26aulast%3DCholewinski%26aufirst%3DG.%26aulast%3DDzierzbicka%26aufirst%3DK.%26aulast%3DTrzonkowski%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520novel%2520mycophenolic%2520acid%2520conjugates%2520containing%2520nitro-acridine%252Facridone%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D54%26spage%3D197%26epage%3D201%26doi%3D10.1016%2Fj.ejmech.2012.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloonan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keating, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meegan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and serotonin transporter activity of 1,3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1328</span>– <span class="NLM_lpage">1348</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.11.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2010.11.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1328-1348&author=Y.+M.+McNamaraauthor=S.+M.+Cloonanauthor=A.+J.+Knoxauthor=J.+J.+Keatingauthor=S.+G.+Butlerauthor=G.+H.+Petersauthor=M.+J.+Meeganauthor=D.+C.+Williams&title=Synthesis+and+serotonin+transporter+activity+of+1%2C3-bis%28aryl%29-2-nitro-1-propenes+as+a+new+class+of+anticancer+agents&doi=10.1016%2Fj.bmc.2010.11.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.11.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.11.054%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamara%26aufirst%3DY.%2BM.%26aulast%3DCloonan%26aufirst%3DS.%2BM.%26aulast%3DKnox%26aufirst%3DA.%2BJ.%26aulast%3DKeating%26aufirst%3DJ.%2BJ.%26aulast%3DButler%26aufirst%3DS.%2BG.%26aulast%3DPeters%26aufirst%3DG.%2BH.%26aulast%3DMeegan%26aufirst%3DM.%2BJ.%26aulast%3DWilliams%26aufirst%3DD.%2BC.%26atitle%3DSynthesis%2520and%2520serotonin%2520transporter%2520activity%2520of%25201%252C3-bis%2528aryl%2529-2-nitro-1-propenes%2520as%2520a%2520new%2520class%2520of%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1328%26epage%3D1348%26doi%3D10.1016%2Fj.bmc.2010.11.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sosič, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirković, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefane, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Development of new cathepsin b inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1021/jm301544x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301544x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=521-533&author=I.+Sosi%C4%8Dauthor=B.+Mirkovi%C4%87author=K.+Arenzauthor=B.+Stefaneauthor=J.+Kosauthor=S.+Gobec&title=Development+of+new+cathepsin+b+inhibitors%3A+combining+bioisosteric+replacements+and+structure-based+design+to+explore+the+structure-activity+relationships+of+nitroxoline+derivatives&doi=10.1021%2Fjm301544x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm301544x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301544x%26sid%3Dliteratum%253Aachs%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3DMirkovi%25C4%2587%26aufirst%3DB.%26aulast%3DArenz%26aufirst%3DK.%26aulast%3DStefane%26aufirst%3DB.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520new%2520cathepsin%2520b%2520inhibitors%253A%2520combining%2520bioisosteric%2520replacements%2520and%2520structure-based%2520design%2520to%2520explore%2520the%2520structure-activity%2520relationships%2520of%2520nitroxoline%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D521%26epage%3D533%26doi%3D10.1021%2Fjm301544x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Csuk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siewert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutnov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidelmann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendisch, V.</span></span> <span> </span><span class="NLM_article-title">β-Nitro substituted carboxylic acids and their cytotoxicity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4011</span>– <span class="NLM_lpage">4013</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2014.06.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4011-4013&author=R.+Csukauthor=L.+Hellerauthor=B.+Siewertauthor=A.+Gutnovauthor=O.+Seidelmannauthor=V.+Wendisch&title=%CE%B2-Nitro+substituted+carboxylic+acids+and+their+cytotoxicity&doi=10.1016%2Fj.bmcl.2014.06.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DCsuk%26aufirst%3DR.%26aulast%3DHeller%26aufirst%3DL.%26aulast%3DSiewert%26aufirst%3DB.%26aulast%3DGutnov%26aufirst%3DA.%26aulast%3DSeidelmann%26aufirst%3DO.%26aulast%3DWendisch%26aufirst%3DV.%26atitle%3D%25CE%25B2-Nitro%2520substituted%2520carboxylic%2520acids%2520and%2520their%2520cytotoxicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4011%26epage%3D4013%26doi%3D10.1016%2Fj.bmcl.2014.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-cheromene derivatives as histone deacetylaes inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4123</span>– <span class="NLM_lpage">4132</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2017.05.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=4123-4132&author=S.+Tanauthor=F.+Heauthor=T.+Kongauthor=J.+Wuauthor=Z.+Liu&title=Design%2C+synthesis+and+tumor+cell+growth+inhibitory+activity+of+3-nitro-2H-cheromene+derivatives+as+histone+deacetylaes+inhibitors&doi=10.1016%2Fj.bmc.2017.05.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520tumor%2520cell%2520growth%2520inhibitory%2520activity%2520of%25203-nitro-2H-cheromene%2520derivatives%2520as%2520histone%2520deacetylaes%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D4123%26epage%3D4132%26doi%3D10.1016%2Fj.bmc.2017.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makawana, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teraiya, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and molecular modeling of novel 1-indolyl acetate 5-nitroimidazole targeting tubulin polymerization as antiproliferative agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2014.07.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=341-351&author=Y.+Duanauthor=Y.+L.+Sangauthor=J.+A.+Makawanaauthor=S.+B.+Teraiyaauthor=Y.+F.+Yaoauthor=D.+J.+Tangauthor=X.+X.+Taoauthor=H.+L.+Zhu&title=Discovery+and+molecular+modeling+of+novel+1-indolyl+acetate+5-nitroimidazole+targeting+tubulin+polymerization+as+antiproliferative+agents&doi=10.1016%2Fj.ejmech.2014.07.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.082%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DSang%26aufirst%3DY.%2BL.%26aulast%3DMakawana%26aufirst%3DJ.%2BA.%26aulast%3DTeraiya%26aufirst%3DS.%2BB.%26aulast%3DYao%26aufirst%3DY.%2BF.%26aulast%3DTang%26aufirst%3DD.%2BJ.%26aulast%3DTao%26aufirst%3DX.%2BX.%26aulast%3DZhu%26aufirst%3DH.%2BL.%26atitle%3DDiscovery%2520and%2520molecular%2520modeling%2520of%2520novel%25201-indolyl%2520acetate%25205-nitroimidazole%2520targeting%2520tubulin%2520polymerization%2520as%2520antiproliferative%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D341%26epage%3D351%26doi%3D10.1016%2Fj.ejmech.2014.07.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Placzek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexheimer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Nitrated indenoisoquinolines as topoisomerase I inhibitors: A systematic study and optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4419</span>– <span class="NLM_lpage">4430</span>, <span class="refDoi"> DOI: 10.1021/jm070361q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070361q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4419-4430&author=A.+Morrellauthor=M.+Placzekauthor=S.+Parmleyauthor=S.+Antonyauthor=T.+S.+Dexheimerauthor=Y.+Pommierauthor=M.+Cushman&title=Nitrated+indenoisoquinolines+as+topoisomerase+I+inhibitors%3A+A+systematic+study+and+optimization&doi=10.1021%2Fjm070361q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fjm070361q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070361q%26sid%3Dliteratum%253Aachs%26aulast%3DMorrell%26aufirst%3DA.%26aulast%3DPlaczek%26aufirst%3DM.%26aulast%3DParmley%26aufirst%3DS.%26aulast%3DAntony%26aufirst%3DS.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DNitrated%2520indenoisoquinolines%2520as%2520topoisomerase%2520I%2520inhibitors%253A%2520A%2520systematic%2520study%2520and%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4419%26epage%3D4430%26doi%3D10.1021%2Fjm070361q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis, reduction potentials, and antitubercular activity of ring A/B analogues of the bioreductive drug (6<i>S</i>)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">645</span>, <span class="refDoi"> DOI: 10.1021/jm801087e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801087e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFais7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=637-645&author=A.+M.+Thompsonauthor=A.+Blaserauthor=R.+F.+Andersonauthor=S.+S.+Shindeauthor=S.+G.+Franzblauauthor=Z.+Maauthor=W.+A.+Dennyauthor=B.+D.+Palmer&title=Synthesis%2C+reduction+potentials%2C+and+antitubercular+activity+of+ring+A%2FB+analogues+of+the+bioreductive+drug+%286S%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm801087e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Reduction Potentials, and Antitubercular Activity of Ring A/B Analogues of the Bioreductive Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span></div><div class="casAuthors">Thompson, Andrew M.; Blaser, Adrian; Anderson, Robert F.; Shinde, Sujata S.; Franzblau, Scott G.; Ma, Zhenkun; Denny, William A.; Palmer, Brian D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">637-645</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nitroimidazooxazine I (PA-824) is a new class of bioreductive drug for tuberculosis.  A series of related bicyclic nitroheterocycles was synthesized, designed to have a wide range of one-electron redn. potentials E(1) (from -570 to -338 mV, compared with -534 mV for I).  The obsd. E(1) values closely correlated with the σm values of the heteroatom at the 4/8-position of the adjacent six-membered ring.  Although the compds. spanned a range of E(1) values around that of I, only the nitroimidazothiazines showed significant antitubercular activity (at a similar level of potency), suggesting that E(1) is not the main driver of efficacy.  Furthermore, there was a correlation between activity and the formation of imidazole ring-reduced products at the two-electron level, pointing to the potential importance of this redn. pathway, which is detd. by the nature of the substituent at the 2-position of the 4-nitroimidazole ring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoalNzH_DuAirVg90H21EOLACvtfcHk0lgz4nM6CFtaCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFais7%252FK&md5=a9fe7edce4c538f14ddec49942a1e9a0</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fjm801087e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801087e%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26aulast%3DShinde%26aufirst%3DS.%2BS.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26atitle%3DSynthesis%252C%2520reduction%2520potentials%252C%2520and%2520antitubercular%2520activity%2520of%2520ring%2520A%252FB%2520analogues%2520of%2520the%2520bioreductive%2520drug%2520%25286S%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D637%26epage%3D645%26doi%3D10.1021%2Fjm801087e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6s)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1021/jm901207n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901207n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKhs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=282-294&author=B.+D.+Palmerauthor=A.+W.+Thompsonauthor=H.+S.+Sutherlandauthor=A.+Blaserauthor=I.+Kmentovaauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Denny&title=Synthesis+and+structure-activity+studies+of+biphenyl+analogues+of+the+tuberculosis+drug+%286s%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm901207n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span></div><div class="casAuthors">Palmer, Brian D.; Thompson, Andrew M.; Sutherland, Hamish S.; Blaser, Adrian; Kmentova, Iveta; Franzblau, Scott G.; Wan, Baojie; Wang, Yuehong; Ma, Zhenkun; Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">282-294</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of biphenyl analogs of the new tuberculosis drug PA-824 e. g. , I was prepd., primarily by coupling the known (6S)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-ol with iodobenzyl halides, followed by Suzuki coupling of these iodides with appropriate arylboronic acids or by assembly of the complete biaryl side chain prior to coupling with the above alc.  Antitubercular activity was detd. under both replicating (MABA) and nonreplicating (LORA) conditions.  Para-Linked biaryls were the most active, followed by meta-linked and then ortho-linked analogs.  A more detailed study of a larger group of para-linked analogs showed a significant correlation between potency (MABA) and both lipophilicity (CLOGP) and the electron-withdrawing properties of terminal ring substituents (.sum.σ).  Selected compds. were evaluated for their efficacy in a mouse model of acute Mycobacterium tuberculosis infection.  In vivo activity correlated well with the stability of compds. to microsomal metab.  Three compds. bearing combinations of lipophilic, electron-withdrawing groups achieved >200-fold higher efficacies than the parent drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5IcLLHAUDWbVg90H21EOLACvtfcHk0ljVkF5jsbtJdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKhs7rL&md5=1ff5a8bd11f095f428898ec13f884259</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm901207n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901207n%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BW.%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520studies%2520of%2520biphenyl%2520analogues%2520of%2520the%2520tuberculosis%2520drug%2520%25286s%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D282%26epage%3D294%26doi%3D10.1021%2Fjm901207n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chains</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1021/jm901378u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901378u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=855-866&author=H.+S.+Sutherlandauthor=A.+Blaserauthor=I.+Kmentovaauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=B.+D.+Palmerauthor=W.+D.+Dennyauthor=A.+M.+Thompson&title=Synthesis+and+structure-activity+relationships+of+antitubercular+2-nitroimidazooxazines+bearing+heterocyclic+side+chains&doi=10.1021%2Fjm901378u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-activity Relationships of Antitubercular 2-Nitroimidazooxazines Bearing Heterocyclic Side Chains</span></div><div class="casAuthors">Sutherland, Hamish S.; Blaser, Adrian; Kmentova, Iveta; Franzblau, Scott G.; Wan, Baojie; Wang, Yuehong; Ma, Zhenkun; Palmer, Brian D.; Denny, William A.; Thompson, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">855-866</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previously, biphenyl analogs of the antituberculosis drug PA-824 were found to display improved potencies against M. tuberculosis but were poorly sol.  Heterobiaryl analogs of these, e.g., I (X = 2,5-thiophenediyl, R = 4-F), in which the first Ph ring was replaced with various 5-membered ring heterocycles, were prepd. with the aim of identifying potent new candidates with improved aq. soly.  The compds. were constructed by coupling the chiral 2-nitroimidazooxazine II with various halomethyl-substituted arylheterocycles, by cycloaddns. to a propargyl ether deriv. of this alc., or by Suzuki couplings on haloheterocyclic Me ether derivs.  The arylheterocyclic compds. were all more hydrophilic than their corresponding biphenyl analogs, and several showed soly. improvements.  1-Methylpyrazole, e.g., I (X = 1-methyl-3,5-pyrazolediyl, R = 4-F3C), 1,3-linked-pyrazole, e.g., I (X = 1,3-pyrazolediyl, R = 4-F), 2,4-linked-triazole, e.g., I [X = 1,2,3-triazole-2,4-diyl, R = 4-(CF3O)] and tetrazole analogs, e.g., I (X = 2,5-tetrazolediyl, R = H) had 3- to 7-fold higher MIC potencies against replicating M. tuberculosis than predicted by their lipophilicities.  Two pyrazole analogs were >10-fold more efficacious than the parent drug in a mouse model of acute M. tuberculosis infection, and one displayed a 2-fold higher soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ42rpfkuyeLVg90H21EOLACvtfcHk0ljVkF5jsbtJdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrrN&md5=f9b6518612795cc55e5f9b8ad784c8c6</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fjm901378u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901378u%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DDenny%26aufirst%3DW.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520antitubercular%25202-nitroimidazooxazines%2520bearing%2520heterocyclic%2520side%2520chains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D855%26epage%3D866%26doi%3D10.1021%2Fjm901378u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7- dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3036</span>– <span class="NLM_lpage">3059</span>, <span class="refDoi"> DOI: 10.1021/jm501608q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501608q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3036-3059&author=B.+D.+Palmerauthor=H.+S.+Sutherlandauthor=A.+Blaserauthor=I.+Kmentovaauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Dennyauthor=A.+M.+Thompson&title=Synthesis+and+structure-activity+relationships+for+extended+side+chain+analogues+of+the+antitubercular+drug+%286S%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-+dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm501608q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm501608q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501608q%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520for%2520extended%2520side%2520chain%2520analogues%2520of%2520the%2520antitubercular%2520drug%2520%25286S%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-%2520dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3036%26epage%3D3059%26doi%3D10.1021%2Fjm501608q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of varied ether linker analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo-[2,1-b][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6563</span>– <span class="NLM_lpage">6585</span>, <span class="refDoi"> DOI: 10.1021/jm200377r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200377r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6563-6585&author=A.+M.+Thompsonauthor=H.+S.+Sutherlandauthor=B.+D.+Palmerauthor=I.+Kmentovaauthor=A.+Blaserauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Denny&title=Synthesis+and+structure-activity+relationships+of+varied+ether+linker+analogues+of+the+antitubercular+drug+%286S%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-dihydro-5H-imidazo-%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm200377r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm200377r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200377r%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520varied%2520ether%2520linker%2520analogues%2520of%2520the%2520antitubercular%2520drug%2520%25286S%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-dihydro-5H-imidazo-%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6563%26epage%3D6585%26doi%3D10.1021%2Fjm200377r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2583</span>– <span class="NLM_lpage">2589</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2017.03.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=28462832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFekt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2583-2589&author=A.+M.+Thompsonauthor=A.+Blaserauthor=B.+D.+Palmerauthor=R.+F.+Andersonauthor=S.+S.+Shindeauthor=D.+Launayauthor=E.+Chatelainauthor=L.+Maesauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Denny&title=6-Nitro-2%2C3-dihydroimidazo%5B2%2C1-b%5D%5B1%2C3%5Dthiazoles%3A+Facile+synthesis+and+comparative+appraisal+against+tuberculosis+and+neglected+tropical+diseases&doi=10.1016%2Fj.bmcl.2017.03.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases</span></div><div class="casAuthors">Thompson, Andrew M.; Blaser, Adrian; Palmer, Brian D.; Anderson, Robert F.; Shinde, Sujata S.; Launay, Delphine; Chatelain, Eric; Maes, Louis; Franzblau, Scott G.; Wan, Baojie; Wang, Yuehong; Ma, Zhenkun; Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2583-2589</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As part of a quest for backups to the antitubercular drug pretomanid (PA-824), we investigated the unexplored 6-nitro-2,3-dihydroimidazo[2,1-b][1,3]-thiazoles and related -oxazoles.  The nitroimidazothiazoles were prepd. in high yield from 2-bromo-4-nitroimidazole via heating with substituted thiiranes and diisopropylethylamine.  Equivalent examples of these two structural classes provided broadly comparable MICs, with 2-Me substitution and extended aryloxymethyl side chains preferred; albeit, S-oxidized thiazoles were ineffective for tuberculosis.  Favorable microsomal stability data for a biaryl thiazole I led to its assessment in an acute Mycobacterium tuberculosis mouse model, alongside the corresponding oxazole II, but the latter proved to be more efficacious.  In vitro screening against kinetoplastid diseases revealed that nitroimidazothiazoles were inactive vs. leishmaniasis but showed interesting activity, superior to that of the nitroimidazooxazoles, against Chagas disease.  Overall, "thio-delamanid" III is regarded as the best lead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSWR54W1PX6LVg90H21EOLACvtfcHk0ljAacyq64ZXrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFekt78%253D&md5=3e747b90744e9d745cd77bd92f59b79c</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.069%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26aulast%3DShinde%26aufirst%3DS.%2BS.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3D6-Nitro-2%252C3-dihydroimidazo%255B2%252C1-b%255D%255B1%252C3%255Dthiazoles%253A%2520Facile%2520synthesis%2520and%2520comparative%2520appraisal%2520against%2520tuberculosis%2520and%2520neglected%2520tropical%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2583%26epage%3D2589%26doi%3D10.1016%2Fj.bmcl.2017.03.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Antitubercular nitroimidazoles revisited: synthesis and activity of the authentic 3-nitro isomer of pretomanid</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1280</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1275-1280&author=A.+M.+Thompsonauthor=M.+Bonnetauthor=H.+H.+Leeauthor=S.+G.+Franzblauauthor=B.+Wanauthor=G.+S.+Wongauthor=C.+B.+Cooperauthor=W.+A.+Denny&title=Antitubercular+nitroimidazoles+revisited%3A+synthesis+and+activity+of+the+authentic+3-nitro+isomer+of+pretomanid&doi=10.1021%2Facsmedchemlett.7b00356"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00356%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DBonnet%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DH.%2BH.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DG.%2BS.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DAntitubercular%2520nitroimidazoles%2520revisited%253A%2520synthesis%2520and%2520activity%2520of%2520the%2520authentic%25203-nitro%2520isomer%2520of%2520pretomanid%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1275%26epage%3D1280%26doi%3D10.1021%2Facsmedchemlett.7b00356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Structure–activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1021/jm2012276</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2012276" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=312-326&author=A.+Blaserauthor=B.+D.+Palmerauthor=H.+S.+Sutherlandauthor=I.+Kmentovaauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=A.+W.+Thompsonauthor=W.+A.+Denny&title=Structure%E2%80%93activity+relationships+for+amide-%2C+carbamate-%2C+and+urea-linked+analogues+of+the+tuberculosis+drug+%286S%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm2012276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships for Amide-, Carbamate-, And Urea-Linked Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span></div><div class="casAuthors">Blaser, Adrian; Palmer, Brian D.; Sutherland, Hamish S.; Kmentova, Iveta; Franzblau, Scott G.; Wan, Baojie; Wang, Yuehong; Ma, Zhenkun; Thompson, Andrew M.; Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">312-326</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Analogs of clin. tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824, I), in which the OCH2 linkage was replaced with amide, carbamate, and urea functionality, were investigated as an alternative approach to address oxidative metab., reduce lipophilicity, and improve aq. soly.  Several sol. monoaryl examples displayed moderately improved (∼2- to 4-fold) potencies against replicating Mycobacterium tuberculosis but were generally inferior inhibitors under anaerobic (nonreplicating) conditions.  More lipophilic biaryl derivs. mostly displayed similar or reduced potencies to these in contrast to the parent biaryl series.  The leading biaryl carbamate demonstrated exceptional metabolic stability and a 5-fold better efficacy than the parent drug in a mouse model of acute M. tuberculosis infection but was poorly sol.  Bioisosteric replacement of this biaryl moiety by arylpiperazine resulted in a sol., orally bioavailable carbamate analog providing identical activity in the acute model, comparable efficacy to OPC-67683 in a chronic infection model, favorable pharmacokinetic profiles across several species, and enhanced safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogqcEH6FbwO7Vg90H21EOLACvtfcHk0lj0lX8E9rVJeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurrE&md5=b515998cf44ca9998fc3434def6f82d4</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Fjm2012276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2012276%26sid%3Dliteratum%253Aachs%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DThompson%26aufirst%3DA.%2BW.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520for%2520amide-%252C%2520carbamate-%252C%2520and%2520urea-linked%2520analogues%2520of%2520the%2520tuberculosis%2520drug%2520%25286S%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D312%26epage%3D326%26doi%3D10.1021%2Fjm2012276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayyar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niyomrattanakit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravindran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dartois, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span> <span> </span><span class="NLM_article-title">Structure–activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((S)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3] oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-Amino PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5639</span>– <span class="NLM_lpage">5659</span>, <span class="refDoi"> DOI: 10.1021/jm1010644</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1010644" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5639-5659&author=J.+Cherianauthor=I.+Choiauthor=A.+Nayyarauthor=U.+H.+Manjunathaauthor=T.+Mukherjeeauthor=Y.+S.+Leeauthor=H.+I.+Boshoffauthor=R.+Singhauthor=Y.+H.+Haauthor=M.+Goodwinauthor=S.+B.+Lakshminarayanaauthor=P.+Niyomrattanakitauthor=J.+Jiricekauthor=S.+Ravindranauthor=T.+Dickauthor=T.+H.+Kellerauthor=V.+Dartoisauthor=C.+E.+Barry&title=Structure%E2%80%93activity+relationships+of+antitubercular+nitroimidazoles.+3.+Exploration+of+the+linker+and+lipophilic+tail+of+%28%28S%29-2-nitro-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5D+oxazin-6-yl%29-%284-trifluoromethoxybenzyl%29amine+%286-Amino+PA-824%29&doi=10.1021%2Fjm1010644"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm1010644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1010644%26sid%3Dliteratum%253Aachs%26aulast%3DCherian%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DI.%26aulast%3DNayyar%26aufirst%3DA.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DMukherjee%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DHa%26aufirst%3DY.%2BH.%26aulast%3DGoodwin%26aufirst%3DM.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DNiyomrattanakit%26aufirst%3DP.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DRavindran%26aufirst%3DS.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520antitubercular%2520nitroimidazoles.%25203.%2520Exploration%2520of%2520the%2520linker%2520and%2520lipophilic%2520tail%2520of%2520%2528%2528S%2529-2-nitro-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255D%2520oxazin-6-yl%2529-%25284-trifluoromethoxybenzyl%2529amine%2520%25286-Amino%2520PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5639%26epage%3D5659%26doi%3D10.1021%2Fjm1010644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kmentova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">8421</span>– <span class="NLM_lpage">8439</span>, <span class="refDoi"> DOI: 10.1021/jm101288t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101288t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8421-8439&author=I.+Kmentovaauthor=H.+S.+Sutherlandauthor=B.+D.+Palmerauthor=A.+Blaserauthor=S.+G.+Franzblauauthor=B.+Wanauthor=Y.+Wangauthor=Z.+Maauthor=W.+A.+Dennyauthor=A.+M.+Thompson&title=Synthesis+and+structure-activity+relationships+of+aza-+and+diazabiphenyl+analogues+of+the+antitubercular+drug+%286S%29-2-nitro-6-%7B%5B4-%28trifluoromethoxy%29benzyl%5Doxy%7D-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Doxazine+%28PA-824%29&doi=10.1021%2Fjm101288t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm101288t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101288t%26sid%3Dliteratum%253Aachs%26aulast%3DKmentova%26aufirst%3DI.%26aulast%3DSutherland%26aufirst%3DH.%2BS.%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DThompson%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520aza-%2520and%2520diazabiphenyl%2520analogues%2520of%2520the%2520antitubercular%2520drug%2520%25286S%2529-2-nitro-6-%257B%255B4-%2528trifluoromethoxy%2529benzyl%255Doxy%257D-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Doxazine%2520%2528PA-824%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8421%26epage%3D8439%26doi%3D10.1021%2Fjm101288t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3650</span>– <span class="NLM_lpage">3653</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2015.06.060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3650-3653&author=Y.+G.+Kangauthor=C.+Y.+Parkauthor=H.+Shinauthor=R.+Singhauthor=G.+Aroraauthor=C.+M.+Yuauthor=Y.+Lee&title=Synthesis+and+anti-tubercular+activity+of+2-nitroimidazooxazines+with+modification+at+the+C-7+position+as+PA-824+analogs&doi=10.1016%2Fj.bmcl.2015.06.060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.060%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DY.%2BG.%26aulast%3DPark%26aufirst%3DC.%2BY.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DArora%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DC.%2BM.%26aulast%3DLee%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520anti-tubercular%2520activity%2520of%25202-nitroimidazooxazines%2520with%2520modification%2520at%2520the%2520C-7%2520position%2520as%2520PA-824%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3650%26epage%3D3653%26doi%3D10.1016%2Fj.bmcl.2015.06.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrieta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebolledo, J. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. K.</span></span> <span> </span><span class="NLM_article-title">Nitrotriazole- and imidazole-based amides and sulfonamides as antitubercular agents</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6828</span>– <span class="NLM_lpage">6836</span>, <span class="refDoi"> DOI: 10.1128/AAC.03644-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1128%2FAAC.03644-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=6828-6836&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=A.+Arenaauthor=F.+Arrietaauthor=J.+C.+J.+Rebolledoauthor=D.+K.+Smith&title=Nitrotriazole-+and+imidazole-based+amides+and+sulfonamides+as+antitubercular+agents&doi=10.1128%2FAAC.03644-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1128%2FAAC.03644-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03644-14%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DArena%26aufirst%3DA.%26aulast%3DArrieta%26aufirst%3DF.%26aulast%3DRebolledo%26aufirst%3DJ.%2BC.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BK.%26atitle%3DNitrotriazole-%2520and%2520imidazole-based%2520amides%2520and%2520sulfonamides%2520as%2520antitubercular%2520agents%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D6828%26epage%3D6836%26doi%3D10.1128%2FAAC.03644-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rane, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangalore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borhade, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khandare, P. K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel 4-nitropyrrole-based 1,3,4-oxadiazole derivatives as antimicrobial and anti-tubercular agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2013.09.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=49-58&author=R.+A.+Raneauthor=P.+Bangaloreauthor=S.+D.+Borhadeauthor=P.+K.+Khandare&title=Synthesis+and+evaluation+of+novel+4-nitropyrrole-based+1%2C3%2C4-oxadiazole+derivatives+as+antimicrobial+and+anti-tubercular+agents&doi=10.1016%2Fj.ejmech.2013.09.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.039%26sid%3Dliteratum%253Aachs%26aulast%3DRane%26aufirst%3DR.%2BA.%26aulast%3DBangalore%26aufirst%3DP.%26aulast%3DBorhade%26aufirst%3DS.%2BD.%26aulast%3DKhandare%26aufirst%3DP.%2BK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%25204-nitropyrrole-based%25201%252C3%252C4-oxadiazole%2520derivatives%2520as%2520antimicrobial%2520and%2520anti-tubercular%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D70%26spage%3D49%26epage%3D58%26doi%3D10.1016%2Fj.ejmech.2013.09.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rane, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naphade, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangalore, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palkar, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpoormath, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel 4-nitropyrrole-based semicarbazide and thiosemicarbazide hybrids with antimicrobial and anti-tubercular</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3079</span>– <span class="NLM_lpage">3083</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2014.05.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3079-3083&author=R.+A.+Raneauthor=S.+S.+Naphadeauthor=P.+K.+Bangaloreauthor=M.+B.+Palkarauthor=M.+S.+Shaikhauthor=R.+Karpoormath&title=Synthesis+of+novel+4-nitropyrrole-based+semicarbazide+and+thiosemicarbazide+hybrids+with+antimicrobial+and+anti-tubercular&doi=10.1016%2Fj.bmcl.2014.05.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DRane%26aufirst%3DR.%2BA.%26aulast%3DNaphade%26aufirst%3DS.%2BS.%26aulast%3DBangalore%26aufirst%3DP.%2BK.%26aulast%3DPalkar%26aufirst%3DM.%2BB.%26aulast%3DShaikh%26aufirst%3DM.%2BS.%26aulast%3DKarpoormath%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520novel%25204-nitropyrrole-based%2520semicarbazide%2520and%2520thiosemicarbazide%2520hybrids%2520with%2520antimicrobial%2520and%2520anti-tubercular%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3079%26epage%3D3083%26doi%3D10.1016%2Fj.bmcl.2014.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussaini, S. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faazil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poornachandra, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajput, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, N. J.</span></span> <span> </span><span class="NLM_article-title">Anti-tubercular agents. Part 8: Synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6842</span>– <span class="NLM_lpage">6846</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2013.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=24206766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yqsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6842-6846&author=A.+Kamalauthor=S.+M.+A.+Hussainiauthor=S.+Faazilauthor=Y.+Poornachandraauthor=G.+N.+Reddyauthor=C.+G.+Kumarauthor=V.+S.+Rajputauthor=C.+Raniauthor=R.+Sharmaauthor=I.+A.+Khanauthor=N.+J.+Babu&title=Anti-tubercular+agents.+Part+8%3A+Synthesis%2C+antibacterial+and+antitubercular+activity+of+5-nitrofuran+based+1%2C2%2C3-triazoles&doi=10.1016%2Fj.bmcl.2013.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles</span></div><div class="casAuthors">Kamal, Ahmed; Hussaini, Syed Mohammed Ali; Faazil, Shaikh; Poornachandra, Y.; Narender Reddy, G.; Kumar, C. Ganesh; Rajput, Vikrant Singh; Rani, Chitra; Sharma, Rashmi; Khan, Inshad Ali; Jagadeesh Babu, N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6842-6846</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 5-nitrofuran-triazole conjugates were synthesized and evaluated for their antimicrobial activity against both Gram-pos. and Gram-neg. bacterial strains.  All the compds. exhibited promising inhibition towards Gram-pos. pathogenic strains, while mild inhibitory effects were obsd. towards Gram-neg. bacterial strains.  Compds. I (R1 = OH, R2 = OMe; R1 = H, R2 =NO2; R1 = F, F2 = Cl; R1 = CF3, R2 = H; R1 = F, R2 = OMe) are most active among the series exhibiting MIC value of 1.17 μg/mL against different bacterial strains.  The bactericidal activity is found to be in accordance with the bacterial growth inhibition data.  Compd. I (R1 = F, F2 = Cl) was found to be equipotent to the std. drug Ciprofloxacin displaying MBC value of 1.17 μg/mL against the bacterial strain Bacillus subtilis.  The compds. have also demonstrated promising antibacterial activity against the resistant strain MRSA and were found to be effective inhibitors of biofilm formation.  The compd. I (R1 = H, R2 =NO2) exhibited excellent anti-biofilm activity with IC50 value as low as 0.8 μg/mL.  These conjugates were also screened for antitubercular activity against Mycobacterium tuberculosis H37Rv strain.  Compd. I (R1 = F, F2 = Cl) showed promising antitubercular activity with MIC value of 0.25 μg/mL.  Most of these compds. are less toxic to normal mammalian cells than the widely used antibacterial drug Ciprofloxacin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8V2Tje3xTfLVg90H21EOLACvtfcHk0ljnIV-aDskuMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yqsLvM&md5=db5f25edbca83b237d335e1833fee991</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DHussaini%26aufirst%3DS.%2BM.%2BA.%26aulast%3DFaazil%26aufirst%3DS.%26aulast%3DPoornachandra%26aufirst%3DY.%26aulast%3DReddy%26aufirst%3DG.%2BN.%26aulast%3DKumar%26aufirst%3DC.%2BG.%26aulast%3DRajput%26aufirst%3DV.%2BS.%26aulast%3DRani%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26aulast%3DBabu%26aufirst%3DN.%2BJ.%26atitle%3DAnti-tubercular%2520agents.%2520Part%25208%253A%2520Synthesis%252C%2520antibacterial%2520and%2520antitubercular%2520activity%2520of%25205-nitrofuran%2520based%25201%252C2%252C3-triazoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6842%26epage%3D6846%26doi%3D10.1016%2Fj.bmcl.2013.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tangallapally, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yendapally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hevener, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaerts, A. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5276</span>– <span class="NLM_lpage">5283</span>, <span class="refDoi"> DOI: 10.1021/jm049972y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049972y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5276-5283&author=R.+P.+Tangallapallyauthor=R.+Yendapallyauthor=R.+E.+Leeauthor=K.+Hevenerauthor=V.+C.+Jonesauthor=A.+J.+M.+Lenaertsauthor=M.+R.+McNeilauthor=Y.+Wangauthor=S.+Franzblauauthor=R.+E.+Lee&title=Synthesis+and+evaluation+of+nitrofuranylamides+as+novel+antituberculosis+agents&doi=10.1021%2Fjm049972y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Fjm049972y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049972y%26sid%3Dliteratum%253Aachs%26aulast%3DTangallapally%26aufirst%3DR.%2BP.%26aulast%3DYendapally%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DR.%2BE.%26aulast%3DHevener%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DV.%2BC.%26aulast%3DLenaerts%26aufirst%3DA.%2BJ.%2BM.%26aulast%3DMcNeil%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFranzblau%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BE.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520nitrofuranylamides%2520as%2520novel%2520antituberculosis%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5276%26epage%3D5283%26doi%3D10.1021%2Fjm049972y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karabanovich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemanová, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smutný, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Székely, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šarkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centárová, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pávková, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Čonka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Němeček, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolaříková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vejsová, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vávrová, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimešová, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabálek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pávek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikušová, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, J.</span></span> <span> </span><span class="NLM_article-title">Development of 3,5-dinitrobenzylsulfanyl-1,3,4-oxadiazoles and thiadiazoles as selective antitubercular agents active against replicating and nonreplicating Mycobacterium tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2362</span>– <span class="NLM_lpage">2380</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00608</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00608" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2362-2380&author=G.+Karabanovichauthor=J.+Zemanov%C3%A1author=T.+Smutn%C3%BDauthor=R.+Sz%C3%A9kelyauthor=M.+%C5%A0arkanauthor=I.+Cent%C3%A1rov%C3%A1author=A.+Vocatauthor=I.+P%C3%A1vkov%C3%A1author=P.+%C4%8Conkaauthor=J.+N%C4%9Bme%C4%8Dekauthor=J.+Stola%C5%99%C3%ADkov%C3%A1author=M.+Vejsov%C3%A1author=K.+V%C3%A1vrov%C3%A1author=V.+Klime%C5%A1ov%C3%A1author=A.+Hrab%C3%A1lekauthor=P.+P%C3%A1vekauthor=S.+T.+Coleauthor=K.+Miku%C5%A1ov%C3%A1author=J.+Roh&title=Development+of+3%2C5-dinitrobenzylsulfanyl-1%2C3%2C4-oxadiazoles+and+thiadiazoles+as+selective+antitubercular+agents+active+against+replicating+and+nonreplicating+Mycobacterium+tuberculosis&doi=10.1021%2Facs.jmedchem.5b00608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis</span></div><div class="casAuthors">Karabanovich, Galina; Zemanova, Julia; Smutny, Tomas; Szekely, Rita; Sarkan, Michal; Centarova, Ivana; Vocat, Anthony; Pavkova, Ivona; Conka, Patrik; Nemecek, Jan; Stolarikova, Jirina; Vejsova, Marcela; Vavrova, Katerina; Klimesova, Vera; Hrabalek, Alexandr; Pavek, Petr; Cole, Stewart T.; Mikusova, Katarina; Roh, Jaroslav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2362-2380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we report the discovery and structure-activity relationships of 5-substituted-2-[(3,5-dinitrobenzyl)sulfanyl]-1,3,4-oxadiazoles and 1,3,4-thiadiazoles as a new class of antituberculosis agents.  The majority of these compds. exhibited outstanding in vitro activity against Mycobacterium tuberculosis CNCTC My 331/88 and six multidrug-resistant clin. isolated strains of M. tuberculosis, with min. inhibitory concn. values as low as 0.03 μM (0.011-0.026 μg/mL).  The investigated compds. had a highly selective antimycobacterial effect because they showed no activity against the other bacteria or fungi tested in this study.  Furthermore, the investigated compds. exhibited low in vitro toxicities in four proliferating mammalian cell lines and in isolated primary human hepatocytes.  Several in vitro genotoxicity assays indicated that the selected compds. have no mutagenic activity.  The oxadiazole and thiadiazole derivs. with the most favorable activity/toxicity profiles also showed potency comparable to that of rifampicin against the nonreplicating streptomycin-starved M. tuberculosis 18b-Lux strain, and therefore, these derivs., are of particular interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgBb0Hpi3vOrVg90H21EOLACvtfcHk0lhPS7-2YsTIlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yqt7Y%253D&md5=788b65627cfd13854c699c08ae7aa756</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00608%26sid%3Dliteratum%253Aachs%26aulast%3DKarabanovich%26aufirst%3DG.%26aulast%3DZemanov%25C3%25A1%26aufirst%3DJ.%26aulast%3DSmutn%25C3%25BD%26aufirst%3DT.%26aulast%3DSz%25C3%25A9kely%26aufirst%3DR.%26aulast%3D%25C5%25A0arkan%26aufirst%3DM.%26aulast%3DCent%25C3%25A1rov%25C3%25A1%26aufirst%3DI.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DP%25C3%25A1vkov%25C3%25A1%26aufirst%3DI.%26aulast%3D%25C4%258Conka%26aufirst%3DP.%26aulast%3DN%25C4%259Bme%25C4%258Dek%26aufirst%3DJ.%26aulast%3DStola%25C5%2599%25C3%25ADkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DVejsov%25C3%25A1%26aufirst%3DM.%26aulast%3DV%25C3%25A1vrov%25C3%25A1%26aufirst%3DK.%26aulast%3DKlime%25C5%25A1ov%25C3%25A1%26aufirst%3DV.%26aulast%3DHrab%25C3%25A1lek%26aufirst%3DA.%26aulast%3DP%25C3%25A1vek%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DMiku%25C5%25A1ov%25C3%25A1%26aufirst%3DK.%26aulast%3DRoh%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%25203%252C5-dinitrobenzylsulfanyl-1%252C3%252C4-oxadiazoles%2520and%2520thiadiazoles%2520as%2520selective%2520antitubercular%2520agents%2520active%2520against%2520replicating%2520and%2520nonreplicating%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2362%26epage%3D2380%26doi%3D10.1021%2Facs.jmedchem.5b00608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trefzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rengifo-Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinner, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, K.</span></span> <span> </span><span class="NLM_article-title">Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-<i>β</i>-D-ribose 2′-epimerase DprE1 of <i>Mycobacterium tuberculosis</i></span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">13663</span>– <span class="NLM_lpage">13665</span>, <span class="refDoi"> DOI: 10.1021/ja106357w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja106357w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=13663-13665&author=C.+Trefzerauthor=M.+Rengifo-Gonzalezauthor=M.+J.+Hinnerauthor=P.+Schneiderauthor=V.+Makarovauthor=S.+T.+Coleauthor=K.+Johnsson&title=Benzothiazinones%3A+prodrugs+that+covalently+modify+the+decaprenylphosphoryl-%CE%B2-D-ribose+2%E2%80%B2-epimerase+DprE1+of+Mycobacterium+tuberculosis&doi=10.1021%2Fja106357w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fja106357w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja106357w%26sid%3Dliteratum%253Aachs%26aulast%3DTrefzer%26aufirst%3DC.%26aulast%3DRengifo-Gonzalez%26aufirst%3DM.%26aulast%3DHinner%26aufirst%3DM.%2BJ.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DJohnsson%26aufirst%3DK.%26atitle%3DBenzothiazinones%253A%2520prodrugs%2520that%2520covalently%2520modify%2520the%2520decaprenylphosphoryl-%25CE%25B2-D-ribose%25202%25E2%2580%25B2-epimerase%2520DprE1%2520of%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D13663%26epage%3D13665%26doi%3D10.1021%2Fja106357w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karoli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuegg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möllmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Identification of antitubercular benzothiazinone compounds by ligand-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7940</span>– <span class="NLM_lpage">7944</span>, <span class="refDoi"> DOI: 10.1021/jm3008882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3008882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ghu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7940-7944&author=T.+Karoliauthor=B.+Beckerauthor=J.+Zueggauthor=U.+M%C3%B6llmannauthor=S.+Ramuauthor=J.+X.+Huangauthor=M.+A.+Cooper&title=Identification+of+antitubercular+benzothiazinone+compounds+by+ligand-based+design&doi=10.1021%2Fjm3008882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Antitubercular Benzothiazinone Compounds by Ligand-Based Design</span></div><div class="casAuthors">Karoli, Tomislav; Becker, Bernd; Zuegg, Johannes; Mollmann, Ute; Ramu, Soumya; Huang, Johnny X.; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7940-7944</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,3-Benzothiazin-4-ones (BTZs) are a novel class of TB drug candidates with potent activity against M. tuberculosis.  An in silico ligand-based model based on structure-activity data from 170 BTZ compds. was used to design a new series.  Compds. were tested against a panel of mycobacterial strains and were profiled for cytotoxicity, stability, and antiproliferative effects.  Several of the compds. showed improved activity against MDR-TB while retaining low toxicity with higher microsomal, metabolic, and plasma stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo55OwRcL9-ebVg90H21EOLACvtfcHk0lhtV9BqnzjCyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ghu73K&md5=8f9d6a494927943613d7cfc78b97a188</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fjm3008882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008882%26sid%3Dliteratum%253Aachs%26aulast%3DKaroli%26aufirst%3DT.%26aulast%3DBecker%26aufirst%3DB.%26aulast%3DZuegg%26aufirst%3DJ.%26aulast%3DM%25C3%25B6llmann%26aufirst%3DU.%26aulast%3DRamu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DJ.%2BX.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%2520antitubercular%2520benzothiazinone%2520compounds%2520by%2520ligand-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7940%26epage%3D7944%26doi%3D10.1021%2Fjm3008882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möllmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span> <span> </span><span class="NLM_article-title">Design and syntheses of anti-tuberculosis agents inspired by BTZ043 using a scaffold simplification strategy</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">587</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1021/ml500039g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500039g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVehtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=587-591&author=R.+Tiwariauthor=U.+M%C3%B6llmannauthor=S.+Choauthor=S.+G.+Franzblauauthor=P.+A.+Millerauthor=M.+J.+Miller&title=Design+and+syntheses+of+anti-tuberculosis+agents+inspired+by+BTZ043+using+a+scaffold+simplification+strategy&doi=10.1021%2Fml500039g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Syntheses of Anti-Tuberculosis Agents Inspired by BTZ043 Using a Scaffold Simplification Strategy</span></div><div class="casAuthors">Tiwari, Rohit; Mollmann, Ute; Cho, Sanghyun; Franzblau, Scott G.; Miller, Patricia A.; Miller, Marvin J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">587-591</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tuberculosis (TB), a disease caused by Mycobacterium tuberculosis (Mtb), is a global public health concern because of the emergence of various resistant strains.  Benzothiazin-4-ones (BTZs), represented by BTZ043, are a promising new class of agents for the treatment of tuberculosis and have been shown to kill Mtb in vitro, ex vivo, and in mouse models of TB.  Herein we report the design and syntheses of nitroarom. sulfonamide, reverse-amide, and ester classes of anti-TB agents using a scaffold simplification strategy based on BTZ043.  The presented work explores the effect of functional groups such as sulfonamides, reverse-amides, and esters that are attached to the nitroarom. rings on their anti-TB activity.  The in vitro activity of the compds. evaluated against the H37Rv strain of Mtb shows that nitroarom. sulfonamides, e.g. I, and nitrobenzoic acid esters, e.g. II, with two nitro substituents were most active and highlights the importance of the electronic character (electron deficient arom. ring) of the nitroarom. ring as a central theme in these types of nitroarom. anti-TB agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiXsl_Y9v5QrVg90H21EOLACvtfcHk0lhtV9BqnzjCyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVehtrg%253D&md5=138de42374225bafdca5435e9e6a0b60</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Fml500039g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500039g%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DM%25C3%25B6llmann%26aufirst%3DU.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DMiller%26aufirst%3DP.%2BA.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DDesign%2520and%2520syntheses%2520of%2520anti-tuberculosis%2520agents%2520inspired%2520by%2520BTZ043%2520using%2520a%2520scaffold%2520simplification%2520strategy%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D587%26epage%3D591%26doi%3D10.1021%2Fml500039g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraski, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krchňák, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colon-Martinez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span> <span> </span><span class="NLM_article-title">Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">3539</span>– <span class="NLM_lpage">3549</span>, <span class="refDoi"> DOI: 10.1021/ja311058q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja311058q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=3539-3549&author=R.+Tiwariauthor=G.+C.+Moraskiauthor=V.+Krch%C5%88%C3%A1kauthor=P.+A.+Millerauthor=M.+Colon-Martinezauthor=E.+Herreroauthor=A.+G.+Oliverauthor=M.+J.+Miller&title=Thiolates+chemically+induce+redox+activation+of+BTZ043+and+related+potent+nitroaromatic+anti-tuberculosis+agents&doi=10.1021%2Fja311058q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents</span></div><div class="casAuthors">Tiwari, Rohit; Moraski, Garrett C.; Krchnak, Viktor; Miller, Patricia A.; Colon-Martinez, Mariangelli; Herrero, Eliza; Oliver, Allen G.; Miller, Marvin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3539-3549</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of multidrug resistant (MDR) and extensively drug resistant (XDR) forms of tuberculosis (TB) has stimulated research efforts globally to expand the new drug pipeline.  Nitroarom. compds., including 1,3-benzothiazin-4-ones (BTZs) and related agents, are a promising new class for the treatment of TB.  Research has shown that the nitroso intermediates of BTZs that are generated in vivo cause suicide inhibition of decaprenylphosphoryl-β-d-ribose 2' oxidase (DprE1), which is responsible for cell wall arabinogalactan biosynthesis.  We have designed and synthesized novel anti-TB agents inspired from BTZs and other nitroarom. compds.  Computational studies indicated that the unsubstituted arom. carbons of BTZ043 and related nitroarom. compds. are the most electron-deficient and might be prone to nucleophilic attack.  Our chem. studies on BTZ043 and the addnl. nitroarom. compds. synthesized by us and others confirmed the postulated reactivity.  The results indicate that nucleophiles such as thiolates, cyanide, and hydride induce nonenzymic redn. of the nitro groups present in these compds. to the corresponding nitroso intermediates by addn. at the unsubstituted electron-deficient arom. carbon present in these compds.  Furthermore, we demonstrate here that these compds. are good candidates for the classical von Richter reaction.  These chem. studies offer an alternate hypothesis for the mechanism of action of nitroarom. anti-TB agents, in that the cysteine thiol(ate) or a hydride source at the active site of DprE1 may trigger the redn. of the nitro groups in a manner similar to the von Richter reaction to the nitroso intermediates, to initiate the inhibition of DprE1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEXS_ZRRGRArVg90H21EOLACvtfcHk0liBQZgsOR4bQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D&md5=e3671cfef9ef47c15087e8299d9db64e</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fja311058q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja311058q%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DKrch%25C5%2588%25C3%25A1k%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DP.%2BA.%26aulast%3DColon-Martinez%26aufirst%3DM.%26aulast%3DHerrero%26aufirst%3DE.%26aulast%3DOliver%26aufirst%3DA.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DThiolates%2520chemically%2520induce%2520redox%2520activation%2520of%2520BTZ043%2520and%2520related%2520potent%2520nitroaromatic%2520anti-tuberculosis%2520agents%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D3539%26epage%3D3549%26doi%3D10.1021%2Fja311058q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5984</span>– <span class="NLM_lpage">5992</span>, <span class="refDoi"> DOI: 10.1021/jm800328v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800328v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5984-5992&author=Y.+Choauthor=T.+R.+Ioergerauthor=J.+C.+Sacchettini&title=Discovery+of+novel+nitrobenzothiazole+inhibitors+for+Mycobacterium+tuberculosis+ATP+phosphoribosyl+transferase+%28HisG%29+through+virtual+screening&doi=10.1021%2Fjm800328v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Nitrobenzothiazole Inhibitors for Mycobacterium tuberculosis ATP Phosphoribosyl Transferase (HisG) through Virtual Screening</span></div><div class="casAuthors">Cho, Yoonsang; Ioerger, Thomas R.; Sacchettini, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5984-5992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HisG is an ATP-phosphoribosyl transferase (ATPPRTase) that catalyzes the first step in the biosynthetic pathway for histidine.  Among the enzymes in this pathway, only HisG represents a potential drug target for tuberculosis.  Only a few inhibitors with limited potency for HisG are currently known.  To discover more potent and diverse inhibitors, virtual screening was performed.  The crystal structure of M. tuberculosis HisG has been solved and reveals a large, solvent-exposed active site with subsites for ATP and PRPP substrates.  Two docking algorithms, GOLD and FLEXX, were used to screen two large libraries, Chembridge and NCI, contg. over 500000 compds. combined.  An initial subset of top-ranked compds. were selected and assayed, and seven were found to have enzyme inhibition activity at micromolar concns.  Several of the hits contained a nitrobenzothiazole fragment, which was predicted to dock into the monophosphate-binding loop, and this binding mode was confirmed by crystallog. evidence.  A secondary screen was performed to identify compds. with similar structures.  Several of these also exhibited micromolar inhibition.  Furthermore, two of the compds. showed bacteriocidal activity in a whole-cell assay against Mycobacterium smegmatis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbgXaEKz2UCrVg90H21EOLACvtfcHk0liBQZgsOR4bQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb3L&md5=dfec06f998fffff9c121e027616c1dbd</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Fjm800328v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800328v%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520novel%2520nitrobenzothiazole%2520inhibitors%2520for%2520Mycobacterium%2520tuberculosis%2520ATP%2520phosphoribosyl%2520transferase%2520%2528HisG%2529%2520through%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5984%26epage%3D5992%26doi%3D10.1021%2Fjm800328v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trunz, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasittichai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torreele, E.</span></span> <span> </span><span class="NLM_article-title">Novel 3-nitro-1h-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8214</span>– <span class="NLM_lpage">8223</span>, <span class="refDoi"> DOI: 10.1021/jm201215n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201215n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8214-8223&author=M.+V.+Papadopoulouauthor=B.+B.+Trunzauthor=W.+D.+Bloomerauthor=C.+McKenzieauthor=S.+R.+Wilkinsonauthor=C.+Prasittichaiauthor=R.+Brunauthor=M.+Kaiserauthor=E.+Torreele&title=Novel+3-nitro-1h-1%2C2%2C4-triazole-based+aliphatic+and+aromatic+amines+as+anti-chagasic+agents&doi=10.1021%2Fjm201215n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm201215n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201215n%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DTrunz%26aufirst%3DB.%2BB.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DMcKenzie%26aufirst%3DC.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DPrasittichai%26aufirst%3DC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DTorreele%26aufirst%3DE.%26atitle%3DNovel%25203-nitro-1h-1%252C2%252C4-triazole-based%2520aliphatic%2520and%2520aromatic%2520amines%2520as%2520anti-chagasic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8214%26epage%3D8223%26doi%3D10.1021%2Fjm201215n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioset, J. R.</span></span> <span> </span><span class="NLM_article-title">Novel 3-nitro-1h-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5554</span>– <span class="NLM_lpage">5565</span>, <span class="refDoi"> DOI: 10.1021/jm300508n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300508n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5554-5565&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=E.+Chatelainauthor=M.+Kaiserauthor=S.+R.+Wilkinsonauthor=C.+McKenzieauthor=J.+R.+Ioset&title=Novel+3-nitro-1h-1%2C2%2C4-triazole-based+amides+and+sulfonamides+as+potential+antitrypanosomal+agents&doi=10.1021%2Fjm300508n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Fjm300508n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300508n%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DMcKenzie%26aufirst%3DC.%26aulast%3DIoset%26aufirst%3DJ.%2BR.%26atitle%3DNovel%25203-nitro-1h-1%252C2%252C4-triazole-based%2520amides%2520and%2520sulfonamides%2520as%2520potential%2520antitrypanosomal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5554%26epage%3D5565%26doi%3D10.1021%2Fjm300508n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepesheva, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilera-Venegas, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioset, J. R.</span></span> <span> </span><span class="NLM_article-title">Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1307</span>– <span class="NLM_lpage">1319</span>, <span class="refDoi"> DOI: 10.1021/jm5015742</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5015742" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns12gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1307-1319&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=G.+I.+Lepeshevaauthor=H.+S.+Rosenzweigauthor=M.+Kaiserauthor=B.+A.+Aguilera-Venegasauthor=S.+R.+Wilkinsonauthor=E.+Chatelainauthor=J.+R.+Ioset&title=Novel+3-nitrotriazole-based+amides+and+carbinols+as+bifunctional+antichagasic+agents&doi=10.1021%2Fjm5015742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3-Nitrotriazole-Based Amides and Carbinols as Bifunctional Antichagasic Agents</span></div><div class="casAuthors">Papadopoulou, Maria V.; Bloomer, William D.; Lepesheva, Galina I.; Rosenzweig, Howard S.; Kaiser, Marcel; Aguilera-Venegas, Benjamin; Wilkinson, Shane R.; Chatelain, Eric; Ioset, Jean-Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1307-1319</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Nitro-1H-1,2,4-triazole-based amides with a linear, rigid core e. g., I, and 3-nitrotriazole-based fluconazole analogs e. g., II, were synthesized as dual functioning antitrypanosomal agents.  Such compds. are excellent substrates for type I nitroreductase (NTR) located in the mitochondrion of trypanosomatids and, at the same time, act as inhibitors of the sterol 14α-demethylase (T. cruzi CYP51) enzyme.  Because combination treatments against parasites are often superior to monotherapy, we believe that this emerging class of bifunctional compds. may introduce a new generation of antitrypanosomal drugs.  In the present work, the synthesis and in vitro and in vivo evaluation of such compds. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHujhVKJ6Sg7Vg90H21EOLACvtfcHk0lheexyIsXqJbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns12gug%253D%253D&md5=184bb84d8cee57c3ae3590bc387c6649</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Fjm5015742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5015742%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DLepesheva%26aufirst%3DG.%2BI.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DAguilera-Venegas%26aufirst%3DB.%2BA.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DIoset%26aufirst%3DJ.%2BR.%26atitle%3DNovel%25203-nitrotriazole-based%2520amides%2520and%2520carbinols%2520as%2520bifunctional%2520antichagasic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1307%26epage%3D1319%26doi%3D10.1021%2Fjm5015742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomer, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szular, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span> <span> </span><span class="NLM_article-title">Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2016.04.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=179-186&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=S.+R.+Wilkinsonauthor=J.+Szularauthor=M.+Kaiser&title=Antitrypanosomal+activity+of+5-nitro-2-aminothiazole-based+compounds&doi=10.1016%2Fj.ejmech.2016.04.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DSzular%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DM.%26atitle%3DAntitrypanosomal%2520activity%2520of%25205-nitro-2-aminothiazole-based%2520compounds%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D117%26spage%3D179%26epage%3D186%26doi%3D10.1016%2Fj.ejmech.2016.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaukel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braillard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowbray, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span> <span> </span><span class="NLM_article-title">Assessment of a pretomanid analogue library for African trypanosomiasis: Hit-to-lead studies on 6-substituted 2-nitro-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]thiazine 8-oxides</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2017.10.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=29191556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2lsr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=207-213&author=A.+M.+Thompsonauthor=A.+J.+Marshallauthor=L.+Maesauthor=N.+Yarlettauthor=C.+J.+Bacchiauthor=E.+Gaukelauthor=S.+A.+Wringauthor=D.+Launayauthor=S.+Braillardauthor=E.+Chatelainauthor=C.+E.+Mowbrayauthor=W.+A.+Denny&title=Assessment+of+a+pretomanid+analogue+library+for+African+trypanosomiasis%3A+Hit-to-lead+studies+on+6-substituted+2-nitro-6%2C7-dihydro-5H-imidazo%5B2%2C1-b%5D%5B1%2C3%5Dthiazine+8-oxides&doi=10.1016%2Fj.bmcl.2017.10.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of a pretomanid analogue library for African trypanosomiasis: Hit-to-lead studies on 6-substituted 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazine 8-oxides</span></div><div class="casAuthors">Thompson, Andrew M.; Marshall, Andrew J.; Maes, Louis; Yarlett, Nigel; Bacchi, Cyrus J.; Gaukel, Eric; Wring, Stephen A.; Launay, Delphine; Braillard, Stephanie; Chatelain, Eric; Mowbray, Charles E.; Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-213</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A 900 compd. nitroimidazole-based library derived from the authors' pretomanid backup program with TB Alliance was screened for utility against human African trypanosomiasis (HAT) by the Drugs for Neglected Diseases initiative.  Potent hits included 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazine 8-oxides, which surprisingly displayed good metabolic stability and excellent cell permeability.  Following comprehensive mouse pharmacokinetic assessments on four hits and detn. of the most active chiral form, a thiazine oxide counterpart of pretomanid (24 ((6S)-2-Nitro-6-[[4-(trifluoromethoxy)benzyl]oxy]-6,7-dihydro-5H-imidazo[2,1-6][1,3]thiazine 8-oxide)) was identified as the best lead.  With once daily oral dosing, this compd. delivered complete cures in an acute infection mouse model of HAT and increased survival times in a stage 2 model, implying the need for more prolonged CNS exposure.  In preliminary SAR findings, antitrypanosomal activity was reduced by removal of the benzylic methylene but enhanced through a phenylpyridine-based side chain, providing important direction for future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEuX9gwE1P1LVg90H21EOLACvtfcHk0lgJTRPFPzNv5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2lsr7N&md5=00573f41d0ae4882b316c5ed36199ef5</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.067%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DMarshall%26aufirst%3DA.%2BJ.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DBraillard%26aufirst%3DS.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DAssessment%2520of%2520a%2520pretomanid%2520analogue%2520library%2520for%2520African%2520trypanosomiasis%253A%2520Hit-to-lead%2520studies%2520on%25206-substituted%25202-nitro-6%252C7-dihydro-5H-imidazo%255B2%252C1-b%255D%255B1%252C3%255Dthiazine%25208-oxides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D207%26epage%3D213%26doi%3D10.1016%2Fj.bmcl.2017.10.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crozet, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasquet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rémusat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapelle, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Méo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanelle, P.</span></span> <span> </span><span class="NLM_article-title">Lowering of 5-nitroimidazole’s mutagenicity: Towards optimal antiparasitic pharmacophore</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">653</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2008.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2008.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=18590939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlWjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=653-659&author=M.+D.+Crozetauthor=C.+Bottaauthor=M.+Gasquetauthor=C.+Curtiauthor=V.+R%C3%A9musatauthor=S.+Hutterauthor=O.+Chapelleauthor=N.+Azasauthor=M.+De+M%C3%A9oauthor=P.+Vanelle&title=Lowering+of+5-nitroimidazole%E2%80%99s+mutagenicity%3A+Towards+optimal+antiparasitic+pharmacophore&doi=10.1016%2Fj.ejmech.2008.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Lowering of 5-nitroimidazole's mutagenicity: Towards optimal antiparasitic pharmacophore</span></div><div class="casAuthors">Crozet, Maxime D.; Botta, Celine; Gasquet, Monique; Curti, Christophe; Remusat, Vincent; Hutter, Sebastien; Chapelle, Olivier; Azas, Nadine; De Meo, Michel; Vanelle, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">653-659</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To improve the antiparasitic pharmacophore, 20 5-nitroimidazoles bearing an arylsulfonylmethyl group I [R1 = Me, (CH2)OH, CH2CH(CH3)OH; R2 = H, Me; X = H, Me, Cl, Br, F] were prepd. from com. imidazoles.  The antiparasitic activity of these mols. was assessed against Trichomonas vaginalis, the in vitro cytotoxicity was evaluated on human monocytes and the mutagenicity was detd. by the Salmonella mutagenicity assay.  All IC50 on T. vaginalis were below the one of metronidazole.  The detn. of the specificity indexes (SIs), defined as the ratios of the cytotoxic activity and the antitrichomonas activity, indicated that 11 derivs. had a SI over the one of metronidazole.  Mols., bearing an addnl. Me group on the 2-position, showed a lower mutagenicity than metronidazole.  Moreover, three derivs. were characterized by a low mutagenicity and an efficient antitrichomonas activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYfgHS61Ra2LVg90H21EOLACvtfcHk0lgJTRPFPzNv5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlWjsL4%253D&md5=2e0745c81e59ce764ecc302bdca7a8e9</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DCrozet%26aufirst%3DM.%2BD.%26aulast%3DBotta%26aufirst%3DC.%26aulast%3DGasquet%26aufirst%3DM.%26aulast%3DCurti%26aufirst%3DC.%26aulast%3DR%25C3%25A9musat%26aufirst%3DV.%26aulast%3DHutter%26aufirst%3DS.%26aulast%3DChapelle%26aufirst%3DO.%26aulast%3DAzas%26aufirst%3DN.%26aulast%3DDe%2BM%25C3%25A9o%26aufirst%3DM.%26aulast%3DVanelle%26aufirst%3DP.%26atitle%3DLowering%2520of%25205-nitroimidazole%25E2%2580%2599s%2520mutagenicity%253A%2520Towards%2520optimal%2520antiparasitic%2520pharmacophore%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D653%26epage%3D659%26doi%3D10.1016%2Fj.ejmech.2008.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Núñez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tlahuext, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moo-Puc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres-Gómez, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes-Martínez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedillo-Rivera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nava-Zuazo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarrete-Vazquez, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and <i>in vitro</i> trichomonicidal, giardicidal and amebicidal activity of N-acetamide(sulfonamide)-2-methyl-4-nitro-1H-imidazolesq</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2975</span>– <span class="NLM_lpage">2984</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2009.01.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=2975-2984&author=E.+Hern%C3%A1ndez-N%C3%BA%C3%B1ezauthor=H.+Tlahuextauthor=R.+Moo-Pucauthor=H.+Torres-G%C3%B3mezauthor=R.+Reyes-Mart%C3%ADnezauthor=R.+Cedillo-Riveraauthor=C.+Nava-Zuazoauthor=G.+Navarrete-Vazquez&title=Synthesis+and+in+vitro+trichomonicidal%2C+giardicidal+and+amebicidal+activity+of+N-acetamide%28sulfonamide%29-2-methyl-4-nitro-1H-imidazolesq&doi=10.1016%2Fj.ejmech.2009.01.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez-N%25C3%25BA%25C3%25B1ez%26aufirst%3DE.%26aulast%3DTlahuext%26aufirst%3DH.%26aulast%3DMoo-Puc%26aufirst%3DR.%26aulast%3DTorres-G%25C3%25B3mez%26aufirst%3DH.%26aulast%3DReyes-Mart%25C3%25ADnez%26aufirst%3DR.%26aulast%3DCedillo-Rivera%26aufirst%3DR.%26aulast%3DNava-Zuazo%26aufirst%3DC.%26aulast%3DNavarrete-Vazquez%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520trichomonicidal%252C%2520giardicidal%2520and%2520amebicidal%2520activity%2520of%2520N-acetamide%2528sulfonamide%2529-2-methyl-4-nitro-1H-imidazolesq%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D2975%26epage%3D2984%26doi%3D10.1016%2Fj.ejmech.2009.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colín-Lozano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">León-Rivera, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan-Bacab, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega-Morales, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moo-Puc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Guerrero, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Núñez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argüello-Garcia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scior, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa-Cabrera, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarrete-Vázquez, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis, <i>in vitro</i> and <i>in vivo</i> giardicidal activity of nitrothiazole-NSAID chimeras displaying broad antiprotozoal spectrum</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3490</span>– <span class="NLM_lpage">3494</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.05.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmcl.2017.05.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=3490-3494&author=B.+Col%C3%ADn-Lozanoauthor=I.+Le%C3%B3n-Riveraauthor=M.+J.+Chan-Bacabauthor=B.+O.+Ortega-Moralesauthor=R.+Moo-Pucauthor=V.+L%C3%B3pez-Guerreroauthor=E.+Hern%C3%A1ndez-N%C3%BA%C3%B1ezauthor=R.+Arg%C3%BCello-Garciaauthor=T.+Sciorauthor=E.+Barbosa-Cabreraauthor=G.+Navarrete-V%C3%A1zquez&title=Synthesis%2C+in+vitro+and+in+vivo+giardicidal+activity+of+nitrothiazole-NSAID+chimeras+displaying+broad+antiprotozoal+spectrum&doi=10.1016%2Fj.bmcl.2017.05.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.05.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.05.071%26sid%3Dliteratum%253Aachs%26aulast%3DCol%25C3%25ADn-Lozano%26aufirst%3DB.%26aulast%3DLe%25C3%25B3n-Rivera%26aufirst%3DI.%26aulast%3DChan-Bacab%26aufirst%3DM.%2BJ.%26aulast%3DOrtega-Morales%26aufirst%3DB.%2BO.%26aulast%3DMoo-Puc%26aufirst%3DR.%26aulast%3DL%25C3%25B3pez-Guerrero%26aufirst%3DV.%26aulast%3DHern%25C3%25A1ndez-N%25C3%25BA%25C3%25B1ez%26aufirst%3DE.%26aulast%3DArg%25C3%25BCello-Garcia%26aufirst%3DR.%26aulast%3DScior%26aufirst%3DT.%26aulast%3DBarbosa-Cabrera%26aufirst%3DE.%26aulast%3DNavarrete-V%25C3%25A1zquez%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520giardicidal%2520activity%2520of%2520nitrothiazole-NSAID%2520chimeras%2520displaying%2520broad%2520antiprotozoal%2520spectrum%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D3490%26epage%3D3494%26doi%3D10.1016%2Fj.bmcl.2017.05.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trunz, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jędrysiak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweats, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwiński, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torreele, E.</span></span> <span> </span><span class="NLM_article-title">1-Aryl-4 nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1524</span>– <span class="NLM_lpage">1535</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.01.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2011.01.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1524-1535&author=B.+B.+Trunzauthor=R.+J%C4%99drysiakauthor=D.+Tweatsauthor=R.+Brunauthor=M.+Kaiserauthor=J.+Suwi%C5%84skiauthor=E.+Torreele&title=1-Aryl-4+nitro-1H-imidazoles%2C+a+new+promising+series+for+the+treatment+of+human+African+trypanosomiasis&doi=10.1016%2Fj.ejmech.2011.01.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.01.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.01.071%26sid%3Dliteratum%253Aachs%26aulast%3DTrunz%26aufirst%3DB.%2BB.%26aulast%3DJ%25C4%2599drysiak%26aufirst%3DR.%26aulast%3DTweats%26aufirst%3DD.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DSuwi%25C5%2584ski%26aufirst%3DJ.%26aulast%3DTorreele%26aufirst%3DE.%26atitle%3D1-Aryl-4%2520nitro-1H-imidazoles%252C%2520a%2520new%2520promising%2520series%2520for%2520the%2520treatment%2520of%2520human%2520African%2520trypanosomiasis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1524%26epage%3D1535%26doi%3D10.1016%2Fj.ejmech.2011.01.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca-Berzal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibáñez-Escribano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reviriego, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagerovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogal-Ruiz, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escario, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soeiro, M. d. N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Barrio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span> <span> </span><span class="NLM_article-title">Antichagasic and trichomonacidal activity of 1-substituted 2-benzyl- 5-nitroindazolin-3-ones and 3-alkoxy-2-benzyl-5-nitro-2Hindazoles</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2016.03.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=295-310&author=C.+Fonseca-Berzalauthor=A.+Ib%C3%A1%C3%B1ez-Escribanoauthor=F.+Reviriegoauthor=J.+Cumellaauthor=P.+Moralesauthor=N.+Jagerovicauthor=J.+J.+Nogal-Ruizauthor=J.+A.+Escarioauthor=P.+B.+da+Silvaauthor=M.+d.+N.+C.+Soeiroauthor=A.+G%C3%B3mez-Barrioauthor=V.+J.+Ar%C3%A1n&title=Antichagasic+and+trichomonacidal+activity+of+1-substituted+2-benzyl-+5-nitroindazolin-3-ones+and+3-alkoxy-2-benzyl-5-nitro-2Hindazoles&doi=10.1016%2Fj.ejmech.2016.03.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.036%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca-Berzal%26aufirst%3DC.%26aulast%3DIb%25C3%25A1%25C3%25B1ez-Escribano%26aufirst%3DA.%26aulast%3DReviriego%26aufirst%3DF.%26aulast%3DCumella%26aufirst%3DJ.%26aulast%3DMorales%26aufirst%3DP.%26aulast%3DJagerovic%26aufirst%3DN.%26aulast%3DNogal-Ruiz%26aufirst%3DJ.%2BJ.%26aulast%3DEscario%26aufirst%3DJ.%2BA.%26aulast%3Dda%2BSilva%26aufirst%3DP.%2BB.%26aulast%3DSoeiro%26aufirst%3DM.%2Bd.%2BN.%2BC.%26aulast%3DG%25C3%25B3mez-Barrio%26aufirst%3DA.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26atitle%3DAntichagasic%2520and%2520trichomonacidal%2520activity%2520of%25201-substituted%25202-benzyl-%25205-nitroindazolin-3-ones%2520and%25203-alkoxy-2-benzyl-5-nitro-2Hindazoles%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D295%26epage%3D310%26doi%3D10.1016%2Fj.ejmech.2016.03.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boiani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerpe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres de Ortiz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera de Bilbao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanabria, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaluff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas de
Arias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maya, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morello, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerecetto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, M.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> and <i>in vivo</i> antitrypanosomatid activity of 5-nitroindazoles</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1034</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2008.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2008.06.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=1034-1040&author=L.+Boianiauthor=A.+Gerpeauthor=V.+J.+Ar%C3%A1nauthor=S.+Torres+de+Ortizauthor=E.+Sernaauthor=N.+Vera+de+Bilbaoauthor=L.+Sanabriaauthor=G.+Yaluffauthor=H.+Nakayamaauthor=A.+Rojas+de%0AAriasauthor=J.+D.+Mayaauthor=J.+A.+Morelloauthor=H.+Cerecettoauthor=M.+Gonz%C3%A1lez&title=In+vitro+and+in+vivo+antitrypanosomatid+activity+of+5-nitroindazoles&doi=10.1016%2Fj.ejmech.2008.06.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DBoiani%26aufirst%3DL.%26aulast%3DGerpe%26aufirst%3DA.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DTorres%2Bde%2BOrtiz%26aufirst%3DS.%26aulast%3DSerna%26aufirst%3DE.%26aulast%3DVera%2Bde%2BBilbao%26aufirst%3DN.%26aulast%3DSanabria%26aufirst%3DL.%26aulast%3DYaluff%26aufirst%3DG.%26aulast%3DNakayama%26aufirst%3DH.%26aulast%3DRojas%2Bde%2BArias%26aufirst%3DA.%26aulast%3DMaya%26aufirst%3DJ.%2BD.%26aulast%3DMorello%26aufirst%3DJ.%2BA.%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitrypanosomatid%2520activity%2520of%25205-nitroindazoles%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D1034%26epage%3D1040%26doi%3D10.1016%2Fj.ejmech.2008.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerpe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmerling, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piro, O. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maya, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olea-Azar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerecetto, H.</span></span> <span> </span><span class="NLM_article-title">Study of 5-nitroindazoles’ anti-Trypanosoma cruzi mode of action: Electrochemical behaviour and ESR spectroscopic studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1545</span>– <span class="NLM_lpage">1553</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2008.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2008.07.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=1545-1553&author=J.+Rodr%C3%ADguezauthor=A.+Gerpeauthor=G.+Aguirreauthor=U.+Kemmerlingauthor=O.+E.+Piroauthor=V.+J.+Ar%C3%A1nauthor=J.+D.+Mayaauthor=C.+Olea-Azarauthor=M.+Gonz%C3%A1lezauthor=H.+Cerecetto&title=Study+of+5-nitroindazoles%E2%80%99+anti-Trypanosoma+cruzi+mode+of+action%3A+Electrochemical+behaviour+and+ESR+spectroscopic+studies&doi=10.1016%2Fj.ejmech.2008.07.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DJ.%26aulast%3DGerpe%26aufirst%3DA.%26aulast%3DAguirre%26aufirst%3DG.%26aulast%3DKemmerling%26aufirst%3DU.%26aulast%3DPiro%26aufirst%3DO.%2BE.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DMaya%26aufirst%3DJ.%2BD.%26aulast%3DOlea-Azar%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26atitle%3DStudy%2520of%25205-nitroindazoles%25E2%2580%2599%2520anti-Trypanosoma%2520cruzi%2520mode%2520of%2520action%253A%2520Electrochemical%2520behaviour%2520and%2520ESR%2520spectroscopic%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D1545%26epage%3D1553%26doi%3D10.1016%2Fj.ejmech.2008.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boiani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olea-Azar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavaggi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerecetto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maya, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco-Pozo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosoy, H. S.</span></span> <span> </span><span class="NLM_article-title">New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: Synthesis, biological evaluation, and mechanism of action studies</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">8186</span>– <span class="NLM_lpage">8196</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.bmc.2009.10.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=8186-8196&author=J.+Rodr%C3%ADguezauthor=V.+J.+Ar%C3%A1nauthor=L.+Boianiauthor=C.+Olea-Azarauthor=M.+L.+Lavaggiauthor=M.+Gonz%C3%A1lezauthor=H.+Cerecettoauthor=J.+D.+Mayaauthor=C.+Carrasco-Pozoauthor=H.+S.+Cosoy&title=New+potent+5-nitroindazole+derivatives+as+inhibitors+of+Trypanosoma+cruzi+growth%3A+Synthesis%2C+biological+evaluation%2C+and+mechanism+of+action+studies&doi=10.1016%2Fj.bmc.2009.10.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DJ.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DBoiani%26aufirst%3DL.%26aulast%3DOlea-Azar%26aufirst%3DC.%26aulast%3DLavaggi%26aufirst%3DM.%2BL.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DMaya%26aufirst%3DJ.%2BD.%26aulast%3DCarrasco-Pozo%26aufirst%3DC.%26aulast%3DCosoy%26aufirst%3DH.%2BS.%26atitle%3DNew%2520potent%25205-nitroindazole%2520derivatives%2520as%2520inhibitors%2520of%2520Trypanosoma%2520cruzi%2520growth%253A%2520Synthesis%252C%2520biological%2520evaluation%252C%2520and%2520mechanism%2520of%2520action%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D8186%26epage%3D8196%26doi%3D10.1016%2Fj.bmc.2009.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vega, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolón, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero-Torres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca-Berzal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escario, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Barrio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gálvez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrero-Ponce, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2012.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=23124218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslOrsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=214-227&author=M.+C.+Vegaauthor=M.+Rol%C3%B3nauthor=A.+Montero-Torresauthor=C.+Fonseca-Berzalauthor=J.+A.+Escarioauthor=A.+G%C3%B3mez-Barrioauthor=J.+G%C3%A1lvezauthor=Y.+Marrero-Ponceauthor=V.+J.+Ar%C3%A1n&title=Synthesis%2C+biological+evaluation+and+chemometric+analysis+of+indazole+derivatives.+1%2C2-Disubstituted+5-nitroindazolinones%2C+new+prototypes+of+antichagasic+drug&doi=10.1016%2Fj.ejmech.2012.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug</span></div><div class="casAuthors">Vega, Maria Celeste; Rolon, Miriam; Montero-Torres, Alina; Fonseca-Berzal, Cristina; Escario, Jose Antonio; Gomez-Barrio, Alicia; Galvez, Jorge; Marrero-Ponce, Yovani; Aran, Vicente J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">214-227</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compds. remains an important goal.  On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3-ones and in order to initiate the optimization of activity of this kind of compds., we have prepd. a series of related analogs and tested in vitro these products against epimastigote forms of Trypanosoma cruzi.  2-Benzyl-1-Pr (I), 2-benzyl-1-iso-Pr (II) and 2-benzyl-1-Bu (III) derivs. have shown high trypanocidal activity and low unspecific toxicity.  Other indazole derivs. with different substitution patterns (1-substituted 3-alkoxy-1H-indazoles and 2-substituted 3-alkoxy-2H-indazoles), arising from the synthetic procedures used to prep. the mentioned indazolinones, have moderate to low effectiveness.  The exploration of SAR information using the concept of an activity landscape has been carried out with SARANEA software.  We have also searched for structural similarities between 225 known antiprotozoan drugs and compd. I.  The results confirm that compds. I-III constitute promising leads and that 5-nitroindazolin-3-one system is a novel anti-T. cruzi scaffold which may represent an important therapeutic alternative for the treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRbqmnzcyFhLVg90H21EOLACvtfcHk0lhvWrk0K3D9TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslOrsr3E&md5=8922d27f24ff8cd9e0395fcc745f6100</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DVega%26aufirst%3DM.%2BC.%26aulast%3DRol%25C3%25B3n%26aufirst%3DM.%26aulast%3DMontero-Torres%26aufirst%3DA.%26aulast%3DFonseca-Berzal%26aufirst%3DC.%26aulast%3DEscario%26aufirst%3DJ.%2BA.%26aulast%3DG%25C3%25B3mez-Barrio%26aufirst%3DA.%26aulast%3DG%25C3%25A1lvez%26aufirst%3DJ.%26aulast%3DMarrero-Ponce%26aufirst%3DY.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520chemometric%2520analysis%2520of%2520indazole%2520derivatives.%25201%252C2-Disubstituted%25205-nitroindazolinones%252C%2520new%2520prototypes%2520of%2520antichagasic%2520drug%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D58%26spage%3D214%26epage%3D227%26doi%3D10.1016%2Fj.ejmech.2012.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca-Berzal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escario, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Barrio, A.</span></span> <span> </span><span class="NLM_article-title">Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1056</span>, <span class="refDoi"> DOI: 10.1007/s00436-013-3740-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1007%2Fs00436-013-3740-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=24435615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=1%3ACAS%3A280%3ADC%252BC2czmt1eisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2014&pages=1049-1056&author=C.+Fonseca-Berzalauthor=J.+A.+Escarioauthor=V.+J.+Ar%C3%A1nauthor=A.+G%C3%B3mez-Barrio&title=Further+insights+into+biological+evaluation+of+new+anti-Trypanosoma+cruzi+5-nitroindazoles&doi=10.1007%2Fs00436-013-3740-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles</span></div><div class="casAuthors">Fonseca-Berzal Cristina; Escario Jose Antonio; Aran Vicente J; Gomez-Barrio Alicia</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1049-56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Twelve molecules from a series of 35 new 5-nitroindazole derivatives, selected from a successful primary screening on Trypanosoma cruzi epimastigotes, have been evaluated against intracellular amastigotes according to the previous results of their trypanocidal activity and unspecific cytotoxicity. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23), and 2-benzyl-1-butyl (24) 5-nitroindazolin-3-ones have inhibited the growth of amastigotes similarly to the reference drugs benznidazole and nifurtimox, inducing complete growth inhibition at concentrations lower than 8 μM (IC50 < 5 μM) and accomplishing great selectivity indexes on the intracellular form of the parasite (SI > 30).  Further in vivo assays were developed only for two of the most active molecules (22 and 24), reaching significant reductions in parasitemia levels (52 % and 77%, respectively) after their oral administration to infected mice.  In addition, none of the mice in experimental and benznidazole groups died, unlike in the control group which is only treated with the vehicle.  The trypanocidal properties found in some of the 5-nitroindazole derivatives assayed in the present work represent an interesting contribution to the urgent need for searching new antichagasic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCTUUnUpSgfijiVMCqkKxVfW6udTcc2eZoGBxS0tqAt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czmt1eisg%253D%253D&md5=080ade604aeaa2acb4074b6a8d061f9e</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1007%2Fs00436-013-3740-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-013-3740-5%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca-Berzal%26aufirst%3DC.%26aulast%3DEscario%26aufirst%3DJ.%2BA.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DG%25C3%25B3mez-Barrio%26aufirst%3DA.%26atitle%3DFurther%2520insights%2520into%2520biological%2520evaluation%2520of%2520new%2520anti-Trypanosoma%2520cruzi%25205-nitroindazoles%26jtitle%3DParasitol.%2520Res.%26date%3D2014%26volume%3D113%26spage%3D1049%26epage%3D1056%26doi%3D10.1007%2Fs00436-013-3740-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca-Berzal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasconcelos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escario, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aran, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Barrio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soeiro, M.</span></span> <span> </span><span class="NLM_article-title">Exploring the potential activity spectrum of two 5-nitroindazolinone prototypes on different Trypanosoma cruzi strains</span>. <i>Parasitol. Open</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">e1</span>, <span class="refDoi"> DOI: 10.1017/pao.2015.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1017%2Fpao.2015.4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=e1&author=C.+Fonseca-Berzalauthor=P.+B.+Da+Silvaauthor=C.+F.+Da+Silvaauthor=M.+Vasconcelosauthor=M.+M.+Batistaauthor=J.+A.+Escarioauthor=V.+J.+Aranauthor=A.+Gomez-Barrioauthor=M.+Soeiro&title=Exploring+the+potential+activity+spectrum+of+two+5-nitroindazolinone+prototypes+on+different+Trypanosoma+cruzi+strains&doi=10.1017%2Fpao.2015.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1017%2Fpao.2015.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252Fpao.2015.4%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca-Berzal%26aufirst%3DC.%26aulast%3DDa%2BSilva%26aufirst%3DP.%2BB.%26aulast%3DDa%2BSilva%26aufirst%3DC.%2BF.%26aulast%3DVasconcelos%26aufirst%3DM.%26aulast%3DBatista%26aufirst%3DM.%2BM.%26aulast%3DEscario%26aufirst%3DJ.%2BA.%26aulast%3DAran%26aufirst%3DV.%2BJ.%26aulast%3DGomez-Barrio%26aufirst%3DA.%26aulast%3DSoeiro%26aufirst%3DM.%26atitle%3DExploring%2520the%2520potential%2520activity%2520spectrum%2520of%2520two%25205-nitroindazolinone%2520prototypes%2520on%2520different%2520Trypanosoma%2520cruzi%2520strains%26jtitle%3DParasitol.%2520Open%26date%3D2015%26volume%3D1%26spage%3De1%26doi%3D10.1017%2Fpao.2015.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reviriego, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marín, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramírez-Macías, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosales, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Moreno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arán, V. J.</span></span> <span> </span><span class="NLM_article-title">New perspectives on the synthesis and antichagasic activity of 3-alkoxy-1-alkyl-5-nitroindazoles</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.12.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;key=10.1016%2Fj.ejmech.2013.12.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=124-134&author=B.+Muroauthor=F.+Reviriegoauthor=P.+Navarroauthor=C.+Mar%C3%ADnauthor=I.+Ram%C3%ADrez-Mac%C3%ADasauthor=M.+J.+Rosalesauthor=M.+S%C3%A1nchez-Morenoauthor=V.+J.+Ar%C3%A1n&title=New+perspectives+on+the+synthesis+and+antichagasic+activity+of+3-alkoxy-1-alkyl-5-nitroindazoles&doi=10.1016%2Fj.ejmech.2013.12.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.12.025%26sid%3Dliteratum%253Aachs%26aulast%3DMuro%26aufirst%3DB.%26aulast%3DReviriego%26aufirst%3DF.%26aulast%3DNavarro%26aufirst%3DP.%26aulast%3DMar%25C3%25ADn%26aufirst%3DC.%26aulast%3DRam%25C3%25ADrez-Mac%25C3%25ADas%26aufirst%3DI.%26aulast%3DRosales%26aufirst%3DM.%2BJ.%26aulast%3DS%25C3%25A1nchez-Moreno%26aufirst%3DM.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26atitle%3DNew%2520perspectives%2520on%2520the%2520synthesis%2520and%2520antichagasic%2520activity%2520of%25203-alkoxy-1-alkyl-5-nitroindazoles%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D74%26spage%3D124%26epage%3D134%26doi%3D10.1016%2Fj.ejmech.2013.12.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i18"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00147">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_65734"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00147">10.1021/acs.jmedchem.8b00147</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Nitro containing drugs/agents and their clinical/preclinical update (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00147/suppl_file/jm8b00147_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00147/suppl_file/jm8b00147_si_001.pdf">jm8b00147_si_001.pdf (827.46 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00147&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00147%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00147" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                13MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67c775944e7f3c9a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
